<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" xml:lang="en"><front id="8fbc927f-0456-4cbc-86d7-32ab762b96ec"><journal-meta id="b33fe965-51cd-4711-ade2-9113ba4489e8"><journal-id journal-id-type="hwp" id="be68fb31-46d0-493b-b20d-2987acc146b2">bmjdrc</journal-id><journal-id journal-id-type="publisher-id" id="675008ab-a7a4-46cf-8faa-5506fb9e9efc">bmjdrc</journal-id><journal-title-group id="b97d4b3b-7139-49f0-9296-cb2ddc10d0c0"><journal-title id="7138fc64-1849-49b6-9233-cf4f9d8c2709">BMJ Open Diabetes Research &amp; Care</journal-title><abbrev-journal-title id="e9133130-899e-4634-bfa1-862504924224">BMJ Open Diab Res Care</abbrev-journal-title></journal-title-group><issn pub-type="ppub" id="8be10e1d-0e4a-4cc9-bb93-589c1ce4ff2d"/><issn pub-type="epub" id="bfa7787d-70af-4528-8c3e-55978c33d95b">2052-4897</issn><publisher id="52cfb8d0-6ebd-4ca9-bd97-225a7d0ee707"><publisher-name id="c83bdacb-c1a8-4976-8db7-8903674b65b2">BMJ Open Diabetes Research &amp; Care</publisher-name><publisher-loc id="b4f80c91-8101-4871-98bc-ebf72369c88d">BMA House, Tavistock Square, London, WC1H 9JR</publisher-loc></publisher></journal-meta><article-meta id="60067cb7-8fc4-4288-b970-04516f5ad00b"><article-id pub-id-type="publisher-id" id="ab14a780-4f65-458b-ab8a-df43b5108289">10.1136/bmjdrc-2018-000591</article-id><article-id pub-id-type="doi" id="7ccec0c6-4455-45ee-ad63-3620c4302254">bmjdrc-2018-000591</article-id><article-categories id="b81909d9-ee11-46db-9fd7-168a0b3576dd"><subj-group subj-group-type="display-channel" id="e3681a2e-ff2e-49f8-aebf-36e4c80a87c8"><subject id="26b7b2eb-11d2-4db5-9fe0-18e737af9781">Original research</subject></subj-group><subj-group subj-group-type="heading" section="front" node-xpath="article-categories" id="e28d1a0c-2e5f-46e2-8746-91193f47464f" data-edited-node="true"><subject>Clinical care/education/nutrition</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" id="e0f404ef-fe56-41aa-b08c-aec738dbe947"><subject id="73666403-5182-4038-a707-6c1e8ef7ebe9">1506</subject></subj-group></article-categories><title-group id="402de34a-ee17-4f84-b3c8-10bc37094a57"><article-title data-head-type="bold" id="49442e32-68d5-4e4c-bfd7-ef8d4b2d50c2"><named-content rid="1545113216126" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" content-type="jrnlQueryRef" specific-use="start" id="10120dab-e888-4f17-b5e6-ca982f01976e" data-answered="true"/>Immune checkpoint inhibitors: an emerging cause of insulin-dependent <named-content id="28da4253-3430-4eb3-a7a5-7c03d8acdf34" content-type="forceJustify" data-title="force justification used for typesetting"> </named-content>diabetes<named-content data-cid="1545121513" id="6fc61db4-4f41-4921-a925-626327b5134a" content-type="del cts-2" specific-use="1545121530474" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 1:55pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121530474">ICI induced diabetes</named-content></article-title></title-group><contrib-group section="front" node-xpath="article-meta" next-xpath="author-notes" data-group="author" id="e54480bf-9da7-4e07-89ce-8a58dea2ead6"><named-content rid="1545113216127" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" content-type="jrnlQueryRef" specific-use="start" id="b5a078a4-6fa9-423b-be03-8526398018cd" data-answered="true"/><contrib contrib-type="author" id="author-63814615" data-id="author-63814615"><name id="0e14dabe-a16a-4a78-bb8f-d3b15e322224"><surname id="4c003f83-900b-4edd-ae9a-64729bc86b5c">Kotwal</surname><given-names id="59e89c6c-dfbc-4210-8d75-9a0356459ad1">Anupam</given-names><prefix id="d9faf053-f465-4707-97db-5e8287c7e302">Dr</prefix><suffix id="c98f4a5b-422b-4fee-bc60-91207a114798"/></name><degrees id="56aa5f5d-1a73-4ecb-9d9b-3c71680194c1">MB</degrees><xref rid="aff1" ref-type="aff" id="6f73ff0c-9957-4d28-996b-598d94fc7c93">1</xref><email id="654242fe-9b4b-4800-a245-58cc63f786cb">kotwal.anupam@mayo.edu</email></contrib><contrib contrib-type="author" id="author-63814636" data-id="author-63814636"><name id="4bab0eb4-61bf-4151-866e-f5d312ff5590"><surname id="75bdc3f2-2199-45cd-aaaf-e552ab3af742">Haddox</surname><given-names id="a4cb130b-923b-4790-85f0-5a24491e222a">Candace</given-names><prefix id="e7e757f8-413b-4aaf-8bd4-fbe4635e612e">Dr</prefix><suffix id="723f604e-496f-47b5-b32f-57222721bb4f"/></name><degrees id="63151469-31a8-4b44-a14d-03a887644b05">MD</degrees><xref rid="aff2" ref-type="aff" id="28c5862a-61c0-4f5d-b7bf-9f01d114af34">2</xref><email id="d590654b-2b6c-416c-8f67-24343ac6361b">candace.haddox@duke.edu</email></contrib><contrib contrib-type="author" id="author-63814660" data-id="author-63814660"><name id="f1c90869-2489-4cb8-be25-8e13532b90b1"><surname id="83fe54e5-841b-429e-902d-e1e4afaf40fa">Block</surname><given-names id="03680764-e654-4d87-925c-befdb0bc6050">Matthew</given-names><prefix id="a3cbaa8e-4979-4e58-8f66-e19737bd8c3f">Dr</prefix><suffix id="0b08a70d-8b1d-4c1d-bbe4-e2f5c2632961"/></name><degrees id="7ff3bf92-7a4d-4343-98ef-e79e13d8bf24">MD</degrees><xref rid="aff3" ref-type="aff" id="2608c2c1-0b54-4c5d-9278-30d5a522b4c6">3</xref><email id="420306c0-00a9-4be0-9fc1-975e3a262510">block.matthew@mayo.edu</email></contrib><contrib corresp="yes" contrib-type="author" id="author-42028932" data-id="author-42028932" data-edited-node="true"><name id="c1f76c17-dd9b-4825-b9e1-b2337cd89020"><surname id="c03bbaf6-fd93-485d-990a-c714e842cd7a">Kudva</surname><given-names id="100755a7-3100-4f75-94c6-59ba6c72a065">Yogish C</given-names><prefix id="f392da7f-21e8-404a-b010-af1d4f6d3e75">Dr</prefix><suffix id="cee281c5-1d4f-4418-b122-d4cecbde02ad"/></name><degrees id="d1de7587-f911-436a-bd96-31e717f4b284">MD, FRCP</degrees><xref id="b018c814-750f-49df-8e02-3c2820e1f5fb" rid="aff1" ref-type="aff">1</xref><xref ref-type="corresp" rid="cor1" id="1572f159-e07c-4335-9ba5-867b5b809774"/><email id="6a5c7932-3535-4c51-bf96-3e3d4a198326">kudva.yogish@mayo.edu</email><contrib-id contrib-id-type="orcid" id="511cbf9a-d9fc-4056-bc5e-6b6d7331fee8">http://orcid.org/0000-0002-4500-8546</contrib-id></contrib><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff1" data-id="aff1" data-edited-node="true"><label id="3194cb3e-3ed8-45bd-a1d9-cd86c26be065">1</label><named-content content-type="dept" id="165327f9-0f56-48f9-93ec-ff43473f1a31">Division of Endocrinology</named-content>, <named-content content-type="institution" id="06eff8e9-7c63-4223-a691-2dd72a67e596">Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine</named-content>, <named-content content-type="city" id="5bdbf440-c4aa-4891-b913-39f1c663b9d4">Rochester</named-content>, <named-content content-type="state" id="59ba4f0e-c661-4c4d-8d18-d33b2dec7fa8">Minnesota</named-content>, <named-content content-type="country" id="6666bc18-8137-45ae-9399-382cd74262a0">USA</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff2" data-id="aff2" data-edited-node="true"><label id="f4d4baf3-b15b-4ea9-a45e-475bc941f9f3">2</label><named-content content-type="dept" id="a6f22610-8028-493a-9dcb-25e18033dbd1">Department of Internal Medicine</named-content>, <named-content content-type="institution" id="05f5416a-93f5-46e2-a0ae-73468b6f364d">Mayo Clinic College of Medicine</named-content>, <named-content content-type="city" id="bdc8bf26-6fe0-4e57-b310-99e8b7cc5a3d">Rochester</named-content>, <named-content content-type="state" id="4c40b95a-d367-4af1-961c-eff5e2345511">Minnesota</named-content>, <named-content content-type="country" id="f931491f-fa97-4cc7-b430-f6cf55e059fe">USA</named-content></aff><aff section="front" node-xpath="contrib-group" prev-xpath="contrib[last()]" id="aff3" data-id="aff3" data-edited-node="true"><label id="f6b95773-f5bf-4ee0-8e1f-2c73251f1aea">3</label><named-content content-type="dept" id="07cba15c-48b7-4fc9-8675-d3cf4f7265b0">Division of Medical Oncology</named-content>, <named-content content-type="institution" id="c8491885-9cf8-47ca-aef0-b46e0eea534c">Mayo Clinic College of Medicine</named-content>, <named-content content-type="city" id="c9c7fa61-6c16-48ad-8293-41086468a4a4">Rochester</named-content>, <named-content content-type="state" id="e59378d7-3325-437c-948b-e8dbcc1fb65b">Minnesota</named-content>, <named-content content-type="country" id="2403f794-8422-4386-a1d1-f46c10af4fc4">USA</named-content></aff></contrib-group><contrib-group content-type="section" id="d410c5fe-138c-42f7-9f42-7e41cec755a5"><contrib contrib-type="editor" id="author-35026035"><name id="f0d41b1e-184a-4128-b898-33bb03c574cf"><surname id="12dbb471-5c2a-4f8e-b931-00e6d09421ab">Umpierrez</surname><given-names id="dc0bf405-7aaa-498b-a3bf-6bad559db036">Guillermo</given-names><prefix id="93a7ba40-49b6-48e8-8cbd-7b9f15668b03">Professor</prefix><suffix id="f706631d-3272-440e-852a-ff81bad661cb"/></name><xref ref-type="aff" rid="ae-aff1" id="fc532cec-90dc-4921-909b-0871fe56cc50"/></contrib><contrib contrib-type="editor" id="author-35331928"><name id="97d99e01-e2ec-414e-b22c-c0cdd0e18ec2"><surname id="456e22d5-30b0-4ceb-9e0e-07492fe2370c">Radziuk</surname><given-names id="c03b02e0-6548-45dc-a028-db7a613ed815">JerryM</given-names><prefix id="11b62bf7-4c07-4ba8-95da-cdf78b895518">Dr</prefix><suffix id="e5ca5cb0-dd7f-45a9-922a-2b75dec636f8"/></name><xref ref-type="aff" rid="ae-aff2" id="cce28e02-0ebc-4868-bf38-c516da44f366"/><xref ref-type="aff" rid="ae-aff3" id="90e09229-c801-4d40-a706-b3b90ac1bbc9"/></contrib><aff id="ae-aff1" data-id="ae-aff1"><department id="e2bdc646-e1fa-4171-ab73-2831a44a5aea">Medicine</department>, <institution id="3c553dda-1dcc-4ef3-ab2c-66df29c4e4a3">Emory University</institution>, <city id="6273603d-d93f-4369-b926-92b3aa27007d">Atlanta</city>, <country id="4d603d26-937a-4dc4-9d3d-1e0fb51726f4">USA</country></aff><aff id="ae-aff2" data-id="ae-aff2"><department id="cb9570e3-62ff-4aaf-bc0b-5f87693dca15">Medicine</department>, <institution id="e5a79b2a-9f59-42e0-9bab-287ee580fb26">The Ottawa Hospital (Civic Campus)</institution>, <city id="ec97807f-66e6-4e39-9509-530eeaebdd7e">Ottawa</city>, <country id="9016e10c-de99-462d-a2d3-10d31547f962">Canada</country></aff><aff id="ae-aff3" data-id="ae-aff3"><department id="03aa632f-91ad-4538-9a5c-7603f7400f75"/>, <institution id="e75e6a7b-2a6b-4ad8-9899-16040873d246"/>, <city id="06c259b8-e28a-484b-bafa-b1a49fce5407">Ottawa</city>, <country id="d915e62e-00e3-48eb-bf4b-4c14771a12c1">Canada</country></aff></contrib-group><author-notes id="37c53713-1a63-4831-92cb-61556bec0641"><corresp section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" id="cor1" data-id="cor1"><name data-class="jrnlAuthor" id="0e2a4f7a-0f16-4675-8ef7-cf2615524c87"><prefix id="90d1c5fd-9c21-48bd-83da-962dc8122de4">Dr</prefix> <given-names id="40706dda-44f6-4d40-be99-659d62a2daba">Yogish C</given-names> <surname id="e64217ad-9a3a-4460-b944-b72e57fd807d">Kudva</surname></name>; <email id="fb3c2f22-4995-4a16-9cd5-e529084b504d">kudva.yogish@mayo.edu</email></corresp><fn fn-type="prepub" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Prepub" id="fn1" data-id="fn1" data-edited-node="true"><label id="c096cdcb-6541-4f86-af41-3ddd5a066195">prepub</label><p id="cc694144-86b2-4ee0-ba30-a94e3704b78a"/></fn><fn fn-type="con" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Contributors" id="fn2" data-id="fn2" data-edited-node="true"><label id="eabc17cf-68f7-4684-bc9e-01402da44142">Contributors</label><p id="e3619966-048b-424e-9eda-1ecc89e50eb0">AK researched the data, analyzed the data and wrote the manuscript; CH researched the data and wrote the manuscript, MB reviewed/edited the manuscript, YCK developed the research question, supervised all aspects of the project as principal investigator and reviewed/edited the manuscript.</p></fn><fn fn-type="conflict" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Competing interests" id="fn3" data-id="fn3" data-edited-node="true"><label id="31bc052b-b44f-486a-8506-f3dbe9a71ffe">Competing interests</label><p id="70d512a8-7526-4c69-9152-34165c85984c">None declared.</p></fn><fn fn-type="consent" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Patient consent for publication" id="fn4" data-id="fn4" data-edited-node="true"><label id="faa3a1e6-3572-4261-8f81-6029fed2dba2">Patient consent for publication</label><p id="2a74c413-042d-4f40-9d3d-d7ef1dfb3efb">Not required.</p></fn><fn fn-type="ethics" data-label="Ethics approval" id="fn5" data-id="fn5"><label id="2d237299-1e4c-4d9f-8314-ca8e218b4dfa">Ethics approval</label><p id="547e4c94-4eb2-415e-8ca8-19d9835bb58e">Mayo Clinic Institutional Review Board.</p></fn><fn fn-type="provenance-and-peer-review" data-label="Provenance and peer review" id="fn6" data-id="fn6"><label id="3a5c6046-4367-423b-8557-f3d48ba09ba1">Provenance and peer review</label><p id="74a32aa4-cdac-4cf6-b723-3b6db5f038cc">Not commissioned; externally peer reviewed.</p></fn><fn fn-type="supplement" data-label="Supplement" data-track="ins" data-cid="1545127047071" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545127047071" id="a414346c-65c8-49c9-9f6a-b0c969f172d4"><label id="e80f2a65-8d3d-429a-ac78-b320e1998462">Supplement</label><p id="bdd4c675-5a21-48e9-b5b9-6ead2edbc2ea">Additional material is published online only. To view please visit the journal online (http://dx.doi.org/10.1136/bmjdrc-2018-000591).</p></fn><fn fn-type="data-sharing-statement" data-label="Data statement" data-track="ins" data-cid="1545214775887" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545214775887" id="6e35f24a-d415-424b-87c4-b8ae2b947693"><label id="0f521e57-c99e-4ea2-b123-848df121205d">Data sharing statement</label><p id="af824a94-df6d-415e-ae4d-3fa3ff6361c3">No additional data are available.</p><p id="e82972d4-7d2e-43ea-b0c2-64b4551f91e1"/><div id="8e67345f-6eb2-4464-9840-dcbeeb8447cc"/><p id="d0cd90b8-b4c8-4092-877d-f9f69a6d6f2d"/></fn><fn fn-type="presented-at" section="front" node-xpath="author-notes" prev-xpath="contrib-group[last()]" data-label="Presented at" id="bf56f3e4-84dc-4d3f-a871-87d3b170ee91" data-track="ins" data-cid="1545216294864" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545216294864" data-edited-node="true"><label id="99f76793-4e42-4aca-a011-8979dd2a4928">Presented at</label><p id="0d2dc1c6-d642-4bb6-ac09-794f7d2ddf9a">The initial abstract of this manuscript was presented at Endocrine Society’s 100th Annual Meeting and Expo, Chicago, Illinois, in March 2018, and published in Endocrine Reviews 2018;39(2).</p></fn><fn fn-type="disclaimer" data-label="Disclaimer" data-track="ins" data-cid="1545441544433" data-username="PV-A027-Ariel (COPYEDITOR)" data-userid="copyeditor 3519816058" data-time="1545441544433" id="87406ca1-c45c-4b7f-b759-d61f0892b745"><label id="b6433c7f-5eb9-4080-85f0-71d9481c3d6a">Disclaimer</label><p id="cf2d1983-c6d2-491b-986f-d58ea3a04376">Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.</p></fn></author-notes><pub-date section="front" node-xpath="article-meta" node-prev-xpath="//author-notes" node-next-xpath="//history" pub-type="ppub" id="aa38d2f6-c3c7-4cc7-ad1a-376833dc7f8f"><day id="0f64b090-a6af-4ca7-9bbd-43b0e4d6bee8">13</day><month id="508ee736-8d48-4284-99a0-b9f3557c1d14">02</month><year id="1e916017-c23b-4b56-bfe9-d38b4efae44f">2019</year></pub-date><pub-date section="front" node-xpath="article-meta" node-prev-xpath="//author-notes" node-next-xpath="//history" pub-type="epub" id="bbae1e38-2d60-43ae-87da-de41b433a514"><day id="d6576352-4aa1-4974-8cbc-c9ae4c04111c">13</day><month id="9ae84b69-ea56-4a09-a850-4e4bd61674b4">02</month><year id="79adb163-004e-41e2-ae5a-2bce168f4676">2019</year></pub-date><volume section="front" node-xpath="article-meta" node-next-xpath="//history" id="38a9f622-164e-422e-a8ce-1bdbf21eafe8">7</volume><issue section="front" node-xpath="article-meta" node-next-xpath="//history" id="eed8cd05-5794-4b4a-886c-3e164c8e64d5">1</issue><elocation-id section="front" node-xpath="article-meta" node-next-xpath="//history" id="02208250-6c9d-4da8-a91e-4facba345d66">e000591</elocation-id><fpage>1</fpage><lpage>10</lpage><history id="2402629d-a2d0-4812-9010-8068d2112cba" data-edited-node="true"><date date-type="received" id="aedca927-07cc-43f5-bb18-878dc664186c"><day id="11a53734-2948-42ee-b858-2f986589df1f">01</day><month id="d27e2699-e15e-4c80-9cdf-c294f18d39b4">08</month><year id="ce229827-b0a7-46da-bb2d-71056f3d48e6">2018</year></date><date date-type="rev-recd" id="a981c8bc-770d-4613-b088-e1d384e40143"><day id="6cfc3cb4-526c-4eab-b120-ac041145b0f1">03</day><month id="e7f36a61-7924-4c61-9ae2-96c33349c768">10</month><year id="dadbf9ef-9372-448e-b756-8520de325c00">2018</year></date><date date-type="accepted" id="536bd0b5-ab1c-4a8e-a250-fdf33ad67f02"><day id="50a8dced-86f7-4b5a-bace-4cf9a7b6e1a1">08</day><month id="3265713b-0a8d-4dec-a6c6-41692a8f002f">11</month><year id="f8364636-78c6-4a20-9f26-d356fd0c5b13">2018</year></date></history><permissions id="11d20080-4a80-4271-b8b3-e540f562627e" data-type="ccbync40" data-edited-node="true"><copyright-statement data-statement="new" id="567165f1-0d9e-43d8-80fc-f4de8783b00f">© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</copyright-statement><copyright-year id="fcd09eea-06aa-42a4-ac02-57d66b5298ad">2019</copyright-year><license xlink:href="http://creativecommons.org/licenses/by-nc/4.0/" license-type="open-access" id="7d4c59bf-ddca-43cc-801f-3cc537484700"><license-p id="a565fec7-f01d-4f05-8ed8-77a61a9ebe4c"><span data-class="xmlOnly" id="aebe4091-beec-45fb-9f00-fa9c34b8f3c4">This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: <ext-link data-class="jrnlExtLink" data-type="uri" data-href="http://creativecommons.org/licenses/by-nc/4.0" id="3086d730-d1be-4c8c-9575-a2a33563af45">http://creativecommons.org/licenses/by-nc/4.0</ext-link></span></license-p></license></permissions><files id="41eed947-bfec-4dd2-9614-98836d4eb3f4"><file file-type="Main Document" file_category="" file_name="bmjdrc-2018-000591-File001.docx" submission_medium="online" id="267e66a6-ce1a-4827-9ecf-08cf34cc349c"><file-format id="c80e81f3-4eb0-4f82-b11c-f69e7f0ec865">docx</file-format><file-extension id="b5534a97-b384-44c1-96dc-4ec9cdc81cb3">docx</file-extension><file-name id="7ee25aee-9032-4342-850b-12830df79ef6">ICI_induced_diabetes_manuscript-Version 3.docx</file-name><file-caption id="8315523b-6b40-44b5-91cb-ba1a3f1c274e"/><file_tag id="88f53cad-af39-41c9-91e6-da8457aa0bbe"/><attribute attr_name="File Designation" id="a162f630-0206-4cf6-be17-ee3f2da791f2">Main Document</attribute></file><file file-type="Colour Image" file_category="" file_name="bmjdrc-2018-000591-File002.jpg" submission_medium="online" id="15f8e7f3-ddb8-4e82-a05c-cda45b5e00f2"><file-format id="5859f11c-d46a-4506-860b-aaad383af789">jpg</file-format><file-extension id="ce2df555-d46b-48cb-be39-865f9811d3a2">jpg</file-extension><file-name id="90323134-f740-4d5d-bf62-638b037ee3cd">Figure 1.jpg</file-name><file-caption id="aaea314e-a94b-42ec-8ea4-555e82fb4409"/><file_tag id="1f3cada1-53bc-4bfd-9831-4e2c6cb33de8"/><attribute attr_name="File Designation" id="9d13a815-e83e-482a-808e-56068de190f0">Colour Image</attribute></file><file file-type="Supplementary File" file_category="" file_name="bmjdrc-2018-000591-File003.docx" submission_medium="online" id="f5bd8378-7301-4efe-bc55-bca27f3873fc"><file-format id="1a326caf-75b2-42d8-98b7-7f408e3b48de">docx</file-format><file-extension id="3ab159bc-66e3-453c-bd24-56bb80a14eb0">docx</file-extension><file-name id="3e0f316e-b7db-45e2-9c98-fdf9ebccf114">Supplemental Table S1.docx</file-name><file-caption id="1290de48-5432-42ad-924b-aed2a6dce202"/><file_tag id="d810f88f-4abd-452f-a952-acbd0a3cccd9"/><attribute attr_name="File Designation" id="a7ebfbfe-a5e3-4a97-ae1c-b5cf7d610ff3">Supplementary File</attribute></file></files><abstract id="bfd7cc03-4361-46b2-ba55-ee51b0c76e89"><title data-level="1" id="5a44d974-5b40-4781-b0cc-ce05037d1022">Abstract</title><title data-level="2" id="e813a5f9-edc2-4eae-a0d9-41fde7b31292">Objective<named-content data-cid="1545113216000" id="97ac5812-0eb2-44b4-84b4-17be462b93f2" content-type="del cts-1" specific-use="1545113216000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216000">:</named-content></title><p id="ce44591f-aa13-4244-9ec4-5eba37c2a295">Insulin-dependent diabetes can occur with immune checkpoint inhibitor (<named-content id="cfcdf2b1-aaca-4c27-9374-241d24109744" data-cid="cfcdf2b1-aaca-4c27-9374-241d24109744" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="71" data-match=" (ICI)" data-pattern="" data-tag-index="1_1" data-time="" data-username="" data-userid="">ICI</named-content>) therapy. We aimed to characterize the frequency, natural history and potential predictors of ICI<named-content data-cid="1545433146" content-type="del cts-3" specific-use="1545433250875" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:00am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433250875" id="456bf51d-3924-4798-8acb-112fce8fbff7"> </named-content><named-content data-cid="1545433147" content-type="ins cts-3" specific-use="1545433251147" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:00am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433251147" id="82122cb7-a0c2-49b9-a1fe-b2c4d88b662f">-</named-content>induced diabetes.</p><title data-level="2" id="c626aa8d-3954-422e-8ac9-f1fb9c5f53e3">Research <named-content data-cid="1545113216000_s" id="dc865175-3a78-4286-8c86-fc403da58416" content-type="del" specific-use="1545113216000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-type="s-case" data-userid="preediting" data-username="Exeter" data-time="1545113216000">Design</named-content><named-content data-cid="1545113216000_s" id="fd1db9f6-b908-4347-9dea-fdd05bff6e04" content-type="ins" specific-use="1545113216000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-type="s-case" data-userid="preediting" data-username="Exeter" data-time="1545113216000">design</named-content> and <named-content data-cid="1545113216001_s" id="aa5a6e63-3920-473b-92a1-fcbf2ea3508f" content-type="del" specific-use="1545113216001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-type="s-case" data-userid="preediting" data-username="Exeter" data-time="1545113216001">Methods</named-content><named-content data-cid="1545113216001_s" id="5df94ffe-fabd-482f-a224-625f4f060fd4" content-type="ins" specific-use="1545113216001" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-type="s-case" data-userid="preediting" data-username="Exeter" data-time="1545113216001">methods</named-content><named-content data-cid="1545121520" id="06f7d102-ed4d-44d3-9a61-e39087970b99" content-type="del cts-2" specific-use="1545121835405" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121835405"> </named-content><named-content data-cid="1545113216001" id="9815a1f6-7863-4945-8306-7be4f8ace141" content-type="del cts-1" specific-use="1545113216000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216000">:</named-content></title><p id="b690547d-f419-4a3d-8a79-4f6a37944cc4">We reviewed <named-content id="6e23ae02-5a3a-4c17-8e4c-29d85573de9c" data-cid="6e23ae02-5a3a-4c17-8e4c-29d85573de9c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="12" data-match="1444" data-replace="1444" data-pattern="1444" data-tag-index="2_2" data-time="" data-username="" data-userid="">1444</named-content> <named-content id="f2380ac7-7f8e-4563-810b-be6e349803e1" data-cid="f2380ac7-7f8e-4563-810b-be6e349803e1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="17" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="2_6" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> treated with ICIs over <named-content id="c3c37fb9-3791-4ba5-bcdb-bea3b05f882a" data-cid="c3c37fb9-3791-4ba5-bcdb-bea3b05f882a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="49" data-match="6 years" data-replace="6" data-pattern="$1" data-tag-index="2_1" data-time="" data-username="" data-userid="">6</named-content> <named-content id="a82bb241-869f-4ec4-9f16-c907f1fba4c4" data-cid="a82bb241-869f-4ec4-9f16-c907f1fba4c4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="50" data-match="6 years" data-replace=" years" data-pattern=" $2" data-tag-index="2_1" data-time="" data-username="" data-userid="">years</named-content> at our cancer <named-content id="800b48c0-6849-4950-b8ee-b3d3d538c9e3" data-cid="800b48c0-6849-4950-b8ee-b3d3d538c9e3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'center' to 'center'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="71" data-match="center" data-replace="center" data-pattern="$1" data-tag-index="2_7" data-function="addTrackChanges" data-time="" data-username="" data-userid="">center</named-content>, and from the <named-content id="3cee7a15-ca0f-4297-8d1b-731d1a47a133" data-cid="3cee7a15-ca0f-4297-8d1b-731d1a47a133" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="92" data-match="1163" data-replace="1163" data-pattern="1163" data-tag-index="2_3" data-time="" data-username="" data-userid="">1163</named-content> <named-content id="05699a6e-51ce-4396-83dc-bfcd69d913d0" data-cid="05699a6e-51ce-4396-83dc-bfcd69d913d0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="97" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="2_8" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> who received <named-content data-cid="1545433155" content-type="ins cts-3" specific-use="1545433306827" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:01am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433306827" id="f52b81dd-ee12-4840-a388-8d23b5c1887d">programmed cell death protein 1 (</named-content>PD-1<named-content data-cid="1545433160" content-type="ins cts-3" specific-use="1545433318602" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:01am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433318602" id="1bdcd91f-f1e0-45ea-9ab5-7874952d6533">)</named-content> inhibitors<named-content data-cid="1545433148" content-type="ins cts-3" specific-use="1545433267631" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:01am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433267631" id="74cc13ee-5feb-40cf-a250-08719d67f9cd">,</named-content> we identified 21 such cases, 12 of which developed new-onset insulin<named-content data-cid="1545433149" content-type="del cts-3" specific-use="1545433273473" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:01am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433273473" id="f5d723b8-b6d7-4a05-a295-8536b63afdcf"> </named-content><named-content data-cid="1545433150" content-type="ins cts-3" specific-use="1545433273746" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:01am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433273746" id="8aeecbc0-8994-4173-b2d4-2d9aeea3547a">-</named-content>dependent diabetes and <named-content data-cid="1545113216004" id="1e9b8c70-cbd7-46a7-b077-b86601150204" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">9</named-content><named-content data-cid="1545113216004" id="54429d71-b41f-4639-8fe7-8632f5fb9ad3" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '9' to 'nine'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="227" data-match="9" data-pattern="" data-tag-index="2_4" data-function="numberToText,addTrackChanges" data-track-change="9" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433151" content-type="del cts-3" specific-use="1545433278811" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:01am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433278811" id="f00c0063-ae03-49e3-97a9-76fa714516ca">nine</named-content></named-content><named-content data-cid="1545433152" content-type="ins cts-3" specific-use="1545433278901" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:01am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433278901" id="2aa27e2d-d68c-4541-9242-18b42be1b621">9</named-content> experienced worsening of pre-existing type <named-content data-cid="1545113216005" id="499bb31e-7454-49ea-9681-e263445f9943" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content data-cid="1545113216005" id="c4470db2-4d83-460a-a6e8-1597eadd79a0" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="272" data-match="2" data-pattern="" data-tag-index="2_5" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433153" content-type="del cts-3" specific-use="1545433281775" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:01am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433281775" id="f69244e8-a51a-4444-9f1f-e2a963c15166">two</named-content></named-content><named-content data-cid="1545433154" content-type="ins cts-3" specific-use="1545433281879" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:01am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433281879" id="8835b6e2-266c-4d4d-bd86-b0421b3547df">2</named-content> diabetes.</p><title data-level="2" id="71097f86-0f82-4383-89ad-f95830a5c409">Results<named-content data-cid="1545113216002" id="17fed577-63b7-4574-85b6-4ecd11611572" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">:</named-content></title><p id="87e41e06-e03d-4afe-8096-b4df4f771cc3">ICI<named-content data-cid="1545433161" id="56408027-8507-45ff-ac81-6a5c0b1e9ee1" content-type="del cts-3" specific-use="1545433324649" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433324649"> </named-content><named-content data-cid="1545433162" id="73a0eb0a-2c28-4c11-88c9-c3c11bbeb3dc" content-type="ins cts-3" specific-use="1545433324951" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433324951">-</named-content>induced diabetes occurred most frequently with pembrolizumab (2.2%) <named-content data-cid="1545113216094" id="8ef94f81-a167-4408-91e6-f3cfc382aee0" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared to</named-content><named-content data-cid="1545113216094" id="927cef61-2ce6-4064-8c2f-960af924aeb5" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="72" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="3_9" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared with</named-content> nivolumab (1%) and ipilimumab (0<named-content data-cid="1545433163" id="f5ef7eca-4b18-4a15-9cfa-76e34895a694" content-type="ins cts-3" specific-use="1545433333489" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433333489">%</named-content>). The median age was <named-content id="f212e57e-02b2-4620-ba3e-ca6b8dd23432" data-cid="f212e57e-02b2-4620-ba3e-ca6b8dd23432" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="138" data-match="61 years" data-replace="61" data-pattern="$1" data-tag-index="3_2" data-time="" data-username="" data-userid="">61</named-content> <named-content id="93e28da2-7361-4d8a-88bd-11604c538798" data-cid="93e28da2-7361-4d8a-88bd-11604c538798" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="140" data-match="61 years" data-replace=" years" data-pattern=" $2" data-tag-index="3_2" data-time="" data-username="" data-userid="">years<named-content data-cid="1545433164" id="b67e0f73-055e-47c5-845b-a8dcf2516e08" content-type="ins cts-3" specific-use="1545433339302" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433339302">,</named-content></named-content> and <named-content data-cid="1545433165" id="0bffd44d-fef1-4c67-a300-f346e4d89024" content-type="ins cts-3" specific-use="1545433347191" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433347191">body mass index</named-content><named-content data-cid="1545433180" id="dd0c7fbc-1838-472a-a6ff-b8b58ebffb11" content-type="del cts-3" specific-use="1545433350932" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433350932">BMI</named-content> was <named-content id="7afec2fc-b547-4d40-b157-8b1cb1406d19" data-cid="7afec2fc-b547-4d40-b157-8b1cb1406d19" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="159" data-match="31 kg/m2" data-replace="31" data-pattern="$1" data-tag-index="3_3" data-time="" data-username="" data-userid="">31</named-content> <named-content id="55feded1-9de5-45da-be89-96d721e99b97" data-cid="55feded1-9de5-45da-be89-96d721e99b97" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣kg/m&lt;sup␣id=&quot;81456d50-ad9c-4822-af83-52842901e207&quot;&gt;2&lt;/sup&gt;' to ' kg/m2'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="161" data-match="31 kg/m2" data-replace=" kg/m2" data-pattern=" $2" data-tag-index="3_3" data-track-change=" kg/m&lt;sup id=&quot;81456d50-ad9c-4822-af83-52842901e207&quot;&gt;2&lt;/sup&gt;" data-time="" data-username="" data-userid="">kg/m<sup id="b3585845-f22e-4648-ad31-d7c6bd3d5fcb">2</sup><named-content data-cid="1549534620" id="ee1c2688-dfa1-4717-bd51-103124c55092" content-type="del cts-4" specific-use="1549534665825" xlink:title="Asha (TYPESETTER)" alt="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-title="Deleted by Asha (TYPESETTER) - Feb 7 2019 3:47pm" data-track-detail="" data-userid="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-username="Asha (TYPESETTER)" data-time="1549534665825"> </named-content></named-content>, which are both higher than expected for spontaneous type <named-content data-cid="1545113216006" id="dfe74aef-45dd-455f-b32e-3f3ba0667793" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content data-cid="1545113216006" id="48460c3d-0039-4cf5-9532-9933f5521715" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="226" data-match="1" data-pattern="" data-tag-index="3_8" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433181" id="4da14906-e9b9-4d75-a5ee-4082a953cf61" content-type="del cts-3" specific-use="1545433356309" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433356309">one</named-content></named-content><named-content data-cid="1545433182" id="ac248f92-cbbc-47ea-a56e-2114b265c51b" content-type="ins cts-3" specific-use="1545433356397" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433356397">1</named-content> diabetes. Other immune<named-content data-cid="1545433183" id="bde3beb8-1487-4495-add6-a30b95ca00dc" content-type="del cts-3" specific-use="1545433359114" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433359114"> </named-content><named-content data-cid="1545433184" id="dc5dd163-0824-4c07-86f7-4c4be8663856" content-type="ins cts-3" specific-use="1545433359378" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433359378">-</named-content>related adverse events occurred in 62%, the most common being immune mediated thyroid disease. New-onset insulin-dependent diabetes developed after a median of <named-content data-cid="1545433185" id="435480b4-3558-41db-89ff-27430b083cf1" content-type="del cts-3" specific-use="1545433371139" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433371139">4</named-content><named-content data-cid="1545433186" id="44e769c1-8e86-4a5e-b23b-aba6275d93f2" content-type="ins cts-3" specific-use="1545433371367" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433371367">four</named-content> cycles or <named-content id="c67de777-f096-45e9-8ecf-8ba4650bb734" data-cid="c67de777-f096-45e9-8ecf-8ba4650bb734" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="423" data-match="5 months" data-replace="5" data-pattern="$1" data-tag-index="3_4" data-time="" data-username="" data-userid="">5</named-content> <named-content id="debe46c1-3e8c-43bb-8124-f3225bf05801" data-cid="debe46c1-3e8c-43bb-8124-f3225bf05801" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="424" data-match="5 months" data-replace=" months" data-pattern=" $2" data-tag-index="3_4" data-time="" data-username="" data-userid="">months</named-content>; <named-content id="07aed140-9d92-4f32-bcac-a8eebfbc7f87" data-cid="07aed140-9d92-4f32-bcac-a8eebfbc7f87" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="433" data-match="67%" data-replace="67" data-pattern="$1" data-tag-index="3_5" data-time="" data-username="" data-userid="">67</named-content><named-content data-cid="1545433190" id="5e66a749-64fe-48b2-9c8d-848d61463648" content-type="del cts-3" specific-use="1545433374849" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433374849"> </named-content><named-content id="148143a2-6ad2-47a2-8dbf-107d1ac26b12" data-cid="148143a2-6ad2-47a2-8dbf-107d1ac26b12" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="435" data-match="67%" data-replace="%" data-pattern="%" data-tag-index="3_5" data-time="" data-username="" data-userid="">%</named-content> presented with diabetic ketoacidosis and <named-content id="3f086ba3-a3b0-4aae-b8bc-a857282fa822" data-cid="3f086ba3-a3b0-4aae-b8bc-a857282fa822" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="478" data-match="83%" data-replace="83" data-pattern="$1" data-tag-index="3_6" data-time="" data-username="" data-userid="">83</named-content><named-content data-cid="1545433191" id="6c34c461-e30c-447b-a8bd-75f2c747414a" content-type="del cts-3" specific-use="1545433378684" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:02am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433378684"> </named-content><named-content id="6ba42f8e-91b0-44b9-b2ac-ff998a76a2fc" data-cid="6ba42f8e-91b0-44b9-b2ac-ff998a76a2fc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="480" data-match="83%" data-replace="%" data-pattern="%" data-tag-index="3_6" data-time="" data-username="" data-userid="">%</named-content> with low or undetectable C-peptide. Autoantibodies were elevated in <named-content id="a3a5b3fe-0893-4757-997c-0f9b58e1704b" data-cid="a3a5b3fe-0893-4757-997c-0f9b58e1704b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="550" data-match="5/7 (71%)" data-replace="5/7" data-pattern="$1" data-tag-index="3_1" data-time="" data-username="" data-userid="">5/7</named-content> <named-content id="5f38e4a0-bafd-4f04-8cf8-1bf6e93dbf53" data-cid="5f38e4a0-bafd-4f04-8cf8-1bf6e93dbf53" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="553" data-match="5/7 (71%)" data-replace=" (71%)" data-pattern=" $2" data-tag-index="3_1" data-time="" data-username="" data-userid="">(71%)</named-content> at the time of new-onset diabetes. Diabetes did not resolve during a median <named-content data-cid="1545113216095" id="82cfe3de-d44f-46fa-9887-4d8c148d8a57" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow up</named-content><named-content data-cid="1545113216095" id="3edb6de5-270e-4450-9daa-ceca8c795be4" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="636" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="3_10" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow-up</named-content> of <named-content id="49593588-df98-4570-a7a1-9fd829047c45" data-cid="49593588-df98-4570-a7a1-9fd829047c45" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="649" data-match="1 year" data-replace="1" data-pattern="$1" data-tag-index="3_7" data-time="" data-username="" data-userid="">1</named-content> <named-content id="6a8c5791-d1ef-4284-afae-cfba549fa737" data-cid="6a8c5791-d1ef-4284-afae-cfba549fa737" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣year' to ' year'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="650" data-match="1 year" data-replace=" year" data-pattern=" $2" data-tag-index="3_7" data-track-change=" year" data-time="" data-username="" data-userid="">year</named-content>.</p><title data-level="2" id="2a35c23c-d063-42a8-ba19-fe2bd8e6037f">Conclusions<named-content data-cid="1545113216003" id="b04be77a-d14e-4daf-87c7-093111a7ece0" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">:</named-content></title><p id="dbd90b6e-933a-44d6-8faf-2fe56e5a480a">PD-1 inhibitors can lead to insulin deficiency presenting as new-onset diabetes or worsening of pre-existing type <named-content data-cid="1545113216007" id="6ad3c102-d626-4f35-b31f-78fa305b14fd" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content data-cid="1545113216007" id="6f2fb085-1c33-4724-9d18-c9bb8d73ceb5" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="114" data-match="2" data-pattern="" data-tag-index="4_2" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433192" content-type="del cts-3" specific-use="1545433395614" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:03am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433395614" id="bf36d1e3-90f6-48a4-baa1-2169ce76a53b">two</named-content></named-content><named-content data-cid="1545433193" content-type="ins cts-3" specific-use="1545433395749" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:03am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433395749" id="7780022d-ebdd-43e3-9d00-7de8a47b7c52">2</named-content> diabetes, with a frequency of <named-content id="9db3c836-0e27-4c23-bc52-56261610ce0b" data-cid="9db3c836-0e27-4c23-bc52-56261610ce0b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="146" data-match="1.8%" data-replace="1.8" data-pattern="$1" data-tag-index="4_1" data-time="" data-username="" data-userid="">1.8</named-content> <named-content id="54f15b30-58e8-4426-a801-eeb10e01297d" data-cid="54f15b30-58e8-4426-a801-eeb10e01297d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="149" data-match="1.8%" data-replace="%" data-pattern="%" data-tag-index="4_1" data-time="" data-username="" data-userid="">%</named-content>. The underlying mechanism appears similar to spontaneous type <named-content data-cid="1545113216008" id="69a4e466-ce98-44d1-98bc-137a8d2c5c9e" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content data-cid="1545113216008" id="6bc8af6e-a212-45cd-9b0e-aba89e532018" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="213" data-match="1" data-pattern="" data-tag-index="4_3" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433194" content-type="del cts-3" specific-use="1545433401524" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:03am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433401524" id="ca1fd559-3d3e-4c2e-8afa-46af97f07dc1">one</named-content></named-content><named-content data-cid="1545433195" content-type="ins cts-3" specific-use="1545433401622" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:03am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433401622" id="0c413768-7bde-4b63-beb5-88f3d63ef31e">1</named-content> diabetes but there is a faster progression to severe insulin deficiency. Better characterization of ICI<named-content data-cid="1545433196" content-type="del cts-3" specific-use="1545433412508" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:03am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433412508" id="4263a5ab-301e-456a-9d23-534ca7259a54"> </named-content><named-content data-cid="1545433197" content-type="ins cts-3" specific-use="1545433412820" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:03am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433412820" id="f82b7078-64d3-4ae9-96c6-6f10b976caa2">-</named-content>induced diabetes will improve <named-content id="624344a5-69f3-424d-a25a-aa40c96fa348" data-cid="624344a5-69f3-424d-a25a-aa40c96fa348" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="349" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="4_4" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content> care and enhance our understanding of immune<named-content data-cid="1545433198" content-type="del cts-3" specific-use="1545433417270" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:03am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433417270" id="1933ae8b-f7a4-4f49-8802-dfb25b200eff"> </named-content><named-content data-cid="1545433199" content-type="ins cts-3" specific-use="1545433417522" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:03am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545433417522" id="9a12c9da-5ece-40a7-ab63-d79ca07f94a6">-</named-content>mediated diabetes.</p></abstract><kwd-group section="front" node-xpath="article-meta" next-xpath="funding-group" id="619c0255-beb3-4a4e-bb7a-f07360f39767"><kwd data-class="jrnlKeyword" id="5e2b076e-4271-475c-8c83-5a9776f3f737"><named-content data-cid="1545121514" content-type="changeCase sty cts-2" specific-use="1545121802710" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/18/2018 2:00pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121802710" id="0c3e5ed9-8a1a-4c96-a1d4-b6ea85660a39">immune pathogenesis typ<span data-class="hidden" hidden-track="track" id="c648e524-4a19-467b-844c-5a4c32441f86">Immune Pathogenesis Typ</span></named-content>e 1 <named-content data-cid="1545121515" content-type="changeCase sty cts-2" specific-use="1545121807618" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/18/2018 2:00pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121807618" id="1473c0f1-0b41-452a-a46b-936edee1154d">di<span data-class="hidden" hidden-track="track" id="c8466ac3-f6f9-4612-b47b-e34ea64a5bb8">Di</span></named-content>abetes</kwd><kwd data-class="jrnlKeyword" id="e883bfb2-cdc8-44a2-8c4b-d6202d2896a9"><named-content data-cid="1545121516" content-type="changeCase sty cts-2" specific-use="1545121813007" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/18/2018 2:00pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121813007" id="4672f4b4-6b73-44f4-b6a3-790490dca9ba">islet auto<span data-class="hidden" hidden-track="track" id="88a4b8d9-4fbf-43a3-b909-e7e8c2e264dd">Islet Auto</span></named-content>immunity</kwd><kwd data-class="jrnlKeyword" id="76c4ee9a-821a-45c2-890d-8f02ee55c859"><named-content data-cid="1545121517" content-type="changeCase sty cts-2" specific-use="1545121817891" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/18/2018 2:00pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121817891" id="a53f621f-b99d-481c-948b-17b51ee8052e">c<span data-class="hidden" hidden-track="track" id="fcf911e0-9348-48b3-8a1f-cd47fa7dbf42">C</span></named-content>ancer</kwd><kwd data-class="jrnlKeyword" id="893ab125-7e18-4aed-b79b-6be5743cb158"><named-content data-cid="1545121518" content-type="changeCase sty cts-2" specific-use="1545121823407" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/18/2018 2:00pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121823407" id="790fac51-4162-4368-99f9-9a702b645164">insulin defi<span data-class="hidden" hidden-track="track" id="085bb0f9-27db-4083-a82d-2c91bb0ec6d6">Insulin Defi</span></named-content>ciency</kwd><kwd data-class="jrnlKeyword" id="e58190ad-a727-4880-bacd-a02b645f2907"><named-content data-cid="1545121519" content-type="changeCase sty cts-2" specific-use="1545121828697" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/18/2018 2:00pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121828697" id="b37fb1f5-b1a1-4b73-a45a-f4794e01553d">adult dia<span data-class="hidden" hidden-track="track" id="a9797790-b474-4376-a9e2-642383c3cb3b">Adult Dia</span></named-content>betes</kwd></kwd-group><funding-group specific-use="FundRef" id="93871a0f-a143-4b88-bdd0-c095cbe37109"><award-group id="fund1" data-id="fund1"><funding-source id="8ea13562-dcf2-4ffb-8f07-074b0834dff1"><institution-wrap id="ec276e89-aa98-4749-9d3c-d37a7cca7022"><institution id="c977ff70-2b2d-4c7a-a1fb-fc32cd49e1fb">Landow gift through the Center for Immunology and Immune Therapies</institution></institution-wrap></funding-source></award-group><award-group id="fund2" data-id="fund2"><funding-source id="2b295f64-66ca-481b-89f1-b1298e5884b2"><institution-wrap id="7f066135-07a1-407e-a91a-239f8a594e69"><institution id="439a4765-b981-4a93-8fed-0939e6120f0d">CTSA Grant from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)</institution></institution-wrap></funding-source><award-id id="0d5ea94e-7e0b-4c57-b73b-d91acda4eaee">UL1 TR002377</award-id></award-group><funding-statement section="article-meta" node-xpath="funding-group" next-xpath="custom-meta-group" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'addDataTempSelector', 'param' : {'component' : 'jrnlFN'}}" data-ele-type="funding-statement" fn-type="funding" data-label="Funding" data-track="ins" data-cid="1545127873873" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545127873873" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:41pm" id="a36d3c5b-737b-4de9-a742-4d29e72070c0" data-edited-node="true">This work was supported by the Landow gift through the Center for Immunology and Immune Therapies, Mayo Foundation. This publication was made possible by CTSA Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH).</funding-statement></funding-group><custom-meta-group id="a763f8fd-0466-48f5-90fc-f9386cdafa9c"><custom-meta id="3ce90e98-c00c-4787-a8cb-bccb99d66e78"><meta-name id="56a593c4-455b-4e45-909f-2c61c895e27a">Copy editing requirement</meta-name><meta-value id="0585a24a-2b8b-454c-8f86-ee081510bb04">2</meta-value></custom-meta><custom-meta id="e4f021fc-7260-4c56-ac1b-33206f0caf06"><meta-name id="6aa27824-3465-463a-bae1-277879f4a56d">payment method</meta-name><meta-value holdtype="NoHold" id="b3fdcfc5-98fd-4c21-8c40-e60859843ec7">Rightslink</meta-value></custom-meta><custom-meta specific-use="hold" data-title="hold" data-type="processed" id="28d53bee-e528-4cdf-9313-135a16c502f3"><meta-name id="3754919a-22c6-4489-b618-587ac580d8e7">Pre-editing</meta-name><meta-value id="2eb7e655-84a7-4579-8546-641e5fad7504"><user-name id="57cce82b-cf83-4c33-a7c9-556525c2d4f5">Workflow</user-name><date-time id="14bae0da-e210-4b35-8e19-e52f186473a2">2018-11-16 20:35:28</date-time><reason id="d316d761-3cc5-4ad2-a682-1b40e5256c2f">Payment Method has hold start</reason></meta-value></custom-meta><custom-meta id="f6497d6d-159d-4c17-8e15-2b1d43969fbf"><meta-name id="94db1737-3d9a-4ac1-a4d0-e01ab3eac60f">payment received</meta-name><meta-value id="729a724d-dce6-4dc1-acc7-198e9d9b74b7">true</meta-value></custom-meta><custom-meta id="878a4d2b-ad9d-4536-9d6a-f6bca0ff0014"><meta-name id="9a613d1c-fe79-4a3f-8316-0614839fc27a">license type</meta-name><meta-value id="5330410f-e3b2-4d23-9518-67c4b7ef7146">CC-BY-NC</meta-value></custom-meta><custom-meta specific-use="query" id="1545113216126" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-answered="true"><meta-value id="f7b71449-025d-4c23-9ca3-cc78816c2afc"><named-content xlink:title="Exeter Pre-editing" specific-use="Dec 18 2018 (11:37)" content-type="Author" alt="preeditor" id="f99b4f51-fbd5-4a3e-b1e0-ec0e5816e9d6">Corrections at this stage should be limited to those that are essential. Extensive corrections will delay the time to publication and may also have to be approved by the Editor. Changes can not be made after the article has published online. Please acknowledge that you have read this message.</named-content><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 (10:23)" content-type="answered" alt="author" id="74d5cfbb-807c-4b46-9168-a842a115ac06">these are correct</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="1545113216127" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-answered="true"><meta-value id="93bd0c20-1776-4ae3-adf8-7f98bc65669c"><named-content xlink:title="Exeter Pre-editing" specific-use="Dec 18 2018 (11:37)" content-type="Author" alt="preeditor" id="59ab2860-d20a-424f-afb3-d55dab658d15">Please check all author names are spelt correctly, and that affiliations and correspondence details are accurate. Please confirm that these are correct.</named-content><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 (10:23)" content-type="answered" alt="author" id="b6c07bf8-4223-4617-a431-3cc35a8376cc">these are correct</named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="b8fa2414-249e-4527-bc85-1b8dd1adb4e1" xlink:title="e28d1a0c-2e5f-46e2-8746-91193f47464f" xlink:actuate="b72f2722-aadb-472b-8934-5065bf31eebf" xlink:role="typesetter" xlink:href="e28d1a0c-2e5f-46e2-8746-91193f47464f"><meta-value><named-content specific-use="historyContent" data-title="" id="3b1ed3fc-4818-45b7-b929-a1cc77f87fd0"><named-content specific-use="change-person" data-title="" id="30befd9d-302f-4ce3-9ba5-92d73d1e409f">Lakshmi</named-content> <named-content specific-use="" data-title="" id="6f0f9ca5-94b8-40a2-ae94-7511585264c1">changed</named-content> <named-content specific-use="oldVal" data-title="Clinical Care/Education/Nutrition" id="b00188af-cd45-4e8b-8d4c-2e6e592cc941">Clinical Care/Education/Nutrition</named-content> <named-content specific-use="" data-title="" id="76053b02-014b-483e-8ecb-baae8a5117a2">to</named-content> <named-content specific-use="newVal" data-title="Clinical care/education/nutrition" id="b3bb1d7c-ec91-4cc8-97dd-8d63eb497923">Clinical care/education/nutrition</named-content> <named-content specific-use="" data-title="" id="d78f2766-bd91-4ac8-85e3-c3daad3811ac"> on</named-content> <named-content specific-use="change-time" data-title="" id="e5d16a60-5bab-4715-91d3-6ed2da843e86">13 Feb 2019 4:32 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="6dcc37c2-b83e-4195-9853-193443756915" xlink:title="2402629d-a2d0-4812-9010-8068d2112cba" xlink:actuate="b72f2722-aadb-472b-8934-5065bf31eebf" xlink:role="typesetter" xlink:href="aa38d2f6-c3c7-4cc7-ad1a-376833dc7f8f"><meta-value><named-content specific-use="historyContent" data-title="" id="deeb7918-80fb-4256-879d-b4dc0f45db3f"><named-content specific-use="change-person" data-title="" id="4df5efae-7ef4-4d67-9b13-ec979d194fed">Lakshmi</named-content> <named-content specific-use="" data-title="" id="5af558c3-f2fe-4197-a58b-eff384bbb925">changed</named-content> <named-content specific-use="oldVal" data-title="" id="456e4153-6c40-45c7-9b96-d297c51a7068">08022019</named-content> <named-content specific-use="" data-title="" id="2404ddc0-f18d-4154-acdf-3f057edc9456">to</named-content> <named-content specific-use="newVal" data-title="" id="170e9e9b-0013-48ee-8bce-2d87b81c19c9">13022019</named-content> <named-content specific-use="" data-title="" id="34c96a56-7c20-48b9-8c87-30a95d73846e"> in ppub field on</named-content> <named-content specific-use="change-time" data-title="" id="01a5e3e4-77f8-4a5b-9140-8fb7ed3bdd73">13 Feb 2019 4:27 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="bf06b7d6-15b2-4bd9-a6bf-a731f3951dc2" xlink:title="2402629d-a2d0-4812-9010-8068d2112cba" xlink:actuate="b72f2722-aadb-472b-8934-5065bf31eebf" xlink:role="typesetter" xlink:href="bbae1e38-2d60-43ae-87da-de41b433a514"><meta-value><named-content specific-use="historyContent" data-title="" id="f8059c7d-c881-4a95-ba20-1899048aab40"><named-content specific-use="change-person" data-title="" id="69983a52-72c8-4bca-ab0f-ed40c09dbf58">Lakshmi</named-content> <named-content specific-use="" data-title="" id="2ac52156-1c0c-4bf9-bf0b-c1db32d4e464">changed</named-content> <named-content specific-use="oldVal" data-title="" id="13379a26-36fb-4820-be21-8e83eadeed1b">08022019</named-content> <named-content specific-use="" data-title="" id="3596b202-84d5-434c-a1c2-bca9e8e47b92">to</named-content> <named-content specific-use="newVal" data-title="" id="c53468fd-7c73-4479-bde0-d521fe7d0a92">13022019</named-content> <named-content specific-use="" data-title="" id="eec86ead-cce5-41c0-8b56-310cac127699"> in epub field on</named-content> <named-content specific-use="change-time" data-title="" id="84d1c70e-3fdf-4fdd-80aa-581a4e9fc7bf">13 Feb 2019 4:27 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="472b3e8d-09d1-40a6-a44a-55b0c97b47f0" xlink:title="2402629d-a2d0-4812-9010-8068d2112cba" xlink:actuate="4f2c2212-f7b3-45db-b01b-6b166bce354e" xlink:role="typesetter" xlink:href="aa38d2f6-c3c7-4cc7-ad1a-376833dc7f8f"><meta-value id="f04fe563-47c0-4840-8ec6-e4bc9f95f235"><named-content specific-use="historyContent" data-title="" id="d22497b0-7189-4f30-9a77-f8c291af750b"><named-content specific-use="change-person" data-title="" id="7114e2aa-341b-411d-8ad5-566d725e1572">Sri Ganesa Balaji</named-content> <named-content specific-use="" data-title="" id="3ad32101-c6af-4814-b81b-3c24be18cba2">inserted</named-content> <named-content specific-use="newVal" data-title="" id="e3bd451f-0fa2-46aa-aed6-102f058a360f">08022019</named-content> <named-content specific-use="" data-title="" id="d6d3a708-3c2e-4cde-a318-8aaac550169f"> in ppub field on</named-content> <named-content specific-use="change-time" data-title="" id="f97aedc5-8e53-46d0-bdee-323b0c739a3a">8 Feb 2019 11:08 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="ba3aa3fd-7730-4325-86ee-21945319048a" xlink:title="2402629d-a2d0-4812-9010-8068d2112cba" xlink:actuate="4f2c2212-f7b3-45db-b01b-6b166bce354e" xlink:role="typesetter" xlink:href="bbae1e38-2d60-43ae-87da-de41b433a514"><meta-value id="cabc5a06-1aac-4391-a7ab-90bad5890da9"><named-content specific-use="historyContent" data-title="" id="ff99041e-d4fe-40bf-9305-a8944a62012c"><named-content specific-use="change-person" data-title="" id="b5e48fe6-b0a5-4eb9-b751-1e71f4a806b7">Sri Ganesa Balaji</named-content> <named-content specific-use="" data-title="" id="fde2f409-7106-41e3-a243-3d43659c5a61">inserted</named-content> <named-content specific-use="newVal" data-title="" id="e6306d2b-044d-459d-baaf-80143889cd27">08022019</named-content> <named-content specific-use="" data-title="" id="01e50526-4043-40f6-89ae-5ff6d3b345e7"> in epub field on</named-content> <named-content specific-use="change-time" data-title="" id="dd6b2681-90ef-435f-a64c-c907933662d3">8 Feb 2019 11:08 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="4e49f1ef-1eb8-4e00-ac7c-b9cea9c73e3b" xlink:title="pubData" xlink:actuate="4f2c2212-f7b3-45db-b01b-6b166bce354e" xlink:role="typesetter" xlink:href="eed8cd05-5794-4b4a-886c-3e164c8e64d5"><meta-value id="8e940d2f-8e0e-4445-ad2e-18011d20de46"><named-content specific-use="historyContent" data-title="" id="1ac5ddfa-34b3-4cc2-845c-f20d1d67de73"><named-content specific-use="change-person" data-title="" id="0ea23e7a-822a-409d-ab0e-15ba27bb5f8b">Sri Ganesa Balaji</named-content> <named-content specific-use="" data-title="" id="e482539d-c233-4dbd-9ae8-ee6cf03d879b">inserted</named-content> <named-content specific-use="newVal" data-title="" id="f70dc140-036b-4e2e-94c5-b308253c63a3">1</named-content> <named-content specific-use="" data-title="" id="97373e19-a6de-42b1-878c-0655ffd9afe3"> in Issue field on</named-content> <named-content specific-use="change-time" data-title="" id="7e088e3b-1ebc-460f-b278-e795c592f0ad">8 Feb 2019 11:07 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="98b856d9-18eb-4b66-8bf9-f586c72a2eb0" xlink:title="pubData" xlink:actuate="4f2c2212-f7b3-45db-b01b-6b166bce354e" xlink:role="typesetter" xlink:href="38a9f622-164e-422e-a8ce-1bdbf21eafe8"><meta-value id="b15eba5a-2d33-4e89-9e3e-5e148a5d2044"><named-content specific-use="historyContent" data-title="" id="14e9b681-d42c-4564-8a83-b7a181e0886a"><named-content specific-use="change-person" data-title="" id="ef83a9f6-93f8-4063-9c98-c370cf4a5d8c">Sri Ganesa Balaji</named-content> <named-content specific-use="" data-title="" id="6c55d149-0e0f-437b-9c03-642d404b165a">inserted</named-content> <named-content specific-use="newVal" data-title="" id="2cef5020-ac22-465f-9111-823028f938c4">7</named-content> <named-content specific-use="" data-title="" id="b60e5787-3616-41b0-9ef8-4940bda77e69"> in Volume field on</named-content> <named-content specific-use="change-time" data-title="" id="e836a9a6-e643-4d00-9c64-ac2230661a97">8 Feb 2019 11:07 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="716d939d-79a3-492f-a106-6dcb77f9a093" xlink:title="11d20080-4a80-4271-b8b3-e540f562627e" xlink:actuate="80cc594c-2ef3-41db-94a0-d5f511bf3915" xlink:role="publisher" xlink:href="fcd09eea-06aa-42a4-ac02-57d66b5298ad"><meta-value id="268ce218-cf9a-46a5-ba7e-210257cfa599"><named-content specific-use="historyContent" data-title="" id="affceb11-cc51-4b2f-9858-3517c3e3c495"><named-content specific-use="change-person" data-title="" id="7e2c372d-4f97-4b5e-852c-ac8590590f45">Nabjyoti</named-content> <named-content specific-use="" data-title="" id="ae7bc535-c12c-4fdf-bab5-996259f229cd">changed</named-content> <named-content specific-use="oldVal" data-title="" id="d28a0e94-dd20-40d3-a751-5bd01b61fe5c">2018</named-content> <named-content specific-use="" data-title="" id="0b56329c-adf4-48c2-8981-2b85f45dd596">to</named-content> <named-content specific-use="newVal" data-title="" id="031ca550-fd11-4589-aefe-a7ad52770a22">2019</named-content> <named-content specific-use="" data-title="" id="ade06f43-c7b9-4aa7-88d5-7c2e58564b39"> on</named-content> <named-content specific-use="change-time" data-title="" id="669f58f4-ccad-4212-a42c-6dc950eaf1a7">2 Jan 2019 9:46 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="6f12f59b-6197-45b8-884f-3f012494f0dd" xlink:title="11d20080-4a80-4271-b8b3-e540f562627e" xlink:actuate="80cc594c-2ef3-41db-94a0-d5f511bf3915" xlink:role="publisher" xlink:href="11d20080-4a80-4271-b8b3-e540f562627e"><meta-value id="6b8bccef-b6b9-4c29-8985-20762ef441f7"><named-content specific-use="historyContent" data-title="" id="9801a2fa-cf74-4a25-b073-100c0cbbdfef"><named-content specific-use="change-person" data-title="" id="aa38f209-5d63-4ce1-beb8-af0968191354">Nabjyoti</named-content> <named-content specific-use="" data-title="" id="f486b9f4-dd1b-4e2e-8c10-858be7ae18ca">checked</named-content> <named-content specific-use="newVal" data-title="" id="1bee98d9-2d91-4521-b436-175dc60a8bfa">CC-BY-NC 4.0</named-content> <named-content specific-use="" data-title="" id="cdffda5b-9475-4615-9fc3-cc4cbaa8528a">on</named-content> <named-content specific-use="change-time" data-title="" id="143cd343-1aae-4139-9e3c-218161fc6a1d">2 Jan 2019 9:46 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="35bf8050-feca-46d5-97a5-635f14099bc7" xlink:title="a36d3c5b-737b-4de9-a742-4d29e72070c0" xlink:actuate="3519816058" xlink:role="copyeditor" xlink:href="a36d3c5b-737b-4de9-a742-4d29e72070c0"><meta-value id="051f207e-c123-4851-ac5b-910a25f3620d"><named-content specific-use="historyContent" data-title="" id="f3df2e69-9ccd-4e69-9040-0e1c20b8a41f"><named-content specific-use="change-person" data-title="" id="677d85f0-ad40-4a9a-ba1f-d684bffcc0b9">PV-A027-Ariel</named-content> <named-content specific-use="" data-title="" id="2a579101-808c-4cd1-a47e-00e4cddb2928">changed</named-content> <named-content specific-use="oldVal" data-title="This work was supported by the Landow gift through the Center for Immunology and Immune Therapies, Mayo Foundation. This publication was made possible by CTSA Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH." id="62d37aaa-6fb7-46d9-890b-141fb440702f">This work was supported by the Landow gift through the Center for Immunology and Immune Therapies, Mayo Foundation. This publication was made possible by CTSA Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.</named-content> <named-content specific-use="" data-title="" id="c890bc5f-2bc0-4287-b6ed-08eb72667994">to</named-content> <named-content specific-use="newVal" data-title="This work was supported by the Landow gift through the Center for Immunology and Immune Therapies, Mayo Foundation. This publication was made possible by CTSA Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH)." id="32061a4f-d937-4a63-92b3-ebbfefa828df">This work was supported by the Landow gift through the Center for Immunology and Immune Therapies, Mayo Foundation. This publication was made possible by CTSA Grant Number UL1 TR002377 from the National Center for Advancing Translational Sciences (NCATS), a component of the National Institutes of Health (NIH).</named-content> <named-content specific-use="" data-title="" id="808c862d-a7d4-47ac-83cc-30e9b5baf4ca"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="2cb0f473-2a3f-4a77-a41e-bad5812b4c7c">22 Dec 2018 9:18 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="2ff53952-40b6-4b52-9bc9-3b836227b1f5" xlink:title="bf56f3e4-84dc-4d3f-a871-87d3b170ee91" xlink:actuate="3519816058" xlink:role="copyeditor" xlink:href="bf56f3e4-84dc-4d3f-a871-87d3b170ee91"><meta-value id="793113b8-aa2f-4102-9b55-d47563e7c925"><named-content specific-use="historyContent" data-title="" id="97b118c9-b01b-43af-9008-0bc452e93c8b"><named-content specific-use="change-person" data-title="" id="cb1a03a7-861f-45e9-86d1-e108db4a3216">PV-A027-Ariel</named-content> <named-content specific-use="" data-title="" id="31d60b30-4391-4b4f-8434-006fe68ff9cc">changed</named-content> <named-content specific-use="oldVal" data-title="The initial abstract of this manuscript was presented at Endocrine Society’s 100th Annual Meeting and Expo, Chicago, IL in March 2018, and published in Endocrine Reviews. 2018;39(2)." id="d1d286cc-8d43-4c35-b3ed-f959e08f7af3">The initial abstract of this manuscript was presented at Endocrine Society’s 100th Annual Meeting and Expo, Chicago, IL in March 2018, and published in Endocrine Reviews. 2018;39(2).</named-content> <named-content specific-use="" data-title="" id="e37377e7-94aa-402d-8a9b-201c35753d5f">to</named-content> <named-content specific-use="newVal" data-title="The initial abstract of this manuscript was presented at Endocrine Society’s 100th Annual Meeting and Expo, Chicago, Illinois, in March 2018, and published in Endocrine Reviews 2018;39(2)." id="3c052e5c-d171-4c64-ad21-dd73c48ee8da">The initial abstract of this manuscript was presented at Endocrine Society’s 100th Annual Meeting and Expo, Chicago, Illinois, in March 2018, and published in Endocrine Reviews 2018;39(2).</named-content> <named-content specific-use="" data-title="" id="a4fb439f-8305-430c-8555-33320d68aee4"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="81002369-b324-44d8-b5f0-c8dad22844a3">22 Dec 2018 9:18 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="f5e17ebc-e77e-4569-b988-ceb97fbbe1db" xlink:title="aff1" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="06eff8e9-7c63-4223-a691-2dd72a67e596"><meta-value id="c2b0bd85-c75f-448b-a619-770a747abe64"><named-content specific-use="historyContent" data-title="" id="399f2f90-9de7-43f4-a343-fd27854131ad"><named-content specific-use="change-person" data-title="" id="0936abc6-34dd-48ab-9ad0-7e70b7c23544">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="ab16cc51-fb31-41ae-be4b-0c53dfcfb931">changed</named-content> <named-content specific-use="oldVal" data-title="Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine," id="c74acba1-4469-47d6-8bb2-6055c7a84d31">Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine,</named-content> <named-content specific-use="" data-title="" id="5a86c0fb-9dd5-4593-8ec6-c554d81643fe">to</named-content> <named-content specific-use="newVal" data-title="Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine" id="236837d4-a169-40ce-98d4-fad301a014a2">Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine</named-content> <named-content specific-use="" data-title="" id="db2e8361-9fec-48cd-86e8-5306166bce12"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="1a4023a2-2f79-49ba-a5b4-3729fd83d426">19 Dec 2018 4:11 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="60af9bbe-6a1e-48eb-94fa-fb5338f6bb06" xlink:title="fn3" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="fn3"><meta-value id="1e18224b-d69f-4c33-ba29-260b293c3c88"><named-content specific-use="historyContent" data-title="" id="e26b5617-779d-4cfc-a2f3-206b9da68195"><named-content specific-use="change-person" data-title="" id="9a138ae1-9ff1-4311-aef6-7c64a89bb6c7">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="c01feccf-48ad-47be-9fda-e654b00181aa">changed</named-content> <named-content specific-use="oldVal" data-title="" id="da05dd3f-a072-40eb-9ca2-6908392a8082">None declared</named-content> <named-content specific-use="" data-title="" id="1e6b7f4f-16fa-4237-9707-19b193813ac2">to</named-content> <named-content specific-use="newVal" data-title="" id="029d6648-0dcf-4bc2-a7ea-5f6c633d0b75">None declared.</named-content> <named-content specific-use="" data-title="" id="ab4d3600-cfd9-4251-8e2b-a89eaffa8f93"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="ac96a941-64f8-4b04-b6ca-edb824dbfdcc">19 Dec 2018 3:37 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="f5748ca3-a35b-4771-a870-c5304dd2bd62" xlink:title="fn4" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="fn4"><meta-value id="51707624-8358-4160-9581-e67928fb86ba"><named-content specific-use="historyContent" data-title="" id="2a48dfca-4bb5-4bd6-b151-e24e8322c179"><named-content specific-use="change-person" data-title="" id="bdc98293-496b-4619-9f0a-3a5749742647">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="efd29f5c-d322-4283-a8b4-98944c978750">changed</named-content> <named-content specific-use="oldVal" data-title="" id="25cf90c6-6033-4b0c-bd1f-9d69c5f91cc6">Not Required</named-content> <named-content specific-use="" data-title="" id="0ac77036-2723-4a3b-be8c-4f61ea98f258">to</named-content> <named-content specific-use="newVal" data-title="" id="4b9e3264-9024-44f6-b357-bb1eb9012977">Not required.</named-content> <named-content specific-use="" data-title="" id="e9a98891-cf72-4637-b033-b18c0a6f173d"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="2dc278b8-d2d2-405b-8f59-c754f37ea166">19 Dec 2018 3:37 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="e3f7a2f7-2aa0-406c-9d75-0357723526c4" xlink:title="fn2" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="fn2"><meta-value id="0f68e11b-4916-4b6a-b812-c62911f6c4f0"><named-content specific-use="historyContent" data-title="" id="970a5946-d0c2-4ca4-b9e7-bde8dcdfe5f1"><named-content specific-use="change-person" data-title="" id="f98b16b6-f685-435b-b212-a335bb6d7387">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="c467e232-33d2-4915-a022-f85a15e20a22">changed</named-content> <named-content specific-use="oldVal" data-title="A.K. researched the data, analyzed the data and wrote the manuscript; C.H. researched the data and wrote the manuscript, M.B. reviewed/edited the manuscript, Y.C.K. developed the research question, supervised all aspects of the project as principal investigator and reviewed/edited the manuscript." id="9691e670-7b9d-43fd-abf7-04a6330bb2c9">A.K. researched the data, analyzed the data and wrote the manuscript; C.H. researched the data and wrote the manuscript, M.B. reviewed/edited the manuscript, Y.C.K. developed the research question, supervised all aspects of the project as principal investigator and reviewed/edited the manuscript.</named-content> <named-content specific-use="" data-title="" id="591d27ca-c7d7-43cf-a4c3-80d12fa7d9d7">to</named-content> <named-content specific-use="newVal" data-title="AK researched the data, analyzed the data and wrote the manuscript; CH researched the data and wrote the manuscript, MB reviewed/edited the manuscript, YCK developed the research question, supervised all aspects of the project as principal investigator and reviewed/edited the manuscript." id="9f2d380c-38c9-47c8-9165-e8171770ce8b">AK researched the data, analyzed the data and wrote the manuscript; CH researched the data and wrote the manuscript, MB reviewed/edited the manuscript, YCK developed the research question, supervised all aspects of the project as principal investigator and reviewed/edited the manuscript.</named-content> <named-content specific-use="" data-title="" id="539aafd8-f077-43fa-982a-20919b1cf228"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="8c49daf0-abd9-4940-b0a9-6771bf898f9c">18 Dec 2018 3:39 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="1921c701-9d52-4a5f-b797-d0142e0461dd" xlink:title="fn1" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="fn1"><meta-value id="23dcf9fd-a725-4f3f-acbb-f128a3c2c167"><named-content specific-use="historyContent" data-title="" id="16ca1009-f82d-4f65-99ff-62bc8570e759"><named-content specific-use="change-person" data-title="" id="03bb7fce-2457-4fea-9556-edf083e89bb6">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="7b4ab41d-de5e-4e94-ac63-590b76abd6fe">deleted</named-content> <named-content specific-use="oldVal" data-title="Additional material is published online only. To view please visit the journal online (http://dx.doi.org/10.1136/bmjdrc-2018-000591)" id="a256bd00-05f8-4aa3-8403-54bbf54f8c34">Additional material is published online only. To view please visit the journal online (http://dx.doi.org/10.1136/bmjdrc-2018-000591)</named-content> <named-content specific-use="" data-title="" id="d56539a2-9d80-4da1-8485-27743454d15c"> in Content field on</named-content> <named-content specific-use="change-time" data-title="" id="0808bbaf-7fe6-499b-b535-9556a8a46a1c">18 Dec 2018 3:27 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="2dd4f571-8c77-4a0b-8786-b0168bc1837c" xlink:title="BLK_F1" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="dd2d68f1-67b1-4cc1-b83d-031a28a49027"><meta-value id="e85aad6a-4d48-4669-bbd4-69ec9805798f"><named-content specific-use="historyContent" data-title="" id="3c204b5c-a347-4b11-8404-6aab99c35613"><p id="c188d543-2cf3-41f2-8c25-f037a06ecf75"><named-content specific-use="change-person" data-title="" id="ddb2f24d-b8fa-4daf-a9b7-6aa9a4ccbe51">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="2459c3d4-d7c5-4ec2-a171-9562cb6a64c4">changed image on</named-content> <named-content specific-use="change-time" data-title="" id="7d570d52-6f21-4112-89aa-2d9fa997bafd">18 Dec 2018 2:18 PM</named-content></p><p data-class="imageContainer" id="8dc2dace-145c-45ee-814f-4ea918628896"><a href="/resources/bmj/bmjdrc/bmjdrc-2018-000591/resources/Figure 1.jpg.JPEG" data-title="Click to view the image" target="_blank" id="b0b8808b-46b4-4412-a9b5-6879e58e7bc7"><graphic xlink:href="/resources/bmj/bmjdrc/bmjdrc-2018-000591/resources/Figure 1.jpg.JPEG" id="ef91999f-63b0-4f6d-8536-1e6e14061c9c"/></a> <named-content specific-use="material-icons" data-title="" id="6648916b-59dd-4050-a656-dde5b56e2aef">arrow_forward</named-content> <a href="/resources/bmj/bmjdrc/bmjdrc-2018-000591/resources/88323657-0117-4da6-9455-e9cd460e267e.tif.JPEG" data-title="Click to view the image" target="_blank" id="f7bc8fc2-2807-4059-a31d-91867511fef9"><graphic xlink:href="/resources/bmj/bmjdrc/bmjdrc-2018-000591/resources/88323657-0117-4da6-9455-e9cd460e267e.tif.JPEG" id="a53707a6-27e1-46c0-8efa-792955e73848"/></a></p><p data-class="hisComment" id="3ffad4cd-0e71-4810-827d-4ba90ea56a80">tiff</p></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="dddbbfc6-54bd-4236-ab00-0904e7bdf736" xlink:title="dd2540c1-23f2-4050-bbbb-028bc45f9187" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="438674b9-0f46-4bbc-bb61-1300776d19d3"><meta-value id="e5e27101-441b-40ef-a6b7-ad4948a0aeff"><named-content specific-use="historyContent" data-title="" id="b8bd24d4-848a-4d44-81a4-d875bec72b01"><named-content specific-use="change-person" data-title="" id="984acc66-8371-4d17-b9cf-ddbb65c16edf">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="fc7e95f6-8b8c-4382-96ae-30a6f8d987d6">inserted</named-content> <named-content specific-use="newVal" data-title="Significance of the studyWhat is already known about this subject?Diabetes mellitus has been rarely reported in clinical trials of immune checkpoint inhibitors (ICIs) for cancer therapy. What are the new findings?We found that ICIs that include PD-1 inhibitors can induce insulin-dependent diabetes, which occurs most frequently with pembrolizumab, can present with diabetic ketoacidosis and does not appear to undergo remission. How might these results change the focus of research or clinical practice?These results highlight the importance of monitoring blood glucose and HbA1c prior to initiating ICIs as well as during follow-up, having a heightened suspicion for the occurrence of diabetes and developing better risk prediction." id="7b1bfcae-b55a-403b-851e-13876fc2ba95">Significance of the studyWhat is already known about this subject?Diabetes mellitus has been rarely reported in clinical trials of immune checkpoint inhibitors (ICIs) for cancer therapy. What are the new findings?We found that ICIs that include PD-1 inhibitors can induce insulin-dependent diabetes, which occurs most frequently with pembrolizumab, can present with diabetic ketoacidosis and does not appear to undergo remission. How might these results change the focus of research or clinical practice?These results highlight the importance of monitoring blood glucose and HbA1c prior to initiating ICIs as well as during follow-up, having a heightened suspicion for the occurrence of diabetes and developing better risk prediction.</named-content> <named-content specific-use="" data-title="" id="5a929490-f4fb-49dc-980d-7141217dc303"> in Box text field on</named-content> <named-content specific-use="change-time" data-title="" id="2c24102d-25be-4239-ae79-fcfab479c948">18 Dec 2018 2:04 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="a40b5961-7155-4717-b7b9-00ec2f63e1e9" xlink:title="aff3" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="2403f794-8422-4386-a1d1-f46c10af4fc4"><meta-value id="5b6d373b-75a5-4ca2-b861-8965466f264a"><named-content specific-use="historyContent" data-title="" id="12c8eea3-1e7c-405c-9bca-433b365033e6"><named-content specific-use="change-person" data-title="" id="55aa1dcb-3ac6-4101-aac0-3a888403da9e">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="5616b33d-09c3-4948-a25d-8743b30934e9">inserted</named-content> <named-content specific-use="newVal" data-title="" id="2e88377c-e8d2-40f3-b8e8-201a4bc0cfc9">USA</named-content> <named-content specific-use="" data-title="" id="2fa4d3a5-4387-4520-b1e1-a2484bc752e6"> in Country field on</named-content> <named-content specific-use="change-time" data-title="" id="2d95aa77-c3f3-445e-b57d-2351309aff38">18 Dec 2018 1:59 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="8bf8d54e-84d7-44df-9777-524ec2392cb9" xlink:title="aff3" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="e59378d7-3325-437c-948b-e8dbcc1fb65b"><meta-value id="35f43aef-5e94-4468-941c-01a67103d1e9"><named-content specific-use="historyContent" data-title="" id="b10b0142-1d01-41b0-85c2-6fccba13b76e"><named-content specific-use="change-person" data-title="" id="d650a2c3-dc3b-45b4-9c80-56c1970f9345">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="75ce4e7d-c9cd-4dce-b3d5-febd27f8d62e">inserted</named-content> <named-content specific-use="newVal" data-title="" id="cf2bb196-6e5d-42d7-ad45-f54808240c52">Minnesota</named-content> <named-content specific-use="" data-title="" id="db362762-aa21-402b-8921-0b568fb34b3c"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="0cee3bb8-cdb2-42cd-b6a4-057d1a277a7e">18 Dec 2018 1:59 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="da96444e-74e5-45be-8d43-c197299cb576" xlink:title="aff3" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="c9c7fa61-6c16-48ad-8293-41086468a4a4"><meta-value id="85025fbc-5f41-45ec-ba6a-061d4e951ac3"><named-content specific-use="historyContent" data-title="" id="6896b262-354b-4f45-b5d6-11ec1ecdc4c3"><named-content specific-use="change-person" data-title="" id="0534fb28-6872-49bf-9ed5-8bc5343733b9">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="f63d6165-47c2-4fd7-ab00-6436f1e6624d">inserted</named-content> <named-content specific-use="newVal" data-title="" id="2040ff60-0ab4-46a2-a452-d3e8e51f44cf">Rochester</named-content> <named-content specific-use="" data-title="" id="f8e6f7c6-a208-4ca9-b848-90b117914502"> in City field on</named-content> <named-content specific-use="change-time" data-title="" id="c04798cb-1374-4187-9495-21757842977d">18 Dec 2018 1:59 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="57665016-5181-466b-9e30-948d4be24f70" xlink:title="aff3" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="c8491885-9cf8-47ca-aef0-b46e0eea534c"><meta-value id="07ef2801-1f5b-42e8-b492-4e4cdb339be4"><named-content specific-use="historyContent" data-title="" id="e8ef7d9e-281c-4f57-87c8-eba611330b0e"><named-content specific-use="change-person" data-title="" id="2293d0b1-15c0-4d81-b383-64a763b0ea86">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="58e3236a-878c-4e8c-85a0-a2179dd1246a">changed</named-content> <named-content specific-use="oldVal" data-title="Division of Medical Oncology, Mayo Clinic College of Medicine" id="9ad6b77e-2e0c-4b81-96c0-cd57faff4b3a">Division of Medical Oncology, Mayo Clinic College of Medicine</named-content> <named-content specific-use="" data-title="" id="ee15fad8-fc1a-492c-a8eb-fb97f849b61f">to</named-content> <named-content specific-use="newVal" data-title="Mayo Clinic College of Medicine" id="b0f77c7e-1222-4460-96f0-041a3ca03e8d">Mayo Clinic College of Medicine</named-content> <named-content specific-use="" data-title="" id="2a29bc1f-e7b3-43d4-83f2-24209d91ad8e"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="d1c847a5-87ed-4d43-8721-06cbc09b000a">18 Dec 2018 1:59 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="35a78670-6238-48ab-bb5c-24456750322a" xlink:title="aff3" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="07cba15c-48b7-4fc9-8675-d3cf4f7265b0"><meta-value id="6d9c101e-e5b3-4c4f-b3a4-25a848d4c99e"><named-content specific-use="historyContent" data-title="" id="6a184d78-6ca6-41b0-bad5-6b2ed8fa0ef7"><named-content specific-use="change-person" data-title="" id="a641af99-f1fb-4e05-a5b9-6036f0f485e7">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="bfc4687b-68c4-4773-97e3-5a6bffaec0d1">inserted</named-content> <named-content specific-use="newVal" data-title="Division of Medical Oncology" id="e282d401-7e3d-4b98-93e0-dbfc5d6ffa14">Division of Medical Oncology</named-content> <named-content specific-use="" data-title="" id="8bfe9b20-9ad2-4b2d-885d-585f3ab55d99"> in Department field on</named-content> <named-content specific-use="change-time" data-title="" id="06510805-68a1-4918-9c68-533769bcd291">18 Dec 2018 1:59 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="a1cb54f4-40b5-44cf-b23c-f738caf4bf37" xlink:title="aff2" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="f931491f-fa97-4cc7-b430-f6cf55e059fe"><meta-value id="274f99c5-3e87-45fa-a129-ace83d50b77f"><named-content specific-use="historyContent" data-title="" id="c12c2f98-1d56-4bd4-b8ad-b064a6972a85"><named-content specific-use="change-person" data-title="" id="6916351e-ce44-43da-8192-6254d2756bdc">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="102fb7a6-f53e-4e64-9ac0-0473fdb88b13">inserted</named-content> <named-content specific-use="newVal" data-title="" id="4c21b10d-9722-4e74-91cf-b0a69a8aeeef">USA</named-content> <named-content specific-use="" data-title="" id="33c3cc98-fa93-4432-a9e1-7a100fcafb95"> in Country field on</named-content> <named-content specific-use="change-time" data-title="" id="aba5cff8-dc5b-467d-a0b8-c3273ac155cb">18 Dec 2018 1:58 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="3465affa-33eb-4dd5-9df1-dd8ae7d67bc8" xlink:title="aff2" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="4c40b95a-d367-4af1-961c-eff5e2345511"><meta-value id="05465438-c748-4b73-ac52-dba35dc1488b"><named-content specific-use="historyContent" data-title="" id="860ea91f-66c6-43e7-a5f4-48785de6a6df"><named-content specific-use="change-person" data-title="" id="cc70bfcd-4076-451b-938e-dd019b591b47">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="48748049-deba-4a2d-a912-61f55b40383f">inserted</named-content> <named-content specific-use="newVal" data-title="" id="879ff7d6-e429-4d73-a364-02e5c2f9968b">Minnesota</named-content> <named-content specific-use="" data-title="" id="fc500b23-6b66-448d-a629-ac08ee2e6fcc"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="e0e427c4-4dec-42fc-bc04-82ee350eee91">18 Dec 2018 1:58 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="ba06da2f-5d7a-489c-969d-46501241960a" xlink:title="aff2" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="bdc8bf26-6fe0-4e57-b310-99e8b7cc5a3d"><meta-value id="d5c93121-2454-4ad8-b052-21f76ae986a7"><named-content specific-use="historyContent" data-title="" id="1d36903d-74b7-46ff-9b3a-a133b3b3e286"><named-content specific-use="change-person" data-title="" id="ada2b44e-c5ad-4544-baf9-47ef1a44bda9">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="0fd63d39-13f6-4825-9cd2-fb4d769007e4">inserted</named-content> <named-content specific-use="newVal" data-title="" id="0dddd729-3d8f-4424-9423-e5eeed74bb1e">Rochester</named-content> <named-content specific-use="" data-title="" id="e342fdff-8563-4eee-b0ef-4ec1192693ef"> in City field on</named-content> <named-content specific-use="change-time" data-title="" id="29a1faee-e7b1-4147-8150-9bb5e7ca29be">18 Dec 2018 1:58 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="1c234564-84c2-4ffb-82c3-f2b95b1ab47a" xlink:title="aff2" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="05f5416a-93f5-46e2-a0ae-73468b6f364d"><meta-value id="0dbc5137-e3ef-4a2b-8a80-58075dbd85cc"><named-content specific-use="historyContent" data-title="" id="1f3056a2-601a-489e-aa76-ce1cb85dda87"><named-content specific-use="change-person" data-title="" id="6b06b4d7-a683-4cda-9293-43232cc97c8d">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="b10ccff6-ddfa-4836-b1d5-a73e2cf22bbc">changed</named-content> <named-content specific-use="oldVal" data-title="Department of Internal Medicine, Mayo Clinic College of Medicine" id="db95e178-9863-4163-bc49-014d58ede031">Department of Internal Medicine, Mayo Clinic College of Medicine</named-content> <named-content specific-use="" data-title="" id="c3004ef7-e3ef-4336-8437-9dc4913124ee">to</named-content> <named-content specific-use="newVal" data-title="Mayo Clinic College of Medicine" id="b9f06239-6db1-4d5e-89f6-264141ec8687">Mayo Clinic College of Medicine</named-content> <named-content specific-use="" data-title="" id="c8f66459-7bd8-4c22-9929-8a40ade79bfc"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="f8a2070f-7e98-4b83-bc2d-c7d6f734784c">18 Dec 2018 1:58 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="10e36944-0fe1-42c5-9ba0-e6998539cc92" xlink:title="aff2" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="a6f22610-8028-493a-9dcb-25e18033dbd1"><meta-value id="0f67f928-eb95-4cb0-8095-2fa0840e42bb"><named-content specific-use="historyContent" data-title="" id="ca5335b7-4cbc-4f43-9c8c-2fda9cec6b29"><named-content specific-use="change-person" data-title="" id="c22bcf71-3db0-4f78-9a24-9529ad2ab026">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="349a753f-54a8-42e7-9b26-e3bacabd828d">inserted</named-content> <named-content specific-use="newVal" data-title="Department of Internal Medicine" id="d243b402-9c92-422b-9d75-a380760f8b49">Department of Internal Medicine</named-content> <named-content specific-use="" data-title="" id="4f8749f9-6837-4175-a865-287fee9c3485"> in Department field on</named-content> <named-content specific-use="change-time" data-title="" id="a5fb57b4-61e1-4e3d-aad5-9cad2a512185">18 Dec 2018 1:58 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="505c23f1-b17f-4312-bdaf-979777385eb2" xlink:title="aff1" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="6666bc18-8137-45ae-9399-382cd74262a0"><meta-value id="5655a04e-e63a-4ecb-b263-31a038c40b3b"><named-content specific-use="historyContent" data-title="" id="703f66f4-6e4e-4599-b036-d48f35455368"><named-content specific-use="change-person" data-title="" id="7bcb660c-bb3f-4b04-856c-b9ccf204f494">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="5b10e5a6-fb80-4758-a8b6-47be01c3837e">inserted</named-content> <named-content specific-use="newVal" data-title="" id="e5e119db-3998-4d33-be1b-3c0d746872ea">USA</named-content> <named-content specific-use="" data-title="" id="48a6dcad-c19e-419e-a71d-f320a73a790c"> in Country field on</named-content> <named-content specific-use="change-time" data-title="" id="bbfa86c9-ccfd-43ea-8e9b-c97a19446de0">18 Dec 2018 1:57 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="834e1549-c7cd-4aaf-af3a-9caf6e49e048" xlink:title="aff1" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="59ba4f0e-c661-4c4d-8d18-d33b2dec7fa8"><meta-value id="cc21459b-d87f-4660-8996-bf628e34f28d"><named-content specific-use="historyContent" data-title="" id="f2733cb9-e6e6-47d7-b213-1025f6d14376"><named-content specific-use="change-person" data-title="" id="b4e07345-d6d5-4e68-ae14-f9f6e18d9465">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="0118b1f5-ba9f-440a-9d93-00dde96928cf">inserted</named-content> <named-content specific-use="newVal" data-title="" id="c30e7f4c-bd9d-43ac-82ce-2dcd2bb7b2b2">Minnesota</named-content> <named-content specific-use="" data-title="" id="b58b72c9-509e-468c-b10b-ca37a7887ddf"> in State field on</named-content> <named-content specific-use="change-time" data-title="" id="a4b394eb-f7ad-42e3-83f6-18e08fbbfbb1">18 Dec 2018 1:57 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="7e6c0ba9-4aaa-4efd-aa66-5ba2f9ea4287" xlink:title="aff1" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="5bdbf440-c4aa-4891-b913-39f1c663b9d4"><meta-value id="ee183f28-5ad7-4991-84aa-d179d5914108"><named-content specific-use="historyContent" data-title="" id="ad826f7b-853b-4ce2-9a1a-4da40cef4784"><named-content specific-use="change-person" data-title="" id="cc192785-f8e2-4a46-828e-5163879b53a5">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="324b9e3e-6ae4-4230-8afa-c96128ad81c5">inserted</named-content> <named-content specific-use="newVal" data-title="" id="0fafec6d-b3ec-455d-8dff-16df36b28cf7">Rochester</named-content> <named-content specific-use="" data-title="" id="5285c8d1-11b2-4a73-9c5f-9f8c11dbe076"> in City field on</named-content> <named-content specific-use="change-time" data-title="" id="63dff8ac-ac59-4d33-bdc4-c9fe4de416da">18 Dec 2018 1:57 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="57d720c4-451a-4c76-8d8d-ff250f2e49e6" xlink:title="aff1" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="06eff8e9-7c63-4223-a691-2dd72a67e596"><meta-value id="75d72856-090e-4f66-ab43-1c23e5cc5a80"><named-content specific-use="historyContent" data-title="" id="2860877e-e8f6-4668-a962-83f3f750eb7a"><named-content specific-use="change-person" data-title="" id="235938b3-8076-4174-8a1d-4cf036de8d05">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="e44707fd-e35f-4f3b-9304-c4223c9e80f5">changed</named-content> <named-content specific-use="oldVal" data-title="Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine, Rochester MN" id="525af16d-ed0a-48b6-a641-c27c10ae7d0d">Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine, Rochester MN</named-content> <named-content specific-use="" data-title="" id="6b02f469-983b-4d77-a08f-5161217bb514">to</named-content> <named-content specific-use="newVal" data-title="Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine," id="7315f937-e271-4850-a198-2d19a3e5c6b1">Diabetes, Metabolism and Nutrition, Mayo Clinic College of Medicine,</named-content> <named-content specific-use="" data-title="" id="15721bc6-10f7-4298-92cc-8a5fcdb38b46"> in Institution field on</named-content> <named-content specific-use="change-time" data-title="" id="fed75780-a335-4a48-b472-1a4dbb62e866">18 Dec 2018 1:57 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="894a2042-8361-40e2-bb3f-f733f67b5998" xlink:title="aff1" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="165327f9-0f56-48f9-93ec-ff43473f1a31"><meta-value id="6a5f356f-acd0-4583-9c24-cbad3a45964e"><named-content specific-use="historyContent" data-title="" id="55cfac0d-4bb6-4c67-937d-40068b8b7f21"><named-content specific-use="change-person" data-title="" id="a4bac60d-ca6e-4d44-af19-c9b5d6778d59">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="62a73a05-1d75-458e-9ba9-1b0acfd2977e">inserted</named-content> <named-content specific-use="newVal" data-title="Division of Endocrinology" id="3e628e53-47d4-46bf-8470-d7df75477215">Division of Endocrinology</named-content> <named-content specific-use="" data-title="" id="7072fd33-381c-40e2-9985-29100704c131"> in Department field on</named-content> <named-content specific-use="change-time" data-title="" id="57c1c947-e081-46af-9faa-c35e29d049f3">18 Dec 2018 1:57 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" section="article-meta" node-xpath="custom-meta-group" id="456d8a57-2111-4997-a15b-8d24323b4316" xlink:title="author-42028932" xlink:actuate="77ed9556-0bad-4403-9bf5-ecf656b6fcc6" xlink:role="preeditor" xlink:href="100755a7-3100-4f75-94c6-59ba6c72a065"><meta-value id="d296379d-7043-4d2a-9daf-91c26cb6aa56"><named-content specific-use="historyContent" data-title="" id="3a3f2a66-e51e-4ee4-996b-0d9531594e53"><named-content specific-use="change-person" data-title="" id="8571a3c7-b926-4823-96e4-5b5a2d0f9a19">Varalakshmi</named-content> <named-content specific-use="" data-title="" id="0fabb650-ee74-47b4-b2a2-8f414408db73">changed</named-content> <named-content specific-use="oldVal" data-title="" id="cd68e095-c50d-4c4f-9cad-edc526d002be">Yogish</named-content> <named-content specific-use="" data-title="" id="f3567564-3f87-4c34-92a1-5a9b1b36a94e">to</named-content> <named-content specific-use="newVal" data-title="" id="96bfbcf4-c0c5-4645-9f55-b2b9606963dd">Yogish C</named-content> <named-content specific-use="" data-title="" id="e104acab-3f4e-457a-bac4-2bcafd8f43c3"> in Given name field on</named-content> <named-content specific-use="change-time" data-title="" id="8ad987ce-debb-4a86-8130-29cf80f65c8a">18 Dec 2018 1:55 PM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="history" id="a5797096-41bc-4cdb-ac68-c63b821128a3" xlink:title="BLK_S1" xlink:actuate="615535ce-d7e3-4a1f-a79a-8c817d3de8a0" xlink:role="typesetter" xlink:href="fd182251-a73c-46f2-9c0c-121ebc41e0cf"><meta-value id="65fe31b7-9774-42f8-bc34-53019eb1426a"><named-content specific-use="historyContent" data-title="" id="60c3efe3-f06f-4b0d-bf71-e47a50e00e6b"><named-content specific-use="change-person" data-title="" id="d8e13b21-01be-42a7-b5ac-773fd5859d57">Karthick</named-content> <named-content specific-use="" data-title="" id="75be4791-bf52-4aff-8f0e-17250754b126">inserted file</named-content> <a href="/resources/bmj/bmjdrc/bmjdrc-2018-000591/resources/6bcab632-4dbf-4b47-b38f-b8dcbea09a61.docx" data-title="Click to open the file" target="_blank" id="57167686-1d9b-4da2-8b32-a3ff551e4475"><named-content specific-use="newVal" data-title="" id="ea4e0588-d9a5-406a-845b-8e687dc7db63">Supplemental Table S1.docx</named-content></a> <named-content specific-use="" data-title="" id="29ed7746-8fb4-47da-8e8b-93fd3f9e9b82">on</named-content> <named-content specific-use="change-time" data-title="" id="6cc0792d-cb1e-4792-8886-3bc67ecdaab4">18 Dec 2018 11:39 AM</named-content></named-content></meta-value></custom-meta><custom-meta specific-use="query" id="2308db83-1cb0-4a43-a1d0-67fb96ebc9dc" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-answered="true"><meta-value id="4ef2f624-f113-406c-abe3-f711a6fcbe46"><named-content xlink:title="Varalakshmi (PREEDITOR)" specific-use="Dec 19 2018 3:49 PM" content-type="Author" alt="preeditor" id="e29381ea-8fc1-4531-8b53-0e845ab80c84">Please check 'Data sharing statement' is accurate.<div id="abf5c919-3332-4264-bbd2-b76af670f837"/></named-content><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 (10:23)" content-type="answered" alt="author" id="137a743b-a3ef-40e6-a739-af8cc4c94486">this is correct</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="fb3d1fe1-060a-43f4-8ced-8340dac19108" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-answered="true"><meta-value id="b5f5fe15-d2ac-4064-8705-7772785d4ebe"><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 10:59 AM" content-type="Publisher" alt="author" id="b0f48286-c953-483d-8ea5-06fbdd4d9d56">first row titled "Pancreatic enzymes" should not have any data as this is heading, data from first row should be moved to second row titled "Mildly elevated"; data from second row should be moved to third row titled "Moderate to severely elevated". the fourth row is okay. </named-content><named-content xlink:title="Nabjyoti (BMJ)" specific-use="Jan 2 2019 (21:38)" content-type="answered" alt="publisher" id="ae3d7f29-80c8-4077-b130-519b30855279">ok</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="d723cef0-299c-437c-a846-d1940e4d832e" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="89deaffe-5fd3-4322-9d62-cf49856d343b"><named-content xlink:title="Nabjyoti (BMJ)" specific-use="Jan 2 2019 9:37 PM" content-type="Typesetter" alt="publisher" id="88028bca-e7e2-48e6-9bef-c52a4a1d132e">See PQ</named-content><named-content xlink:title="Thilip (TYPESETTER)" specific-use="Jan 4 2019 (16:58)" content-type="reply" alt="typesetter" id="a3765303-5345-49a9-b096-e582ca47157a">Done</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="1db2dae9-7091-415b-a108-2f1ac322d1a5" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-answered="true" data-replied="true"><meta-value id="814cb5b0-e9b9-4b27-a8df-839f442a1a0a"><named-content xlink:title="Nabjyoti (BMJ)" specific-use="Jan 2 2019 9:40 PM" content-type="Typesetter" alt="publisher" id="8121c3ec-364c-45e2-8b84-e6a5efee0723">Refer to three PQs to shift the values one row above. </named-content><named-content xlink:title="Thilip (TYPESETTER)" specific-use="Jan 4 2019 (16:46)" content-type="reply" alt="typesetter" id="73a284c1-904b-4533-86af-a9708d82089d">Done</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="10a42f4e-b804-46de-9104-13a90ca9970f" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-style="left: 459px; top: 254.672px;" data-answered="true"><meta-value id="1a84d9d9-a0e8-4a4a-bafd-28a359a8445b"><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 11:23 AM" content-type="Publisher" alt="author" id="cd601c8f-b128-47f7-8785-5467577572a0">data in this row needs to be moved up to row titled "MDI oral agent"</named-content><named-content xlink:title="Nabjyoti (BMJ)" specific-use="Jan 2 2019 (21:40)" content-type="answered" alt="publisher" id="31374743-2e55-43af-b3af-e3c560a0f054">ok</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="776da93c-0d13-4ce8-aa68-ae8b919ec054" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-style="left: 459px; top: 311.672px;" data-answered="true"><meta-value id="7fc624b0-ad2a-44e5-b2a5-8ff2779bc3e9"><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 11:23 AM" content-type="Publisher" alt="author" id="540f455d-d937-4c32-9584-5df8ca2dbaf0">data in this row needs to be moved up to row titled "Basal insulin oral agent"</named-content><named-content xlink:title="Nabjyoti (BMJ)" specific-use="Jan 2 2019 (21:40)" content-type="answered" alt="publisher" id="9ea221c8-fa6f-4496-bdab-f7014546b75e">ok</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="307f3c0b-4694-425d-9217-e690c51f81d6" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-style="left: 459px; top: 356.672px;" data-answered="true"><meta-value id="1258dab0-2016-4ee7-a7b7-1abd5e16cd1d"><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 11:24 AM" content-type="Publisher" alt="author" id="ea10bb08-3301-403c-9e87-cadaf255a435">data in this row needs to be moved up to row titled "Insulin pump"</named-content><named-content xlink:title="Nabjyoti (BMJ)" specific-use="Jan 2 2019 (21:41)" content-type="answered" alt="publisher" id="2b5c19f9-0a07-426a-83d4-e2bf56b5e242">ok</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="688924c3-cf9d-41ca-971a-311a0f5ce488" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-answered="true"><meta-value id="414467ef-8d7a-44be-a13a-92665ee2ed2d"><named-content xlink:title="PV-A027-Ariel (COPYEDITOR)" specific-use="Dec 22 2018 7:15 AM" content-type="Author" alt="copyeditor" id="1102968a-98ea-4c97-9529-d9432df29038">Please provide the expansion of FDA.</named-content><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="‎Dec 25 2018 (21:58)" content-type="answered" alt="author" id="c4bb4d3c-bbd2-4801-a052-f19315461f24">Food and Drug Administration</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="003ccf08-cf4f-4d6a-9512-febb99ef768a" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-answered="true"><meta-value id="703ddaf7-5c5b-4acf-9a2d-6cfa43257377"><named-content xlink:title="PV-A027-Ariel (COPYEDITOR)" specific-use="Dec 22 2018 7:28 AM" content-type="Author" alt="copyeditor" id="b8b3a511-de33-49e7-a4b6-be0880cd3e82">Please provide the expansion of HLA.</named-content><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 (10:19)" content-type="answered" alt="author" id="cdea4b02-c1b6-4f0f-851e-65677581e07c">human leukocyte antigen</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="5be9e6f1-57f6-4a57-84fe-db72340c9264" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="b7036cc5-042a-4c7b-8c3f-d9f47a52b768"><named-content xlink:title="PV-A027-Ariel (COPYEDITOR)" specific-use="Dec 22 2018 7:28 AM" content-type="Typesetter" alt="copyeditor" id="be072597-be55-432b-85c6-6e22a3a035ce">'Stamatouli <italic id="cf3a9694-2370-4365-b9a9-77b365c3b13f">et al</italic>': Please check if this should be linked.</named-content><named-content xlink:title="Asha (TYPESETTER)" specific-use="Dec 22 2018 (13:01)" content-type="reply" alt="typesetter" id="b93cf1f2-cd8c-4b0d-9523-c76dc7b772d5">Linked</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="7126c9c6-3c32-42e0-8524-e694d76daac0" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="d21bc39e-48d9-4e49-bb67-aa59af1f30cd"><named-content xlink:title="PV-A027-Ariel (COPYEDITOR)" specific-use="Dec 22 2018 9:24 AM" content-type="Author" alt="copyeditor" id="2abaf9d4-9ccb-4bb3-946a-9ec996e4cc73">Please provide the expansion of β-OHB.</named-content><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 (10:24)" content-type="reply" alt="author" id="65fa7b1c-b40c-44a4-9dca-2c43a5a03888">provided now in footnote</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="665ca8a2-6851-464e-994c-0af39b320aaf" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="d31d5c65-bed7-4923-8a3c-de61d92e8a8d"><named-content xlink:title="PV-A027-Ariel (COPYEDITOR)" specific-use="Dec 22 2018 9:33 AM" content-type="Author" alt="copyeditor" id="8d0e17c3-f7fa-4d07-a159-7ae6cb9057cf">Please provide the expansion of GGT.</named-content><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 (10:25)" content-type="reply" alt="author" id="fc0e6980-660e-4bf4-88e6-f7aeb554b5d4">provided now in footnote</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="c911859b-4b80-48db-83aa-c833bcd16c37" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="5f3291d4-5798-4e37-8f68-dbbb6ec76bce"><named-content xlink:title="PV-A027-Ariel (COPYEDITOR)" specific-use="Dec 22 2018 9:25 AM" content-type="Author" alt="copyeditor" id="65098656-e266-423a-91f6-c9e727f6e08f">Please provide the expansion of ZnT8A.</named-content><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 (10:26)" content-type="reply" alt="author" id="9e41cc57-7e08-4885-bffa-8da9c59cc7f0">provided now in footnote</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="d990bd30-1596-424a-8854-1771138d21ad" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="adcb764a-dd2b-43bf-9164-f272cdf1aaf6"><named-content xlink:title="PV-A027-Ariel (COPYEDITOR)" specific-use="Dec 22 2018 8:43 AM" content-type="Author" alt="copyeditor" id="1cfb9d88-cf8c-4221-8771-aba97e19ecb6">Please provide the expansion of TZD.</named-content><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 (10:28)" content-type="reply" alt="author" id="510e8fd1-d29d-47a7-838c-e8a688f6fe4d">provided now in footnote</named-content></meta-value></custom-meta><custom-meta specific-use="query" id="228b1ba7-4e44-495d-b25d-43f56d87a9ab" section="article-meta" node-xpath="custom-meta-group" xlink:type="action" data-type="action" data-replied="true"><meta-value id="5eb6c042-d196-409b-adfe-a057ea6c302d"><named-content xlink:title="PV-A027-Ariel (COPYEDITOR)" specific-use="Dec 22 2018 8:34 AM" content-type="Author" alt="copyeditor" id="b24f38e8-d8aa-4d52-9576-add56cc3b7de">'HbA1c i 10%': Please check if this is correct.</named-content><named-content xlink:title="Yogish C Kudva (AUTHOR)" specific-use="Dec 26 2018 (10:27)" content-type="reply" alt="author" id="b8f7e68e-878c-4b48-8097-71be714011b3">deleted "i". this was a typo</named-content></meta-value></custom-meta></custom-meta-group><counts id="e00002d1-7f59-4526-a606-a13d68885af0"><fig-count count="1"/><table-count count="4"/><equation-count count="0"/><ref-count count="21"/><page-count count="9.5"/><word-count count="7084"/></counts></article-meta></front><body id="0ae29f61-4611-4af8-a51a-545ff40e0cdd"><span data-class="jrnlDeleted" id="f1341d0a-9e34-4dc0-86c6-c59009108b79"><bold id="6ba22e05-5cfc-4e31-940b-833eabc7776c">Title:</bold></span><p data-class="jrnlDeleted" data-head-type="bold" headweightage="" id="872835b5-1bff-44af-8ffa-1abdc22409d8"><span data-class="Del cts-1" id="faf7abad-8865-4f7d-92b3-a3b5baea44e9"><bold id="9387a06a-43d1-42a6-894c-02a1814f985c">Running title:</bold></span></p><span data-class="jrnlDeleted" id="0b3ded07-3973-4860-ae09-497106c3198b">Authors:</span><span data-class="jrnlDeleted" id="21da3661-bbb3-4014-8041-f92463cdbeeb"><bold id="bd07f1e8-2e74-4849-b712-fbce3e8a8aa8">Affiliations:</bold></span><p data-class="jrnlDeleted" headweightage="41" id="4dea0901-cd4d-4bba-865b-929523920025"><span data-class="Del cts-1" id="dc145830-6e5d-4fe9-838f-2cbed2309407">Correspondence:</span></p><p data-class="jrnlDeleted" id="dbd64ff8-1a6d-4ec9-b4fd-6dd0fac302d0">Yogish C. Kudva, MD, FRCP</p><p data-class="jrnlDeleted" data-style="font-family: 'Calibri',sans-serif; font-size: 11.0pt; line-height: normal; margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" fontsize="12.0" id="804d3a61-6c55-49ed-bf79-cbdbeb3186ab">Division of Endocrinology, Diabetes, Metabolism and Nutrition</p><p data-class="jrnlDeleted" data-style="font-family: 'Calibri',sans-serif; font-size: 11.0pt; line-height: normal; margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" fontsize="12.0" id="520388c3-b97d-4895-923a-517506c885eb">Mayo Building</p><p data-class="jrnlDeleted" data-style="font-family: 'Calibri',sans-serif; font-size: 11.0pt; line-height: normal; margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" fontsize="12.0" id="48577ed7-072f-45e8-9d56-b805b125a351">Mayo Clinic</p><p data-class="jrnlDeleted" data-style="font-family: 'Calibri',sans-serif; font-size: 11.0pt; line-height: normal; margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" fontsize="12.0" id="ec6bafad-ae64-4c89-80af-d197620e6e0c">200 First Street SW</p><p data-class="jrnlDeleted" data-style="font-family: 'Calibri',sans-serif; font-size: 11.0pt; line-height: normal; margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" fontsize="12.0" id="7d041471-87a4-416a-9e0a-08cfb3552f20">Rochester, MN 55905</p><p data-class="jrnlDeleted" id="e8538690-99ff-4669-91f7-ed33c0061d79">Phone: 507 284 3964</p><p data-class="jrnlDeleted" data-style="font-family: 'Calibri',sans-serif; font-size: 11.0pt; line-height: normal; margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" fontsize="12.0" id="0de9143f-5037-4d83-9250-f717fc15fe8c">Fax: 507 284 5745</p><p data-class="jrnlDeleted" data-style="font-family: 'Calibri',sans-serif; font-size: 11.0pt; line-height: normal; margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" fontsize="12.0" colorcode="blue" textdecoration=" underline" id="ef4fc39a-4a0a-4c91-829f-b989f9759277">Email: Kudva.yogish@mayo.edu</p><p data-class="jrnlDeleted" headweightage="41" id="dc2dd46e-ede0-4144-af6d-22b70e86c8e7"><span data-class="Del cts-1" id="ed584739-935e-449e-af4a-8d5cde03c812">Word count: 3729</span></p><title data-level="1" data-class="jrnlDeleted" old-class="" id="347d5185-e698-4c0c-b4ac-c2357d21efed"><named-content data-cid="1545121521" id="0978cc2e-28b0-4287-8173-023d5ad99f86" content-type="del cts-2" specific-use="1545121843819" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121843819">Significance of the study</named-content></title><h0 data-class="jrnlDeleted" id="60cfa859-9b3d-4bfb-b548-2212d1c0af7b" old-class="jrnlHead0"><named-content data-cid="1545121521" content-type="del cts-2" specific-use="1545121843819" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121843819" id="8a583c94-e8e9-44d7-9204-c5885f14ba50">What is already known about this subject?</named-content></h0><p data-class="jrnlDeleted" data-class-name="SecPara" id="f7b513d1-5960-44f3-8309-5e938df30da4" old-class="jrnlListPara"><named-content id="d37dacc7-9a59-44ed-8222-351c43165705" data-cid="d37dacc7-9a59-44ed-8222-351c43165705" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid="">· </named-content><named-content data-cid="1545121521" content-type="del cts-2" specific-use="1545121843819" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121843819" id="30664771-275b-4bcc-983b-be69327f3176">Diabetes mellitus has been rarely reported in clinical trials of </named-content><named-content id="4f5c81ac-9a3a-4032-a9cf-f30788480ce4" data-cid="4f5c81ac-9a3a-4032-a9cf-f30788480ce4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="71" data-match="immune checkpoint inhibitors" data-pattern="" data-tag-index="" data-abbr="ICI" data-time="" data-username="" data-userid=""><named-content data-cid="1545121521" content-type="del cts-2" specific-use="1545121843819" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121843819" id="8c7c5359-f5a7-429f-971e-a4cef7e37498">immune checkpoint inhibitors</named-content></named-content><named-content data-cid="1545121521" content-type="del cts-2" specific-use="1545121843819" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121843819" id="1e0e80a4-b0ae-4be9-80c6-682f858241bd"> (</named-content><named-content id="aa25ff71-4168-4940-9299-4a17df3ab707" data-cid="aa25ff71-4168-4940-9299-4a17df3ab707" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="101" data-match=" (ICIs)" data-pattern="" data-tag-index="6_1" data-time="" data-username="" data-userid=""><named-content data-cid="1545121521" content-type="del cts-2" specific-use="1545121843819" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121843819" id="db94ccb0-2737-4761-a036-3682540a1357">ICIs</named-content></named-content><named-content data-cid="1545121521" content-type="del cts-2" specific-use="1545121843819" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121843819" id="3a8fe05e-76b9-4a72-a4d2-db7ddabe5c71">) for cancer therapy.</named-content></p><h0 data-class="jrnlDeleted" data-label="true" id="5d05e6b7-2e44-4ca2-9fb0-7a3a3df55fc9" old-class="jrnlHead0"><named-content data-cid="1545121521" content-type="del cts-2" specific-use="1545121843819" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121843819" id="749210ca-5248-46bd-aa84-1dba90016a50">What are the new findings?</named-content></h0><p data-class="jrnlDeleted" data-class-name="SecPara" id="f0e9efff-d9fc-45f9-879b-5c53108527f8" old-class="jrnlListPara"><named-content id="266f3109-0f2c-480f-b898-7507ce3726f1" data-cid="266f3109-0f2c-480f-b898-7507ce3726f1" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid="">· </named-content><named-content data-cid="1545121521" content-type="del cts-2" specific-use="1545121843819" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121843819" id="8209ea45-cbb5-4de7-9a15-49f735b2044b">We found that ICIs that include PD-1 inhibitors can induce insulin-dependent diabetes, which occurs most frequently with pembrolizumab, can present with diabetic ketoacidosis and does not appear to undergo remission.</named-content></p><h0 data-class="jrnlDeleted" id="e45acb43-626e-4fbe-b57b-8bae0af160ae" old-class="jrnlHead0"><named-content data-cid="1545121521" content-type="del cts-2" specific-use="1545121843819" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121843819" id="407da96b-f746-493d-9e0c-087964069c2c">How might these results change the focus of research or clinical practice?</named-content></h0><p data-class="jrnlDeleted" data-class-name="SecPara" id="5f8f792e-c0e9-493a-89b8-c6add82e3f24" contenteditable="true" old-class="jrnlListPara"><named-content id="8fca1581-0c34-4cf2-ad59-9deaa4990bfd" data-cid="8fca1581-0c34-4cf2-ad59-9deaa4990bfd" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid="">· </named-content><named-content data-cid="1545121521" content-type="del cts-2" specific-use="1545121843819" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545121843819" id="d67e0487-4810-4fca-9427-845fd96ae961">These results highlight the importance of monitoring blood glucose and HbA1c prior to initiating ICIs as well as during follow-up, having a heightened suspicion for the occurrence of diabetes and developing better risk prediction.</named-content></p><boxed-text content-type="jrnlInlineBoxBlock" id="dd2540c1-23f2-4050-bbbb-028bc45f9187" data-id="BLK_IB1" insert-citation="false" data-stream-name="a_IB1" data-uncited="true"><caption id="1aa4ec09-64ee-4e4e-bd38-6e60bf974d2c"><title id="438674b9-0f46-4bbc-bb61-1300776d19d3" data-id="IB1">Significance of th<named-content id="c0e58dd2-0622-4d73-b976-bced2faa4b4b" data-cid="1545433926" content-type="del cts-3" specific-use="1545443001640" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:43am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545443001640" data-username="PV-A027-Ariel (COPYEDITOR)">e</named-content><named-content id="facd413d-7895-4d16-8dd7-cc3daf9b0ef3" data-cid="1545433927" content-type="ins cts-3" specific-use="1545443001990" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:43am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545443001990" data-username="PV-A027-Ariel (COPYEDITOR)">is</named-content> study</title></caption><title data-class="jrnlBoxHead" id="d70d4297-2a4f-4e43-bcb8-109eac5f3f9d" contenteditable="true">What is already known about this subject?</title><list id="cbd77b5b-a7fe-4b1f-bb7e-abb4a24a55a5" list-content="ul" list-type="disc"><list-item id="37d360fa-49a7-4c7b-b1c1-3a61870c7d89"><p id="02ecb7b1-807f-49a1-aabf-db09112eb42b">Diabetes mellitus has been rarely reported in clinical trials of immune checkpoint inhibitors (ICIs) for cancer therapy.</p></list-item></list><title data-class="jrnlBoxHead" id="068e08aa-f6fa-4b50-a026-91321e8553f7" contenteditable="true">What are the new findings?</title><list id="52512b81-679e-4dd9-b9ef-cec5518e1c9a" list-content="ul" list-type="disc"><list-item id="5c86ba06-1dcb-4fdc-ac5e-c62a794dbe1f"><p id="bdd96263-1ded-44b2-a6f3-30fd9b4bbc7f">We found that ICIs that include <named-content id="7d74ce43-d200-41c0-ad34-1e030d5ed42a" data-cid="1545433200" content-type="ins cts-3" specific-use="1545433915156" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:11am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545433915156" data-username="PV-A027-Ariel (COPYEDITOR)">programmed cell death protein 1</named-content><named-content id="a525b75a-fdc1-44cc-9b6e-ddffee88e890" data-cid="1545433201" content-type="del cts-3" specific-use="1545433917650" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:11am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545433917650" data-username="PV-A027-Ariel (COPYEDITOR)">PD-1</named-content> inhibitors can induce insulin-dependent diabetes, which occurs most frequently with pembrolizumab, can present with diabetic ketoacidosis and does not appear to undergo remission.</p></list-item></list><title data-class="jrnlBoxHead" id="3edc3b1c-2ec8-4214-9b12-c725fb675908" contenteditable="true"><named-content id="92407404-81f2-40d8-90cc-cf9ea0a551ad" data-cid="1545121534" content-type="del cts-2" specific-use="1545122148034" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:05pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545122148034" data-username="Varalakshmi (PREEDITOR)"> </named-content><named-content id="ccbfbf83-bf59-4cfe-9276-f24234660d8e" data-cid="1545433202" content-type="ins cts-3" specific-use="1545433933791" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:12am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545433933791" data-username="PV-A027-Ariel (COPYEDITOR)"><span id="26ba24f3-53b4-49b9-be72-6dc7c00b5c52"><span id="e4937ce5-4f22-484b-89ab-a6ed9d29fb11">How might these results change the focus of research or clinical practice?</span></span></named-content><named-content id="96ca1888-cca7-4065-b194-6d7db0966040" data-cid="1545433203" content-type="del cts-3" specific-use="1545433935524" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:12am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545433935524" data-username="PV-A027-Ariel (COPYEDITOR)">How might these results change the focus of research or clinical practice?</named-content></title><list id="fab88b35-d2ef-4a83-91f1-e40eb5f9482f" list-content="ul" list-type="disc"><list-item id="73441964-f3a9-48c5-a1e4-c41802b0e739"><p id="c3aace72-3e62-4bd4-9d11-e1303b3b6809">These results highlight the importance of monitoring blood glucose and <named-content id="49512274-d533-409c-a8a9-3374856f313b" data-cid="1545433204" content-type="ins cts-3" specific-use="1545433975286" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:12am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545433975286" data-username="PV-A027-Ariel (COPYEDITOR)"><span id="40b17de6-08ba-42d5-b313-0c4330dc07aa">hemoglobin A1c</span></named-content><named-content id="52e65fec-e236-4ec6-bcfd-0c313b0d9b6d" data-cid="1545433205" content-type="del cts-3" specific-use="1545433977415" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:12am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545433977415" data-username="PV-A027-Ariel (COPYEDITOR)">HbA1c</named-content> prior to initiating ICIs as well as during follow-up, having a heightened suspicion for the occurrence of diabetes and developing better risk prediction.</p></list-item></list></boxed-text><title data-level="1" data-class="jrnlHead1" old-class="" id="b682bbb4-9ba0-4f4d-be3a-428edcc17d5e">Introduction</title><p data-class="jrnlSecPara" id="51c8fbe6-f720-4b20-943d-7f013d0e0620" data-word-spacing="0.43w">A balance between immune stimulation and inhibition is essential for homeostasis. In the setting of malignancy, this balance is augmented, allowing tumors to evade immune-mediated cell death.<xref id="673ddc66-c114-491b-97fc-ef56cd23d0a1" ref-type="bibr" rid="R1" data-citation-string=" R1 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="192" data-match="1" data-pattern="" data-tag-index="11_1" data-track-change="1"><sup id="52ae607e-901e-46f5-979d-1c68e0c1cada">1</sup></xref> Recently, monoclonal antibodies have been developed against immune checkpoints namely cytotoxic T lymphocyte antigen 4 (CTLA-4), programmed cell death protein 1 (PD-1), or programmed cell death protein-ligand 1 (PD-L1). CTLA-4 is expressed on T cells where its role is to down<named-content data-cid="1545433206" id="b47596fa-4c0d-4849-8f7b-a791ee5a18e0" content-type="del cts-3" specific-use="1545434016852" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:13am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434016852">-</named-content>regulate T<named-content data-cid="1545433207" id="27118538-59bf-4647-95aa-cce23b8fd219" content-type="del cts-3" specific-use="1545434018361" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:13am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434018361">-</named-content><named-content data-cid="1545433208" id="74ba9027-f139-45f3-b37a-1ef0601a780c" content-type="ins cts-3" specific-use="1545434018604" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:13am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434018604"> </named-content>cell proliferation <named-content data-cid="1545113216096" id="7c590a25-2c08-4b04-b183-5503b2344101" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">upon</named-content><named-content id="743fed9e-c512-4bd6-a86e-c14eaccd5b17" data-cid="1545113216096" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'upon' to 'on'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="503" data-match="upon" data-replace="on" data-pattern="on" data-tag-index="11_3" data-function="addTrackChanges" data-track-change="upon" data-userid="preediting" data-username="Exeter" data-time="1545113216002">on</named-content> B7 engagement early in immune response, primarily in lymph nodes. PD-1 is expressed on activated T cells, including T regulatory cells, B cells, and myeloid cells. Its major role is to limit the activity of T cells in peripheral tissues at the time of an inflammatory response and to limit autoimmunity. In the context of cancer, it binds to its ligands PD-L1 and PD-L2 expressed on tumor cells <named-content data-cid="1545433209" id="0ab3c17e-04a8-4839-a07f-3089fd7ddfb3" content-type="ins cts-3" specific-use="1545434042763" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434042763">that</named-content><named-content data-cid="1545433213" id="b180acae-431f-4f2a-9294-4fe66ac024cb" content-type="del cts-3" specific-use="1545434048120" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434048120">which</named-content> causes inhibition of T<named-content data-cid="1545433214" id="80c1a654-11d1-4e90-89dc-7a90b157c631" content-type="del cts-3" specific-use="1545434051635" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434051635">-</named-content><named-content data-cid="1545433215" id="a658964c-0d67-4d87-be93-73a76f734630" content-type="ins cts-3" specific-use="1545434051939" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434051939"> </named-content>cell receptor<named-content data-cid="1545433216" id="fe0283c6-fb9d-4621-9529-ccc386f312e5" content-type="del cts-3" specific-use="1545434054743" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434054743"> </named-content><named-content data-cid="1545433217" id="95558ba2-db3b-439d-9b5a-032a9b6eda42" content-type="ins cts-3" specific-use="1545434055041" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434055041">-</named-content>mediated positive signaling, leading to reduced proliferation, reduced cytokine secretion, and reduced survival of effector T cells. PD-1 is also expressed on regulatory T cells, where it may enhance their proliferation after binding to the ligands. This combined effect suppresses intrinsic immune-mediated antitumor activity.<xref id="40110311-2473-4ced-be8a-4a72b532cc31" ref-type="bibr" rid="R2" data-citation-string=" R2 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1274" data-match="2" data-pattern="" data-tag-index="11_2" data-track-change="2"><sup id="3a2b1ae6-76fa-4a7a-b861-76d3298b2180">2</sup></xref></p><p data-class="jrnlSecPara" id="9dbda812-8e0a-43b2-90b3-7b30d7563e21" data-word-spacing="0.43w">The <named-content id="46c1a665-495e-4924-b5e6-1c039314a9b1" data-cid="46c1a665-495e-4924-b5e6-1c039314a9b1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-type="EXPN" data-userid="" data-time="" data-username="" data-tag-index="" data-pattern="" data-match="immune checkpoint inhibitors" data-offset="4" data-tag-desc="EXPN" data-abbr="ICI">immune checkpoint inhibitors</named-content> (<named-content id="682a5bc1-3b9d-4942-bdd9-235a5be04311" data-cid="682a5bc1-3b9d-4942-bdd9-235a5be04311" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-type="ABBR" data-userid="" data-time="" data-username="" data-tag-index="12_5" data-pattern="" data-match=" (ICIs)" data-offset="34" data-tag-desc="ABBR">ICIs</named-content>) are monoclonal antibodies designed to block these checkpoints, thus resulting in a de<named-content id="b62ec47a-cd4b-4866-b1ff-cb9c8d9137e3" data-cid="1545433218" content-type="del cts-3" specific-use="1545434076264" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434076264" data-username="PV-A027-Ariel (COPYEDITOR)">-</named-content>repression of cytotoxic T cell function,<xref id="8201c7f7-2082-4ca0-9519-7e060180dad9" ref-type="bibr" rid="R3 R4" data-citation-string=" R3 R4 " data-tag-type="BIBREF" data-track-change="3, 4" data-tag-index="12_1" data-pattern="" data-match="3, 4" data-offset="167" data-tag-desc="BIBREF"><sup id="4680e5a8-d880-403c-ba02-d37e9530c87a">3 4</sup></xref> in turn leading to enhanced anti<named-content id="c715d734-6eb2-4c7f-9490-707625b6683a" data-cid="1545433219" content-type="del cts-3" specific-use="1545434081684" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434081684" data-username="PV-A027-Ariel (COPYEDITOR)">-</named-content>tumor immune response. Blocking these regulatory molecules, however, also causes breaches in self-tolerance leading to a large spectrum of <named-content id="8efbf751-62a6-48f6-b345-aba2587280a1" data-cid="8efbf751-62a6-48f6-b345-aba2587280a1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-type="EXPN" data-userid="" data-time="" data-username="" data-tag-index="" data-pattern="" data-match="immune related adverse events" data-offset="346" data-tag-desc="EXPN" data-abbr="IRAE">immune<named-content id="a26b2811-def3-4b06-a419-c74ee2bfcd8b" data-cid="1545433221" content-type="del cts-3" specific-use="1545434092078" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434092078" data-username="PV-A027-Ariel (COPYEDITOR)"> </named-content><named-content id="9e01ef8a-8d7a-430d-a15c-28844f053e87" data-cid="1545433220" content-type="ins cts-3" specific-use="1545434089536" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434089536" data-username="PV-A027-Ariel (COPYEDITOR)">-</named-content>related adverse events</named-content> (<named-content id="9edb1d98-9e59-4adf-a57d-45decfa2c1cd" data-cid="9edb1d98-9e59-4adf-a57d-45decfa2c1cd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-type="ABBR" data-userid="" data-time="" data-username="" data-tag-index="12_6" data-pattern="" data-match=" (IRAEs)" data-offset="377" data-tag-desc="ABBR">IRAEs</named-content>).<xref id="5e10bb29-f15c-4439-8aa7-ed355dd4333f" ref-type="bibr" rid="R5" data-citation-string=" R5 " data-tag-type="BIBREF" data-track-change="5" data-tag-index="12_2" data-pattern="" data-match="5" data-offset="385" data-tag-desc="BIBREF"><sup id="22d373fe-4900-4302-8e2c-4ad9d701736b">5</sup></xref> The ICIs include CTLA-4 inhibitors <named-content id="3d8a2cda-8155-4b0e-9feb-deff98b4834c" data-cid="1545433222" content-type="del cts-3" specific-use="1545434122595" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434122595" data-username="PV-A027-Ariel (COPYEDITOR)">I</named-content><named-content id="2966ee75-3171-45ab-9d85-17fa77765bd6" data-cid="1545433223" content-type="ins cts-3" specific-use="1545434122991" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434122991" data-username="PV-A027-Ariel (COPYEDITOR)">i</named-content>pilimumab and <named-content id="f04af8a8-4c23-4ea1-ac4b-6df8f64b4831" data-cid="1545433225" content-type="del cts-3" specific-use="1545434125341" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434125341" data-username="PV-A027-Ariel (COPYEDITOR)">T</named-content><named-content id="762cc8c0-f7e4-453c-8712-b05dfecb73b0" data-cid="1545433224" content-type="ins cts-3" specific-use="1545434124900" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434124900" data-username="PV-A027-Ariel (COPYEDITOR)">t</named-content>remelimumab <named-content rid="688924c3-cf9d-41ca-971a-311a0f5ce488" data-class="jrnlQueryRef" data-type="start" id="f6788f42-9a65-4ba5-9fa9-f8c68c73fe6a" data-query-ref="true" data-query-type="action" data-query-for="author" data-topic="action" data-query-from="copyeditor" data-message="{'funcToCall': 'highlightQuery'}" data-event="click" data-channel="query" specific-use="start" content-type="jrnlQueryRef" data-answered="true"/><named-content rid="688924c3-cf9d-41ca-971a-311a0f5ce488" data-class="jrnlQueryRef" data-type="end" id="3cacbc3a-e9d3-4efa-b348-f82e6f2a86ce" specific-use="end" content-type="jrnlQueryRef" data-answered="true"/><named-content data-cid="1545840464" id="eb4b59ca-22be-429b-aa54-e3447c9c7692" content-type="del cts-5" specific-use="1545841171379" xlink:title="Yogish C Kudva (AUTHOR)" alt="author 3684625162" data-title="Deleted by Yogish C Kudva (AUTHOR) - Dec 26 2018 10:19am" data-track-detail="" data-userid="author 3684625162" data-username="Yogish C Kudva (AUTHOR)" data-time="1545841171379">(</named-content><named-content data-cid="1545840465" id="f98ebc10-25ee-420e-8923-6053e6dc7d03" content-type="ins cts-5" specific-use="1545841173139" xlink:title="Yogish C Kudva (AUTHOR)" alt="author 3684625162" data-title="Inserted by Yogish C Kudva (AUTHOR) - Dec 26 2018 10:19am" data-track-detail="" data-userid="author 3684625162" data-username="Yogish C Kudva (AUTHOR)" data-time="1545841173139">[</named-content>not <named-content data-cid="1546444800" id="5be2015c-6193-479c-8c62-cc742ef0a5eb" content-type="del cts-6" specific-use="1546444847497" xlink:title="Nabjyoti (BMJ)" alt="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-title="Deleted by Nabjyoti (BMJ) - Jan 2 2019 9:30pm" data-track-detail="" data-userid="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-username="Nabjyoti (BMJ)" data-time="1546444847497">FDA</named-content><named-content data-cid="1545840429" id="59efc8c1-de4c-4e2f-8118-c69aedbeee98" content-type="ins cts-5" specific-use="1545841156819" xlink:title="Yogish C Kudva (AUTHOR)" alt="author 3684625162" data-title="Inserted by Yogish C Kudva (AUTHOR) - Dec 26 2018 10:19am" data-track-detail="" data-userid="author 3684625162" data-username="Yogish C Kudva (AUTHOR)" data-time="1545841156819"><named-content data-cid="1546444800" id="7e0f93ee-186f-41e1-8e27-0670944c648a" content-type="del cts-6" specific-use="1546444847497" xlink:title="Nabjyoti (BMJ)" alt="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-title="Deleted by Nabjyoti (BMJ) - Jan 2 2019 9:30pm" data-track-detail="" data-userid="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-username="Nabjyoti (BMJ)" data-time="1546444847497"> (</named-content>Food and Drug Administration<named-content data-cid="1546444801" id="64edc374-180c-490d-a748-b1b76f8d4655" content-type="ins cts-6" specific-use="1546444852201" xlink:title="Nabjyoti (BMJ)" alt="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-title="Inserted by Nabjyoti (BMJ) - Jan 2 2019 9:30pm" data-track-detail="" data-userid="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-username="Nabjyoti (BMJ)" data-time="1546444852201"> (FDA</named-content>)</named-content> approved<named-content data-cid="1545840466" id="5c91bea3-2664-448d-8251-6163f68d42a8" content-type="del cts-5" specific-use="1545841176757" xlink:title="Yogish C Kudva (AUTHOR)" alt="author 3684625162" data-title="Deleted by Yogish C Kudva (AUTHOR) - Dec 26 2018 10:19am" data-track-detail="" data-userid="author 3684625162" data-username="Yogish C Kudva (AUTHOR)" data-time="1545841176757">)</named-content><named-content data-cid="1545840467" id="fe52acd7-eb11-44f1-bd12-99e3ba7b6a29" content-type="ins cts-5" specific-use="1545841177386" xlink:title="Yogish C Kudva (AUTHOR)" alt="author 3684625162" data-title="Inserted by Yogish C Kudva (AUTHOR) - Dec 26 2018 10:19am" data-track-detail="" data-userid="author 3684625162" data-username="Yogish C Kudva (AUTHOR)" data-time="1545841177386">]</named-content>, PD-1 inhibitors <named-content id="dce91617-46a8-45dd-b37b-9b055df5e9a9" data-cid="1545433226" content-type="del cts-3" specific-use="1545434140874" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434140874" data-username="PV-A027-Ariel (COPYEDITOR)">P</named-content><named-content id="5cb78074-b0fe-480e-b768-6025390dda72" data-cid="1545433227" content-type="ins cts-3" specific-use="1545434141176" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434141176" data-username="PV-A027-Ariel (COPYEDITOR)">p</named-content>embrolizumab and <named-content id="96c1f90b-d5f3-4acd-8bf0-971f83d1ef09" data-cid="1545433228" content-type="del cts-3" specific-use="1545434143338" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434143338" data-username="PV-A027-Ariel (COPYEDITOR)">N</named-content><named-content id="dc82ecaf-58e7-494c-bb25-d404e15458f4" data-cid="1545433229" content-type="ins cts-3" specific-use="1545434143728" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434143728" data-username="PV-A027-Ariel (COPYEDITOR)">n</named-content>ivolumab, and PD-L1 inhibitors <named-content id="9cd4f75b-0951-468a-aeea-b6f7e49220f8" data-cid="1545433230" content-type="del cts-3" specific-use="1545434146583" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434146583" data-username="PV-A027-Ariel (COPYEDITOR)">A</named-content><named-content id="5b6ca856-b0fa-4721-bcfd-6b28c8a7af0e" data-cid="1545433231" content-type="ins cts-3" specific-use="1545434146798" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434146798" data-username="PV-A027-Ariel (COPYEDITOR)">a</named-content>tezolizumab and <named-content id="03190a3f-8521-45e5-8018-1e4b74bc64f7" data-cid="1545433232" content-type="del cts-3" specific-use="1545434148202" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434148202" data-username="PV-A027-Ariel (COPYEDITOR)">A</named-content><named-content id="79bc420c-eb81-4310-85ed-df4af3bf7bb0" data-cid="1545433233" content-type="ins cts-3" specific-use="1545434148506" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434148506" data-username="PV-A027-Ariel (COPYEDITOR)">a</named-content>velumab. Endocrine IRAEs reported with ICIs include hypophysitis, thyroiditis, and in rare cases adrenalitis or diabetes mellitus. The hypophysitis usually affects the anterior pituitary and can lead to central hypothyroidism, hypogonadotrophic hypogonadism and/or secondary adrenal insufficiency. This has been a well<named-content id="f98dacb2-b1f8-44a1-8f4a-f0cb060f6e21" data-cid="1545433234" content-type="del cts-3" specific-use="1545434165025" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434165025" data-username="PV-A027-Ariel (COPYEDITOR)"> </named-content><named-content id="d440e05b-c6f5-4588-bbe2-faee27961fb9" data-cid="1545433235" content-type="ins cts-3" specific-use="1545434165366" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434165366" data-username="PV-A027-Ariel (COPYEDITOR)">-</named-content>characterized IRAE of the CTLA-4 inhibitor ipilimumab.<xref id="cf362e16-b44a-44a7-a6c0-f0384ffda06c" ref-type="bibr" rid="R6" data-citation-string=" R6 " data-tag-type="BIBREF" data-track-change="6" data-tag-index="12_3" data-pattern="" data-match="6" data-offset="930" data-tag-desc="BIBREF"><sup id="9d2dd15d-f367-4625-a9de-71e530d3f8a6">6</sup></xref> Adrenal insufficiency has also been described in these <named-content id="53ed552c-7449-49f7-b7f7-6394e5118170" data-cid="53ed552c-7449-49f7-b7f7-6394e5118170" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-type="HIGH" data-userid="" data-time="" data-username="" data-tag-index="12_7" data-pattern="$1" data-match="patients" data-offset="989" data-tag-desc="HIGH" data-replace="patients" data-function="addTrackChanges">patients</named-content> but that is mostly secondary due to hypophysitis or chronic glucocorticoid use either for the cancer or managing other IRAEs. In theory, there is concern for immune<named-content id="32a9ffc4-59d1-47be-a9bf-a2cc8bf9bccb" data-cid="1545433236" content-type="del cts-3" specific-use="1545434794970" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:26am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434794970" data-username="PV-A027-Ariel (COPYEDITOR)"> </named-content><named-content id="6c74dd18-c4fe-4629-92b9-ad15601fad4a" data-cid="1545433237" content-type="ins cts-3" specific-use="1545434795910" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:26am" data-track-detail="" data-userid="copyeditor 3519816058" data-time="1545434795910" data-username="PV-A027-Ariel (COPYEDITOR)">-</named-content>mediated adrenalitis, but that has not been reported very clearly mostly due to lack of comprehensive hormone panel and imaging<named-content data-cid="1545840499" id="2a4be336-f5cb-43a3-937a-f0e335d9dc24" content-type="del cts-5" specific-use="1545841938256" xlink:title="Yogish C Kudva (AUTHOR)" alt="author 3684625162" data-title="Deleted by Yogish C Kudva (AUTHOR) - Dec 26 2018 10:32am" data-track-detail="" data-userid="author 3684625162" data-username="Yogish C Kudva (AUTHOR)" data-time="1545841938256"> performed</named-content>. The occurrence of immune mediated thyroid disease has been described in more detail, occurring more frequently with PD-1 inhibitor use<xref id="195132db-cab8-475a-9106-58bc4f9342f3" ref-type="bibr" rid="R7 R8" data-citation-string=" R7 R8 " data-tag-type="BIBREF" data-track-change="7, 8" data-tag-index="12_4" data-pattern="" data-match="7, 8" data-offset="1438" data-tag-desc="BIBREF"><sup id="bcb6a4a0-b5b6-404e-a969-79806c5f874b">7 8</sup></xref> as <named-content id="c7cd1b08-74a1-4439-abc1-a7fa0fdb416f" data-cid="1545113216097" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-time="1545113216002" data-username="Exeter">compared to</named-content><named-content id="3bfa9f85-2115-43d2-a05e-28a9a7819fa7" data-cid="1545113216097" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-type="HIGH" data-track-change="compared to" data-userid="preediting" data-time="1545113216002" data-username="Exeter" data-tag-index="12_8" data-pattern="compared with" data-match="compared to" data-offset="1447" data-tag-desc="HIGH" data-replace="compared with" data-function="addTrackChanges">compared with</named-content> CTLA-4 inhibitor use.</p><p data-class="jrnlSecPara" id="b9ea6278-aca0-4aaa-aa57-5b5883b713e1" data-word-spacing="0.43w">The use of harmonized terminologies to report and describe IRAEs is a major issue in the field at this time. The quality of endocrine IRAE data reporting in clinical trials is suboptimal,<xref id="dacf42bc-cdd7-487b-9d15-2a9f264d4813" ref-type="bibr" rid="R9" data-citation-string=" R9 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="188" data-match="9" data-pattern="" data-tag-index="13_1" data-track-change="9"><sup id="3b2f49c7-a6b2-4836-a676-4e30ff036ddd">9</sup></xref> and important data such as the time of onset, clinical course and possible reversibility of such events are not systematically recorded or reported. New onset of diabetes mellitus has not been reported in clinical trials of CTLA-4 inhibitors and has been reported in<named-content id="89e4893f-b256-43b5-80b8-f03979bca302" data-cid="89e4893f-b256-43b5-80b8-f03979bca302" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣&lt;' to '⍽&lt;'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="458" data-match="in &amp;lt;1% of" data-replace=" &lt;" data-pattern=" $2" data-tag-index="13_7" data-track-change=" &amp;lt;" data-time="" data-username="" data-userid=""> &lt;</named-content><named-content id="209f0e34-54bb-46cc-b983-cb4561b310ec" data-cid="209f0e34-54bb-46cc-b983-cb4561b310ec" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="460" data-match="in &amp;lt;1% of" data-replace="1%" data-pattern="$3" data-tag-index="13_7" data-time="" data-username="" data-userid="">1%</named-content> of <named-content id="a7f9172f-d5f0-4a6f-a157-794b008ba52b" data-cid="a7f9172f-d5f0-4a6f-a157-794b008ba52b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="466" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="13_12" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> in PD-1 inhibitor clinical trials. However, higher rates of up to <named-content id="d9d71911-0a43-483b-bfaf-79bd15df1c03" data-cid="d9d71911-0a43-483b-bfaf-79bd15df1c03" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="541" data-match="1.5%" data-replace="1.5" data-pattern="$1" data-tag-index="13_8" data-time="" data-username="" data-userid="">1.5</named-content><named-content id="848b3ecc-70d9-47dc-ad3c-d4fe8b349412" data-cid="848b3ecc-70d9-47dc-ad3c-d4fe8b349412" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="544" data-match="1.5%" data-replace="%" data-pattern="%" data-tag-index="13_8" data-time="" data-username="" data-userid="">%</named-content> were reported with combined use of CTLA-4 and PD-1 inhibitors recently.<xref id="be7b38d1-0314-4269-b312-fdc94959a108" ref-type="bibr" rid="R10" data-citation-string=" R10 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="618" data-match="10" data-pattern="" data-tag-index="13_2" data-track-change="10"><sup id="ed916cb2-d40b-460f-a3ec-a65170dc1722">10</sup></xref> Clinical trials for PD-L1 inhibitors have not reported new<named-content data-cid="1545433938" id="89cea0e0-e5d6-4896-8300-01f9d9632216" content-type="del cts-3" specific-use="1545443379466" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:49am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443379466"> </named-content><named-content data-cid="1545433939" id="ef04ac56-4a7a-4df4-a7bb-781c67dd1c85" content-type="ins cts-3" specific-use="1545443379725" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:49am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443379725">-</named-content>onset diabetes, but a case of this has been published.<xref id="962f6a2f-b0c3-46da-a027-0a99bafaa48c" ref-type="bibr" rid="R11" data-citation-string=" R11 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="737" data-match="11" data-pattern="" data-tag-index="13_3" data-track-change="11"><sup id="6a3a0d5d-97db-487c-bb10-4b0ebaaeb2c6">11</sup></xref> A recent meta-analysis of clinical trials of ICIs demonstrated <named-content id="debeab45-9619-4dc8-8d64-b268a1b5b896" data-cid="debeab45-9619-4dc8-8d64-b268a1b5b896" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="805" data-match="0.2%" data-replace="0.2" data-pattern="$1" data-tag-index="13_9" data-time="" data-username="" data-userid="">0.2</named-content><named-content id="978f96d1-8b15-4f0f-8ca5-5400a69b572f" data-cid="978f96d1-8b15-4f0f-8ca5-5400a69b572f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="808" data-match="0.2%" data-replace="%" data-pattern="%" data-tag-index="13_9" data-time="" data-username="" data-userid="">%</named-content> frequency of insulin-deficient diabetes.<xref id="4600fe97-030c-4920-b965-97ff22081af4" ref-type="bibr" rid="R12" data-citation-string=" R12 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="851" data-match="12" data-pattern="" data-tag-index="13_4" data-track-change="12"><sup id="43616ff8-b6eb-4010-816c-0a468e58bf98">12</sup></xref> A recent review of 24 reported cases from multiple centers has synthesized the available information.<xref id="ce47da46-d85c-4bdd-979e-8e010bc3c454" ref-type="bibr" rid="R13" data-citation-string=" R13 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="958" data-match="13" data-pattern="" data-tag-index="13_5" data-track-change="13"><sup id="4175f375-2215-46b2-905f-f79ea63273db">13</sup></xref> A case series of <named-content data-cid="1545433238" id="c1e56515-c4a0-44db-adc0-657dca016472" content-type="del cts-3" specific-use="1545434864840" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:27am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434864840">5</named-content><named-content data-cid="1545433239" id="6e14b0af-d747-429a-afa8-31379b7f0cfb" content-type="ins cts-3" specific-use="1545434865313" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:27am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434865313">five</named-content> <named-content id="209bb79d-6a33-4e77-bea0-4bf9491644a3" data-cid="209bb79d-6a33-4e77-bea0-4bf9491644a3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="982" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="13_13" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> who developed autoimmune diabetes after starting an anti-PD-1 agent described possible risk factors, including <named-content rid="003ccf08-cf4f-4d6a-9512-febb99ef768a" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" data-style="" content-type="jrnlQueryRef" specific-use="start" id="4c5edd46-0aa3-44b3-b822-aa61d9a866c3" data-answered="true"/><named-content data-cid="1546444811" id="d5c36f5c-599e-41d0-8425-e9930599c8c7" content-type="del cts-6" specific-use="1546444889147" xlink:title="Nabjyoti (BMJ)" alt="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-title="Deleted by Nabjyoti (BMJ) - Jan 2 2019 9:31pm" data-track-detail="" data-userid="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-username="Nabjyoti (BMJ)" data-time="1546444889147">HLA</named-content><named-content rid="003ccf08-cf4f-4d6a-9512-febb99ef768a" data-class="jrnlQueryRef" data-type="end" content-type="jrnlQueryRef" specific-use="end" id="fa57e799-e04a-4c84-8cc1-fe8b4a0b2d7f" data-answered="true"/><named-content data-cid="1546444811" id="fc50c9b9-ac97-4982-bfea-12d727d5dfb1" content-type="del cts-6" specific-use="1546444889147" xlink:title="Nabjyoti (BMJ)" alt="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-title="Deleted by Nabjyoti (BMJ) - Jan 2 2019 9:31pm" data-track-detail="" data-userid="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-username="Nabjyoti (BMJ)" data-time="1546444889147"> </named-content><named-content data-cid="1545840468" id="7f8bf3cd-1c94-4e08-93ae-75c545e6d929" content-type="ins cts-5" specific-use="1545841203875" xlink:title="Yogish C Kudva (AUTHOR)" alt="author 3684625162" data-title="Inserted by Yogish C Kudva (AUTHOR) - Dec 26 2018 10:20am" data-track-detail="" data-userid="author 3684625162" data-username="Yogish C Kudva (AUTHOR)" data-time="1545841203875"><named-content data-cid="1546444811" id="c7ffd4d5-9fc6-443e-ae56-e03740d9cb40" content-type="del cts-6" specific-use="1546444889147" xlink:title="Nabjyoti (BMJ)" alt="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-title="Deleted by Nabjyoti (BMJ) - Jan 2 2019 9:31pm" data-track-detail="" data-userid="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-username="Nabjyoti (BMJ)" data-time="1546444889147">(</named-content>human leukocyte antigen<named-content data-cid="1546444806" id="6a3f3448-2fc2-4157-b72c-420405132256" content-type="ins cts-6" specific-use="1546444882120" xlink:title="Nabjyoti (BMJ)" alt="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-title="Inserted by Nabjyoti (BMJ) - Jan 2 2019 9:31pm" data-track-detail="" data-userid="publisher 80cc594c-2ef3-41db-94a0-d5f511bf3915" data-username="Nabjyoti (BMJ)" data-time="1546444882120"> (HLA</named-content>) </named-content>association and combined use of checkpoint inhibitors.<xref id="82cbd32a-763c-456b-8ff8-89c36a8f8776" ref-type="bibr" rid="R14" data-citation-string=" R14 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1161" data-match="14" data-pattern="" data-tag-index="13_6" data-track-change="14"><sup id="cd059d8f-8470-4198-958c-69fdcabca1e4">14</sup></xref> More recently, <named-content rid="5be9e6f1-57f6-4a57-84fe-db72340c9264" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="typesetter" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" data-style="" content-type="jrnlQueryRef" specific-use="start" id="d965c011-0252-45da-b2bc-8f85c40ddfd4" data-replied="true"/>Stamatouli<named-content rid="5be9e6f1-57f6-4a57-84fe-db72340c9264" data-class="jrnlQueryRef" data-type="end" content-type="jrnlQueryRef" specific-use="end" id="aeca3227-b7a1-4593-9709-f65b866b8f38" data-replied="true"/> <named-content id="ee14382b-3c7d-426e-9bd6-00ff31ba7401" data-cid="ee14382b-3c7d-426e-9bd6-00ff31ba7401" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="1192" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="13_10" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="9d8e95f2-75ce-49e9-9b2f-818428698b1e">et al</italic></named-content><named-content id="d73738d8-71d0-409d-ae44-54001ae3ea41" data-cid="d73738d8-71d0-409d-ae44-54001ae3ea41" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ETLDOT" data-track-detail="" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="1197" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="13_11" data-time="" data-username="" data-userid=""><named-content data-cid="1545463825" id="b3b7399e-32fb-4aef-a8a4-a82b5d93998d" content-type="del cts-4" specific-use="1545463883546" xlink:title="Asha (TYPESETTER)" alt="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-title="Deleted by Asha (TYPESETTER) - Dec 22 2018 1:01pm" data-track-detail="" data-userid="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-username="Asha (TYPESETTER)" data-time="1545463883546">.</named-content><xref id="d0be8d28-7945-4ea0-9f96-235ba8e39e70" ref-type="bibr" rid="R15" data-citation-string=" R15 " data-track="ins" data-cid="1545463881051" data-username="Asha (TYPESETTER)" data-userid="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-time="1545463881051" data-cite-type="insert"><sup id="e1aaab35-b281-4986-9a24-548a33314fcf">15</sup></xref> </named-content>reported on their experience with 24 <named-content id="93486b2f-c221-4687-a9eb-8bfbc441f413" data-cid="93486b2f-c221-4687-a9eb-8bfbc441f413" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1236" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="13_14" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> of ICI<named-content data-cid="1545433243" id="ea530301-a668-4f00-8680-bf7359694f9f" content-type="del cts-3" specific-use="1545434915008" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:28am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434915008"> </named-content><named-content data-cid="1545433244" id="0510bed6-c0f1-4796-a803-3e483b049196" content-type="ins cts-3" specific-use="1545434915876" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:28am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434915876">-</named-content>induced diabetes showing an association with HLA-DR4 (15). Most of these studies have reported on their experience based on <named-content id="2a754ac9-d599-4d41-bfe1-0230fab5cc79" data-cid="2a754ac9-d599-4d41-bfe1-0230fab5cc79" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1376" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="13_15" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> referred for concern of ICI<named-content data-cid="1545433245" id="f4533ac5-635c-4e50-8226-7c32cb643138" content-type="del cts-3" specific-use="1545434975068" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:29am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434975068"> </named-content><named-content data-cid="1545433246" id="4bab3a7e-64b5-4091-9486-5ee847f0eeaf" content-type="ins cts-3" specific-use="1545434975333" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:29am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545434975333">-</named-content>induced diabetes, hence the frequency of this condition has not been well addressed in real world practice. The natural history of the disease and its associated risk factors also need better characterization, and we aimed to address these knowledge gaps.</p><title data-level="1" data-class="jrnlHead1" old-class="" id="77a585d8-1fe3-4e13-95a6-34bcc3c08006">Methods</title><title data-level="2" data-class="jrnlHead2" old-class="" id="143f4dfc-6cb6-4814-8fff-194fe58e06d9"><named-content data-cid="1545113216121" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002" data-reason="truecase" id="28d96b13-713c-426e-9de3-ae1eeb9841f4">Subject Identification and Case Definition</named-content><named-content data-cid="1545113216121" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002" data-reason="truecase" id="d8f06de8-2b5b-4466-ab54-e793b93d0053">Subject identification and case definition</named-content></title><p data-class="jrnlSecPara" id="40a191ce-0aaa-4cee-a9fb-0c3eed9ab48c" data-word-spacing="0.43w">After receiving approval from the Mayo Clinic Institutional Review Board, we reviewed our cancer <named-content id="3a08eca8-799a-4d96-9693-0c03ff70cde1" data-cid="3a08eca8-799a-4d96-9693-0c03ff70cde1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'center' to 'center'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="97" data-match="center" data-replace="center" data-pattern="$1" data-tag-index="14_6" data-function="addTrackChanges" data-time="" data-username="" data-userid="">center</named-content> database of <named-content id="e7a61811-f708-4419-a86a-e4e7c7ea262d" data-cid="e7a61811-f708-4419-a86a-e4e7c7ea262d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="116" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="14_7" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> treated with a CTLA-4 inhibitor (ipilimumab) or PD-1 inhibitor (pembrolizumab and nivolumab) from January<named-content data-cid="1545433247" id="ee11e2a9-4df4-4388-aefa-1677f888ae29" content-type="del cts-3" specific-use="1545435051832" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:30am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435051832">,</named-content> 2012 t<named-content data-cid="1545433249" id="a557b9e8-4876-4daf-9b95-08236fe111bc" content-type="ins cts-3" specific-use="1545435056610" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:30am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435056610">o</named-content><named-content data-cid="1545433250" id="8c818bde-64b4-48ef-9fcd-9ab13de193ed" content-type="del cts-3" specific-use="1545435058947" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:30am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435058947">hrough</named-content> December<named-content data-cid="1545433248" id="f7323419-ecc6-44a1-9754-fe5c41f80362" content-type="del cts-3" specific-use="1545435054443" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:30am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435054443">,</named-content> 2017. During this time period, a total of <named-content id="4abf19b5-2a2e-4aeb-bc30-cf2655968904" data-cid="4abf19b5-2a2e-4aeb-bc30-cf2655968904" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="297" data-match="1444" data-replace="1444" data-pattern="1444" data-tag-index="14_5" data-time="" data-username="" data-userid="">1444</named-content> <named-content data-cid="1545433251" id="045e883e-4de2-4712-84d7-386dd6060c4b" content-type="ins cts-3" specific-use="1545435065265" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:31am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435065265">patients with </named-content>cancer<named-content data-cid="1545433265" id="a50098dc-b9b0-45f8-8b38-d1a599ba88c9" content-type="del cts-3" specific-use="1545435071855" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:31am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435071855"> </named-content><named-content id="91f72320-2a35-4243-9a18-0b662911dbd7" data-cid="91f72320-2a35-4243-9a18-0b662911dbd7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="309" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="14_8" data-function="addTrackChanges" data-time="" data-username="" data-userid=""><named-content data-cid="1545433265" id="125aa574-e2c9-47e4-89f0-78981e75b58b" content-type="del cts-3" specific-use="1545435071855" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:31am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435071855">patients</named-content></named-content> received therapy with one of these ICIs, of which 281 received ipilimumab, 774 received pembrolizumab and 389 received nivolumab. From this list, medical charts were reviewed to identify cases concerning for ICI<named-content data-cid="1545433929" id="af08baf1-6891-4f9e-8ab7-56f8cf803bce" content-type="del cts-3" specific-use="1545443064134" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443064134"> </named-content><named-content data-cid="1545433930" id="db5ed6ca-3f94-4045-99ad-607061bfc38e" content-type="ins cts-3" specific-use="1545443065013" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443065013">-</named-content>induced insulin-dependent diabetes based on the following criteria:</p><list id="d836f48c-a934-4920-8cfd-6c85f40825c3" list-content="ol" list-type="order"><list-item id="a9a4caff-a91c-4eca-ae1d-924ee7d280d1"><p data-class="jrnlListPara" data-class-name="SecPara" id="ff0a43a3-a4a4-40d8-800f-e80fb85d9076"><named-content id="53e7bb73-d808-47ad-8ed1-4e45be738ce9" data-cid="53e7bb73-d808-47ad-8ed1-4e45be738ce9" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid="">1.</named-content>New diagnosis of insulin-dependent diabetes or hyperglycemic crisis.</p></list-item><list-item id="80eab1a5-240c-44fa-a440-e734501aff11"><p data-class="jrnlListPara" data-class-name="SecPara" id="d4a1e7e1-2840-4930-99e9-add57e04bc9b"><named-content id="9d38a7d3-6706-40b2-b8d9-78682a44a21c" data-cid="9d38a7d3-6706-40b2-b8d9-78682a44a21c" content-type="del cts-1" specific-use="" xlink:title="" alt="" data-title="" data-track-detail="" data-time="" data-username="" data-userid="">2.</named-content>Worsening of pre<named-content data-cid="1545433266" content-type="del cts-3" specific-use="1545435107610" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:31am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435107610" id="827c4178-4f5d-447e-8681-0d88dc285a3c">-</named-content>diabetes or type <named-content data-cid="1545113216009" id="08322475-467c-479b-a0bb-712e8b87d17e" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="3aa62e4a-f41c-4649-8b64-b8f7cfa504a0" data-cid="1545113216009" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="38" data-match="2" data-pattern="" data-tag-index="16_4" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433267" content-type="del cts-3" specific-use="1545435110283" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:31am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435110283" id="e57370ee-6f09-4b6f-8bd8-293e8ca9be36">two</named-content></named-content><named-content data-cid="1545433270" content-type="ins cts-3" specific-use="1545435111610" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:31am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435111610" id="c0ff19f4-52fd-447b-898f-af148e0cf468">2</named-content> diabetes without another attributable reason, defined as an increase in hemoglobin A1c (HbA1c) value by <named-content id="e5c6f99b-6ae9-4b19-a97f-61722923f0ed" data-cid="e5c6f99b-6ae9-4b19-a97f-61722923f0ed" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="144" data-match="10%" data-replace="10" data-pattern="$1" data-tag-index="16_1" data-time="" data-username="" data-userid="">10</named-content><named-content id="308017c1-b531-4943-8dd1-01d13b5bc076" data-cid="308017c1-b531-4943-8dd1-01d13b5bc076" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="146" data-match="10%" data-replace="%" data-pattern="%" data-tag-index="16_1" data-time="" data-username="" data-userid="">%</named-content> in <named-content id="214e5d39-1516-4808-ba8a-66a55c8a9fd9" data-cid="214e5d39-1516-4808-ba8a-66a55c8a9fd9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="151" data-match="6 months" data-replace="6" data-pattern="$1" data-tag-index="16_2" data-time="" data-username="" data-userid="">6</named-content><named-content id="a9f27866-b160-4761-b9a3-5a5f2761a252" data-cid="a9f27866-b160-4761-b9a3-5a5f2761a252" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="152" data-match="6 months" data-replace=" months" data-pattern=" $2" data-tag-index="16_2" data-time="" data-username="" data-userid=""> months</named-content>, clinical need for a second anti<named-content data-cid="1545433271" content-type="del cts-3" specific-use="1545435122145" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435122145" id="f3956458-2932-4ee4-bae3-53a4bd9c9557">-</named-content>hyperglycemic agent or insulin, diabetic ketoacidosis (<named-content id="ce8acba6-0a74-4f50-a0c9-396d9201e53c" data-cid="ce8acba6-0a74-4f50-a0c9-396d9201e53c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="248" data-match=" (DKA)" data-pattern="" data-tag-index="16_3" data-time="" data-username="" data-userid="">DKA</named-content>)<named-content data-cid="1545433272" content-type="del cts-3" specific-use="1545435125365" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435125365" id="1fc96a9e-46fa-4d8a-bd23-65983daabb9c">,</named-content><named-content data-cid="1545433273" content-type="ins cts-3" specific-use="1545435136328" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435136328" id="f2ce2f19-97c0-4b56-ba53-60e30a1f5952">,</named-content> or new<named-content data-cid="1545433940" content-type="del cts-3" specific-use="1545443382445" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:49am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443382445" id="27b51b0b-2c11-4514-8e0d-3cdbc07825b5"> </named-content><named-content data-cid="1545433941" content-type="ins cts-3" specific-use="1545443382733" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:49am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443382733" id="30377d60-815f-4774-8277-1333201ce0f0">-</named-content>onset ketonuria or ketonemia.</p></list-item></list><p data-class="jrnlSecPara" id="a415b68f-aabb-414a-b0f1-c6bf879bc5bd" data-word-spacing="0.43w">We chose duration of <named-content id="07dade40-cf4b-4f19-ba85-904963321b85" data-cid="07dade40-cf4b-4f19-ba85-904963321b85" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="21" data-match="6 months" data-replace="6" data-pattern="$1" data-tag-index="17_1" data-time="" data-username="" data-userid="">6</named-content><named-content id="1a0b5573-e128-4250-b5de-efc8f6c90c05" data-cid="1a0b5573-e128-4250-b5de-efc8f6c90c05" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="22" data-match="6 months" data-replace=" months" data-pattern=" $2" data-tag-index="17_1" data-time="" data-username="" data-userid=""> months</named-content> to ensure that we saw a pattern of persistent worsening. We chose an increase in HbA1c of <named-content id="94be042e-5166-4f92-95ab-1d33bacb9850" data-cid="94be042e-5166-4f92-95ab-1d33bacb9850" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="120" data-match="10 %" data-replace="10" data-pattern="$1" data-tag-index="17_2" data-time="" data-username="" data-userid="">10</named-content><named-content id="9134a22a-f5c2-4c6e-859c-c679e2ce375a" data-cid="9134a22a-f5c2-4c6e-859c-c679e2ce375a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣%' to '%'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="122" data-match="10 %" data-replace="%" data-pattern="%" data-tag-index="17_2" data-track-change=" %" data-time="" data-username="" data-userid="">%</named-content> since we believe this represents a significant change. We excluded <named-content id="ee38baed-7ea0-408d-8a53-2c3be7e0b52f" data-cid="ee38baed-7ea0-408d-8a53-2c3be7e0b52f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="192" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="17_5" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with pre-existing type <named-content data-cid="1545113216010" id="f26e8362-3a6f-4095-bf1a-bc6c54f93283" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="be1d39b2-9253-46a3-abd9-08249303f9d3" data-cid="1545113216010" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="224" data-match="1" data-pattern="" data-tag-index="17_3" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433274" id="15111932-4f9b-44f3-b78d-965bbe7fe883" content-type="del cts-3" specific-use="1545435422703" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:37am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435422703">one</named-content></named-content><named-content data-cid="1545433275" id="03bf8a80-25cd-4dd8-a23a-c1dba33a5c2b" content-type="ins cts-3" specific-use="1545435422844" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:37am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435422844">1</named-content> diabetes and those with type <named-content data-cid="1545113216011" id="f6d034a3-1df1-419a-8c3a-8f976b15e9c7" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="9629228e-9528-4e08-b6be-bb71e043c251" data-cid="1545113216011" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="255" data-match="2" data-pattern="" data-tag-index="17_4" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433276" id="e4eb3842-f84a-435e-8d4e-8f8e7e6482fe" content-type="del cts-3" specific-use="1545435425740" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:37am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435425740">two</named-content></named-content><named-content data-cid="1545433277" id="b711bc7c-0b81-4580-ae62-cf8a27a0bf85" content-type="ins cts-3" specific-use="1545435425836" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:37am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435425836">2</named-content> diabetes on insulin pump prior to ICI initiation<named-content data-cid="1545433278" id="ab419dd2-974b-4245-8605-60f756c9731d" content-type="del cts-3" specific-use="1545435428751" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:37am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435428751">,</named-content> but did not identify any such <named-content id="32096a99-f4ee-4b7a-b5d8-92b2736b19a0" data-cid="32096a99-f4ee-4b7a-b5d8-92b2736b19a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="337" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="17_6" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> during subject identification. We collected data for baseline variables at the start of ICI therapy, diabetes<named-content data-cid="1545433279" id="e95e9d69-ac6a-4d25-bca8-db0642d922d6" content-type="del cts-3" specific-use="1545435434604" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:37am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435434604"> </named-content><named-content data-cid="1545433280" id="0f7329d9-95fc-41ec-96af-026556108a74" content-type="ins cts-3" specific-use="1545435434887" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:37am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435434887">-</named-content>related clinical and laboratory variables at the time of diagnosis and also at the most recent <named-content data-cid="1545113216098" id="17bc8355-862c-496e-a31e-0c69896df5ec" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow up</named-content><named-content id="8fc49d55-c1fa-45b2-98a1-a0b0620ec549" data-cid="1545113216098" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="551" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="17_7" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow-up</named-content>.</p><title data-level="2" data-class="jrnlHead2" old-class="" id="35f64f07-f727-4601-a2c9-ff7d7e31c78d">Laboratory testing</title><p data-class="jrnlSecPara" id="87c80c02-bd2c-4cff-bf9b-fb9165895a22" data-word-spacing="0.43w">All laboratory testing was performed at the Mayo Medical Laboratory, Rochester, Minnesota. Autoantibodies associated with type <named-content data-cid="1545113216012" id="27a475a2-832a-431e-9408-9852846bd689" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="490c0769-dc3b-4495-9beb-26b3f8460d58" data-cid="1545113216012" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="127" data-match="1" data-pattern="" data-tag-index="18_2" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433281" id="27fc360b-36fb-4f7d-868a-1511feef9fd7" content-type="del cts-3" specific-use="1545435449197" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:37am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435449197">one</named-content></named-content><named-content data-cid="1545433284" id="d5a8e011-e2d9-48e1-be08-bc96dc5d34e8" content-type="ins cts-3" specific-use="1545435450098" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:37am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435450098">1</named-content> diabetes that were measured included antibodies against glutamic acid decarboxylase 65 (GAD65), islet antigen 2<named-content data-cid="1545433925" id="8355ffa1-d0b3-4f02-8e6f-73a9028bab7c" content-type="del cts-3" specific-use="1545442614176" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:36am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442614176"> (IA-2)</named-content>, zinc transporter 8<named-content data-cid="1545433923" id="f8c10439-2002-4b00-9e6e-d57e7393d085" content-type="del cts-3" specific-use="1545442595675" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:36am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442595675"> (ZnT8)</named-content> and insulin autoantibodies<named-content data-cid="1545433924" id="5e0b3225-ad67-4664-a83f-89883981f5ca" content-type="del cts-3" specific-use="1545442602901" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:36am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442602901"> (</named-content><named-content id="b4152a24-06d0-40f1-9f8b-d5229de115bb" data-cid="b4152a24-06d0-40f1-9f8b-d5229de115bb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="303" data-match=" (IAA)" data-pattern="" data-tag-index="18_1" data-time="" data-username="" data-userid=""><named-content data-cid="1545433924" id="a87fad56-ee03-4002-b03e-89872b432f49" content-type="del cts-3" specific-use="1545442602901" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:36am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442602901">IAA</named-content></named-content><named-content data-cid="1545433924" id="f086234c-0ab7-4dd1-af29-d531356642c1" content-type="del cts-3" specific-use="1545442602901" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:36am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442602901">)</named-content>.</p><title data-level="1" data-class="jrnlHead1" old-class="" id="87f4ab63-603d-4f49-9471-0cef51a92c8e">Results</title><title data-level="2" data-class="jrnlHead2" old-class="" id="ef61ca44-3525-4a02-b220-302f33fe9fc3">Frequency of ICI<named-content data-cid="1545433285" content-type="del cts-3" specific-use="1545435483164" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435483164" id="531139e4-00a9-4a1f-820c-1789b6b1a01b"> </named-content><named-content data-cid="1545433286" content-type="ins cts-3" specific-use="1545435483413" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435483413" id="48392eab-2b57-44e7-b625-7fcaf9173dee">-</named-content>induced diabetes</title><p data-class="jrnlSecPara" id="62d4c9ac-b122-4004-8d3a-8122f2f5967b" data-word-spacing="0.43w">From a total of <named-content id="8ad968d6-af41-46ec-bf7d-92782cfa0d20" data-cid="8ad968d6-af41-46ec-bf7d-92782cfa0d20" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="16" data-match="1444" data-replace="1444" data-pattern="1444" data-tag-index="19_15" data-time="" data-username="" data-userid="">1444</named-content> ICI<named-content data-cid="1545433287" id="ab8ed555-7b16-4dd0-8f01-d24bfbb0efd4" content-type="del cts-3" specific-use="1545435496955" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435496955"> </named-content><named-content data-cid="1545433288" id="f7a5aea6-1962-47d5-a2c9-8fda494e2ff9" content-type="ins cts-3" specific-use="1545435498349" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435498349">-</named-content>treated<named-content data-cid="1545433289" id="979d1105-d2a4-4158-8597-a949b9c5da18" content-type="ins cts-3" specific-use="1545435499679" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435499679"> patients with</named-content> cancer<named-content data-cid="1549534621" id="657a1cb1-948b-4206-be34-844d0aa2d558" content-type="del cts-4" specific-use="1549534670214" xlink:title="Asha (TYPESETTER)" alt="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-title="Deleted by Asha (TYPESETTER) - Feb 7 2019 3:47pm" data-track-detail="" data-userid="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-username="Asha (TYPESETTER)" data-time="1549534670214"> </named-content><named-content id="3f66e759-1f47-464d-9b0d-7641270566f7" data-cid="3f66e759-1f47-464d-9b0d-7641270566f7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="40" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="19_28" data-function="addTrackChanges" data-time="" data-username="" data-userid=""><named-content data-cid="1545840501" id="ecc00b08-7b65-4082-8e7d-b524cd38ea0d" content-type="del cts-5" specific-use="1545842314165" xlink:title="Yogish C Kudva (AUTHOR)" alt="author 3684625162" data-title="Deleted by Yogish C Kudva (AUTHOR) - Dec 26 2018 10:38am" data-track-detail="" data-userid="author 3684625162" data-username="Yogish C Kudva (AUTHOR)" data-time="1545842314165">patient</named-content></named-content>, 21 <named-content id="22d8a9f1-b365-4a9b-9ae0-096c895ca132" data-cid="22d8a9f1-b365-4a9b-9ae0-096c895ca132" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="53" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="19_29" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> (1.4%) met criteria for ICI<named-content data-cid="1545433305" id="e2e6bd25-76a9-411e-8992-d8e332b4a12f" content-type="del cts-3" specific-use="1545435508037" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435508037"> </named-content><named-content data-cid="1545433306" id="0b4e9674-09a2-4ffb-abb5-c58e4eff9192" content-type="ins cts-3" specific-use="1545435508301" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435508301">-</named-content>induced diabetes, of which <named-content id="28ce72e5-0fe3-476a-8030-4bd2d6e1495c" data-cid="28ce72e5-0fe3-476a-8030-4bd2d6e1495c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="117" data-match="12 (0.8%)" data-replace="12" data-pattern="$1" data-tag-index="19_1" data-time="" data-username="" data-userid="">12</named-content><named-content id="8b9d453a-9817-467b-ab32-f40cb8bacd88" data-cid="8b9d453a-9817-467b-ab32-f40cb8bacd88" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="119" data-match="12 (0.8%)" data-replace=" (0.8%)" data-pattern=" $2" data-tag-index="19_1" data-time="" data-username="" data-userid=""> (0.8%)</named-content> had new<named-content data-cid="1545433942" id="7f230eea-bcb0-4d1e-b28a-85bfd1ed94e1" content-type="del cts-3" specific-use="1545443385384" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:49am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443385384"> </named-content><named-content data-cid="1545433943" id="fddd62ea-dcd4-498d-af5a-bdf8b7f8a7ad" content-type="ins cts-3" specific-use="1545443385671" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:49am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443385671">-</named-content>onset insulin-dependent diabetes and <named-content id="a9fca6a0-eec8-4ed1-b6f0-8bd930a3d245" data-cid="a9fca6a0-eec8-4ed1-b6f0-8bd930a3d245" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="172" data-match="9 (0.6%)" data-replace="9" data-pattern="$1" data-tag-index="19_2" data-time="" data-username="" data-userid="">9</named-content><named-content id="9083375a-f26a-4835-b0f1-26d018f1fb73" data-cid="9083375a-f26a-4835-b0f1-26d018f1fb73" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="173" data-match="9 (0.6%)" data-replace=" (0.6%)" data-pattern=" $2" data-tag-index="19_2" data-time="" data-username="" data-userid=""> (0.6%)</named-content> had unexplained worsening of pre<named-content data-cid="1545433307" id="e5a072db-a34d-4d4b-a72e-2c0003c5826c" content-type="ins cts-3" specific-use="1545435515371" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435515371">-</named-content>existing type <named-content data-cid="1545113216013" id="97986ee5-71e1-4d31-b3e5-1ca65fe5dc1d" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="387bbb58-a411-459a-ba2c-c8fb0b51a21d" data-cid="1545113216013" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="227" data-match="2" data-pattern="" data-tag-index="19_17" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433308" id="a461ae0d-6804-4eed-9d48-505bb10a9e50" content-type="del cts-3" specific-use="1545435518500" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435518500">two</named-content></named-content><named-content data-cid="1545433309" id="9243bf9c-c64e-4ab6-a431-0a1595c53e7b" content-type="ins cts-3" specific-use="1545435518609" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435518609">2</named-content> diabetes. There were no cases of ICI<named-content data-cid="1545433310" id="e4f47362-5b68-4d20-916b-6de12368dbcd" content-type="del cts-3" specific-use="1545435521243" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435521243"> </named-content><named-content data-cid="1545433311" id="7b00723f-c904-4231-b946-97e4545676f0" content-type="ins cts-3" specific-use="1545435521537" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435521537">-</named-content>induced diabetes in the 281 <named-content id="1dcf7356-b141-4a9c-ba9b-1ddcbd2562ef" data-cid="1dcf7356-b141-4a9c-ba9b-1ddcbd2562ef" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="294" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="19_30" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> treated with CTLA-4 inhibitor ipilimumab alone, 25 of whom had pre-exisiting type <named-content data-cid="1545113216014" id="291771ad-1b3a-413b-8554-d4fa0708f691" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="dcec60c8-5f6b-4a0b-9d7f-c97618cef1e6" data-cid="1545113216014" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="385" data-match="2" data-pattern="" data-tag-index="19_18" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433312" id="209e74b8-00e2-42bc-96df-bde90804aee2" content-type="del cts-3" specific-use="1545435528512" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435528512">two</named-content></named-content><named-content data-cid="1545433313" id="7edafa34-f22b-48fa-ba78-d9a32ade6783" content-type="ins cts-3" specific-use="1545435528618" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435528618">2</named-content> diabetes. <named-content data-cid="1545113216099" id="bc45cdf0-5b4e-419e-9b7e-bafea7720fa9" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">Amongst</named-content><named-content id="dafb6df7-f7b9-4822-a3e2-42ced08b4154" data-cid="1545113216099" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'Amongst' to 'Among'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="397" data-match="Amongst" data-replace="Among" data-pattern="Among" data-tag-index="19_31" data-function="addTrackChanges" data-track-change="Amongst" data-userid="preediting" data-username="Exeter" data-time="1545113216002">Among</named-content> the <named-content id="e448df7a-38c4-4be0-a983-9435725de409" data-cid="e448df7a-38c4-4be0-a983-9435725de409" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="THSE" data-track-detail="" data-tag-desc="THSE" data-tag-type="THSE" data-offset="409" data-match="1163" data-replace="1163" data-pattern="1163" data-tag-index="19_16" data-time="" data-username="" data-userid="">1163</named-content> <named-content id="af518f9b-210b-4625-99ba-e105aeabd329" data-cid="af518f9b-210b-4625-99ba-e105aeabd329" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="414" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="19_32" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> treated with a PD-1 inhibitor, <named-content id="df0bc158-9bfb-48b7-91bc-aee33e5f66a0" data-cid="df0bc158-9bfb-48b7-91bc-aee33e5f66a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="454" data-match="21 (1.8%)" data-replace="21" data-pattern="$1" data-tag-index="19_3" data-time="" data-username="" data-userid="">21</named-content><named-content id="2b618801-58db-4f20-a8db-443b0b27e42d" data-cid="2b618801-58db-4f20-a8db-443b0b27e42d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="456" data-match="21 (1.8%)" data-replace=" (1.8%)" data-pattern=" $2" data-tag-index="19_3" data-time="" data-username="" data-userid=""> (1.8%)</named-content> (17 on pembrolizumab and <named-content data-cid="1545113216015" id="bb67cba7-b430-4a6b-afc5-000f01280fcc" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">4</named-content><named-content id="b0e2da9a-5f57-488f-83d1-af4714f57ca3" data-cid="1545113216015" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '4' to 'four'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="489" data-match="4" data-pattern="" data-tag-index="19_19" data-function="numberToText,addTrackChanges" data-track-change="4" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433314" id="7ac595b9-7289-4f78-91e5-22329372a003" content-type="del cts-3" specific-use="1545435538753" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435538753">four</named-content></named-content><named-content data-cid="1545433315" id="70c69222-0202-4bfe-b51c-6bc067b0c74d" content-type="ins cts-3" specific-use="1545435538859" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:38am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435538859">4</named-content> on nivolumab) met criteria for ICI<named-content data-cid="1545433316" id="4b0f1b17-8d8d-4d41-83d5-d7a4abd9ea0d" content-type="del cts-3" specific-use="1545435541046" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435541046"> </named-content><named-content data-cid="1545433317" id="0b107398-88de-4f6b-8ea4-1e6342957d12" content-type="ins cts-3" specific-use="1545435541303" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435541303">-</named-content>induced diabetes, of which <named-content id="c3751f77-8f37-4790-9453-d42b3b84d36e" data-cid="c3751f77-8f37-4790-9453-d42b3b84d36e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="553" data-match="12 (1%)" data-replace="12" data-pattern="$1" data-tag-index="19_4" data-time="" data-username="" data-userid="">12</named-content><named-content id="10bfac55-bc24-48af-9c39-6ada42950cb8" data-cid="10bfac55-bc24-48af-9c39-6ada42950cb8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="555" data-match="12 (1%)" data-replace=" (1%)" data-pattern=" $2" data-tag-index="19_4" data-time="" data-username="" data-userid=""> (1%)</named-content> had new-onset insulin-dependent diabetes and <named-content id="b89430f3-f242-46aa-b2ad-876a7007b4bc" data-cid="b89430f3-f242-46aa-b2ad-876a7007b4bc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="606" data-match="9 (0.8%)" data-replace="9" data-pattern="$1" data-tag-index="19_5" data-time="" data-username="" data-userid="">9</named-content><named-content id="e743e32f-f649-45e6-8d9d-2101e1e20d5d" data-cid="e743e32f-f649-45e6-8d9d-2101e1e20d5d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="607" data-match="9 (0.8%)" data-replace=" (0.8%)" data-pattern=" $2" data-tag-index="19_5" data-time="" data-username="" data-userid=""> (0.8%)</named-content> experienced worsening of pre-existing type <named-content data-cid="1545113216016" id="dde4ecd6-02b5-410d-8756-f0b56bf74990" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="ecec42dd-31e0-4d82-850e-1eefe1141f5a" data-cid="1545113216016" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="658" data-match="2" data-pattern="" data-tag-index="19_20" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433318" id="82f4dff9-51e5-42c9-8816-513bbc024097" content-type="del cts-3" specific-use="1545435548257" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435548257">two</named-content></named-content><named-content data-cid="1545433319" id="f4963ebd-7971-413f-b28c-068faee215ef" content-type="ins cts-3" specific-use="1545435548366" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435548366">2</named-content> diabetes. In this cohort, 96 had pre-existing <named-content data-cid="1545113216100" id="9a75cb2f-5323-4d93-b20e-8762f2e8f275" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">prediabetes</named-content><named-content id="94e71313-f23e-482f-a7e3-db9be2b6a2be" data-cid="1545113216100" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'prediabetes' to 'pre-diabetes'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="706" data-match="prediabetes" data-replace="pre-diabetes" data-pattern="pre-diabetes" data-tag-index="19_33" data-function="addTrackChanges" data-track-change="prediabetes" data-userid="preediting" data-username="Exeter" data-time="1545113216002">pre<named-content data-cid="1545433320" id="10791f1b-9db3-4c16-85f8-b43f7c1320a2" content-type="del cts-3" specific-use="1545435551409" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435551409">-</named-content>diabetes</named-content> or type <named-content data-cid="1545113216017" id="30328651-e20d-4a2e-b372-e12b2470f2aa" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="9b8515be-6247-48a2-a985-0aedeb2c3bfd" data-cid="1545113216017" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="726" data-match="2" data-pattern="" data-tag-index="19_21" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433321" id="afa7df9e-b690-4965-9502-8198578a8518" content-type="del cts-3" specific-use="1545435553705" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435553705">two</named-content></named-content><named-content data-cid="1545433322" id="6ab0000e-7f1a-4231-9b2b-ffa1b36293ea" content-type="ins cts-3" specific-use="1545435553822" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435553822">2</named-content> diabetes, out of which <named-content id="25c065ce-45f5-4213-9b8e-1441c87f1d56" data-cid="25c065ce-45f5-4213-9b8e-1441c87f1d56" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="751" data-match="9 (9.3%)" data-replace="9" data-pattern="$1" data-tag-index="19_6" data-time="" data-username="" data-userid="">9</named-content><named-content id="734a4e02-1601-4a40-8f25-db5e3049312d" data-cid="734a4e02-1601-4a40-8f25-db5e3049312d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="752" data-match="9 (9.3%)" data-replace=" (9.3%)" data-pattern=" $2" data-tag-index="19_6" data-time="" data-username="" data-userid=""> (9.3%)</named-content> had worsening of glycemic control after ICI initiation. Among the 774 <named-content id="d0925e7d-f528-4e91-8ab1-1fcf26114aca" data-cid="d0925e7d-f528-4e91-8ab1-1fcf26114aca" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="830" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="19_34" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> treated with pembrolizumb, <named-content id="80052cbd-44f2-4810-bcc2-0f74ee8b2b8d" data-cid="80052cbd-44f2-4810-bcc2-0f74ee8b2b8d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="866" data-match="17 (2.2%)" data-replace="17" data-pattern="$1" data-tag-index="19_7" data-time="" data-username="" data-userid="">17</named-content><named-content id="43a05245-9611-4f1b-852b-17d16aa94690" data-cid="43a05245-9611-4f1b-852b-17d16aa94690" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="868" data-match="17 (2.2%)" data-replace=" (2.2%)" data-pattern=" $2" data-tag-index="19_7" data-time="" data-username="" data-userid=""> (2.2%)</named-content> met criteria for ICI<named-content data-cid="1545433323" id="a03d62ac-cb9e-46b8-abda-7dc08587f1c6" content-type="del cts-3" specific-use="1545435565739" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435565739"> </named-content><named-content data-cid="1545433324" id="e530731f-904c-454d-8dd8-6a90ee8f6940" content-type="ins cts-3" specific-use="1545435566073" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435566073">-</named-content>induced diabetes, of which <named-content id="a1ac09c6-ffcf-4aff-b190-ee3b59169d63" data-cid="a1ac09c6-ffcf-4aff-b190-ee3b59169d63" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="924" data-match="11 (1.4%)" data-replace="11" data-pattern="$1" data-tag-index="19_8" data-time="" data-username="" data-userid="">11</named-content><named-content id="286ef64c-c04c-4515-9245-e15da74e6c87" data-cid="286ef64c-c04c-4515-9245-e15da74e6c87" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="926" data-match="11 (1.4%)" data-replace=" (1.4%)" data-pattern=" $2" data-tag-index="19_8" data-time="" data-username="" data-userid=""> (1.4%)</named-content> had new-onset insulin-dependent diabetes and <named-content id="f5416892-e99e-4841-96e1-a610fafd9712" data-cid="f5416892-e99e-4841-96e1-a610fafd9712" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="979" data-match="6 (0.8%)" data-replace="6" data-pattern="$1" data-tag-index="19_9" data-time="" data-username="" data-userid="">6</named-content><named-content id="0d33544f-129c-4aa0-8275-8bce1f2b736f" data-cid="0d33544f-129c-4aa0-8275-8bce1f2b736f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="980" data-match="6 (0.8%)" data-replace=" (0.8%)" data-pattern=" $2" data-tag-index="19_9" data-time="" data-username="" data-userid=""> (0.8%)</named-content> had worsening of pre-existing type <named-content data-cid="1545113216018" id="603e0e79-8e91-43e1-8fde-1e0514ef5ba0" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="05ac5887-5aa8-4db7-a4a2-bcc8f4e8a993" data-cid="1545113216018" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1023" data-match="2" data-pattern="" data-tag-index="19_22" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433325" id="d1fc7877-68d5-4615-94a4-76723d8e6558" content-type="del cts-3" specific-use="1545435571540" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435571540">two</named-content></named-content><named-content data-cid="1545433326" id="f1ad09c4-88d3-4410-a605-9ae81cb18c8f" content-type="ins cts-3" specific-use="1545435571648" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435571648">2</named-content> diabetes. In this cohort, <named-content data-cid="1545113216019" id="de4eba63-c8c1-4623-a19e-6d55da8855f9" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">4</named-content><named-content id="399827b4-600f-4082-961b-4353ee4c4d91" data-cid="1545113216019" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '4' to 'four'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1051" data-match="4" data-pattern="" data-tag-index="19_23" data-function="numberToText,addTrackChanges" data-track-change="4" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433334" id="93b58c90-c6c8-45e7-82db-8b5ea2daab54" content-type="del cts-3" specific-use="1545435754454" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435754454">four</named-content></named-content><named-content data-cid="1545433335" id="3024bb9b-03d9-4c13-91e2-d8202e259591" content-type="ins cts-3" specific-use="1545435754566" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435754566">4</named-content> had <named-content data-cid="1545113216101" id="9824a61f-f797-4efe-a8b6-1bad934cd9cb" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">prediabetes</named-content><named-content id="303b1ea6-a063-4989-a07f-61af385f1367" data-cid="1545113216101" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'prediabetes' to 'pre-diabetes'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1057" data-match="prediabetes" data-replace="pre-diabetes" data-pattern="pre-diabetes" data-tag-index="19_35" data-function="addTrackChanges" data-track-change="prediabetes" data-userid="preediting" data-username="Exeter" data-time="1545113216002">pre<named-content data-cid="1545433327" id="49558f89-6abf-4055-b330-d9a2eb191ebf" content-type="del cts-3" specific-use="1545435742127" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435742127">-</named-content>diabetes</named-content> and 52 <named-content data-cid="1545433328" id="d4eeb94d-d913-4f7b-b2e0-725486eba761" content-type="ins cts-3" specific-use="1545435746418" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435746418">had </named-content>type <named-content data-cid="1545113216020" id="b5b64623-e18b-44ba-8b8f-e94f1f33a3c2" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="8e36763e-deca-4f02-a1ef-5e409e1d48b8" data-cid="1545113216020" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1081" data-match="2" data-pattern="" data-tag-index="19_24" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433332" id="5ed6d0ee-64da-420f-ae36-61c71543f663" content-type="del cts-3" specific-use="1545435750070" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435750070">two</named-content></named-content><named-content data-cid="1545433333" id="8c8da522-7b89-4dfe-9dfa-19da50183895" content-type="ins cts-3" specific-use="1545435750192" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435750192">2</named-content> diabetes before ICI initiation, and <named-content id="ba41c783-066a-4b69-93b8-c54f89ee4559" data-cid="ba41c783-066a-4b69-93b8-c54f89ee4559" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="1119" data-match="6/56 (10.7%)" data-replace="6/56" data-pattern="$1" data-tag-index="19_10" data-time="" data-username="" data-userid="">6/56</named-content><named-content id="3b76f046-f27a-4b5a-a37f-1d8f527e3ae3" data-cid="3b76f046-f27a-4b5a-a37f-1d8f527e3ae3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1123" data-match="6/56 (10.7%)" data-replace=" (10.7%)" data-pattern=" $2" data-tag-index="19_10" data-time="" data-username="" data-userid=""> (10.7%)</named-content> had worsening of glycemic control after ICI initiation. Among the 389 <named-content id="8b53132c-c012-4f23-9c24-e1164fc6e158" data-cid="8b53132c-c012-4f23-9c24-e1164fc6e158" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1202" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="19_36" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> treated with nivolumab, <named-content id="12c9693f-2c3b-4301-9a91-1ab8984f61ba" data-cid="12c9693f-2c3b-4301-9a91-1ab8984f61ba" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="1235" data-match="4 (1%)" data-replace="4" data-pattern="$1" data-tag-index="19_11" data-time="" data-username="" data-userid="">4</named-content><named-content id="67197741-d524-4e2f-ae32-2414ae01fb16" data-cid="67197741-d524-4e2f-ae32-2414ae01fb16" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1236" data-match="4 (1%)" data-replace=" (1%)" data-pattern=" $2" data-tag-index="19_11" data-time="" data-username="" data-userid=""> (1%)</named-content> met criteria for ICI<named-content data-cid="1545433336" id="2f2700bd-01e0-40ef-b126-7f28962ab148" content-type="del cts-3" specific-use="1545435763838" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435763838"> </named-content><named-content data-cid="1545433337" id="02774e1e-b84d-440c-8f46-057f53e8844a" content-type="ins cts-3" specific-use="1545435764142" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435764142">-</named-content>induced diabetes, of which <named-content id="5d1119a9-9a7d-4434-82df-68a17324c61f" data-cid="5d1119a9-9a7d-4434-82df-68a17324c61f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="1290" data-match="1 (0.2%)" data-replace="1" data-pattern="$1" data-tag-index="19_12" data-time="" data-username="" data-userid="">1</named-content><named-content id="cca8f1ab-793a-4ee5-9cc1-b108bb5bbcaf" data-cid="cca8f1ab-793a-4ee5-9cc1-b108bb5bbcaf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1291" data-match="1 (0.2%)" data-replace=" (0.2%)" data-pattern=" $2" data-tag-index="19_12" data-time="" data-username="" data-userid=""> (0.2%)</named-content> had new-onset insulin-dependent diabetes and <named-content id="f7e20e7a-e236-4f86-8a97-acc591ec5b08" data-cid="f7e20e7a-e236-4f86-8a97-acc591ec5b08" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="1344" data-match="3 (0.8%)" data-replace="3" data-pattern="$1" data-tag-index="19_13" data-time="" data-username="" data-userid="">3</named-content><named-content id="ff7be018-b36c-48b8-80e3-26a415a6d4e7" data-cid="ff7be018-b36c-48b8-80e3-26a415a6d4e7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1345" data-match="3 (0.8%)" data-replace=" (0.8%)" data-pattern=" $2" data-tag-index="19_13" data-time="" data-username="" data-userid=""> (0.8%)</named-content> had worsening of pre-existing type <named-content data-cid="1545113216021" id="bb45405c-f461-4f02-bc72-e68b32acea89" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="0fb479a6-a271-4ebf-93ba-a0ca949aec5c" data-cid="1545113216021" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1388" data-match="2" data-pattern="" data-tag-index="19_25" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433338" id="dd8567ea-8544-48d8-8ded-aa2ae0b9b465" content-type="del cts-3" specific-use="1545435773856" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435773856">two</named-content></named-content><named-content data-cid="1545433339" id="ecdb15d7-bf1e-4c8e-9d64-6142715b6edb" content-type="ins cts-3" specific-use="1545435773972" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435773972">2</named-content> diabetes. In this cohort, <named-content data-cid="1545113216022" id="f59f4944-83c7-4ab8-a07a-d6ebac743144" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="af87f68a-dbbb-4d62-80b3-87cb33d838bb" data-cid="1545113216022" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1416" data-match="2" data-pattern="" data-tag-index="19_26" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433343" id="91947b0f-5086-4920-bf83-90560ac11679" content-type="del cts-3" specific-use="1545435783744" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:43am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435783744">two</named-content></named-content><named-content data-cid="1545433344" id="c7caf0b7-35d6-418c-9941-c8e31b08c52f" content-type="ins cts-3" specific-use="1545435783855" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:43am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435783855">2</named-content> had <named-content data-cid="1545113216102" id="d4f6a24d-e6cd-4c42-ac42-ffb51c1fb918" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">prediabetes</named-content><named-content id="87b9d791-fd8c-41dc-b033-069114060579" data-cid="1545113216102" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'prediabetes' to 'pre-diabetes'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1422" data-match="prediabetes" data-replace="pre-diabetes" data-pattern="pre-diabetes" data-tag-index="19_37" data-function="addTrackChanges" data-track-change="prediabetes" data-userid="preediting" data-username="Exeter" data-time="1545113216002">pre<named-content data-cid="1545433340" id="d400a31b-6dc7-4365-ad5f-6b8a6fa50b44" content-type="del cts-3" specific-use="1545435778337" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435778337">-</named-content>diabetes</named-content> and 38 had type <named-content data-cid="1545113216023" id="d32f5e4a-91ed-4a9f-a5ce-ce16eeb1cb0e" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="d6a85c89-c173-4321-8460-b5dea567480b" data-cid="1545113216023" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1450" data-match="2" data-pattern="" data-tag-index="19_27" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433341" id="c124c4fc-9a2e-4f98-992e-8ed2b7824e24" content-type="del cts-3" specific-use="1545435781036" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:43am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435781036">two</named-content></named-content><named-content data-cid="1545433342" id="8fb05b0e-43a0-4626-9665-0bc4f1c5dba2" content-type="ins cts-3" specific-use="1545435781153" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:43am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435781153">2</named-content> diabetes before ICI initiation, and <named-content id="0e614ea5-ded2-4191-b7a7-0397d384deb4" data-cid="0e614ea5-ded2-4191-b7a7-0397d384deb4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="1488" data-match="3/40 (7.5%)" data-replace="3/40" data-pattern="$1" data-tag-index="19_14" data-time="" data-username="" data-userid="">3/40</named-content><named-content id="7a0571f5-46bf-4320-8fcd-d2cde7476254" data-cid="7a0571f5-46bf-4320-8fcd-d2cde7476254" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1492" data-match="3/40 (7.5%)" data-replace=" (7.5%)" data-pattern=" $2" data-tag-index="19_14" data-time="" data-username="" data-userid=""> (7.5%)</named-content> had worsening of glycemic control after ICI initiation.</p><title data-level="2" data-class="jrnlHead2" old-class="" id="c7d238b7-262c-4d86-b21f-b9333a732851">Baseline characteristics at ICI initiation</title><p data-class="jrnlSecPara" id="c883dc1d-33b4-47c0-9022-62b1144b34bc" data-word-spacing="0.43w">The <named-content id="4e19a159-1aa3-4ff5-a2e2-4f0464f7c0e4" data-cid="4e19a159-1aa3-4ff5-a2e2-4f0464f7c0e4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="4" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="20_20" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> had a median age at ICI initiation of <named-content id="f3be556e-5585-4838-805d-61f497e1a628" data-cid="f3be556e-5585-4838-805d-61f497e1a628" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="51" data-match="61.3 years" data-replace="61.3" data-pattern="$1" data-tag-index="20_4" data-time="" data-username="" data-userid="">61.3</named-content><named-content id="ff1fe126-6088-4684-be0e-6369f254b407" data-cid="ff1fe126-6088-4684-be0e-6369f254b407" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="55" data-match="61.3 years" data-replace=" years" data-pattern=" $2" data-tag-index="20_4" data-time="" data-username="" data-userid=""> years</named-content>, <named-content id="726ccd92-ae2c-4dbd-8051-97643d5542f0" data-cid="726ccd92-ae2c-4dbd-8051-97643d5542f0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="63" data-match="57%" data-replace="57" data-pattern="$1" data-tag-index="20_5" data-time="" data-username="" data-userid="">57</named-content><named-content id="fefc7d78-3de6-4e26-a53e-8ecbb1805da0" data-cid="fefc7d78-3de6-4e26-a53e-8ecbb1805da0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="65" data-match="57%" data-replace="%" data-pattern="%" data-tag-index="20_5" data-time="" data-username="" data-userid="">%</named-content> were male, <named-content id="b0803391-4a67-459e-905c-f2c76d2af3dc" data-cid="b0803391-4a67-459e-905c-f2c76d2af3dc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="78" data-match="95%" data-replace="95" data-pattern="$1" data-tag-index="20_6" data-time="" data-username="" data-userid="">95</named-content><named-content id="1ad8d765-7281-4f91-a8f8-64a6413e6dd9" data-cid="1ad8d765-7281-4f91-a8f8-64a6413e6dd9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="80" data-match="95%" data-replace="%" data-pattern="%" data-tag-index="20_6" data-time="" data-username="" data-userid="">%</named-content> were Caucasian, and median <named-content id="cf00067d-fd4d-4598-bb4a-20069ea26f17" data-cid="cf00067d-fd4d-4598-bb4a-20069ea26f17" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="109" data-match="body mass index" data-pattern="" data-tag-index="" data-abbr="BMI" data-time="" data-username="" data-userid="">body mass index</named-content> (<named-content id="49548a63-c7ac-49f9-9c10-f28f6c7e8645" data-cid="49548a63-c7ac-49f9-9c10-f28f6c7e8645" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="126" data-match=" (BMI)" data-pattern="" data-tag-index="20_16" data-time="" data-username="" data-userid="">BMI</named-content>) was <named-content id="532d6bb5-9b08-4c15-a863-a9f2aed5f95c" data-cid="532d6bb5-9b08-4c15-a863-a9f2aed5f95c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="135" data-match="31.4 kg/m2" data-replace="31.4" data-pattern="$1" data-tag-index="20_7" data-time="" data-username="" data-userid="">31.4</named-content><named-content id="bf9aeaca-c232-482f-809f-4ec65c156e92" data-cid="bf9aeaca-c232-482f-809f-4ec65c156e92" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣kg/m&lt;sup␣id=&quot;2e2deefa-5e61-4351-b533-587010555d2d&quot;&gt;2&lt;/sup&gt;' to ' kg/m2'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="139" data-match="31.4 kg/m2" data-replace=" kg/m2" data-pattern=" $2" data-tag-index="20_7" data-track-change=" kg/m&lt;sup id=&quot;2e2deefa-5e61-4351-b533-587010555d2d&quot;&gt;2&lt;/sup&gt;" data-time="" data-username="" data-userid=""> kg/m<sup id="2e2deefa-5e61-4351-b533-587010555d2d">2</sup></named-content>. Fourteen <named-content data-cid="1545433345" id="f5457632-8407-4540-84b8-db4bbd503628" content-type="del cts-3" specific-use="1545435857123" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435857123">%</named-content><named-content data-cid="1545433346" id="40e92e09-fb1b-4069-aeb1-15ef32a129ea" content-type="ins cts-3" specific-use="1545435857933" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545435857933">percent</named-content> had a personal history of autoimmunity (all with Hashimoto’s thyroiditis) and <named-content id="3293afbc-beab-40b7-91c2-d847f2c127d2" data-cid="3293afbc-beab-40b7-91c2-d847f2c127d2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="238" data-match="24%" data-replace="24" data-pattern="$1" data-tag-index="20_8" data-time="" data-username="" data-userid="">24</named-content><named-content id="abee489c-e492-4a35-a64a-773f0f23ed78" data-cid="abee489c-e492-4a35-a64a-773f0f23ed78" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="240" data-match="24%" data-replace="%" data-pattern="%" data-tag-index="20_8" data-time="" data-username="" data-userid="">%</named-content> had a family history of autoimmunity. Information regarding family history was only available for 15 <named-content id="e4405f71-29f3-43c1-90d2-0e99a984f2b5" data-cid="e4405f71-29f3-43c1-90d2-0e99a984f2b5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="343" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="20_21" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>. ICIs were prescribed for various malignancies<named-content data-cid="1545840506" id="91f5e21a-90d3-4083-bd2a-db4c3736cabc" content-type="ins cts-5" specific-use="1545842504146" xlink:title="Yogish C Kudva (AUTHOR)" alt="author 3684625162" data-title="Inserted by Yogish C Kudva (AUTHOR) - Dec 26 2018 10:41am" data-track-detail="" data-userid="author 3684625162" data-username="Yogish C Kudva (AUTHOR)" data-time="1545842504146">,</named-content> with the most common being melanoma (45%) and lung cancer (25%). Eighty<named-content data-cid="1545433353" id="eff89c9d-8afa-42a4-8cb6-2acd5ad55a9d" content-type="del cts-3" specific-use="1545436357391" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:52am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545436357391"> </named-content><named-content data-cid="1545433354" id="d118e09b-60b6-445e-9a22-75b095c3ddf2" content-type="ins cts-3" specific-use="1545436357635" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:52am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545436357635">-</named-content>one <named-content data-cid="1545433355" id="7facaf21-71ee-4308-ac4c-ff91ed0b0dff" content-type="del cts-3" specific-use="1545436359484" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:52am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545436359484">%</named-content><named-content data-cid="1545433356" id="4db3511a-4650-49bc-86c6-5a0bd4946d9e" content-type="ins cts-3" specific-use="1545436359747" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:52am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545436359747">per cent</named-content> of the <named-content id="863ba74d-87fd-4aba-b071-30cc62536598" data-cid="863ba74d-87fd-4aba-b071-30cc62536598" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="484" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="20_22" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> were treated with pembrolizumab and the rest with nivolumab; <named-content data-cid="1545113216024" id="72b5e8b2-c8da-4736-abae-700bbf0b5da3" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="12b59f41-5640-45af-9c11-c38a34041488" data-cid="1545113216024" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="554" data-match="2" data-pattern="" data-tag-index="20_17" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002">two</named-content> <named-content id="cf6d7375-ab08-4fdb-b3ec-3ff00d55b89d" data-cid="cf6d7375-ab08-4fdb-b3ec-3ff00d55b89d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="556" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="20_23" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> had received ipilimumab prior to therapy with pembrolizumab. Those that developed new-onset insulin-dependent diabetes had a median age at ICI initiation of <named-content id="3a1e7c3c-1e94-4433-9ccb-796dff11f6ab" data-cid="3a1e7c3c-1e94-4433-9ccb-796dff11f6ab" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="722" data-match="68 years" data-replace="68" data-pattern="$1" data-tag-index="20_9" data-time="" data-username="" data-userid="">68</named-content><named-content id="2c4161ad-e87f-439a-a7d6-6c1e279e8a46" data-cid="2c4161ad-e87f-439a-a7d6-6c1e279e8a46" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="724" data-match="68 years" data-replace=" years" data-pattern=" $2" data-tag-index="20_9" data-time="" data-username="" data-userid=""> years</named-content>, <named-content id="9e1bbc73-d5cb-4917-b1a4-1adb414dadbd" data-cid="9e1bbc73-d5cb-4917-b1a4-1adb414dadbd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="732" data-match="50%" data-replace="50" data-pattern="$1" data-tag-index="20_10" data-time="" data-username="" data-userid="">50</named-content><named-content id="a0b51663-cb39-4245-ae94-cbc317829e75" data-cid="a0b51663-cb39-4245-ae94-cbc317829e75" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="734" data-match="50%" data-replace="%" data-pattern="%" data-tag-index="20_10" data-time="" data-username="" data-userid="">%</named-content> were male, all were Caucasian with a median BMI of <named-content id="e463900f-3f3b-420c-b9ef-49e05875e48e" data-cid="e463900f-3f3b-420c-b9ef-49e05875e48e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="787" data-match="32.2 kg/m2" data-replace="32.2" data-pattern="$1" data-tag-index="20_11" data-time="" data-username="" data-userid="">32.2</named-content><named-content id="c72a81ae-8939-41f9-b393-74340492352e" data-cid="c72a81ae-8939-41f9-b393-74340492352e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣kg/m&lt;sup␣id=&quot;1d1716af-19bd-402f-9fd2-ecaa47b35ce8&quot;&gt;2&lt;/sup&gt;' to ' kg/m2'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="791" data-match="32.2 kg/m2" data-replace=" kg/m2" data-pattern=" $2" data-tag-index="20_11" data-track-change=" kg/m&lt;sup id=&quot;1d1716af-19bd-402f-9fd2-ecaa47b35ce8&quot;&gt;2&lt;/sup&gt;" data-time="" data-username="" data-userid=""> kg/m<sup id="1d1716af-19bd-402f-9fd2-ecaa47b35ce8">2</sup></named-content>. Those that had worsening of pre-existing type <named-content data-cid="1545113216025" id="e777f584-05d9-47ed-94c1-3a4080a9a1e3" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="0a75aa29-3374-4fe3-84ef-fc28db7806ad" data-cid="1545113216025" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="845" data-match="2" data-pattern="" data-tag-index="20_18" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433364" id="5e103280-595d-4d6a-9efa-e30223640353" content-type="del cts-3" specific-use="1545436379050" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:52am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545436379050">two</named-content></named-content><named-content data-cid="1545433365" id="4c85293e-bda2-4547-a719-da755b8c86e4" content-type="ins cts-3" specific-use="1545436379170" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:52am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545436379170">2</named-content> diabetes had a median age at ICI initiation of <named-content id="117071f0-12d5-43bc-ad5d-5a55f26b97b4" data-cid="117071f0-12d5-43bc-ad5d-5a55f26b97b4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="894" data-match="57 years" data-replace="57" data-pattern="$1" data-tag-index="20_12" data-time="" data-username="" data-userid="">57</named-content><named-content id="226d9af8-5828-4691-81d5-a87d79aecb81" data-cid="226d9af8-5828-4691-81d5-a87d79aecb81" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="896" data-match="57 years" data-replace=" years" data-pattern=" $2" data-tag-index="20_12" data-time="" data-username="" data-userid=""> years</named-content>, <named-content id="8aa12cfb-cebd-483e-8007-c77f711233b1" data-cid="8aa12cfb-cebd-483e-8007-c77f711233b1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="904" data-match="67%" data-replace="67" data-pattern="$1" data-tag-index="20_13" data-time="" data-username="" data-userid="">67</named-content><named-content id="d65a6b56-e5e8-4639-a090-8c9901cb2591" data-cid="d65a6b56-e5e8-4639-a090-8c9901cb2591" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="906" data-match="67%" data-replace="%" data-pattern="%" data-tag-index="20_13" data-time="" data-username="" data-userid="">%</named-content> were male, <named-content id="280da969-cf80-4d5f-87f0-ef8820b5898a" data-cid="280da969-cf80-4d5f-87f0-ef8820b5898a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="919" data-match="89%" data-replace="89" data-pattern="$1" data-tag-index="20_14" data-time="" data-username="" data-userid="">89</named-content><named-content id="41b58831-018f-45cb-b5ba-69176dc66b05" data-cid="41b58831-018f-45cb-b5ba-69176dc66b05" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="921" data-match="89%" data-replace="%" data-pattern="%" data-tag-index="20_14" data-time="" data-username="" data-userid="">%</named-content> were Caucasian with a median BMI of <named-content id="dc8203d4-3cae-4778-93a3-453cf13fc3a9" data-cid="dc8203d4-3cae-4778-93a3-453cf13fc3a9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="959" data-match="27 kg/m2" data-replace="27" data-pattern="$1" data-tag-index="20_15" data-time="" data-username="" data-userid="">27</named-content><named-content id="286b13ff-48ff-4772-967f-6685ffa29b8f" data-cid="286b13ff-48ff-4772-967f-6685ffa29b8f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣kg/m&lt;sup␣id=&quot;88441eda-8698-413c-be87-6164d094ad96&quot;&gt;2&lt;/sup&gt;' to ' kg/m2'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="961" data-match="27 kg/m2" data-replace=" kg/m2" data-pattern=" $2" data-tag-index="20_15" data-track-change=" kg/m&lt;sup id=&quot;88441eda-8698-413c-be87-6164d094ad96&quot;&gt;2&lt;/sup&gt;" data-time="" data-username="" data-userid=""> kg/m<sup id="88441eda-8698-413c-be87-6164d094ad96">2</sup></named-content>. Other baseline characteristics are mentioned in <named-content id="b091cc0f-d73f-4bb9-a46e-4ad6b32cb2b1" data-cid="1545122284464" content-type="ins cts-1" specific-use="1545122284464" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:08pm" data-track-detail="" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545122284464"><xref id="f3b05c36-04b1-4503-90bb-63110b3cc96b" ref-type="table" rid="T1" data-citation-string=" T1 " data-cite-type="insert" data-anchor="true">table 1</xref></named-content><named-content data-cid="1545121537" id="86dd8354-75c0-4c3e-9f7e-45689ff7dc78" content-type="ins cts-2" specific-use="1545122292640" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:08pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122292640"> and </named-content><named-content id="f1262092-9604-4066-aeef-1971c09737a6" data-cid="1545122320756" content-type="ins cts-1" specific-use="1545122320755" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:08pm" data-track-detail="" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545122320755"><named-content data-cid="1545433366" id="4cfd2e06-ea28-4ce9-845f-ede83e68197d" content-type="del cts-3" specific-use="1545436388963" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:53am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545436388963">(</named-content><xref id="c6ba5dde-4462-4559-9d1c-d7c24fe77906" ref-type="supplementary-material" rid="S1" data-citation-string=" S1 " data-cite-type="insert"><named-content id="96f4e6a0-3dea-49dc-803c-72ac083c1653" data-cid="1545213937054" content-type="del cts-1" specific-use="1545213937054" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 19 2018 3:35pm" data-track-detail="" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545213937054">online supplement table 1</named-content><span data-class="cts-1" id="92d2188c-932b-4409-a05f-14d3a50f84d3" data-cid="1545215441071" data-title="Deleted by Jansi Verginiya (PREEDITOR) - Dec 19 2018 4:00pm" data-track-detail="" data-username="Jansi Verginiya (PREEDITOR)" data-userid="preeditor 31aba277-762c-444b-9327-b0959ffe642d" data-time="1545215441070" data-track="del">online supplement table 1S</span><named-content id="f0d3ff04-741e-469e-9ac0-0f73b96dd0ae" data-cid="1545215441107" content-type="ins cts-1" specific-use="1545215441106" xlink:title="Jansi Verginiya (PREEDITOR)" alt="preeditor 31aba277-762c-444b-9327-b0959ffe642d" data-title="Inserted by Jansi Verginiya (PREEDITOR) - Dec 19 2018 4:00pm" data-track-detail="" data-username="Jansi Verginiya (PREEDITOR)" data-userid="preeditor 31aba277-762c-444b-9327-b0959ffe642d" data-time="1545215441106">online supplement table S1</named-content></xref><named-content data-cid="1545433367" id="976dc31e-d4e6-43f5-a7d3-ce2e07f8afe9" content-type="del cts-3" specific-use="1545436391676" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:53am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545436391676">)</named-content></named-content><named-content data-cid="1545121543" id="226be630-c7cc-4356-8846-5fa1f51890d1" content-type="del cts-2" specific-use="1545122413965" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:10pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122413965">Table S1</named-content>.</p><table-wrap id="BLK_T1" data-id="BLK_T1" data-stream-name="a_T1" position="float"><label id="884bd104-c4c9-41fd-aea3-df8c7fec2f60"><named-content data-cid="1546365745988" id="d4dfa8e0-32ba-455a-945e-55d97382e714" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Table 1</named-content></label><caption id="ad5d157e-4a7a-4872-a924-0a57f6c1c847"><title id="T1" data-id="T1">Baseline characteristics in <named-content id="873833ea-1800-4520-aee9-741156070818" data-cid="873833ea-1800-4520-aee9-741156070818" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="37" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="157_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content><named-content data-cid="1545113216125" id="f5db8d45-0972-445f-bd1b-a8fd4a7dd0f4" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002" data-reason="truecase"> with PD-1 inhibitor induced diabetes prior to initiation of PD-1 inhibitor. RPG: random plasma glucose; FPG: fasting plasma glucose; HbA1c: hemoglobin A1c.</named-content><named-content data-cid="1545113216125" id="7067e662-0fa2-4ee6-b02e-b45a17cddf22" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002" data-reason="truecase"> with PD-1 inhibitor<named-content data-cid="1545433370" id="917fe00d-94c2-4742-8c3a-6e44093a7f4f" content-type="del cts-3" specific-use="1545436428128" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:53am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545436428128"> </named-content><named-content data-cid="1545433371" id="43fe37e2-328a-44c6-a642-a41f4db3b205" content-type="ins cts-3" specific-use="1545436428488" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 7:53am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545436428488">-</named-content>induced diabetes prior to initiation of PD-1 inhibitor<named-content data-cid="1545121572" id="451a7466-012f-453b-9229-2841f475e9fc" content-type="del cts-2" specific-use="1545122963924" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:19pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122963924">. </named-content><named-content data-cid="1545121551" id="e3027ede-bf30-423f-8e98-3703fabf7399" content-type="del cts-2" specific-use="1545122424639" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:10pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122424639">RPG: random plasma glucose; Fpg: fasting plasma glucose; HbA1c: hemoglobin A1c.</named-content></named-content></title></caption><table data-col-count="4" id="686bbf6e-88d5-4ed8-8b1b-f875a38d1547" data-old-attributes="&quot;data-table-type&quot;:&quot;undefined&quot;;&quot;data-col-widths-px&quot;:&quot;149,79,135,148&quot;;&quot;data-font-size&quot;:&quot;9px&quot;" data-changed-attributes="data-table-type,data-col-widths-px,data-font-size" data-table-type="doubleColumn" data-col-widths-px="189,96,123,103.276" data-font-size="9px"><thead id="4d860116-d99f-4ec6-9023-300963fe9d94" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;" data-changed-attributes="data-font-size" data-font-size="9px"><tr data-col-count="5" id="403ee0ab-8d93-4e5b-aa0d-3337d3a14f79"><td data-original-border="border:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="a5185ebc-bde9-4936-82a8-ce4cc17362a2" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="bottom"><p id="f23b5a7c-7cf4-4b53-9cf6-7b4b8d9a69ce" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Baseline characteristics</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="28e01de7-8c99-40ea-9f7d-f9662e2e1c97" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;" data-changed-attributes="valign" valign="bottom" rowspan="2"><p id="559554ea-673c-4e57-9885-201659b6cc46" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">All cases (<named-content id="8c09e526-df2c-41cd-8ab2-01e076067553" data-cid="8c09e526-df2c-41cd-8ab2-01e076067553" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="11" data-match="n=21" data-replace="n" data-pattern="$1" data-tag-index="42_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="94e108c2-5f03-4a86-8eda-fc8d4789c9f6" data-cid="94e108c2-5f03-4a86-8eda-fc8d4789c9f6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="12" data-match="n=21" data-replace="=" data-pattern="$2" data-tag-index="42_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="c38b2690-4619-4c0f-bfac-6e228a414bc9" data-cid="c38b2690-4619-4c0f-bfac-6e228a414bc9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="13" data-match="n=21" data-replace="21" data-pattern="$3" data-tag-index="42_1" data-time="" data-username="" data-userid="">21</named-content>)</p></td><td rowspan="2" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="d873fa09-0670-455d-be49-9d6073a6b097" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;" data-changed-attributes="valign" valign="bottom"><p id="564451f3-7f1c-41e5-a39a-839b68200545" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">New-onset insulin-dependent diabetes (<named-content id="b5ee7e2b-83c6-4542-b8e4-eb01cd4d8749" data-cid="b5ee7e2b-83c6-4542-b8e4-eb01cd4d8749" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="38" data-match="n=12" data-replace="n" data-pattern="$1" data-tag-index="43_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="d7a8a523-0135-4713-b16c-b696b6d8901d" data-cid="d7a8a523-0135-4713-b16c-b696b6d8901d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="39" data-match="n=12" data-replace="=" data-pattern="$2" data-tag-index="43_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="c2b4c16f-c604-4733-9b46-7708f60a7945" data-cid="c2b4c16f-c604-4733-9b46-7708f60a7945" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="40" data-match="n=12" data-replace="12" data-pattern="$3" data-tag-index="43_1" data-time="" data-username="" data-userid="">12</named-content>)</p></td><td data-class="" rowspan="2" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="a24d8bcb-bd18-49e7-8244-d13fd621b204" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;" data-changed-attributes="valign" valign="bottom"><p id="83cabc2a-8ecc-4f62-a23d-7a98e532dcb8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Worsening of type <named-content data-cid="1545113216078" id="971cd637-dde1-4cd6-8dd7-19664f35c4bb" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="9540c4c3-92eb-47b7-9670-dece0038603f" data-cid="1545113216078" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="18" data-match="2" data-pattern="" data-tag-index="44_2" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433372" id="5c9cb065-ee42-4bc6-b43d-1945646fdb4a" content-type="del cts-3" specific-use="1545437044879" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:04am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437044879">two</named-content></named-content><named-content data-cid="1545433373" id="89b1be09-cbc8-4d31-b28c-06ad00e0c72c" content-type="ins cts-3" specific-use="1545437045026" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:04am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437045026">2</named-content> diabetes (<named-content id="d169f3b8-a4f9-403e-8992-808caca181fa" data-cid="d169f3b8-a4f9-403e-8992-808caca181fa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="30" data-match="n=9" data-replace="n" data-pattern="$1" data-tag-index="44_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="30be5886-bbb7-4150-8676-18814191075d" data-cid="30be5886-bbb7-4150-8676-18814191075d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="31" data-match="n=9" data-replace="=" data-pattern="$2" data-tag-index="44_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="c1019155-bb58-4912-a8b6-eff30006ab00" data-cid="c1019155-bb58-4912-a8b6-eff30006ab00" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="32" data-match="n=9" data-replace="9" data-pattern="$3" data-tag-index="44_1" data-time="" data-username="" data-userid="">9</named-content>)</p></td></tr><tr data-col-count="5" id="96e809d5-29ed-452f-8b2a-2408a1035cad"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="dbeeb68b-01fa-4ca8-b4b1-6c336f71a8ad" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="bottom"><p id="247354c2-40f9-4858-9427-b48f807919b5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">N (%) or median (<named-content id="45abb227-26e7-4b0c-8082-0100c440488a" data-cid="45abb227-26e7-4b0c-8082-0100c440488a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="17" data-match=" (IQR)" data-pattern="" data-tag-index="45_1" data-time="" data-username="" data-userid="">IQR</named-content>)</p></td></tr></thead><tbody id="8a0c5493-7642-4795-8217-2e177f54cc6e" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;" data-changed-attributes="data-font-size" data-font-size="9px"><tr data-col-count="5" id="95348f16-6490-4a24-93bf-de3a396d3575" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="ea82bdeb-dc5a-4be8-8cf3-8f4d2debd306" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="5d4b35b9-125d-47fa-a781-df89c60c8839" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Age at ICI initiation (years)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="2a7881ba-3cdb-40e6-be95-62b3f8e1b9ba" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;41&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="affe3c04-2e4b-47e8-a309-e87fd8a6aafd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="f4507a6e-5cbf-4630-9bb6-f661dff1a9e8" data-cid="f4507a6e-5cbf-4630-9bb6-f661dff1a9e8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="61.3 (54.5 – 70)" data-replace="61.3 " data-pattern="$1 " data-tag-index="47_1" data-time="" data-username="" data-userid="">61.3 </named-content><named-content id="0eca069b-135b-40cc-bd57-a6e29d0852e9" data-cid="0eca069b-135b-40cc-bd57-a6e29d0852e9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="5" data-match="61.3 (54.5 – 70)" data-replace="(54.5" data-pattern="$2" data-tag-index="47_1" data-time="" data-username="" data-userid="">(54.5</named-content><named-content id="e01bc6cc-670a-4ade-aeae-1eb05e67d164" data-cid="e01bc6cc-670a-4ade-aeae-1eb05e67d164" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="10" data-match="61.3 (54.5 – 70)" data-replace="–" data-pattern="–" data-tag-index="47_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="2e637226-86e6-46f3-975f-35e0e603c4ae" data-cid="2e637226-86e6-46f3-975f-35e0e603c4ae" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="15" data-match="61.3 (54.5 – 70)" data-replace="70)" data-pattern="$4" data-tag-index="47_1" data-time="" data-username="" data-userid="">70)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="f1c372af-faad-4197-b78d-474d0e1c1066" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;6.671875&quot;;&quot;data-left-indent-space&quot;:&quot;6.671875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="703496d4-2222-4fb4-9b41-49aa123d67dd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="0d0c1ac2-b6df-45f4-89e8-f3c2fb7653c4" data-cid="0d0c1ac2-b6df-45f4-89e8-f3c2fb7653c4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="67.9 (60.2 – 71.2)" data-replace="67.9 " data-pattern="$1 " data-tag-index="48_1" data-time="" data-username="" data-userid="">67.9 </named-content><named-content id="d05965ba-8326-445c-8824-04cd9e3cd689" data-cid="d05965ba-8326-445c-8824-04cd9e3cd689" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="5" data-match="67.9 (60.2 – 71.2)" data-replace="(60.2" data-pattern="$2" data-tag-index="48_1" data-time="" data-username="" data-userid="">(60.2</named-content><named-content id="09a18126-418a-49ec-bbdb-79fb957cae69" data-cid="09a18126-418a-49ec-bbdb-79fb957cae69" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="10" data-match="67.9 (60.2 – 71.2)" data-replace="–" data-pattern="–" data-tag-index="48_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="21742307-b7a7-47e1-8775-7513191aaeb6" data-cid="21742307-b7a7-47e1-8775-7513191aaeb6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="15" data-match="67.9 (60.2 – 71.2)" data-replace="71.2)" data-pattern="$4" data-tag-index="48_1" data-time="" data-username="" data-userid="">71.2)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="6ebe5302-8009-4551-b25a-990723bcfe34" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="6002fd43-9ed7-46bb-bf3f-041ce28305ef" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="9cf4939f-3c76-4860-891c-091382e7e6ff" data-cid="9cf4939f-3c76-4860-891c-091382e7e6ff" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="57.4 (51 – 62.9)" data-replace="57.4 " data-pattern="$1 " data-tag-index="49_1" data-time="" data-username="" data-userid="">57.4 </named-content><named-content id="c2dde1c3-0065-4391-a134-b240ee39ea03" data-cid="c2dde1c3-0065-4391-a134-b240ee39ea03" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="5" data-match="57.4 (51 – 62.9)" data-replace="(51" data-pattern="$2" data-tag-index="49_1" data-time="" data-username="" data-userid="">(51</named-content><named-content id="c8c6b972-17f7-4827-8fc7-43e83500bea0" data-cid="c8c6b972-17f7-4827-8fc7-43e83500bea0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="57.4 (51 – 62.9)" data-replace="–" data-pattern="–" data-tag-index="49_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="455cc604-5927-4320-b0fb-0fe5b13c8f5f" data-cid="455cc604-5927-4320-b0fb-0fe5b13c8f5f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="57.4 (51 – 62.9)" data-replace="62.9)" data-pattern="$4" data-tag-index="49_1" data-time="" data-username="" data-userid="">62.9)</named-content></p></td></tr><tr data-col-count="5" id="6f7a34d2-563f-4d65-b6a9-aaeb1bc5dd6b"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="5f11d91c-1615-40bd-b8b5-9a30db00b8aa" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="b63c17a1-9b47-447d-905e-109106c4c46a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Male</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="37dd6b7e-47d6-4779-bcd0-b1e2175253eb" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="f4123a2e-3857-4536-9c6d-154a268ddd4c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="96494ad0-ba7c-4dbc-9859-dd772984c805" data-cid="96494ad0-ba7c-4dbc-9859-dd772984c805" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="12 (57.1)" data-replace="12" data-pattern="$1" data-tag-index="51_1" data-time="" data-username="" data-userid="">12</named-content><named-content id="17f2167e-b5a9-410d-9855-7e6030b604eb" data-cid="17f2167e-b5a9-410d-9855-7e6030b604eb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="12 (57.1)" data-replace=" (57.1)" data-pattern=" $2" data-tag-index="51_1" data-time="" data-username="" data-userid=""> (57.1)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="d9f6752a-3de5-4aec-ba53-868b23585ca1" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="7ab1c5e3-58b6-4262-a3a6-d6f24a862ac0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="fc921ad5-770e-46da-8480-4be8968dc817" data-cid="fc921ad5-770e-46da-8480-4be8968dc817" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="6 (50)" data-replace="6" data-pattern="$1" data-tag-index="52_1" data-time="" data-username="" data-userid="">6</named-content><named-content id="b6580356-f0ee-4c54-bcc9-4575cb1a4e08" data-cid="b6580356-f0ee-4c54-bcc9-4575cb1a4e08" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="6 (50)" data-replace=" (50)" data-pattern=" $2" data-tag-index="52_1" data-time="" data-username="" data-userid=""> (50)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="01ae7113-59d8-460b-a30b-d8e65f6bbf4c" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="4878ab31-79df-4925-9bab-e1f930120fb1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="68648d51-a7ec-42f7-a70d-c9201f79e55b" data-cid="68648d51-a7ec-42f7-a70d-c9201f79e55b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="6 (66.7)" data-replace="6" data-pattern="$1" data-tag-index="53_1" data-time="" data-username="" data-userid="">6</named-content><named-content id="2224964f-9dd5-41fa-93f3-a683943b6c37" data-cid="2224964f-9dd5-41fa-93f3-a683943b6c37" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="6 (66.7)" data-replace=" (66.7)" data-pattern=" $2" data-tag-index="53_1" data-time="" data-username="" data-userid=""> (66.7)</named-content></p></td></tr><tr data-col-count="5" id="e2c69a7d-762d-4a1e-a53a-830041ccb75d" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="7f9570ab-ac19-47a1-846f-67ea8650eeaf" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;colspan&quot;:&quot;4&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top" colspan="4"><p id="37aa8e93-b3f5-4c1d-8668-0e6ed4242cf5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545121565" id="27b06eba-dc18-44cf-a36d-a1dc67ae473c" content-type="styrm cts-2" specific-use="1545122734150" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Bold Removed by Varalakshmi (PREEDITOR) - Dec 18 2018 2:15pm" data-track-detail="" data-format-command="bold" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122734150" data-track-hint="Bold Removed">Race</named-content></p> </td></tr><tr data-col-count="5" id="f99bbc81-e204-4d78-baca-5ef1bf90e479"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="0418092b-3cab-4ddc-9a08-41b81ebb126a" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="819ede6d-d77b-4e11-a902-a1f5c32e183d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> White</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="6dbdb64d-7786-4614-abc1-7dfc4b9bdca6" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="b8762157-be3b-4f96-9f39-385208367aef" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="7dee186a-ca39-450f-a591-39d504cb5465" data-cid="7dee186a-ca39-450f-a591-39d504cb5465" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="20 (95.2)" data-replace="20" data-pattern="$1" data-tag-index="56_1" data-time="" data-username="" data-userid="">20</named-content><named-content id="4cdb63d0-5d36-4209-8815-effa94ca8bed" data-cid="4cdb63d0-5d36-4209-8815-effa94ca8bed" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="20 (95.2)" data-replace=" (95.2)" data-pattern=" $2" data-tag-index="56_1" data-time="" data-username="" data-userid=""> (95.2)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="be84cd3b-5e8d-4237-abb2-eb40da636592" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;6.671875&quot;;&quot;data-left-indent-space&quot;:&quot;6.671875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="51b83303-43dc-4fa1-a5c5-e7ae5e2f9812" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4bf8a0a4-43db-45df-b4a8-6ef56522d7e0" data-cid="4bf8a0a4-43db-45df-b4a8-6ef56522d7e0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="12 (100)" data-replace="12" data-pattern="$1" data-tag-index="57_1" data-time="" data-username="" data-userid="">12</named-content><named-content id="9f933c86-1d7d-48a9-8fcb-322249c072b6" data-cid="9f933c86-1d7d-48a9-8fcb-322249c072b6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="12 (100)" data-replace=" (100)" data-pattern=" $2" data-tag-index="57_1" data-time="" data-username="" data-userid=""> (100)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="50f1b4d6-0403-494d-ae7d-859e1a6f3b81" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="a6a6be20-a1c8-457e-91d1-073217e30286" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="d4e51f9c-8224-4700-9b35-71ec9f2eea15" data-cid="d4e51f9c-8224-4700-9b35-71ec9f2eea15" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="8 (88.9)" data-replace="8" data-pattern="$1" data-tag-index="58_1" data-time="" data-username="" data-userid="">8</named-content><named-content id="7d56e397-683b-4ce7-ad8e-9c9bec7ddfa6" data-cid="7d56e397-683b-4ce7-ad8e-9c9bec7ddfa6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="8 (88.9)" data-replace=" (88.9)" data-pattern=" $2" data-tag-index="58_1" data-time="" data-username="" data-userid=""> (88.9)</named-content></p></td></tr><tr data-col-count="5" id="5b3a2ca9-86db-4f0d-8426-2d70178249b4" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="e18aa7f7-2943-44cd-82e6-9a8664018bff" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="32d098b6-a27c-428a-b145-89720d5bfea6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Black</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="573c71af-c01d-4f38-9667-a94288f97937" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="9867f103-1f98-4a33-92a6-752c043ed6fa" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="095ed3cc-34e4-44a3-9f28-845370f3d765" data-cid="095ed3cc-34e4-44a3-9f28-845370f3d765" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (4.8)" data-replace="1" data-pattern="$1" data-tag-index="60_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="eb753a8d-a67f-4128-8fc7-29f7a48ae585" data-cid="eb753a8d-a67f-4128-8fc7-29f7a48ae585" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (4.8)" data-replace=" (4.8)" data-pattern=" $2" data-tag-index="60_1" data-time="" data-username="" data-userid=""> (4.8)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="0bd14d44-230d-46f0-b862-d48851520813" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="c30c6fa5-11b9-4f6a-9591-eabf70d16f47" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="94926f5c-de76-4392-ad72-47851c8310d9" data-cid="94926f5c-de76-4392-ad72-47851c8310d9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0 (0)" data-replace="0" data-pattern="$1" data-tag-index="61_1" data-time="" data-username="" data-userid="">0</named-content><named-content id="33085461-ef9a-443c-a8d0-a1818e54465c" data-cid="33085461-ef9a-443c-a8d0-a1818e54465c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="0 (0)" data-replace=" (0)" data-pattern=" $2" data-tag-index="61_1" data-time="" data-username="" data-userid=""> (0)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="1e99c8d6-cf89-46b2-8c20-c8bce9b5b72b" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="9c2f86d0-7031-40f4-ac59-fdff2a8753d6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="8195aaf3-4ca0-4550-b4c8-228ddc81b3f2" data-cid="8195aaf3-4ca0-4550-b4c8-228ddc81b3f2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="62_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="9434cf15-6cca-414c-a394-923338c291e1" data-cid="9434cf15-6cca-414c-a394-923338c291e1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="62_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="8a346101-1fe5-4fb6-b960-7b9c55d1fef1"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d8c7aac2-575f-42eb-ae94-ddf19d5a6f31" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="de4b0a9c-c26e-4f5f-acf7-18365acc044e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content id="4cd91419-aac2-4b7b-a282-9a4030e55789" data-cid="4cd91419-aac2-4b7b-a282-9a4030e55789" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="0" data-match="Body mass index" data-pattern="" data-tag-index="" data-abbr="BMI" data-time="" data-username="" data-userid="">Body mass index</named-content> (kg/m<sup id="fb821dd2-f539-4c40-b322-c8651cf3eb79">2</sup>) at ICI initiation</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="546321e2-b8fd-4f5b-9246-a8c9fe2f2919" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;41&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="823d9550-bfa2-47fc-b36b-e7dd911491f6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="b90f0668-9caa-4153-b5d9-e99648f116fa" data-cid="b90f0668-9caa-4153-b5d9-e99648f116fa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="31.5 (25 – 36.7)" data-replace="31.5 " data-pattern="$1 " data-tag-index="64_1" data-time="" data-username="" data-userid="">31.5 </named-content><named-content id="8ae72a5a-fe84-4183-8f23-5c28d56d14fc" data-cid="8ae72a5a-fe84-4183-8f23-5c28d56d14fc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="5" data-match="31.5 (25 – 36.7)" data-replace="(25" data-pattern="$2" data-tag-index="64_1" data-time="" data-username="" data-userid="">(25</named-content><named-content id="daba8796-1aae-454d-b026-815245867f35" data-cid="daba8796-1aae-454d-b026-815245867f35" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="31.5 (25 – 36.7)" data-replace="–" data-pattern="–" data-tag-index="64_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="286886d7-b5b1-44df-946f-43b4ad6e5d60" data-cid="286886d7-b5b1-44df-946f-43b4ad6e5d60" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="31.5 (25 – 36.7)" data-replace="36.7)" data-pattern="$4" data-tag-index="64_1" data-time="" data-username="" data-userid="">36.7)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="6a931731-40c6-4d3a-86ae-88ad2d27695a" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;6.671875&quot;;&quot;data-left-indent-space&quot;:&quot;6.671875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="c2978290-17b4-416b-9e02-1b8c0f8824c0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="108f9f5e-f784-4eb1-aefd-0f3f70f4a12d" data-cid="108f9f5e-f784-4eb1-aefd-0f3f70f4a12d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="32.2 (24.9 -37.7)" data-replace="32.2 " data-pattern="$1 " data-tag-index="65_1" data-time="" data-username="" data-userid="">32.2 </named-content><named-content id="f3e54e9f-c9e8-4954-b354-9a5ac2ab2d24" data-cid="f3e54e9f-c9e8-4954-b354-9a5ac2ab2d24" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="5" data-match="32.2 (24.9 -37.7)" data-replace="(24.9" data-pattern="$2" data-tag-index="65_1" data-time="" data-username="" data-userid="">(24.9</named-content><named-content id="0dd4c06a-2930-4ad9-a4c0-662bb4769cf0" data-cid="0dd4c06a-2930-4ad9-a4c0-662bb4769cf0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣-' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="10" data-match="32.2 (24.9 -37.7)" data-replace="–" data-pattern="–" data-tag-index="65_1" data-track-change=" -" data-time="" data-username="" data-userid="">–</named-content><named-content id="392b309e-79cd-4a76-a8d9-b6e1612e743a" data-cid="392b309e-79cd-4a76-a8d9-b6e1612e743a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="12" data-match="-37.7" data-replace="37.7" data-pattern="$4" data-tag-index="65_1" data-time="" data-username="" data-userid="">37.7</named-content>)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="a97f9635-cd7a-4280-8d07-be45bf7d1808" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="aad27268-3df2-40cb-8311-ad0aa8734e29" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="c4f54083-4899-4bbc-8020-1312dbedf769" data-cid="c4f54083-4899-4bbc-8020-1312dbedf769" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="27.5 (24.9 – 35.6)" data-replace="27.5 " data-pattern="$1 " data-tag-index="66_1" data-time="" data-username="" data-userid="">27.5 </named-content><named-content id="5d44ff34-8d9b-47a6-a768-0b65c56f82d3" data-cid="5d44ff34-8d9b-47a6-a768-0b65c56f82d3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="5" data-match="27.5 (24.9 – 35.6)" data-replace="(24.9" data-pattern="$2" data-tag-index="66_1" data-time="" data-username="" data-userid="">(24.9</named-content><named-content id="1f94b5a4-fd9c-47db-a4db-90a9ca159c69" data-cid="1f94b5a4-fd9c-47db-a4db-90a9ca159c69" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="10" data-match="27.5 (24.9 – 35.6)" data-replace="–" data-pattern="–" data-tag-index="66_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="c6a19097-3fd9-4eeb-877e-4ab0b4ea9a0c" data-cid="c6a19097-3fd9-4eeb-877e-4ab0b4ea9a0c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="15" data-match="27.5 (24.9 – 35.6)" data-replace="35.6)" data-pattern="$4" data-tag-index="66_1" data-time="" data-username="" data-userid="">35.6)</named-content></p></td></tr><tr data-col-count="5" id="4fbb8187-5ff4-4272-a9f0-7a50a8c16bf5" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="6de10b11-acaa-49ce-9cba-9d1abd0abed7" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="63444b61-bd96-48ed-8101-623c688be4e8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545121566" id="b1476676-e6f7-49e5-94bd-79b6616de46d" content-type="styrm cts-2" specific-use="1545122738388" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Bold Removed by Varalakshmi (PREEDITOR) - Dec 18 2018 2:15pm" data-track-detail="" data-format-command="bold" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122738388" data-track-hint="Bold Removed">Personal history of autoimmunity</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="1cf9b0f6-f638-4a23-bffe-287b67e35a5f" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="703e3e8f-1228-44e8-aa7f-83752d2dfc87" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="5f8fe6a5-7901-4e40-952c-7e14b17f9656" data-cid="5f8fe6a5-7901-4e40-952c-7e14b17f9656" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="3 (14.3)" data-replace="3" data-pattern="$1" data-tag-index="68_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="d881ce4a-9c1b-40dd-b6d0-5db0de979c5d" data-cid="d881ce4a-9c1b-40dd-b6d0-5db0de979c5d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="3 (14.3)" data-replace=" (14.3)" data-pattern=" $2" data-tag-index="68_1" data-time="" data-username="" data-userid=""> (14.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="b8abe808-a6a5-4145-b5b0-22cf4c29f45e" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="ebbeb49a-b740-4ece-9b8a-43072a8035a5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4df38661-adb4-4a02-bd1f-daf0f9a51e96" data-cid="4df38661-adb4-4a02-bd1f-daf0f9a51e96" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (16.7)" data-replace="2" data-pattern="$1" data-tag-index="69_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="baaf6cb8-19fd-4d53-bf88-e628deea1a80" data-cid="baaf6cb8-19fd-4d53-bf88-e628deea1a80" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (16.7)" data-replace=" (16.7)" data-pattern=" $2" data-tag-index="69_1" data-time="" data-username="" data-userid=""> (16.7)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="f985819c-1104-4111-afd6-d38befabbe8d" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="f82e41ad-5c69-4e8c-bdde-541337f3c565" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="0fe89809-148f-40fb-a3f6-9041c2192ecc" data-cid="0fe89809-148f-40fb-a3f6-9041c2192ecc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="70_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="cd0c3711-12f3-4a8d-83c3-3de98a1fe9ea" data-cid="cd0c3711-12f3-4a8d-83c3-3de98a1fe9ea" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="70_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="4a88ba32-0ea8-44ca-bcee-b9cb9d23ce29"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="128e08ef-a893-445d-8a62-8c25c6ee9008" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="18317595-8647-466c-a4ca-fe2a1223622c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Hashimoto’s thyroiditis</p></td><td data-class="" data-original-space="1" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="97b12648-0771-4b5a-9d24-835d4eadea7e" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="7e080669-0f71-405d-acc5-b1291a5574ac" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content data-cid="1545121552" id="f74e14d8-b33f-4f89-b42b-146ec62c36e5" content-type="ins cts-2" specific-use="1545122488660" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:11pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122488660"><span id="b562712a-0a8c-426a-9065-17eef12b81d7">3</span><span id="dde90da0-8dcf-41f8-9b15-f3fca8bb3bc8"> (14.3)</span></named-content></p></td><td data-class="" data-original-space="1" data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="c2db702f-2a25-40e8-b33c-7c13541448d0" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="d1dd7022-593d-4b0f-93db-04b4d2a21fad" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content data-cid="1545121554" id="9be28173-df4b-4463-8890-ab1df7e2e214" content-type="ins cts-2" specific-use="1545122499686" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:11pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122499686"><span id="0d8d011e-08f4-4d32-ad0f-2f1e9897d5b1">2</span><span id="c6e8ad76-c7aa-4c90-87f4-1637a6bc9ce4"> (16.7)</span></named-content></p></td><td data-class="" data-original-space="1" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="1892aa8f-7efb-4cf7-bf7c-13e9b457fe16" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="acb14993-66b3-47d7-9f54-be7d32d66e08" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content data-cid="1545121555" id="64c2f51f-3d72-4881-9d78-c42dfcc2bd26" content-type="ins cts-2" specific-use="1545122506222" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:11pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122506222"><span id="988d0c0a-9aa2-4207-9bb0-fb8a0ab0b8ce">1</span><span id="9d1bb9a3-3c73-401d-b587-d30c58933138"> (11.1)</span></named-content></p></td></tr><tr data-col-count="5" id="b24b4bc8-3bcb-4483-b621-0490547281e8" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="ba1ed43f-2558-42d7-bfe1-0ac2507a6354" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="3195699f-f826-456c-99a4-f53008f2754d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545121567" id="fdc82059-dd5d-49b2-977d-75c669766d92" content-type="styrm cts-2" specific-use="1545122743825" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Bold Removed by Varalakshmi (PREEDITOR) - Dec 18 2018 2:15pm" data-track-detail="" data-format-command="bold" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122743825" data-track-hint="Bold Removed">Family history of autoimmunity</named-content> (<named-content id="7d27056f-c21a-4c95-b376-e7cf99dad69c" data-cid="7d27056f-c21a-4c95-b376-e7cf99dad69c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="32" data-match="n=15" data-replace="n" data-pattern="$1" data-tag-index="75_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="83ba87f3-579f-48b5-8581-95b742e7787f" data-cid="83ba87f3-579f-48b5-8581-95b742e7787f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="33" data-match="n=15" data-replace="=" data-pattern="$2" data-tag-index="75_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="742bb76d-6f5d-474b-9392-9b6bcf1faa28" data-cid="742bb76d-6f5d-474b-9392-9b6bcf1faa28" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="34" data-match="n=15" data-replace="15" data-pattern="$3" data-tag-index="75_1" data-time="" data-username="" data-userid="">15</named-content>)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="4a80e9c1-655e-4f5e-8744-77e8fccdbcea" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="8cbf60db-fe4a-41e8-9034-86e5536e2965" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="c1a7b83f-ee9d-43ac-9f26-2c1af4572e98" data-cid="c1a7b83f-ee9d-43ac-9f26-2c1af4572e98" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="5 (23.8)" data-replace="5" data-pattern="$1" data-tag-index="76_1" data-time="" data-username="" data-userid="">5</named-content><named-content id="2af68d08-43be-42de-a195-99ddba9e3fe0" data-cid="2af68d08-43be-42de-a195-99ddba9e3fe0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="5 (23.8)" data-replace=" (23.8)" data-pattern=" $2" data-tag-index="76_1" data-time="" data-username="" data-userid=""> (23.8)</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="aa6ec70f-2d0a-45f6-9c9b-b803bbd1d369" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;0&quot;;&quot;data-left-indent-space&quot;:&quot;0&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="59781d43-a727-4460-9475-d4f834042043" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="e4e1ddd3-63b5-4cef-85e6-d40866e91776" data-cid="e4e1ddd3-63b5-4cef-85e6-d40866e91776" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="4/11 (33" data-replace="4/11" data-pattern="$1" data-tag-index="77_1" data-time="" data-username="" data-userid="">4/11</named-content><named-content id="aed9080d-365d-430a-97d7-4ea8935d47f3" data-cid="aed9080d-365d-430a-97d7-4ea8935d47f3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="4/11 (33" data-replace=" (33" data-pattern=" $2" data-tag-index="77_1" data-time="" data-username="" data-userid=""> (33</named-content>.<named-content data-cid="1545463953" id="5fa62189-4101-4442-a1ec-74c0efc3157e" content-type="del cts-4" specific-use="1545469592590" xlink:title="Asha (TYPESETTER)" alt="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-title="Deleted by Asha (TYPESETTER) - Dec 22 2018 2:36pm" data-track-detail="" data-userid="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-username="Asha (TYPESETTER)" data-time="1545469592590"> </named-content>3)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="35bfc355-bdef-4827-90ce-79a659ca23d8" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;1.671875&quot;;&quot;data-left-indent-space&quot;:&quot;1.671875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="12451b00-9a47-469e-9da3-045e520cf658" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="0732fd7b-4bf9-4a3b-9ba2-b6efc17a4413" data-cid="0732fd7b-4bf9-4a3b-9ba2-b6efc17a4413" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1/4 (11.1)" data-replace="1/4" data-pattern="$1" data-tag-index="78_1" data-time="" data-username="" data-userid="">1/4</named-content><named-content id="dfe55496-cbcb-42ff-9206-a2ac54a1cf5b" data-cid="dfe55496-cbcb-42ff-9206-a2ac54a1cf5b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="1/4 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="78_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="3b10538c-4aeb-4d41-acd0-7fb938c87a7b"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="fa11bf8b-5477-41bc-aff4-72c731435f60" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="e49543c6-65f9-448b-90a8-0f8fe3b38689" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1545121556" id="ba6a33f0-c147-437f-9c03-143a5893f25f" content-type="ins cts-2" specific-use="1545122537739" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122537739">Hashimoto’s thyroiditis</named-content><named-content data-cid="1545121557" id="dd9a5756-c782-434a-a284-c41eb38740dd" content-type="del cts-2" specific-use="1545122542044" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122542044">Celiac disease</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="f2838180-8f86-43b3-ae1c-2ade48f19071" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="18b2b002-9caa-4b02-a4af-ac83b9f6d67e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="b1384360-65d1-49fb-8406-62079aabac61" data-cid="b1384360-65d1-49fb-8406-62079aabac61" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (4.8)" data-replace="1" data-pattern="$1" data-tag-index="81_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="6ef0edcc-6b6b-4274-bbb4-c52235db4157" data-cid="6ef0edcc-6b6b-4274-bbb4-c52235db4157" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (4.8)" data-replace=" (4.8)" data-pattern=" $2" data-tag-index="81_1" data-time="" data-username="" data-userid=""> (4.8)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="59f4de32-0db8-4aa9-a4d5-bf204e5bac22" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="8ac18732-5c82-4662-b463-ba128cd8f865" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="1611c07b-2401-4692-8749-41c69d0ac469" data-cid="1611c07b-2401-4692-8749-41c69d0ac469" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="82_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="96e3719b-07fa-445e-af45-84842d8a550a" data-cid="96e3719b-07fa-445e-af45-84842d8a550a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="82_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="fbf9f361-49f2-4cbf-b790-6326395f9f2c" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.765625&quot;;&quot;data-left-indent-space&quot;:&quot;8.765625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="73ba89a7-1a3d-4c7c-a21e-47cbe185bebe" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="0f8335f7-3f31-45fc-b353-37f635ba2746" data-cid="0f8335f7-3f31-45fc-b353-37f635ba2746" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s789_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td></tr><tr data-col-count="5" id="f649486f-dfcc-4651-b8fa-e448b6addc91" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="3f90246b-0821-40b4-8888-9b73982ac3a1" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="bc15b185-2e01-426f-a401-8c820e9a565d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1545121558" id="37cbca55-aba2-46de-846a-89f4b18a8fb1" content-type="ins cts-2" specific-use="1545122544608" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122544608">Celiac disease</named-content><named-content data-cid="1545121559" id="29a33efd-4995-4508-997f-319dd01c0531" content-type="del cts-2" specific-use="1545122554873" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122554873">Ulcerative colitis</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="048d0414-1962-419c-9af9-9ddf9ce4aedc" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="704ea225-5288-4cb7-af9a-cd1d1358cb26" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="1e13bc96-08f9-46e6-8af6-d03a78c4b805" data-cid="1e13bc96-08f9-46e6-8af6-d03a78c4b805" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (4.8)" data-replace="1" data-pattern="$1" data-tag-index="84_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="835b962a-c60e-40e0-b40f-4e73431168f1" data-cid="835b962a-c60e-40e0-b40f-4e73431168f1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (4.8)" data-replace=" (4.8)" data-pattern=" $2" data-tag-index="84_1" data-time="" data-username="" data-userid=""> (4.8)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="aff60d43-61d3-450a-8db9-74c34d2a6fc6" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="b0c2b848-11a0-471e-b27c-61de7340a2b2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4881056c-bf28-4706-8095-3be5d349cdf1" data-cid="4881056c-bf28-4706-8095-3be5d349cdf1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="85_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="1597f503-3976-45f2-bc51-7a9b5f79118e" data-cid="1597f503-3976-45f2-bc51-7a9b5f79118e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="85_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="7cbd446a-d93b-426c-8f32-cea6c908dd6c" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.765625&quot;;&quot;data-left-indent-space&quot;:&quot;8.765625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="bf9b9895-18af-4393-ac27-08264f2374d3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="67fe4580-75d3-4fb5-9f61-b8398c9bfcfa" data-cid="67fe4580-75d3-4fb5-9f61-b8398c9bfcfa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s794_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td></tr><tr data-col-count="5" id="c281de6e-b890-4077-bb9f-f129ceb02615"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="74e74dee-3fc9-425c-9bed-df6c5dafa6df" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="ae7ef657-b8f3-498c-989f-d58569b89059" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1545121560" id="d32e7163-e895-4a23-a8a0-55fd1b944452" content-type="ins cts-2" specific-use="1545122556896" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122556896">Ulcerative colitis</named-content><named-content data-cid="1545121561" id="302a4004-add1-4272-8df6-efd45fa4f0c5" content-type="del cts-2" specific-use="1545122561336" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122561336">Psoriasis</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="6ac6b943-cd20-4b53-a84c-18ee9d13e1be" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="22723ed9-cdb6-456d-b0c3-bc8e5d96c437" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="1ce1af29-4f42-43af-ae50-9ca3f53020f0" data-cid="1ce1af29-4f42-43af-ae50-9ca3f53020f0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (4.8)" data-replace="1" data-pattern="$1" data-tag-index="87_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="4061941d-877d-4b94-8e87-d8b42c9e4312" data-cid="4061941d-877d-4b94-8e87-d8b42c9e4312" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (4.8)" data-replace=" (4.8)" data-pattern=" $2" data-tag-index="87_1" data-time="" data-username="" data-userid=""> (4.8)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="3f5bd938-11c9-45ef-8d9b-3e55f2ce8814" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="75995823-2d88-4607-a5d9-264f3d682914" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="fe37849e-7f60-4eab-93ee-fcafc3128a9e" data-cid="fe37849e-7f60-4eab-93ee-fcafc3128a9e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="88_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="cd5f2169-fba9-4b42-b74c-3739521e83aa" data-cid="cd5f2169-fba9-4b42-b74c-3739521e83aa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="88_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="1afb11b9-f2fd-4a6d-a2c0-12cd035ff569" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.765625&quot;;&quot;data-left-indent-space&quot;:&quot;8.765625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="46b2359c-cfa7-489f-9b77-b80e085d69bb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="06da4b67-4525-4e32-a11e-3c340cc5dcb2" data-cid="06da4b67-4525-4e32-a11e-3c340cc5dcb2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s799_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td></tr><tr data-col-count="5" id="a8c6ab92-e368-45a4-9cb1-0e83f5070f1f" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="66f46909-07fe-4603-aef9-d47327a1dfc0" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="155a9ec0-32b2-4bd1-98bc-c2f401d61b21" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1545121562" id="069c71c6-d178-4ea9-a5c0-de0a6f7bcdab" content-type="ins cts-2" specific-use="1545122564120" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122564120">Psoriasis</named-content><named-content data-cid="1545121563" id="061c39df-e59d-4364-82b9-f11f67c23664" content-type="del cts-2" specific-use="1545122569920" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122569920">Type </named-content><named-content data-cid="1545113216079" id="699c55c1-62d7-45c7-8997-f33aaf68b93c" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="d58d6456-8fa1-4ddd-b933-127cc2fcbc0b" data-cid="1545113216079" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="5" data-match="1" data-pattern="" data-tag-index="89_1" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545121563" id="b34e4c9a-a7fe-45bd-af4a-6669e6d9b414" content-type="del cts-2" specific-use="1545122569920" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122569920">one</named-content></named-content><named-content data-cid="1545121563" id="9bacd47f-1514-4e61-a5a2-0c58ee15804c" content-type="del cts-2" specific-use="1545122569920" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122569920"> diabetes</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="919cc163-a179-4034-9ad8-0cb35591bcb4" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="fc3d40a5-6d35-4858-953f-2329a7e8bbc0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="601e16f7-d36c-432f-a7ea-989b5fe68b0c" data-cid="601e16f7-d36c-432f-a7ea-989b5fe68b0c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (4.8)" data-replace="1" data-pattern="$1" data-tag-index="90_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="6526628b-0c70-4022-822b-fc3071fd1f46" data-cid="6526628b-0c70-4022-822b-fc3071fd1f46" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (4.8)" data-replace=" (4.8)" data-pattern=" $2" data-tag-index="90_1" data-time="" data-username="" data-userid=""> (4.8)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="49285d7f-1fb7-4f5f-8fc0-ece162e9d67b" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;11.265625&quot;;&quot;data-left-indent-space&quot;:&quot;11.265625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="45da3505-3579-474b-baec-318eb1310a0a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="283d08f1-eafb-4fc7-a1eb-fa87b20270f3" data-cid="283d08f1-eafb-4fc7-a1eb-fa87b20270f3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s803_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="84c20e0a-bc89-4f61-8162-f2e6b3eb22d3" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="839c9b6e-4def-4ca1-bf11-c57ff116fdd6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="f3200dbd-ed1c-48c5-bf57-214ab6f32c67" data-cid="f3200dbd-ed1c-48c5-bf57-214ab6f32c67" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="91_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="bdb657c8-ab6b-4772-9aed-fcd04f90fb96" data-cid="bdb657c8-ab6b-4772-9aed-fcd04f90fb96" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="91_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="96262ed2-2cc2-4d2b-8d16-9bc4d6a893e3"><td data-class="" data-original-space="1" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="db5acac4-3848-42b1-87c4-aecbfe607c01" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="15562cd0-6f43-4b70-bdfb-a8a7251b100e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1545121564" id="39d4d82d-9a30-4549-a20c-4a76f1c6ba82" content-type="ins cts-2" specific-use="1545122571390" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122571390">Type <named-content data-cid="1545433374" id="27e18fad-f4b1-4598-ba8c-cabe1653be1c" content-type="del cts-3" specific-use="1545437090218" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:04am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437090218">one</named-content><named-content data-cid="1545433377" id="d9bdb2be-c756-4654-b4ac-d20da77f8be0" content-type="ins cts-3" specific-use="1545437090898" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:04am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437090898">1</named-content> diabetes</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="1c756e64-c904-446d-be8b-18f819b8cb76" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="d4800afa-ce00-40c2-8641-584455032ecf" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="26a4da42-f97b-4cf6-bc7a-ce9c33d85b1f" data-cid="26a4da42-f97b-4cf6-bc7a-ce9c33d85b1f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (4.8)" data-replace="1" data-pattern="$1" data-tag-index="92_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="f9adf471-37f0-43d6-8cf9-638f6ecdabf0" data-cid="f9adf471-37f0-43d6-8cf9-638f6ecdabf0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (4.8)" data-replace=" (4.8)" data-pattern=" $2" data-tag-index="92_1" data-time="" data-username="" data-userid=""> (4.8)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="d04863b5-d13b-4907-98a1-12a04b225935" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="f560d3d9-a7d0-4b58-9fee-d44838f3ae77" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="efd278f7-1111-4003-aa1f-8a4bd04885a7" data-cid="efd278f7-1111-4003-aa1f-8a4bd04885a7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="93_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="ee465d75-f798-4c4d-8628-7c92c0a5e357" data-cid="ee465d75-f798-4c4d-8628-7c92c0a5e357" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="93_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="62a332c9-7459-45cb-8800-12f0a4124641" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.765625&quot;;&quot;data-left-indent-space&quot;:&quot;8.765625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="08692aa4-80b5-48a0-9c67-dd72830ac7b1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="597dd3b3-625e-4090-9f9d-bcecc663060f" data-cid="597dd3b3-625e-4090-9f9d-bcecc663060f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s809_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td></tr><tr data-col-count="5" id="9bd2f9dd-ff12-4ec3-8afc-3b3f59ec4558" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="a678dded-22d7-4a82-ac79-4beee5d694da" colspan="4" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;colspan&quot;:&quot;4&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="54b696c7-de4e-434c-bb6a-b789135169d7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545121568" id="377b88df-6402-419d-987c-e7b193d7034c" content-type="styrm cts-2" specific-use="1545122747348" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Bold Removed by Varalakshmi (PREEDITOR) - Dec 18 2018 2:15pm" data-track-detail="" data-format-command="bold" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122747348" data-track-hint="Bold Removed">Malignancy</named-content></p> </td></tr><tr data-col-count="5" id="2738d048-d6a9-43fe-8c27-167fa719a2ea"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="1c4d64cc-6e8b-4466-addd-a5e57c061006" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="1de8382f-8cee-4501-a0fe-06cdc4d4b229" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Lung cancer</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="2b1c9b5e-6611-4424-90ff-c87692e74c79" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="86b89239-e7c9-4fd5-ab79-c00970cacbab" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="a89b06df-b17e-476d-8338-25602df888f8" data-cid="a89b06df-b17e-476d-8338-25602df888f8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="5 (25)" data-replace="5" data-pattern="$1" data-tag-index="96_1" data-time="" data-username="" data-userid="">5</named-content><named-content id="28beec2b-1e6c-4e5b-bde8-63bba02d2263" data-cid="28beec2b-1e6c-4e5b-bde8-63bba02d2263" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="5 (25)" data-replace=" (25)" data-pattern=" $2" data-tag-index="96_1" data-time="" data-username="" data-userid=""> (25)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="2033220f-a348-4f20-8e7d-8c4ed00cf02d" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="1d63ae1c-3816-404d-885b-35d2eadb9d7d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="a523fde4-d587-4b26-a7e0-88be9a35177d" data-cid="a523fde4-d587-4b26-a7e0-88be9a35177d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (16.7)" data-replace="2" data-pattern="$1" data-tag-index="97_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="1d613de7-6f64-4f77-ba7e-99117f76a272" data-cid="1d613de7-6f64-4f77-ba7e-99117f76a272" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (16.7)" data-replace=" (16.7)" data-pattern=" $2" data-tag-index="97_1" data-time="" data-username="" data-userid=""> (16.7)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="a3cda87c-1f04-490c-bd60-d934d2bbe97e" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="a3576b3a-f28b-49dd-8d0f-f9b057fc556b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="a49a5147-eeaf-49ee-ad6d-7d0195d8dfe3" data-cid="a49a5147-eeaf-49ee-ad6d-7d0195d8dfe3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="3 (33.3)" data-replace="3" data-pattern="$1" data-tag-index="98_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="54dd1e84-4490-47e2-85a7-2c13ef4442ee" data-cid="54dd1e84-4490-47e2-85a7-2c13ef4442ee" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="3 (33.3)" data-replace=" (33.3)" data-pattern=" $2" data-tag-index="98_1" data-time="" data-username="" data-userid=""> (33.3)</named-content></p></td></tr><tr data-col-count="5" id="3fb4189c-6b8b-4317-8e94-d301ccfa3f35" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="ec5d0f36-f5d0-402e-9eec-1a199ecba87d" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="2a3e774f-4378-4793-82fa-eeb927d8fbcb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Melanoma</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="603d7ed9-dc30-4cf1-9af2-b7a3e252ade0" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="bbd77207-6962-4beb-adbf-058aafd1ba12" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="52f7335f-642d-4417-b750-37c44686ec7b" data-cid="52f7335f-642d-4417-b750-37c44686ec7b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="9 (45)" data-replace="9" data-pattern="$1" data-tag-index="100_1" data-time="" data-username="" data-userid="">9</named-content><named-content id="d4864b9a-1dce-4bdc-b84c-f9095969d17f" data-cid="d4864b9a-1dce-4bdc-b84c-f9095969d17f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="9 (45)" data-replace=" (45)" data-pattern=" $2" data-tag-index="100_1" data-time="" data-username="" data-userid=""> (45)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="cfb9f35a-75f1-4fc7-a244-a516ac02478a" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="7e57f6fc-1a3a-43ce-8e57-d02e1d91f65b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="0629cdef-c85c-4221-ada0-48fbacdfb3b0" data-cid="0629cdef-c85c-4221-ada0-48fbacdfb3b0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="7 (58.3)" data-replace="7" data-pattern="$1" data-tag-index="101_1" data-time="" data-username="" data-userid="">7</named-content><named-content id="8c40cd45-a277-40ad-a10a-5f8a7a8e1e23" data-cid="8c40cd45-a277-40ad-a10a-5f8a7a8e1e23" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="7 (58.3)" data-replace=" (58.3)" data-pattern=" $2" data-tag-index="101_1" data-time="" data-username="" data-userid=""> (58.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="89961841-9969-4fa0-93d5-a39504c19bf1" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="cab7d735-68cc-4c08-932c-573585efed8e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="2398dc09-cc1e-42c9-8c30-28424acc1073" data-cid="2398dc09-cc1e-42c9-8c30-28424acc1073" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (22.2)" data-replace="2" data-pattern="$1" data-tag-index="102_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="5db69da1-393c-4ff9-a27f-1411eae6181b" data-cid="5db69da1-393c-4ff9-a27f-1411eae6181b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (22.2)" data-replace=" (22.2)" data-pattern=" $2" data-tag-index="102_1" data-time="" data-username="" data-userid=""> (22.2)</named-content></p></td></tr><tr data-col-count="5" id="db03563c-0ddd-4bb2-939a-d5f03023bffe"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="6029c40d-4158-475e-89b5-8a0d89c18f4e" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="4bed2ce8-8f96-4369-b2c1-6a7aa33ee73d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Breast cancer</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="61fecfa0-94a6-466c-8a3c-867c5634a44b" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="a39c533a-b1ae-4cb1-ab33-f26dee80ec66" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="b52a744e-6477-4a1b-b169-ce98a280c7c1" data-cid="b52a744e-6477-4a1b-b169-ce98a280c7c1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (10)" data-replace="2" data-pattern="$1" data-tag-index="104_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="7ff9b1ad-c0d0-4be3-9008-24f04fbd3b1e" data-cid="7ff9b1ad-c0d0-4be3-9008-24f04fbd3b1e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (10)" data-replace=" (10)" data-pattern=" $2" data-tag-index="104_1" data-time="" data-username="" data-userid=""> (10)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="89eaac70-9557-4ee5-96df-29e8204f5661" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="fb0b438e-5733-41b7-8e79-bc64e5b95796" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="332df15b-64ca-4a81-bb40-325ebaaab134" data-cid="332df15b-64ca-4a81-bb40-325ebaaab134" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="105_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="9ebe9c8f-7138-4392-ac16-4cf9558db5a4" data-cid="9ebe9c8f-7138-4392-ac16-4cf9558db5a4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="105_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="cbc0b3d3-c989-4448-bc65-8ad1580cd926" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="5c791d8f-9c6b-49c7-a5ee-9c7d1856bda6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="186afc3f-0649-4740-af38-aecdd53acbb0" data-cid="186afc3f-0649-4740-af38-aecdd53acbb0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="106_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="e1be5ff1-5002-4a27-b2b5-88658aeddf00" data-cid="e1be5ff1-5002-4a27-b2b5-88658aeddf00" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="106_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="e47258c4-2f33-488e-8ab2-92dfda4ead10" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="961b9a16-86a0-4639-9220-c08a5428cbc7" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="f075466f-4748-44b0-9d01-34c8dd0fb737" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Renal cell cancer</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="fed2a14b-64d1-4812-9284-7212bc5b9afe" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="1d0f2fee-7059-452d-86eb-4aa1046e8dfd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="65d30193-d88f-4c1b-a2bf-8b6645f449c0" data-cid="65d30193-d88f-4c1b-a2bf-8b6645f449c0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (5)" data-replace="1" data-pattern="$1" data-tag-index="108_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="217b196f-a026-4cf1-bac7-15aba6938965" data-cid="217b196f-a026-4cf1-bac7-15aba6938965" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (5)" data-replace=" (5)" data-pattern=" $2" data-tag-index="108_1" data-time="" data-username="" data-userid=""> (5)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="79252eca-2347-4c75-b49c-3d511b2ccff1" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="a11f6772-b227-442a-8f1e-3cb434b6d170" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="3e11473c-05e7-4263-9dee-b5d88afebd41" data-cid="3e11473c-05e7-4263-9dee-b5d88afebd41" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="109_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="211d8528-6706-4589-92c4-c261fd8d0e72" data-cid="211d8528-6706-4589-92c4-c261fd8d0e72" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="109_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="cb03b3dd-d99f-460f-a3ee-02282b7b5d04" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.765625&quot;;&quot;data-left-indent-space&quot;:&quot;8.765625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="9e07fd3c-cd45-48bb-ba3e-a2825e0eeb77" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="50f23c37-840c-44ff-83bb-ad572a04337f" data-cid="50f23c37-840c-44ff-83bb-ad572a04337f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s834_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td></tr><tr data-col-count="5" id="4f21a540-1ea8-4336-a510-80cf477acc65"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="3379f7eb-9421-4658-8052-1b8148acff02" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="55ba796f-1e5d-4648-8ba5-f1c9bac01a21" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Multiple myeloma</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="0c9c75d8-0d07-4b90-864e-780cdfe037aa" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="d85a13c5-3aad-4a62-baed-dfa196662c11" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="594988cd-1f3e-4cda-878c-301082ab14d2" data-cid="594988cd-1f3e-4cda-878c-301082ab14d2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (5)" data-replace="1" data-pattern="$1" data-tag-index="111_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="24f2f807-0d66-46f3-a9ec-150f315fd355" data-cid="24f2f807-0d66-46f3-a9ec-150f315fd355" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (5)" data-replace=" (5)" data-pattern=" $2" data-tag-index="111_1" data-time="" data-username="" data-userid=""> (5)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="5928aa30-7045-4636-9e06-f6f2308db5cf" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="eb47ffc6-7417-44bc-b876-24019787b833" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4a89ecb7-0e62-4e03-be2a-d6d6799f3a73" data-cid="4a89ecb7-0e62-4e03-be2a-d6d6799f3a73" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="112_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="30682af0-1200-4bbd-a98a-1eaa547eed9b" data-cid="30682af0-1200-4bbd-a98a-1eaa547eed9b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="112_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="c1b45578-f793-4a60-879c-b70a4563d974" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.765625&quot;;&quot;data-left-indent-space&quot;:&quot;8.765625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="02ae3683-f30b-4ecb-9518-1ae1f2a1d903" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="33186bbd-d7cf-4490-8c3b-4aae2c4956e8" data-cid="33186bbd-d7cf-4490-8c3b-4aae2c4956e8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s839_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td></tr><tr data-col-count="5" id="a4ab0672-cf93-4317-99f4-3dfa3f3d2e2a" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="b919cc12-be8a-4ec1-b9d7-a06f18456f24" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="ef93bbc5-6dea-45db-a2d6-f419ce642b70" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Lymphoma</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="eada9f01-5825-435d-b66d-b4c86e46744c" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="effa8591-4e51-4175-98d0-568408352344" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="781a2bc7-631a-44e2-863d-2f26c8eb5f0c" data-cid="781a2bc7-631a-44e2-863d-2f26c8eb5f0c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (5)" data-replace="1" data-pattern="$1" data-tag-index="114_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="dd5aa0b5-4e8a-4ff8-838d-7c6ddecb9444" data-cid="dd5aa0b5-4e8a-4ff8-838d-7c6ddecb9444" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (5)" data-replace=" (5)" data-pattern=" $2" data-tag-index="114_1" data-time="" data-username="" data-userid=""> (5)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="28072de4-a6f6-4805-a696-863dd52e08c0" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;11.265625&quot;;&quot;data-left-indent-space&quot;:&quot;11.265625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="b6276e82-adec-4e94-9aca-2f6b9a0b24a1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4df40d37-9bf8-49ff-89bf-df6697866fd2" data-cid="4df40d37-9bf8-49ff-89bf-df6697866fd2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s843_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="68a43319-ab09-450b-9e09-65f7f40ee58e" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="ea2919ae-b27e-46a4-8c74-b52fcc447f08" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="9b2cf881-3f4c-4cf6-b9d1-88ba5fa36dd4" data-cid="9b2cf881-3f4c-4cf6-b9d1-88ba5fa36dd4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="115_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="edb07aa5-0ebb-42b6-b776-8c17348ff3f3" data-cid="edb07aa5-0ebb-42b6-b776-8c17348ff3f3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="115_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="d6fd9ade-bbfc-4751-80fa-a8fd9b0fc44c"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="e9b95cea-fcf5-479d-b295-a47d42f08618" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="10fedf3e-4bc4-47a4-9510-2cf4119f2f58" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Merkel cell cancer</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="ba52f480-b43a-4e92-9854-c6d4de7bc711" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="9ba66501-41a4-47a3-92ff-cc48851782cf" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="fde36eb3-4142-43e4-ae41-78a3bf7c92ff" data-cid="fde36eb3-4142-43e4-ae41-78a3bf7c92ff" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (5)" data-replace="1" data-pattern="$1" data-tag-index="117_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="6de9bfa7-b7b5-4483-88f9-f816716efd59" data-cid="6de9bfa7-b7b5-4483-88f9-f816716efd59" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (5)" data-replace=" (5)" data-pattern=" $2" data-tag-index="117_1" data-time="" data-username="" data-userid=""> (5)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="225d0e34-5b43-4d83-8f29-5c702553b24d" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="78b91095-f3ec-458c-8ecc-29fab6911f9c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="71f91f2e-95fd-4cd8-99b8-ad53e9a3b1ab" data-cid="71f91f2e-95fd-4cd8-99b8-ad53e9a3b1ab" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="118_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="40817ab1-28b6-4833-a4f4-586c45a31c8c" data-cid="40817ab1-28b6-4833-a4f4-586c45a31c8c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="118_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="341d1184-d8a6-4ef1-86c7-423bc61b3910" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.765625&quot;;&quot;data-left-indent-space&quot;:&quot;8.765625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="a0b783a4-baa6-452f-8666-c42c0af1e4ac" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="f4e4c3cd-be1a-48f9-beaa-bce6454e9ff6" data-cid="f4e4c3cd-be1a-48f9-beaa-bce6454e9ff6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s849_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td></tr><tr data-col-count="5" id="d6ac0aa6-c833-4a53-a95d-869aaf1219fd" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="0ee03c61-c7f9-46cd-a17b-8a8b5bbd854f" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="401192d9-98e0-4f84-ad77-f5210d1e1afd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Esophageal cancer</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="182a0269-379f-459a-8768-ceadda0eb4d5" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="5cdc948b-ccfd-4e2c-bb37-da32fe93efdc" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="3b237feb-7bad-4e1c-b232-1ef63606565b" data-cid="3b237feb-7bad-4e1c-b232-1ef63606565b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (5)" data-replace="1" data-pattern="$1" data-tag-index="120_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="8ffb9f2c-0813-42e2-b3a2-7d0cbf729c32" data-cid="8ffb9f2c-0813-42e2-b3a2-7d0cbf729c32" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (5)" data-replace=" (5)" data-pattern=" $2" data-tag-index="120_1" data-time="" data-username="" data-userid=""> (5)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="e292ae2d-93e2-4f0f-a758-5e7794a2e079" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;11.265625&quot;;&quot;data-left-indent-space&quot;:&quot;11.265625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="bc2ef3b1-bcc4-4f6e-8413-1ab445f694b5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="c1f2d373-935d-4001-b0d8-2f4c7d844757" data-cid="c1f2d373-935d-4001-b0d8-2f4c7d844757" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s853_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="970cbc26-51ee-4c38-a0fb-4a2eaea516d1" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="00492637-c868-4781-8b29-9c03a0ca180a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="b04473af-cb70-4928-8e2c-7bf140e5fec4" data-cid="b04473af-cb70-4928-8e2c-7bf140e5fec4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="121_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="b0a8b672-306b-4e4a-8f44-8e2f6a2c8b5c" data-cid="b0a8b672-306b-4e4a-8f44-8e2f6a2c8b5c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="121_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="3ab763fb-9dd8-4ed3-8112-e081ea2614bf"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="13004a65-4d97-4913-bede-0e00aa7fc8af" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="75d42270-ddd0-45ec-acaa-1ad0e76b2dc5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Pancreatic cancer</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="779e75b8-79cd-4114-84fc-10467ab543a6" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="6534d6cb-2b12-478d-809a-1cd9d3ba56aa" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="d03403a8-ce66-4fba-986c-2f47015b2ac7" data-cid="d03403a8-ce66-4fba-986c-2f47015b2ac7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (5)" data-replace="1" data-pattern="$1" data-tag-index="123_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="4322759a-85ae-4217-90fc-96429a05aceb" data-cid="4322759a-85ae-4217-90fc-96429a05aceb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (5)" data-replace=" (5)" data-pattern=" $2" data-tag-index="123_1" data-time="" data-username="" data-userid=""> (5)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="304930d0-5c88-4caf-8ad7-2590980d3897" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;11.265625&quot;;&quot;data-left-indent-space&quot;:&quot;11.265625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="7500e000-83fc-486a-b265-ad5d19906bb2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="734222c7-11f0-41aa-8b3d-4e3ff1929eb9" data-cid="734222c7-11f0-41aa-8b3d-4e3ff1929eb9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s858_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="7d536c5c-73b6-4657-aeef-7e5e3d25c5b3" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="03bbaa51-b553-4759-a74f-751add97a24d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="fe5291cb-99aa-4c61-a4b9-e05dd38bf0ab" data-cid="fe5291cb-99aa-4c61-a4b9-e05dd38bf0ab" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="124_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="f5eaf798-50b9-4670-b5b5-090d5612b2fa" data-cid="f5eaf798-50b9-4670-b5b5-090d5612b2fa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="124_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="d0e0b236-8fb8-4775-9b92-2f3b65599a7c" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="97c7551f-9240-4554-ba03-f25d34aa40ec" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="98ebc0f5-4142-478d-839f-6b7de9edaf49" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RPG (mg/dL) at ICI initiation</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="ab77fcbe-3ddc-40de-b1b0-9efe3a631ce2" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;0&quot;;&quot;data-left-indent-space&quot;:&quot;0&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="41ef3c66-5d5b-4b3a-8008-4b632a009654" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="b5b65086-c607-4720-9ea8-08704419dd2e" data-cid="b5b65086-c607-4720-9ea8-08704419dd2e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="116 (98 – 154)" data-replace="116 " data-pattern="$1 " data-tag-index="126_1" data-time="" data-username="" data-userid="">116 </named-content><named-content id="972e08de-9a51-4970-8849-b954e01ca2a0" data-cid="972e08de-9a51-4970-8849-b954e01ca2a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="116 (98 – 154)" data-replace="(98" data-pattern="$2" data-tag-index="126_1" data-time="" data-username="" data-userid="">(98</named-content><named-content id="6f311454-f1e2-4532-9d21-932946d04fa3" data-cid="6f311454-f1e2-4532-9d21-932946d04fa3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="116 (98 – 154)" data-replace="–" data-pattern="–" data-tag-index="126_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="7c1f54ca-5c43-40bf-8cd5-2b9d13646b1b" data-cid="7c1f54ca-5c43-40bf-8cd5-2b9d13646b1b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="12" data-match="116 (98 – 154)" data-replace="154)" data-pattern="$4" data-tag-index="126_1" data-time="" data-username="" data-userid="">154)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="72a6b02c-79c2-4b47-b0eb-ebdf47bdb15e" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;2.5&quot;;&quot;data-left-indent-space&quot;:&quot;2.5&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="65ccd4f0-fa2d-486f-ba56-724784ba0568" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="6b193860-db18-4540-858d-7fca7e146e8e" data-cid="6b193860-db18-4540-858d-7fca7e146e8e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="115 (84 – 140)" data-replace="115 " data-pattern="$1 " data-tag-index="127_1" data-time="" data-username="" data-userid="">115 </named-content><named-content id="7448d652-dd26-4643-8baf-e389f5c925f0" data-cid="7448d652-dd26-4643-8baf-e389f5c925f0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="115 (84 – 140)" data-replace="(84" data-pattern="$2" data-tag-index="127_1" data-time="" data-username="" data-userid="">(84</named-content><named-content id="983012fc-3f64-4e65-a02c-918516f937dd" data-cid="983012fc-3f64-4e65-a02c-918516f937dd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="115 (84 – 140)" data-replace="–" data-pattern="–" data-tag-index="127_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="12767f99-228e-4bef-89c5-7bddba24e1e3" data-cid="12767f99-228e-4bef-89c5-7bddba24e1e3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="12" data-match="115 (84 – 140)" data-replace="140)" data-pattern="$4" data-tag-index="127_1" data-time="" data-username="" data-userid="">140)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="671c09b4-126d-481a-bec1-1e4e5514c359" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;0&quot;;&quot;data-left-indent-space&quot;:&quot;0&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="9b781a57-16d9-4062-ac15-c31f83bd22b9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="eb39caca-b7a4-4c09-bf2a-e2521b394bd6" data-cid="eb39caca-b7a4-4c09-bf2a-e2521b394bd6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="158 (107 – 254)" data-replace="158 " data-pattern="$1 " data-tag-index="128_1" data-time="" data-username="" data-userid="">158 </named-content><named-content id="b63aaae9-18d0-49fc-8773-0e8258984000" data-cid="b63aaae9-18d0-49fc-8773-0e8258984000" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="158 (107 – 254)" data-replace="(107" data-pattern="$2" data-tag-index="128_1" data-time="" data-username="" data-userid="">(107</named-content><named-content id="16e0ce24-7fe4-48b8-b4c0-6f5e1ce6c990" data-cid="16e0ce24-7fe4-48b8-b4c0-6f5e1ce6c990" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="158 (107 – 254)" data-replace="–" data-pattern="–" data-tag-index="128_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="66f48af2-1da4-4815-9eb4-d3e47c41cc15" data-cid="66f48af2-1da4-4815-9eb4-d3e47c41cc15" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="158 (107 – 254)" data-replace="254)" data-pattern="$4" data-tag-index="128_1" data-time="" data-username="" data-userid="">254)</named-content></p></td></tr><tr data-col-count="5" id="65bbf980-ff07-4aec-93ef-0a7ff08b6197"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="6701624d-f4b1-4377-964f-a7db23c634c7" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="9d6c0c21-21bd-47c1-a9bf-4303d4655dbb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG (mg/dL) at ICI initiation</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="9dc200fa-a82a-443c-9f79-8b566fb238a3" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;0&quot;;&quot;data-left-indent-space&quot;:&quot;0&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="93ccec79-d8aa-47f1-958b-5e0f5931a472" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="ae224f19-ba25-4b63-b86f-1bf2f9063380" data-cid="ae224f19-ba25-4b63-b86f-1bf2f9063380" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="108 (99 – 132)" data-replace="108 " data-pattern="$1 " data-tag-index="130_1" data-time="" data-username="" data-userid="">108 </named-content><named-content id="30d55f04-a906-40e3-9e4c-98489e38fbae" data-cid="30d55f04-a906-40e3-9e4c-98489e38fbae" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="108 (99 – 132)" data-replace="(99" data-pattern="$2" data-tag-index="130_1" data-time="" data-username="" data-userid="">(99</named-content><named-content id="ce42cf3e-af7f-4bdb-ab63-4797e8d8acf7" data-cid="ce42cf3e-af7f-4bdb-ab63-4797e8d8acf7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="108 (99 – 132)" data-replace="–" data-pattern="–" data-tag-index="130_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="7997ffe6-dbd6-4b02-a641-d26cff8ee346" data-cid="7997ffe6-dbd6-4b02-a641-d26cff8ee346" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="12" data-match="108 (99 – 132)" data-replace="132)" data-pattern="$4" data-tag-index="130_1" data-time="" data-username="" data-userid="">132)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="ea71c62b-8371-467a-8bb2-dd8af955d7d9" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;2.5&quot;;&quot;data-left-indent-space&quot;:&quot;2.5&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="9431b159-b5ab-4654-86f2-21521308f8ef" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="390a8a4c-70e6-46f4-a645-1766aa86b8d2" data-cid="390a8a4c-70e6-46f4-a645-1766aa86b8d2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="102 (93 – 108)" data-replace="102 " data-pattern="$1 " data-tag-index="131_1" data-time="" data-username="" data-userid="">102 </named-content><named-content id="1af07994-4291-49fc-b67a-73e080e2d171" data-cid="1af07994-4291-49fc-b67a-73e080e2d171" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="102 (93 – 108)" data-replace="(93" data-pattern="$2" data-tag-index="131_1" data-time="" data-username="" data-userid="">(93</named-content><named-content id="c2403ee5-f20f-4b64-996c-d41956641ae9" data-cid="c2403ee5-f20f-4b64-996c-d41956641ae9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="102 (93 – 108)" data-replace="–" data-pattern="–" data-tag-index="131_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="37f22afa-f34d-4b90-9934-c6457b62caa4" data-cid="37f22afa-f34d-4b90-9934-c6457b62caa4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="12" data-match="102 (93 – 108)" data-replace="108)" data-pattern="$4" data-tag-index="131_1" data-time="" data-username="" data-userid="">108)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="c0343fbe-838b-403e-8d8d-48ff0a52c8a2" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;0&quot;;&quot;data-left-indent-space&quot;:&quot;0&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="4d27a7ec-0e4f-467e-8e39-73a00df3ed32" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="506a0c18-ba01-4891-bd63-57b0f3a18891" data-cid="506a0c18-ba01-4891-bd63-57b0f3a18891" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="132 (114 – 153)" data-replace="132 " data-pattern="$1 " data-tag-index="132_1" data-time="" data-username="" data-userid="">132 </named-content><named-content id="fbafd3f7-8e50-4c8a-86a8-fdf7d40ba192" data-cid="fbafd3f7-8e50-4c8a-86a8-fdf7d40ba192" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="132 (114 – 153)" data-replace="(114" data-pattern="$2" data-tag-index="132_1" data-time="" data-username="" data-userid="">(114</named-content><named-content id="e7df39d9-1cd9-4531-b4db-c0723385fdf3" data-cid="e7df39d9-1cd9-4531-b4db-c0723385fdf3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="132 (114 – 153)" data-replace="–" data-pattern="–" data-tag-index="132_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="ba2785f4-4cff-4e2d-825f-42b35e71f4a0" data-cid="ba2785f4-4cff-4e2d-825f-42b35e71f4a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="132 (114 – 153)" data-replace="153)" data-pattern="$4" data-tag-index="132_1" data-time="" data-username="" data-userid="">153)</named-content></p></td></tr><tr data-col-count="5" id="75bd0c4c-0f47-4d82-8094-472f4314bb2a" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="66d24027-87ac-49d5-b89c-a3333a1b3a76" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="7f76e79d-857a-42ca-a963-271e1cf16af2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">HbA1c (%) at ICI initiation</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="4e983029-6274-47e0-b9a3-4feeb86880c6" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="f157aefb-a902-4c07-bfa1-5b1baeaca9e3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="19e3811a-a3e1-459f-a419-12dd5586e8b5" data-cid="19e3811a-a3e1-459f-a419-12dd5586e8b5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="8 (6.8 – 8.6)" data-replace="8 " data-pattern="$1 " data-tag-index="134_1" data-time="" data-username="" data-userid="">8 </named-content><named-content id="eb02318f-ad4f-4491-9b14-aba5937a7869" data-cid="eb02318f-ad4f-4491-9b14-aba5937a7869" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="2" data-match="8 (6.8 – 8.6)" data-replace="(6.8" data-pattern="$2" data-tag-index="134_1" data-time="" data-username="" data-userid="">(6.8</named-content><named-content id="ae8b7aa2-0ba1-4997-82af-200d20a22fcb" data-cid="ae8b7aa2-0ba1-4997-82af-200d20a22fcb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="8 (6.8 – 8.6)" data-replace="–" data-pattern="–" data-tag-index="134_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="107485da-584d-4e85-8c12-80a45313903d" data-cid="107485da-584d-4e85-8c12-80a45313903d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="11" data-match="8 (6.8 – 8.6)" data-replace="8.6)" data-pattern="$4" data-tag-index="134_1" data-time="" data-username="" data-userid="">8.6)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="a5a6585a-a488-481e-95f1-20c850185329" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;47.25&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;11.265625&quot;;&quot;data-left-indent-space&quot;:&quot;11.265625&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="f004ead3-2879-4e3f-9c61-632ce49d434b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="0068a8ab-65ca-434c-92c1-4f8f90f3d6fc" data-cid="0068a8ab-65ca-434c-92c1-4f8f90f3d6fc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s873_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="d3ffa47a-2b7c-42e9-b16e-f7fdc3e231ed" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="e80d8fd1-9339-4394-b5b3-438f7a2f9881" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4295a10e-4739-403f-8385-fab6095f6c46" data-cid="4295a10e-4739-403f-8385-fab6095f6c46" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="8 (6.8 – 8.6)" data-replace="8 " data-pattern="$1 " data-tag-index="135_1" data-time="" data-username="" data-userid="">8 </named-content><named-content id="4e6539e0-9ada-46a7-9dcd-07d228f7d0a1" data-cid="4e6539e0-9ada-46a7-9dcd-07d228f7d0a1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="2" data-match="8 (6.8 – 8.6)" data-replace="(6.8" data-pattern="$2" data-tag-index="135_1" data-time="" data-username="" data-userid="">(6.8</named-content><named-content id="3ac91aba-dce9-4b9f-8441-925acbca331a" data-cid="3ac91aba-dce9-4b9f-8441-925acbca331a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="8 (6.8 – 8.6)" data-replace="–" data-pattern="–" data-tag-index="135_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="a162b8d0-6c3a-43de-acfd-6fa122454da6" data-cid="a162b8d0-6c3a-43de-acfd-6fa122454da6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="11" data-match="8 (6.8 – 8.6)" data-replace="8.6)" data-pattern="$4" data-tag-index="135_1" data-time="" data-username="" data-userid="">8.6)</named-content></p></td></tr><tr data-col-count="5" id="0d63f940-c1c3-4633-9033-84ca6cbc9387"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="0962b10f-2b7a-4346-bd46-3e60bf684d76" colspan="4" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;colspan&quot;:&quot;4&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="6ddb4620-f17d-4fb6-8d81-ade699ade70c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545121569" id="dbd7f597-6d80-4e99-89be-12149d35e6c0" content-type="styrm cts-2" specific-use="1545122751944" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Bold Removed by Varalakshmi (PREEDITOR) - Dec 18 2018 2:15pm" data-track-detail="" data-format-command="bold" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122751944" data-track-hint="Bold Removed">ICI therapy</named-content></p> </td></tr><tr data-col-count="5" id="f47b7c99-bb7c-47f9-b525-3d8385192083" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="23100999-0d53-47c3-b7f9-38073b7ed9fa" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="a7748cbe-2549-4462-82b7-b9078dc993a2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Pembrolizumab</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="56d12fb6-b704-45b7-bf88-959bec57e4b3" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="4fb8360b-3e12-4570-a370-901c2267a7e5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="e02bc6e2-f402-4413-a152-a3fbd7f97943" data-cid="e02bc6e2-f402-4413-a152-a3fbd7f97943" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="17 (81)" data-replace="17" data-pattern="$1" data-tag-index="138_1" data-time="" data-username="" data-userid="">17</named-content><named-content id="2dd20c56-3ca7-417a-abc8-f93e33924416" data-cid="2dd20c56-3ca7-417a-abc8-f93e33924416" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="17 (81)" data-replace=" (81)" data-pattern=" $2" data-tag-index="138_1" data-time="" data-username="" data-userid=""> (81)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="b75b183f-0b3b-437b-bb0d-a6f1235453ed" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;6.671875&quot;;&quot;data-left-indent-space&quot;:&quot;6.671875&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="839b4939-c127-4ce2-9132-d4f46a9a0168" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="f011a390-49f1-416e-b733-64b9f96bf52d" data-cid="f011a390-49f1-416e-b733-64b9f96bf52d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="11 (91.7)" data-replace="11" data-pattern="$1" data-tag-index="139_1" data-time="" data-username="" data-userid="">11</named-content><named-content id="31aca184-3d27-4211-96db-bb027642d234" data-cid="31aca184-3d27-4211-96db-bb027642d234" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="11 (91.7)" data-replace=" (91.7)" data-pattern=" $2" data-tag-index="139_1" data-time="" data-username="" data-userid=""> (91.7)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="ed8f9141-ccc9-4e5b-bfb3-e6a38b5a654d" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="82181bd3-ff27-4980-9a33-480d9832edba" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4bf5cb76-379d-43eb-9656-46b77db41297" data-cid="4bf5cb76-379d-43eb-9656-46b77db41297" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="6 (66.7)" data-replace="6" data-pattern="$1" data-tag-index="140_1" data-time="" data-username="" data-userid="">6</named-content><named-content id="ef801afa-879b-4897-a17a-3b563b7f5a82" data-cid="ef801afa-879b-4897-a17a-3b563b7f5a82" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="6 (66.7)" data-replace=" (66.7)" data-pattern=" $2" data-tag-index="140_1" data-time="" data-username="" data-userid=""> (66.7)</named-content></p></td></tr><tr data-col-count="5" id="cb1bb896-367b-485c-9c6c-9b7517cb64cd"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="9e8498f3-f34d-4725-85dc-655720939da8" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="0a1c9b53-71d3-4260-a3da-0db52c1f28f2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Nivolumab</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="539238d0-c754-419f-9012-72c2acba39d9" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="93aed538-8177-46ff-927a-7b979223617e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="f89aa2a3-3e6a-4a8b-b7ca-0489cb9a8961" data-cid="f89aa2a3-3e6a-4a8b-b7ca-0489cb9a8961" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="4 (19)" data-replace="4" data-pattern="$1" data-tag-index="142_1" data-time="" data-username="" data-userid="">4</named-content><named-content id="6de367d3-5c53-4518-9280-abf4a64ff0ca" data-cid="6de367d3-5c53-4518-9280-abf4a64ff0ca" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="4 (19)" data-replace=" (19)" data-pattern=" $2" data-tag-index="142_1" data-time="" data-username="" data-userid=""> (19)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="1b221266-09de-48a6-b7a5-1fc2dfe27626" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="d80df235-40ab-4e13-be15-7e061d34a05e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="0bc6f468-80fe-4cd9-8ade-e84b1d41fc7c" data-cid="0bc6f468-80fe-4cd9-8ade-e84b1d41fc7c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="143_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="9b97beee-b44c-448a-b3c2-ec1019b470fc" data-cid="9b97beee-b44c-448a-b3c2-ec1019b470fc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="143_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="96dc6f68-af06-40e8-9c58-b9d5d93fb20e" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="6cbe020f-e150-4397-b56e-ad52f2713c1e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="1c4c830f-4c48-4f78-ad6a-abfc0eb80cc5" data-cid="1c4c830f-4c48-4f78-ad6a-abfc0eb80cc5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="3 (33.3)" data-replace="3" data-pattern="$1" data-tag-index="144_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="eda8b61e-28d0-4a46-a772-06207a7132d4" data-cid="eda8b61e-28d0-4a46-a772-06207a7132d4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="3 (33.3)" data-replace=" (33.3)" data-pattern=" $2" data-tag-index="144_1" data-time="" data-username="" data-userid=""> (33.3)</named-content></p></td></tr><tr data-col-count="5" id="d71f2f9f-29ca-43a0-854e-76c3af3f6e9b" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="aea7450d-a3f5-4c82-9072-81c5985fd7a0" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="4aae1b63-331c-4113-a5e7-17202535c68a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545121570" id="9e5b63ee-067d-4e32-93af-93fd40c1d7b0" content-type="styrm cts-2" specific-use="1545122755408" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Bold Removed by Varalakshmi (PREEDITOR) - Dec 18 2018 2:15pm" data-track-detail="" data-format-command="bold" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122755408" data-track-hint="Bold Removed">Other ICI used</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="979ba6ca-c591-4f31-8804-56a536f41807" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="caa4928b-ea57-4abf-b7e8-0ef553c600db" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="25d4aea5-73b7-4529-98a0-ef5b5ff4ddc7" data-cid="25d4aea5-73b7-4529-98a0-ef5b5ff4ddc7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (9.5)" data-replace="2" data-pattern="$1" data-tag-index="146_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="db64f5c0-0101-4a2d-b26e-c31b7650b745" data-cid="db64f5c0-0101-4a2d-b26e-c31b7650b745" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (9.5)" data-replace=" (9.5)" data-pattern=" $2" data-tag-index="146_1" data-time="" data-username="" data-userid=""> (9.5)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="a1fd628b-805f-4fcb-8c89-afb18d8103da" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="7a79771a-e6a2-485d-b121-403fd47030f9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="7c9eae5b-fec0-4953-950c-616178271a17" data-cid="7c9eae5b-fec0-4953-950c-616178271a17" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="147_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="9a1e62f2-166b-4c2d-ba03-c4cd36f451ae" data-cid="9a1e62f2-166b-4c2d-ba03-c4cd36f451ae" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="147_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="723eef2c-84dc-47dd-98d4-af1db6d5a1f8" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="d3e9da62-d613-47f8-a870-25681df709d7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="858c75c2-1008-43fe-a9f0-0dcd0a7d9a3a" data-cid="858c75c2-1008-43fe-a9f0-0dcd0a7d9a3a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="148_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="6ee7431b-c7ed-4743-88ea-a86bf87466ee" data-cid="6ee7431b-c7ed-4743-88ea-a86bf87466ee" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="148_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="19d61b00-7e43-40f2-bad2-c028945f6a42"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="39d4a09f-949b-41e6-a194-b14a03d03c7a" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="f8af8744-3242-43e7-8c44-a97746191fcb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Ipilimumab</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="d99d9c60-a842-4e3d-8511-b6efd52117fb" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="b90ba4a7-616d-4540-a684-590f22e05ac4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="db6ee852-1ac8-459f-81fd-b7d4f05daad0" data-cid="db6ee852-1ac8-459f-81fd-b7d4f05daad0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2(9.5)" data-replace="2" data-pattern="$1" data-tag-index="150_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="84c2d85f-57c4-4820-8fdd-d7d0a72930d1" data-cid="84c2d85f-57c4-4820-8fdd-d7d0a72930d1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(9.5)' to '␣(9.5)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2(9.5)" data-replace=" (9.5)" data-pattern=" $2" data-tag-index="150_1" data-track-change="(9.5)" data-time="" data-username="" data-userid=""> (9.5)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="1503b80f-250c-40df-8f37-b2f29f15695a" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="a9b5f8a0-c43f-44de-9977-2c8a96c816b1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="ce799d87-e4db-4758-8723-3019364b5e21" data-cid="ce799d87-e4db-4758-8723-3019364b5e21" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="151_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="129ef6a4-69bf-4a70-b896-954b85991bc2" data-cid="129ef6a4-69bf-4a70-b896-954b85991bc2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="151_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="4a6dde22-11db-4f81-b97e-63e7f1e09489" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="cddcb0f0-349a-4349-b7f4-614998fd1e9d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="7e5ebae8-74d2-4d5b-8f7a-a4b8209dd845" data-cid="7e5ebae8-74d2-4d5b-8f7a-a4b8209dd845" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="152_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="90f1b5a6-2dd8-4278-841f-4f71e2d000ce" data-cid="90f1b5a6-2dd8-4278-841f-4f71e2d000ce" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="152_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="123fba75-bf1b-4ae0-a994-fa3512891343" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="28a86148-d9d2-48cc-b801-f313062b2c73" data-old-attributes="&quot;valign&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;1&quot;" data-changed-attributes="valign" valign="top"><p id="378ba0f4-dde4-4e55-8d5d-ed8bf6868c04" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Glucocorticoid use</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="af2af2a9-aa7d-413a-abd8-92e9c7358fe7" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;38.921875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="ca755f25-e25c-4b24-986b-7d2bbe6df2a0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="5721c0b9-c4a1-45d6-adf8-af39dfb9776e" data-cid="5721c0b9-c4a1-45d6-adf8-af39dfb9776e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="7 (35)" data-replace="7" data-pattern="$1" data-tag-index="154_1" data-time="" data-username="" data-userid="">7</named-content><named-content id="1b6804b5-d25f-44a9-b1ad-fedae26eacc1" data-cid="1b6804b5-d25f-44a9-b1ad-fedae26eacc1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="7 (35)" data-replace=" (35)" data-pattern=" $2" data-tag-index="154_1" data-time="" data-username="" data-userid=""> (35)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="09452231-4652-4520-ada0-3feded45461e" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="ce7fcd59-a0db-4c17-a710-5ef527af22e5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="7c2bc61b-f3c6-4220-9745-e8534d2f94ad" data-cid="7c2bc61b-f3c6-4220-9745-e8534d2f94ad" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="4 (33.3)" data-replace="4" data-pattern="$1" data-tag-index="155_1" data-time="" data-username="" data-userid="">4</named-content><named-content id="de0bb2bd-176b-4096-8dc0-ea17c2d6f7fc" data-cid="de0bb2bd-176b-4096-8dc0-ea17c2d6f7fc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="4 (33.3)" data-replace=" (33.3)" data-pattern=" $2" data-tag-index="155_1" data-time="" data-username="" data-userid=""> (33.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="2574b63b-b332-43e9-8c53-2159c4bc7a13" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;45.171875&quot;;&quot;valign&quot;:&quot;bottom&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,valign,data-left-space,data-left-indent-space" valign="top" align="left"><p id="2cf9e5d9-080c-4dba-8a57-9b4fd86ec201" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="3889c00f-1a92-40fc-ab1c-50e00a9958f7" data-cid="3889c00f-1a92-40fc-ab1c-50e00a9958f7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="3 (33.3)" data-replace="3" data-pattern="$1" data-tag-index="156_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="9f6359ab-a190-4a4e-960c-7dedc6507f44" data-cid="9f6359ab-a190-4a4e-960c-7dedc6507f44" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="3 (33.3)" data-replace=" (33.3)" data-pattern=" $2" data-tag-index="156_1" data-time="" data-username="" data-userid=""> (33.3)</named-content></p></td></tr></tbody></table><table-wrap-foot id="8f1cfdec-2925-40c2-b6f2-39e24a9f176f"><fn data-class="jrnlTblFoot" fn-type="abbrev" data-def-list="true" id="54830298-5eb0-464d-96c9-20d95f545ff9"><p id="91093d26-6ae9-4bf6-b2fe-24f8d85defb5"><def-list id="e4fb648a-607a-4229-b514-7bc468c64739"><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="fa654b41-7b15-4d11-9a50-6e8dc85e1435" fn-type="abbrev" data-id="T1_FN1"><term data-class="jrnlAbbrevTerm" id="e79adc65-5d55-4f1e-bcfb-c6c40597bda6">FPG</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="0e91925b-480b-4735-8e9c-17a5547e2db4"><p id="4d98ed31-2f15-4dd8-b2f1-1e25e2827e6e">fasting plasma glucose</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="a446f268-9b81-4acc-b851-f6ccc7457322" fn-type="abbrev" data-id="T1_FN1"><term data-class="jrnlAbbrevTerm" id="140307ad-49e3-4683-887a-7c579df90d56">HbA1c</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="558afa14-b042-4af5-803f-6cf11174d371"><p id="a920f567-adaf-4df4-bd8f-cda2c133ddb0">hemoglobin A1c</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="e80f7779-f320-4c39-b36f-485e234ff304" fn-type="abbrev" data-id="T1_FN1"><term data-class="jrnlAbbrevTerm" id="1ff6c4c7-3862-4246-8ad3-d7c033fc310e">ICI</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="1273393f-5956-45fa-946c-412e5445f0a4"><p id="79831b65-5f13-414e-9dd8-3c147500d16d">immune checkpoint inhibitor</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="7eeb1fd7-4e91-4929-a30b-f87c0b2a6e7e" fn-type="abbrev" data-id="T1_FN1"><term data-class="jrnlAbbrevTerm" id="d709fddc-926a-42c4-8986-5279dfe9e6a9">PD-1</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="08036586-971b-4a82-97fa-e8da61aed7de"><p id="587de8b4-84d0-48ed-938e-156117e5147f">programmed cell death protein 1</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="c4e1fa7f-8e36-40d1-ac7e-f86935cb1065" fn-type="abbrev" data-id="T1_FN1"><term data-class="jrnlAbbrevTerm" id="c496cb7f-58d6-4f60-90d3-419a5a772083">RPG</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="1e46b646-ce84-4001-80fe-a4d53b761bfd"><p id="ce953c7a-1ba9-46d6-9fa2-51ac1f17e71a">random plasma glucose</p></def>.</def-item></def-list></p></fn></table-wrap-foot></table-wrap><title data-level="2" data-class="jrnlHead2" old-class="" id="eeccb702-18e0-45e3-93be-3872b7682715">Disease characteristics of new-onset insulin-dependent diabetes</title><p data-class="jrnlSecPara" id="38bd1a79-396c-4f7f-ac9b-8a13da449248" data-word-spacing="0.43w">New-onset insulin-dependent diabetes developed in 12 <named-content id="06841d67-6934-4043-81c0-8e8cafd627ce" data-cid="06841d67-6934-4043-81c0-8e8cafd627ce" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="53" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="21_29" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> after a median of <named-content data-cid="1545433378" id="8abf6827-28a9-472b-a654-5d4da46501d8" content-type="del cts-3" specific-use="1545437190095" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437190095">4</named-content><named-content data-cid="1545433379" id="c05430ad-1baa-4d54-a756-9c8907243ec0" content-type="ins cts-3" specific-use="1545437190564" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437190564">four</named-content> cycles of ICI or <named-content id="5b7b8928-785b-4851-ac1a-d8150c770f21" data-cid="5b7b8928-785b-4851-ac1a-d8150c770f21" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="99" data-match="5 months" data-replace="5" data-pattern="$1" data-tag-index="21_9" data-time="" data-username="" data-userid="">5</named-content><named-content id="47ffd8bb-442a-4941-9d8a-ec8147a456ea" data-cid="47ffd8bb-442a-4941-9d8a-ec8147a456ea" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="100" data-match="5 months" data-replace=" months" data-pattern=" $2" data-tag-index="21_9" data-time="" data-username="" data-userid=""> months</named-content> since initiation of ICI therapy. The HbA1c at presentation was 9.7 (IQR <named-content id="9077eecf-ed82-4e1e-aaa5-4a68039fc1bd" data-cid="9077eecf-ed82-4e1e-aaa5-4a68039fc1bd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="180" data-match="8.6 – 10.7) %" data-replace="8.6" data-pattern="$2" data-tag-index="21_6" data-time="" data-username="" data-userid="">8.6</named-content><named-content id="fa036475-976e-42cb-8450-a9aa8c9969a5" data-cid="fa036475-976e-42cb-8450-a9aa8c9969a5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="183" data-match="8.6 – 10.7) %" data-replace="–" data-pattern="–" data-tag-index="21_6" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="3bf2a5e4-8b58-4bd9-96f6-bc2a80d2f0ac" data-cid="3bf2a5e4-8b58-4bd9-96f6-bc2a80d2f0ac" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="188" data-match="8.6 – 10.7) %" data-replace="10.7)" data-pattern="$4" data-tag-index="21_6" data-time="" data-username="" data-userid="">10.7)</named-content><named-content id="96928a30-92c7-43a6-9877-909f015d72ee" data-cid="96928a30-92c7-43a6-9877-909f015d72ee" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣%' to '%'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="193" data-match="8.6 – 10.7) %" data-replace="%" data-pattern="%" data-tag-index="21_6" data-track-change=" %" data-time="" data-username="" data-userid="">%</named-content> or 83 (IQR <named-content id="84eb5f3d-e664-4db0-8d0b-5d4b0580b7ed" data-cid="84eb5f3d-e664-4db0-8d0b-5d4b0580b7ed" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="207" data-match="70 – 93) mmol/mol" data-replace="70" data-pattern="$2" data-tag-index="21_7" data-time="" data-username="" data-userid="">70</named-content><named-content id="337cc40b-dba6-45d9-ac2a-1bb75061f728" data-cid="337cc40b-dba6-45d9-ac2a-1bb75061f728" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="209" data-match="70 – 93) mmol/mol" data-replace="–" data-pattern="–" data-tag-index="21_7" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="718990a7-63b7-4236-a726-adc76a962025" data-cid="718990a7-63b7-4236-a726-adc76a962025" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="214" data-match="70 – 93) mmol/mol" data-replace="93)" data-pattern="$4" data-tag-index="21_7" data-time="" data-username="" data-userid="">93)</named-content><named-content id="dcbbf040-69b2-4660-9992-1c3187892680" data-cid="dcbbf040-69b2-4660-9992-1c3187892680" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/mol' to ' mmol/mol'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="217" data-match="70 – 93) mmol/mol" data-replace=" mmol/mol" data-pattern=" $5" data-tag-index="21_7" data-track-change=" mmol/mol" data-time="" data-username="" data-userid=""> mmol/mol</named-content>. Eight <named-content id="d197cb58-162e-4d61-accd-df5deda56799" data-cid="d197cb58-162e-4d61-accd-df5deda56799" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="234" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="21_30" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> (67%) presented with DKA at the time of diagnosis, with one of them having concomitant <named-content id="8f8a626b-fd51-4dd0-90b4-042236d9d21c" data-cid="8f8a626b-fd51-4dd0-90b4-042236d9d21c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="330" data-match="hyperglycemic hyperosmolar state" data-pattern="" data-tag-index="" data-abbr="HHS" data-time="" data-username="" data-userid="">hyperglycemic hyperosmolar state</named-content><named-content data-cid="1545433383" id="860c5f8c-19e3-455b-8c49-d7d631605996" content-type="del cts-3" specific-use="1545437231010" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437231010"> (</named-content><named-content id="f289860a-b224-4ff4-a701-3093954bcc52" data-cid="f289860a-b224-4ff4-a701-3093954bcc52" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="364" data-match=" (HHS)" data-pattern="" data-tag-index="21_15" data-time="" data-username="" data-userid=""><named-content data-cid="1545433383" id="109300df-1a3b-4cdb-ac46-4c1c49e92eed" content-type="del cts-3" specific-use="1545437231010" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437231010">HHS</named-content></named-content><named-content data-cid="1545433383" id="a54e6c37-2b00-4f40-b52c-f56a03c22f13" content-type="del cts-3" specific-use="1545437231010" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437231010">)</named-content>. C-peptide was tested in <named-content data-cid="1545113216026" id="90057b38-6ad9-4a5e-88e0-9ec60a95bf1e" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">6</named-content><named-content id="0241ca32-7bb3-4bdb-b35d-43a78549e278" data-cid="1545113216026" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '6' to 'six'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="394" data-match="6" data-pattern="" data-tag-index="21_19" data-function="numberToText,addTrackChanges" data-track-change="6" data-userid="preediting" data-username="Exeter" data-time="1545113216002">six</named-content> <named-content id="ae687adb-7dd3-46bb-9860-f9305a0c6931" data-cid="ae687adb-7dd3-46bb-9860-f9305a0c6931" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="396" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="21_31" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>, of which <named-content id="d1cd3e72-8580-4be2-9923-39cdbe2b6daa" data-cid="d1cd3e72-8580-4be2-9923-39cdbe2b6daa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="415" data-match="5 (83%)" data-replace="5" data-pattern="$1" data-tag-index="21_3" data-time="" data-username="" data-userid=""><named-content data-cid="1545433384" id="ea2a771c-ce64-41e2-aeb0-7646f9549f5a" content-type="del cts-3" specific-use="1545437272598" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437272598">5</named-content></named-content><named-content id="f12d8854-53d0-4bfc-8cdd-28a2def8535c" data-cid="f12d8854-53d0-4bfc-8cdd-28a2def8535c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="416" data-match="5 (83%)" data-replace=" (83%)" data-pattern=" $2" data-tag-index="21_3" data-time="" data-username="" data-userid=""><named-content data-cid="1545433385" id="54442039-f616-4d75-9ed9-e39f78189653" content-type="ins cts-3" specific-use="1545437273101" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437273101">five</named-content> (83%)</named-content> had a low (reference range <named-content id="5ce4ec75-c1dd-41a3-a919-91a48da0a9bf" data-cid="5ce4ec75-c1dd-41a3-a919-91a48da0a9bf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="450" data-match="1.1 – 4.4 ng/mL" data-replace="1.1" data-pattern="$2" data-tag-index="21_8" data-time="" data-username="" data-userid="">1.1</named-content><named-content id="9bff6c2f-c9b2-49c7-bb85-ba12b78b355e" data-cid="9bff6c2f-c9b2-49c7-bb85-ba12b78b355e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="453" data-match="1.1 – 4.4 ng/mL" data-replace="–" data-pattern="–" data-tag-index="21_8" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="c109bfb9-3cdf-4782-976e-63f2b2fbb560" data-cid="c109bfb9-3cdf-4782-976e-63f2b2fbb560" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="458" data-match="1.1 – 4.4 ng/mL" data-replace="4.4" data-pattern="$1" data-tag-index="21_8" data-time="" data-username="" data-userid="">4.4</named-content><named-content id="3d8db5e0-a711-4d83-9df0-4ec7ca9356b1" data-cid="3d8db5e0-a711-4d83-9df0-4ec7ca9356b1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣ng/mL' to ' ng/mL'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="461" data-match="1.1 – 4.4 ng/mL" data-replace=" ng/mL" data-pattern=" $2" data-tag-index="21_8" data-track-change=" ng/mL" data-time="" data-username="" data-userid=""> ng/mL</named-content>) or undetectable level. Pancreatic enzymes were tested at the time of diagnosis in <named-content data-cid="1545113216027" id="4da9f76c-4422-4cef-be43-5fd2d852475e" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">7</named-content><named-content id="417bcd36-57ec-4ae3-93e4-7a750ec29740" data-cid="1545113216027" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '7' to 'seven'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="551" data-match="7" data-pattern="" data-tag-index="21_20" data-function="numberToText,addTrackChanges" data-track-change="7" data-userid="preediting" data-username="Exeter" data-time="1545113216002">seven</named-content> <named-content id="941f61ed-c977-4129-962e-c39d84d4753c" data-cid="941f61ed-c977-4129-962e-c39d84d4753c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="553" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="21_32" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>, with increase in <named-content data-cid="1545113216028" id="e46c41e8-e599-4945-94cf-30e3f32679a1" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">4</named-content><named-content id="fd629eea-03ec-4924-9c0d-fcfc7618019f" data-cid="1545113216028" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '4' to 'four'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="580" data-match="4" data-pattern="" data-tag-index="21_21" data-function="numberToText,addTrackChanges" data-track-change="4" data-userid="preediting" data-username="Exeter" data-time="1545113216002">four</named-content> <named-content id="70e1ac64-906b-4027-9582-f80a8b51e40f" data-cid="70e1ac64-906b-4027-9582-f80a8b51e40f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="582" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="21_33" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> (57%) (<named-content data-cid="1545113216029" id="cdc25e74-9d3b-4d69-a6df-f4783a5410ab" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="7fdfe4e3-4bd3-4cc2-851e-cfecd654af6f" data-cid="1545113216029" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="598" data-match="1" data-pattern="" data-tag-index="21_22" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002">one</named-content> had mild elevation and <named-content data-cid="1545113216030" id="f54c05ee-d254-4cee-a979-e455ccb99672" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">3</named-content><named-content id="ab6ff505-738a-4606-b8e8-3d8e5b9309b4" data-cid="1545113216030" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '3' to 'three'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="623" data-match="3" data-pattern="" data-tag-index="21_23" data-function="numberToText,addTrackChanges" data-track-change="3" data-userid="preediting" data-username="Exeter" data-time="1545113216002">three</named-content> had elevation more than <named-content data-cid="1545113216031" id="f53064e8-127d-4770-90ae-1b47194fa558" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="3373b713-b0a0-4ea3-a2e2-bbc613cdbc97" data-cid="1545113216031" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="649" data-match="2" data-pattern="" data-tag-index="21_24" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002">two</named-content> times the upper limit of normal). Fluorodeoxyglucose (<named-content id="3e689e23-f174-4994-8940-1140c23b89c2" data-cid="3e689e23-f174-4994-8940-1140c23b89c2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="705" data-match=" (FDG)" data-pattern="" data-tag-index="21_16" data-time="" data-username="" data-userid="">FDG</named-content>)-positron emission tomography (<named-content id="1fbfc691-3a89-4248-ace1-80559c8dba5b" data-cid="1fbfc691-3a89-4248-ace1-80559c8dba5b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="740" data-match=" (PET)" data-pattern="" data-tag-index="21_17" data-time="" data-username="" data-userid="">PET</named-content>) scan was performed within <named-content id="380fbae3-7fc3-4241-9f3c-2817cb8aab14" data-cid="380fbae3-7fc3-4241-9f3c-2817cb8aab14" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="771" data-match="4 months" data-replace="4" data-pattern="$1" data-tag-index="21_11" data-time="" data-username="" data-userid="">4</named-content><named-content id="eb54ac72-4f81-4874-a0b5-a13b87ab6356" data-cid="eb54ac72-4f81-4874-a0b5-a13b87ab6356" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="772" data-match="4 months" data-replace=" months" data-pattern=" $2" data-tag-index="21_11" data-time="" data-username="" data-userid=""> months</named-content> of diagnosis in <named-content data-cid="1545113216032" id="4f6a53b2-2d77-46c0-b0d0-8d3a136b6201" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">5</named-content><named-content id="0b4af894-6091-4ab0-8955-04699679141c" data-cid="1545113216032" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '5' to 'five'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="796" data-match="5" data-pattern="" data-tag-index="21_25" data-function="numberToText,addTrackChanges" data-track-change="5" data-userid="preediting" data-username="Exeter" data-time="1545113216002">five</named-content> <named-content id="0049afee-3c12-4196-a3ba-41f1709d0b98" data-cid="0049afee-3c12-4196-a3ba-41f1709d0b98" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="798" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="21_34" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>, of which one (<named-content id="4b45db3d-459b-410d-8a90-dce6c1728cdd" data-cid="4b45db3d-459b-410d-8a90-dce6c1728cdd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="822" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="21_35" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content> 10) demonstrated diffusely increased pancreatic uptake (<xref id="840c881a-7a41-4368-b148-f2963996305f" ref-type="fig" rid="F1" data-citation-string=" F1 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="886" data-match="Figure 1" data-pattern="" data-tag-index="21_1" data-anchor="true"><named-content data-cid="1546365745978" id="f1311ed5-f263-4730-bd34-7937bc592cc8" content-type="del cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Figure 1</named-content><named-content data-cid="1546365745978" id="4af96355-f4c0-4632-bd4e-c42d93ffa95c" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">figure 1</named-content></xref>) at the initial scan. At least one antibody associated with type <named-content data-cid="1545113216033" id="4e0cddb2-e25d-49cb-9869-8a91cb824288" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="a7fbb7d1-f2a0-45cb-bb2f-e7807095e806" data-cid="1545113216033" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="960" data-match="1" data-pattern="" data-tag-index="21_26" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433389" id="ca3cb9c9-6690-49ff-8587-8968d62feeea" content-type="del cts-3" specific-use="1545437326356" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437326356">one</named-content></named-content><named-content data-cid="1545433390" id="177bc0ad-a7b6-4688-bd00-6eeabeb23fcd" content-type="ins cts-3" specific-use="1545437326510" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437326510">1</named-content> diabetes was tested in <named-content data-cid="1545113216034" id="957bdb55-0996-4f79-ada8-15cc818145b0" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">7</named-content><named-content id="43798c73-c3c5-41da-a12c-7f6caa185ccd" data-cid="1545113216034" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '7' to 'seven'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="985" data-match="7" data-pattern="" data-tag-index="21_27" data-function="numberToText,addTrackChanges" data-track-change="7" data-userid="preediting" data-username="Exeter" data-time="1545113216002">seven</named-content> <named-content id="44136f23-e13c-4c5c-abd6-c5b555dad827" data-cid="44136f23-e13c-4c5c-abd6-c5b555dad827" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="987" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="21_36" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>, of which <named-content id="461eddfb-0b7c-4468-a695-7cf2fe6aed0f" data-cid="461eddfb-0b7c-4468-a695-7cf2fe6aed0f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="1006" data-match="5 (71%)" data-replace="5" data-pattern="$1" data-tag-index="21_4" data-time="" data-username="" data-userid=""><named-content data-cid="1545433391" id="88784c78-b3c8-4222-a7c1-c6ce0629e03f" content-type="del cts-3" specific-use="1545437340153" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:09am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437340153">5</named-content></named-content><named-content id="14db81c4-0560-4539-9a86-e476884649c9" data-cid="14db81c4-0560-4539-9a86-e476884649c9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1007" data-match="5 (71%)" data-replace=" (71%)" data-pattern=" $2" data-tag-index="21_4" data-time="" data-username="" data-userid=""><named-content data-cid="1545433392" id="3488f6ac-5f73-4197-8c70-2104b8042f3a" content-type="ins cts-3" specific-use="1545437340419" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:09am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437340419">five</named-content> (71%)</named-content> had at least one positive antibody, with antibody against GAD65 being the most common in <named-content id="2932cabf-e319-4740-b766-c24cf5a99377" data-cid="2932cabf-e319-4740-b766-c24cf5a99377" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="1103" data-match="4/7 (57%)" data-replace="4/7" data-pattern="$1" data-tag-index="21_5" data-time="" data-username="" data-userid="">4/7</named-content><named-content id="7d54aff4-ad3c-46b5-8a3d-2ded4e9cd487" data-cid="7d54aff4-ad3c-46b5-8a3d-2ded4e9cd487" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1106" data-match="4/7 (57%)" data-replace=" (57%)" data-pattern=" $2" data-tag-index="21_5" data-time="" data-username="" data-userid=""> (57%)</named-content>. <named-content data-cid="1545433396" id="40b1c6be-f81d-4cd8-80a4-ce548e57a434" content-type="ins cts-3" specific-use="1545437347125" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:09am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437347125">Fifty percent</named-content><named-content id="9375f69c-fa8f-427e-a78b-50612ed943e4" data-cid="9375f69c-fa8f-427e-a78b-50612ed943e4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1114" data-match="50%" data-replace="50" data-pattern="$1" data-tag-index="21_12" data-time="" data-username="" data-userid=""><named-content data-cid="1545433409" id="958c2404-85dd-4b1f-ae74-434bdac7ca31" content-type="del cts-3" specific-use="1545437350459" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:09am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437350459">50</named-content></named-content><named-content id="446eb9a6-801b-4e01-a962-cf2444b7aa72" data-cid="446eb9a6-801b-4e01-a962-cf2444b7aa72" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1116" data-match="50%" data-replace="%" data-pattern="%" data-tag-index="21_12" data-time="" data-username="" data-userid=""><named-content data-cid="1545433409" id="7637040e-fa3f-4ccc-9ce5-daf8e317eb10" content-type="del cts-3" specific-use="1545437350459" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:09am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437350459">%</named-content></named-content> of <named-content id="229f8799-c07d-4e8c-a746-0d45993657f4" data-cid="229f8799-c07d-4e8c-a746-0d45993657f4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1121" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="21_37" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> developed another IRAE during the follow-up duration, with the most common being thyroiditis (manifested as primary hypothyroidism or thyrotoxicosis followed by primary hypothyroidism) in <named-content id="e2b808ba-af1b-460f-9d2d-45456f3210e6" data-cid="e2b808ba-af1b-460f-9d2d-45456f3210e6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1318" data-match="42%" data-replace="42" data-pattern="$1" data-tag-index="21_13" data-time="" data-username="" data-userid="">42</named-content><named-content id="3c779d8f-759d-4097-8e8b-7bad0f963a80" data-cid="3c779d8f-759d-4097-8e8b-7bad0f963a80" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1320" data-match="42%" data-replace="%" data-pattern="%" data-tag-index="21_13" data-time="" data-username="" data-userid="">%</named-content>. <named-content id="5ab94ddc-3e2b-4581-be74-979a718e9294" data-cid="5ab94ddc-3e2b-4581-be74-979a718e9294" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="1323" data-match="Multiple daily injections of insulin" data-pattern="" data-tag-index="" data-abbr="MDI" data-time="" data-username="" data-userid="">Multiple daily injections of insulin</named-content> (<named-content id="c1945ad8-81c2-4568-bec5-abef3834e433" data-cid="c1945ad8-81c2-4568-bec5-abef3834e433" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="1361" data-match=" (MDI)" data-pattern="" data-tag-index="21_18" data-time="" data-username="" data-userid="">MDI</named-content>) was initiated and continued for all except one <named-content id="3215a6e0-07ec-496f-a0e7-37ea73d50a86" data-cid="3215a6e0-07ec-496f-a0e7-37ea73d50a86" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1413" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="21_38" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content> that transitioned to insulin pump during median <named-content data-cid="1545113216103" id="871c72c9-471a-4add-999d-28dd5d477ee1" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow up</named-content><named-content id="730799f1-8d6c-414a-85ec-4f84d637eaa1" data-cid="1545113216103" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1469" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="21_39" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow-up</named-content> duration of <named-content id="0b288c68-518e-416a-aa8a-cf53cdbe98e2" data-cid="0b288c68-518e-416a-aa8a-cf53cdbe98e2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1491" data-match="13 months" data-replace="13" data-pattern="$1" data-tag-index="21_14" data-time="" data-username="" data-userid="">13</named-content><named-content id="a2ac97f2-4b8a-420b-8850-e12d0412d8d4" data-cid="a2ac97f2-4b8a-420b-8850-e12d0412d8d4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1493" data-match="13 months" data-replace=" months" data-pattern=" $2" data-tag-index="21_14" data-time="" data-username="" data-userid=""> months</named-content> since ICI initiation. Other disease characteristics are mentioned in <xref id="eaadb9f3-816a-4ef8-a743-54010031a8ca" ref-type="table" rid="T2 T3" data-citation-string=" T2 T3 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="1570" data-match="Table 2 and Table 3" data-pattern="" data-tag-index="21_2" data-track="del" data-cid="1545209406795" data-username="Sneka (PREEDITOR)" data-userid="preeditor 18f55500-5243-43e4-b9f9-343ccaadeb34" data-time="1545209406795"><named-content data-cid="1546365745979" id="a34fe413-b9b7-4e00-8d80-a64db2f70a2a" content-type="del cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Table 2 and Table 3</named-content><named-content data-cid="1546365745979" id="5289a2e2-17ce-495b-baf7-116ca38ab88e" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">tables 2 and 3</named-content></xref><xref id="7e99e756-638c-4863-8871-50d61bee7adf" ref-type="table" rid="T2 T3" data-citation-string=" T2 T3 " data-track="ins" data-cid="1545209406803" data-username="Sneka (PREEDITOR)" data-userid="preeditor 18f55500-5243-43e4-b9f9-343ccaadeb34" data-time="1545209406803" data-cite-type="insert" data-anchor="true">tables 2 and 3</xref>.</p><fig id="BLK_F1" data-id="BLK_F1" data-stream-name="a_F1" data-edited-node="true" data-page-num="5" data-float-placement="SingleColumn" position="float" fig-type="figure"><label id="0e27ddb1-c482-494d-beb9-8b55424e5ac2"><named-content data-cid="1546365745980" id="62fdaa5d-4d3c-4c52-b983-9a0a8af6821c" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Figure 1</named-content></label><caption id="447d57c9-4a34-436b-8733-cfa487af6ea3"><title id="F1" data-id="F1">PET scan performed at diagnosis of new-onset insulin-dependent diabetes demonstrating diffusely increased FDG uptake in the pancreas of <named-content id="8615559e-205e-41cd-8a83-d5ba9403a9cf" data-cid="8615559e-205e-41cd-8a83-d5ba9403a9cf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="146" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="35_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content> 10.<named-content data-cid="1545433410" content-type="ins cts-3" specific-use="1545437376560" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:09am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437376560" id="e3d52067-2c2e-420c-afae-b90da3c23fa2"> FDG, </named-content><named-content data-cid="1545433418" content-type="ins cts-3" specific-use="1545437384769" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:09am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437384769" id="9a595ccf-3627-49f4-b0e6-8702e8c9aa33">fluorodeoxyglucose; PET, </named-content><named-content data-cid="1545433429" content-type="ins cts-3" specific-use="1545437407300" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437407300" id="343d9fc1-787e-4aaa-9e82-5ab217453580">positron emission tomography.</named-content></title></caption><graphic xlink:href="" id="0455f11a-c539-4698-8095-ae92bd2b925b" data-alt-src="" data-primary-extension="" data-old-src="/resources/bmj/bmjdrc/bmjdrc-2018-000591/resources/Figure 1.jpg.JPEG" data-track="del"/><graphic xlink:href="/resources/bmj/bmjdrc/bmjdrc-2018-000591/resources/88323657-0117-4da6-9455-e9cd460e267e.tif.JPEG" id="dd2d68f1-67b1-4cc1-b83d-031a28a49027" data-alt-src="/resources/bmj/bmjdrc/bmjdrc-2018-000591/resources/88323657-0117-4da6-9455-e9cd460e267e.tif.JPEG" data-primary-extension="tif" data-original-name="Figure_1" data-track="ins" data-cid="1545122892648" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545122892648" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:18pm"/></fig><table-wrap id="BLK_T2" data-id="BLK_T2" data-stream-name="a_T2" position="float"><label id="2810420d-2ce6-4c5f-aaf0-cc152ec1ea36"><named-content data-cid="1546365745981" id="a176c768-abf1-46ee-aa53-f1f90f4517ba" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Table 2</named-content></label><caption id="3cd13d08-e207-446d-ba1f-d0c06735c8eb"><title id="T2" data-id="T2">Disease characteristics of <named-content id="0e3ecb87-7684-4b2c-9262-06092c4ed6a9" data-cid="0e3ecb87-7684-4b2c-9262-06092c4ed6a9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="36" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="283_4" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with PD-1 inhibitor<named-content data-cid="1545433432" id="2f87933b-0c89-45d8-8773-c8eec32fe666" content-type="del cts-3" specific-use="1545437414183" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437414183"> </named-content><named-content data-cid="1545433433" id="4ee52b03-2f03-4d16-805e-4f0bf9788894" content-type="ins cts-3" specific-use="1545437414517" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437414517">-</named-content>induced diabetes<named-content data-cid="1545124881" id="e6c37eb8-577e-4285-9d7d-2381463b468e" content-type="del cts-2" specific-use="1545125429482" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125429482">. *</named-content><named-content id="88bdcc3f-b2e0-437a-be93-d76c30357df9" data-cid="88bdcc3f-b2e0-437a-be93-d76c30357df9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="84" data-match="n=1 had" data-replace="n" data-pattern="$1" data-tag-index="283_2" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid=""><named-content data-cid="1545124881" id="2c5094fc-41ce-457c-bbe8-b8626e0286eb" content-type="del cts-2" specific-use="1545125429482" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125429482">n</named-content></named-content><named-content id="33bd29fd-3468-4274-b09b-07058c2b5069" data-cid="33bd29fd-3468-4274-b09b-07058c2b5069" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="85" data-match="n=1 had" data-replace="=" data-pattern="$2" data-tag-index="283_2" data-time="" data-username="" data-userid=""><named-content data-cid="1545124881" id="24fdfb54-505b-48fb-a61b-b2164ee1534c" content-type="del cts-2" specific-use="1545125429482" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125429482">=</named-content></named-content><named-content id="3808c660-16c7-4880-837f-bda3260a62c1" data-cid="3808c660-16c7-4880-837f-bda3260a62c1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="SNUM" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="SNUM" data-offset="86" data-match="n=1 had" data-pattern="" data-tag-index="283_2" data-time="" data-username="" data-userid=""><named-content data-cid="1545124881" id="ed6976db-8192-4b2b-b8cd-18cad8ce7ceb" content-type="del cts-2" specific-use="1545125429482" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125429482">1</named-content></named-content><named-content data-cid="1545124881" id="33e95321-9b24-484a-8349-f42382280661" content-type="del cts-2" specific-use="1545125429482" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125429482"> had concomitant </named-content><named-content id="772262a7-03df-4f7c-bade-dfc1aeb05166" data-cid="772262a7-03df-4f7c-bade-dfc1aeb05166" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="104" data-match="hyperglycemic hyperosmolar state" data-pattern="" data-tag-index="" data-abbr="HHS" data-time="" data-username="" data-userid=""><named-content data-cid="1545124881" id="cd58ed49-c0fa-4856-8e31-f4e346607d71" content-type="del cts-2" specific-use="1545125429482" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125429482">hyperglycemic hyperosmolar state</named-content></named-content><named-content data-cid="1545113216122" id="ef0e9377-8c5b-4e61-9ae7-5de305f688a5" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002" data-reason="truecase">. RPG: random plasma glucose; FPG: fasting plasma glucose; HbA1c: hemoglobin A1c.</named-content><named-content data-cid="1545113216122" id="69a539b1-b38b-4746-bb87-2ecaf5bae4f0" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002" data-reason="truecase"><named-content data-cid="1545121571" id="6dbca1c1-7b38-45cf-8879-04c5a80f13c0" content-type="del cts-2" specific-use="1545122909972" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 2:18pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545122909972">. RPG: random plasma glucose; Fpg: fasting plasma glucose; HbA1c: hemoglobin A1c.</named-content></named-content></title></caption><named-content rid="10a42f4e-b804-46de-9104-13a90ca9970f" data-class="jrnlQueryRef" data-type="end" content-type="jrnlQueryRef" specific-use="end" id="4216d8a3-ef16-4506-9ae6-ed34915eec6d" data-answered="true"/><named-content rid="776da93c-0d13-4ce8-aa68-ae8b919ec054" data-class="jrnlQueryRef" data-type="end" content-type="jrnlQueryRef" specific-use="end" id="6ef70b29-1ed8-48c3-97e5-96cdd21fa6ce" data-answered="true"/><named-content rid="307f3c0b-4694-425d-9217-e690c51f81d6" data-class="jrnlQueryRef" data-type="end" content-type="jrnlQueryRef" specific-use="end" id="36e3cffc-790c-4dd5-9074-04477d74f873" data-answered="true"/><table data-col-count="4" data-caption-link="T1" id="8610c199-3c6e-4abe-8f30-b64fa5236cc9" data-col-widths-px="207.111,88,121,95.165" data-table-type="doubleColumn" data-old-attributes="&quot;data-table-type&quot;:&quot;doubleColumn&quot;;&quot;data-col-widths-px&quot;:&quot;158.6,107.6,119.6,118.6,6.6&quot;;&quot;data-font-size&quot;:&quot;9px&quot;" data-changed-attributes="data-table-type,data-col-widths-px,data-font-size" data-font-size="9px"><thead id="f7ba5ced-14c3-4627-a433-e929c8109c0a" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;" data-changed-attributes="data-font-size" data-font-size="9px"><tr data-col-count="5" id="eddd2aa2-9548-4c01-984d-2504d2ccb504"><td data-class="" data-original-border="border:solid windowtext 1.0pt;" data-original-padding="padding: 0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="6111fa66-127d-4931-a4ae-ee31de736e7a" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="3bc61e92-5df5-4a70-9e25-fd4919860a3a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Disease characteristics</p></td><td rowspan="2" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="9401f5d9-1967-4795-b06a-6fef0e5e9d20" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="bc2b9047-819e-4d58-9d64-aacdd4403d9b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">All cases (<named-content id="058a2bcb-cb12-40f8-ba1d-aca3fa5476c3" data-cid="058a2bcb-cb12-40f8-ba1d-aca3fa5476c3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="11" data-match="n=21" data-replace="n" data-pattern="$1" data-tag-index="159_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="e6ccf887-42c8-44da-abed-494de2dd3a68" data-cid="e6ccf887-42c8-44da-abed-494de2dd3a68" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="12" data-match="n=21" data-replace="=" data-pattern="$2" data-tag-index="159_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="2cdc990d-06eb-410d-bca7-c3d8d10f2a99" data-cid="2cdc990d-06eb-410d-bca7-c3d8d10f2a99" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="13" data-match="n=21" data-replace="21" data-pattern="$3" data-tag-index="159_1" data-time="" data-username="" data-userid="">21</named-content>)</p></td><td rowspan="2" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="0be09991-5608-45f6-b58f-e3327b1e7874" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="9424b118-aead-47f6-a744-b6992768a79e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">New-onset insulin-dependent diabetes (<named-content id="4a548d7a-5f58-46c2-82cf-21897a706b70" data-cid="4a548d7a-5f58-46c2-82cf-21897a706b70" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="38" data-match="n=12" data-replace="n" data-pattern="$1" data-tag-index="160_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="a466a6cc-79bf-4a15-82d2-15aa8a0776a1" data-cid="a466a6cc-79bf-4a15-82d2-15aa8a0776a1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="39" data-match="n=12" data-replace="=" data-pattern="$2" data-tag-index="160_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="3455b812-5fc0-4c1a-be96-a80df5fa6318" data-cid="3455b812-5fc0-4c1a-be96-a80df5fa6318" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="40" data-match="n=12" data-replace="12" data-pattern="$3" data-tag-index="160_1" data-time="" data-username="" data-userid="">12</named-content>)</p></td><td data-class="" rowspan="2" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="a33eed68-3964-44c5-bc17-e9f2af4b5de6" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="420771f0-0318-4ef6-89ac-21baa447646b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Worsening of type <named-content data-cid="1545113216035" id="bf098328-d047-4cd5-b032-92519915c475" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="d0c335f5-fbb6-45f8-84d1-3f941f49d219" data-cid="1545113216035" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="18" data-match="2" data-pattern="" data-tag-index="161_2" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433434" id="a0c489ae-e12a-4248-a008-bc275477b168" content-type="del cts-3" specific-use="1545437427687" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437427687">two</named-content></named-content><named-content data-cid="1545433435" id="27c96647-b154-4adc-9fd8-698757023f3b" content-type="ins cts-3" specific-use="1545437427853" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545437427853">2</named-content> diabetes (<named-content id="6fa9a6f1-290b-48aa-9c91-66f2c11978ad" data-cid="6fa9a6f1-290b-48aa-9c91-66f2c11978ad" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'n' to 'n'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="30" data-match="n=9" data-replace="n" data-pattern="$1" data-tag-index="161_1" data-function="lowercase,removeItalics" data-time="" data-username="" data-userid="">n</named-content><named-content id="f1840239-4ccd-4d8f-8aac-87db430c54e2" data-cid="f1840239-4ccd-4d8f-8aac-87db430c54e2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="31" data-match="n=9" data-replace="=" data-pattern="$2" data-tag-index="161_1" data-time="" data-username="" data-userid="">=</named-content><named-content id="3a107453-b835-41c6-ac2e-521518d7c505" data-cid="3a107453-b835-41c6-ac2e-521518d7c505" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="32" data-match="n=9" data-replace="9" data-pattern="$3" data-tag-index="161_1" data-time="" data-username="" data-userid="">9</named-content>)</p></td></tr><tr data-col-count="5" id="d5ab644d-4cd8-4e9c-ab10-8d7e502d0f48"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="7177a436-981e-400d-b426-89fb49e842fe" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="608f4814-a638-465b-9dfa-84a3254261b2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">N (%) or median (<named-content id="5eaeb063-946d-4b3e-a70c-5303c74aa594" data-cid="5eaeb063-946d-4b3e-a70c-5303c74aa594" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="17" data-match=" (IQR)" data-pattern="" data-tag-index="162_1" data-time="" data-username="" data-userid="">IQR</named-content>)</p></td></tr></thead><tbody id="85ddbf70-0e60-409f-ad0e-92439cde6e61" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;" data-changed-attributes="data-font-size" data-font-size="9px"><tr data-col-count="5" id="516198c7-4bee-41dd-a2ab-8bd378460472" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="ea226117-2d8e-42e0-bdef-c6d89e7cf09d" valign="top" colspan="4" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;colspan&quot;:&quot;4&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="5739e7b3-827b-49bd-b81f-e65c6484289f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545124884" id="4cbda3da-d5ad-4fba-a414-b2cc38646112" content-type="styrm cts-2" specific-use="1545125948216" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Bold Removed by Varalakshmi (PREEDITOR) - Dec 18 2018 3:09pm" data-track-detail="" data-format-command="bold" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125948216" data-track-hint="Bold Removed">Time from ICI initiation to diagnosis</named-content></p> </td></tr><tr data-col-count="5" id="eba5928b-5ebf-4066-ab94-b19627488dbd"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="4e3c0e31-2d75-4b1b-8afb-ccabb3048e85" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="697fc89e-eb21-4096-aca4-cc741cc794a0"> <named-content data-cid="1545216228" id="13b6952e-589c-453e-a763-a275bb5c43a7" content-type="del cts-1" specific-use="1545217353024" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 19 2018 4:32pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545217353024"/><named-content data-cid="1545216209" id="5bea5d48-079e-40ed-8741-3ad41ffd3a99" content-type="ins cts-1" specific-use="1545217040144" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 19 2018 4:27pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545217040144">Numberof ICI cycles</named-content><named-content data-cid="1545216210" id="68cec36b-ad92-48fd-b9de-03cbf7dc0904" content-type="del cts-1" specific-use="1545217042459" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 19 2018 4:27pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545217042459">Duration (months)</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="20480f95-e1af-4946-bca5-c22b79032dbb" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="97e4f3e0-d817-4115-a725-8951bd873e1b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="380b808c-b87a-4286-93ab-def226fdead9" data-cid="380b808c-b87a-4286-93ab-def226fdead9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="4 (2 – 5.5)" data-replace="4 " data-pattern="$1 " data-tag-index="166_1" data-time="" data-username="" data-userid="">4 </named-content><named-content id="03d282d1-28c1-4c18-9bf3-ab71dfb43545" data-cid="03d282d1-28c1-4c18-9bf3-ab71dfb43545" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="2" data-match="4 (2 – 5.5)" data-replace="(2" data-pattern="$2" data-tag-index="166_1" data-time="" data-username="" data-userid="">(2</named-content><named-content id="44c7d6b0-24b9-43e7-b366-7852ea33a331" data-cid="44c7d6b0-24b9-43e7-b366-7852ea33a331" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="4" data-match="4 (2 – 5.5)" data-replace="–" data-pattern="–" data-tag-index="166_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="8b3e369b-7e8a-41c3-89ab-a7399df9253a" data-cid="8b3e369b-7e8a-41c3-89ab-a7399df9253a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="9" data-match="4 (2 – 5.5)" data-replace="5.5)" data-pattern="$4" data-tag-index="166_1" data-time="" data-username="" data-userid="">5.5)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="cce91f76-a01b-4ec4-bbe1-079715b53968" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="aec3551f-4cba-4f8c-bd72-e37a32bbd7fb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4f789f94-be5a-46d0-9c85-f0c69ce5f91f" data-cid="4f789f94-be5a-46d0-9c85-f0c69ce5f91f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="4 (2 – 5.8)" data-replace="4 " data-pattern="$1 " data-tag-index="167_1" data-time="" data-username="" data-userid="">4 </named-content><named-content id="328c76f9-aee5-48bd-b13d-24cbb758d05d" data-cid="328c76f9-aee5-48bd-b13d-24cbb758d05d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="2" data-match="4 (2 – 5.8)" data-replace="(2" data-pattern="$2" data-tag-index="167_1" data-time="" data-username="" data-userid="">(2</named-content><named-content id="a18ece3a-b53b-42fd-a868-258dd623d8c5" data-cid="a18ece3a-b53b-42fd-a868-258dd623d8c5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="4" data-match="4 (2 – 5.8)" data-replace="–" data-pattern="–" data-tag-index="167_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="47f1a8cf-a4f2-44ba-ad03-e4c165a370b6" data-cid="47f1a8cf-a4f2-44ba-ad03-e4c165a370b6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="9" data-match="4 (2 – 5.8)" data-replace="5.8)" data-pattern="$4" data-tag-index="167_1" data-time="" data-username="" data-userid="">5.8)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="a2f2ceaf-5dc0-44d7-934e-ca44a8b2deff" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="06ecdedf-fd22-45de-8bfc-b4e9da0721f6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="b608e202-1f35-49ba-b27a-5234edc0666f" data-cid="b608e202-1f35-49ba-b27a-5234edc0666f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="4 (2.5 – 9)" data-replace="4 " data-pattern="$1 " data-tag-index="168_1" data-time="" data-username="" data-userid="">4 </named-content><named-content id="0d7d5657-7f65-42a8-8045-7655da60f83f" data-cid="0d7d5657-7f65-42a8-8045-7655da60f83f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="2" data-match="4 (2.5 – 9)" data-replace="(2.5" data-pattern="$2" data-tag-index="168_1" data-time="" data-username="" data-userid="">(2.5</named-content><named-content id="6a712ed6-734f-4469-9442-96e52d2520d3" data-cid="6a712ed6-734f-4469-9442-96e52d2520d3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="4 (2.5 – 9)" data-replace="–" data-pattern="–" data-tag-index="168_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="3e38c01e-19b1-493c-a56e-517e18b0c0b5" data-cid="3e38c01e-19b1-493c-a56e-517e18b0c0b5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="11" data-match="4 (2.5 – 9)" data-replace="9)" data-pattern="$4" data-tag-index="168_1" data-time="" data-username="" data-userid="">9)</named-content></p></td></tr><tr data-col-count="5" id="8793ddf8-5679-4c9c-8748-d55e21d39d44" data-fill="true"><td data-class="" data-original-space="1" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="fad1f787-b61e-4374-bc95-6a2e6c7099b8" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="74d947d5-7fa0-404c-bec5-93fc24b43cb5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content data-cid="1545216205" id="26801346-f3ea-47e1-9f1b-b55d78a72cb3" content-type="del cts-1" specific-use="1545216822104" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 19 2018 4:23pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545216822104"/><named-content data-cid="1545216180" id="17cc9d67-55a6-4347-bc3e-cdbcc6d60ef6" content-type="ins cts-1" specific-use="1545216488667" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 19 2018 4:18pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545216488667">Duration (months)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="fea2ffc0-4f8d-4066-88f8-a4e486f9ddf1" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;53.421875&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="d53d6790-bfc3-476b-be4e-a8765f51af82" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="3b9aeb12-eeb8-4d61-be3a-0a6d10736ce0" data-cid="3b9aeb12-eeb8-4d61-be3a-0a6d10736ce0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="4.8 (2 – 8.2)" data-replace="4.8 " data-pattern="$1 " data-tag-index="169_1" data-time="" data-username="" data-userid="">4.8 </named-content><named-content id="be3959de-4621-4c31-bf60-a71a718d897e" data-cid="be3959de-4621-4c31-bf60-a71a718d897e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="4.8 (2 – 8.2)" data-replace="(2" data-pattern="$2" data-tag-index="169_1" data-time="" data-username="" data-userid="">(2</named-content><named-content id="d2283a98-53f5-4cf2-8798-fa6d66f6d354" data-cid="d2283a98-53f5-4cf2-8798-fa6d66f6d354" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="4.8 (2 – 8.2)" data-replace="–" data-pattern="–" data-tag-index="169_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="8737f5fe-166f-43d2-96a7-f1de6320bae9" data-cid="8737f5fe-166f-43d2-96a7-f1de6320bae9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="11" data-match="4.8 (2 – 8.2)" data-replace="8.2)" data-pattern="$4" data-tag-index="169_1" data-time="" data-username="" data-userid="">8.2)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="d1a3a1b0-810e-4579-8d90-551e60bb1d63" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;51.828125&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="7d43465a-c0bf-46da-97b6-0ee8b905b0c9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="e34e9e14-33dd-4722-a631-038cf0072ee0" data-cid="e34e9e14-33dd-4722-a631-038cf0072ee0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="4.9 (2.2 – 8.1)" data-replace="4.9 " data-pattern="$1 " data-tag-index="170_1" data-time="" data-username="" data-userid="">4.9 </named-content><named-content id="6cae348a-a27f-4cc6-b37d-edbfbf276c53" data-cid="6cae348a-a27f-4cc6-b37d-edbfbf276c53" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="4.9 (2.2 – 8.1)" data-replace="(2.2" data-pattern="$2" data-tag-index="170_1" data-time="" data-username="" data-userid="">(2.2</named-content><named-content id="cf765a96-cc6c-428b-95d9-9250d7f99ca3" data-cid="cf765a96-cc6c-428b-95d9-9250d7f99ca3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="4.9 (2.2 – 8.1)" data-replace="–" data-pattern="–" data-tag-index="170_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="db6b783f-777f-4223-82bb-548faa3ca610" data-cid="db6b783f-777f-4223-82bb-548faa3ca610" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="4.9 (2.2 – 8.1)" data-replace="8.1)" data-pattern="$4" data-tag-index="170_1" data-time="" data-username="" data-userid="">8.1)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="61985465-e692-4cf8-83da-0d74185f3d95" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;53.421875&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="052af718-660b-49ab-a6f4-486cabe56018" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="d3356e3d-455d-405e-8bc1-7acb0c81db5f" data-cid="d3356e3d-455d-405e-8bc1-7acb0c81db5f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="3.9 (1.8 – 10.3)" data-replace="3.9 " data-pattern="$1 " data-tag-index="171_1" data-time="" data-username="" data-userid="">3.9 </named-content><named-content id="3df8e9a5-1fc2-4a0d-a162-69c178acd45b" data-cid="3df8e9a5-1fc2-4a0d-a162-69c178acd45b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="3.9 (1.8 – 10.3)" data-replace="(1.8" data-pattern="$2" data-tag-index="171_1" data-time="" data-username="" data-userid="">(1.8</named-content><named-content id="6c587afb-037a-4bce-b895-4ffdf0960a0e" data-cid="6c587afb-037a-4bce-b895-4ffdf0960a0e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="3.9 (1.8 – 10.3)" data-replace="–" data-pattern="–" data-tag-index="171_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="78925912-a498-46e0-bbb0-aa7beb0c439c" data-cid="78925912-a498-46e0-bbb0-aa7beb0c439c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="3.9 (1.8 – 10.3)" data-replace="10.3)" data-pattern="$4" data-tag-index="171_1" data-time="" data-username="" data-userid="">10.3)</named-content></p></td></tr><tr data-col-count="5" id="a17d7ea0-5273-426f-b47c-62ba932245f5"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="08dbe6d6-8a65-4ba8-bb82-e78f9cbd998a" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="69f10fa9-416f-42ac-822d-4622aec50bcb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Weight change (kg) from ICI initiation to diagnosis</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="09b066f4-e9a1-4c5a-8a38-ddd3675bc8ab" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;53.421875&quot;;&quot;data-left-space&quot;:&quot;6.34375&quot;;&quot;data-left-indent-space&quot;:&quot;6.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="bd92f989-8f2d-4276-9c8f-c87a74f404e0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="59bb4b33-9901-4b51-9fe8-ffdbb15be18f" data-cid="59bb4b33-9901-4b51-9fe8-ffdbb15be18f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-3.3" data-replace="−" data-pattern="−" data-tag-index="173_3" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="13295cad-9955-4085-81b9-8e5d70e106b8" data-cid="13295cad-9955-4085-81b9-8e5d70e106b8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-3.3" data-replace="3.3" data-pattern="$2" data-tag-index="173_3" data-time="" data-username="" data-userid="">3.3</named-content><named-content id="379698e7-dccd-4e79-b506-02ef55d730a0" data-cid="379698e7-dccd-4e79-b506-02ef55d730a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="3 (-7.1" data-replace=" (-7.1" data-pattern=" $2" data-tag-index="173_1" data-time="" data-username="" data-userid=""> (<named-content data-cid="1545463951" id="0ca4dc54-8f52-40ea-9930-76fdc9ee0c97" content-type="del cts-4" specific-use="1545464154650" xlink:title="Asha (TYPESETTER)" alt="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-title="Deleted by Asha (TYPESETTER) - Dec 22 2018 1:05pm" data-track-detail="" data-userid="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-username="Asha (TYPESETTER)" data-time="1545464154650">-</named-content><named-content data-cid="1545463952" id="e6e4a1a5-d411-48f5-8c9c-ca154cc3a97c" content-type="ins cts-4" specific-use="1545464154787" xlink:title="Asha (TYPESETTER)" alt="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-title="Inserted by Asha (TYPESETTER) - Dec 22 2018 1:05pm" data-track-detail="" data-userid="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-username="Asha (TYPESETTER)" data-time="1545464154787">–</named-content>7.1</named-content> to<named-content id="442020b8-0a57-4742-ab71-04d6acb3951c" data-cid="442020b8-0a57-4742-ab71-04d6acb3951c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣+' to '⍽+'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="13" data-match="to +0.2" data-replace=" +" data-pattern=" $2" data-tag-index="173_2" data-track-change=" +" data-time="" data-username="" data-userid=""> +</named-content><named-content id="ddda766a-5193-4ddb-b17f-3d2ba74630e1" data-cid="ddda766a-5193-4ddb-b17f-3d2ba74630e1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="15" data-match="to +0.2" data-replace="0.2" data-pattern="$3" data-tag-index="173_2" data-time="" data-username="" data-userid="">0.2</named-content>)</p></td><td data-class="" data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="98fe08ef-cd9e-4a35-af93-3b4da70d5125" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;51.828125&quot;;&quot;data-left-space&quot;:&quot;3.84375&quot;;&quot;data-left-indent-space&quot;:&quot;3.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="3be7794d-fb76-4462-b276-91a21e73b40c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="9681cc86-9d01-4370-93c3-a212e9aa485d" data-cid="9681cc86-9d01-4370-93c3-a212e9aa485d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '−'" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="HYPTOMIN" data-offset="0" data-match="-3.4" data-replace="−" data-pattern="−" data-tag-index="174_3" data-track-change="-" data-time="" data-username="" data-userid="">−</named-content><named-content id="1c695289-61fd-423b-926f-890793caa838" data-cid="1c695289-61fd-423b-926f-890793caa838" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="HYPTOMIN,VAL" data-tag-type="VAL" data-offset="1" data-match="-3.4" data-replace="3.4" data-pattern="$1 " data-tag-index="174_2" data-time="" data-username="" data-userid="">3.4</named-content><named-content id="c6db2d48-ed67-4547-845c-dd6b54863c40" data-cid="c6db2d48-ed67-4547-845c-dd6b54863c40" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="4 (-7.3" data-replace=" (-7.3" data-pattern=" $2" data-tag-index="174_1" data-time="" data-username="" data-userid=""> (<named-content data-cid="1545463949" id="d27b0800-5b5f-4807-9007-87d38bb6f819" content-type="del cts-4" specific-use="1545464149599" xlink:title="Asha (TYPESETTER)" alt="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-title="Deleted by Asha (TYPESETTER) - Dec 22 2018 1:05pm" data-track-detail="" data-userid="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-username="Asha (TYPESETTER)" data-time="1545464149599">-</named-content><named-content data-cid="1545463950" id="ff186f85-2b8d-4241-b95d-b88d8ac40b1c" content-type="ins cts-4" specific-use="1545464149850" xlink:title="Asha (TYPESETTER)" alt="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-title="Inserted by Asha (TYPESETTER) - Dec 22 2018 1:05pm" data-track-detail="" data-userid="typesetter 74d455fb-5d27-44fd-a9e5-5e6807bcf916" data-username="Asha (TYPESETTER)" data-time="1545464149850">–</named-content>7.3</named-content><named-content id="792a4d85-f351-4e64-b233-66916f4f2dcb" data-cid="792a4d85-f351-4e64-b233-66916f4f2dcb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGC" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="10" data-match="3.4 (-7.3 to -2.4)" data-replace=" to " data-pattern=" $3 " data-tag-index="174_2" data-time="" data-username="" data-userid=""> to </named-content><named-content id="31c5032b-6f8b-412d-88f3-e930b2bc79ad" data-cid="31c5032b-6f8b-412d-88f3-e930b2bc79ad" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="14" data-match="3.4 (-7.3 to -2.4)" data-replace="-2.4)" data-pattern="$4" data-tag-index="174_2" data-time="" data-username="" data-userid="">-2.4)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="42f87b2a-8c04-4a0c-a6aa-9624adb8143e" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;53.421875&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="907acb1b-8ebf-479a-bde5-800dbb174589" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="5126c3c4-913e-4139-b6a5-66789ea0bf2c" data-cid="5126c3c4-913e-4139-b6a5-66789ea0bf2c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0.3 (-7.6" data-replace="0.3" data-pattern="$1" data-tag-index="175_1" data-time="" data-username="" data-userid="">0.3</named-content><named-content id="978a644d-b78b-46d3-8b50-1f6b744da4bd" data-cid="978a644d-b78b-46d3-8b50-1f6b744da4bd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="0.3 (-7.6" data-replace=" (-7.6" data-pattern=" $2" data-tag-index="175_1" data-time="" data-username="" data-userid=""> (-7.6</named-content> to<named-content id="cbd5fea9-3b7b-49ed-b934-4a83d9651a8a" data-cid="cbd5fea9-3b7b-49ed-b934-4a83d9651a8a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣+' to '⍽+'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="12" data-match="to +7.6" data-replace=" +" data-pattern=" $2" data-tag-index="175_2" data-track-change=" +" data-time="" data-username="" data-userid=""> +</named-content><named-content id="289e9814-5ed7-4a6f-9347-f9e073898be4" data-cid="289e9814-5ed7-4a6f-9347-f9e073898be4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="14" data-match="to +7.6" data-replace="7.6" data-pattern="$3" data-tag-index="175_2" data-time="" data-username="" data-userid="">7.6</named-content>)</p></td></tr><tr data-col-count="5" id="d382614d-d41b-4ab4-96a5-5272f3d9b4e9" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="76cc52b5-3790-46a7-a195-e7e21fc2b6b5" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="359f61d6-b508-43f5-9084-fccc2ed655a9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RPG (mg/dL) at diagnosis</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="2d5e0f55-a796-41cc-a6cf-2fa3cdaa931b" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;0&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;2.5&quot;;&quot;data-left-indent-space&quot;:&quot;2.5&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="c7eb5163-2313-4ac8-970a-2e452ad8e68f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="090c2c96-9aca-48cc-9d2e-887a6a7d0800" data-cid="090c2c96-9aca-48cc-9d2e-887a6a7d0800" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="460 (372 – 807.5)" data-replace="460 " data-pattern="$1 " data-tag-index="177_1" data-time="" data-username="" data-userid="">460 </named-content><named-content id="85ee9d3f-0085-4713-b708-02b8a4a8a3a7" data-cid="85ee9d3f-0085-4713-b708-02b8a4a8a3a7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="460 (372 – 807.5)" data-replace="(372" data-pattern="$2" data-tag-index="177_1" data-time="" data-username="" data-userid="">(372</named-content><named-content id="afbfedef-1e0b-4064-903a-da7dea21d93e" data-cid="afbfedef-1e0b-4064-903a-da7dea21d93e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="460 (372 – 807.5)" data-replace="–" data-pattern="–" data-tag-index="177_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="61044864-b2f7-4d95-a59a-339d509d6a58" data-cid="61044864-b2f7-4d95-a59a-339d509d6a58" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="460 (372 – 807.5)" data-replace="807.5)" data-pattern="$4" data-tag-index="177_1" data-time="" data-username="" data-userid="">807.5)</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="25422c94-4315-4746-a8cc-5f5cfb0e9e2e" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;0&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;0&quot;;&quot;data-left-indent-space&quot;:&quot;0&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="8fe7307e-3247-407b-933d-008a202ba3d6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="8d9f1edc-9422-4f30-b74a-cf8dcfe15191" data-cid="8d9f1edc-9422-4f30-b74a-cf8dcfe15191" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="600 (429 – 971)" data-replace="600 " data-pattern="$1 " data-tag-index="178_1" data-time="" data-username="" data-userid="">600 </named-content><named-content id="92747647-38e0-4829-8d16-60bf893b7f1f" data-cid="92747647-38e0-4829-8d16-60bf893b7f1f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="600 (429 – 971)" data-replace="(429" data-pattern="$2" data-tag-index="178_1" data-time="" data-username="" data-userid="">(429</named-content><named-content id="5a49484f-68d2-4f31-b7c3-bd59287d6ff6" data-cid="5a49484f-68d2-4f31-b7c3-bd59287d6ff6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="600 (429 – 971)" data-replace="–" data-pattern="–" data-tag-index="178_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="26b07a4d-6855-4bcb-acad-ecd1e722427a" data-cid="26b07a4d-6855-4bcb-acad-ecd1e722427a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="600 (429 – 971)" data-replace="971)" data-pattern="$4" data-tag-index="178_1" data-time="" data-username="" data-userid="">971)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="b08bce8a-ee5e-4cf0-8d2f-538dae2d1863" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;0&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;30.28125&quot;;&quot;data-left-indent-space&quot;:&quot;30.28125&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="d7638e55-3fc9-4647-860d-8da206653e95" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="9b18816b-c37b-40fd-96bd-62a38a906ff8" data-cid="9b18816b-c37b-40fd-96bd-62a38a906ff8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="308 (224.3 – 533.2)" data-replace="308 " data-pattern="$1 " data-tag-index="179_1" data-time="" data-username="" data-userid="">308 </named-content><named-content id="6cea4afe-3b27-43ab-ac0d-f6a633e603a2" data-cid="6cea4afe-3b27-43ab-ac0d-f6a633e603a2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="308 (224.3 – 533.2)" data-replace="(224.3" data-pattern="$2" data-tag-index="179_1" data-time="" data-username="" data-userid="">(224.3</named-content><named-content id="1c790bf7-4eb8-41d6-90d4-53c0b8d2e2be" data-cid="1c790bf7-4eb8-41d6-90d4-53c0b8d2e2be" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="10" data-match="308 (224.3 – 533.2)" data-replace="–" data-pattern="–" data-tag-index="179_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="f6a97871-74ac-480b-820b-26c50311e82e" data-cid="f6a97871-74ac-480b-820b-26c50311e82e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="15" data-match="308 (224.3 – 533.2)" data-replace="533.2)" data-pattern="$4" data-tag-index="179_1" data-time="" data-username="" data-userid="">533.2)</named-content></p></td></tr><tr data-col-count="5" id="d8259fbb-73ab-4cd5-a9ca-cf9376d67c15"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="8b7f26dc-5d74-4031-b913-7b060f02005d" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="bc90db91-1dd8-4ef9-91b6-ed00f2601a1e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG (mg/dL) at diagnosis</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="94e80587-c8d6-4ccf-ab56-000437c0ee63" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;0&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;2.5&quot;;&quot;data-left-indent-space&quot;:&quot;2.5&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="3e880688-cec0-49ad-9a5a-4de579cc7d85" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="03a8a4e1-6970-496b-832f-0a53f668e215" data-cid="03a8a4e1-6970-496b-832f-0a53f668e215" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="285 (206.5 – 316)" data-replace="285 " data-pattern="$1 " data-tag-index="181_1" data-time="" data-username="" data-userid="">285 </named-content><named-content id="2ca348ad-bdde-4bb7-9b1f-c67a52f6c281" data-cid="2ca348ad-bdde-4bb7-9b1f-c67a52f6c281" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="285 (206.5 – 316)" data-replace="(206.5" data-pattern="$2" data-tag-index="181_1" data-time="" data-username="" data-userid="">(206.5</named-content><named-content id="3040345a-4333-4ead-9290-84c36b6387ee" data-cid="3040345a-4333-4ead-9290-84c36b6387ee" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="10" data-match="285 (206.5 – 316)" data-replace="–" data-pattern="–" data-tag-index="181_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="c180a12c-0c8f-4b62-a713-fd4dd16fd737" data-cid="c180a12c-0c8f-4b62-a713-fd4dd16fd737" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="15" data-match="285 (206.5 – 316)" data-replace="316)" data-pattern="$4" data-tag-index="181_1" data-time="" data-username="" data-userid="">316)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="7f71f63f-ca42-45cc-a12f-ea6e1fe2d749" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;0&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;0&quot;;&quot;data-left-indent-space&quot;:&quot;0&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="ee7a7f29-1ba4-4ba6-a679-26f2e45fc8b4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="54d6e869-f3c3-40eb-8d4b-3cd44f0b4bda" data-cid="54d6e869-f3c3-40eb-8d4b-3cd44f0b4bda" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="298 (212.8 – 331.5)" data-replace="298 " data-pattern="$1 " data-tag-index="182_1" data-time="" data-username="" data-userid="">298 </named-content><named-content id="caf13a96-5088-46d9-b6ad-dd89cf743257" data-cid="caf13a96-5088-46d9-b6ad-dd89cf743257" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="298 (212.8 – 331.5)" data-replace="(212.8" data-pattern="$2" data-tag-index="182_1" data-time="" data-username="" data-userid="">(212.8</named-content><named-content id="d2e80be8-e835-4e15-974c-137fcc0e36a0" data-cid="d2e80be8-e835-4e15-974c-137fcc0e36a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="10" data-match="298 (212.8 – 331.5)" data-replace="–" data-pattern="–" data-tag-index="182_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="f8974238-554d-4cc3-9b94-8b87675d7205" data-cid="f8974238-554d-4cc3-9b94-8b87675d7205" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="15" data-match="298 (212.8 – 331.5)" data-replace="331.5)" data-pattern="$4" data-tag-index="182_1" data-time="" data-username="" data-userid="">331.5)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="bca1539a-e90a-4471-a79b-511de81698d3" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;0&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;30.28125&quot;;&quot;data-left-indent-space&quot;:&quot;30.28125&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="86fb89eb-0dd9-4992-b47a-835892f70794" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="16b1d13c-72c3-4d26-a665-32c643d16154" data-cid="16b1d13c-72c3-4d26-a665-32c643d16154" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="230 (199 – 307.5)" data-replace="230 " data-pattern="$1 " data-tag-index="183_1" data-time="" data-username="" data-userid="">230 </named-content><named-content id="a62065bd-a482-4458-bb58-37dc0f61b0e2" data-cid="a62065bd-a482-4458-bb58-37dc0f61b0e2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="230 (199 – 307.5)" data-replace="(199" data-pattern="$2" data-tag-index="183_1" data-time="" data-username="" data-userid="">(199</named-content><named-content id="36388b9f-fe20-4274-847a-3422ebc5df7a" data-cid="36388b9f-fe20-4274-847a-3422ebc5df7a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="230 (199 – 307.5)" data-replace="–" data-pattern="–" data-tag-index="183_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="edb1e866-77d9-4b93-855e-d7515ce48042" data-cid="edb1e866-77d9-4b93-855e-d7515ce48042" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="230 (199 – 307.5)" data-replace="307.5)" data-pattern="$4" data-tag-index="183_1" data-time="" data-username="" data-userid="">307.5)</named-content></p></td></tr><tr data-col-count="5" id="75c4fac6-ff7c-4812-9b76-c9685f4da387" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="19f92bc6-8ed4-4bb0-98e5-0bffcf05dd2b" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="6212158b-67e1-437a-8a53-d5043b254694" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">HbA1c at diagnosis</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="30cae620-08fc-4c4b-800f-34f480a6dee3" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;53.421875&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="ed5c5db1-0caa-4967-90c0-a57434120140" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="e3b11d5e-e4b3-4465-8d41-ad28f448f99f" data-cid="e3b11d5e-e4b3-4465-8d41-ad28f448f99f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="9.9 (8.7 – 11.1" data-replace="9.9 " data-pattern="$1 " data-tag-index="185_1" data-time="" data-username="" data-userid="">9.9 </named-content><named-content id="af163622-59f0-42e3-84f6-729061ec52c8" data-cid="af163622-59f0-42e3-84f6-729061ec52c8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="9.9 (8.7 – 11.1" data-replace="(8.7" data-pattern="$2" data-tag-index="185_1" data-time="" data-username="" data-userid="">(8.7</named-content><named-content id="936e221b-cae6-4982-bd44-eaf1571b9731" data-cid="936e221b-cae6-4982-bd44-eaf1571b9731" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="9.9 (8.7 – 11.1" data-replace="–" data-pattern="–" data-tag-index="185_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="a90e7fe8-51af-45fb-994b-3757fffef14c" data-cid="a90e7fe8-51af-45fb-994b-3757fffef14c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="9.9 (8.7 – 11.1" data-replace="11.1" data-pattern="$4" data-tag-index="185_1" data-time="" data-username="" data-userid="">11.1</named-content>);</p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="46ac5b87-561e-41fa-a029-b2ebad19e446" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;51.828125&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="51d0810b-cdb5-43a7-b3a7-7f81bcc3bf80" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="5a14a385-7462-4209-9da6-176bd9323fa4" data-cid="5a14a385-7462-4209-9da6-176bd9323fa4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="9.7 (8.6 – 10.7" data-replace="9.7 " data-pattern="$1 " data-tag-index="186_1" data-time="" data-username="" data-userid="">9.7 </named-content><named-content id="3059f647-51da-419a-8854-be9a0f2dc911" data-cid="3059f647-51da-419a-8854-be9a0f2dc911" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="9.7 (8.6 – 10.7" data-replace="(8.6" data-pattern="$2" data-tag-index="186_1" data-time="" data-username="" data-userid="">(8.6</named-content><named-content id="e487ae8a-f8fa-4818-855b-5b26a6374052" data-cid="e487ae8a-f8fa-4818-855b-5b26a6374052" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="9.7 (8.6 – 10.7" data-replace="–" data-pattern="–" data-tag-index="186_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="915ea866-69b5-4c4c-acb5-d3745e1bb456" data-cid="915ea866-69b5-4c4c-acb5-d3745e1bb456" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="9.7 (8.6 – 10.7" data-replace="10.7" data-pattern="$4" data-tag-index="186_1" data-time="" data-username="" data-userid="">10.7</named-content>);</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="967f5dac-02d1-430b-af6d-8fce688cfbb7" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;34.453125&quot;;&quot;data-left-indent-space&quot;:&quot;34.453125&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="baf89b12-af13-4cdf-83ff-a86ad2ea9a1b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="e6453dce-6d87-4ed0-8cb5-3efab9b46ffa" data-cid="e6453dce-6d87-4ed0-8cb5-3efab9b46ffa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="10 (8.8 – 11.6" data-replace="10 " data-pattern="$1 " data-tag-index="187_1" data-time="" data-username="" data-userid="">10 </named-content><named-content id="e29412f3-985e-497b-b507-01c4d78368dd" data-cid="e29412f3-985e-497b-b507-01c4d78368dd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="3" data-match="10 (8.8 – 11.6" data-replace="(8.8" data-pattern="$2" data-tag-index="187_1" data-time="" data-username="" data-userid="">(8.8</named-content><named-content id="28bbaa18-c9e6-42c8-a367-fb649cd56339" data-cid="28bbaa18-c9e6-42c8-a367-fb649cd56339" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="7" data-match="10 (8.8 – 11.6" data-replace="–" data-pattern="–" data-tag-index="187_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="31a7dbeb-db09-4ab0-8841-a05fb1dec103" data-cid="31a7dbeb-db09-4ab0-8841-a05fb1dec103" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="12" data-match="10 (8.8 – 11.6" data-replace="11.6" data-pattern="$4" data-tag-index="187_1" data-time="" data-username="" data-userid="">11.6</named-content>);</p></td></tr><tr data-col-count="5" id="881c063b-f157-4759-8312-0550b4d7d43f"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="27e03c42-139d-4b5e-a5e8-276ed6ed5f39" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="509f7105-ca61-4b26-ba15-1da602ee35b8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">(%; mmol/mol)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="cb01e08b-c8c7-404b-9287-4dab95ea8403" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;5&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;6.671875&quot;;&quot;data-left-indent-space&quot;:&quot;6.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="e686d581-f1a5-4540-b616-a86e00898e3e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4c8ff225-bb54-4425-ae70-0931c67edba4" data-cid="4c8ff225-bb54-4425-ae70-0931c67edba4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="85 (72 – 98)" data-replace="85 " data-pattern="$1 " data-tag-index="189_1" data-time="" data-username="" data-userid="">85 </named-content><named-content id="3c8aa1c0-0a18-4a5c-94a3-8a38271750b1" data-cid="3c8aa1c0-0a18-4a5c-94a3-8a38271750b1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="3" data-match="85 (72 – 98)" data-replace="(72" data-pattern="$2" data-tag-index="189_1" data-time="" data-username="" data-userid="">(72</named-content><named-content id="b4764a00-7917-4da0-a20b-8611f9429cfd" data-cid="b4764a00-7917-4da0-a20b-8611f9429cfd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="85 (72 – 98)" data-replace="–" data-pattern="–" data-tag-index="189_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="a67e2e79-e306-46ef-a884-54a47d332726" data-cid="a67e2e79-e306-46ef-a884-54a47d332726" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="11" data-match="85 (72 – 98)" data-replace="98)" data-pattern="$4" data-tag-index="189_1" data-time="" data-username="" data-userid="">98)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="bb31a3fe-2cf1-4023-8cfe-b75a9e8f27ed" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;5&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="bc1ab857-aba2-40e8-a1e4-c2f93ae717a4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="b7a9a3ec-3f7b-4ed7-a8ad-e6a107637b72" data-cid="b7a9a3ec-3f7b-4ed7-a8ad-e6a107637b72" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="83 (70 – 93)" data-replace="83 " data-pattern="$1 " data-tag-index="190_1" data-time="" data-username="" data-userid="">83 </named-content><named-content id="e2f63459-11a9-4fc3-8345-4f85eca1d0f3" data-cid="e2f63459-11a9-4fc3-8345-4f85eca1d0f3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="3" data-match="83 (70 – 93)" data-replace="(70" data-pattern="$2" data-tag-index="190_1" data-time="" data-username="" data-userid="">(70</named-content><named-content id="aa883795-7396-40f7-8704-75c00f956141" data-cid="aa883795-7396-40f7-8704-75c00f956141" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="83 (70 – 93)" data-replace="–" data-pattern="–" data-tag-index="190_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="043d4637-f2fa-4f20-a2a1-707732d13720" data-cid="043d4637-f2fa-4f20-a2a1-707732d13720" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="11" data-match="83 (70 – 93)" data-replace="93)" data-pattern="$4" data-tag-index="190_1" data-time="" data-username="" data-userid="">93)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="8e89da1f-3a4f-485e-ab5f-7fc082c5303d" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;5&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;34.453125&quot;;&quot;data-left-indent-space&quot;:&quot;34.453125&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="fe4dd9fc-f590-4c77-b559-daa43cdcbc93" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="2f0b6d9e-8bb8-41b5-b6c6-a9ce6459d5bc" data-cid="2f0b6d9e-8bb8-41b5-b6c6-a9ce6459d5bc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="86 (73 – 103)" data-replace="86 " data-pattern="$1 " data-tag-index="191_1" data-time="" data-username="" data-userid="">86 </named-content><named-content id="8f1dd8e1-6818-46d9-8092-3b91283a740b" data-cid="8f1dd8e1-6818-46d9-8092-3b91283a740b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="3" data-match="86 (73 – 103)" data-replace="(73" data-pattern="$2" data-tag-index="191_1" data-time="" data-username="" data-userid="">(73</named-content><named-content id="004733c9-a377-49b0-b650-7ac0f53a395e" data-cid="004733c9-a377-49b0-b650-7ac0f53a395e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="6" data-match="86 (73 – 103)" data-replace="–" data-pattern="–" data-tag-index="191_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="4887357a-0cfd-42ea-93f3-e1b003446243" data-cid="4887357a-0cfd-42ea-93f3-e1b003446243" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="11" data-match="86 (73 – 103)" data-replace="103)" data-pattern="$4" data-tag-index="191_1" data-time="" data-username="" data-userid="">103)</named-content></p></td></tr><tr data-col-count="5" id="dd9aed99-5094-49c1-b7a5-22bc8f23fc39" data-fill="true"><td data-class="" rowspan="2" data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="2ec39ecb-f0fc-400d-b2ba-4e608360cd48" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="974884b5-dd66-43b7-a499-92f3ea7ccab1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Diabetic ketoacidosis</p></td><td data-class="" rowspan="2" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="ec620d59-d272-424a-b61d-f38fe3ae2c4e" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="1f054b1a-7e66-4931-b37b-fc9111bb6735" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="adfc14f8-46a3-4316-8123-0a894518a58d" data-cid="adfc14f8-46a3-4316-8123-0a894518a58d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="8 (38.1)" data-replace="8" data-pattern="$1" data-tag-index="193_1" data-time="" data-username="" data-userid="">8</named-content><named-content id="bda06840-be45-479d-8b50-f17e73128159" data-cid="bda06840-be45-479d-8b50-f17e73128159" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="8 (38.1)" data-replace=" (38.1)" data-pattern=" $2" data-tag-index="193_1" data-time="" data-username="" data-userid=""> (38.1)</named-content><sup id="235859ee-388b-4792-82f7-4da8e670953e">*</sup></p></td><td data-class="" rowspan="2" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="203f6b3a-284d-41eb-8a12-69149b19d941" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="c09974f1-cf2a-4a6c-aef2-70dda691531f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="baf591d9-714b-4a7e-b831-7bd4e900f023" data-cid="baf591d9-714b-4a7e-b831-7bd4e900f023" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="8 (66.7)" data-replace="8" data-pattern="$1" data-tag-index="194_1" data-time="" data-username="" data-userid="">8</named-content><named-content id="160c20db-7bd7-4190-b86c-41321defabbe" data-cid="160c20db-7bd7-4190-b86c-41321defabbe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="8 (66.7)" data-replace=" (66.7)" data-pattern=" $2" data-tag-index="194_1" data-time="" data-username="" data-userid=""> (66.7)</named-content><named-content data-cid="1545216248" id="c1d44545-4694-44d3-8566-b2c61669b183" content-type="del cts-1" specific-use="1545218006691" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 19 2018 4:43pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545218006691"> </named-content><named-content data-cid="1545216247" id="d3eca2a9-3705-4281-87c8-6a5b5178eb20" content-type="styrm cts-1" specific-use="1545218004111" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Superscript Removed by Varalakshmi (PREEDITOR) - Dec 19 2018 4:43pm" data-track-detail="" data-format-command="superscript" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545218004111" data-track-hint="Superscript Removed">*</named-content></p></td><td data-class="" rowspan="2" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="11d76736-b119-495e-8324-42336fa7a0dd" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="b0ad1715-75bc-4f4b-8318-433b356c6593" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="87d5d0a3-7185-45d0-9640-c8ea4cebb4a9" data-cid="87d5d0a3-7185-45d0-9640-c8ea4cebb4a9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0 (0)" data-replace="0" data-pattern="$1" data-tag-index="195_1" data-time="" data-username="" data-userid="">0</named-content><named-content id="d67452fa-97e9-4d82-a88f-7894ce729715" data-cid="d67452fa-97e9-4d82-a88f-7894ce729715" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="0 (0)" data-replace=" (0)" data-pattern=" $2" data-tag-index="195_1" data-time="" data-username="" data-userid=""> (0)</named-content></p></td></tr><tr data-col-count="5" id="140e0ec4-32f2-496d-b13e-7df55fbb60c8" data-fill="true"/><tr data-col-count="5" id="11d6da80-ca86-4a7b-b22a-210f7b5705a4"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="c3d77540-952d-4870-ba90-92358c7b9e7c" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="c0889ace-04d4-4724-83c0-86cd9bf8367a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Low C-<named-content data-cid="1545433436" id="e0030b24-217c-49c6-bb4d-184bef0225bb" content-type="del cts-3" specific-use="1545438184666" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438184666"> </named-content>peptide level (reference <named-content id="5bd7eccb-8166-43c6-929d-8af11c2452bb" data-cid="5bd7eccb-8166-43c6-929d-8af11c2452bb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="32" data-match="1.1 – 4.4 ng/mL" data-replace="1.1" data-pattern="$2" data-tag-index="196_1" data-time="" data-username="" data-userid="">1.1</named-content><named-content id="e12949ef-89e1-4c48-ab1c-0a19214fb829" data-cid="e12949ef-89e1-4c48-ab1c-0a19214fb829" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="35" data-match="1.1 – 4.4 ng/mL" data-replace="–" data-pattern="–" data-tag-index="196_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="69825b52-33d2-4bb9-acf7-954f74eabfd6" data-cid="69825b52-33d2-4bb9-acf7-954f74eabfd6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="40" data-match="1.1 – 4.4 ng/mL" data-replace="4.4" data-pattern="$1" data-tag-index="196_1" data-time="" data-username="" data-userid="">4.4</named-content><named-content id="9d888f85-e5a3-41bd-b9f8-fa1ebcbbbe46" data-cid="9d888f85-e5a3-41bd-b9f8-fa1ebcbbbe46" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣ng/mL' to ' ng/mL'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="43" data-match="1.1 – 4.4 ng/mL" data-replace=" ng/mL" data-pattern=" $2" data-tag-index="196_1" data-track-change=" ng/mL" data-time="" data-username="" data-userid=""> ng/mL</named-content>)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e2b2a2d9-2e3b-4840-a51a-d368b72d77e1" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="23315553-2bf0-456d-8e39-90a7c8ab28ef" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="593c2dbb-5956-424f-b763-bca5efee979c" data-cid="593c2dbb-5956-424f-b763-bca5efee979c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="5/7 (71.4)" data-replace="5/7" data-pattern="$1" data-tag-index="197_1" data-time="" data-username="" data-userid="">5/7</named-content><named-content id="f6af7519-8d5c-4e4d-a6e9-1395253d9a30" data-cid="f6af7519-8d5c-4e4d-a6e9-1395253d9a30" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="5/7 (71.4)" data-replace=" (71.4)" data-pattern=" $2" data-tag-index="197_1" data-time="" data-username="" data-userid=""> (71.4)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="c7280265-c68a-41e0-9525-56c673350793" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;1.671875&quot;;&quot;data-left-indent-space&quot;:&quot;1.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="4ad7c5b5-6043-483a-80ac-8cb4e0f46cd0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="a4eb258f-2ad1-4043-b81f-6e6ae2dbf6e3" data-cid="a4eb258f-2ad1-4043-b81f-6e6ae2dbf6e3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="5/6 (83.3)" data-replace="5/6" data-pattern="$1" data-tag-index="198_1" data-time="" data-username="" data-userid="">5/6</named-content><named-content id="7a5337ba-142a-4ff8-93de-ac313cdfc2ef" data-cid="7a5337ba-142a-4ff8-93de-ac313cdfc2ef" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="5/6 (83.3)" data-replace=" (83.3)" data-pattern=" $2" data-tag-index="198_1" data-time="" data-username="" data-userid=""> (83.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="4b018d74-7ea5-42cb-9e5c-03b5655775c5" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;31.953125&quot;;&quot;data-left-indent-space&quot;:&quot;31.953125&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="bd8f34bb-94f4-491d-a0e0-d663653b9a71" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="6b6c3f80-6d48-4e84-b8ff-318dd6e8aca1" data-cid="6b6c3f80-6d48-4e84-b8ff-318dd6e8aca1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0/1 (0)" data-replace="0/1" data-pattern="$1" data-tag-index="199_1" data-time="" data-username="" data-userid="">0/1</named-content><named-content id="68cf91e1-d5d5-4260-9676-9e8f84492829" data-cid="68cf91e1-d5d5-4260-9676-9e8f84492829" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="0/1 (0)" data-replace=" (0)" data-pattern=" $2" data-tag-index="199_1" data-time="" data-username="" data-userid=""> (0)</named-content></p></td></tr><tr data-col-count="5" id="2c760499-687a-46b7-a3e3-9da944d74186" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="f2026c05-4bfe-461f-b3c3-1ce46f8c2372" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="0c70175e-0bf8-49fe-9173-168b89afad85" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545124885" id="8a6220bb-c828-441d-a13b-82217272bfb2" content-type="styrm cts-2" specific-use="1545125965042" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Bold Removed by Varalakshmi (PREEDITOR) - Dec 18 2018 3:09pm" data-track-detail="" data-format-command="bold" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125965042" data-track-hint="Bold Removed"><named-content rid="fb3d1fe1-060a-43f4-8ced-8340dac19108" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="publisher" data-query-from="author" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" content-type="jrnlQueryRef" specific-use="start" id="cffcf79b-1fe8-44e4-af91-17d2a059dbe7" data-answered="true"/>Pancreatic <named-content rid="d723cef0-299c-437c-a846-d1940e4d832e" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="typesetter" data-query-from="publisher" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="6c3315e2-4b29-4be5-a3bd-ea7ad4246a65" content-type="jrnlQueryRef" specific-use="start" data-replied="true"/>enzymes<named-content rid="d723cef0-299c-437c-a846-d1940e4d832e" data-class="jrnlQueryRef" data-type="end" id="fdb7cac1-6dd9-41de-ad24-939dcad7c79c" content-type="jrnlQueryRef" specific-use="end" data-replied="true"/><named-content rid="fb3d1fe1-060a-43f4-8ced-8340dac19108" data-class="jrnlQueryRef" data-type="end" data-query-type="action" content-type="jrnlQueryRef" specific-use="end" id="484e8c62-3b5d-4d5d-9f9c-4b0f2f525d3a" data-answered="true"/></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="2b77b63a-714c-4896-8941-adfbeeb322c9" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;0&quot;;&quot;data-left-indent-space&quot;:&quot;0&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p data-class="jrnlDeleted" id="b4697b3a-7018-49a1-864b-e4a22a2d3757" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align" old-class="jrnlTblBody" align="left"><named-content id="6dcf0224-3b64-4647-ae60-43f4a447f487" data-cid="6dcf0224-3b64-4647-ae60-43f4a447f487" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="4/14 (28.6)" data-replace="4/14" data-pattern="$1" data-tag-index="201_1" data-time="" data-username="" data-userid=""><named-content data-cid="1546594842" id="f8556303-dc18-4e13-a421-0148e6645223" content-type="del cts-7" specific-use="1546595995631" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Deleted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595995631">4/14</named-content></named-content><named-content id="f6c74430-8809-4952-812e-2e7458519a61" data-cid="f6c74430-8809-4952-812e-2e7458519a61" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="4/14 (28.6)" data-replace=" (28.6)" data-pattern=" $2" data-tag-index="201_1" data-time="" data-username="" data-userid=""><named-content data-cid="1546594842" id="3eb4a1e1-b249-4b4d-a5f4-927ab96326bb" content-type="del cts-7" specific-use="1546595995631" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Deleted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595995631"> (28.6)</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="d8cc3df9-62d4-4ca6-b5b6-ce6d797257fe" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;1.671875&quot;;&quot;data-left-indent-space&quot;:&quot;1.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p data-class="jrnlDeleted" id="a1dbec81-60fa-4688-b3b1-2bf6f3299942" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align" old-class="jrnlTblBody" align="left"><named-content id="98dad871-d197-4f28-9a02-77bef2ac375e" data-cid="98dad871-d197-4f28-9a02-77bef2ac375e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1/7 (14.3)" data-replace="1/7" data-pattern="$1" data-tag-index="202_1" data-time="" data-username="" data-userid=""><named-content data-cid="1546594838" id="c7dcf69a-d164-429d-9679-edae0ba151bd" content-type="del cts-7" specific-use="1546595978276" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Deleted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595978276">1/7</named-content></named-content><named-content id="6f8616aa-a626-46c0-a702-dd15e9e6a438" data-cid="6f8616aa-a626-46c0-a702-dd15e9e6a438" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="1/7 (14.3)" data-replace=" (14.3)" data-pattern=" $2" data-tag-index="202_1" data-time="" data-username="" data-userid=""><named-content data-cid="1546594838" id="5fb71ea9-fac3-45c1-92a4-0666640a46fe" content-type="del cts-7" specific-use="1546595978276" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Deleted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595978276"> (14.3)</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="722e2b57-d5ed-40b6-9cdf-8ab9a57473b9" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;31.953125&quot;;&quot;data-left-indent-space&quot;:&quot;31.953125&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p data-class="jrnlDeleted" id="0bb1ae88-a85f-448e-8d81-cc33420e1346" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align" old-class="jrnlTblBody" align="left"><named-content id="0e24999c-35a0-4a42-bf2f-9b4267c4f307" data-cid="0e24999c-35a0-4a42-bf2f-9b4267c4f307" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="3/7 (42.8)" data-replace="3/7" data-pattern="$1" data-tag-index="203_1" data-time="" data-username="" data-userid=""><named-content data-cid="1546594834" id="709675ce-68f7-4775-86a2-66a3508401ea" content-type="del cts-7" specific-use="1546595959513" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Deleted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595959513">3/7</named-content></named-content><named-content id="5e5ff58c-c860-4c02-9306-1bffcf040cff" data-cid="5e5ff58c-c860-4c02-9306-1bffcf040cff" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="3/7 (42.8)" data-replace=" (42.8)" data-pattern=" $2" data-tag-index="203_1" data-time="" data-username="" data-userid=""><named-content data-cid="1546594834" id="10ca61eb-233e-4011-a6d3-bebe26d980ff" content-type="del cts-7" specific-use="1546595959513" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Deleted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595959513"> (42.8)</named-content></named-content></p></td></tr><tr data-col-count="5" id="301ecb3f-2646-486f-8cef-c5aa7d186707"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="cc59a0fa-a8bd-4653-998e-46c26fdd8955" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="0719ace0-872b-4bd4-8905-c19e63c34e3d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Mildly elevated</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="ff4c3550-dc93-462f-b934-8ec2bd88ac17" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;0&quot;;&quot;data-left-indent-space&quot;:&quot;0&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="5b548e56-6e6f-4e90-820a-2dc0efb72d34" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="ce196541-f41f-43c3-94a5-c5c2aa204228" data-cid="ce196541-f41f-43c3-94a5-c5c2aa204228" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="4/14 (28.6)" data-replace=" (28.6)" data-pattern=" $2" data-tag-index="205_1" data-time="" data-username="" data-userid=""><named-content data-cid="1546594844" id="08bdf5f5-53a9-4f8c-bb6e-f6675490c24f" content-type="ins cts-7" specific-use="1546596001127" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Inserted by Thilip (TYPESETTER) - Jan 4 2019 3:30pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546596001127"><named-content data-cid="1546594845" id="14e8e6f5-acfd-4a53-9218-1e9992f477e8" content-type="ins cts-7" specific-use="1546596002355" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Inserted by Thilip (TYPESETTER) - Jan 4 2019 3:30pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546596002355">4/14 (28.6)</named-content></named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="25dc4b12-9763-42ae-9cdc-43a2e5fa68e4" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;1.671875&quot;;&quot;data-left-indent-space&quot;:&quot;1.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="673f425f-be7a-49da-a236-7b3f0e5266ad" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="fd22ed72-238a-4503-b7d0-1fe6be7cb305" data-cid="fd22ed72-238a-4503-b7d0-1fe6be7cb305" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="3/7 (42.8)" data-replace=" (42.8)" data-pattern=" $2" data-tag-index="206_1" data-time="" data-username="" data-userid=""><named-content data-cid="1546594840" id="39cb85f3-85a2-438d-a94c-fc237533b67f" content-type="ins cts-7" specific-use="1546595985313" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Inserted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595985313"><named-content data-cid="1546594841" id="18473277-3858-4c1b-a591-8c0724ce66bb" content-type="ins cts-7" specific-use="1546595986602" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Inserted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595986602">1/7 (14.3)</named-content></named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="a62034b5-2823-42ce-ab3c-8163b813ca06" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;31.953125&quot;;&quot;data-left-indent-space&quot;:&quot;31.953125&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="ce424c56-ea6b-4b44-bb5b-9e9e7693d371" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="a90b928c-a08d-4bc6-bc8d-c4c4ffa3febc" data-cid="a90b928c-a08d-4bc6-bc8d-c4c4ffa3febc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '(14.3)' to '␣(14.3)'" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="1/7(14.3)" data-replace=" (14.3)" data-pattern=" $2" data-tag-index="207_1" data-track-change="(14.3)" data-time="" data-username="" data-userid=""><named-content data-cid="1546594836" id="19b394c2-154b-4507-9be2-6a3d3c79831b" content-type="ins cts-7" specific-use="1546595968487" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Inserted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595968487"><named-content data-cid="1546594837" id="4db868ef-b267-41ba-b412-803dc0041000" content-type="ins cts-7" specific-use="1546595974148" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Inserted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595974148">3/7 (42.8)</named-content></named-content></named-content></p></td></tr><tr data-col-count="5" id="a039ffa1-6d06-43d3-8946-8cb404407d1b" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="9837a9c9-e392-4762-bca4-c591c3c75f70" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;colspan&quot;:&quot;4&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="f2e96e5c-2667-45a7-a035-48ac6880d4bb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Moderate<named-content data-cid="1545433437" id="627fd06b-51b1-4491-a6ac-a9b15c631df8" content-type="del cts-3" specific-use="1545438189624" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438189624">-</named-content><named-content data-cid="1545433438" id="9b053273-914b-4a9e-9aeb-193c27313ec5" content-type="ins cts-3" specific-use="1545438189869" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438189869"> to </named-content>severely elevated (<named-content id="1e6fc286-5ce0-4501-b6e0-0a9e09f1ac83" data-cid="1e6fc286-5ce0-4501-b6e0-0a9e09f1ac83" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="28" data-match="&amp;gt;2" data-replace="&gt;" data-pattern="$2" data-tag-index="208_1" data-time="" data-username="" data-userid="">&gt;</named-content><named-content id="57cc035f-0e4a-43b2-8402-8fcbf3245e39" data-cid="57cc035f-0e4a-43b2-8402-8fcbf3245e39" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="SNUM" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="SNUM" data-offset="29" data-match="&amp;gt;2" data-pattern="" data-tag-index="208_1" data-time="" data-username="" data-userid="">2</named-content> times upper limit of normal)</p> </td><td data-class="" id="f22f0472-c719-4af9-bc45-8fce2649ce91" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align,valign,data-col-index" align="left" valign="top" data-col-index="2"><p id="0ae1af96-4651-44b1-8e66-fddacd545151"><named-content data-cid="1546594829" id="0eda81c9-73b9-4d3b-8eb2-fa6aa2acb551" content-type="ins cts-7" specific-use="1546595945287" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Inserted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595945287">4/14 (28.6)</named-content></p></td><td data-class="" id="5f5a1664-3a15-4549-aaf6-771cb85dea5e" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align,valign,data-col-index" align="left" valign="top" data-col-index="3"><p id="3dfbb91e-74ae-43a2-88f8-e898d5b61712"><named-content data-cid="1546594831" id="eb890c77-9f12-44ee-9c0d-4c6a9706e77c" content-type="ins cts-7" specific-use="1546595949972" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Inserted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595949972">3/7 (42.8)</named-content></p></td><td data-class="" id="02ceefad-ef97-4524-9794-1eb1a9e151d6" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align,valign,data-col-index" align="left" valign="top" data-col-index="4"><p id="e79ffcb2-a7b8-4163-a384-2f68e47ab322"><named-content data-cid="1546594833" id="dff6a71a-f1fb-47af-9968-2c914e4da759" content-type="ins cts-7" specific-use="1546595956026" xlink:title="Thilip (TYPESETTER)" alt="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-title="Inserted by Thilip (TYPESETTER) - Jan 4 2019 3:29pm" data-track-detail="" data-userid="typesetter 321b47f6-3e89-4373-9302-4177702ffb45" data-username="Thilip (TYPESETTER)" data-time="1546595956026">1/7 (14.3)</named-content></p></td></tr><tr data-col-count="5" id="d312d72b-29b9-454b-837e-15f4acaa0c69"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="ac9562a9-5034-4175-a789-8dded6c6fe9b" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="9720f570-e1c4-4d71-a893-31b1438861f1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Not elevated</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="354001d1-6b8f-4eab-8848-90b082578f7c" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;0&quot;;&quot;data-left-indent-space&quot;:&quot;0&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="1e857760-e4d7-4793-89c5-366e8d9cb73f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="dedca6f3-be86-4e35-91d5-e06a23c81594" data-cid="dedca6f3-be86-4e35-91d5-e06a23c81594" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="6/14 (42.8)" data-replace="6/14" data-pattern="$1" data-tag-index="210_1" data-time="" data-username="" data-userid="">6/14</named-content><named-content id="00505578-d6c0-45c5-a4f7-274532e23cce" data-cid="00505578-d6c0-45c5-a4f7-274532e23cce" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="6/14 (42.8)" data-replace=" (42.8)" data-pattern=" $2" data-tag-index="210_1" data-time="" data-username="" data-userid=""> (42.8)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="1c709c48-1e72-4be3-8330-f3998dcb8348" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;1.671875&quot;;&quot;data-left-indent-space&quot;:&quot;1.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="73d65d16-07ec-4f7b-ae6a-1f75bc8b18b1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="153899e5-923c-4f4a-8fd8-f2b6118805ae" data-cid="153899e5-923c-4f4a-8fd8-f2b6118805ae" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="3/7 (42.8)" data-replace="3/7" data-pattern="$1" data-tag-index="211_1" data-time="" data-username="" data-userid="">3/7</named-content><named-content id="473f1ff3-8c33-4039-a6cd-e3451ecf3e49" data-cid="473f1ff3-8c33-4039-a6cd-e3451ecf3e49" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="3/7 (42.8)" data-replace=" (42.8)" data-pattern=" $2" data-tag-index="211_1" data-time="" data-username="" data-userid=""> (42.8)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="1223d317-e68d-4e27-81cc-ec22203c2696" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;31.953125&quot;;&quot;data-left-indent-space&quot;:&quot;31.953125&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="ad20c32d-477b-4018-b3d0-5f27a8fd4125" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="aa248446-db7d-416c-987d-97eed15adcc9" data-cid="aa248446-db7d-416c-987d-97eed15adcc9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="3/7 (42.8)" data-replace="3/7" data-pattern="$1" data-tag-index="212_1" data-time="" data-username="" data-userid="">3/7</named-content><named-content id="19170d4a-6079-4a6a-9c6f-bc22f4cf9e92" data-cid="19170d4a-6079-4a6a-9c6f-bc22f4cf9e92" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="3/7 (42.8)" data-replace=" (42.8)" data-pattern=" $2" data-tag-index="212_1" data-time="" data-username="" data-userid=""> (42.8)</named-content></p></td></tr><tr data-col-count="5" id="9475676b-e007-4934-873b-94859ce0e119" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="2cbba03f-7a14-4b1f-8bbc-7e7e600af24c" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="5efe769e-5d3d-4d64-8049-804e7d693374" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545124886" id="a3c14591-29bc-44f2-8f16-dcbeed2f5766" content-type="styrm cts-2" specific-use="1545125979565" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Bold Removed by Varalakshmi (PREEDITOR) - Dec 18 2018 3:09pm" data-track-detail="" data-format-command="bold" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125979565" data-track-hint="Bold Removed">Antibody positivity</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="a4e218dd-7675-4341-8bd0-e51a3f3e5139" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="1aeff8cf-4b3e-4097-a9b7-49043d7d848e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="cfc4624b-19a1-4aa3-a459-2296502200c4" data-cid="cfc4624b-19a1-4aa3-a459-2296502200c4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="5/7 (71.4)" data-replace="5/7" data-pattern="$1" data-tag-index="214_1" data-time="" data-username="" data-userid="">5/7</named-content><named-content id="3a2ffc8e-ba36-4da9-88ae-ee3986de3e80" data-cid="3a2ffc8e-ba36-4da9-88ae-ee3986de3e80" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="5/7 (71.4)" data-replace=" (71.4)" data-pattern=" $2" data-tag-index="214_1" data-time="" data-username="" data-userid=""> (71.4)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="1293841d-0294-4003-b280-99868c321957" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;1.671875&quot;;&quot;data-left-indent-space&quot;:&quot;1.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="2cb9e66d-d69f-425e-b276-e3ed8f2e5a34" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="adbdc8c3-af38-4793-a0b4-02782b2e07d4" data-cid="adbdc8c3-af38-4793-a0b4-02782b2e07d4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="5/7 (71.4)" data-replace="5/7" data-pattern="$1" data-tag-index="215_1" data-time="" data-username="" data-userid="">5/7</named-content><named-content id="d3549f7c-e784-4406-ab8c-85be1887c71f" data-cid="d3549f7c-e784-4406-ab8c-85be1887c71f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="5/7 (71.4)" data-replace=" (71.4)" data-pattern=" $2" data-tag-index="215_1" data-time="" data-username="" data-userid=""> (71.4)</named-content></p></td><td rowspan="5" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="e99ca819-ed24-4364-9372-ddfc8f86c479" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;53.421875&quot;;&quot;data-left-space&quot;:&quot;0&quot;;&quot;data-left-indent-space&quot;:&quot;0&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="a62d82f4-17e5-4f51-97a4-d40e987db75c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align">Not checked</p></td></tr><tr data-col-count="5" id="a5853063-e104-4f73-b187-ed8684ef9deb" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="141edacc-db54-4f37-afa5-7a124a3cf2ef" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="8a749f3d-2f11-4883-82be-14873ca02a7a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> GAD65 (reference<named-content id="8da04692-fdd6-4763-898d-77bd8b911fd3" data-cid="8da04692-fdd6-4763-898d-77bd8b911fd3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣≤' to '⍽≤'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="16" data-match="reference ≤0.02 nmol/L" data-replace=" ≤" data-pattern=" $2" data-tag-index="217_1" data-track-change=" ≤" data-time="" data-username="" data-userid=""> ≤</named-content><named-content id="9c81a4a3-14e1-4a04-a2fd-2a629edb91ef" data-cid="9c81a4a3-14e1-4a04-a2fd-2a629edb91ef" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="20" data-match="reference ≤0.02 nmol/L" data-replace="0.02" data-pattern="$1" data-tag-index="217_1" data-time="" data-username="" data-userid="">0.02</named-content><named-content id="e4c9d546-cb00-4b30-ab2f-61d43cccbc6f" data-cid="e4c9d546-cb00-4b30-ab2f-61d43cccbc6f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣nmol/L' to ' nmol/L'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="24" data-match="reference ≤0.02 nmol/L" data-replace=" nmol/L" data-pattern=" $2" data-tag-index="217_1" data-track-change=" nmol/L" data-time="" data-username="" data-userid=""> nmol/L</named-content>)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="427f0c56-b746-4197-9d45-2455073a15b0" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="1a60559e-5ccb-4236-a890-2a5202e01317" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="54de4718-bc37-474c-9ee5-ad78c75f8ff5" data-cid="54de4718-bc37-474c-9ee5-ad78c75f8ff5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="4/7 (57.1)" data-replace="4/7" data-pattern="$1" data-tag-index="218_1" data-time="" data-username="" data-userid="">4/7</named-content><named-content id="08315e75-9a8a-4aef-9c07-2213f71d1bbe" data-cid="08315e75-9a8a-4aef-9c07-2213f71d1bbe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="4/7 (57.1)" data-replace=" (57.1)" data-pattern=" $2" data-tag-index="218_1" data-time="" data-username="" data-userid=""> (57.1)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="c0abe2f8-35c2-492e-89ce-64174d2ba88d" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;1.671875&quot;;&quot;data-left-indent-space&quot;:&quot;1.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="b4a4ad5b-acf0-46eb-87fe-a399b13b0de5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4dd97097-dd17-468d-a884-c6cb6bded39c" data-cid="4dd97097-dd17-468d-a884-c6cb6bded39c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="4/7 (57.1)" data-replace="4/7" data-pattern="$1" data-tag-index="219_1" data-time="" data-username="" data-userid="">4/7</named-content><named-content id="54c23acf-09b0-424c-9b70-8f8004f67b3b" data-cid="54c23acf-09b0-424c-9b70-8f8004f67b3b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="4/7 (57.1)" data-replace=" (57.1)" data-pattern=" $2" data-tag-index="219_1" data-time="" data-username="" data-userid=""> (57.1)</named-content></p></td></tr><tr data-col-count="5" id="e9374f10-0219-4a2f-9be2-00a87e3c9e0d" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d84515f9-2cd1-453e-bb48-810cefdb766a" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="b162cf12-01f2-4212-b26d-ca1918550560" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> IAA (reference<named-content id="3f717b4a-5421-43c8-b502-73c049e1d9ee" data-cid="3f717b4a-5421-43c8-b502-73c049e1d9ee" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣≤' to '⍽≤'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="14" data-match="reference ≤0.02 nmol/L" data-replace=" ≤" data-pattern=" $2" data-tag-index="220_1" data-track-change=" ≤" data-time="" data-username="" data-userid=""> ≤</named-content><named-content id="909ca43f-9a17-4f48-9e5c-1b75d96c4649" data-cid="909ca43f-9a17-4f48-9e5c-1b75d96c4649" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="18" data-match="reference ≤0.02 nmol/L" data-replace="0.02" data-pattern="$1" data-tag-index="220_1" data-time="" data-username="" data-userid="">0.02</named-content><named-content id="ce4387b3-05e5-4203-a7fd-d6d7660dd697" data-cid="ce4387b3-05e5-4203-a7fd-d6d7660dd697" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣nmol/L' to ' nmol/L'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="22" data-match="reference ≤0.02 nmol/L" data-replace=" nmol/L" data-pattern=" $2" data-tag-index="220_1" data-track-change=" nmol/L" data-time="" data-username="" data-userid=""> nmol/L</named-content>)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="12969de7-825e-4a0f-87b1-c9679e1760fb" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="cf598add-5a86-4c31-99ac-61a7bc843b48" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="17471956-67bf-4ed2-ad9a-aec94a9c603a" data-cid="17471956-67bf-4ed2-ad9a-aec94a9c603a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2/6 (33.3)" data-replace="2/6" data-pattern="$1" data-tag-index="221_1" data-time="" data-username="" data-userid="">2/6</named-content><named-content id="190c43d9-ef78-4534-bef1-116e8b63dac3" data-cid="190c43d9-ef78-4534-bef1-116e8b63dac3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="2/6 (33.3)" data-replace=" (33.3)" data-pattern=" $2" data-tag-index="221_1" data-time="" data-username="" data-userid=""> (33.3)</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="1584c689-2052-42a9-9123-76780be67388" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;1.671875&quot;;&quot;data-left-indent-space&quot;:&quot;1.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="64cb6862-7207-4823-a967-d4f85eb8f20a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="72e556d5-ecc0-4e18-9168-030a0973f797" data-cid="72e556d5-ecc0-4e18-9168-030a0973f797" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2/6 (33.3)" data-replace="2/6" data-pattern="$1" data-tag-index="222_1" data-time="" data-username="" data-userid="">2/6</named-content><named-content id="a0bfad96-7883-441d-9e80-79a86f4536c3" data-cid="a0bfad96-7883-441d-9e80-79a86f4536c3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="2/6 (33.3)" data-replace=" (33.3)" data-pattern=" $2" data-tag-index="222_1" data-time="" data-username="" data-userid=""> (33.3)</named-content></p></td></tr><tr data-col-count="5" id="e384e5ce-bd86-498a-ac4b-81727c0f291f" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="01888d18-0fdc-4b73-b0ce-320a656d7064" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="7eb04ea8-9045-4903-ad2b-81d713e28195" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> IA-2 (reference<named-content id="e273850d-4980-4b9e-acd5-1ff9747cf8e8" data-cid="e273850d-4980-4b9e-acd5-1ff9747cf8e8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣≤' to '⍽≤'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="15" data-match="reference ≤0.02 nmol/L" data-replace=" ≤" data-pattern=" $2" data-tag-index="223_1" data-track-change=" ≤" data-time="" data-username="" data-userid=""> ≤</named-content><named-content id="665a2016-d8a3-4582-b858-d0ae60c944a0" data-cid="665a2016-d8a3-4582-b858-d0ae60c944a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="19" data-match="reference ≤0.02 nmol/L" data-replace="0.02" data-pattern="$1" data-tag-index="223_1" data-time="" data-username="" data-userid="">0.02</named-content><named-content id="69addde7-58f6-48dc-b3ec-15134f96fd82" data-cid="69addde7-58f6-48dc-b3ec-15134f96fd82" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣nmol/L' to ' nmol/L'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="23" data-match="reference ≤0.02 nmol/L" data-replace=" nmol/L" data-pattern=" $2" data-tag-index="223_1" data-track-change=" nmol/L" data-time="" data-username="" data-userid=""> nmol/L</named-content>)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="18f2b2cd-ecfc-4be8-a315-ee10809e2238" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="9f969040-74ab-4059-a840-3e148c5be08a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="c5a50fe0-c56c-423b-ad2e-4eee6b1cbd2e" data-cid="c5a50fe0-c56c-423b-ad2e-4eee6b1cbd2e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1/6 (16.7)" data-replace="1/6" data-pattern="$1" data-tag-index="224_1" data-time="" data-username="" data-userid="">1/6</named-content><named-content id="c1477027-10ae-4073-b2b9-15d85f2261c5" data-cid="c1477027-10ae-4073-b2b9-15d85f2261c5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="1/6 (16.7)" data-replace=" (16.7)" data-pattern=" $2" data-tag-index="224_1" data-time="" data-username="" data-userid=""> (16.7)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="6b607b23-dbab-4950-9587-5bdcf9e22d0b" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;1.671875&quot;;&quot;data-left-indent-space&quot;:&quot;1.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="85226fac-d7ee-4003-98bc-631fe9350256" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="10a7f762-1204-44e5-8f96-ff1bb8a5ffc6" data-cid="10a7f762-1204-44e5-8f96-ff1bb8a5ffc6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1/6 (16.7)" data-replace="1/6" data-pattern="$1" data-tag-index="225_1" data-time="" data-username="" data-userid="">1/6</named-content><named-content id="4dcc30f8-8aa4-463f-b5c6-d5ee1aa4578a" data-cid="4dcc30f8-8aa4-463f-b5c6-d5ee1aa4578a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="1/6 (16.7)" data-replace=" (16.7)" data-pattern=" $2" data-tag-index="225_1" data-time="" data-username="" data-userid=""> (16.7)</named-content></p></td></tr><tr data-col-count="5" id="0a839eed-30df-462c-9f8d-c604909e089f" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="b36fda92-8ad7-4d6b-890d-a348e4baa2e4" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="331229ae-9ac2-4f66-97a5-c6f9c9a6b68a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> ZnT8 (reference<named-content id="d32da771-dec8-4fe3-bdb8-f93c99a3c5aa" data-cid="d32da771-dec8-4fe3-bdb8-f93c99a3c5aa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣&lt;' to '⍽&lt;'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="15" data-match="reference &amp;lt;15 U/mL" data-replace=" &lt;" data-pattern=" $2" data-tag-index="226_1" data-track-change=" &amp;lt;" data-time="" data-username="" data-userid=""> &lt;</named-content><named-content id="7092bb7e-301c-4b08-ab06-d542f72600a5" data-cid="7092bb7e-301c-4b08-ab06-d542f72600a5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="17" data-match="reference &amp;lt;15 U/mL" data-replace="15" data-pattern="$3" data-tag-index="226_1" data-time="" data-username="" data-userid="">15</named-content><named-content id="f50765e5-f039-439b-8980-78eb70d51cd8" data-cid="f50765e5-f039-439b-8980-78eb70d51cd8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣U/mL' to ' U/mL'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="UNT" data-offset="19" data-match="reference &amp;lt;15 U/mL" data-replace=" U/mL" data-pattern=" $6" data-tag-index="226_1" data-track-change=" U/mL" data-time="" data-username="" data-userid=""> U/mL</named-content>)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="12856fb8-3efc-44e1-a49e-5b9d9657d9da" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="9b277d8b-fcd9-4a6f-88ab-e5cf1a0ce8ee" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="6f88071f-579e-4e0e-bd0f-a04bf0937528" data-cid="6f88071f-579e-4e0e-bd0f-a04bf0937528" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0/4 (0)" data-replace="0/4" data-pattern="$1" data-tag-index="227_1" data-time="" data-username="" data-userid="">0/4</named-content><named-content id="b1291881-667b-4b73-9d61-25276fb20ab4" data-cid="b1291881-667b-4b73-9d61-25276fb20ab4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="0/4 (0)" data-replace=" (0)" data-pattern=" $2" data-tag-index="227_1" data-time="" data-username="" data-userid=""> (0)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="9f7d2d6b-9626-47aa-b79f-f1a027ae1dff" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;1.671875&quot;;&quot;data-left-indent-space&quot;:&quot;1.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="fa713aeb-b400-4389-8549-91e6c6a3451a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="ecb60be4-f2db-49e7-b6c3-8630778c6906" data-cid="ecb60be4-f2db-49e7-b6c3-8630778c6906" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0/4 (0)" data-replace="0/4" data-pattern="$1" data-tag-index="228_1" data-time="" data-username="" data-userid="">0/4</named-content><named-content id="39751f58-d72e-4766-907c-4b457f736f8e" data-cid="39751f58-d72e-4766-907c-4b457f736f8e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="0/4 (0)" data-replace=" (0)" data-pattern=" $2" data-tag-index="228_1" data-time="" data-username="" data-userid=""> (0)</named-content></p></td></tr><tr data-col-count="5" id="546d8447-26fc-4304-a1c3-e3c7a6f211b3"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d3829614-61a8-4c07-b418-89aa19d9cc78" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="22a80a5e-6c0f-4e7f-9916-d49653e1cc58" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Increased pancreas FDG uptake</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e273110b-b016-431e-a35c-9748bca16896" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="63ed489a-7048-4b48-ae22-771d56dca83b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="390aa931-ad12-4a05-8d93-0b86ad25e27f" data-cid="390aa931-ad12-4a05-8d93-0b86ad25e27f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1/9 (11.1)" data-replace="1/9" data-pattern="$1" data-tag-index="230_1" data-time="" data-username="" data-userid="">1/9</named-content><named-content id="eed105d0-b2e7-4cc4-96a7-0ee0b5997740" data-cid="eed105d0-b2e7-4cc4-96a7-0ee0b5997740" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="1/9 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="230_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="5c9f2567-9faf-4d46-b543-d21b378ece8b" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;1.671875&quot;;&quot;data-left-indent-space&quot;:&quot;1.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="a55525d8-d20a-4023-9bee-a16732a3ff68" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="96b6e318-0848-474e-aef8-1e643bca1372" data-cid="96b6e318-0848-474e-aef8-1e643bca1372" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1/5 (20)" data-replace="1/5" data-pattern="$1" data-tag-index="231_1" data-time="" data-username="" data-userid="">1/5</named-content><named-content id="44810ffc-b6ae-4654-9382-f3edc7eb2fb1" data-cid="44810ffc-b6ae-4654-9382-f3edc7eb2fb1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="1/5 (20)" data-replace=" (20)" data-pattern=" $2" data-tag-index="231_1" data-time="" data-username="" data-userid=""> (20)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="46ff51ba-c1d6-4ff6-98be-dd64f4cd9ff8" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;31.953125&quot;;&quot;data-left-indent-space&quot;:&quot;31.953125&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="b8ed8eb7-a360-4fa7-bf89-e240975e678b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="baadec09-ce73-4787-a766-16b18c6196d5" data-cid="baadec09-ce73-4787-a766-16b18c6196d5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0/4 (0)" data-replace="0/4" data-pattern="$1" data-tag-index="232_1" data-time="" data-username="" data-userid="">0/4</named-content><named-content id="ba19f2b2-6fcb-48b1-9ce4-b8f5fae460b4" data-cid="ba19f2b2-6fcb-48b1-9ce4-b8f5fae460b4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="3" data-match="0/4 (0)" data-replace=" (0)" data-pattern=" $2" data-tag-index="232_1" data-time="" data-username="" data-userid=""> (0)</named-content></p></td></tr><tr data-col-count="5" id="5b0acefd-fd40-4349-b86c-2cf588ca35e2" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="a290bd3c-5441-440f-808f-b42b2fe4b7dd" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="90216c47-9d69-4bd2-b4fc-a6f480e0c2b9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545124887" id="a1851085-7e2c-479c-b2b4-571597ac0693" content-type="styrm cts-2" specific-use="1545125983022" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Bold Removed by Varalakshmi (PREEDITOR) - Dec 18 2018 3:09pm" data-track-detail="" data-format-command="bold" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125983022" data-track-hint="Bold Removed">Other IRAE</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="c403b858-dc93-431b-9eea-3ae22ef4afcf" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;6.671875&quot;;&quot;data-left-indent-space&quot;:&quot;6.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="79a5bf41-89d2-43d6-986e-2614553a5aca" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="0ae0896b-83a5-4460-8332-0900d86f0255" data-cid="0ae0896b-83a5-4460-8332-0900d86f0255" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="13 (61.9)" data-replace="13" data-pattern="$1" data-tag-index="234_1" data-time="" data-username="" data-userid="">13</named-content><named-content id="f06ab3bd-b80c-4dc6-83bc-d62d8f09ddf3" data-cid="f06ab3bd-b80c-4dc6-83bc-d62d8f09ddf3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="13 (61.9)" data-replace=" (61.9)" data-pattern=" $2" data-tag-index="234_1" data-time="" data-username="" data-userid=""> (61.9)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="89212d46-3c11-4631-8934-a4b28cdf2306" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="c91148c9-f05e-4803-9c0b-1738c90bbe38" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="8e87f981-0331-4877-a2f8-1f7540733146" data-cid="8e87f981-0331-4877-a2f8-1f7540733146" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="6 (50)" data-replace="6" data-pattern="$1" data-tag-index="235_1" data-time="" data-username="" data-userid="">6</named-content><named-content id="99d051d3-f495-41ef-90fe-efd3b92b7f90" data-cid="99d051d3-f495-41ef-90fe-efd3b92b7f90" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="6 (50)" data-replace=" (50)" data-pattern=" $2" data-tag-index="235_1" data-time="" data-username="" data-userid=""> (50)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="91d4dbb1-18fe-4044-8b34-bb31ba800637" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="03e8865e-c14b-4973-9070-401955c6142e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="020eccd9-91fa-48d3-ab52-3610d833b3d3" data-cid="020eccd9-91fa-48d3-ab52-3610d833b3d3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="7 (77.8)" data-replace="7" data-pattern="$1" data-tag-index="236_1" data-time="" data-username="" data-userid="">7</named-content><named-content id="95185404-8414-4cc5-9ff5-5d5821db861f" data-cid="95185404-8414-4cc5-9ff5-5d5821db861f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="7 (77.8)" data-replace=" (77.8)" data-pattern=" $2" data-tag-index="236_1" data-time="" data-username="" data-userid=""> (77.8)</named-content></p></td></tr><tr data-col-count="5" id="30c4b749-38f7-410c-82aa-f432b6b3be88"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="10eb0546-202a-4a12-82d9-020b9f78a94c" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="abec2135-c7db-47a8-803b-fcc58fcda885" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Thyroiditis</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="8484c089-9666-47d9-944a-b1b109b2a3fb" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;5&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="9e5e3ef8-132a-4268-abe7-bfbb228309a9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="cde223c7-d8fd-4429-9433-beafa0e9fd67" data-cid="cde223c7-d8fd-4429-9433-beafa0e9fd67" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="9 (69.2)" data-replace="9" data-pattern="$1" data-tag-index="238_1" data-time="" data-username="" data-userid="">9</named-content><named-content id="93a1f21f-ac83-4e36-aad8-331899bf5421" data-cid="93a1f21f-ac83-4e36-aad8-331899bf5421" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="9 (69.2)" data-replace=" (69.2)" data-pattern=" $2" data-tag-index="238_1" data-time="" data-username="" data-userid=""> (69.2)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="7cecd364-da64-420f-933f-824308a4f11f" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="e5773a08-5ac3-43b2-bf86-65a581f89496" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="28a4fb4c-0326-4d9c-bb83-b0cd5cfb30e9" data-cid="28a4fb4c-0326-4d9c-bb83-b0cd5cfb30e9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="5 (41.7)" data-replace="5" data-pattern="$1" data-tag-index="239_1" data-time="" data-username="" data-userid="">5</named-content><named-content id="bdc25c55-333a-4e83-87ef-7d9ddfa857b8" data-cid="bdc25c55-333a-4e83-87ef-7d9ddfa857b8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="5 (41.7)" data-replace=" (41.7)" data-pattern=" $2" data-tag-index="239_1" data-time="" data-username="" data-userid=""> (41.7)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="d0480301-1bdc-4ba4-b958-b657a3140324" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="e21b4bc7-d2f6-4193-b22a-ac643f7efce1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="92bd4186-0027-4caf-8ed2-a3779f368b49" data-cid="92bd4186-0027-4caf-8ed2-a3779f368b49" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="4 (44.4)" data-replace="4" data-pattern="$1" data-tag-index="240_1" data-time="" data-username="" data-userid="">4</named-content><named-content id="4955d98f-aa53-46ac-a9e9-0003dfd922a3" data-cid="4955d98f-aa53-46ac-a9e9-0003dfd922a3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="4 (44.4)" data-replace=" (44.4)" data-pattern=" $2" data-tag-index="240_1" data-time="" data-username="" data-userid=""> (44.4)</named-content></p></td></tr><tr data-col-count="5" id="1122bd72-50b5-47c4-b9e1-08b1c2e2b15b" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="bfe79d77-732c-4b0f-9d10-cc7edf55ea66" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="57c091fd-f27a-48cc-b79b-673293590be7" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Hypophysitis</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="9f318010-4060-4ccb-9401-c34be9d5208f" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="02040c79-e8ae-4861-ad83-371fcfaabde5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="8c02f904-ca71-473f-8aae-6e1e7c84a52f" data-cid="8c02f904-ca71-473f-8aae-6e1e7c84a52f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="3 (23.1)" data-replace="3" data-pattern="$1" data-tag-index="242_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="6b359cab-24ec-4307-a69b-3ae1c1046201" data-cid="6b359cab-24ec-4307-a69b-3ae1c1046201" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="3 (23.1)" data-replace=" (23.1)" data-pattern=" $2" data-tag-index="242_1" data-time="" data-username="" data-userid=""> (23.1)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="4ace197b-8c95-4d69-9ee6-30dc55cfab2c" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="0c816737-d845-462a-a440-1b364ecc34ff" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="14c73d69-eb6c-465b-b4f1-f86751a3db4d" data-cid="14c73d69-eb6c-465b-b4f1-f86751a3db4d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (16.7)" data-replace="2" data-pattern="$1" data-tag-index="243_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="0c0097fb-6598-4490-8cca-7228f9a9f219" data-cid="0c0097fb-6598-4490-8cca-7228f9a9f219" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (16.7)" data-replace=" (16.7)" data-pattern=" $2" data-tag-index="243_1" data-time="" data-username="" data-userid=""> (16.7)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="6e934b85-ecb8-4858-92f6-5cc54d2c6106" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="744c61a3-ac32-4ad2-9429-40d596284761" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="9ad0e495-03c5-4832-8680-d6bef5aa920a" data-cid="9ad0e495-03c5-4832-8680-d6bef5aa920a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="244_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="f6806533-bd04-49aa-a1e5-16653d021122" data-cid="f6806533-bd04-49aa-a1e5-16653d021122" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="244_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="bba25604-2e86-4b5e-ba4d-e8993f062ac0"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="99a57a8a-23cb-429f-92cc-d1fd6167dfd1" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="b25f48cd-24f0-40a1-aacb-4cf7f61e1998" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Dermatitis</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="88759cca-6e2c-47f0-b0d0-27bc9e689afb" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="48be578a-c9f5-4e13-912d-7e01d75f12fa" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="9b174c58-f4a4-4442-92f3-85540d2385fc" data-cid="9b174c58-f4a4-4442-92f3-85540d2385fc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="2 (15.4)" data-replace="2" data-pattern="$1" data-tag-index="246_1" data-time="" data-username="" data-userid="">2</named-content><named-content id="98d57753-47b4-4a8a-bee4-05b116df200a" data-cid="98d57753-47b4-4a8a-bee4-05b116df200a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="2 (15.4)" data-replace=" (15.4)" data-pattern=" $2" data-tag-index="246_1" data-time="" data-username="" data-userid=""> (15.4)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="2a85e13b-1162-4697-a53b-fe7d69e7a41b" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="68977e1e-dbf6-4e58-9026-aadba9a3ed6a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="a4573a4e-c4fb-45d4-83d5-d6e58756de16" data-cid="a4573a4e-c4fb-45d4-83d5-d6e58756de16" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="247_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="ae6294c6-2f13-47ce-9553-35c6129a51cb" data-cid="ae6294c6-2f13-47ce-9553-35c6129a51cb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="247_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="20c7e4ad-c8bd-4c2e-a2f5-46b2e9a7082b" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="6a8310c1-c1b9-4df4-b0b9-9d3ebae8c6b4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="90940601-b7b9-4b53-b559-970301294912" data-cid="90940601-b7b9-4b53-b559-970301294912" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="248_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="e8a9bea8-fefd-43ba-a93a-fdd26e93a4bc" data-cid="e8a9bea8-fefd-43ba-a93a-fdd26e93a4bc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="248_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="8f731c38-6898-47da-910e-940125f5de4b" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="cdd681f0-0a5e-4dfd-9dd3-8746d49f965b" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="fd94d258-154a-4427-9e24-314461ac3a78" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Ocular</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="cc6bc9ea-824f-4a3f-8f7c-cc6441c79ad1" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="697a0d28-84fb-4438-9f81-61c917d0ca41" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="dd9fbe35-a721-4fa1-936b-838d6aa7c451" data-cid="dd9fbe35-a721-4fa1-936b-838d6aa7c451" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (7.7" data-replace="1" data-pattern="$1" data-tag-index="250_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="b1d1948c-428a-4027-a60b-71318561cf19" data-cid="b1d1948c-428a-4027-a60b-71318561cf19" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (7.7" data-replace=" (7.7" data-pattern=" $2" data-tag-index="250_1" data-time="" data-username="" data-userid=""> (7.7</named-content>)</p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="610e21f6-6196-4df9-a4f3-340dcff107df" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;51.828125&quot;;&quot;data-left-space&quot;:&quot;8.765625&quot;;&quot;data-left-indent-space&quot;:&quot;8.765625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="fd3bf31a-3a23-4c03-b930-2d727f1e7f31" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4bc3f911-7cd3-42e3-92b0-effcf9dfecad" data-cid="4bc3f911-7cd3-42e3-92b0-effcf9dfecad" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1037_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="ac545bd7-906b-49d4-af94-f1ba879c310c" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="e7c40bc5-931b-4ef3-893d-dec86252ade6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="eef8202c-986e-42c2-97fa-9944944e21fd" data-cid="eef8202c-986e-42c2-97fa-9944944e21fd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="251_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="5449945c-a600-4253-8bc1-464cf0b6a1bb" data-cid="5449945c-a600-4253-8bc1-464cf0b6a1bb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="251_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="ab2930a6-8a61-4194-ac8c-328becd210df"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="c707520c-025c-480e-9578-3d222b3c6e68" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="5e451a7b-97b9-4e95-8a94-9f27d459da00" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Hepatitis</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="c083c94b-b64a-46e5-b911-b261db874573" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="16c8aa20-e411-4ab5-b71a-2f6cc196670a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="a9b0744d-3370-41b4-abfb-b3b315a400c6" data-cid="a9b0744d-3370-41b4-abfb-b3b315a400c6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (7.7" data-replace="1" data-pattern="$1" data-tag-index="253_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="93f42597-90f9-48f6-8fcb-cd5e3b274780" data-cid="93f42597-90f9-48f6-8fcb-cd5e3b274780" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (7.7" data-replace=" (7.7" data-pattern=" $2" data-tag-index="253_1" data-time="" data-username="" data-userid=""> (7.7</named-content>)</p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="4b9c3bb9-0ff6-4fd3-ba3d-6e2aab42b1c2" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;51.828125&quot;;&quot;data-left-space&quot;:&quot;8.765625&quot;;&quot;data-left-indent-space&quot;:&quot;8.765625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="3173af8a-2627-40bf-a70a-f7aeffe4c8fd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="08d0a02d-fe34-4316-a08e-9630189f2cb1" data-cid="08d0a02d-fe34-4316-a08e-9630189f2cb1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1042_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="23a26e6b-dde0-499a-9e3c-9313b541d4df" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="02955b2b-4652-4944-8337-794b4ced649a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="62b122df-9b15-4485-8f71-c6e95d1b789a" data-cid="62b122df-9b15-4485-8f71-c6e95d1b789a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (11.1)" data-replace="1" data-pattern="$1" data-tag-index="254_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="ba1b272a-24b1-4ab7-863c-accf18cb6e87" data-cid="ba1b272a-24b1-4ab7-863c-accf18cb6e87" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (11.1)" data-replace=" (11.1)" data-pattern=" $2" data-tag-index="254_1" data-time="" data-username="" data-userid=""> (11.1)</named-content></p></td></tr><tr data-col-count="5" id="bc04a46f-3d93-4293-b464-f1360b7e79be" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d6b60140-4a68-4eb6-b160-3a941c466cae" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="ef9180ff-aede-4c7b-b1d6-417b3bc7a3a1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Arthritis</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e760ed92-ee3c-4b5e-a938-bbfd1549f7a7" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="2e74ed10-3716-4266-bf44-295f2ce646ab" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="065cc729-5c4b-4bb9-8993-3d5f74a23506" data-cid="065cc729-5c4b-4bb9-8993-3d5f74a23506" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (7.7" data-replace="1" data-pattern="$1" data-tag-index="256_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="7abba510-7c25-4b5c-9da7-04e25fdaa45a" data-cid="7abba510-7c25-4b5c-9da7-04e25fdaa45a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (7.7" data-replace=" (7.7" data-pattern=" $2" data-tag-index="256_1" data-time="" data-username="" data-userid=""> (7.7</named-content>)</p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="d1d7cbd4-c833-4bda-ac2f-e9418dbc8a00" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="9bf5084e-31cf-4903-acfb-7e333a4c367f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="ea4e869c-02b7-4c00-8be2-26113d8a80dc" data-cid="ea4e869c-02b7-4c00-8be2-26113d8a80dc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="257_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="f018ce4c-96b4-492c-b29f-2c7f0b9050ed" data-cid="f018ce4c-96b4-492c-b29f-2c7f0b9050ed" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="257_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="4a2102c8-ddae-47ac-b159-cfca9aa039b3" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;53.421875&quot;;&quot;data-left-space&quot;:&quot;39.046875&quot;;&quot;data-left-indent-space&quot;:&quot;39.046875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="14a38ec7-6c10-40db-bf1f-7d46beab5103" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="74f133d0-e929-4104-917c-534b95508d16" data-cid="74f133d0-e929-4104-917c-534b95508d16" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1048_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td></tr><tr data-col-count="5" id="20dcec1e-f380-4340-a0dd-477de629ca7c"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="30f6eaf2-43ba-46ca-9f77-03abe5fa772d" valign="top" colspan="4" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;colspan&quot;:&quot;4&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="39d9fb5e-e639-4b65-be1c-3e01d8e8f3e4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545124888" id="1730bc61-904d-4c92-a137-4a2a06f93179" content-type="styrm cts-2" specific-use="1545125987834" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Bold Removed by Varalakshmi (PREEDITOR) - Dec 18 2018 3:09pm" data-track-detail="" data-format-command="bold" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125987834" data-track-hint="Bold Removed">Diabetes therapy at latest follow-up visit</named-content></p> </td></tr><tr data-col-count="5" id="49791c5a-56ee-4ea4-95a3-fa0b6fb6723d" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="dbbb7f96-36db-4f88-85ed-97633823cb50" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;colspan&quot;:&quot;4&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="607bf32d-f8ee-4d19-916d-650e105a9584" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> <named-content id="28c3e518-1370-46f7-b9aa-30bfc29cddab" data-cid="28c3e518-1370-46f7-b9aa-30bfc29cddab" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAR" data-offset="0" data-match="MDI +/- oral" data-replace="MDI" data-pattern="$1" data-tag-index="259_1" data-time="" data-username="" data-userid="">MDI<named-content id="995f72af-d0be-433d-9b3e-74a3d3d6c7e6" data-cid="1545438217033" content-type="ins cts-1" specific-use="1545438217033" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:23am" data-track-detail="" data-username="PV-A027-Ariel (COPYEDITOR)" data-userid="copyeditor 3519816058" data-time="1545438217033">±</named-content></named-content><named-content id="2a0db36f-ac24-409c-ab55-98ed14ab0815" data-cid="2a0db36f-ac24-409c-ab55-98ed14ab0815" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣+/-␣' to '+/-'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="3" data-match="MDI +/- oral" data-replace="+/-" data-pattern="$2" data-tag-index="259_1" data-track-change=" +/- " data-time="" data-username="" data-userid=""><named-content data-cid="1545433442" id="7f182ca0-788c-4eec-8c61-2911349bb29d" content-type="del cts-3" specific-use="1545438220958" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438220958">+/-</named-content></named-content>oral agent<span data-class="jrnlDeleted" id="a3259cde-12fd-43b5-99d6-62861278eb41" data-track="del" data-modified="Remove empty tag"/><span data-class="jrnlDeleted" id="7bd35178-c450-482a-9354-89a8bbec2648" data-track="del" data-modified="Remove empty tag"/></p> </td><td data-class="" id="20fe8459-94d4-4345-a197-e76538357590" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align,valign,data-col-index" align="left" valign="top" data-col-index="2"><p id="4b48d1f7-06f8-4209-930d-016e056ddd2c">19 (90.5)</p></td><td data-class="" id="9bf704e9-7d0f-4b0b-a55c-139523ac7c97" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align,valign,data-col-index" align="left" valign="top" data-col-index="3"><p id="7b79a7d7-c69a-423d-85e4-7792c4793fd3">11 (91.7)</p></td><td data-class="" id="406a8df9-b795-4a8c-8353-dca4e1b25dd6" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align,valign,data-col-index" align="left" valign="top" data-col-index="4"><p id="afd1f4b5-bd68-4d4d-8224-d5b8dcb8a469">7 (77.8)</p></td></tr><tr data-col-count="5" id="6730f94f-e84d-48c4-925e-ec6e1e0040ed"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="3942e3ca-0f36-4e8e-82ec-2b664e3de16f" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="61622d13-71f7-461a-9df3-c2e5c7bce8c2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Basal insulin<named-content data-cid="1545433443" id="31668fea-919a-4d3a-8634-77d35a189d67" content-type="ins cts-3" specific-use="1545438226121" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438226121">±</named-content><named-content id="66c83b9c-1c21-4eb8-908c-ea1e077ad637" data-cid="66c83b9c-1c21-4eb8-908c-ea1e077ad637" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣+/-␣' to '⍽+/-'" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="13" data-match="insulin +/- oral" data-replace=" +/-" data-pattern=" $2" data-tag-index="260_1" data-track-change=" +/- " data-time="" data-username="" data-userid=""><named-content data-cid="1545433444" id="15ba8c73-b86d-4a5f-8d5f-e846fcc71666" content-type="del cts-3" specific-use="1545438228077" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438228077"> +/-</named-content></named-content>oral agent</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="90226517-a2a2-4cb7-a834-7c29767efa43" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;6.671875&quot;;&quot;data-left-indent-space&quot;:&quot;6.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="b2162fb8-a09e-42b7-a64f-270456d4d3b3"><named-content rid="1db2dae9-7091-415b-a108-2f1ac322d1a5" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="typesetter" data-query-from="publisher" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" id="a2d9dd7e-ebe0-414c-b215-64b013c37f29" content-type="jrnlQueryRef" specific-use="start" data-answered="true" data-replied="true"/>1 (4.8)</p></td><td data-class="" data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="557c558e-f87a-46bb-90c1-87d6d75f1338" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="d44b41bb-23dd-4d28-8689-8e377d40ee74" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="b3751708-d709-4e3b-ab96-8356c1a99eb2" data-cid="b3751708-d709-4e3b-ab96-8356c1a99eb2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="11 (91.7)" data-replace="11" data-pattern="$1" data-tag-index="262_1" data-time="" data-username="" data-userid=""><named-content rid="10a42f4e-b804-46de-9104-13a90ca9970f" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="publisher" data-query-from="author" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" content-type="jrnlQueryRef" specific-use="start" id="e317a742-edaa-4e35-b552-8a97c09f29b0" data-answered="true"/></named-content><named-content id="757534e1-fc7f-44a7-95d4-bd39c1b7c1fc" data-cid="757534e1-fc7f-44a7-95d4-bd39c1b7c1fc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="2" data-match="11 (91.7)" data-replace=" (91.7)" data-pattern=" $2" data-tag-index="262_1" data-time="" data-username="" data-userid="">0 (0)</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="a9a70f18-8bed-4de6-8c42-afd83f89d6cb" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;undefined&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="2996e9f0-249a-4459-b942-f5959ba28630" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><span data-class="jrnlDeleted" id="20dbbacc-1136-420f-828b-7e6df4b68816" data-cid="20dbbacc-1136-420f-828b-7e6df4b68816" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="7 (77.8)" data-replace="7" data-pattern="$1" data-tag-index="263_1" data-time="" data-username="" data-userid="" data-track="del" data-modified="Remove empty tag"/><named-content id="94abbaa5-c296-4855-a7e2-07017e6905b1" data-cid="94abbaa5-c296-4855-a7e2-07017e6905b1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="7 (77.8)" data-replace=" (77.8)" data-pattern=" $2" data-tag-index="263_1" data-time="" data-username="" data-userid="">2 (22.2)</named-content></p></td></tr><tr data-col-count="5" id="22b8a771-7162-4410-8276-64406f09cc93" data-fill="true"><td data-class="" data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="6de1c237-6605-4207-9430-09af11758f49" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="1e75346b-defd-4d9f-aa8f-1efef9ddef44" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"> Insulin pump</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="10994cc1-61b1-4b40-87dd-2f20330837cd" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;5&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="f4485d39-6763-48e5-b34f-d527dab3d4bd" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="4a71cc62-2bae-4db8-b1cb-06bbe1fafb4e" data-cid="4a71cc62-2bae-4db8-b1cb-06bbe1fafb4e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (4.8)" data-replace="1" data-pattern="$1" data-tag-index="265_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="a28c7706-e1c3-46fd-a484-9872fc831682" data-cid="a28c7706-e1c3-46fd-a484-9872fc831682" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (4.8)" data-replace=" (4.8)" data-pattern=" $2" data-tag-index="265_1" data-time="" data-username="" data-userid=""> (4.8)</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="778ca3cf-7f8f-41f7-8758-6aeaaba052a2" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;5&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="906a2cba-19e3-4174-ab8c-34de5d637f2e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="21dfc847-f937-4ecc-bdfb-c2d36d8bf4bf" data-cid="21dfc847-f937-4ecc-bdfb-c2d36d8bf4bf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="0 (0)" data-replace="0" data-pattern="$1" data-tag-index="266_1" data-time="" data-username="" data-userid=""><named-content rid="776da93c-0d13-4ce8-aa68-ae8b919ec054" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="publisher" data-query-from="author" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" content-type="jrnlQueryRef" specific-use="start" id="2b9f3b5a-5822-4f89-9898-48d089ec9ba9" data-answered="true"/>1 (8.3)</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="b9f0f1b3-1ec9-434a-ac66-54ab96d18050" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="1894863d-3bc5-420f-a5e1-c503a4fc9eb8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align">0 (0)</p></td></tr><tr data-col-count="5" id="21a518de-fc04-4353-bc17-59aaaa5c41ce"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="5ccaf3c8-c074-4278-9139-67dd8de68798" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="d92e6ed2-1bdc-41f9-ab98-4b14876d1f69" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545113216104" id="47a1e7a0-aaf5-411d-9e31-1225cef50029" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">Follow up</named-content><named-content id="7542ff38-9208-4799-a8fd-c640eab04c1c" data-cid="1545113216104" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'Follow␣up' to 'Follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="0" data-match="Follow up" data-replace="Follow-up" data-pattern="Follow-up" data-tag-index="271_1" data-function="addTrackChanges" data-track-change="Follow up" data-userid="preediting" data-username="Exeter" data-time="1545113216002">Follow-up</named-content> duration after ICI start (months)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="8320f00e-d9c8-4186-8ef0-03033c8b336c" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;53.421875&quot;;&quot;data-left-space&quot;:&quot;6.671875&quot;;&quot;data-left-indent-space&quot;:&quot;6.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="ab2e7f0d-14bb-4497-abcc-c1f10d221b8d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="17c2e4ec-24e4-49c5-ae34-5a0183f59326" data-cid="17c2e4ec-24e4-49c5-ae34-5a0183f59326" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="17.9 (10.4 – 28.3)" data-replace="17.9 " data-pattern="$1 " data-tag-index="272_1" data-time="" data-username="" data-userid="">17.9 </named-content><named-content id="e106de7a-8c7f-4129-9caa-d48b42f667d6" data-cid="e106de7a-8c7f-4129-9caa-d48b42f667d6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="5" data-match="17.9 (10.4 – 28.3)" data-replace="(10.4" data-pattern="$2" data-tag-index="272_1" data-time="" data-username="" data-userid="">(10.4</named-content><named-content id="af9e6359-ab9b-4960-ad30-1c2b3ebda61a" data-cid="af9e6359-ab9b-4960-ad30-1c2b3ebda61a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="10" data-match="17.9 (10.4 – 28.3)" data-replace="–" data-pattern="–" data-tag-index="272_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="dd72dcc1-236d-42f0-a3a0-58a19edc7c0c" data-cid="dd72dcc1-236d-42f0-a3a0-58a19edc7c0c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="15" data-match="17.9 (10.4 – 28.3)" data-replace="28.3)" data-pattern="$4" data-tag-index="272_1" data-time="" data-username="" data-userid="">28.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="a4ce1d7a-3cd9-4c2e-89f1-561974664ba1" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;51.828125&quot;;&quot;data-left-space&quot;:&quot;4.171875&quot;;&quot;data-left-indent-space&quot;:&quot;4.171875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="49a007b5-92fc-43d0-a5f7-99ef4dd0ddf8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="c5bd13d9-1be7-4f69-adff-36bdc79f4524" data-cid="c5bd13d9-1be7-4f69-adff-36bdc79f4524" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="12.9 (10.4 – 24.3)" data-replace="12.9 " data-pattern="$1 " data-tag-index="273_1" data-time="" data-username="" data-userid="">12.9 </named-content><named-content id="f168e624-79a7-422b-8299-b7c4eb25a170" data-cid="f168e624-79a7-422b-8299-b7c4eb25a170" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="5" data-match="12.9 (10.4 – 24.3)" data-replace="(10.4" data-pattern="$2" data-tag-index="273_1" data-time="" data-username="" data-userid="">(10.4</named-content><named-content id="c9d9c32b-9b2d-4925-9d4d-ba98c6178982" data-cid="c9d9c32b-9b2d-4925-9d4d-ba98c6178982" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="10" data-match="12.9 (10.4 – 24.3)" data-replace="–" data-pattern="–" data-tag-index="273_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="08662299-2ae7-4fbe-98ed-ba52b92a7984" data-cid="08662299-2ae7-4fbe-98ed-ba52b92a7984" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="15" data-match="12.9 (10.4 – 24.3)" data-replace="24.3)" data-pattern="$4" data-tag-index="273_1" data-time="" data-username="" data-userid="">24.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="7906474f-a119-4d8d-b452-5b2a3ad5e09d" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;34.453125&quot;;&quot;data-left-indent-space&quot;:&quot;34.453125&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="f314548a-601d-4e36-b12c-46eeb82a1b1e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="01eb28e0-d423-4306-b12a-8b6f73e016f9" data-cid="01eb28e0-d423-4306-b12a-8b6f73e016f9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="26 (14.8 – 30.7)" data-replace="26 " data-pattern="$1 " data-tag-index="274_1" data-time="" data-username="" data-userid="">26 </named-content><named-content id="bd9a7c0a-1103-4a22-a653-af85675f2ffa" data-cid="bd9a7c0a-1103-4a22-a653-af85675f2ffa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="3" data-match="26 (14.8 – 30.7)" data-replace="(14.8" data-pattern="$2" data-tag-index="274_1" data-time="" data-username="" data-userid="">(14.8</named-content><named-content id="4bf34a0f-a50a-4c62-8ce8-6e08d2c9395a" data-cid="4bf34a0f-a50a-4c62-8ce8-6e08d2c9395a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="26 (14.8 – 30.7)" data-replace="–" data-pattern="–" data-tag-index="274_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="c9fe3e25-a44f-4894-97f3-c614ad4f14ff" data-cid="c9fe3e25-a44f-4894-97f3-c614ad4f14ff" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="26 (14.8 – 30.7)" data-replace="30.7)" data-pattern="$4" data-tag-index="274_1" data-time="" data-username="" data-userid="">30.7)</named-content></p></td></tr><tr data-col-count="5" id="ca8724bb-8cd6-4fd1-a70b-a61fa2883403" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="326929ee-b0db-4c41-9323-238fd0027d28" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="64825179-4342-462f-8295-d8c40751ff24" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545113216105" id="cc719b1b-b5ca-41b8-838c-329ba8ca0245" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">Follow up</named-content><named-content id="259ef92d-8428-455e-859f-24a6a337bd73" data-cid="1545113216105" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'Follow␣up' to 'Follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="0" data-match="Follow up" data-replace="Follow-up" data-pattern="Follow-up" data-tag-index="275_1" data-function="addTrackChanges" data-track-change="Follow up" data-userid="preediting" data-username="Exeter" data-time="1545113216002">Follow-up</named-content> duration after diagnosis (months)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="cf26e240-1279-4c69-9c41-e5d6d7fbb4c2" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;5&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;53.421875&quot;;&quot;data-left-space&quot;:&quot;6.671875&quot;;&quot;data-left-indent-space&quot;:&quot;6.671875&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="8b903b75-2ba9-4d1e-bf16-25e91465597b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="affc02a1-87c4-44cd-b67d-18c43339734b" data-cid="affc02a1-87c4-44cd-b67d-18c43339734b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="12.5 (5.3 – 20.7)" data-replace="12.5 " data-pattern="$1 " data-tag-index="276_1" data-time="" data-username="" data-userid="">12.5 </named-content><named-content id="babefec7-2e90-4461-b872-d10030ede225" data-cid="babefec7-2e90-4461-b872-d10030ede225" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="5" data-match="12.5 (5.3 – 20.7)" data-replace="(5.3" data-pattern="$2" data-tag-index="276_1" data-time="" data-username="" data-userid="">(5.3</named-content><named-content id="b62de909-207e-42ff-906d-05c176e9c305" data-cid="b62de909-207e-42ff-906d-05c176e9c305" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="9" data-match="12.5 (5.3 – 20.7)" data-replace="–" data-pattern="–" data-tag-index="276_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="d1a8891e-1e78-4932-a207-ef416dc07297" data-cid="d1a8891e-1e78-4932-a207-ef416dc07297" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="14" data-match="12.5 (5.3 – 20.7)" data-replace="20.7)" data-pattern="$4" data-tag-index="276_1" data-time="" data-username="" data-userid="">20.7)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="0aa9c004-4129-4cc9-b6fb-c872c1752fc0" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;5&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;51.828125&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="668731d6-47ae-402c-bcd1-e16994fe4e14" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="0ac12c02-d473-4aaf-800e-e6ba026392df" data-cid="0ac12c02-d473-4aaf-800e-e6ba026392df" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="9.7 (3.9 – 12.9)" data-replace="9.7 " data-pattern="$1 " data-tag-index="277_1" data-time="" data-username="" data-userid="">9.7 </named-content><named-content id="2fe8abf5-a91c-4934-8390-31d59d3658e4" data-cid="2fe8abf5-a91c-4934-8390-31d59d3658e4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="4" data-match="9.7 (3.9 – 12.9)" data-replace="(3.9" data-pattern="$2" data-tag-index="277_1" data-time="" data-username="" data-userid="">(3.9</named-content><named-content id="c1631e12-6ef5-4937-9494-c9c2277d0a5c" data-cid="c1631e12-6ef5-4937-9494-c9c2277d0a5c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="8" data-match="9.7 (3.9 – 12.9)" data-replace="–" data-pattern="–" data-tag-index="277_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="a7f1183a-8a17-4f8e-93c6-269ea94f6a72" data-cid="a7f1183a-8a17-4f8e-93c6-269ea94f6a72" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="13" data-match="9.7 (3.9 – 12.9)" data-replace="12.9)" data-pattern="$4" data-tag-index="277_1" data-time="" data-username="" data-userid="">12.9)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="daca31f4-18e2-48b6-b13f-33d6aa773a6a" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;5&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;53.421875&quot;;&quot;data-left-space&quot;:&quot;34.453125&quot;;&quot;data-left-indent-space&quot;:&quot;34.453125&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="81ff117d-f799-4e2d-b781-ed3b34c1eaf0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="abec7036-bf17-4ad0-a31e-05fb74181055" data-cid="abec7036-bf17-4ad0-a31e-05fb74181055" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="VAL" data-offset="0" data-match="17.2 (9.7 – 23.7)" data-replace="17.2 " data-pattern="$1 " data-tag-index="278_1" data-time="" data-username="" data-userid="">17.2 </named-content><named-content id="aec5879e-2e82-4795-a9d2-94918ee12fdb" data-cid="aec5879e-2e82-4795-a9d2-94918ee12fdb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="5" data-match="17.2 (9.7 – 23.7)" data-replace="(9.7" data-pattern="$2" data-tag-index="278_1" data-time="" data-username="" data-userid="">(9.7</named-content><named-content id="77af7fcb-b42a-4038-9970-86a22b8fe80d" data-cid="77af7fcb-b42a-4038-9970-86a22b8fe80d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="9" data-match="17.2 (9.7 – 23.7)" data-replace="–" data-pattern="–" data-tag-index="278_1" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="053c49ce-81f3-4bbc-9230-882a657e47ab" data-cid="053c49ce-81f3-4bbc-9230-882a657e47ab" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="14" data-match="17.2 (9.7 – 23.7)" data-replace="23.7)" data-pattern="$4" data-tag-index="278_1" data-time="" data-username="" data-userid="">23.7)</named-content></p></td></tr><tr data-col-count="5" id="7f876b58-331b-4a9c-9102-c46f982daaeb"><td data-original-border="border:solid windowtext 1.0pt;border-top: none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="fbf544b3-d3d7-4b26-b007-763424befe32" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="a946d1de-365b-47e7-8906-c3a62ad8738a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Deaths (all from cancer)</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="5b15a7f1-9010-4009-bedd-f1836a227e54" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;;&quot;data-left-indent&quot;:&quot;5&quot;;&quot;data-align-left-width&quot;:&quot;15.015625&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;10.84375&quot;;&quot;data-left-indent-space&quot;:&quot;10.84375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="ad6dd990-85a6-48ad-8f12-96ce0a84f4b6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="555ba08b-2856-4614-a079-d20a49ea0ea7" data-cid="555ba08b-2856-4614-a079-d20a49ea0ea7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="4 (19)" data-replace="4" data-pattern="$1" data-tag-index="280_1" data-time="" data-username="" data-userid="">4</named-content><named-content id="ef93f6d5-e1c8-4db6-8951-cf41f183b77a" data-cid="ef93f6d5-e1c8-4db6-8951-cf41f183b77a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="4 (19)" data-replace=" (19)" data-pattern=" $2" data-tag-index="280_1" data-time="" data-username="" data-userid=""> (19)</named-content></p></td><td data-original-border="border-top:none;border-left:none;border-bottom: solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="502661a6-d0d2-4db7-ba07-d90d5de4db7d" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;;&quot;data-left-indent&quot;:&quot;10&quot;;&quot;data-align-left-width&quot;:&quot;12.515625&quot;;&quot;data-align-right-width&quot;:&quot;49.75&quot;;&quot;data-left-space&quot;:&quot;8.34375&quot;;&quot;data-left-indent-space&quot;:&quot;8.34375&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="8c2ab11c-c52b-436d-bae0-c0aaa79cffff" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="a3a1575a-7a46-4b31-a796-201a976c2eaa" data-cid="a3a1575a-7a46-4b31-a796-201a976c2eaa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="1 (8.3)" data-replace="1" data-pattern="$1" data-tag-index="281_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="3422bb59-3409-4c56-ac4a-413a7a5128cf" data-cid="3422bb59-3409-4c56-ac4a-413a7a5128cf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="1 (8.3)" data-replace=" (8.3)" data-pattern=" $2" data-tag-index="281_1" data-time="" data-username="" data-userid=""> (8.3)</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="274bf870-1650-4b54-aea6-10d53ffa8f64" data-auto-align="true" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;;&quot;data-left-indent&quot;:&quot;5&quot;;&quot;data-align-left-width&quot;:&quot;42.796875&quot;;&quot;data-align-right-width&quot;:&quot;51.34375&quot;;&quot;data-left-space&quot;:&quot;38.625&quot;;&quot;data-left-indent-space&quot;:&quot;38.625&quot;;&quot;align&quot;:&quot;left&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" align="left"><p id="c6449a43-964f-44c1-9a7f-608fb4df920f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;" data-old-attributes="&quot;align&quot;:&quot;undefined&quot;;" data-changed-attributes="align"><named-content id="c70ae06e-0b3e-4ff8-9dd6-150a0ff773bd" data-cid="c70ae06e-0b3e-4ff8-9dd6-150a0ff773bd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="0" data-match="3 (33.3)" data-replace="3" data-pattern="$1" data-tag-index="282_1" data-time="" data-username="" data-userid="">3</named-content><named-content id="93c2cbc2-342f-4d11-ab13-ecaa0fb9a563" data-cid="93c2cbc2-342f-4d11-ab13-ecaa0fb9a563" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1" data-match="3 (33.3)" data-replace=" (33.3)" data-pattern=" $2" data-tag-index="282_1" data-time="" data-username="" data-userid=""> (33.3)</named-content></p></td></tr></tbody></table><table-wrap-foot id="8727d87a-bd9b-4aa7-b5b3-f4be5f248509"><fn data-class="jrnlTblFoot" data-id="T2_FN1" fn-type="linked-fn" id="3a81c9c3-d289-4c77-8782-a6f6c2bb7d47"><label data-class="jrnlFNLabel" id="6aab1471-db24-45d2-8ef6-e23152a93b89">*</label><p id="91a7df5b-a02f-4fae-a557-74ec122701f4"><named-content data-cid="1545124882" id="4d2276d1-5683-4dd0-94d9-1741787cdc9a" content-type="ins cts-2" specific-use="1545125450949" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:00pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545125450949">n=1 had concomitant hyperglycemic hyperosmolar state.</named-content></p></fn><fn data-class="jrnlTblFoot" fn-type="abbrev" data-def-list="true" id="bd52c67d-f873-4349-ac49-bb877d7ac8d6"><p id="224e79a4-eb2e-433a-b2cf-db40f1d3680c"><def-list id="ff85adf2-0306-47bd-a1f3-6910d02122ae"><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="37dffaa8-c00c-47d6-8ae1-5172b7f4b7a2" fn-type="abbrev" data-id="T2_FN2"><term data-class="jrnlAbbrevTerm" id="5a552842-939e-4620-823d-ab67646bd0d3">FPG</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="a9677622-7d69-46aa-abcd-70e3ec178ae3"><p id="9e53eac9-0df4-4ed8-9666-499e3f7f5c63">fasting plasma glucose</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="4d16fc68-cbd9-4475-a0da-b10d9e4b9760" fn-type="abbrev" data-id="T2_FN2"><term data-class="jrnlAbbrevTerm" id="ffc5f3dc-6368-4cbd-b6b5-b6e389fc0901">HbA1c</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="d9afb2c1-b296-40a8-b22e-4dce1d6a4c61"><p id="cc65a8ec-7052-41e7-b254-eb53f2c666b8">hemoglobin A1c</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="9585b3b9-8dba-4581-a961-edbefcd76437" fn-type="abbrev" data-id="T2_FN2"><term data-class="jrnlAbbrevTerm" id="31592eb5-2dce-4ddd-a8a5-0480c1f913c5">ICI</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="20f66b3b-f9b9-4874-b2c1-cc117a8f45c7"><p id="deedf131-ef04-4b79-80ba-8fa32b2b5adf">immune checkpoint inhibitor</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="a55ccd20-063c-4013-a739-66b57447a54f" fn-type="abbrev" data-id="T2_FN2"><term data-class="jrnlAbbrevTerm" id="1f3ef37b-78f4-4071-a274-5ea29bfb7cd7">PD-1</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="249fec48-23a1-477f-8c42-7748c9f1b038"><p id="c270b917-3ca3-4db9-90f5-a56065ee08cb">programmed cell death protein 1</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="c53e885e-a8b8-49f7-b15c-23f345d089c2" fn-type="abbrev" data-id="T2_FN2"><term data-class="jrnlAbbrevTerm" id="ea9e2f32-5506-4721-94a2-c1569a42cc50">RPG</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="c6f8b3bc-36db-43fa-b073-16d26ef4a825"><p id="1e5ce396-ae0c-404b-b2d5-3f8470a7d1cd">random plasma glucose</p></def>.</def-item></def-list></p></fn></table-wrap-foot></table-wrap><table-wrap id="BLK_T3" data-id="BLK_T3" data-stream-name="a_T3" position="float"><label id="258cb92a-258f-4bfd-9fc1-f363c80abf13"><named-content data-cid="1546365745982" id="a0e5480a-ff34-4891-82eb-861a2deed976" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Table 3</named-content></label><caption id="3ef73d1b-733e-40b9-af4c-33ff9c98c7ed"><title id="T3" data-id="T3">Disease characteristics and course of individual <named-content id="0131b123-7756-4e6b-a4b8-0752ab175c16" data-cid="0131b123-7756-4e6b-a4b8-0752ab175c16" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="58" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="375_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content><named-content data-cid="1545113216123" id="5d78272d-959e-4b5b-a9bb-dec316c675ba" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002" data-reason="truecase"> with PD-1 inhibitor induced new-onset insulin-dependent diabetes. RPG: random plasma glucose; FPG: fasting plasma glucose; HbA1c: hemoglobin A1c.</named-content><named-content data-cid="1545113216123" id="96aa3776-6a16-4da4-953e-f8ed784b8889" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002" data-reason="truecase"> with PD-1 inhibitor induced new-onset insulin-dependent diabetes<named-content data-cid="1545124889" id="0b713f99-bf7f-4645-a5a8-e33ac0232020" content-type="del cts-2" specific-use="1545126124844" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:12pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545126124844">. RPG: random plasma glucose; Fpg: fasting plasma glucose; HbA1c: hemoglobin A1c.</named-content></named-content></title></caption><table data-col-count="10" id="t2_1" data-caption-link="T2" data-col-widths-px="24,28,65,80,151,54,65,100,58,65.851" data-table-type="landScape" data-old-attributes="&quot;data-table-type&quot;:&quot;doubleColumn&quot;;&quot;data-col-widths-px&quot;:&quot;15.4,23.4,75.4,56.4,64.4,48.4,60.4,52.4,64.4,50.4&quot;;&quot;data-font-size&quot;:&quot;8px&quot;" data-changed-attributes="data-table-type,data-col-widths-px,data-font-size" data-font-size="8px"><thead id="d6767d24-f0b0-4b7f-aeb1-0d09a1a20f39" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;" data-changed-attributes="data-font-size" data-font-size="8px"><tr data-col-count="10" id="10460f6b-e000-407f-a167-250eb79c2669"><td data-original-border="border:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="7e2918b2-7c32-46d9-8f07-9babd12eec21" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="d53dc065-b731-4eba-b078-429e551e6303" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pt</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="d9d7ee65-642f-43e4-9dc6-49bf84de14b8" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="625bd8b4-49c3-4a03-bc17-d3e36c3a9873" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">BMI</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="1c1cf0a7-2db0-49fa-9aa1-605f0f62d9de" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="219ea3ea-10ad-4874-822a-688c4a7bb3c6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">ICI</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="de97bd58-245d-43c9-b436-2dce9b01c796" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="d29991f7-9ac2-445d-8423-df5669f79a81" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pre-ICI laboratory data</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="39a8634e-39f6-4224-9238-f349dc50602a" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="8c11bc01-fe79-4336-8138-6f328d8f7c14" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Presentation</p></td><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="6e59e12d-e67b-46e6-89f3-5e277c198015" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;6&quot;"><p id="9cee5111-7d92-44d2-918d-5ab3cebee7af" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545433794" id="64fdc65e-d2f8-4177-b119-7d4f08e07dac" content-type="del cts-3" specific-use="1545441640451" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:20am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441640451">c</named-content><named-content data-cid="1545433795" id="c4c509de-ad73-442c-98c1-9f5967a0c8c3" content-type="ins cts-3" specific-use="1545441640650" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:20am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441640650">C</named-content>-peptide (ng/mL), PG (mg/dL)</p></td><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="a8b90a1e-a508-48f8-97cf-72108d8efbbd" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="02853b72-a841-4e06-8ab0-9a00ad3cbde9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Doses/</p><p id="84c3fd44-3c18-4f9d-bf92-7c70c0149d78" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545433800" id="c86b1bdc-658d-48f2-8e45-6f3b44e54f23" content-type="del cts-3" specific-use="1545441682137" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:21am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441682137">T</named-content><named-content data-cid="1545433801" id="98b3b9bc-2fce-4ae7-aa05-123d2114ad23" content-type="ins cts-3" specific-use="1545441682541" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:21am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441682541">t</named-content>ime (mo<named-content data-cid="1545433796" id="a1f6b865-4c3f-4816-a395-6680a2db4972" content-type="ins cts-3" specific-use="1545441644653" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:20am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441644653">nths</named-content>) to presentation</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="51a8c580-1b02-460c-99e5-723afaa21e5b" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="fa61c349-468d-4f73-8626-b8bc01a3712d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Antibodies</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="44ccfa62-0895-4448-8f4d-1636b3aeb968" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="bacc2736-bd7c-4943-bbe7-8eb25ca1eae9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Other IRAE</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="ac2714d2-4858-47de-9db9-77139db031dd" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="3ae48cee-13e8-4ee4-b163-f4711ae68af3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Therapy</p></td></tr></thead><tbody id="8a23a581-d6bf-49e5-b501-f50cf019d708" data-old-attributes="&quot;data-font-size&quot;:&quot;undefined&quot;;" data-changed-attributes="data-font-size" data-font-size="8px"><tr data-col-count="10" id="60236d9d-2d1a-4406-84db-d26e6b711a90" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="36941724-4ad0-4a86-a86d-7b58c79f578a" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="f5d4836e-c7d8-496f-bf58-d61b64b8974b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">1</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="53dbbfd1-4ba7-4c32-8f61-ea6b3c271e7e" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="323d8533-3c1e-40d0-a99e-9d7dbeaab87b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">25</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="3222de98-595e-43be-abe2-ac2b0c44480c" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="2d6ac6b1-b67b-43f9-b649-6f861731c451" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="3b1c89e5-e72a-42d8-b4ff-91e5b21afcb3" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="a6fa0207-5cf2-4d8d-8aa4-5f7061a707a8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="2bc91b3d-a21e-405c-a9c7-6ed8e1ccae86" data-cid="2bc91b3d-a21e-405c-a9c7-6ed8e1ccae86" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="95 mg/dL" data-replace="95" data-pattern="$1" data-tag-index="295_1" data-time="" data-username="" data-userid="">95</named-content><named-content id="0e38dce6-a9a2-4187-8080-19fa9e9b3464" data-cid="0e38dce6-a9a2-4187-8080-19fa9e9b3464" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="6" data-match="95 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="295_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG <named-content id="f3df45d3-af51-4538-aa24-1bd0f87afab3" data-cid="f3df45d3-af51-4538-aa24-1bd0f87afab3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="18" data-match="96 mg/dL" data-replace="96" data-pattern="$1" data-tag-index="295_2" data-time="" data-username="" data-userid="">96</named-content><named-content id="d6f7b673-276c-4210-ae61-8f6d629491bd" data-cid="d6f7b673-276c-4210-ae61-8f6d629491bd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="20" data-match="96 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="295_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433802" id="1446a02d-7351-468b-a5eb-76a0e1f24823" content-type="ins cts-3" specific-use="1545441697966" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:21am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441697966">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="af966f71-b50b-45da-97d8-d0d4b944b2f6" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="9d8e5749-09c7-4370-812d-3f14f6921be5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><bold id="8766b105-4245-41ab-9931-a9e117608ef0">Mild DKA</bold>: RPG <named-content id="007b1750-e181-4d7b-873f-8a0c3fcb35f8" data-cid="007b1750-e181-4d7b-873f-8a0c3fcb35f8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="14" data-match="580 mg/dL" data-replace="580" data-pattern="$1" data-tag-index="296_1" data-time="" data-username="" data-userid="">580</named-content><named-content id="c374895a-cde9-4edc-bf8e-c9c4dc510656" data-cid="c374895a-cde9-4edc-bf8e-c9c4dc510656" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="17" data-match="580 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="296_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 8.6%, urine ketone 40, <named-content data-cid="1545433874" id="c0bb3008-9554-4bbb-9dda-4bfbcf982ce7" content-type="ins cts-3" specific-use="1545442314607" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:31am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442314607">and </named-content>β-OHB <named-content id="c3bee0d6-ce6c-4844-b77b-052ce18eb324" data-cid="c3bee0d6-ce6c-4844-b77b-052ce18eb324" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="61" data-match="1.3 mmol/L" data-replace="1.3" data-pattern="$1" data-tag-index="296_2" data-time="" data-username="" data-userid="">1.3</named-content><named-content id="43dca0c3-0800-4493-bfa7-a0fbe5a69b64" data-cid="43dca0c3-0800-4493-bfa7-a0fbe5a69b64" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/L' to ' mmol/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="64" data-match="1.3 mmol/L" data-replace=" mmol/L" data-pattern=" $2" data-tag-index="296_2" data-track-change=" mmol/L" data-time="" data-username="" data-userid=""> mmol/L<named-content data-cid="1545433803" id="aeaabea4-615d-46a3-a6de-edb53b8627d1" content-type="ins cts-3" specific-use="1545441706449" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:21am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441706449">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="58e062a3-0127-4b0f-a8b0-746d8ce49534" data-auto-align="true" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" data-align="." data-align-left-width="9.25" data-align-right-width="24.46875" data-left-space="4.796875" data-left-indent-space="4.796875"><p id="248a0ba9-350c-4edb-9a71-e421a0fef257" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="2f81d05e-2ed3-4f8f-af51-7d817821bb2b" data-cid="2f81d05e-2ed3-4f8f-af51-7d817821bb2b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.9, 129" data-replace="0.9" data-pattern="$2" data-tag-index="s392_1" data-time="" data-username="" data-userid="">0.9</named-content><named-content id="aac55517-6b56-49c8-8ee5-8ac4aa83d177" data-cid="aac55517-6b56-49c8-8ee5-8ac4aa83d177" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGC" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="3" data-match="0.9, 129" data-replace=", " data-pattern="$3 " data-tag-index="s392_1" data-time="" data-username="" data-userid="">, </named-content><named-content id="1ce2b899-3d85-412f-afff-7d806b6131c3" data-cid="1ce2b899-3d85-412f-afff-7d806b6131c3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="5" data-match="0.9, 129" data-replace="129" data-pattern="$4" data-tag-index="s392_1" data-time="" data-username="" data-userid="">129</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="296d8963-b162-44b1-8567-04d48fd3bec7" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="8467c49e-bf43-47d8-b8a5-d2a8be727af4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">2/2.1</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="a6b379de-7e07-4366-84dd-59e282d98a0b" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="de799514-33fc-4820-b1d3-351fca0b44c3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">GAD65 0.06; IAA and IA-2A negative<named-content data-cid="1545433804" id="924700cc-a504-4252-874c-d27dc660f636" content-type="ins cts-3" specific-use="1545441724939" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441724939">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="81c859aa-688c-47b1-b207-e86ebd2550be" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="0d19c346-4dc5-4172-b744-e7cfd7c03133" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Thyroiditis<named-content data-cid="1545433805" id="03a277fe-d6d6-4395-8164-952c44022988" content-type="ins cts-3" specific-use="1545441727273" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441727273">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="819acd0b-99dc-4ea4-aa86-6d57d82189d0" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="65581e06-8238-459b-a535-4b80a4e4f874" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433806" id="55fd10c6-3158-4ed6-9a0e-e12c175df96b" content-type="ins cts-3" specific-use="1545441729171" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441729171">.</named-content></p></td></tr><tr data-col-count="10" id="65af409b-0571-4610-ad55-f36b867b7b99"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="211fd084-4f93-4cdf-84d5-3aded43f78e5" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="95b0ccfe-bca7-4ff0-a1f7-92ba98a001f2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">2</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="9a99fffe-08a7-4e68-9d5d-2db461428a1b" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="ff6d6f1c-3571-4754-ba53-fd4c0acd4c33" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">35</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="a9679c38-ef17-4be0-b2e5-0e00c41086be" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="5e1ca7db-a8dd-4bf6-9125-1d1e09c749b9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="a93ca001-c799-4d9a-9fcb-904a24d53998" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="e897dd8b-58f8-44a6-a0f1-2ec90edf3533" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="e8829dde-c359-4cdb-9218-e7c2e471d930" data-cid="e8829dde-c359-4cdb-9218-e7c2e471d930" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="78 mg/dL" data-replace="78" data-pattern="$1" data-tag-index="303_1" data-time="" data-username="" data-userid="">78</named-content><named-content id="f109506c-3370-419c-9d8f-0e61d4a4a493" data-cid="f109506c-3370-419c-9d8f-0e61d4a4a493" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="6" data-match="78 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="303_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433807" id="5149e692-0f09-4ae4-b41c-cbc7744975bb" content-type="ins cts-3" specific-use="1545441732629" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441732629">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="f567ee42-576f-4395-ac4a-970252d3f7fc" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="acd5e644-2906-4e6f-9f97-927f98b8609b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><bold id="bfccf633-6cd0-43c0-8596-0931d90fbc81">Severe DKA</bold>: RPG <named-content id="f34a0b87-9f52-4568-8ef4-2cb318ca6639" data-cid="f34a0b87-9f52-4568-8ef4-2cb318ca6639" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="16" data-match="971 mg/dL" data-replace="971" data-pattern="$1" data-tag-index="304_1" data-time="" data-username="" data-userid="">971</named-content><named-content id="5e4132cd-6698-4997-85bc-85e7c2294afc" data-cid="5e4132cd-6698-4997-85bc-85e7c2294afc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="19" data-match="971 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="304_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 10.7%, β-OHB <named-content id="4b7461b0-8c25-4658-b1a0-7a29a8665894" data-cid="4b7461b0-8c25-4658-b1a0-7a29a8665894" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="47" data-match="10.8 mmol/L" data-replace="10.8" data-pattern="$1" data-tag-index="304_2" data-time="" data-username="" data-userid="">10.8</named-content><named-content id="839780bc-e195-498b-b244-656b8d32c407" data-cid="839780bc-e195-498b-b244-656b8d32c407" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/L' to ' mmol/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="51" data-match="10.8 mmol/L" data-replace=" mmol/L" data-pattern=" $2" data-tag-index="304_2" data-track-change=" mmol/L" data-time="" data-username="" data-userid=""> mmol/L</named-content>, <named-content data-cid="1545433878" id="7ca2c7e6-1c76-4a84-ac29-7a287fbaf810" content-type="ins cts-3" specific-use="1545442317735" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:31am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442317735">and </named-content>lipase <named-content id="72a132e4-c4bb-4860-b024-d00b75f1ed84" data-cid="72a132e4-c4bb-4860-b024-d00b75f1ed84" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="67" data-match="661 IU/L" data-replace="661" data-pattern="$1" data-tag-index="304_3" data-time="" data-username="" data-userid="">661</named-content><named-content id="afe1a18a-6777-4c04-9541-a37b15fc8c46" data-cid="afe1a18a-6777-4c04-9541-a37b15fc8c46" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣IU/L' to ' IU/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="70" data-match="661 IU/L" data-replace=" IU/L" data-pattern=" $2" data-tag-index="304_3" data-track-change=" IU/L" data-time="" data-username="" data-userid=""> IU/L<named-content data-cid="1545433808" id="5351f6cb-d63c-454e-9db1-5b862b2d3d67" content-type="ins cts-3" specific-use="1545441737232" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441737232">.</named-content></named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="486cde2b-e41d-4207-bb00-410d6d8f8014" data-auto-align="true" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" data-align="." data-align-left-width="9.25" data-align-right-width="24.46875" data-left-space="0" data-left-indent-space="0"><p id="59df3027-060f-4ea2-b2f1-7876a939843c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="79964f09-25b6-4a75-a3be-4028c2616549" data-cid="79964f09-25b6-4a75-a3be-4028c2616549" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="0" data-match="&amp;lt;0.1" data-replace="&lt;" data-pattern="$2" data-tag-index="305_1" data-time="" data-username="" data-userid="">&lt;</named-content><named-content id="66142ace-539f-4b98-ae13-14fd0029306d" data-cid="66142ace-539f-4b98-ae13-14fd0029306d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1" data-match="&amp;lt;0.1" data-replace="0.1" data-pattern="$3" data-tag-index="305_1" data-time="" data-username="" data-userid="">0.1</named-content>, 147</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="bd3a394a-5136-4010-bd15-2d1ac364ba47" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="db9cf85e-f08e-4fc8-a93a-a5764f5a4c8a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">1/2.2</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="3245f607-4fb7-47c9-a39d-400128f7f09f" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="07c069df-9e1a-475d-98a3-25280af1c242" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">GAD65 0.21; IAA and IA-2A negative<named-content data-cid="1545433811" id="2c0a2c8d-eb33-4e95-ae88-e33e7ff1c9b0" content-type="ins cts-3" specific-use="1545441748212" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441748212">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="8bd6831d-56b5-4577-b1de-2f25ef77179c" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="e3ad621b-eea2-4482-b4b7-8ab4a0f8e97b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Thyroiditis<named-content data-cid="1545433812" id="125bbca3-074a-4c6f-8b26-dd05476b387f" content-type="ins cts-3" specific-use="1545441750029" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441750029">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="0bd22b2e-1b62-4122-ab50-2faf316c39af" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="1df194a8-887a-4649-a5c9-e33d5d1d7b13" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI →</p><p id="17e656b7-9daa-4df5-a1ce-23f4d9bf7b08" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content data-cid="1545433814" id="7b3068e9-9759-49f0-b2ce-ec140d6f7611" content-type="del cts-3" specific-use="1545441753910" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441753910">I</named-content><named-content data-cid="1545433815" id="1bf9b5ca-23d8-40f2-b2cd-b636e3812171" content-type="ins cts-3" specific-use="1545441754373" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441754373">i</named-content>nsulin pump<named-content data-cid="1545433813" id="f3d78805-623b-46a8-be3d-d399a3da6df5" content-type="ins cts-3" specific-use="1545441752463" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441752463">.</named-content></p></td></tr><tr data-col-count="10" id="9d8ebcd2-5e31-4cd7-8520-9ade2696f9c4" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="6a4de1e0-0b8f-4a4d-b6f0-c320eba0a7d9" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="db45d3d7-091c-48e8-8a52-0cc7c11aa4ed" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">3</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="b4065c91-7127-4cea-8cbf-cb24eaf8738f" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="045ca267-67b5-43d0-a819-cd31524689f3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">38</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="58a502ee-10ec-4618-a420-feba3ae93bb4" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="981529a8-65b8-4512-a67d-677d619b0070" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="760cecf1-0788-41a0-b9f9-e14c3dc939e9" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="24bd0474-31bd-4267-9549-82eb94cd8969" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="3e3e1c62-00a2-4c22-805a-e07d5af851aa" data-cid="3e3e1c62-00a2-4c22-805a-e07d5af851aa" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="83 mg/dL" data-replace="83" data-pattern="$1" data-tag-index="312_1" data-time="" data-username="" data-userid="">83</named-content><named-content id="b997d8a0-8301-4660-973a-3c646aab7627" data-cid="b997d8a0-8301-4660-973a-3c646aab7627" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="6" data-match="83 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="312_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG <named-content id="0e9bde48-b395-41e9-a601-144c50620bed" data-cid="0e9bde48-b395-41e9-a601-144c50620bed" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="18" data-match="108 mg/dL" data-replace="108" data-pattern="$1" data-tag-index="312_2" data-time="" data-username="" data-userid="">108</named-content><named-content id="41c0a27f-67d5-42c5-8bdc-951238dc1568" data-cid="41c0a27f-67d5-42c5-8bdc-951238dc1568" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="21" data-match="108 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="312_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433816" id="715faefc-f08d-4544-9bba-8a430d1f5ded" content-type="ins cts-3" specific-use="1545441761830" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441761830">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="769e8382-114d-405c-91f2-23b10797d281" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="85ec02ca-6426-4adc-af36-81f5a4a4322b" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><bold id="e480ffd3-6ca3-41c4-9b75-480b87dc2f02">DKA/HHS</bold>: RPG <named-content id="6830d778-a5b7-4a19-8c48-c182d9cbac20" data-cid="6830d778-a5b7-4a19-8c48-c182d9cbac20" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="13" data-match="972 mg/dL" data-replace="972" data-pattern="$1" data-tag-index="313_1" data-time="" data-username="" data-userid="">972</named-content><named-content id="13357a2e-6dc9-4275-916b-68f35390b489" data-cid="13357a2e-6dc9-4275-916b-68f35390b489" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="16" data-match="972 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="313_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 7.8%, <named-content data-cid="1545433884" id="d282540d-950d-4a0e-bff2-52feb5cf163f" content-type="ins cts-3" specific-use="1545442321867" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442321867">and </named-content>β-OHB <named-content id="983c8ecd-5c37-4115-89f7-79e114892c27" data-cid="983c8ecd-5c37-4115-89f7-79e114892c27" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="43" data-match="3.7 mmol/L" data-replace="3.7" data-pattern="$1" data-tag-index="313_2" data-time="" data-username="" data-userid="">3.7</named-content><named-content id="3c82c254-0241-4380-842f-a4ac7100001e" data-cid="3c82c254-0241-4380-842f-a4ac7100001e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/L' to ' mmol/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="46" data-match="3.7 mmol/L" data-replace=" mmol/L" data-pattern=" $2" data-tag-index="313_2" data-track-change=" mmol/L" data-time="" data-username="" data-userid=""> mmol/L</named-content><named-content data-cid="1545433817" id="20876aaf-828d-4ece-9054-7a69b877e51e" content-type="del cts-3" specific-use="1545441763227" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441763227">,</named-content><named-content data-cid="1545433820" id="4f7d97cc-a61b-42a1-a88d-a2b38e0d40d1" content-type="ins cts-3" specific-use="1545441764832" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441764832">.</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="1ded953f-3534-4d3e-ad67-3c8dc16cb8a7" data-auto-align="true" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" data-align="." data-align-left-width="9.25" data-align-right-width="24.46875" data-left-space="0" data-left-indent-space="0"><p id="4477fc8d-afce-496c-8985-0665e04d4072" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="47d30b61-170d-4cc7-844f-8baa4bb2df22" data-cid="47d30b61-170d-4cc7-844f-8baa4bb2df22" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="OPR" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="OPR" data-offset="0" data-match="&amp;lt;0.1" data-replace="&lt;" data-pattern="$2" data-tag-index="314_1" data-time="" data-username="" data-userid="">&lt;</named-content><named-content id="aa180a74-66c8-4b8d-9d18-f62f797d0273" data-cid="aa180a74-66c8-4b8d-9d18-f62f797d0273" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAR,OPR,VAL,OPRS,VALS,UNT" data-tag-type="VAL" data-offset="1" data-match="&amp;lt;0.1" data-replace="0.1" data-pattern="$3" data-tag-index="314_1" data-time="" data-username="" data-userid="">0.1</named-content>, 278</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="5c20f6e8-4f63-456e-a137-0ae71226ad63" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="dfba8cc8-5d7d-442e-960b-21ecf92002d4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">1/0.6</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="af105378-4eac-4e37-8d98-6e409fea7cf1" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="3ba71cd7-e023-4daa-b553-e995456fb00d" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">GAD65 15.4, IAA <named-content data-cid="1545433922" id="e6f46c7f-7300-4e24-98ed-41416eee02de" content-type="ins cts-3" specific-use="1545442577686" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:36am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442577686">0</named-content>.05, IA-2A 0.17; ZnT8A negative<named-content data-cid="1545433821" id="af7c61b8-ccf4-416f-9b08-e6426b4662fd" content-type="ins cts-3" specific-use="1545441766782" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441766782">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="b22363af-2ccc-4e74-a342-08cdfbc5f524" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="1430f681-3162-4ed5-b730-b4127b9ba84f" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Thyroiditis<named-content data-cid="1545433822" id="15f62bdc-ef7c-456c-84b8-cc456634ba61" content-type="ins cts-3" specific-use="1545441774428" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441774428">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="870215d6-8fab-40f3-9010-56725b05bf76" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="6767e493-07fd-494e-9e23-242ac5217259" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433823" id="829ee5f4-c16f-440f-af12-da88c9fcff3a" content-type="ins cts-3" specific-use="1545441775680" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441775680">.</named-content></p></td></tr><tr data-col-count="10" id="0b39156f-d3ab-4e9a-aed4-1125143b36ff"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="1af42f94-6e22-4b14-8537-ea30aa0a09e6" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="ea58f2b1-139f-43e9-ad5c-1c23f11c90f2" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">4</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="41d841d7-5187-4a17-922f-bad15f7e804d" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="89a831d0-c3e4-41a3-9497-9b7cad116c15" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">25</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="66f4dbec-f03a-4c7f-97b7-4d07ce90a701" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="b6f23e2a-a61b-4ffd-bc21-e40fa63cdc50" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="175c7864-4982-4e9f-a07c-ef099f316500" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="4cf546cf-c8ba-49ee-856c-b994d9bba097" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Not tested<named-content data-cid="1545433824" id="762e02ca-50e6-440d-aaa3-4d3f241b0ab2" content-type="ins cts-3" specific-use="1545441777427" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441777427">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="d7a10f33-4359-452d-a11f-7dda9fa0aa75" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="3ac88c6d-7277-4392-9f18-984c793ae663" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RPG <named-content id="bb7e5524-27e8-4818-916d-f8056c357c12" data-cid="bb7e5524-27e8-4818-916d-f8056c357c12" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="600 mg/dL" data-replace="600" data-pattern="$1" data-tag-index="321_1" data-time="" data-username="" data-userid="">600</named-content><named-content id="57cb7dba-1020-4747-95ba-d63a70b54d4c" data-cid="57cb7dba-1020-4747-95ba-d63a70b54d4c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="600 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="321_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 10.5%,<named-content data-cid="1545433888" id="883cf8c7-2964-45ff-aeaa-8fbf2f2dd9ff" content-type="ins cts-3" specific-use="1545442330992" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442330992"> and</named-content> trace urine ketone<named-content data-cid="1545433825" id="5459d859-50a1-4665-a602-b9c9ac24901a" content-type="ins cts-3" specific-use="1545441778937" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:22am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441778937">.</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="e9b5d60d-df2a-4a3c-812e-3f2e8eda2e4d" data-auto-align="true" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" data-align="." data-align-left-width="9.25" data-align-right-width="24.46875" data-left-space="4.796875" data-left-indent-space="4.796875"><p id="2f99228e-39e5-4d96-b5e6-2ba063fcb9d2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="053e32b1-7546-49b7-be7f-1df32c644628" data-cid="053e32b1-7546-49b7-be7f-1df32c644628" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.3, 250" data-replace="0.3" data-pattern="$2" data-tag-index="s433_1" data-time="" data-username="" data-userid="">0.3</named-content><named-content id="12ea0cc2-db69-403e-b434-fa8191ba9007" data-cid="12ea0cc2-db69-403e-b434-fa8191ba9007" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGC" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="3" data-match="0.3, 250" data-replace=", " data-pattern="$3 " data-tag-index="s433_1" data-time="" data-username="" data-userid="">, </named-content><named-content id="30743ac6-cde1-4371-898a-45bc12a21ac0" data-cid="30743ac6-cde1-4371-898a-45bc12a21ac0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="5" data-match="0.3, 250" data-replace="250" data-pattern="$4" data-tag-index="s433_1" data-time="" data-username="" data-userid="">250</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="e013cafc-b9dd-48fa-bf27-b7efbda73d7d" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="25b200c1-54e1-47a9-af0d-fd80b1acb707" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">3/4.8</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="39ef3f7f-904f-4c80-a51a-ba3a92dd352e" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="f32c0e28-69cf-47cc-adee-83118ccb4d68" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">IAA 0.14; GAD 65, IA-2A, ZnT8A negative<named-content data-cid="1545433826" id="904d8d5e-6d1a-415e-a8e0-08da2a4713b9" content-type="ins cts-3" specific-use="1545441782017" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441782017">.</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="ebc40925-30dc-464b-8efa-8b2c879792cb" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="fa2a82a6-9b30-4ef7-babb-a08c495bc7ea" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="f591c992-3cfa-4e60-b0a5-57e373312293" data-cid="f591c992-3cfa-4e60-b0a5-57e373312293" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1153_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="f27137db-34d2-4345-9ddb-b1b875c8d6d3" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="0d1c6dbf-ed3d-40bf-849f-c8988d36ca00" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Metformin → MDI<named-content data-cid="1545433827" id="2c3e343c-de21-415a-8c00-a338900a9223" content-type="ins cts-3" specific-use="1545441783412" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441783412">.</named-content></p></td></tr><tr data-col-count="10" id="df8fb1b9-70c3-40ac-a1d3-e83a3ed66921" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="90b6d1bf-7163-4e57-abf1-68281f4821d7" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="7c5c68e3-2887-407d-9a47-a4e96014ad0b" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">5</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="57d0ffbf-d17f-4e75-8811-907e86b20d2f" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="b33091d9-79fa-4085-b08b-df42f503f9c0" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">23</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="6bcb376a-02f6-4a07-8580-f643b8cd0a88" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="738d08e4-21cb-483f-85c0-be6c54fe696c" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Nivolumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="3d8fed90-3292-42ef-a9e0-b4c8d6b503f6" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="c178da98-68d4-459e-8978-94327fd26183" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG tested once <named-content id="9af043ad-b6ee-4fac-b354-1792b42ef87f" data-cid="9af043ad-b6ee-4fac-b354-1792b42ef87f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="16" data-match="105 mg/dL" data-replace="105" data-pattern="$1" data-tag-index="327_1" data-time="" data-username="" data-userid="">105</named-content><named-content id="4c52c5c3-caf0-43e2-8f84-f79077c2ef46" data-cid="4c52c5c3-caf0-43e2-8f84-f79077c2ef46" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="19" data-match="105 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="327_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433828" id="de2ce269-86b4-4e01-a6fd-a36f38cbde68" content-type="ins cts-3" specific-use="1545441785703" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441785703">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="0381659a-3104-4bb7-930e-d7e0d12ab13d" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="51011f09-298f-4a13-aa87-11d9096134d3" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RPG <named-content id="a1902786-3dc7-487f-8357-5e791f5f50a9" data-cid="a1902786-3dc7-487f-8357-5e791f5f50a9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="600 mg/dL" data-replace="600" data-pattern="$1" data-tag-index="328_1" data-time="" data-username="" data-userid="">600</named-content><named-content id="4adc6758-0f97-47ae-858f-4d0d265173a2" data-cid="4adc6758-0f97-47ae-858f-4d0d265173a2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="600 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="328_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433829" id="08c5cb93-c3b5-4ae5-bf8f-3c5663ecd858" content-type="ins cts-3" specific-use="1545441786992" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441786992">.</named-content></named-content></p></td><td data-original-space="1" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="c89e88b7-109e-4b84-8f3c-b2a727ac21c9" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align" data-align="."><p id="36ddb406-b992-44a1-b0d3-fdda05382fc3" data-original-margin="margin-top:0cm;margin-right:0cm; margin-bottom:10.0pt;margin-left:36.0pt;"/></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="8cf2eb14-90ed-4ba7-b21e-19bc9486ff90" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="1daad8a8-19e8-4a7c-94dd-0dcd7b7b2046" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">4/5.5</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="955248bb-803a-4f0e-8e6f-b2e1f18b6394" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="2a884371-a933-46e5-bc6f-ee57238a2085" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="aa4c23fc-3b32-4324-8b52-4558497c90de" data-cid="aa4c23fc-3b32-4324-8b52-4558497c90de" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1162_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="ba087081-432e-4329-948c-82fba767fdfc" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="c002e1a1-419f-4ed7-8add-86589a2f4363" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Thyroiditis<named-content data-cid="1545433830" id="66b17dc8-c4ad-43c0-81cd-0266b7b6553f" content-type="ins cts-3" specific-use="1545441788819" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441788819">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="42e1b269-8854-4c8f-a9d2-e626e3e7183e" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="4969cfc7-eb69-4881-a7a9-cd5990bd8e65" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433831" id="c9a61e35-9584-49a8-b296-ead0abc5d3bc" content-type="ins cts-3" specific-use="1545441790394" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441790394">.</named-content></p></td></tr><tr data-col-count="10" id="92d1657d-e7bb-4e03-96b0-467e9c87d89b"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="d666750b-b50c-4263-85fd-0f2c7954956f" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="6499accc-bdd1-4963-89a8-298f5e8c1d30" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">6</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="4f480e89-1da0-4139-b114-3d003cc71eb1" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="d0321f24-a596-49c2-ae60-7f920db8353c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">35</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="7465f87d-e326-4b38-8355-b904ab0e6153" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="670d1abc-73c0-4889-b04b-564ad983a188" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Ipilimumab → Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="306fbd62-9d5b-4890-8f03-8441b88a5ee4" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="1e87b44f-c968-4401-801b-54239b090f40" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="9d0bf938-8fcd-4eda-a78d-2cc246c20f6b" data-cid="9d0bf938-8fcd-4eda-a78d-2cc246c20f6b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="108 mg/dL" data-replace="108" data-pattern="$1" data-tag-index="333_1" data-time="" data-username="" data-userid="">108</named-content><named-content id="5742f24d-7381-4d8f-93d2-a696cde935f8" data-cid="5742f24d-7381-4d8f-93d2-a696cde935f8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="108 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="333_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG tested once <named-content id="995deded-8fd7-4e07-b82a-dfc7ea85eaac" data-cid="995deded-8fd7-4e07-b82a-dfc7ea85eaac" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="31" data-match="140 mg/dL" data-replace="140" data-pattern="$1" data-tag-index="333_2" data-time="" data-username="" data-userid="">140</named-content><named-content id="7151ff07-5d7f-430a-9d02-0bdfa2cc34f5" data-cid="7151ff07-5d7f-430a-9d02-0bdfa2cc34f5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="34" data-match="140 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="333_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 5.4%<named-content data-cid="1545433832" id="91083800-673d-4b43-8b8d-46cc02582679" content-type="ins cts-3" specific-use="1545441792017" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441792017">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="25c5a87e-c3c4-4578-915a-d9db7ea78592" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="986dfff6-d112-4c30-8394-f4fa241662e6" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RPG <named-content id="f2bf4b94-285e-48e2-8530-6f694c2b0d58" data-cid="f2bf4b94-285e-48e2-8530-6f694c2b0d58" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="377 mg/dL" data-replace="377" data-pattern="$1" data-tag-index="334_1" data-time="" data-username="" data-userid="">377</named-content><named-content id="74850bec-4f45-4b97-82d9-a6ef9c661769" data-cid="74850bec-4f45-4b97-82d9-a6ef9c661769" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="377 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="334_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, FPG 321, <named-content data-cid="1545433892" id="d0438d8c-85b2-4b33-8971-1616b380d286" content-type="ins cts-3" specific-use="1545442335994" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442335994">and </named-content>HbA1c 9.7%<named-content data-cid="1545433833" id="494c9533-9dc5-43c2-9f98-d4a824f5b443" content-type="ins cts-3" specific-use="1545441793723" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441793723">.</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="99afa186-f38a-4e6d-9329-4e3e60979dc4" data-auto-align="true" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" data-align="." data-align-left-width="9.25" data-align-right-width="24.46875" data-left-space="4.796875" data-left-indent-space="4.796875"><p id="53f1ae87-d69c-4b87-921f-fb8602581fd5" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="4e42bee3-7e25-4901-84c6-219cf8a84b0b" data-cid="4e42bee3-7e25-4901-84c6-219cf8a84b0b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="5.2, 321" data-replace="5.2" data-pattern="$2" data-tag-index="s456_1" data-time="" data-username="" data-userid="">5.2</named-content><named-content id="81244e69-3c12-4a42-87e7-636a4328869f" data-cid="81244e69-3c12-4a42-87e7-636a4328869f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGC" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="3" data-match="5.2, 321" data-replace=", " data-pattern="$3 " data-tag-index="s456_1" data-time="" data-username="" data-userid="">, </named-content><named-content id="6e6f2d50-4065-498b-8ff3-993564472c04" data-cid="6e6f2d50-4065-498b-8ff3-993564472c04" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="5" data-match="5.2, 321" data-replace="321" data-pattern="$4" data-tag-index="s456_1" data-time="" data-username="" data-userid="">321</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="e951dfb2-450d-44be-b201-5dedc6aebb4e" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="a02ea20c-e2b8-46e9-9a1d-f63ca53c8721" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">6/4.9</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="10e0833c-8ae7-411f-8b06-0250153393b2" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="15e5d2e6-0ad9-4e20-a2b1-10b8ff93a657" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="d619bd73-ebb3-41b7-941f-cb529adfcc70" data-cid="d619bd73-ebb3-41b7-941f-cb529adfcc70" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1173_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="0a394d1a-02ef-48c5-a1af-f73a0eef5cc1" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="3ba7fac5-40e9-4dd8-bf92-6950a4072a1d" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="6fbbb055-d588-4e28-9872-2cf34c5b0c23" data-cid="6fbbb055-d588-4e28-9872-2cf34c5b0c23" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1174_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="6665bc14-c3e7-4405-85cf-f849fde0d5da" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="67235d79-aee9-42a2-8e73-24b834cb9aa0" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Metformin → MDI<named-content data-cid="1545433834" id="cf2f1bdd-42f5-4b1d-b121-337e738bee6d" content-type="ins cts-3" specific-use="1545441795640" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441795640">.</named-content></p></td></tr><tr data-col-count="10" id="c9fab1a2-395b-4c66-b2fd-7378ec38b8bd" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="f74c591c-a144-4673-81a7-2d0fee7f4932" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="f6e477da-ddaa-4972-8a1a-5d507cc8a82f" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">7</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="814b1bee-899a-4cc6-b707-6ec0e7afbcc6" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="e6da424c-587a-4ee2-bcfc-c43a04065ea3" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">31</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="466f62bb-fd8d-43b9-9923-32304f39cded" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="b19d9cda-ac4f-4703-8a2a-f04e7ebc2e84" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="e3cd063f-ed12-4d4f-8c1a-6c3c9605dce1" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="d8e0cc17-5ebc-4220-9e96-1b7a13d6b4eb" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="04edc23c-6b87-4a44-a6b8-0562a77b7f27" data-cid="04edc23c-6b87-4a44-a6b8-0562a77b7f27" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="86 mg/dL" data-replace="86" data-pattern="$1" data-tag-index="339_1" data-time="" data-username="" data-userid="">86</named-content><named-content id="da3a53fd-1585-473e-ba30-2e5a257e07a0" data-cid="da3a53fd-1585-473e-ba30-2e5a257e07a0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="6" data-match="86 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="339_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG tested once <named-content id="ca1595eb-53ee-4998-a6f8-e4c061fca212" data-cid="ca1595eb-53ee-4998-a6f8-e4c061fca212" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="30" data-match="141 mg/dL" data-replace="141" data-pattern="$1" data-tag-index="339_2" data-time="" data-username="" data-userid="">141</named-content><named-content id="09bd2bbe-afb6-4107-88e6-17d09137b064" data-cid="09bd2bbe-afb6-4107-88e6-17d09137b064" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="33" data-match="141 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="339_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433835" id="b51013e7-af7b-4219-82c2-7b29207741c0" content-type="ins cts-3" specific-use="1545441810917" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441810917">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="a465f25a-3b1f-4e0c-9a23-4fd448531261" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="c5fd1eb3-d402-4a73-a7e3-bd74ec8921c0" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><bold id="7f4ad8dc-735f-4d66-ba69-fdefc508a696">Severe DKA:</bold> RPG <named-content id="234a73c2-73b1-4af4-82c3-6b8907f95cbe" data-cid="234a73c2-73b1-4af4-82c3-6b8907f95cbe" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="16" data-match="644 mg/dL" data-replace="644" data-pattern="$1" data-tag-index="340_1" data-time="" data-username="" data-userid="">644</named-content><named-content id="c9e56d9c-f799-4a83-8cfb-311ef5b15bc5" data-cid="c9e56d9c-f799-4a83-8cfb-311ef5b15bc5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="19" data-match="644 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="340_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 9.7%, <named-content data-cid="1545433896" id="398b5faa-1fcd-45d3-9e18-f27a9f0e671f" content-type="ins cts-3" specific-use="1545442342345" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442342345">and </named-content>β-OHB <named-content id="f67eb87f-3fc0-44ae-b9fb-77fdb6492ff1" data-cid="f67eb87f-3fc0-44ae-b9fb-77fdb6492ff1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="46" data-match="6.8 mmol/L" data-replace="6.8" data-pattern="$1" data-tag-index="340_2" data-time="" data-username="" data-userid="">6.8</named-content><named-content id="166565d2-c8af-4718-9fba-2e86163f6459" data-cid="166565d2-c8af-4718-9fba-2e86163f6459" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/L' to ' mmol/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="49" data-match="6.8 mmol/L" data-replace=" mmol/L" data-pattern=" $2" data-tag-index="340_2" data-track-change=" mmol/L" data-time="" data-username="" data-userid=""> mmol/L<named-content data-cid="1545433836" id="0d2f7909-26e4-46d2-a026-f24507564df6" content-type="ins cts-3" specific-use="1545441813643" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441813643">.</named-content></named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="0ae2aaf7-9e7f-4c67-bdaf-2c4ad6ab41a7" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" data-align="." data-align-left-width="9.25" data-align-right-width="24.46875" data-left-space="5.25" data-left-indent-space="5.25"><p id="2923367a-0a91-4631-b924-08c64c6cf3c4" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="9e8a5dcd-44a8-4db5-ac34-96bae8077e77" data-cid="9e8a5dcd-44a8-4db5-ac34-96bae8077e77" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1181_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="b2e13991-92ea-48ec-8ef1-f4dc35ab2416" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="da1770ce-3028-469c-871d-c8934b7d698d" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">5/7.8</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="eaa13018-561d-490e-82ea-88546d05a62a" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="9b96e7db-d883-4f98-a7fa-fd3bbb3b798a" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">GAD65 negative<named-content data-cid="1545433837" id="07e4007f-011f-47b3-ad04-204fa10e445d" content-type="ins cts-3" specific-use="1545441815594" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441815594">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="6c550c8b-62a1-49a1-872a-e23a81f7d0e9" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="4ca17349-3823-4f56-9dbd-6ef36566edd3" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Thyroiditis<named-content data-cid="1545433841" id="2a3438d5-96a4-4a71-a145-98f1e1c9136f" content-type="del cts-3" specific-use="1545441820131" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441820131">,</named-content><named-content data-cid="1545433842" id="393e0079-5218-4dd1-8164-4e70bafd247e" content-type="ins cts-3" specific-use="1545441820374" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441820374"> and</named-content> <named-content data-cid="1545433839" id="ff08039c-d2d2-424c-a069-ec8ed202a8cd" content-type="del cts-3" specific-use="1545441818238" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441818238">H</named-content><named-content data-cid="1545433840" id="4faa2aa5-54e4-4f3f-aeb0-106e05d757d2" content-type="ins cts-3" specific-use="1545441819048" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441819048">h</named-content>ypophysitis<named-content data-cid="1545433838" id="f52a7833-8f9c-4302-b23a-88768dd284a9" content-type="ins cts-3" specific-use="1545441816810" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441816810">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="6bb786ff-318c-489a-a1f5-34ab613c1a6d" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="c9216466-ea62-4323-a556-512899b9892e" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433846" id="fa86ef5a-3d8f-4afb-b731-f35665d2a4e0" content-type="ins cts-3" specific-use="1545441822297" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441822297">.</named-content></p></td></tr><tr data-col-count="10" id="f3926ee9-dc28-4d88-a5bd-587c4227b115"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="a3fb6140-0e44-4fe0-8c2c-25837e55e579" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="36c55ed5-6ece-4096-b992-b7ccfe77bf18" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">8</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="ed4f9205-8dba-4cf8-b1e4-1b133c4f6f34" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="81e39861-9c9f-4b4b-a1a5-501f320c63b7" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">33</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="75711a44-592c-4d00-9e69-674c4c642d79" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="caba3a10-ec25-4fdc-be12-0236f2db4924" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="742519f3-8495-4703-b1e8-115eafadff7b" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="0d250daa-741d-469a-b6fb-4c22ac82f9ec" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG tested once <named-content id="fb281031-529e-4b09-9483-b1ef50a64346" data-cid="fb281031-529e-4b09-9483-b1ef50a64346" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="16" data-match="106 mg/dL" data-replace="106" data-pattern="$1" data-tag-index="346_1" data-time="" data-username="" data-userid="">106</named-content><named-content id="62f779c4-74f3-4a54-afb6-a9ed2200c431" data-cid="62f779c4-74f3-4a54-afb6-a9ed2200c431" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="19" data-match="106 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="346_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433847" id="f66d046f-fb2e-489c-aa94-c34a9fb6507d" content-type="ins cts-3" specific-use="1545441824648" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441824648">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="e4c004d1-7aa1-4917-be01-2d05c1bfb050" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="6d3025e9-18d3-4482-85c2-fafb4bff5782" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><bold id="d8720751-aeab-429c-8d89-3941d8948200">Mild DKA:</bold> RPG <named-content id="369ad492-30ff-4b93-aac7-9b789c199060" data-cid="369ad492-30ff-4b93-aac7-9b789c199060" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="14" data-match="460 mg/dL" data-replace="460" data-pattern="$1" data-tag-index="347_1" data-time="" data-username="" data-userid="">460</named-content><named-content id="59a9c033-d9fe-4701-9ae6-dd6d378d0db7" data-cid="59a9c033-d9fe-4701-9ae6-dd6d378d0db7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="17" data-match="460 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="347_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, FPG <named-content id="009c539b-d629-4fa1-b375-fac2acd0d744" data-cid="009c539b-d629-4fa1-b375-fac2acd0d744" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="29" data-match="311 mg/dL" data-replace="311" data-pattern="$1" data-tag-index="347_2" data-time="" data-username="" data-userid="">311</named-content><named-content id="f8288956-5cdd-40f8-8435-98b4f4124c1f" data-cid="f8288956-5cdd-40f8-8435-98b4f4124c1f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="32" data-match="311 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="347_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 7.8, <named-content data-cid="1545433849" id="ef59ad35-3ab6-4c43-9e37-fcc3ab3f77cf" content-type="del cts-3" specific-use="1545441828868" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441828868">U</named-content><named-content data-cid="1545433850" id="59cb9e68-8244-423a-9a71-c2b1b4f6efe4" content-type="ins cts-3" specific-use="1545441829284" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441829284">u</named-content>rine ketone 750, β-OHB <named-content id="d81d1372-2d4c-4f3e-8463-12eb7becd842" data-cid="d81d1372-2d4c-4f3e-8463-12eb7becd842" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="76" data-match="0.2 mmol/L" data-replace="0.2" data-pattern="$1" data-tag-index="347_3" data-time="" data-username="" data-userid="">0.2</named-content><named-content id="c1c6ec74-8619-4549-9594-5c87471b8807" data-cid="c1c6ec74-8619-4549-9594-5c87471b8807" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/L' to ' mmol/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="79" data-match="0.2 mmol/L" data-replace=" mmol/L" data-pattern=" $2" data-tag-index="347_3" data-track-change=" mmol/L" data-time="" data-username="" data-userid=""> mmol/L</named-content>,<named-content data-cid="1545433900" id="f024bdfe-cbf7-413a-82b8-8cc5ec95b927" content-type="ins cts-3" specific-use="1545442360830" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442360830"> and</named-content> lipase <named-content id="4fe7a94f-4b56-4ffa-97eb-e54b5c8aeb13" data-cid="4fe7a94f-4b56-4ffa-97eb-e54b5c8aeb13" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="95" data-match="120 IU/L" data-replace="120" data-pattern="$1" data-tag-index="347_4" data-time="" data-username="" data-userid="">120</named-content><named-content id="dd9fe2d9-0fd0-4531-8ef2-43761f1e9e1f" data-cid="dd9fe2d9-0fd0-4531-8ef2-43761f1e9e1f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣IU/L' to ' IU/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="98" data-match="120 IU/L" data-replace=" IU/L" data-pattern=" $2" data-tag-index="347_4" data-track-change=" IU/L" data-time="" data-username="" data-userid=""> IU/L<named-content data-cid="1545433848" id="ad51e9e4-9a90-47a8-b9d5-05de88e66eab" content-type="ins cts-3" specific-use="1545441826189" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441826189">.</named-content></named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="265136be-4bef-46b6-b43e-27e0683cab23" data-auto-align="true" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" data-align="." data-align-left-width="9.25" data-align-right-width="24.46875" data-left-space="4.796875" data-left-indent-space="4.796875"><p id="a9cb7d64-534d-4c89-a0a9-c498111474a3" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="13d9fa45-5b06-445d-a5c6-642f6362b4b3" data-cid="13d9fa45-5b06-445d-a5c6-642f6362b4b3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.7, 142" data-replace="0.7" data-pattern="$2" data-tag-index="s476_1" data-time="" data-username="" data-userid="">0.7</named-content><named-content id="246f3d5e-5ed8-4186-bf1e-7b639bb713d2" data-cid="246f3d5e-5ed8-4186-bf1e-7b639bb713d2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGC" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="3" data-match="0.7, 142" data-replace=", " data-pattern="$3 " data-tag-index="s476_1" data-time="" data-username="" data-userid="">, </named-content><named-content id="2eba5602-5463-43fd-8491-dadc8eae96b4" data-cid="2eba5602-5463-43fd-8491-dadc8eae96b4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="5" data-match="0.7, 142" data-replace="142" data-pattern="$4" data-tag-index="s476_1" data-time="" data-username="" data-userid="">142</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="725e2a81-7314-460a-8ccf-366659046ad4" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="b73ba7ab-cd4e-4eb4-be25-da8125b00c32" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">17/9.7</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="31893fb8-fcf4-42d7-bf7f-bc8f99af0dbe" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="d73066ad-81ea-498a-85dc-af53eb553dba" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">GAD65 0.05; IAA, IA-2A, ZnT8A negative<named-content data-cid="1545433851" id="265913e8-97b1-40b5-9069-ee5c7442fbbb" content-type="ins cts-3" specific-use="1545441832909" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441832909">.</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="26579f3d-a996-4d79-94b7-1861d9c5fefd" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="2bbbb6b6-028c-4a07-96b8-09235c213015" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="8a7bdb68-a421-4030-9313-c595b97e482c" data-cid="8a7bdb68-a421-4030-9313-c595b97e482c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1194_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="47f39039-cf3c-465d-813d-ab8fd9a48179" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="7902bb77-d5ef-4378-82ac-d440970d8e2e" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Metformin <named-content data-cid="1545433853" id="64ff48bc-1beb-4185-83da-347bc82b8cd8" content-type="del cts-3" specific-use="1545441839253" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441839253">B</named-content><named-content data-cid="1545433854" id="714e707c-cf9d-447c-97eb-09e4ee63c19d" content-type="ins cts-3" specific-use="1545441840176" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441840176">b</named-content>asal insulin → MDI<named-content data-cid="1545433852" id="e72d8017-7c20-4ca9-935a-1367c28d1b58" content-type="ins cts-3" specific-use="1545441836916" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:23am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441836916">.</named-content></p></td></tr><tr data-col-count="10" id="56849fe6-908a-4963-812a-f81525e7f080" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="e7d50335-2726-45e5-8780-f448f2eb378e" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="8b4cb0b5-7582-4fbd-9bec-110f10eeb1f0" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">9</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="cfc706b4-63bd-4e4b-b9f6-93360c3ef7d6" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="2c283e98-b530-4833-ad47-bc8006253a1f" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">45</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="e18e4c5e-e8de-46be-aade-6088ff3fc745" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="79918911-f45a-4a84-958f-dfa134a0b16b" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="f8ded393-6120-4dd9-b072-a6d9cc04f5d1" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="e7c0bc70-47fe-4d67-8aac-728a08737301" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="b7aaf119-9931-4be0-8e5b-c87b69455189" data-cid="b7aaf119-9931-4be0-8e5b-c87b69455189" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="96 mg/dL" data-replace="96" data-pattern="$1" data-tag-index="353_1" data-time="" data-username="" data-userid="">96</named-content><named-content id="3489aa97-c803-464c-8f59-32d4d81fb44c" data-cid="3489aa97-c803-464c-8f59-32d4d81fb44c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="6" data-match="96 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="353_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG <named-content id="065d8892-76b2-447d-b755-c49c769577ab" data-cid="065d8892-76b2-447d-b755-c49c769577ab" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="18" data-match="114 mg/dL" data-replace="114" data-pattern="$1" data-tag-index="353_2" data-time="" data-username="" data-userid="">114</named-content><named-content id="34e84929-50c8-41c9-9ecf-97680d5d1172" data-cid="34e84929-50c8-41c9-9ecf-97680d5d1172" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="21" data-match="114 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="353_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433855" id="e22df3af-9115-4985-be9a-a51f12f0eed9" content-type="ins cts-3" specific-use="1545441850144" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441850144">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="e5fe9bef-c958-456b-b699-320f709197cb" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="d532e2c0-4c1a-494f-8839-2fff4174f0a4" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><bold id="32d33554-c7f9-466e-9df5-2000943f9d42">Severe DKA:</bold> RPG <named-content id="968ba9d9-077a-4b12-a4ec-9ac24262033e" data-cid="968ba9d9-077a-4b12-a4ec-9ac24262033e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="16" data-match="429 mg/dL" data-replace="429" data-pattern="$1" data-tag-index="354_1" data-time="" data-username="" data-userid="">429</named-content><named-content id="c09fa586-f2da-48b4-9c58-da827a4ed81a" data-cid="c09fa586-f2da-48b4-9c58-da827a4ed81a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="19" data-match="429 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="354_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, FPG <named-content id="f60f32d9-3bd4-4017-a66f-61e7c8444b54" data-cid="f60f32d9-3bd4-4017-a66f-61e7c8444b54" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="31" data-match="236 mg/dL" data-replace="236" data-pattern="$1" data-tag-index="354_2" data-time="" data-username="" data-userid="">236</named-content><named-content id="2237cc69-eb8f-40af-92a7-575b8a7982ba" data-cid="2237cc69-eb8f-40af-92a7-575b8a7982ba" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="34" data-match="236 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="354_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 11.3%, urine ketone 750,<named-content data-cid="1545433904" id="69f238d5-84f7-4e3c-84b0-2eae4fb15fc6" content-type="ins cts-3" specific-use="1545442365187" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442365187"> and</named-content> β-<named-content rid="7126c9c6-3c32-42e0-8524-e694d76daac0" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" data-style="" content-type="jrnlQueryRef" specific-use="start" id="8f77ac0d-cd30-4c90-afaf-376346756618" data-replied="true"/>OHB<named-content rid="7126c9c6-3c32-42e0-8524-e694d76daac0" data-class="jrnlQueryRef" data-type="end" content-type="jrnlQueryRef" specific-use="end" id="50c1b343-1933-4be4-bf38-3f7773be7390" data-replied="true"/> <named-content id="a883c13d-4ad8-4b4e-86a6-c748baa481d5" data-cid="a883c13d-4ad8-4b4e-86a6-c748baa481d5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="80" data-match="8 mmol/L" data-replace="8" data-pattern="$1" data-tag-index="354_3" data-time="" data-username="" data-userid="">8</named-content><named-content id="15fa945d-3adf-45a4-91e9-6e9d798fd4ed" data-cid="15fa945d-3adf-45a4-91e9-6e9d798fd4ed" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/L' to ' mmol/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="81" data-match="8 mmol/L" data-replace=" mmol/L" data-pattern=" $2" data-tag-index="354_3" data-track-change=" mmol/L" data-time="" data-username="" data-userid=""> mmol/L<named-content data-cid="1545433856" id="25f86f86-1c54-419f-beaf-c3b84c695afa" content-type="ins cts-3" specific-use="1545441852211" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441852211">.</named-content></named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="63df7c94-148e-4b7c-a725-589e66d65e7b" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" data-align="." data-align-left-width="9.25" data-align-right-width="24.46875" data-left-space="5.25" data-left-indent-space="5.25"><p id="367d4382-bd90-4eb6-b8dc-0d78f78dd628" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="c40fec86-e6e1-41fa-ab81-3eb6863d7336" data-cid="c40fec86-e6e1-41fa-ab81-3eb6863d7336" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1201_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="c2d1f3f0-ec8e-45c3-86b9-c62bfb30a0a0" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="c4cd514f-9377-4353-883c-252d5d1142d7" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">16/23.6</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="251286a5-f06f-4c56-8ad3-fcb6525fb7e0" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="146ce286-171e-454b-8b8a-35cdb4856650" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="aee9e5c0-f68c-43f5-8dd5-3d401ff9a4e0" data-cid="aee9e5c0-f68c-43f5-8dd5-3d401ff9a4e0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1203_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="7a136015-f533-4e33-bb9b-bc24540020be" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="028a5dfa-9906-4013-9abe-6e37baf910c0" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Dermatitis, hypophysitis<named-content data-cid="1545433921" id="6ae6181b-24ea-4699-9367-b075de044443" content-type="ins cts-3" specific-use="1545442418749" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:33am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442418749">,</named-content><named-content data-cid="1545433858" id="0f1942d8-1e57-464f-a905-4ae9d1c764ae" content-type="del cts-3" specific-use="1545441869652" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441869652">,</named-content><named-content data-cid="1545433859" id="fcc8f452-9db8-4f3c-99e6-62cd820125ca" content-type="ins cts-3" specific-use="1545441869865" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441869865"> and</named-content> arthritis<named-content data-cid="1545433857" id="91db7ca1-7a08-48d2-90cb-64026ef80de5" content-type="ins cts-3" specific-use="1545441867553" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441867553">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="2cc49c2a-3232-4b83-993b-0861a5a067c0" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="03422cc8-9683-4fb9-a1c0-927e889bfcd1" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433863" id="122f71f0-cf75-42a0-8c15-4e823d372fcc" content-type="ins cts-3" specific-use="1545441871944" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441871944">.</named-content></p></td></tr><tr data-col-count="10" id="64d6a34d-5be1-4f06-bb59-29937893451e"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="4bf8c7e7-5538-4974-96c6-1af8c552125b" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="920e224a-e288-4f8e-8eef-ccd41aeddd45" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">10</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="1ddac6c5-cd97-45ed-ab8b-5ff7fcf15250" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="19483b57-46a6-4cca-b169-8a864a3ac165" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">25</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="338f6c6c-da61-440e-90ed-e5f11bf810bb" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="209376c2-6b2c-428b-bf89-9221441bd8ed" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="3be4ceb2-4ab1-4df0-999c-340b5ed8fb2c" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="5e61c2f7-ffe3-4a0d-abd3-652aac5ff1d6" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG tested once <named-content id="2abe1200-d183-4d34-98cf-613516fc7f67" data-cid="2abe1200-d183-4d34-98cf-613516fc7f67" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="16" data-match="126 mg/dL" data-replace="126" data-pattern="$1" data-tag-index="359_1" data-time="" data-username="" data-userid="">126</named-content><named-content id="c86ef933-a499-48d1-977e-1dd15283a5d6" data-cid="c86ef933-a499-48d1-977e-1dd15283a5d6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="19" data-match="126 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="359_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433864" id="bdbc7e7e-039b-4c00-8942-c7088c92d8f8" content-type="ins cts-3" specific-use="1545441874642" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441874642">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="bc7528dc-e3cc-4d12-9d39-b0c6157f5bcf" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="4342018d-0a1d-4d0e-b10d-235d2ce8ba6d" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><bold id="d13925d0-e0a1-4b1f-a31d-9eef1969113b">Mild DKA:</bold> RPG <named-content id="d8673783-3cc8-4a18-930c-50026b1609cc" data-cid="d8673783-3cc8-4a18-930c-50026b1609cc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="14" data-match="426 mg/dL" data-replace="426" data-pattern="$1" data-tag-index="360_1" data-time="" data-username="" data-userid="">426</named-content><named-content id="b5be5a78-6abd-4bee-9508-84f475f25240" data-cid="b5be5a78-6abd-4bee-9508-84f475f25240" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="17" data-match="426 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="360_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, FPG <named-content id="a9379e7f-67b3-4321-bf38-30b36ce0a752" data-cid="a9379e7f-67b3-4321-bf38-30b36ce0a752" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="29" data-match="335 mg/dL" data-replace="335" data-pattern="$1" data-tag-index="360_2" data-time="" data-username="" data-userid="">335</named-content><named-content id="a542533e-69c5-4d8c-acb3-5d6e5eac18a8" data-cid="a542533e-69c5-4d8c-acb3-5d6e5eac18a8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="32" data-match="335 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="360_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 11.2%<named-content data-cid="1545433865" id="955b7054-3707-4d8c-a745-40ea08e9a24d" content-type="styrm cts-3" specific-use="1545441879426" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Bold Removed by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-format-command="bold" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441879426" data-track-hint="Bold Removed">,</named-content> β-OHB <named-content id="34d5c47e-01c3-4938-8237-3a8fc70a5f50" data-cid="34d5c47e-01c3-4938-8237-3a8fc70a5f50" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="60" data-match="1.9 mmol/L" data-replace="1.9" data-pattern="$1" data-tag-index="360_3" data-time="" data-username="" data-userid="">1.9</named-content><named-content id="6a7a83c6-53dd-4f73-b5e8-858efec481d4" data-cid="6a7a83c6-53dd-4f73-b5e8-858efec481d4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/L' to ' mmol/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="63" data-match="1.9 mmol/L" data-replace=" mmol/L" data-pattern=" $2" data-tag-index="360_3" data-track-change=" mmol/L" data-time="" data-username="" data-userid=""> mmol/L</named-content>,<named-content data-cid="1545433908" id="fa7406b9-9b4b-4e0c-b98e-2ecd68b629b6" content-type="ins cts-3" specific-use="1545442368911" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442368911"> and</named-content> increased pancreas FDG uptake<named-content data-cid="1545433912" id="744069b0-2b11-49a9-9601-6fab5e5455bd" content-type="ins cts-3" specific-use="1545442370749" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442370749">.</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="858ceb50-df10-4fb8-af14-c57b17495ce1" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" data-align="." data-align-left-width="9.25" data-align-right-width="24.46875" data-left-space="5.25" data-left-indent-space="5.25"><p id="29d99791-c035-425d-97fd-8af18dfa42fb" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a69f7548-389e-42fa-b869-b56cb20558a8" data-cid="a69f7548-389e-42fa-b869-b56cb20558a8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1211_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="74629265-d888-42c2-ae60-e8366a254a27" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="d7b23152-35b1-466e-bb54-d2107ad21132" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">4/3</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="47db5827-fff2-4eb5-86e7-bb766e45b9f6" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="da91d92d-e72e-4348-92a8-82bbf0224a23" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="10aef6b4-5fbb-4e53-bbc8-9915c112c319" data-cid="10aef6b4-5fbb-4e53-bbc8-9915c112c319" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1213_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="31c8feb7-f688-4928-b60e-73dc0635a3b4" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="d5ee4d41-2c6f-491d-9968-1d6cbf64dedb" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a76d3968-c791-4929-aafb-946295d0724c" data-cid="a76d3968-c791-4929-aafb-946295d0724c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1214_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="0ffe11e5-6f5b-408c-9604-97a6081ed9c4" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="6f23df0b-04c0-423f-9993-c577c8bddb40" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433866" id="75f0668c-e337-4792-8fd8-85e3b0c314d9" content-type="ins cts-3" specific-use="1545441884336" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441884336">.</named-content></p></td></tr><tr data-col-count="10" id="3c6ec342-9334-425b-8071-e755db2ea99b" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="8b67e61c-b0e0-4e22-897b-68bc5be812e6" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="0f6ba33b-6a07-4a1c-b1fc-f06ef442063f" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">11</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="3f00175b-0dc3-4b98-af71-f5d19d278a87" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="be558f1d-e5fd-405e-9281-a6de8eb34fc2" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">23</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="daf8ebcb-96f4-4f4b-89f8-0a74198d6fc0" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="ad5435f1-5986-4659-b515-eed2236c4d86" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="2428c21b-8a82-4d7f-9776-2ee25461f550" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="dc02b089-544e-4dbd-a77b-dcfd7ad3c9e9" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">RPG <named-content id="d85caf06-079d-44f6-aabe-3efb8a9b3e89" data-cid="d85caf06-079d-44f6-aabe-3efb8a9b3e89" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="84 mg/dL" data-replace="84" data-pattern="$1" data-tag-index="364_1" data-time="" data-username="" data-userid="">84</named-content><named-content id="32a9ea4e-4382-4dfe-82a6-44d6353099cc" data-cid="32a9ea4e-4382-4dfe-82a6-44d6353099cc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="6" data-match="84 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="364_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433869" id="0a703b5d-1ee5-4716-9433-0361f498d4c9" content-type="ins cts-3" specific-use="1545441899209" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441899209">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="ab4de8ec-f6e7-4118-b665-77a9086bd1d2" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="e3443321-c742-49da-bcc3-0310827f0a23" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><bold id="6fb4530f-ba09-4122-9c86-6f58e9b84c32">Severe DKA:</bold> RPG <named-content id="232737b1-1692-4dea-a5c0-7496f50177fb" data-cid="232737b1-1692-4dea-a5c0-7496f50177fb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="16" data-match="1389 mg/dL" data-replace="1389" data-pattern="1389" data-tag-index="365_1" data-time="" data-username="" data-userid="">1389</named-content><named-content id="34e2af84-8c70-4f67-aa16-374035bb9831" data-cid="34e2af84-8c70-4f67-aa16-374035bb9831" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="20" data-match="1389 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="365_1" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 8.8%, β-OHB <named-content id="7eff974d-6109-48e7-91ef-d3760b8f2967" data-cid="7eff974d-6109-48e7-91ef-d3760b8f2967" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="47" data-match="14 mmol/L" data-replace="14" data-pattern="$1" data-tag-index="365_2" data-time="" data-username="" data-userid="">14</named-content><named-content id="fd0fb7aa-6c49-490d-b6f7-2cc3699cbc4b" data-cid="fd0fb7aa-6c49-490d-b6f7-2cc3699cbc4b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/L' to ' mmol/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="49" data-match="14 mmol/L" data-replace=" mmol/L" data-pattern=" $2" data-tag-index="365_2" data-track-change=" mmol/L" data-time="" data-username="" data-userid=""> mmol/L</named-content>, lipase 226,<named-content data-cid="1545433913" id="de1a66f6-7483-4016-8e7e-3d04c4b6716d" content-type="ins cts-3" specific-use="1545442378974" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:32am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442378974"> and</named-content> <named-content rid="665ca8a2-6851-464e-994c-0af39b320aaf" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" data-style="" content-type="jrnlQueryRef" specific-use="start" id="8b3323b9-5658-40f8-a7c4-c7fd1668627b" data-replied="true"/>GGT<named-content rid="665ca8a2-6851-464e-994c-0af39b320aaf" data-class="jrnlQueryRef" data-type="end" content-type="jrnlQueryRef" specific-use="end" id="a25f232a-f0c3-4a03-873c-6ea60ddf2bab" data-replied="true"/> 227<named-content data-cid="1545433867" id="b8f7ddee-e968-4f4d-9c25-fcceca8f3591" content-type="ins cts-3" specific-use="1545441886294" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441886294">.</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="25352b88-f5a1-4268-a683-68a991df5262" data-auto-align="true" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" data-align="." data-align-left-width="9.25" data-align-right-width="24.46875" data-left-space="4.796875" data-left-indent-space="4.796875"><p id="497336b2-7ba6-48e8-9453-ee14ac203806" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="a22b481e-058d-4fac-a59d-491739a41356" data-cid="a22b481e-058d-4fac-a59d-491739a41356" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="0" data-match="0.4, 866" data-replace="0.4" data-pattern="$2" data-tag-index="s506_1" data-time="" data-username="" data-userid="">0.4</named-content><named-content id="e7a1dcfb-494e-40db-aa9b-512ebca18778" data-cid="e7a1dcfb-494e-40db-aa9b-512ebca18778" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGC" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="3" data-match="0.4, 866" data-replace=", " data-pattern="$3 " data-tag-index="s506_1" data-time="" data-username="" data-userid="">, </named-content><named-content id="03c97f07-c2ea-4856-89bc-84581959f62a" data-cid="03c97f07-c2ea-4856-89bc-84581959f62a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="5" data-match="0.4, 866" data-replace="866" data-pattern="$4" data-tag-index="s506_1" data-time="" data-username="" data-userid="">866</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="19f5ade1-59fd-4cf4-b907-a98072117d18" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="6f334e8d-947d-45e0-8748-2d87feb24927" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">2/0.7</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="57c6c2fd-dfb2-4c85-9463-52b7b6ede38a" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="aab1794a-ad8d-43f6-aa8c-f1c3b0e86f38" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="12565bcf-c867-45d7-8dd1-9670065b657c" data-cid="12565bcf-c867-45d7-8dd1-9670065b657c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1223_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="c142f190-9b3e-4627-8a6f-0c957efe3abf" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="7e3b96d7-4d02-4e21-8e8e-f0899e64dfac" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="703046a2-f1b3-47b6-8b25-a5e1df9c358f" data-cid="703046a2-f1b3-47b6-8b25-a5e1df9c358f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1224_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="b6336fde-8e17-48ee-8a96-c5b7cc9180de" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="e5c09d33-c30b-4dda-ae02-89e632fcab05" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433868" id="d5da027f-5f03-4f7c-85cc-230674ee6ce2" content-type="ins cts-3" specific-use="1545441895435" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:24am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441895435">.</named-content></p></td></tr><tr data-col-count="10" id="d2e5187f-ed63-4945-82e2-3b7295f38aaf"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="8c77e1bb-8547-4400-afd9-5dcba02df901" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="fc1440d3-6f4c-4e30-a33d-2594b774fac9" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">12</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="43a744dd-ffe2-4ae0-a821-7470b4fa281b" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="ff53e807-7a29-41cd-93b2-a338b24ee5a3" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">46</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="016feff8-4271-40f1-9b87-4f01d18faa27" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="2a0f7c2e-17e4-44e2-ab5f-6e8a4642e640" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="8545c40e-78b5-4805-935f-fb2ee6d32951" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="3f94f1c0-bf3b-4220-afee-b5e4944874d5" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="0abb51c5-af04-4b83-b854-a34e5adc0e68" data-cid="0abb51c5-af04-4b83-b854-a34e5adc0e68" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="99 mg/dL" data-replace="99" data-pattern="$1" data-tag-index="370_1" data-time="" data-username="" data-userid="">99</named-content><named-content id="b9d9618b-ea38-46b2-a008-32569eb97269" data-cid="b9d9618b-ea38-46b2-a008-32569eb97269" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="6" data-match="99 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="370_1" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433870" id="ba9652b0-fc72-4f9c-b925-836cd9fb148e" content-type="ins cts-3" specific-use="1545441900487" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:25am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441900487">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="548c4009-b14c-4c0a-8257-2884b334b31d" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="af38c3d4-b847-47e8-926a-f32f99673857" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><bold id="0bc4ebe5-126b-4cf3-8e03-7ce1fb5d23d9">Mild ketosis:</bold> FPG <named-content id="a1721792-157a-473a-a234-8ae7b0ce9fbf" data-cid="a1721792-157a-473a-a234-8ae7b0ce9fbf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="18" data-match="448 mg/dL" data-replace="448" data-pattern="$1" data-tag-index="371_1" data-time="" data-username="" data-userid="">448</named-content><named-content id="9047b2bc-1156-43cd-aa7c-b0d7f6845ac8" data-cid="9047b2bc-1156-43cd-aa7c-b0d7f6845ac8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="21" data-match="448 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="371_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>,<named-content data-cid="1545433917" id="897fb1c7-7436-45bb-aca6-8fea4e1a7363" content-type="ins cts-3" specific-use="1545442385548" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:33am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545442385548"> and</named-content> HbA1c 10.6 β-OHB <named-content id="db9e5cbb-62e4-4b06-9c5c-fea02f48c0fd" data-cid="db9e5cbb-62e4-4b06-9c5c-fea02f48c0fd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="47" data-match="1.2 mmol/L" data-replace="1.2" data-pattern="$1" data-tag-index="371_2" data-time="" data-username="" data-userid="">1.2</named-content><named-content id="bbcd47e8-be4d-4055-8e64-28e0f09122c3" data-cid="bbcd47e8-be4d-4055-8e64-28e0f09122c3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/L' to ' mmol/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="50" data-match="1.2 mmol/L" data-replace=" mmol/L" data-pattern=" $2" data-tag-index="371_2" data-track-change=" mmol/L" data-time="" data-username="" data-userid=""> mmol/L<named-content data-cid="1545433871" id="b79e4958-c926-47c5-8ad5-640fe6058049" content-type="ins cts-3" specific-use="1545441901624" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:25am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441901624">.</named-content></named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="a3ba06b3-b5bf-40d6-bc3d-5121305bdb80" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;" data-changed-attributes="data-align,data-align-left-width,data-align-right-width,data-left-space,data-left-indent-space" data-align="." data-align-left-width="9.25" data-align-right-width="24.46875" data-left-space="5.25" data-left-indent-space="5.25"><p id="4332db2f-7f75-4936-b4b2-8f65d96db6d9" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="f421a81f-aeab-41e0-b2ed-65537908f14d" data-cid="f421a81f-aeab-41e0-b2ed-65537908f14d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1231_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="adec128c-0fa9-454a-beae-e89a3e4c02b4" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="bb96b185-1005-4655-9093-0dd6d70b9d63" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">4/8.2</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="1371cf31-9305-4690-8d90-1b6460fc216d" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="57ab699f-a557-4f30-baa9-c89dbe3bbbc3" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">GAD65, IAA, IA-2A, <named-content rid="c911859b-4b80-48db-83aa-c833bcd16c37" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" data-style="" content-type="jrnlQueryRef" specific-use="start" id="009ee9fb-866f-4b30-8c09-b2df5b2ae803" data-replied="true"/>ZnT8A<named-content rid="c911859b-4b80-48db-83aa-c833bcd16c37" data-class="jrnlQueryRef" data-type="end" content-type="jrnlQueryRef" specific-use="end" id="6de6bdc3-7855-4e44-909c-0e5036f520ea" data-replied="true"/> negative<named-content data-cid="1545433872" id="5de68dd3-602d-48b5-97e4-ff1985a19d77" content-type="ins cts-3" specific-use="1545441903124" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:25am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441903124">.</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-8" data-col-index="9" id="7d95b81d-2aca-42c3-b353-9ac18238f23c" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;9&quot;"><p id="74a352af-0c70-4803-b3a7-3a66b210ac49" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="b40bf847-4997-4732-9bf0-1739536e98bd" data-cid="b40bf847-4997-4732-9bf0-1739536e98bd" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1234_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-9" data-col-index="10" id="d876f49f-2865-4118-ab82-ec73c90c3f25" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;10&quot;"><p id="b00f34d7-348a-477d-9eef-0ac26f67ae04" data-original-margin=" margin-bottom: 10.0pt; margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433873" id="d254c773-8b29-4232-aef0-b0d0941885a4" content-type="ins cts-3" specific-use="1545441904422" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:25am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441904422">.</named-content></p></td></tr></tbody></table><table-wrap-foot id="594b6e66-2ff0-41ed-86c7-52433442fa09"><fn data-class="jrnlTblFoot" fn-type="abbrev" data-def-list="true" id="47f84f44-517e-4a19-87b0-5cd30e500000"><p id="ede4d6e6-5e12-4fac-b317-ab731214f10b"><def-list id="a7c80842-91ca-4a32-9a25-3ed121d435ac"><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="4de89554-8f40-4810-91a0-8be497422465" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="a50d1fc9-7cf4-48db-a112-8490cfe51374">BMI</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="a997f964-4638-464e-a325-d3efe8a1339a"><p id="57d6fcb6-f506-4057-8c20-ac83eb817c53">body mass index</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="23a1ffab-303a-4216-af5f-0ade53eadddb" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="b4de1ae7-3424-49fc-9f39-9e335ae012c1">DKA</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="4c656e60-5311-43d1-9dad-6d9bb59d07f2"><p id="f0f2cce2-a72a-436b-98b2-177573c21396">diabetic ketoacidosis</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="57c9dacd-6811-40b1-8e84-958abc9acba8" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="3ba90835-5f34-4506-9736-fe48a6176197">FPG</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="f6ab9e16-45da-4e2b-a75a-a3b07c7c0016"><p id="25562ea0-61f2-4e61-8172-e01229d1dd9e">fasting plasma glucose</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="91cd0d1b-3704-48c2-a4cd-a976b9e35202" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="b7983000-e875-4650-b825-4488992b2307">GAD65</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="7052b951-d888-4823-b301-f0507dc1e83a"><p id="8f1f8b09-74bf-4f5c-94b3-4507f6806ef3">glutamic acid decarboxylase 65</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="85659358-41f1-4107-b24f-279e1d061af4" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="2a5fffcf-55e4-48ea-8811-1ff8d0f4bf05">GGT</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="2f9148c9-4dce-4307-901a-7ad6a71206b2"><p id="10a7c009-be9e-4a99-9cdc-25a055929947">gamma-glutamyl transferase</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="22c8283d-7ae9-4a3c-b3ba-924073ed95d9" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="d37ae34f-ff9e-440c-b8b9-26ccd89a8487">HHS</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="268258dc-a7a4-4c5d-acdb-afa458359d39"><p id="505c4613-ad74-4c3b-8d34-c071d31bfc72">hyperglycemic hyperosmolar state</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="bb21358f-b159-45dd-a64b-151701f4b7c7" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="1256c660-d680-4616-ad9a-067ab492f0de">HbA1c</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="5b2130f2-d61a-45c3-bad5-45bbba40a161"><p id="6636956c-ad2f-44d0-ab3e-2a18ed052ac7">hemoglobin A1c</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="835138af-b83f-4f7d-994b-46c5d4ad58ad" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="b705039a-55b6-42c5-8304-b18fdc5bd11f">IA-2</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="9db604bd-0156-44f7-b118-fa3341a6282f"><p id="8c631152-85c0-4d9c-8e48-c344f2ac3629">islet antigen 2</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="0cfaa666-98d0-4ee4-af5d-fc0ae40a78f5" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="0e89842b-e92f-4bc9-b767-d071d06d24d0">IAA</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="5cce815d-28f6-4778-82fc-a0116f8ddddf"><p id="aa1137d3-71bd-4e23-a7f8-86762d89c98d">insulin autoantibodies</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="852fc717-53d7-4b7c-8e2c-81e2e13979ca" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="02e0a7f7-d995-420a-8393-8ffe32952115">ICI</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="d1b00d20-a1b1-4690-a5f4-c9528eb71b6f"><p id="2ede9997-f2f3-4cfb-b06b-906c8dba4c01">immune checkpoint inhibitor</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="e2847657-d9d4-4d34-bebb-5937a33de671" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="06b9e8a9-bf8e-434a-a5ea-7eaa171dca3d">IRAE</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="f2ed0d01-e642-4867-b353-63b1dd6be85d"><p id="a7550c44-7795-4b8e-83af-a463af45fc3e">immune-related adverse event</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="56032c66-3fb0-4ce9-8f83-5878511d06d1" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="d6c5f853-e903-4e7d-8f9c-6532824fda05">MDI</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="50c9fb5e-f2d3-4273-bd17-3bf8b137b02b"><p id="7d1e908b-c017-461b-a5bb-dfa78c01d1da">multiple daily injections of insulin</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="e71293be-2247-4977-b758-cc2d08f704a6" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="5db65041-4918-4e6d-904b-1c9716abc35f">β-OHB</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="abb87cde-e6ee-4c68-88b2-e773ab4c514a"><p id="df0d673f-7f4d-4187-9946-ddac64f5dae2">beta-hydroxybutyrate</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="4a7082e9-d6bd-4af5-a3a9-9177ec7b8c4f" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="e90aa5c1-7116-430d-9f6b-d40d9a982df3">PD-1</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="09c779aa-40b0-455c-be92-37badc01bb8a"><p id="38ead74c-ebd1-4ae4-98ab-3129e03192a1">programmed cell death protein 1</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="d552404c-348a-4e1b-bc6a-342c96c6f3f7" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="0e7c8166-c805-4a06-ac44-2b9bdd32a7c8">RPG</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="171d977b-1f87-4034-b57e-eb6b1956be27"><p id="15a2e3f2-111d-42aa-9a3b-c1805c27e5c8">random plasma glucose</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="8f9206c7-48e9-4f26-b18f-10ca71bf6413" fn-type="abbrev" data-id="T3_FN1"><term data-class="jrnlAbbrevTerm" id="f8aaa7ab-6487-4474-a5b8-2b9d184a3a89">ZnT8A</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="737f0a68-b899-4ce9-86f6-24878ded164f"><p id="03d5cea6-d394-44ba-8cbd-55637567de45">Zinc transporter 8 antibody</p></def>.</def-item></def-list></p></fn></table-wrap-foot></table-wrap><table-wrap id="BLK_T4" data-id="BLK_T4" data-stream-name="a_T4" position="float"><label id="28f9791b-3cb3-41d6-866f-18b4c97b075a"><named-content data-cid="1546365745984" id="315e6876-bf82-4077-8a24-738439e40f92" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Table 4</named-content></label><caption id="086d3c35-bf61-415f-86b5-e407fc4021cc"><title id="T4" data-id="T4">Disease characteristics and course of individual <named-content id="bd02f813-bab7-4d62-89af-aa5fa6d0997e" data-cid="bd02f813-bab7-4d62-89af-aa5fa6d0997e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="58" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="444_3" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with PD-1 inhibitor<named-content data-cid="1545433453" id="3f9ddd0b-b93e-4291-b24e-c76ddd9f6375" content-type="del cts-3" specific-use="1545438921512" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:35am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438921512"> </named-content><named-content data-cid="1545433454" id="b7f03ff0-3dd1-4f14-b71f-7a342660da17" content-type="ins cts-3" specific-use="1545438923039" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:35am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438923039">-</named-content>induced worsening of pre-existing type <named-content data-cid="1545113216049" id="28c298cb-54f2-447e-8855-aebd1dc2a69c" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="d2e5124a-f958-4f2c-812d-827727768ed3" data-cid="1545113216049" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="126" data-match="2" data-pattern="" data-tag-index="444_2" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433455" id="bebed521-1088-406a-95d0-998d8c571091" content-type="del cts-3" specific-use="1545438927016" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:35am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438927016">two</named-content></named-content><named-content data-cid="1545113216124" id="a0837dfc-face-453a-b2f3-f9131d045fd9" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002" data-reason="truecase"> diabetes. RPG: random plasma glucose; FPG: fasting plasma glucose; HbA1c: hemoglobin A1c.</named-content><named-content data-cid="1545113216124" id="537e2085-6801-4e24-af3d-58e7f4570d3f" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002" data-reason="truecase"><named-content data-cid="1545433456" id="4c4bb72e-2dbb-45c9-bfd3-67bdbc34729c" content-type="ins cts-3" specific-use="1545438927263" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:35am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438927263">2</named-content> diabetes<named-content data-cid="1545124890" id="b68bdf68-8a3e-4eea-86fc-a7b347a0c929" content-type="del cts-2" specific-use="1545126658060" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:20pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545126658060">. RPG: random plasma glucose; Fpg: fasting plasma glucose; HbA1c: hemoglobin A1c.</named-content></named-content></title></caption><table data-col-count="8" id="t3_1" data-caption-link="T3" data-col-widths-px="24,31,69,116,211,67,86,86" data-table-type="landScape" data-old-attributes="&quot;data-table-type&quot;:&quot;doubleColumn&quot;;&quot;data-col-widths-px&quot;:&quot;18.5,28.5,86.5,64.5,107.5,69.5,73.5,62.5&quot;" data-changed-attributes="data-table-type,data-col-widths-px"><thead id="b3121e83-4d6c-4b16-b000-7abc16f6aea0"><tr data-col-count="8" id="ca0b591f-ca46-44e3-962f-bb7fc1b8ac16"><td data-original-border="border:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="fb4a39b9-43df-4d6c-ae88-0e756acf3514" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="56cf8e11-17c4-4bc4-80e2-cd025ad5d48c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pt</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="a057ca96-6d5c-435e-92fd-962c71057b67" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="964dd890-a31a-497c-81c1-a612b85a3fd0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">BMI</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="912516e8-7445-4907-a565-9b775ebfb19e" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="ceb00fa7-9fda-4d33-bb6d-f335a76c8210" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">ICI</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="11930dcf-054c-4dc3-8a54-b6d66423ee14" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="05a10209-2cd6-4b53-8b1d-ba16547d7b54" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pre-ICI laboratory data</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="0b44f375-60d2-4541-afe5-129df066b7e4" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="adb8d17e-a0c2-4959-b1b4-aaa03267773f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Presentation</p></td><td data-class="" data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="8bcfe7bf-20e4-4036-83b8-db9c84e639b9" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;6&quot;"><p id="d115d819-5177-453e-9794-4ec75bb24b28" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Doses/<named-content data-cid="1545433457" id="3bb0a155-8faa-4aa4-b140-d5ae963c6bc4" content-type="del cts-3" specific-use="1545438944003" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:35am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438944003">T</named-content><named-content data-cid="1545433458" id="0919d279-bbde-4f64-a1ab-f30b8c6da928" content-type="ins cts-3" specific-use="1545438944247" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:35am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438944247">t</named-content>ime (mo<named-content data-cid="1545433459" id="3badc849-d110-43d7-97b3-bb706ece4af7" content-type="ins cts-3" specific-use="1545438946433" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:35am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438946433">nths</named-content>) to presentation</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="8f260214-0ad6-4a4c-8871-2a8a3cf444a1" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="1f946f74-8cf2-413e-9a55-ef7c460b066c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Other IRAE</p></td><td data-original-border="border:solid windowtext 1.0pt; border-left:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="65b720d5-8f75-472e-8e07-9efcdd4e1a63" valign="bottom" data-old-attributes="&quot;valign&quot;:&quot;bottom&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="2bb4e315-b98e-411f-accf-71d04b4800e5" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Therapy</p></td></tr></thead><tbody id="649f7e07-712d-4c56-a48e-8f8ecd0b0328"><tr data-col-count="8" id="b8ae07d8-1e16-41d6-a2f2-d2ae5c929ca4" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="2fe60221-04e4-4e06-bbe4-fd357baded28" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="b0ede70b-fb1f-48c8-927f-fbee435e13d2" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">13</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="e55da948-cf41-4edb-a4f5-955e3defc5ba" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="a9fff8b2-2b4b-4544-a441-845f467cee97" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">33.3</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="e13cbd1d-e05e-4e19-990f-6dea8560887a" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="761bbd76-c322-436e-9a02-3fcfb0d19350" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Nivolumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="c6778501-101e-4ef7-86fb-55564811fa0f" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="1f6a2681-31a2-44ef-8eff-65e9dda5d463" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="c7a4265e-6897-4f36-b534-6a3f9ba04db3" data-cid="c7a4265e-6897-4f36-b534-6a3f9ba04db3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="166 mg/dL" data-replace="166" data-pattern="$1" data-tag-index="385_1" data-time="" data-username="" data-userid="">166</named-content><named-content id="2d68c633-1768-4cd6-998d-04e35bef1fde" data-cid="2d68c633-1768-4cd6-998d-04e35bef1fde" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="166 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="385_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 8.1%<named-content data-cid="1545433463" id="a227da3f-2fa8-47da-9968-d1a953241179" content-type="ins cts-3" specific-use="1545438962163" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:36am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438962163">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="5d9bedbc-1cd1-42e7-a1ff-f37d47b566dc" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="498797cd-a793-4b1f-a55c-4c3709d1fed9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">HbA1c 10%, FPG <named-content id="ccc202a1-4cc7-4f9d-8f9b-9dc58a271de7" data-cid="ccc202a1-4cc7-4f9d-8f9b-9dc58a271de7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="15" data-match="300 mg/dL" data-replace="300" data-pattern="$1" data-tag-index="386_1" data-time="" data-username="" data-userid="">300</named-content><named-content id="b736c48d-b9bd-4dc9-9d8a-f7e19552128d" data-cid="b736c48d-b9bd-4dc9-9d8a-f7e19552128d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="18" data-match="300 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="386_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433531" id="f618f87a-76c6-4f23-b2df-df121c6ad03e" content-type="ins cts-3" specific-use="1545439450753" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439450753">,</named-content></named-content><named-content data-cid="1545433464" id="322488ed-43b9-466c-aca9-68819dd472bf" content-type="del cts-3" specific-use="1545438965083" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:36am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438965083">,</named-content> RPG <named-content id="626d81ba-cd60-4003-94b7-df53a1d7a7ed" data-cid="626d81ba-cd60-4003-94b7-df53a1d7a7ed" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="30" data-match="580 mg/dL" data-replace="580" data-pattern="$1" data-tag-index="386_2" data-time="" data-username="" data-userid="">580</named-content><named-content id="a06460ad-3f3f-49fe-89a0-e3ad70b519cb" data-cid="a06460ad-3f3f-49fe-89a0-e3ad70b519cb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="33" data-match="580 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="386_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433469" id="97a7bcc7-7b81-459e-a71d-199b5df6c5df" content-type="ins cts-3" specific-use="1545438966752" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:36am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438966752">.</named-content></named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="c231841f-db98-4d0d-9bfa-a9b93680158e" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;"><p id="d5c8ce95-4128-4766-b11d-04e8b0c423e8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">2/3.9</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="3c197152-34b6-44db-86de-30f337340cda" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="bba6cfdb-adf8-46bf-83c9-3d2f895f6546" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Thyroiditis<named-content data-cid="1545433473" id="969e96a1-24a0-475b-ac8c-f0ec2193b7ee" content-type="ins cts-3" specific-use="1545439207359" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:40am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439207359">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="607e0ad0-d6ad-4857-b7b2-5a96b123c549" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="2180a7a3-361c-47d5-b69b-5413b4365a75" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content rid="d990bd30-1596-424a-8854-1771138d21ad" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" data-style="" content-type="jrnlQueryRef" specific-use="start" id="35f0ead0-d778-4c98-ba40-bff3263a7e1b" data-replied="true"/>TZD<named-content rid="d990bd30-1596-424a-8854-1771138d21ad" data-class="jrnlQueryRef" data-type="end" content-type="jrnlQueryRef" specific-use="end" id="91231f71-4953-4036-a31b-9c66774ec49e" data-replied="true"/><named-content data-cid="1545433447" id="e77c771b-0c7b-4208-9194-b827d0b37537" content-type="del cts-3" specific-use="1545438889867" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:34am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438889867">,</named-content><named-content data-cid="1545433448" id="ac1b3aca-98a9-4b72-9306-b1f414daf8f3" content-type="ins cts-3" specific-use="1545438890113" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:34am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438890113"> and</named-content> <named-content data-cid="1545433445" id="13c806bc-7d4b-41d1-b50a-087e32fa49b2" content-type="del cts-3" specific-use="1545438540876" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:29am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438540876">B</named-content><named-content data-cid="1545433446" id="fce3f7b4-2a1c-4331-aec8-8e0c5fd6d347" content-type="ins cts-3" specific-use="1545438541458" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:29am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438541458">b</named-content>asal insulin<named-content data-cid="1545433452" id="9399a8bb-6196-4161-bcfa-750afb018247" content-type="ins cts-3" specific-use="1545438892051" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:34am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545438892051">.</named-content></p></td></tr><tr data-col-count="8" id="0b677d09-b053-40b1-8110-eb66fe000105"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="952308fe-b2c2-4716-9ef1-f9f8d5072fb1" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="1e209800-e8a6-459f-a077-f5489c1148bb" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">14</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="29caa926-69fd-4d16-8c14-0d55f2836471" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="d44ef9c1-e38a-449d-8bcb-5bcb50cb1a76" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">24.4</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="8a99a81c-6363-47a2-94af-dce183b36774" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="16746da1-d580-435a-8722-0b0ba83814ad" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Nivolumab</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="b319237f-bf12-48fc-8a6c-88dd665ac0be" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="725e71e9-1252-4d14-ba6c-dd9333e0d4ad" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="02e36ab8-9851-428a-b5bf-81213ffbdbe8" data-cid="02e36ab8-9851-428a-b5bf-81213ffbdbe8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="197 mg/dL" data-replace="197" data-pattern="$1" data-tag-index="392_1" data-time="" data-username="" data-userid="">197</named-content><named-content id="34636bb8-87b5-431e-a97b-ab7ee59f7b71" data-cid="34636bb8-87b5-431e-a97b-ab7ee59f7b71" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="197 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="392_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG <named-content id="cec7f900-c614-41c7-bd70-aba32998859f" data-cid="cec7f900-c614-41c7-bd70-aba32998859f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="19" data-match="273 mg/dL" data-replace="273" data-pattern="$1" data-tag-index="392_2" data-time="" data-username="" data-userid="">273</named-content><named-content id="39e61e92-fc6b-4a2f-8d5a-24304c687a07" data-cid="39e61e92-fc6b-4a2f-8d5a-24304c687a07" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="22" data-match="273 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="392_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 8.2%</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="3443ed9b-4bed-4609-aa7c-5ba9c44fd2cb" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="0d5aa3c1-d833-46ab-adc4-5534342053c0" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">HbA1c <named-content rid="228b1ba7-4e44-495d-b25d-43f56d87a9ab" data-class="jrnlQueryRef" data-type="start" data-query-ref="true" data-query-for="author" data-query-from="copyeditor" data-channel="query" data-topic="action" data-event="click" data-message="{'funcToCall': 'highlightQuery'}" data-query-type="action" data-style="" content-type="jrnlQueryRef" specific-use="start" id="5be5304b-e41d-4df6-9f93-3610d5136ee1" data-replied="true"/><named-content rid="228b1ba7-4e44-495d-b25d-43f56d87a9ab" data-class="jrnlQueryRef" data-type="end" content-type="jrnlQueryRef" specific-use="end" id="b1fbaba9-c10c-4e58-92bd-e23956183324" data-replied="true"/><named-content data-cid="1545840498" id="89d952aa-88be-46df-9440-326dc8584223" content-type="del cts-5" specific-use="1545841608948" xlink:title="Yogish C Kudva (AUTHOR)" alt="author 3684625162" data-title="Deleted by Yogish C Kudva (AUTHOR) - Dec 26 2018 10:26am" data-track-detail="" data-userid="author 3684625162" data-username="Yogish C Kudva (AUTHOR)" data-time="1545841608948">i</named-content>10%, RPG <named-content id="2e0cb19d-dd89-43a9-b096-6ba2da44f32b" data-cid="2e0cb19d-dd89-43a9-b096-6ba2da44f32b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="17" data-match="378 mg/dL" data-replace="378" data-pattern="$1" data-tag-index="393_1" data-time="" data-username="" data-userid="">378</named-content><named-content id="e96363f0-4bfb-4cfd-a7b4-b0167f8b80be" data-cid="e96363f0-4bfb-4cfd-a7b4-b0167f8b80be" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="20" data-match="378 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="393_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, FPG <named-content id="1499912b-aec6-4f20-a17e-704a786dd047" data-cid="1499912b-aec6-4f20-a17e-704a786dd047" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="32" data-match="311 mg/dL" data-replace="311" data-pattern="$1" data-tag-index="393_2" data-time="" data-username="" data-userid="">311</named-content><named-content id="8787f8b1-c864-49fa-ba31-2f80cf37926c" data-cid="8787f8b1-c864-49fa-ba31-2f80cf37926c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="35" data-match="311 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="393_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, β-OHB <named-content id="62b24a08-228f-4dc9-b28f-270208133db4" data-cid="62b24a08-228f-4dc9-b28f-270208133db4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="50" data-match="1.8 mmol/L" data-replace="1.8" data-pattern="$1" data-tag-index="393_3" data-time="" data-username="" data-userid="">1.8</named-content><named-content id="ec44fd30-7eb3-4819-b790-a904af794a41" data-cid="ec44fd30-7eb3-4819-b790-a904af794a41" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/L' to ' mmol/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="53" data-match="1.8 mmol/L" data-replace=" mmol/L" data-pattern=" $2" data-tag-index="393_3" data-track-change=" mmol/L" data-time="" data-username="" data-userid=""> mmol/L</named-content>; <named-content data-cid="1545433470" id="08a6a9b9-35ec-4941-a8dc-db228aa67db8" content-type="del cts-3" specific-use="1545439186547" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439186547">M</named-content><named-content data-cid="1545433471" id="0c11afe4-f651-42e8-9625-ef4ee602eea0" content-type="ins cts-3" specific-use="1545439186917" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:39am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439186917">m</named-content>ethylprednisolone <named-content id="9825475e-920f-47aa-a084-628605d11c88" data-cid="9825475e-920f-47aa-a084-628605d11c88" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="81" data-match="1000 mg" data-replace="1000" data-pattern="1000" data-tag-index="393_4" data-time="" data-username="" data-userid="">1000</named-content><named-content id="05354188-a42b-40b6-96d2-61d16222abf1" data-cid="05354188-a42b-40b6-96d2-61d16222abf1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg' to ' mg'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="85" data-match="1000 mg" data-replace=" mg" data-pattern=" $2" data-tag-index="393_4" data-track-change=" mg" data-time="" data-username="" data-userid=""> mg</named-content> daily for <named-content id="34db7bfc-263c-443a-9c1f-6ce030123b97" data-cid="34db7bfc-263c-443a-9c1f-6ce030123b97" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="99" data-match="1 week" data-replace="1" data-pattern="$1" data-tag-index="393_5" data-time="" data-username="" data-userid="">1</named-content><named-content id="bc556950-dcb1-4790-8af7-ceafb6061944" data-cid="bc556950-dcb1-4790-8af7-ceafb6061944" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣week' to ' week'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="100" data-match="1 week" data-replace=" week" data-pattern=" $2" data-tag-index="393_5" data-track-change=" week" data-time="" data-username="" data-userid=""> week</named-content>.</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="66024428-f1b5-4f84-9b53-36d103d87ed9" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;"><p id="d478e266-645e-46b2-98e8-10d63eae7467" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">4/5.7</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="427028c6-a01f-412c-b6e2-19799f2d3f3c" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="3c390d5c-8a07-4d5c-b9fa-bcc81464771f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Dermatitis; secondary adrenal insufficiency<named-content data-cid="1545433472" id="7bf8aa69-0328-4aea-ab3b-1f0458a6075c" content-type="ins cts-3" specific-use="1545439205707" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:40am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439205707">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="f3d2e824-defd-4c09-818a-28560e0b1cec" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="2b9d487c-779a-4588-9b9c-72dbdfe56b9d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433474" id="3ad52ddd-fa39-4302-9714-5cf6350a8be4" content-type="ins cts-3" specific-use="1545439209668" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:40am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439209668">.</named-content></p></td></tr><tr data-col-count="8" id="0a076876-fc85-44fd-95c2-0505a3e9ebd5" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="1df32b4a-6cd1-4861-bbc4-4621a527dc5a" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="a692e1f5-0767-4265-993a-b6230c9b6034" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">15</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="c21c57e6-d657-4061-9848-b6185a5a622c" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="a9928352-c623-415a-a8dd-d6676281a827" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">25.5</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="bde5cb83-c9a8-4081-8fb4-6846ebbc143f" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="0dcbf828-e628-4f52-82a6-271e65202c6e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="34e9d970-4534-450c-8ba2-022c64ab07f9" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="69fe460d-aba3-431e-abd8-5139a958ea7f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="9ad66cc9-a113-4227-b785-0c0e0d74625a" data-cid="9ad66cc9-a113-4227-b785-0c0e0d74625a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="104 mg/dL" data-replace="104" data-pattern="$1" data-tag-index="399_1" data-time="" data-username="" data-userid="">104</named-content><named-content id="7d8a86de-edcb-4462-bd72-be624f70fa05" data-cid="7d8a86de-edcb-4462-bd72-be624f70fa05" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="104 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="399_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 6.2%<named-content data-cid="1545433475" id="823ddc04-d081-4c8f-b714-cb77abd5e088" content-type="ins cts-3" specific-use="1545439213083" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:40am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439213083">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="a9148e6d-bf37-470b-90c4-7ae0a91dc556" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="702c2db8-9a16-4c64-85c3-99ee1fabb31d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">HbA1c 8.6%, RPG <named-content id="ef8f862a-99d7-43e6-a8bf-da0ba6d3ff64" data-cid="ef8f862a-99d7-43e6-a8bf-da0ba6d3ff64" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="16" data-match="239 mg/dL" data-replace="239" data-pattern="$1" data-tag-index="400_1" data-time="" data-username="" data-userid="">239</named-content><named-content id="a0a346ec-10a0-4d48-8cf7-2c163e4369dc" data-cid="a0a346ec-10a0-4d48-8cf7-2c163e4369dc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="19" data-match="239 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="400_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, FPG <named-content id="4f621562-30b6-4d75-ac79-7878f373287a" data-cid="4f621562-30b6-4d75-ac79-7878f373287a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="31" data-match="190 mg/dL" data-replace="190" data-pattern="$1" data-tag-index="400_2" data-time="" data-username="" data-userid="">190</named-content><named-content id="abe38324-e08d-4b5b-9b72-37b451b34f7b" data-cid="abe38324-e08d-4b5b-9b72-37b451b34f7b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="34" data-match="190 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="400_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433476" id="ed623958-d280-4860-81a4-a9ae7d050d2d" content-type="ins cts-3" specific-use="1545439215764" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:40am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439215764">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="91f58572-170d-4b2a-b0d7-0d89a46e8cec" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;"><p id="8165be2b-29a8-40c3-92f7-c6954bdac8ff" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">12/5</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="11c99096-ba7b-4033-b56d-cfaacd87dc00" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="385136d5-d7f8-41cc-b4d7-ac576cca1d7f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Thyroiditis<named-content data-cid="1545433477" id="01558e1a-5c1d-411a-8404-0d85ac2175a4" content-type="ins cts-3" specific-use="1545439220315" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:40am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439220315">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="bf4ca1f3-bf0d-4a83-a2ff-19190a5f2eb6" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="9ca6f9f3-aa56-4d28-9db9-155d22f5cb7b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Basal insulin<named-content data-cid="1545433478" id="614f8fd4-ec44-466e-86a2-dc07b373b825" content-type="ins cts-3" specific-use="1545439221719" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:40am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439221719">.</named-content></p></td></tr><tr data-col-count="8" id="2b8926b1-2c63-4644-ba99-5ca2cc21eb74"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="277057ca-f54a-4799-925b-86a3f213f7fd" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="e4b640d5-2ba4-44fd-86bf-2a6e7d4c3b95" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">16</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="874cd4fd-dfa9-46b0-9ed2-747b23e0f04c" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="e50f0a05-27df-41c1-a448-1fe7da1a0b76" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">27.1</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="ace5d053-3e50-44aa-8b29-1e7cdea5b6c4" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="3fe0f825-a555-4f33-b7ca-edb8e47721f6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="a878fed8-3733-41fe-b14f-cfc92e6ab01d" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="35095ff4-51a8-4896-80ce-c2699d181e00" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="558d5ad1-b071-4d51-85e1-5bcbad970c64" data-cid="558d5ad1-b071-4d51-85e1-5bcbad970c64" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="111 mg/dL" data-replace="111" data-pattern="$1" data-tag-index="406_1" data-time="" data-username="" data-userid="">111</named-content><named-content id="412597f5-57d7-491f-a115-8f34ca965a6d" data-cid="412597f5-57d7-491f-a115-8f34ca965a6d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="111 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="406_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG <named-content id="9fb35566-e525-42f7-810c-830d11de0c5b" data-cid="9fb35566-e525-42f7-810c-830d11de0c5b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="19" data-match="132 mg/dL" data-replace="132" data-pattern="$1" data-tag-index="406_2" data-time="" data-username="" data-userid="">132</named-content><named-content id="e7952463-2622-4921-ad67-abee61ce81e2" data-cid="e7952463-2622-4921-ad67-abee61ce81e2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="22" data-match="132 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="406_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 8%<named-content data-cid="1545433479" id="9ec49a1d-9d9f-40a8-ab91-227d77b7c0bb" content-type="ins cts-3" specific-use="1545439223945" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:40am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439223945">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="eb66e986-2619-4927-a66f-eb5eed4a8b10" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="76492170-7d4e-4fc1-bc72-73be5d3c313a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">HbA1c 11.3%, RPG <named-content id="d629eea9-ea55-436d-8a87-ceb259dcacf5" data-cid="d629eea9-ea55-436d-8a87-ceb259dcacf5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="17" data-match="367 mg/dL" data-replace="367" data-pattern="$1" data-tag-index="407_1" data-time="" data-username="" data-userid="">367</named-content><named-content id="9b190324-e6fd-49d7-8990-a1faafdbfb68" data-cid="9b190324-e6fd-49d7-8990-a1faafdbfb68" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="20" data-match="367 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="407_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, FPG <named-content id="d4567357-0ca2-42d1-89a6-836e600764d5" data-cid="d4567357-0ca2-42d1-89a6-836e600764d5" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="32" data-match="222 mg/dL" data-replace="222" data-pattern="$1" data-tag-index="407_2" data-time="" data-username="" data-userid="">222</named-content><named-content id="34e4b709-3e9f-49c1-b5c7-c3c996b3fc0a" data-cid="34e4b709-3e9f-49c1-b5c7-c3c996b3fc0a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="35" data-match="222 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="407_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433484" id="22f9d1d4-31e2-4202-8e4a-be6a059b8fac" content-type="ins cts-3" specific-use="1545439231789" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:40am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439231789">.</named-content></named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="4f9f72ad-9ba7-499c-8357-b23e20b4b154" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;"><p id="660f7974-b500-4f5c-9f3a-f9dd19fed07c" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">5/3.8</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="85ae8f24-76fb-4e8e-ba92-bea36e0f26c3" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="882c91b9-1067-4528-82fc-b1d727116708" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Ocular<named-content data-cid="1545433485" id="4e25a515-a43b-4200-8141-d15f5a503424" content-type="ins cts-3" specific-use="1545439233252" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:40am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439233252">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="f17a4826-4a57-4f7e-8378-7701cd7f3fa8" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="4330fbcb-cce2-4ae2-9be3-c3a6f2c12c50" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Metformin<named-content data-cid="1545433933" id="5c91e705-f12e-4d5e-bc01-a8033c71ad39" content-type="del cts-3" specific-use="1545443148001" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:45am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443148001">,</named-content><named-content data-cid="1545433934" id="9b0ee80b-df49-4b0c-aa24-78f219773755" content-type="ins cts-3" specific-use="1545443148542" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:45am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443148542"> and</named-content> MDI<named-content data-cid="1545433486" id="dfa7d210-d38b-426e-889a-b9a62bc143c2" content-type="ins cts-3" specific-use="1545439240857" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:40am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439240857">.</named-content></p></td></tr><tr data-col-count="8" id="fb2e07f4-2691-4925-9df4-6a8b8aea4cf5" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="67476516-e3d2-4404-9edf-70f36f01d771" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="67a72c5d-df0a-4189-b463-42c9116f071d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">17</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="9b23592c-9e96-4c98-be96-f1fddcb857e5" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="f9428d6a-5cfd-4d4e-8c47-6b5a6590d729" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">37.9</p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="e13183e2-a2db-4310-a00a-d0ef162ae32a" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="e258e350-6dcb-4d11-a2cb-620063b95377" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="58b5712f-64f7-4327-9a56-6d6bf416444c" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="4eebb9d4-1bb3-4924-be74-abcc907396d6" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="3fefd5e0-1d45-4925-8192-f06f02f08630" data-cid="3fefd5e0-1d45-4925-8192-f06f02f08630" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="121 mg/dL" data-replace="121" data-pattern="$1" data-tag-index="413_1" data-time="" data-username="" data-userid="">121</named-content><named-content id="deff109b-650a-49ae-b5b8-1bef36cfdefc" data-cid="deff109b-650a-49ae-b5b8-1bef36cfdefc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="121 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="413_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 7.4%<named-content data-cid="1545433520" id="6d6e5361-d264-4626-b10b-af61ae0f4bd9" content-type="ins cts-3" specific-use="1545439341290" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439341290">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="e9fe216d-aba3-4c64-baed-e36463c35769" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="ce143f3c-d4b5-4c09-9cf9-4741fede5205" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="d0ee4874-a478-4a0a-8c83-0dc2339a1fa3" data-cid="d0ee4874-a478-4a0a-8c83-0dc2339a1fa3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="208 mg/dL" data-replace="208" data-pattern="$1" data-tag-index="414_1" data-time="" data-username="" data-userid="">208</named-content><named-content id="37ed671c-0690-47d8-a284-d06af351772c" data-cid="37ed671c-0690-47d8-a284-d06af351772c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="208 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="414_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 9%<named-content data-cid="1545433527" id="23c676b1-8883-413f-a8a5-865a5fab049f" content-type="del cts-3" specific-use="1545439440767" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439440767">,</named-content><named-content data-cid="1545433528" id="a8068582-4fa3-4021-98c1-e373d9859f89" content-type="ins cts-3" specific-use="1545439441122" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439441122">.</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="1f98cc44-ef81-4aad-9a49-df058eac25a1" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;"><p id="c3e15a06-c6f8-4e88-9f6d-eaaee50376f4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">4/1.4</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="ebab4732-55dd-4b7e-893c-2d6a04566d72" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="a28e33af-6b3c-4fd1-893c-17c2c5719490" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="50a50aa7-5167-4cd7-b8d7-3773e2c962f2" data-cid="50a50aa7-5167-4cd7-b8d7-3773e2c962f2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1299_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="8de18a34-1b3b-47f8-954a-d415e9a882d7" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="23a2e2c0-7233-4915-a73e-e2a5bf792ce4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI</p></td></tr><tr data-col-count="8" id="733bb5c7-d319-4d28-a1ac-9adae89dd194"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="b26de344-4279-43ac-8f1a-7b1528f1cd28" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="d701fa95-8373-440d-b9f8-086047ad9b63" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">18</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="bf0c4319-27b3-406f-8ac9-0075c281c5d5" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="32742cf6-7990-4a7f-b36e-32e763269629" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">45.2</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="d32a62ca-3dc5-4960-911a-6e0f155d8531" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="f4877913-d9a2-455c-afb4-a1880fe57020" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="0b3cbc6a-d438-4db6-b43c-443dabd7ed79" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="7b428f40-df17-4881-9cb3-e265a4a47930" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="fddbf4cb-7f80-42a4-a834-9226725dca6e" data-cid="fddbf4cb-7f80-42a4-a834-9226725dca6e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="140 mg/dL" data-replace="140" data-pattern="$1" data-tag-index="419_1" data-time="" data-username="" data-userid="">140</named-content><named-content id="f8858818-036c-44d7-95f0-7a8d36fa790a" data-cid="f8858818-036c-44d7-95f0-7a8d36fa790a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="140 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="419_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 6.6%<named-content data-cid="1545433521" id="07e2b1d2-62b8-43a6-9f53-be520c8b4676" content-type="ins cts-3" specific-use="1545439342743" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439342743">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="20a205d0-4c04-4ac8-9b32-d2ab122996fb" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="20908215-13da-4d47-8c9f-105fbdab381f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="e833920a-6260-49bc-a209-416c059c676b" data-cid="e833920a-6260-49bc-a209-416c059c676b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="230 mg/dL" data-replace="230" data-pattern="$1" data-tag-index="420_1" data-time="" data-username="" data-userid="">230</named-content><named-content id="c082c3bb-854f-4dba-8b64-2c5ed24e284f" data-cid="c082c3bb-854f-4dba-8b64-2c5ed24e284f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="230 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="420_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG <named-content id="b6b3560c-b777-45f3-844f-f855efc00e89" data-cid="b6b3560c-b777-45f3-844f-f855efc00e89" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="19" data-match="249 mg/dL" data-replace="249" data-pattern="$1" data-tag-index="420_2" data-time="" data-username="" data-userid="">249</named-content><named-content id="df786c93-1343-481f-8e3b-1c559cccf0f3" data-cid="df786c93-1343-481f-8e3b-1c559cccf0f3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="22" data-match="249 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="420_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 8.1%,<named-content data-cid="1545216243" id="dccec490-0d80-4973-b9dc-95e6043fbd96" content-type="del cts-1" specific-use="1545217672710" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 19 2018 4:37pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545217672710"> </named-content><named-content data-cid="1545216246" id="7e4d502b-f183-41fb-9a54-1b5357f857f4" content-type="del cts-1" specific-use="1545217694319" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 19 2018 4:38pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545217694319">,</named-content><named-content data-cid="1545216245" id="47b05614-7971-4dd2-8d65-9ed21e3d843e" content-type="del cts-1" specific-use="1545217692337" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 19 2018 4:38pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545217692337"> </named-content><named-content data-cid="1545433490" id="6520232f-9a93-4ca8-8e2d-44c2228661bd" content-type="ins cts-3" specific-use="1545439300386" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439300386"> </named-content><named-content data-cid="1545433492" id="2f378d6b-0fac-4203-bb4f-901b6ee7f6ff" content-type="del cts-3" specific-use="1545439301633" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439301633">D</named-content><named-content data-cid="1545433491" id="12c6862f-b209-4f9c-96f8-72f4639511ad" content-type="ins cts-3" specific-use="1545439301088" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439301088">d</named-content>examethasone <named-content data-cid="1545113216050" id="71a3f171-9c0b-4f58-bb33-d99466ea80cd" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="1e1aacfe-fab4-4721-bc05-506ae08c3dc1" data-cid="1545113216050" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="58" data-match="2" data-pattern="" data-tag-index="420_5" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433487" id="beacd85a-0add-42d9-8d33-26c27d517693" content-type="del cts-3" specific-use="1545439292707" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439292707">two</named-content></named-content><named-content id="cdd964b7-402e-423e-902e-468f90015a34" data-cid="cdd964b7-402e-423e-902e-468f90015a34" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣gm' to ' gm'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="59" data-match="2 gm" data-replace=" gm" data-pattern=" $2" data-tag-index="420_3" data-track-change=" gm" data-time="" data-username="" data-userid=""><named-content data-cid="1545433488" id="67b077a8-238a-419c-8f4d-98b52a94aaa4" content-type="ins cts-3" specific-use="1545439292941" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439292941">2</named-content> g<named-content data-cid="1545433489" id="d6b0524f-1f7c-4d61-8dd1-67c9833cfa9a" content-type="del cts-3" specific-use="1545439294002" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439294002">m</named-content></named-content> daily for <named-content id="3e20b79c-22aa-43c9-994c-a7cc3be48de9" data-cid="3e20b79c-22aa-43c9-994c-a7cc3be48de9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="73" data-match="5 months" data-replace="5" data-pattern="$1" data-tag-index="420_4" data-time="" data-username="" data-userid="">5</named-content><named-content id="2ba6c290-33d5-40d5-8d38-de63e813c621" data-cid="2ba6c290-33d5-40d5-8d38-de63e813c621" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="74" data-match="5 months" data-replace=" months" data-pattern=" $2" data-tag-index="420_4" data-time="" data-username="" data-userid=""> months</named-content>.</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="b3075823-6e62-4e95-a5ca-b2231a32bcbf" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;"><p id="1c588582-f8b2-4e34-9981-9b1a06b4d999" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">3/6.9</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="f17a98d8-7f95-4aad-a359-0ca5d2579754" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="760656d2-4bf3-4c26-98bc-f2a52eb26a07" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Thyroiditis<named-content data-cid="1545433495" id="b5c79ecd-a270-4d32-a4a5-30a1ad71cc69" content-type="del cts-3" specific-use="1545439308514" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439308514">,</named-content><named-content data-cid="1545433496" id="7623b38e-4a61-43e6-a359-f92a776cf2a8" content-type="ins cts-3" specific-use="1545439308862" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439308862"> and</named-content> <named-content data-cid="1545433501" id="095dadd3-f028-4450-a473-7cc67ed0fddf" content-type="del cts-3" specific-use="1545439311875" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439311875">H</named-content><named-content data-cid="1545433502" id="45e3cef6-bef9-4f21-958c-31a060371652" content-type="ins cts-3" specific-use="1545439312305" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439312305">h</named-content>ypophysitis<named-content data-cid="1545433500" id="9c644de0-3386-48ea-af80-96d9c6cd6c21" content-type="ins cts-3" specific-use="1545439310095" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439310095">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="d4dad6b6-7d34-432a-9280-7ab10a71b244" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="26de78e5-44e8-476d-9315-e82fd36edac1" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Metformin<named-content data-cid="1545433503" id="745a836a-5197-4ed6-8309-17e84e9a115b" content-type="del cts-3" specific-use="1545439314057" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439314057">,</named-content><named-content data-cid="1545433504" id="9a584811-455a-4685-baa3-30424c9e7933" content-type="ins cts-3" specific-use="1545439314307" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439314307"> and</named-content> MDI<named-content data-cid="1545433508" id="7a4a2e1a-8630-4ed6-ad72-16002c838c78" content-type="ins cts-3" specific-use="1545439315359" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439315359">.</named-content></p></td></tr><tr data-col-count="8" id="17540763-bdc7-447e-91f9-b0d19525ce9f" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="a08fb950-7c10-4b4a-818d-636713a38ae8" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="d49f5aae-c750-41a0-98d1-5f7075c67baf" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">19</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="af308f7b-db46-45e3-9081-3fc0a0c30e32" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="4af421be-a3ae-41b7-957f-bae12fe9a01a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">27.5</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="a4a7b8ca-c4cc-4483-b7e1-302df2783fe6" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="9c9f7aed-2a2a-4a43-8292-864d1792056b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Ipilimumab → Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="70605222-288f-49b3-87b4-193226a67f88" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="e1fd0ddf-709c-412c-8f52-f49afb454ffc" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="03ba29e7-1234-4ad2-b189-a8da452b5088" data-cid="03ba29e7-1234-4ad2-b189-a8da452b5088" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="117 mg/dL" data-replace="117" data-pattern="$1" data-tag-index="426_1" data-time="" data-username="" data-userid="">117</named-content><named-content id="62a752ab-afbe-4762-b3d1-41f52f981755" data-cid="62a752ab-afbe-4762-b3d1-41f52f981755" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="117 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="426_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL<named-content data-cid="1545433522" id="4d72bd3e-7679-4f32-b35e-59d0c1f45093" content-type="ins cts-3" specific-use="1545439344972" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439344972">.</named-content></named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="f3911fdf-6408-475a-8cc4-77ac845ff71c" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="988045f9-2815-4c5e-be8e-4fd4f930981f" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="4e2dfb20-d726-4fb9-b219-105763f6f549" data-cid="4e2dfb20-d726-4fb9-b219-105763f6f549" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="304 mg/dL" data-replace="304" data-pattern="$1" data-tag-index="427_1" data-time="" data-username="" data-userid="">304</named-content><named-content id="16c849b2-7c1a-45fc-b2f5-0a44e0f702bf" data-cid="16c849b2-7c1a-45fc-b2f5-0a44e0f702bf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="304 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="427_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 11.8%<named-content data-cid="1545433493" id="4d32229c-eacb-4f0c-90b4-dff0108edba0" content-type="del cts-3" specific-use="1545439305019" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439305019">,</named-content><named-content data-cid="1545433494" id="78bc8c51-83bf-422f-a39f-41fd113880e2" content-type="ins cts-3" specific-use="1545439305383" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439305383">.</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="a9ae51bb-0862-4262-98b2-b753d7c70656" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;"><p id="faa951ee-645e-424d-995f-616a22086251" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">13/12.3</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="91e33b22-4b8c-4461-9d0d-2cfc9efccfb6" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="f713729f-6efc-4e88-971d-37ad21d6c1d8" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Hepatitis<named-content data-cid="1545433511" id="e897b4a6-70cb-4e7a-a299-8153861d3e39" content-type="ins cts-3" specific-use="1545439319810" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439319810">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="0b4f1557-0856-48a5-a7eb-7a7ab2ea86ad" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="0255085d-098e-444c-ad00-f9bf41089c8d" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433509" id="c0e03496-f3a1-4c65-922e-c61dc4a20136" content-type="ins cts-3" specific-use="1545439316811" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439316811">.</named-content></p></td></tr><tr data-col-count="8" id="29910d22-2b4d-4f67-9c32-4937a8d49d63"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="1ce14f28-a812-4f34-99e3-019289922df9" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="2885e196-aea4-46d9-955b-86c384466bdf" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">20</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="b7292ff2-8a9f-4e19-9140-b2256401326f" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="a980fea9-1e71-469e-aa1d-70340cfb4410" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">32.3</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="8f679efe-9bf9-4870-b0a2-ea92c40914d1" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="2f250174-c516-4933-ade4-6a770f5b1617" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Nivolumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="e2225a4d-7891-4c7c-830a-b8f9b7b436dc" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="9ecc5320-617e-4f1d-a435-23b680cc7561" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="06f279a7-8543-46da-835e-7105654ebfe0" data-cid="06f279a7-8543-46da-835e-7105654ebfe0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="112 mg/dL" data-replace="112" data-pattern="$1" data-tag-index="433_1" data-time="" data-username="" data-userid="">112</named-content><named-content id="95ff1e68-7e28-4f85-9a24-7f03e6327aa9" data-cid="95ff1e68-7e28-4f85-9a24-7f03e6327aa9" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="112 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="433_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG <named-content id="6ffc86e4-78a2-4567-9d6d-d4a3abef422a" data-cid="6ffc86e4-78a2-4567-9d6d-d4a3abef422a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="19" data-match="158 mg/dL" data-replace="158" data-pattern="$1" data-tag-index="433_2" data-time="" data-username="" data-userid="">158</named-content><named-content id="035f4fa5-4e94-4254-a322-42e7d7bb1ad1" data-cid="035f4fa5-4e94-4254-a322-42e7d7bb1ad1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="22" data-match="158 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="433_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 8.8%<named-content data-cid="1545433523" id="d8ed52f2-71c0-4738-8087-44d9eecef0e5" content-type="ins cts-3" specific-use="1545439347536" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439347536">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="2dadfc6c-3fcf-4ee9-8be3-c7421ff712d1" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="82972c81-be01-4843-b78e-d3750bf381d4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="339d809b-8f90-4128-9beb-8c34be9818f2" data-cid="339d809b-8f90-4128-9beb-8c34be9818f2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="154 mg/dL" data-replace="154" data-pattern="$1" data-tag-index="434_1" data-time="" data-username="" data-userid="">154</named-content><named-content id="df72f9e1-0af7-4744-be51-2cd2fe6986ac" data-cid="df72f9e1-0af7-4744-be51-2cd2fe6986ac" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="154 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="434_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG <named-content id="6956cb9c-0c0a-4200-9d07-b6889e445f2e" data-cid="6956cb9c-0c0a-4200-9d07-b6889e445f2e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="19" data-match="180 mg/dL" data-replace="180" data-pattern="$1" data-tag-index="434_2" data-time="" data-username="" data-userid="">180</named-content><named-content id="19ab1858-aae9-4f44-9794-56da56ecf717" data-cid="19ab1858-aae9-4f44-9794-56da56ecf717" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="22" data-match="180 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="434_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 9.5%, GGT <named-content id="227bdbea-3095-4b3e-af0e-27ead10b6f39" data-cid="227bdbea-3095-4b3e-af0e-27ead10b6f39" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="46" data-match="257 IU/L" data-replace="257" data-pattern="$1" data-tag-index="434_3" data-time="" data-username="" data-userid="">257</named-content><named-content id="24ebca05-7379-473c-a701-554dbcea1294" data-cid="24ebca05-7379-473c-a701-554dbcea1294" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣IU/L' to ' IU/L'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="49" data-match="257 IU/L" data-replace=" IU/L" data-pattern=" $2" data-tag-index="434_3" data-track-change=" IU/L" data-time="" data-username="" data-userid=""> IU/L</named-content>, <named-content data-cid="1545433513" id="d66847d4-7cf2-4177-ab3f-f4b60b1d175b" content-type="del cts-3" specific-use="1545439326863" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439326863">D</named-content><named-content data-cid="1545433514" id="26091781-915b-4114-85cf-cc264d1dac5e" content-type="ins cts-3" specific-use="1545439327328" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439327328">d</named-content>examethasone <named-content data-cid="1545113216051" id="4169b117-eb63-4a51-9b35-e31e68be73e7" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">8</named-content><named-content id="cc8ecfb9-55f9-443f-9518-1c33dd9fe09d" data-cid="1545113216051" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '8' to 'eight'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="70" data-match="8" data-pattern="" data-tag-index="434_5" data-function="numberToText,addTrackChanges" data-track-change="8" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433515" id="1a8a6c3e-2c89-48c9-920d-dea9a031a308" content-type="del cts-3" specific-use="1545439330551" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439330551">eight</named-content></named-content><named-content data-cid="1545433516" id="8a62889d-508e-4cce-bb06-e4305331750e" content-type="ins cts-3" specific-use="1545439330788" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439330788">8</named-content> g<named-content data-cid="1545433517" id="13884c67-8152-4ff6-811e-bee346ef2395" content-type="del cts-3" specific-use="1545439332429" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439332429">ram</named-content> daily for <named-content id="bbc4d492-b875-4a7c-9e03-89d695a13a05" data-cid="bbc4d492-b875-4a7c-9e03-89d695a13a05" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="87" data-match="1 week" data-replace="1" data-pattern="$1" data-tag-index="434_4" data-time="" data-username="" data-userid="">1</named-content><named-content id="9cf41cac-5ffa-411c-b900-6c9d9ccfe45b" data-cid="9cf41cac-5ffa-411c-b900-6c9d9ccfe45b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣week' to ' week'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="88" data-match="1 week" data-replace=" week" data-pattern=" $2" data-tag-index="434_4" data-track-change=" week" data-time="" data-username="" data-userid=""> week</named-content>.</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="b261bfa3-72dd-4dda-90d1-5fbc030aa935" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;"><p id="8f2ce3a6-339e-46f4-9fa6-14514fe36101" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">1/1.8</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="3bf101fa-d30a-4e2d-ace0-a85e996ee003" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="cb08a5be-29a4-4ecc-9c53-fcb2a6ec0a2b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Thyroiditis<named-content data-cid="1545433512" id="695c62e9-1421-4562-846a-b1992d6da159" content-type="ins cts-3" specific-use="1545439321136" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439321136">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="4f510f15-50e9-44c8-93e3-9e72152288c3" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="b57dfd76-4ed6-4457-aead-c41938304e50" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433510" id="9f8bd531-94d3-4347-9f55-8d7ce4869bfa" content-type="ins cts-3" specific-use="1545439318135" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:41am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439318135">.</named-content></p></td></tr><tr data-col-count="8" id="4efa7740-8887-4fdb-bf47-0d307a3c81bb" data-fill="true"><td data-original-border="border:solid windowtext 1.0pt; border-top:none;" data-original-padding="padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-0" data-col-index="1" id="b8f6c95d-0fb1-45c7-b7d1-eae4b45aeb35" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;1&quot;"><p id="53b5a361-6b61-4fcb-a571-3d35f595bc3e" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">21</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-1" data-col-index="2" id="a5a66c6c-4fa8-4d64-b3b6-ee34941d4532" data-auto-align="true" data-align="decimal" valign="top" data-old-attributes="&quot;data-align&quot;:&quot;decimal&quot;;&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;2&quot;"><p id="a35e1b1a-db4a-4eca-8ca5-af5823c5c40a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">18.4</p></td><td data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-2" data-col-index="3" id="1daca2ee-b3c6-4731-bc9e-7b8bb7184e70" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;3&quot;"><p id="f920bdf2-87c6-4d1d-9dd7-a0f9e08f37d9" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">Pembrolizumab</p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-3" data-col-index="4" id="cd8f6325-8bce-4eb5-9dca-4906038b28e3" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;4&quot;"><p id="de7e9284-1ddc-4283-86d3-43720cc362e4" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="80a8cde4-2b25-4d50-afa8-eb0891e38b60" data-cid="80a8cde4-2b25-4d50-afa8-eb0891e38b60" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="141 mg/dL" data-replace="141" data-pattern="$1" data-tag-index="440_1" data-time="" data-username="" data-userid="">141</named-content><named-content id="c2036e45-fffb-481d-88e9-298378941c9c" data-cid="c2036e45-fffb-481d-88e9-298378941c9c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="141 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="440_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG <named-content id="f9d46969-95a4-4ca2-bb1d-e54d0151f647" data-cid="f9d46969-95a4-4ca2-bb1d-e54d0151f647" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="19" data-match="235 mg/dL" data-replace="235" data-pattern="$1" data-tag-index="440_2" data-time="" data-username="" data-userid="">235</named-content><named-content id="ec4d892b-9d18-494d-9c9f-ba7bf3f8fb81" data-cid="ec4d892b-9d18-494d-9c9f-ba7bf3f8fb81" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="22" data-match="235 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="440_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 9.2%<named-content data-cid="1545433524" id="8f0ab819-d38f-4113-ade2-3bc6cc1b21f9" content-type="ins cts-3" specific-use="1545439349514" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439349514">.</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left: none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-4" data-col-index="5" id="110d5039-7682-4949-8226-4a103a955e9d" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;5&quot;"><p id="5091e752-2e08-4f9f-89e3-bd59d4242ea3" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">FPG <named-content id="a4491e31-ba60-40d6-a564-13e414c4628d" data-cid="a4491e31-ba60-40d6-a564-13e414c4628d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="4" data-match="606 mg/dL" data-replace="606" data-pattern="$1" data-tag-index="441_1" data-time="" data-username="" data-userid="">606</named-content><named-content id="5eb62b53-2d80-45c8-9def-0f4f07234535" data-cid="5eb62b53-2d80-45c8-9def-0f4f07234535" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="7" data-match="606 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="441_1" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, RPG <named-content id="a997a6bf-b7a8-4df1-925b-972ed723c006" data-cid="a997a6bf-b7a8-4df1-925b-972ed723c006" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="19" data-match="999 mg/dL" data-replace="999" data-pattern="$1" data-tag-index="441_2" data-time="" data-username="" data-userid="">999</named-content><named-content id="5dc57197-bed0-4ac6-831a-a2c4b70f22c0" data-cid="5dc57197-bed0-4ac6-831a-a2c4b70f22c0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="22" data-match="999 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="441_2" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content>, HbA1c 12%<named-content data-cid="1545433525" id="f893def4-c5b5-4f64-808a-073bbf9d9f65" content-type="ins cts-3" specific-use="1545439351859" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439351859">.</named-content></p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-5" data-col-index="6" id="74475ec7-60a6-434d-88f2-b08050a452b2" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;6&quot;"><p id="ff11f76d-b073-4b16-aaf1-0a4e07dfc02a" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">3/1.7</p></td><td data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-6" data-col-index="7" id="821f785c-96cf-42a4-8804-303b59f8ecc0" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;7&quot;"><p id="976ce7f1-6c22-402f-89e6-46aa62906a6b" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;"><named-content id="00d617cb-7bce-4d74-b9ef-e4543afa915a" data-cid="00d617cb-7bce-4d74-b9ef-e4543afa915a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="HYPTONDASH" data-tag-type="HYPTONDASH" data-offset="0" data-match="-" data-replace="–" data-pattern="–" data-tag-index="s1345_1" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content></p></td><td data-class="" data-original-border="border-top:none;border-left:none; border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;" data-original-padding=" padding:0cm 5.4pt 0cm 5.4pt;" data-col-pos="col-7" data-col-index="8" id="cb3cf979-d956-45ef-86bd-924961bb44f5" valign="top" data-old-attributes="&quot;valign&quot;:&quot;top&quot;;&quot;data-col-index&quot;:&quot;8&quot;"><p id="dde6f265-ca55-4745-986d-aa4fd46af026" data-original-margin=" margin-left: 0cm; margin-right: 0cm; margin-top: 0cm;">MDI<named-content data-cid="1545433526" id="36e78999-af98-4f19-af30-5de11c4b1a41" content-type="ins cts-3" specific-use="1545439355889" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:42am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439355889">.</named-content></p></td></tr></tbody></table><table-wrap-foot id="bf41f677-538e-45bf-9230-c15831105daa"><fn data-class="jrnlTblFoot" fn-type="abbrev" data-def-list="true" id="6473a117-c6ce-4ab1-9f36-17e02f538d18"><p id="b20f1be9-158e-40da-820d-003a7e98500e"><def-list id="279c99fc-a7d6-4df4-8d01-2c93f0c2107b"><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="f291ad15-0d56-4f19-bdcf-227a9dd24e5c" fn-type="abbrev" data-id="T4_FN1"><term data-class="jrnlAbbrevTerm" id="7f5ef232-554b-4e52-8d26-90f9720c6094">BMI</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="c2577bea-0434-4a63-a476-8d020e420703"><p id="41f9da4c-ac2a-4e3c-bf54-364c6719a4d3">body mass index</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="58e3fa5b-1e6e-416e-967c-3c24d2fa27de" fn-type="abbrev" data-id="T4_FN1"><term data-class="jrnlAbbrevTerm" id="1a074b85-b879-4d15-abd7-460c9b3e7775">FPG</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="7a1b1128-c738-4c65-8c1d-3e8f7f81c6c1"><p id="8bbb5edd-c682-4232-99dd-91e6c511d075">fasting plasma glucose</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="f1c0a7aa-32e8-40a3-b7dd-b97ac483f2d5" fn-type="abbrev" data-id="T4_FN1"><term data-class="jrnlAbbrevTerm" id="270df4f6-a468-459e-b1ef-151e5baa371e">HbA1c</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="375b8294-64e0-47d2-a1e3-14da8069c356"><p id="47d9e67b-510c-4ea0-b751-e9d8caceccf4">hemoglobin A1c</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="f4718db3-545c-43e2-8e46-7a2b813bfa22" fn-type="abbrev" data-id="T4_FN1"><term data-class="jrnlAbbrevTerm" id="7ba2980a-2424-4412-bf21-b643dd1225cf">IA-2</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="38d6da05-856c-4d4e-b36d-d8f870a0b8c4"><p id="23e485b3-7a1a-45b8-adfb-ab3186348d96">islet antigen 2</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="29120229-c632-4af3-b96e-6635379f9422" fn-type="abbrev" data-id="T4_FN1"><term data-class="jrnlAbbrevTerm" id="9894add5-a169-43c8-af8b-431174187848">IAA</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="abaf90cd-825e-495d-b2f5-9db525a6ab41"><p id="825212e3-ced6-4069-a050-6d203f107748">insulin autoantibodies</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="932a14df-d1a5-44db-830e-0012679536c8" fn-type="abbrev" data-id="T4_FN1"><term data-class="jrnlAbbrevTerm" id="74d05bbe-dc8d-4f9f-89f6-128b105b0c00">IRAE</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="a14ab394-d033-410e-ae4a-5c4bad8c7723"><p id="79b314b9-09b8-4ce3-8f71-bda271d3aba8">immune-related adverse events</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="09e4cd4d-4119-42e1-857b-ba5005fe12f8" fn-type="abbrev" data-id="T4_FN1"><term data-class="jrnlAbbrevTerm" id="ff023814-44b2-4662-802b-95630864cac2">MDI</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="9ac4acb3-60fa-4a39-b371-3c7f149d17af"><p id="b0b8fdc7-fc5f-498a-9cd7-b0a1b0b933d8">multiple daily injections of insulin</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="55bb9796-2f8a-4f81-8e4e-19e162bc919e" fn-type="abbrev" data-id="T4_FN1"><term data-class="jrnlAbbrevTerm" id="612f3e67-d5d2-49a7-9933-caed0a90f1e9">RPG</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="e2b3a9ad-e118-4b0f-924a-2ad47a527063"><p id="a3f09614-0cfe-45ba-9e26-fee76d765cd5">random plasma glucose</p></def>; </def-item><def-item data-class="jrnlTblDefItem" data-channel="components" data-topic="PopUp" data-event="click" data-message="{'funcToCall': 'populateAbbrevFootNote', 'param' : {'component' : 'jrnlAbbrevFoot'}}" alphabetical-order="true" id="3c9b341d-9aa5-4b7c-9975-286dfbc0fb79" fn-type="abbrev" data-id="T4_FN1"><term data-class="jrnlAbbrevTerm" id="cd60115f-a7ca-49a2-a75a-3b8e10d83a1a">TZD</term>, <def data-class="jrnlFootDefinition" remove-last-node-suffix="true" set-last-node-suffix="." id="db84ca00-89af-442d-90ca-bf7f51d6fe5c"><p id="919910c2-34cb-49c5-b029-045283fdd625">Thiazolidinedione</p></def>.</def-item></def-list></p></fn></table-wrap-foot></table-wrap><title data-level="2" data-class="jrnlHead2" old-class="" id="a0902798-fee8-4171-b37a-99f337bc0706">Disease characteristics of worsening type 2 diabetes</title><p data-class="jrnlSecPara" id="670bb725-f789-49ba-a3bd-017c6bfc0fe1" data-word-spacing="0.43w">There was unexplained worsening of glycemic control in <named-content data-cid="1545113216036" id="85a6d535-9221-4847-bba3-c17acd4f356e" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">9</named-content><named-content id="22dec60a-866e-4e60-8518-3fadd85d1e98" data-cid="1545113216036" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '9' to 'nine'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="55" data-match="9" data-pattern="" data-tag-index="22_10" data-function="numberToText,addTrackChanges" data-track-change="9" data-userid="preediting" data-username="Exeter" data-time="1545113216002">nine</named-content> <named-content id="4bf2b56b-0c84-4bdf-902d-43090d57aeca" data-cid="4bf2b56b-0c84-4bdf-902d-43090d57aeca" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="57" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="22_24" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with pre-existing type <named-content data-cid="1545113216037" id="4ffbd794-0591-4cc6-88a7-8b5174faed22" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="14035367-0dba-46a8-9f25-acf1afd42d85" data-cid="1545113216037" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="89" data-match="2" data-pattern="" data-tag-index="22_11" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433532" id="df1df87b-c59f-461c-a31b-3d7ad1926a4b" content-type="del cts-3" specific-use="1545439477775" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439477775">two</named-content></named-content><named-content data-cid="1545433533" id="4b79b636-f057-4f51-9f53-6b7e6dfcf5b5" content-type="ins cts-3" specific-use="1545439478016" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439478016">2</named-content> diabetes after a median of <named-content data-cid="1545433534" id="79ac744d-7f42-4a50-b5c5-d2f3d46bc312" content-type="del cts-3" specific-use="1545439479695" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439479695">4</named-content><named-content data-cid="1545433535" id="40725b55-1560-49ba-bbe0-0d2e88c76597" content-type="ins cts-3" specific-use="1545439479954" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439479954">four</named-content> cycles of ICI or <named-content id="aba35461-21bc-4235-b9ea-af58489e0c10" data-cid="aba35461-21bc-4235-b9ea-af58489e0c10" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="137" data-match="4 months" data-replace="4" data-pattern="$1" data-tag-index="22_3" data-time="" data-username="" data-userid="">4</named-content><named-content id="dfd6bd9f-c1b7-45ef-ad36-ee34492c1113" data-cid="dfd6bd9f-c1b7-45ef-ad36-ee34492c1113" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="138" data-match="4 months" data-replace=" months" data-pattern=" $2" data-tag-index="22_3" data-time="" data-username="" data-userid=""> months</named-content> since initiation of ICI therapy. The median HbA1c at presentation was <named-content id="88a03516-b9c4-4f09-bd2d-19edd959dbb1" data-cid="88a03516-b9c4-4f09-bd2d-19edd959dbb1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="216" data-match="10%" data-replace="10" data-pattern="$1" data-tag-index="22_4" data-time="" data-username="" data-userid="">10</named-content><named-content id="92972b00-8216-4500-9666-56e85347f8f1" data-cid="92972b00-8216-4500-9666-56e85347f8f1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="218" data-match="10%" data-replace="%" data-pattern="%" data-tag-index="22_4" data-time="" data-username="" data-userid="">%</named-content> or <named-content id="d63dd051-ac5f-45e0-bff6-c815053643a8" data-cid="d63dd051-ac5f-45e0-bff6-c815053643a8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="223" data-match="86 mmol/mol" data-replace="86" data-pattern="$1" data-tag-index="22_5" data-time="" data-username="" data-userid="">86</named-content><named-content id="acbc928d-058c-48ea-b4d9-d68b3b92464f" data-cid="acbc928d-058c-48ea-b4d9-d68b3b92464f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mmol/mol' to ' mmol/mol'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="225" data-match="86 mmol/mol" data-replace=" mmol/mol" data-pattern=" $2" data-tag-index="22_5" data-track-change=" mmol/mol" data-time="" data-username="" data-userid=""> mmol/mol<named-content data-cid="1545433539" id="556699e2-cc26-4a67-9fdd-e5cd1863536d" content-type="ins cts-3" specific-use="1545439487448" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439487448">,</named-content></named-content> and median RPG was <named-content id="1bdbbf85-72d0-49e8-a53c-f7e96d980099" data-cid="1bdbbf85-72d0-49e8-a53c-f7e96d980099" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="254" data-match="308 mg/dL" data-replace="308" data-pattern="$1" data-tag-index="22_6" data-time="" data-username="" data-userid="">308</named-content><named-content id="2924e23e-5041-47b2-9c6e-f8de8d379815" data-cid="2924e23e-5041-47b2-9c6e-f8de8d379815" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣mg/dL' to ' mg/dL'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="257" data-match="308 mg/dL" data-replace=" mg/dL" data-pattern=" $2" data-tag-index="22_6" data-track-change=" mg/dL" data-time="" data-username="" data-userid=""> mg/dL</named-content> (IQR <named-content id="287f3444-9a30-4492-83a9-6190818ff035" data-cid="287f3444-9a30-4492-83a9-6190818ff035" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="269" data-match="224 – 533)" data-replace="224" data-pattern="$2" data-tag-index="22_2" data-time="" data-username="" data-userid="">224</named-content><named-content id="bc8df9be-8602-4085-a850-22ad593ea762" data-cid="bc8df9be-8602-4085-a850-22ad593ea762" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣–␣' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="272" data-match="224 – 533)" data-replace="–" data-pattern="–" data-tag-index="22_2" data-track-change=" – " data-time="" data-username="" data-userid="">–</named-content><named-content id="5982cdb5-5c26-4d51-bc96-a7fd93e89ecb" data-cid="5982cdb5-5c26-4d51-bc96-a7fd93e89ecb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="277" data-match="224 – 533)" data-replace="533)" data-pattern="$4" data-tag-index="22_2" data-time="" data-username="" data-userid="">533)</named-content>. Pancreatic enzymes were tested in <named-content data-cid="1545113216038" id="20effeeb-023e-451d-bd5b-2d27eec5fd5c" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">7</named-content><named-content id="b70d981c-dde5-446a-abf4-53e0977daea1" data-cid="1545113216038" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '7' to 'seven'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="317" data-match="7" data-pattern="" data-tag-index="22_12" data-function="numberToText,addTrackChanges" data-track-change="7" data-userid="preediting" data-username="Exeter" data-time="1545113216002">seven</named-content> <named-content id="126e383a-c43d-494b-8ea8-5ecc4891b778" data-cid="126e383a-c43d-494b-8ea8-5ecc4891b778" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="319" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="22_25" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>, with increase in <named-content data-cid="1545113216039" id="18a071c5-aa51-472d-a93e-73904e385727" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">4</named-content><named-content id="d24fb6fd-cb2f-41e0-a48b-ebf9e450eaeb" data-cid="1545113216039" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '4' to 'four'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="346" data-match="4" data-pattern="" data-tag-index="22_13" data-function="numberToText,addTrackChanges" data-track-change="4" data-userid="preediting" data-username="Exeter" data-time="1545113216002">four</named-content> <named-content id="e57c43fa-b9e0-410e-96b0-52c0f095916c" data-cid="e57c43fa-b9e0-410e-96b0-52c0f095916c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="348" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="22_26" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> (57%) (<named-content data-cid="1545113216040" id="8332fbf5-a53e-4dda-bbb9-17aa5bca6675" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">3</named-content><named-content id="8b025cd2-29bb-4bb6-8461-5e9475ed6d6d" data-cid="1545113216040" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '3' to 'three'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="364" data-match="3" data-pattern="" data-tag-index="22_14" data-function="numberToText,addTrackChanges" data-track-change="3" data-userid="preediting" data-username="Exeter" data-time="1545113216002">three</named-content> had mild elevation and <named-content data-cid="1545113216041" id="12ba30a5-76fd-49c1-b801-c126a0ed1bcd" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="078e3944-94f1-4afc-9381-cd80aad7c25f" data-cid="1545113216041" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="389" data-match="1" data-pattern="" data-tag-index="22_15" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002">one</named-content> had elevation more than <named-content data-cid="1545113216042" id="17178207-2ec4-4724-8f5d-724f8381029b" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="9bff470b-73f0-4f25-81a5-d176fa5cdf22" data-cid="1545113216042" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="415" data-match="2" data-pattern="" data-tag-index="22_16" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002">two</named-content> times the upper limit of normal). FDG-PET was performed within <named-content id="63f0bde6-6d93-4e5d-a0ae-f0d76397378f" data-cid="63f0bde6-6d93-4e5d-a0ae-f0d76397378f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="480" data-match="4 months" data-replace="4" data-pattern="$1" data-tag-index="22_7" data-time="" data-username="" data-userid="">4</named-content><named-content id="19710002-7581-441e-ac8b-50fffb6e1ac6" data-cid="19710002-7581-441e-ac8b-50fffb6e1ac6" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="481" data-match="4 months" data-replace=" months" data-pattern=" $2" data-tag-index="22_7" data-time="" data-username="" data-userid=""> months</named-content> of case development in <named-content data-cid="1545113216043" id="713b46b2-af33-4c0e-ae2f-2bdb1ac1f048" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">4</named-content><named-content id="01dae563-ff16-4b19-9f71-2b29013df851" data-cid="1545113216043" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '4' to 'four'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="512" data-match="4" data-pattern="" data-tag-index="22_17" data-function="numberToText,addTrackChanges" data-track-change="4" data-userid="preediting" data-username="Exeter" data-time="1545113216002">four</named-content> <named-content id="a1cf957e-6346-4659-90c4-b493504f6d39" data-cid="a1cf957e-6346-4659-90c4-b493504f6d39" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="514" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="22_27" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>, none of which showed increased pancreatic uptake. None of these <named-content id="ab960806-cf9e-4434-b182-d2b474f7e009" data-cid="ab960806-cf9e-4434-b182-d2b474f7e009" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="588" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="22_28" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> underwent testing for type <named-content data-cid="1545113216044" id="7128e74e-d25b-474e-97e6-40f028e922f1" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="9ac2d2cd-d902-438c-ac8b-85f471cf915a" data-cid="1545113216044" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="624" data-match="1" data-pattern="" data-tag-index="22_18" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433540" id="f7fb570d-a84b-4104-91da-f6f0c4ea6e27" content-type="del cts-3" specific-use="1545439875399" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439875399">one</named-content></named-content><named-content data-cid="1545433541" id="854aa2bc-40ba-4113-918f-3fdaee47638e" content-type="ins cts-3" specific-use="1545439875647" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439875647">1</named-content> diabetes<named-content data-cid="1545433542" id="d4b4b0b1-c227-4f07-a445-620546a3a00e" content-type="del cts-3" specific-use="1545439877941" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439877941"> </named-content><named-content data-cid="1545433543" id="205eaa24-33c1-45b2-b90e-f477ab8263b5" content-type="ins cts-3" specific-use="1545439878375" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439878375">-</named-content>associated antibodies. C-peptide was normal in the <named-content data-cid="1545113216045" id="104bb226-48ab-4ea5-b6c8-5128fc659f5b" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="03f2bf5c-0e79-457c-b2d0-a90885a1d98d" data-cid="1545113216045" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="686" data-match="1" data-pattern="" data-tag-index="22_19" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002">one</named-content> <named-content id="9d7025a4-6f4a-43e3-b978-45c005976e27" data-cid="9d7025a4-6f4a-43e3-b978-45c005976e27" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="688" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="22_29" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content> with worsening glycemic control who underwent testing. At the time of worsening of type <named-content data-cid="1545113216046" id="5bc72f75-fd56-40f4-96e6-9e78eb458df0" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="423722e7-f565-4457-b7f5-5d0ccd981cb3" data-cid="1545113216046" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="784" data-match="2" data-pattern="" data-tag-index="22_20" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433544" id="f4ea5d00-e4b2-4d86-a939-6c540e586ebe" content-type="del cts-3" specific-use="1545439887223" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439887223">two</named-content></named-content><named-content data-cid="1545433545" id="eeccfeaa-34f7-441f-beed-87c98e8a6711" content-type="ins cts-3" specific-use="1545439887462" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439887462">2</named-content> diabetes, there was initiation of insulin in <named-content data-cid="1545113216047" id="58d7e769-6163-4db7-a929-f7ac2b2d43a7" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">6</named-content><named-content id="bfb3a46a-5ee1-4a82-bd23-9784111985a0" data-cid="1545113216047" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '6' to 'six'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="831" data-match="6" data-pattern="" data-tag-index="22_21" data-function="numberToText,addTrackChanges" data-track-change="6" data-userid="preediting" data-username="Exeter" data-time="1545113216002">six</named-content> <named-content id="de342e53-bcb8-446d-ab32-a60b59c6878a" data-cid="de342e53-bcb8-446d-ab32-a60b59c6878a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="833" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="22_30" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> (MDI initiated in <named-content data-cid="1545433546" id="72a6af5d-211b-4133-9f8d-7a5556e366fa" content-type="del cts-3" specific-use="1545439892566" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439892566">4</named-content><named-content data-cid="1545433547" id="fa6a65b1-6edb-4e30-99a0-7729bdaeccc4" content-type="ins cts-3" specific-use="1545439893024" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439893024">four</named-content>, basal insulin initiated in <named-content data-cid="1545433551" id="72e1184b-bbe1-4398-9409-e731e4aeeef6" content-type="del cts-3" specific-use="1545439896578" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439896578">2</named-content><named-content data-cid="1545433552" id="72cbec17-25d8-44a3-9240-c55fa43993bd" content-type="ins cts-3" specific-use="1545439896971" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439896971">two</named-content>), conversion from basal insulin to MDI in <named-content data-cid="1545113216048" id="60876d36-1ce2-42c6-a825-cf0f381cc143" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="049647ec-1dd2-48d3-8c8e-cddffea6f29e" data-cid="1545113216048" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="934" data-match="2" data-pattern="" data-tag-index="22_22" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002">two</named-content> <named-content id="e0810452-d95c-49a8-9141-d6e480823f04" data-cid="e0810452-d95c-49a8-9141-d6e480823f04" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="936" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="22_31" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content><named-content data-cid="1545433555" id="07d8425d-d00f-4376-9489-3cc7f28863e3" content-type="del cts-3" specific-use="1545439901148" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439901148">,</named-content><named-content data-cid="1545433556" id="55779c0c-4bd8-41f7-860d-f545690670a2" content-type="ins cts-3" specific-use="1545439905395" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439905395">,</named-content> and increase in total daily dose of MDI by 100 units in one <named-content id="5c7b08cd-7cbe-44cc-b002-12a3a358fd22" data-cid="5c7b08cd-7cbe-44cc-b002-12a3a358fd22" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1006" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="22_32" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content>. Seventy<named-content data-cid="1545433557" id="41cc2e87-5425-4fb1-85c7-bdd805ba9533" content-type="del cts-3" specific-use="1545439909871" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439909871"> </named-content><named-content data-cid="1545433558" id="60c07bdd-51f9-410d-aa61-394651436bf0" content-type="ins cts-3" specific-use="1545439910223" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439910223">-</named-content>eight <named-content data-cid="1545433559" id="8ded3739-d52e-45a6-85c6-0a6d1d33fc3b" content-type="del cts-3" specific-use="1545439911861" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439911861">%</named-content><named-content data-cid="1545433560" id="06164053-7a51-4b50-8e81-92737ca68be0" content-type="ins cts-3" specific-use="1545439912512" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:51am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545439912512">percent</named-content> developed another IRAE, with the most common being thyroiditis (manifested as primary hypothyroidism or thyrotoxicosis followed by primary hypothyroidism) in <named-content id="6f0170f5-d5c4-477a-af61-231bce37f7ee" data-cid="6f0170f5-d5c4-477a-af61-231bce37f7ee" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1189" data-match="44%" data-replace="44" data-pattern="$1" data-tag-index="22_8" data-time="" data-username="" data-userid="">44</named-content><named-content id="15bf3a5d-eafe-4307-9311-32554d1ab75b" data-cid="15bf3a5d-eafe-4307-9311-32554d1ab75b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1191" data-match="44%" data-replace="%" data-pattern="%" data-tag-index="22_8" data-time="" data-username="" data-userid="">%</named-content>. All <named-content id="60efd425-d334-4f46-816f-e79fd723bc77" data-cid="60efd425-d334-4f46-816f-e79fd723bc77" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1198" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="22_33" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> were on MDI (7/9, 78 %) or basal insulin (2/9, 22%) without any de-escalation in dose during the median <named-content data-cid="1545113216106" id="7c89a8f4-6055-4c4c-8865-3197a5022aa5" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow up</named-content><named-content id="ba2426e7-6add-4794-80f4-547d2828c327" data-cid="1545113216106" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1311" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="22_34" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow-up</named-content> duration of <named-content id="5c3108b5-400f-44b7-bf32-d041a2343326" data-cid="5c3108b5-400f-44b7-bf32-d041a2343326" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1333" data-match="26 months" data-replace="26" data-pattern="$1" data-tag-index="22_9" data-time="" data-username="" data-userid="">26</named-content><named-content id="e897a2c7-5507-4a42-a48d-0b655c5b0922" data-cid="e897a2c7-5507-4a42-a48d-0b655c5b0922" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1335" data-match="26 months" data-replace=" months" data-pattern=" $2" data-tag-index="22_9" data-time="" data-username="" data-userid=""> months</named-content> since ICI initiation. Other disease characteristics are mentioned in <xref id="c394cf46-f081-4479-9311-f66656cd5aea" ref-type="table" rid="T2 T4" data-citation-string=" T2 T4 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="1412" data-match="Table 2 and Table 4" data-pattern="" data-tag-index="22_1" data-track="del" data-cid="1545209420499" data-username="Sneka (PREEDITOR)" data-userid="preeditor 18f55500-5243-43e4-b9f9-343ccaadeb34" data-time="1545209420499"><named-content data-cid="1546365745983" id="2f21a3d6-42a2-4a5c-a699-cdc7dcc067c0" content-type="del cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Table 2 and Table 4</named-content><named-content data-cid="1546365745983" id="373d0cea-1ddd-40d8-a077-cb783f402a4f" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">tables 2 and 4</named-content></xref><xref id="7bb0db33-38be-47ca-90d7-7b75ce41ab80" ref-type="table" rid="T2 T4" data-citation-string=" T2 T4 " data-track="ins" data-cid="1545209420508" data-username="Sneka (PREEDITOR)" data-userid="preeditor 18f55500-5243-43e4-b9f9-343ccaadeb34" data-time="1545209420508" data-cite-type="insert" data-anchor="true">tables 2 and 4</xref>.</p><title data-level="1" data-class="jrnlHead1" old-class="" id="c573706d-699f-4eeb-9b45-87e7b1490856">Discussion</title><p data-class="jrnlSecPara" id="b52a5d4e-7ebb-4864-98dc-f6671ae85652" data-word-spacing="0.43w">We report the frequency, clinical features and <named-content data-cid="1545113216107" id="a9ce9c25-03d8-4279-93a5-4d7df5d1a027" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow up</named-content><named-content id="2b40c396-53cd-45c2-b7b3-5bd52290ee12" data-cid="1545113216107" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="47" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="23_1" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow-up</named-content> of new-onset insulin-dependent diabetes and significant unexplained worsening of glycemic control in <named-content id="84a3972e-5b77-4413-8640-cfdc7a508dff" data-cid="84a3972e-5b77-4413-8640-cfdc7a508dff" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="158" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="23_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> receiving ICIs for various cancers. We confirmed the absence of occurrence of this IRAE in <named-content id="77921914-5436-4e02-bb61-4c467ee09374" data-cid="77921914-5436-4e02-bb61-4c467ee09374" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="258" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="23_3" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> receiving CTLA-4 inhibitors and report a slightly increased frequency of this disorder in <named-content id="49272f34-3057-4ab8-b444-93e10fd3407d" data-cid="49272f34-3057-4ab8-b444-93e10fd3407d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="357" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="23_4" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> receiving one of the PD-1 inhibitors. Other immune checkpoint manipulation approaches, such as <named-content data-cid="1545433567" id="5e89df15-1965-49f1-a383-c1fb18e2c906" content-type="del cts-3" specific-use="1545440127957" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:55am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440127957">programmed cell death protein ligand 1 (</named-content>PD-L1<named-content data-cid="1545433568" id="6e99e6ad-e0a2-4861-a3c1-1c14a6fd3fe1" content-type="del cts-3" specific-use="1545440130677" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:55am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440130677">)</named-content> inhibition are now being used<named-content data-cid="1545433569" id="543323a5-c9e9-4897-82f8-0a6c29ecadf8" content-type="del cts-3" specific-use="1545440132813" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:55am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440132813">,</named-content> and will require investigation for IRAEs including diabetes.</p><title data-level="2" data-class="jrnlHead2" old-class="" id="37c87c2f-afc3-4302-999b-7292bdc3dd7c">Case identification and frequency</title><p data-class="jrnlSecPara" id="499790d6-79bb-42d4-99b2-6f96be71247d" data-word-spacing="0.43w">Among the PD-1 inhibitor<named-content data-cid="1545433570" id="beee784f-5b98-4882-9ec4-6210adfaa0f3" content-type="del cts-3" specific-use="1545440155749" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:55am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440155749"> </named-content><named-content data-cid="1545433571" id="c35a1844-3590-4313-a991-1ba6e1c29f58" content-type="ins cts-3" specific-use="1545440156752" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:55am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440156752">-</named-content>treated <named-content id="37d1dba1-fcf7-45f5-8649-74fdba1f6bbc" data-cid="37d1dba1-fcf7-45f5-8649-74fdba1f6bbc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="33" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="24_11" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>, 12 developed new-onset insulin-<named-content data-cid="1545433572" id="831677dd-e1f2-4345-8802-259f127e48c4" content-type="del cts-3" specific-use="1545440159210" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:55am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440159210"> </named-content>dependent diabetes and 9 out of 96 with pre-existing <named-content data-cid="1545113216108" id="1b087fcd-73ea-4124-9386-6d9aca865977" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">prediabetes</named-content><named-content id="566497cc-1530-4819-82b6-c9997ab68351" data-cid="1545113216108" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'prediabetes' to 'pre-diabetes'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="128" data-match="prediabetes" data-replace="pre-diabetes" data-pattern="pre-diabetes" data-tag-index="24_12" data-function="addTrackChanges" data-track-change="prediabetes" data-userid="preediting" data-username="Exeter" data-time="1545113216002">pre<named-content data-cid="1545433575" id="c9fbf26a-1262-4914-922b-c0cfcd703e92" content-type="del cts-3" specific-use="1545440165054" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440165054">-</named-content>diabetes</named-content> or type <named-content data-cid="1545113216052" id="564f0937-9975-4722-ab3e-90980e2371a1" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="7fbd58ca-bc7d-4bfb-ad03-6fde93b82ea6" data-cid="1545113216052" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="148" data-match="2" data-pattern="" data-tag-index="24_2" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433573" id="cdc3fdbd-a781-43d3-8048-de9aac26593a" content-type="del cts-3" specific-use="1545440163201" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440163201">two</named-content></named-content><named-content data-cid="1545433574" id="3b7bbcc9-5977-43da-8e81-9eaa6b970401" content-type="ins cts-3" specific-use="1545440163467" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440163467">2</named-content> diabetes had worsening of glycemic control. Those with worsening of pre-existing type <named-content data-cid="1545113216053" id="c4afa5fd-ded5-458f-9ec8-631ec056aac2" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="db26c34c-0936-44bd-8000-327e93e28054" data-cid="1545113216053" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="236" data-match="2" data-pattern="" data-tag-index="24_3" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433576" id="413ecc82-0a01-4177-9e80-e9f0a9212cbc" content-type="del cts-3" specific-use="1545440169667" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440169667">two</named-content></named-content><named-content data-cid="1545433577" id="f2d25941-688a-4a4f-b9a8-85f57cb290c6" content-type="ins cts-3" specific-use="1545440169915" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440169915">2</named-content> diabetes in the absence of other predisposing factors had initiation of insulin therapy in most of these <named-content id="8513279d-935b-4e00-a551-5565e65c348d" data-cid="8513279d-935b-4e00-a551-5565e65c348d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="343" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="24_13" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content><named-content data-cid="1545433578" id="b58d3178-2268-427d-8362-52e89f1bbad3" content-type="del cts-3" specific-use="1545440174365" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440174365">, </named-content><named-content data-cid="1545433580" id="5265f537-1f85-42d6-b1e7-615d77a686bc" content-type="ins cts-3" specific-use="1545440175062" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440175062"> </named-content>and intensification in the rest. This demonstrates a temporal association between the initiation of ICI and development of β cell failure leading to insulin deficiency. This is similar to the rapid onset of hyperglycemia in cases of ICI<named-content data-cid="1545433581" id="447ebdae-494e-47bb-835c-0aa239335612" content-type="del cts-3" specific-use="1545440185412" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440185412"> </named-content><named-content data-cid="1545433582" id="a3a39df4-60b0-41d8-a581-1618ddbd275a" content-type="ins cts-3" specific-use="1545440185763" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440185763">-</named-content>induced diabetes reported in literature.<xref id="d445d26f-1bb9-448d-bb99-60c8ccf4c278" ref-type="bibr" rid="R13 R15" data-citation-string=" R13 R15 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="632" data-match="13, 15" data-pattern="" data-tag-index="24_1" data-track-change="13, 15"><sup id="91cfec01-9740-4678-ad8b-88c42536c995">13 15</sup></xref> However, as seen in our study, ICI use can also lead to significant worsening of glycemic control in pre-existing type <named-content data-cid="1545113216054" id="44cc15be-83de-4bb9-849d-0b55cfcbb100" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="3938ff80-599a-48d5-b73d-80361d31de64" data-cid="1545113216054" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="760" data-match="2" data-pattern="" data-tag-index="24_4" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433583" id="080551b8-308a-406a-89b9-2c9714c0330e" content-type="del cts-3" specific-use="1545440193112" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440193112">two</named-content></named-content><named-content data-cid="1545433584" id="85426d39-1bf7-4734-b326-6583622018e4" content-type="ins cts-3" specific-use="1545440193364" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440193364">2</named-content> diabetes, and this aspect has not been explored much in the available literature. We used strict criteria to classify these as induced by ICI therapy. However, limited laboratory characterization was available for these <named-content data-cid="1545113216055" id="3fdddcf1-3220-4e12-9f17-3285c11c907e" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">9</named-content><named-content id="56438a1e-8d1b-4c22-a406-43c0e4cf3d45" data-cid="1545113216055" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '9' to 'nine'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="982" data-match="9" data-pattern="" data-tag-index="24_5" data-function="numberToText,addTrackChanges" data-track-change="9" data-userid="preediting" data-username="Exeter" data-time="1545113216002">nine</named-content> cases in the medical records, with no testing for antibodies associated with type <named-content data-cid="1545113216056" id="f99208c5-27a3-475d-a28e-55ab82d70d38" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="a320c245-d45e-4974-94a4-edfde6d34210" data-cid="1545113216056" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1066" data-match="1" data-pattern="" data-tag-index="24_6" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433585" id="586b314b-f49b-42be-9d88-8f6188930871" content-type="del cts-3" specific-use="1545440206833" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440206833">one</named-content></named-content><named-content data-cid="1545433588" id="118ca1fb-d151-49b0-ac0d-f0735a1ebcbd" content-type="ins cts-3" specific-use="1545440207920" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 8:56am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440207920">1</named-content> diabetes and C-peptide testing for only <named-content data-cid="1545113216057" id="cda102df-6bc3-4683-b5ea-f218e663ab3a" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="0e74eaa8-9e89-466e-a14f-ef5d38176954" data-cid="1545113216057" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1108" data-match="1" data-pattern="" data-tag-index="24_7" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002">one</named-content> <named-content id="4db9363c-e8ef-4509-a50b-1e9acf18156e" data-cid="4db9363c-e8ef-4509-a50b-1e9acf18156e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1110" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="24_14" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content>. We also investigated the use of glucocorticoids that occurred in <named-content data-cid="1545113216058" id="80875d2e-d314-437c-83f3-ef9490cabadb" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">7</named-content><named-content id="336ea1ba-5a26-48ad-8b40-26ebea88a1f3" data-cid="1545113216058" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '7' to 'seven'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1184" data-match="7" data-pattern="" data-tag-index="24_8" data-function="numberToText,addTrackChanges" data-track-change="7" data-userid="preediting" data-username="Exeter" data-time="1545113216002">seven</named-content> <named-content id="7550c605-124d-45d7-b0f1-ed68011ae9ea" data-cid="7550c605-124d-45d7-b0f1-ed68011ae9ea" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1186" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="24_15" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>. It is unlikely that diabetes in these <named-content id="b8ef6d55-2927-467a-8acf-1de3b20fa9e0" data-cid="b8ef6d55-2927-467a-8acf-1de3b20fa9e0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1234" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="24_16" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> was caused by glucocorticoids, as they are not known to cause absolute insulin deficiency. Among the <named-content id="0ffed35b-9a25-4c01-9f13-dd2915d18534" data-cid="0ffed35b-9a25-4c01-9f13-dd2915d18534" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1344" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="24_17" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> <named-content data-cid="1545433591" id="502d6a24-4d3b-49db-b661-9f1bf5820c5e" content-type="del cts-3" specific-use="1545440709196" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:05am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440709196">that</named-content><named-content data-cid="1545433592" id="b2090b69-71be-4d2a-b0fb-fc3e2c92f583" content-type="ins cts-3" specific-use="1545440709454" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:05am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440709454">who</named-content> had worsening of pre-existing type <named-content data-cid="1545113216059" id="c9b9ca9e-9512-4bc2-8bea-4db091cdeb7a" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="609d5fd7-865f-4760-b1f1-ebf8ad000bc4" data-cid="1545113216059" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1393" data-match="2" data-pattern="" data-tag-index="24_9" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433589" id="8e4f6e4e-1624-4003-874f-f9c072b059e5" content-type="del cts-3" specific-use="1545440706237" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:05am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440706237">two</named-content></named-content><named-content data-cid="1545433590" id="a390682b-cacd-49de-a81c-fce9882d3c05" content-type="ins cts-3" specific-use="1545440706555" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:05am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440706555">2</named-content> diabetes, <named-content data-cid="1545113216060" id="3585547f-bf23-4b9f-931c-62ca6d648a5e" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">3</named-content><named-content id="042b1c17-6ac1-4def-b81c-0b476908e998" data-cid="1545113216060" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '3' to 'three'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1405" data-match="3" data-pattern="" data-tag-index="24_10" data-function="numberToText,addTrackChanges" data-track-change="3" data-userid="preediting" data-username="Exeter" data-time="1545113216002">three</named-content> were on glucocorticoids but did not have decrease in insulin dose after glucocorticoids were discontinued.</p><p data-class="jrnlSecPara" id="ec82c9e2-17b5-4028-8b00-103563eea644">As <named-content data-cid="1545113216109" id="af4cf398-a36b-440c-8b52-4cd592843015" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared to</named-content><named-content id="185101cb-9aa0-4cbe-9330-16ce5967dceb" data-cid="1545113216109" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="3" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="25_29" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared with</named-content> other studies <named-content data-cid="1545433595" content-type="ins cts-3" specific-use="1545440719571" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:05am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440719571" id="3a28e5e7-b5bd-4ae6-ae5a-265d498a1a01">that</named-content><named-content data-cid="1545433599" content-type="del cts-3" specific-use="1545440721592" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:05am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440721592" id="0d1d9d3e-4ca9-4108-85e5-b7b15bb85b29">which</named-content> have mostly reported on <named-content id="31dfb058-5498-4685-84b8-7e9efc5f2a81" data-cid="31dfb058-5498-4685-84b8-7e9efc5f2a81" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="59" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="25_30" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> referred for concern of diabetes after ICI therapy, we reviewed the medical records of all <named-content id="2b06f4d8-8fce-49ab-8b31-3176e2bbb565" data-cid="2b06f4d8-8fce-49ab-8b31-3176e2bbb565" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="159" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="25_31" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> treated with CTLA-4 and PD-1 inhibitors at our institution over a period of <named-content id="b85bacf2-0ee7-4671-997a-a44d85e03582" data-cid="b85bacf2-0ee7-4671-997a-a44d85e03582" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="244" data-match="6 years" data-replace="6" data-pattern="$1" data-tag-index="25_9" data-time="" data-username="" data-userid="">6</named-content><named-content id="b7d1a8a3-47df-4ca2-9bc5-141ba5c7dec0" data-cid="b7d1a8a3-47df-4ca2-9bc5-141ba5c7dec0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="245" data-match="6 years" data-replace=" years" data-pattern=" $2" data-tag-index="25_9" data-time="" data-username="" data-userid=""> years</named-content>, with at least a <named-content id="015103a4-936b-4f90-a4b6-be6d5ea50f17" data-cid="015103a4-936b-4f90-a4b6-be6d5ea50f17" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="269" data-match="6 month" data-replace="6" data-pattern="$1" data-tag-index="25_10" data-time="" data-username="" data-userid="">6</named-content><named-content id="68d981a0-d63e-48fe-9c29-c06c04f68fce" data-cid="68d981a0-d63e-48fe-9c29-c06c04f68fce" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣month' to ' month'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="270" data-match="6 month" data-replace=" month" data-pattern=" $2" data-tag-index="25_10" data-track-change=" month" data-time="" data-username="" data-userid=""><named-content data-cid="1545433600" content-type="del cts-3" specific-use="1545440730564" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:05am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440730564" id="82e2e4b3-6749-49b7-9117-a66393e7f0a2"> </named-content><named-content data-cid="1545433601" content-type="ins cts-3" specific-use="1545440730908" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:05am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440730908" id="40d16dbf-c196-4c5f-b5ad-72d6cc0960d2">-</named-content>month</named-content> follow-up duration after initiating ICI therapy. This adds to the strength of our study for being able to ascertain the frequency of ICI<named-content data-cid="1545433602" content-type="del cts-3" specific-use="1545440772398" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440772398" id="99c7150a-26a9-4b21-8bed-8b7d98cd5499"> </named-content><named-content data-cid="1545433603" content-type="ins cts-3" specific-use="1545440773445" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440773445" id="fc1cea4d-6b79-4fbf-b1bc-bb3fa7e7aa76">-</named-content>induced diabetes. Overall, <named-content id="429799c2-ac9e-4a7b-a334-d832f2c7df12" data-cid="429799c2-ac9e-4a7b-a334-d832f2c7df12" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="441" data-match="1.4%" data-replace="1.4" data-pattern="$1" data-tag-index="25_11" data-time="" data-username="" data-userid="">1.4</named-content><named-content id="86e9926f-9728-4da4-b1e0-957c30352309" data-cid="86e9926f-9728-4da4-b1e0-957c30352309" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="444" data-match="1.4%" data-replace="%" data-pattern="%" data-tag-index="25_11" data-time="" data-username="" data-userid="">%</named-content> of the entire group developed new-onset insulin-dependent diabetes or significant worsening of type <named-content data-cid="1545113216061" id="c54e36e0-64a7-4783-bbbf-4b92247a655b" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="d434e61b-a2b7-4c89-9ffe-864f359d6007" data-cid="1545113216061" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="546" data-match="2" data-pattern="" data-tag-index="25_21" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433604" content-type="del cts-3" specific-use="1545440778178" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440778178" id="7184f281-750a-4c54-b65a-d84a72ab698c">two</named-content></named-content><named-content data-cid="1545433605" content-type="ins cts-3" specific-use="1545440778438" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440778438" id="a8db90d6-0701-425b-a95f-450eae878bbb">2</named-content> diabetes. There were no cases in the 281 <named-content id="b5a5d1ff-57ed-4c58-8698-5febb69c19e2" data-cid="b5a5d1ff-57ed-4c58-8698-5febb69c19e2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="589" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="25_32" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> treated with CTLA-4 inhibitor ipilimumab. Stamatouli <named-content id="b5723470-91c6-4444-8710-3c04b622b908" data-cid="b5723470-91c6-4444-8710-3c04b622b908" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="651" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="25_16" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="86c1618e-c45c-424c-a758-b821a053f699">et al</italic></named-content><named-content id="595bcda5-509b-4619-9f75-3de8d88bb7e7" data-cid="595bcda5-509b-4619-9f75-3de8d88bb7e7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ETLDOT" data-track-detail="" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="656" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="25_27" data-time="" data-username="" data-userid=""><named-content id="6419f23c-d75e-4779-bab0-8b5d1ea540bc" data-cid="6419f23c-d75e-4779-bab0-8b5d1ea540bc" content-type="del cts-1" specific-use="1545113216002 data-cid=" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002 data-cid=">.</named-content></named-content><xref id="53eabe32-70b4-42de-b0bd-1980d5ba1797" ref-type="bibr" rid="R15" data-citation-string=" R15 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="659" data-match="15" data-pattern="" data-tag-index="25_1" data-track-change="15"><sup id="779c2dc2-bc2f-4c56-badf-d8e8f8b20889">15</sup></xref> and Iyer <named-content id="51e2223c-88f8-44ca-8279-a39cfedb6411" data-cid="51e2223c-88f8-44ca-8279-a39cfedb6411" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'et␣al' to '&lt;i&gt;et␣al&lt;/i&gt;'" data-track-detail="" data-tag-desc="ETL" data-tag-type="ETL" data-offset="672" data-match="et al" data-replace="&lt;i&gt;et al&lt;/i&gt;" data-pattern="&lt;i&gt;et al&lt;/i&gt;" data-tag-index="25_17" data-track-change="et al" data-time="" data-username="" data-userid=""><italic id="99a601e8-369b-4be9-b25a-17c2d395c30a">et al</italic></named-content><named-content id="91e403c2-d597-4465-9bd0-09f4aa4e1337" data-cid="91e403c2-d597-4465-9bd0-09f4aa4e1337" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ETLDOT" data-track-detail="" data-tag-desc="ETLDOT" data-tag-type="ETLDOT" data-offset="677" data-match="." data-replace="delete" data-pattern="delete" data-tag-index="25_28" data-time="" data-username="" data-userid=""><named-content id="89fc2ac9-e4a8-46a0-a40e-6b702b938e66" data-cid="89fc2ac9-e4a8-46a0-a40e-6b702b938e66" content-type="del cts-1" specific-use="1545113216002 data-cid=" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002 data-cid=">.</named-content></named-content><xref id="167b967f-14ff-48dc-a82a-0d09c217c4b2" ref-type="bibr" rid="R16" data-citation-string=" R16 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="680" data-match="16" data-pattern="" data-tag-index="25_2" data-track-change="16"><sup id="63209975-cfb9-4c7b-a569-732cdb99f836">16</sup></xref> have reported on their experience with ICI<named-content data-cid="1545433606" content-type="del cts-3" specific-use="1545440789012" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440789012" id="72df5d6b-e365-4abd-b5ca-45110ebcd943"> </named-content><named-content data-cid="1545433607" content-type="ins cts-3" specific-use="1545440789380" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440789380" id="17bfd317-a797-4fc4-8e90-24224657f202">-</named-content>induced diabetes<named-content data-cid="1545433608" content-type="del cts-3" specific-use="1545440792063" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440792063" id="ee579d0b-ee91-4a29-a690-0c4a3c86420d">,</named-content> and also did not find any cases with CTLA-4 inhibitor therapy. <named-content data-cid="1545433609" content-type="ins cts-3" specific-use="1545440794733" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440794733" id="f8ed8185-67e8-4bf7-be98-d6607557a436">However,</named-content><named-content data-cid="1545433619" content-type="del cts-3" specific-use="1545440799310" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440799310" id="6e7bbae9-3efc-464d-bf97-214d2f12075b">On the other hand,</named-content> <named-content id="60069679-1c6f-4ad2-b4db-526f98db41dc" data-cid="60069679-1c6f-4ad2-b4db-526f98db41dc" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="827" data-match="1.8%" data-replace="1.8" data-pattern="$1" data-tag-index="25_12" data-time="" data-username="" data-userid="">1.8</named-content><named-content id="cda68bc9-f817-4fd5-bcd3-b966fbf89da2" data-cid="cda68bc9-f817-4fd5-bcd3-b966fbf89da2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="830" data-match="1.8%" data-replace="%" data-pattern="%" data-tag-index="25_12" data-time="" data-username="" data-userid="">%</named-content> of those treated with PD-1 inhibitors developed ICI<named-content data-cid="1545433931" content-type="del cts-3" specific-use="1545443070485" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443070485" id="fd32c08d-1a9f-4c27-9c4a-76fe606ccc9a"> </named-content><named-content data-cid="1545433932" content-type="ins cts-3" specific-use="1545443070837" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:44am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443070837" id="5f597105-6ab5-4126-9c68-a6776daecddc">-</named-content>induced diabetes, of which <named-content id="9f603840-c8c2-443e-a103-c28db7d7a5fb" data-cid="9f603840-c8c2-443e-a103-c28db7d7a5fb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="911" data-match="1%" data-replace="1" data-pattern="$1" data-tag-index="25_13" data-time="" data-username="" data-userid="">1</named-content><named-content id="62dc6d98-9ef4-4325-8fef-f1540ee3a755" data-cid="62dc6d98-9ef4-4325-8fef-f1540ee3a755" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="912" data-match="1%" data-replace="%" data-pattern="%" data-tag-index="25_13" data-time="" data-username="" data-userid="">%</named-content> had new-onset insulin-dependent diabetes and <named-content id="3a95301c-46ff-4899-8b80-b6635db9fefb" data-cid="3a95301c-46ff-4899-8b80-b6635db9fefb" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="959" data-match="0.8%" data-replace="0.8" data-pattern="$1" data-tag-index="25_14" data-time="" data-username="" data-userid="">0.8</named-content><named-content id="f9e46a14-cf93-48f0-aa54-e1e27f4d0136" data-cid="f9e46a14-cf93-48f0-aa54-e1e27f4d0136" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="962" data-match="0.8%" data-replace="%" data-pattern="%" data-tag-index="25_14" data-time="" data-username="" data-userid="">%</named-content> demonstrated worsening of pre-existing type <named-content data-cid="1545113216062" id="bf661802-7f09-4633-9d46-6e89cd8c9dff" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="62cd71a0-228b-4ddf-a370-48d6e48a3922" data-cid="1545113216062" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1008" data-match="2" data-pattern="" data-tag-index="25_22" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433620" content-type="del cts-3" specific-use="1545440806501" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440806501" id="c6c434e9-e841-4574-8f9b-ab660ee6b89a">two</named-content></named-content><named-content data-cid="1545433621" content-type="ins cts-3" specific-use="1545440806792" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440806792" id="57fa835b-ab49-4cdc-b0c7-0b5cc0732fa5">2</named-content> diabetes. In our study, <named-content id="6949d9b6-cb0f-424d-8c18-d1877cadd88c" data-cid="6949d9b6-cb0f-424d-8c18-d1877cadd88c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="PER" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="PER" data-offset="1034" data-match="9/96 (9.3%)" data-replace="9/96" data-pattern="$1" data-tag-index="25_8" data-time="" data-username="" data-userid="">9/96</named-content><named-content id="98679a81-db61-44b0-8558-cf8d7bf529e1" data-cid="98679a81-db61-44b0-8558-cf8d7bf529e1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="PER,VAL,UNT" data-tag-type="VAL" data-offset="1038" data-match="9/96 (9.3%)" data-replace=" (9.3%)" data-pattern=" $2" data-tag-index="25_8" data-time="" data-username="" data-userid=""> (9.3%)</named-content> <named-content id="48c6c34f-a796-474c-bf67-1b3cac91243d" data-cid="48c6c34f-a796-474c-bf67-1b3cac91243d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1046" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="25_33" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with pre-existing <named-content data-cid="1545113216110" id="9fc89c91-7cca-4064-892f-7908a0c82175" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">prediabetes</named-content><named-content id="3df38930-3cb6-430f-b64e-ff15d82e2336" data-cid="1545113216110" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'prediabetes' to 'pre-diabetes'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1073" data-match="prediabetes" data-replace="pre-diabetes" data-pattern="pre-diabetes" data-tag-index="25_34" data-function="addTrackChanges" data-track-change="prediabetes" data-userid="preediting" data-username="Exeter" data-time="1545113216002">pre<named-content data-cid="1545433622" content-type="del cts-3" specific-use="1545440810084" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440810084" id="a273489e-ac51-4697-8b64-9c00e4db8ba2">-</named-content>diabetes</named-content> or type <named-content data-cid="1545113216063" id="df41f249-c5ba-4113-8ebb-704d36e39a3a" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="a0540491-05cc-4cf3-8170-e0562cda855e" data-cid="1545113216063" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1093" data-match="2" data-pattern="" data-tag-index="25_23" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433623" content-type="del cts-3" specific-use="1545440812639" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440812639" id="0abed09a-f8bb-4aa4-a4b4-7ef538352121">two</named-content></named-content><named-content data-cid="1545433624" content-type="ins cts-3" specific-use="1545440812883" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440812883" id="2d02b5c1-e172-4bfe-bb06-317afbcc05c0">2</named-content> diabetes had worsening of glycemic control after starting PD-1 inhibitor therapy. The frequency of new<named-content data-cid="1545433944" content-type="del cts-3" specific-use="1545443389443" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:49am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443389443" id="27ee9142-3008-499d-b72b-2c1637a9ce07"> </named-content><named-content data-cid="1545433945" content-type="ins cts-3" specific-use="1545443389729" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:49am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545443389729" id="f964d151-3310-4730-a65f-a6ef53087b4d">-</named-content>onset insulin-dependent diabetes of <named-content id="8cec5c9d-5e32-4c38-9bc2-1dfb5b61acce" data-cid="8cec5c9d-5e32-4c38-9bc2-1dfb5b61acce" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="1234" data-match="1%" data-replace="1" data-pattern="$1" data-tag-index="25_15" data-time="" data-username="" data-userid="">1</named-content><named-content id="b74fd90a-fda8-4a86-88ef-ddbd16225945" data-cid="b74fd90a-fda8-4a86-88ef-ddbd16225945" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="1235" data-match="1%" data-replace="%" data-pattern="%" data-tag-index="25_15" data-time="" data-username="" data-userid="">%</named-content> seen in our cohort of PD-1 inhibitor<named-content data-cid="1545433625" content-type="del cts-3" specific-use="1545440819845" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:06am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440819845" id="42713ae5-0ec0-4c95-9dfd-bcb341465005"> </named-content><named-content data-cid="1545433626" content-type="ins cts-3" specific-use="1545440820186" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440820186" id="a32e13d9-d919-4ef1-bad5-1662052a90e6">-</named-content>treated <named-content id="a711721a-d58f-46ad-9719-a2e379a34971" data-cid="a711721a-d58f-46ad-9719-a2e379a34971" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1282" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="25_35" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> is higher than that reported by a recent meta-analysis from available clinical trials.<xref id="6f64fa03-1071-40b1-8710-de8096bfd6a5" ref-type="bibr" rid="R12" data-citation-string=" R12 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1378" data-match="12" data-pattern="" data-tag-index="25_3" data-track-change="12"><sup id="764651d1-437d-4783-a297-cd94860ea1eb">12</sup></xref> This discrepancy between clinical practice and trial data might be due to better characterization of diabetes in clinical practice and longer <named-content data-cid="1545113216111" id="dc56b472-7ba0-4aaf-94fd-e1813707a93b" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow up</named-content><named-content id="b20362dd-38b8-4c7a-adbe-5be38a5641bd" data-cid="1545113216111" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1525" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="25_36" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow-up</named-content> after ICI therapy initiation. The difference in frequency of ICI<named-content data-cid="1545433627" content-type="del cts-3" specific-use="1545440832526" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440832526" id="9b4f8f43-2fa4-414d-8a18-e37e784aad9e"> </named-content><named-content data-cid="1545433628" content-type="ins cts-3" specific-use="1545440833638" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440833638" id="eba28fe1-f1f9-43b9-8767-bd52be2047db">-</named-content>induced diabetes between the different ICIs may in part be related to the expression of the specific checkpoints that they inhibit. CTLA-4 has been demonstrated to be expressed on pituitary cells. Accordingly, the CTLA-4 inhibitor ipilimumab has been shown to cause hypophysitis with highest frequency <named-content data-cid="1545113216112" id="d8551f3e-aba7-4a23-91ba-47b1516b4b89" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">amongst</named-content><named-content id="f48c94ce-c492-4c38-a6c7-8e84f6895d5b" data-cid="1545113216112" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'amongst' to 'among'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1902" data-match="amongst" data-replace="among" data-pattern="among" data-tag-index="25_37" data-function="addTrackChanges" data-track-change="amongst" data-userid="preediting" data-username="Exeter" data-time="1545113216002">among</named-content> all ICIs.<xref id="1c8e4788-8acf-42b5-9145-e66b67e4e74e" ref-type="bibr" rid="R12" data-citation-string=" R12 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1920" data-match="12" data-pattern="" data-tag-index="25_4" data-track-change="12"><sup id="4b664d8b-cc99-4b89-bf89-74a8f186bacf">12</sup></xref> <named-content data-cid="1545433629" content-type="ins cts-3" specific-use="1545440846176" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440846176" id="6fde3cc9-d300-443c-8eaf-1b40ea9a3519">However</named-content><named-content data-cid="1545433636" content-type="del cts-3" specific-use="1545440849034" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440849034" id="41012d6e-abf9-4bde-9082-6921ba51c8a2">On the other hand</named-content>, both <named-content id="2d170adc-8263-46c3-9291-1128e46245d3" data-cid="2d170adc-8263-46c3-9291-1128e46245d3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'in vitro' to 'in vitro'" data-track-detail="" data-tag-desc="FNW" data-tag-type="FNW" data-offset="1949" data-match="in vitro" data-pattern="" data-tag-index="25_18" data-function="removeItalics" data-time="" data-username="" data-userid="">in vitro</named-content> and <named-content id="1cd82ada-135a-4498-b802-7a03624d664e" data-cid="1cd82ada-135a-4498-b802-7a03624d664e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'in vivo' to 'in vivo'" data-track-detail="" data-tag-desc="FNW" data-tag-type="FNW" data-offset="1962" data-match="in vivo" data-pattern="" data-tag-index="25_19" data-function="removeItalics" data-time="" data-username="" data-userid="">in vivo</named-content> studies have demonstrated an association between PD-1 and autoimmune diabetes. <named-content id="cd253fee-1b6a-4794-b931-8514076e8159" data-cid="cd253fee-1b6a-4794-b931-8514076e8159" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="2049" data-match="Single nucleotide polymorphisms" data-pattern="" data-tag-index="" data-abbr="SNP" data-time="" data-username="" data-userid="">Single<named-content data-cid="1545433638" content-type="del cts-3" specific-use="1545440861227" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440861227" id="692885f5-af9b-4bbb-bb01-115f37d82aaa"> </named-content><named-content data-cid="1545433639" content-type="ins cts-3" specific-use="1545440861707" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440861707" id="f7539f54-15e6-4180-8b09-135364819182">-</named-content>nucleotide polymorphisms</named-content><named-content data-cid="1545433637" content-type="del cts-3" specific-use="1545440859494" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440859494" id="67a15b1f-a35b-4a64-8dc5-152a5b8321ca"> (</named-content><named-content id="796bec8b-d638-42fb-9b26-dc782fdce94b" data-cid="796bec8b-d638-42fb-9b26-dc782fdce94b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="2082" data-match=" (SNPs)" data-pattern="" data-tag-index="25_20" data-time="" data-username="" data-userid=""><named-content data-cid="1545433637" content-type="del cts-3" specific-use="1545440859494" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440859494" id="b5d84fc0-7108-4f44-b0d2-bc25bc7a7e72">SNPs</named-content></named-content><named-content data-cid="1545433637" content-type="del cts-3" specific-use="1545440859494" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440859494" id="762b4bec-d4b1-4248-8586-9b199a5edc89">)</named-content> in the PD-1 gene have been demonstrated to be enriched in individuals with type <named-content data-cid="1545113216064" id="35b7cfb6-6a96-4903-8b5b-5e22cdc240b4" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="f40c8cd3-4c24-4a3e-8105-77ad33aa2f10" data-cid="1545113216064" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="2168" data-match="1" data-pattern="" data-tag-index="25_24" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433640" content-type="del cts-3" specific-use="1545440870529" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440870529" id="3c3b57cf-d125-4ef3-b423-d16f2dde7253">one</named-content></named-content><named-content data-cid="1545433641" content-type="ins cts-3" specific-use="1545440870790" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440870790" id="6f33e0fb-a0c7-47f5-af68-c78d9f81404f">1</named-content> diabetes (12.2%) <named-content data-cid="1545113216113" id="3deca1dd-3977-403d-87bb-702db78601e6" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared to</named-content><named-content id="3027bc88-7eea-40bd-b297-6a6e2ffbe8ca" data-cid="1545113216113" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="2187" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="25_38" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared with</named-content> controls (6.8%), implicating the PD-1 pathway in the development of immune<named-content data-cid="1545433642" content-type="del cts-3" specific-use="1545440877810" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440877810" id="80285c5a-b936-43db-92bd-69a2482d1f45"> </named-content><named-content data-cid="1545433643" content-type="ins cts-3" specific-use="1545440878231" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:07am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440878231" id="aad9627d-2bea-4bf2-a57d-dcdbf16d515c">-</named-content>mediated diabetes.<xref id="d19a4e06-cbfd-4bfe-98e4-26249ce58f9e" ref-type="bibr" rid="R17" data-citation-string=" R17 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="2293" data-match="17" data-pattern="" data-tag-index="25_5" data-track-change="17"><sup id="2af85d4b-4308-4e22-be2c-478992a1b98e">17</sup></xref> Analysis of peripheral blood mononuclear cells from long-standing type <named-content data-cid="1545113216065" id="66988bff-ba22-4f96-a623-3c378fd23699" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="23715530-2a5c-4377-be94-6b353df4e44f" data-cid="1545113216065" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="2369" data-match="1" data-pattern="" data-tag-index="25_25" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433644" content-type="del cts-3" specific-use="1545440883964" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440883964" id="094550cf-221a-4951-9f47-ee34346b7504">one</named-content></named-content><named-content data-cid="1545433645" content-type="ins cts-3" specific-use="1545440884302" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440884302" id="0ef927f6-f877-4019-85f6-f924aa456033">1</named-content> diabetes <named-content id="1f85ecc3-b8a0-465a-b4b5-18ce0c5ca76c" data-cid="1f85ecc3-b8a0-465a-b4b5-18ce0c5ca76c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="2380" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="25_39" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> <named-content id="e5121c72-f6f4-4b5d-b141-dc513b394ea7" data-cid="e5121c72-f6f4-4b5d-b141-dc513b394ea7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed 'versus' to 'vs'" data-track-detail="" data-tag-desc="VERSUS" data-tag-type="VERSUS" data-offset="2389" data-match="versus" data-replace="vs" data-pattern="vs" data-tag-index="25_42" data-track-change="versus" data-time="" data-username="" data-userid="">v<named-content data-cid="1545433646" content-type="ins cts-3" specific-use="1545440885419" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440885419" id="38497503-a9fe-47af-bf60-94868b95f048">ersu</named-content>s</named-content> healthy controls stimulated with CD3/CD28 to induce proliferation of T-regulatory cells has demonstrated lower expression of PD-1 on the surface of these cells.<xref id="e23fc013-2bbc-4e97-9b2a-bce6b9fa5903" ref-type="bibr" rid="R18" data-citation-string=" R18 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="2557" data-match="18" data-pattern="" data-tag-index="25_6" data-track-change="18"><sup id="a7386bde-2da4-461e-b83e-3221f935f33c">18</sup></xref> Another study of 22 Japanese type <named-content data-cid="1545113216066" id="2ce4421f-418a-4521-adb4-4dc80270571c" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="97f6bcf8-47e3-4413-b87c-87efe6cfbb59" data-cid="1545113216066" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="2596" data-match="1" data-pattern="" data-tag-index="25_26" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433650" content-type="del cts-3" specific-use="1545440893690" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440893690" id="e58341d5-ddb9-4569-ac8d-6f33e162c2af">one</named-content></named-content><named-content data-cid="1545433651" content-type="ins cts-3" specific-use="1545440893983" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440893983" id="12f8f31d-7057-4cdd-9fff-84ff1277d5a4">1</named-content> diabetes <named-content id="4cec63aa-5628-4ffa-b7e2-b84d9c922eb0" data-cid="4cec63aa-5628-4ffa-b7e2-b84d9c922eb0" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="2607" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="25_41" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> compared with 29 healthy controls demonstrated lower PD-1 expression on CD4 positive T cells.<xref id="413c02f9-2a41-48e0-a368-cbac1b8dccc1" ref-type="bibr" rid="R19" data-citation-string=" R19 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="2710" data-match="19" data-pattern="" data-tag-index="25_7" data-track-change="19"><sup id="e2d3f381-80ee-4fae-bfa8-02ae25f52844">19</sup></xref> These data provide some mechanistic insight into the development of insulin-dependent diabetes with the use of PD-1 inhibitors.</p><title data-level="2" data-class="jrnlHead2" old-class="" id="cc87ea95-98fd-4291-a44f-fac3dcc0035e">Disease characteristics and natural history of ICI<named-content data-cid="1545433652" content-type="del cts-3" specific-use="1545440902227" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440902227" id="4dd3c54b-6831-422c-8c74-d360f3b1f1d0"> </named-content><named-content data-cid="1545433653" content-type="ins cts-3" specific-use="1545440902565" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440902565" id="317d7231-c383-4871-bb3d-0f3348a714ca">-</named-content>induced diabetes</title><p data-class="jrnlSecPara" id="663742bf-1544-4aba-b9a3-19c6e7d274b3">In this study, insulin deficiency occurred at a median of <named-content id="e15f5ded-02dc-44b0-8aa8-fb5dcb843fd3" data-cid="e15f5ded-02dc-44b0-8aa8-fb5dcb843fd3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGS" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGS" data-offset="58" data-match="4-5 months" data-replace="4" data-pattern="$2" data-tag-index="26_5" data-time="" data-username="" data-userid="">4</named-content><named-content id="f01ffc58-0608-4c89-8a82-03783c11454a" data-cid="f01ffc58-0608-4c89-8a82-03783c11454a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '-' to '–'" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGC" data-offset="59" data-match="4-5 months" data-replace="–" data-pattern="–" data-tag-index="26_5" data-track-change="-" data-time="" data-username="" data-userid="">–</named-content><named-content id="9f51ab06-1492-454e-8ce5-2b2552d789be" data-cid="9f51ab06-1492-454e-8ce5-2b2552d789be" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="RNGE" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="RNGE" data-offset="60" data-match="4-5 months" data-replace="5" data-pattern="$4" data-tag-index="26_5" data-time="" data-username="" data-userid="">5</named-content><named-content id="f7bf17b3-be87-4f92-a9ac-bdab01d797d8" data-cid="f7bf17b3-be87-4f92-a9ac-bdab01d797d8" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,RNGS,RNGC,RNGE,UNT" data-tag-type="UNT" data-offset="61" data-match="4-5 months" data-replace=" months" data-pattern=" $5" data-tag-index="26_5" data-time="" data-username="" data-userid=""> months</named-content> after ICI initiation or <named-content data-cid="1545433654" content-type="del cts-3" specific-use="1545440917427" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440917427" id="21ed9740-7d6e-4204-9e75-2837b176b180">4</named-content><named-content data-cid="1545433655" content-type="ins cts-3" specific-use="1545440918104" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440918104" id="7bfb6bee-8e3f-423b-beaa-d2ece85134c1">four</named-content> cycles of ICI therapy<named-content data-cid="1545433659" content-type="del cts-3" specific-use="1545440921306" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440921306" id="ab9d1483-3c5d-4763-b4f3-2c407a2d164d">,</named-content><named-content data-cid="1545433660" content-type="ins cts-3" specific-use="1545440921837" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440921837" id="8d39c241-f5bd-458c-980a-1f8fae7385a2">;</named-content> however, some <named-content id="0b69eebf-2828-4b9d-96eb-967ad7de8a99" data-cid="0b69eebf-2828-4b9d-96eb-967ad7de8a99" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="132" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="26_8" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> developed it within a few weeks<named-content data-cid="1545433661" content-type="ins cts-3" specific-use="1545440931205" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440931205" id="6fb3a163-8f26-4565-b28e-2741555fb9e4">,</named-content> whereas others<named-content data-cid="1545433670" content-type="ins cts-3" specific-use="1545440935459" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:08am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545440935459" id="3e3968b9-e463-4bce-89a3-5b09451e3cbe"> developed it</named-content> much later, especially one <named-content id="7b3b97ab-f380-4d05-8ba3-7006243eed44" data-cid="7b3b97ab-f380-4d05-8ba3-7006243eed44" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="215" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="26_9" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content> that presented with severe DKA after 16 cycles or <named-content id="e4a65b9d-8ed5-4b5e-9e3d-c94b9f3c878f" data-cid="e4a65b9d-8ed5-4b5e-9e3d-c94b9f3c878f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="273" data-match="24 months" data-replace="24" data-pattern="$1" data-tag-index="26_6" data-time="" data-username="" data-userid="">24</named-content><named-content id="682350d1-5709-44c3-9261-d3c8a6a36f0d" data-cid="682350d1-5709-44c3-9261-d3c8a6a36f0d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="275" data-match="24 months" data-replace=" months" data-pattern=" $2" data-tag-index="26_6" data-time="" data-username="" data-userid=""> months</named-content> since ICI initiation (<xref ref-type="table" rid="T3" data-citation-string=" T3 " data-tag-desc="FIGTBLREF" data-tag-type="FIGTBLREF" data-offset="305" data-match="Table 3" data-pattern="" data-tag-index="26_1" id="49fb4a29-4de7-4fe7-bdbd-12508e6670f3"><named-content data-cid="1546365745985" id="69ac4393-2dc6-46c7-9361-289e14ac3e5b" content-type="del cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Table 3</named-content><named-content data-cid="1546365745985" id="d864df9c-dea0-494d-9806-0651781f32a5" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">table 3</named-content></xref>). The few <named-content id="b0622835-3e2c-4bd7-bb26-cd381c86a5f7" data-cid="b0622835-3e2c-4bd7-bb26-cd381c86a5f7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="323" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="26_10" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> that did undergo pre<named-content data-cid="1545433685" content-type="del cts-3" specific-use="1545441004757" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441004757" id="02eba2d2-9b3d-4afe-9874-215124b5ddde">-</named-content>therapy testing in the new-onset diabetes group demonstrated normoglycemia prior to ICI therapy. This progression to insulin deficiency, which was acute and severe in most cases as demonstrated by the frequency of DKA, appears to be more rapid as <named-content data-cid="1545113216114" id="ea79b5f7-460e-4192-8422-e23c2b9190b8" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared to</named-content><named-content id="3c61598c-2983-4588-a779-0d4e08e3ac88" data-cid="1545113216114" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="600" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="26_11" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared with</named-content> spontaneous type <named-content data-cid="1545113216067" id="f5f7d8b2-4858-4f06-bd3e-acd51cb33d41" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="0ff03bcd-a7fc-48b5-bf10-aea82c4e685a" data-cid="1545113216067" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="629" data-match="1" data-pattern="" data-tag-index="26_7" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433686" content-type="del cts-3" specific-use="1545441016400" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441016400" id="1fb74b5c-df44-407e-96b2-277c8130bedc">one</named-content></named-content><named-content data-cid="1545433687" content-type="ins cts-3" specific-use="1545441016660" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441016660" id="002a9e1b-74e9-4fc6-9b67-bcb28ab76319">1</named-content> diabetes, suggesting a faster rate of β cell failure in <named-content id="7aca55e7-3fa9-4832-a536-b4c95e4ff642" data-cid="7aca55e7-3fa9-4832-a536-b4c95e4ff642" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="688" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="26_12" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> who develop ICI<named-content data-cid="1545433688" content-type="del cts-3" specific-use="1545441021283" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441021283" id="9109e05f-ba74-4619-a9bc-86ea48cdaa41"> </named-content><named-content data-cid="1545433689" content-type="ins cts-3" specific-use="1545441021669" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441021669" id="11eef536-5c77-45c9-a348-02c914d4e417">-</named-content>induced diabetes. The other cases of ICI<named-content data-cid="1545433690" content-type="del cts-3" specific-use="1545441024477" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441024477" id="799a0d1e-5f63-4933-b2eb-c00d1ff4bff4"> </named-content><named-content data-cid="1545433691" content-type="ins cts-3" specific-use="1545441024997" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441024997" id="45de2523-cea1-45df-8346-fb235851ba1f">-</named-content>induced diabetes reported in the literature have demonstrated a similar rapid progression to hyperglycemia.<xref id="54192552-ce86-42d8-ab07-f8ed59cadef4" ref-type="bibr" rid="R13 R15" data-citation-string=" R13 R15 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="862" data-match="13, 15" data-pattern="" data-tag-index="26_2" data-track-change="13, 15"><sup id="a86ccd2d-79e3-4540-8e4d-4be18cb472cf">13 15</sup></xref> With our knowledge of the mechanism of these ICIs, we hypothesize that T<named-content data-cid="1545433692" content-type="del cts-3" specific-use="1545441031709" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441031709" id="aad39ca7-6631-4391-a91c-130774a79fba">-</named-content><named-content data-cid="1545433693" content-type="ins cts-3" specific-use="1545441032491" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441032491" id="d227bd89-af94-4397-a87e-87d8e4a7488b"> </named-content>cell<named-content data-cid="1545433694" content-type="del cts-3" specific-use="1545441034081" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441034081" id="57e440a9-823b-4876-bfbc-b766cf6b3528"> </named-content><named-content data-cid="1545433695" content-type="ins cts-3" specific-use="1545441035013" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441035013" id="09b32cbb-8ad0-4962-9fc2-275a103062c5">-</named-content>mediated destruction of β cells is the underlying cause of ICI<named-content data-cid="1545433696" content-type="del cts-3" specific-use="1545441039499" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441039499" id="dadcb09a-a482-4e21-b60b-37162df7e353"> </named-content><named-content data-cid="1545433697" content-type="ins cts-3" specific-use="1545441039824" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441039824" id="ecbb157d-7574-470c-bc65-ee1e6831bac9">-</named-content>induced diabetes. In this study, we did not evaluate the response of malignancy to ICIs, but some available studies have suggested a possible association between the development of IRAE and better malignancy response to a specific ICI.<xref id="71a1456e-a352-4802-acaa-81b45b3fbc05" ref-type="bibr" rid="R15 R20 R21" data-citation-string=" R15 R20 R21 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1249" data-match="15, 20, 21" data-pattern="" data-tag-index="26_3" data-track-change="15, 20, 21"><sup id="227a4ea2-f99d-4e31-a61e-971158943668">15 20 21</sup></xref> This would make theoretical sense since ICI<named-content data-cid="1545433698" content-type="del cts-3" specific-use="1545441050046" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441050046" id="3c223028-8a56-47c6-82d1-81715aa5dcb9"> </named-content><named-content data-cid="1545433699" content-type="ins cts-3" specific-use="1545441050394" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441050394" id="4804d80c-213a-4a97-9f89-2862241d879c">-</named-content>mediated de<named-content data-cid="1545433700" content-type="del cts-3" specific-use="1545441052289" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441052289" id="b7309ceb-1c85-4b82-8168-61b8da19525e">-</named-content>repression of T<named-content data-cid="1545433701" content-type="del cts-3" specific-use="1545441054439" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441054439" id="49ce088b-641b-4744-b865-5d32c645a2db">-</named-content><named-content data-cid="1545433702" content-type="ins cts-3" specific-use="1545441054888" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441054888" id="02931b5b-c403-4b49-87a9-ae83591ac9f5"> </named-content>cells is responsible for both the anti<named-content data-cid="1545433703" content-type="del cts-3" specific-use="1545441056544" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:10am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441056544" id="109ea009-706c-4a73-86c4-13e3ab85895e">-</named-content>tumor response as well as autoimmune adverse events. Two-thirds of our <named-content id="d7a22270-be92-482b-9209-b86260794625" data-cid="d7a22270-be92-482b-9209-b86260794625" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1444" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="26_13" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with new<named-content data-cid="1545433704" content-type="del cts-3" specific-use="1545441060690" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:11am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441060690" id="8452fa22-4782-4cf6-b6cf-57a4ea46e2e8"> </named-content><named-content data-cid="1545433705" content-type="ins cts-3" specific-use="1545441061008" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:11am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441061008" id="357a86c2-5959-45b4-85f5-8591b1d97a45">-</named-content>onset insulin-dependent diabetes presented with DKA, suggesting rapid progression to severe insulin deficiency in these <named-content id="26710f81-385a-4a65-ab43-bd68dc36de2a" data-cid="26710f81-385a-4a65-ab43-bd68dc36de2a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1582" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="26_14" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>. All <named-content id="ed744b39-4937-45a0-a83a-bbf2af57e6be" data-cid="ed744b39-4937-45a0-a83a-bbf2af57e6be" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1596" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="26_15" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> were on insulin during the <named-content data-cid="1545113216115" id="78a2a9d8-8ab9-4c0a-852c-2b95e681c500" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow up</named-content><named-content id="72184e03-39e7-4667-b0fe-89349afc0e75" data-cid="1545113216115" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'follow␣up' to 'follow-up'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1632" data-match="follow up" data-replace="follow-up" data-pattern="follow-up" data-tag-index="26_16" data-function="addTrackChanges" data-track-change="follow up" data-userid="preediting" data-username="Exeter" data-time="1545113216002">follow-up</named-content> duration, most being on MDI, and none of them were able to de-escalate their therapy. This suggests that remission of ICI<named-content data-cid="1545433706" content-type="del cts-3" specific-use="1545441080807" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:11am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441080807" id="9027bd78-7ef3-4bdd-a989-683f4642e218"> </named-content><named-content data-cid="1545433707" content-type="ins cts-3" specific-use="1545441081231" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:11am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441081231" id="22730aaa-9f8c-4954-8918-65b3e436f1e0">-</named-content>induced diabetes is unlikely. In literature, remission of such cases is reported rarely, with only 1/21 cases reported to have undergone remission in the experience from MD Anderson Cancer <named-content id="d0046b36-e6bc-4f56-9a35-bf6ed5aba05b" data-cid="d0046b36-e6bc-4f56-9a35-bf6ed5aba05b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'Center' to 'Center'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1953" data-match="Center" data-replace="Center" data-pattern="$1" data-tag-index="26_17" data-function="addTrackChanges" data-time="" data-username="" data-userid="">Center</named-content>.<xref id="03afd569-214b-48ac-a8ff-99b5f421a6ba" ref-type="bibr" rid="R16" data-citation-string=" R16 " data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="1961" data-match="16" data-pattern="" data-tag-index="26_4" data-track-change="16"><sup id="4b3765a1-1c14-45a9-aa96-32a43b8fe611">16</sup></xref> In terms of management, some earlier reported cases in the literature were administered glucocorticoids, possibly related to information available from treating other IRAEs. However, those cases did not have improvement in their glycemic control. The <named-content id="5c4ef4f5-3ec3-4b6a-8bdd-b40280e1277b" data-cid="5c4ef4f5-3ec3-4b6a-8bdd-b40280e1277b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="2217" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="26_18" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> reported in our study did not receive glucocorticoids for therapy of ICI<named-content data-cid="1545433708" content-type="del cts-3" specific-use="1545441102933" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:11am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441102933" id="8e271956-86b4-41ee-b1ba-4f6a13ce3d66"> </named-content><named-content data-cid="1545433709" content-type="ins cts-3" specific-use="1545441103317" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:11am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441103317" id="9864b6fb-d44a-40ca-bb93-443ece7dd413">-</named-content>induced diabetes.</p><title data-level="2" data-class="jrnlHead2" old-class="" id="819a1538-04c9-4c10-a9b0-8a59fff12bf8">Potential factors influencing disease occurrence and severity</title><p data-class="jrnlSecPara" id="022326ec-c566-4f45-aebb-4dbff7847748">Even with the retrospective nature of this study and limited information available from review of chart records, we identified some potential predictive factors, which could influence the frequency of occurrence, or the natural history of ICI<named-content data-cid="1545433710" id="2ff9a1de-a1bd-43c7-878c-ac5a6f6aa526" content-type="del cts-3" specific-use="1545441226596" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:13am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441226596"> </named-content><named-content data-cid="1545433711" id="3bc4574a-96b3-443d-807e-bdf9cf36f984" content-type="ins cts-3" specific-use="1545441226930" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:13am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441226930">-</named-content>induced diabetes. We evaluated the predisposition to autoimmunity by reporting on family history or personal history of autoimmune conditions. In those with new-onset insulin-dependent diabetes, <named-content id="9b4e6e5d-d337-4d3b-bbec-900ef52fb80c" data-cid="9b4e6e5d-d337-4d3b-bbec-900ef52fb80c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="438" data-match="17%" data-replace="17" data-pattern="$1" data-tag-index="27_4" data-time="" data-username="" data-userid="">17</named-content><named-content id="a0e82103-e4c0-4347-946d-399688dc61d7" data-cid="a0e82103-e4c0-4347-946d-399688dc61d7" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="440" data-match="17%" data-replace="%" data-pattern="%" data-tag-index="27_4" data-time="" data-username="" data-userid="">%</named-content> had a personal history of autoimmunity (all with Hashimoto's thyroiditis), and 1/3<sup id="6a036a5f-315e-4ec8-826c-95ba778d95ee"><named-content data-cid="1545433712" id="a225ea81-29dd-49a4-a247-7b1742dc09f1" content-type="del cts-3" specific-use="1545441235966" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:13am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441235966">rd</named-content></sup> had a family history of autoimmunity <named-content data-cid="1545124891" id="d3178926-9306-4ad6-a961-8f5517f98136" content-type="del cts-2" specific-use="1545126898261" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Deleted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:24pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545126898261">(</named-content><named-content id="31959641-0f38-417b-a665-9d3ce3213f43" data-cid="1545126896189" content-type="ins cts-1" specific-use="1545126896189" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:24pm" data-track-detail="" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545126896189">(<xref ref-type="table" rid="T1" data-citation-string=" T1 " data-cite-type="insert" id="134fded8-323a-4b51-89f8-7274740e696d">table 1</xref></named-content><named-content data-cid="1545124893" id="31384c8b-3510-4e8f-a28d-129c85ef0667" content-type="ins cts-2" specific-use="1545126901794" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:25pm" data-track-detail="" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545126901794"> and</named-content> <named-content id="239fa62c-b9aa-492c-b1c8-df0d778fe7b5" data-cid="1545126927172" content-type="ins cts-1" specific-use="1545126927172" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="Inserted by Varalakshmi (PREEDITOR) - Dec 18 2018 3:25pm" data-track-detail="" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545126927172"><xref ref-type="supplementary-material" rid="S1" data-citation-string=" S1 " data-cite-type="insert" id="0ba6fe55-66d0-4506-9743-c869bb2bd0ee">online supplement table S1</xref></named-content>). However, because family history was obtained from the medical record in this retrospective study, the rate of positive family history could be under<named-content data-cid="1545433714" id="c974fab1-48df-4cf8-8860-b25b093c55f1" content-type="ins cts-3" specific-use="1545441243730" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441243730">-</named-content>reported. In the entire cohort, almost two-thirds of our cohort had another IRAE, with the most common being thyroiditis. Hence, the presence of one IRAE may raise the suspicion for occurrence of another. Autoantibodies associated with type <named-content data-cid="1545113216068" id="7aae0248-8fb1-41a2-97dd-bffdc92bdd4d" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="48330ae1-3d31-4cd1-adca-9d5d3c214f84" data-cid="1545113216068" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="990" data-match="1" data-pattern="" data-tag-index="27_6" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433715" id="0c92a4ef-1972-44fe-9a0d-a7ea374f5c19" content-type="del cts-3" specific-use="1545441254868" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441254868">one</named-content></named-content><named-content data-cid="1545433716" id="8491f34c-1ba2-40ce-b665-44b61746af11" content-type="ins cts-3" specific-use="1545441255194" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441255194">1</named-content> diabetes were positive in <named-content data-cid="1545433717" id="eea0744b-e879-4c54-a3d5-f8e2e93ed406" content-type="del cts-3" specific-use="1545441257114" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441257114">5</named-content><named-content data-cid="1545433720" id="5ca354a1-34bd-4399-bbcd-371e81632aac" content-type="ins cts-3" specific-use="1545441257965" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441257965">five</named-content> of <named-content data-cid="1545433724" id="9c9a13c5-a842-4a99-9e7b-9ea2abb5d310" content-type="del cts-3" specific-use="1545441259801" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441259801">7</named-content><named-content data-cid="1545433725" id="0f3d91ca-685d-4dbb-8f47-79385dd98f79" content-type="ins cts-3" specific-use="1545441260099" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441260099">seven</named-content> <named-content id="f6973011-a5e8-4f73-bcce-696a61280a9d" data-cid="f6973011-a5e8-4f73-bcce-696a61280a9d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1025" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="27_9" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>, all of which had new-onset insulin-dependent diabetes. Unfortunately, these antibodies were not tested prior to initiating ICI therapy; hence<named-content data-cid="1545433730" id="db11fe68-8e65-4215-8bf6-9e9c8b6b4186" content-type="ins cts-3" specific-use="1545441267117" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441267117">,</named-content> we are not able to comment on their status as a biomarker for predicting the development of ICI<named-content data-cid="1545433731" id="9ae66154-987f-410f-b408-cda7a7a31c4c" content-type="del cts-3" specific-use="1545441272237" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441272237"> </named-content><named-content data-cid="1545433732" id="ce2e0a2d-3764-41c2-962f-13131e8f1f7c" content-type="ins cts-3" specific-use="1545441272685" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441272685">-</named-content>induced diabetes. However, the information available from these antibodies at the time of diagnosis<named-content data-cid="1545433733" id="1496a7ae-db7d-48da-a301-c804b1d2bd0f" content-type="del cts-3" specific-use="1545441278663" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441278663">,</named-content> does suggest their role in disease prognostication. <named-content id="74ce7931-0aee-4972-a599-a342783bde2f" data-cid="74ce7931-0aee-4972-a599-a342783bde2f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'Patient' to 'Patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1426" data-match="Patient" data-replace="Patient" data-pattern="$1" data-tag-index="27_10" data-function="addTrackChanges" data-time="" data-username="" data-userid="">Patient</named-content> <named-content data-cid="1545113216069" id="227d6e87-74b2-445c-9ddb-17985d8742f2" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">3</named-content><named-content id="49cdb42d-77d6-48b1-a6d8-ae1f19136263" data-cid="1545113216069" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '3' to 'three'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1434" data-match="3" data-pattern="" data-tag-index="27_7" data-function="numberToText,addTrackChanges" data-track-change="3" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433734" id="af451e68-1f2e-443c-90a3-b44857ddb9ed" content-type="del cts-3" specific-use="1545441283214" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441283214">three</named-content></named-content><named-content data-cid="1545433735" id="f8adeede-3620-40fc-9c48-47a4f00af2f5" content-type="ins cts-3" specific-use="1545441283492" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441283492">3</named-content> who had the most number of positive antibodies had the shortest duration between initiation of ICI and new<named-content data-cid="1545433736" id="806d3c5d-925d-4ad5-a273-dfcea720c07b" content-type="del cts-3" specific-use="1545441287595" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441287595"> </named-content><named-content data-cid="1545433737" id="eb2f9e13-1b75-455c-8ec0-5a068a527b10" content-type="ins cts-3" specific-use="1545441288525" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441288525">-</named-content>onset insulin-dependent diabetes. He also presented with concomitant DKA and <named-content id="83929595-93f7-4ba8-9941-a0abc0f14405" data-cid="83929595-93f7-4ba8-9941-a0abc0f14405" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="1620" data-match="hyperglycemic hyperosmolar state" data-pattern="" data-tag-index="" data-abbr="HHS" data-time="" data-username="" data-userid="">hyperglycemic hyperosmolar state</named-content>. Overall, the frequent occurrence of other IRAEs and antibody positivity in <named-content id="67d61d65-f37f-4756-ab9f-7e7e73d6b21c" data-cid="67d61d65-f37f-4756-ab9f-7e7e73d6b21c" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1729" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="27_11" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with new<named-content data-cid="1545433738" id="2d63d588-45d9-486d-8a73-1ee074fa94ae" content-type="del cts-3" specific-use="1545441295822" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441295822"> </named-content><named-content data-cid="1545433739" id="e3c3f013-6e3f-41c6-a024-e1769ca686bb" content-type="ins cts-3" specific-use="1545441296357" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441296357">-</named-content>onset insulin-dependent diabetes fits with the autoimmune nature of ICI<named-content data-cid="1545433740" id="7466d658-28af-45e2-a26d-b62f98120894" content-type="del cts-3" specific-use="1545441299389" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441299389"> </named-content><named-content data-cid="1545433741" id="3d92be83-73ae-433d-a0d2-e3a2691be7bf" content-type="ins cts-3" specific-use="1545441299723" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:14am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441299723">-</named-content>induced diabetes. Some of the <named-content id="ed87745d-94dc-43b0-bb95-f242ac1c7a3e" data-cid="ed87745d-94dc-43b0-bb95-f242ac1c7a3e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="1849" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="27_12" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with worsening of pre-existing type <named-content data-cid="1545113216070" id="c7699bfb-f1a5-46d4-9cbd-9493defa6c15" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="19fe0adb-e0af-410e-ba31-62c432944c47" data-cid="1545113216070" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="1894" data-match="2" data-pattern="" data-tag-index="27_8" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433742" id="e837ae01-b819-45b0-a23e-eb96989b6616" content-type="del cts-3" specific-use="1545441303853" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441303853">two</named-content></named-content><named-content data-cid="1545433743" id="56406666-aeac-4650-922e-9d2a5bd13620" content-type="ins cts-3" specific-use="1545441304131" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441304131">2</named-content> diabetes did not have optimal glycemic control prior to ICI<named-content data-cid="1545840507" content-type="ins cts-5" specific-use="1545844845117" xlink:title="Yogish C Kudva (AUTHOR)" alt="author 3684625162" data-title="Inserted by Yogish C Kudva (AUTHOR) - Dec 26 2018 11:20am" data-track-detail="" data-userid="author 3684625162" data-username="Yogish C Kudva (AUTHOR)" data-time="1545844845117" id="dffcf7d9-4ba1-4f75-b9eb-e92547eaa30e">,</named-content> highlighting the need to address diabetes control more closely.</p><p data-class="jrnlSecPara" id="f4da6f1b-11ec-4a23-8456-276f8fce8e97">New-onset insulin-dependent diabetes in the setting of ICI therapy shares some similarities with spontaneous type <named-content data-cid="1545113216071" id="5ec7fd92-5dfb-42be-9753-ef86b0d4ed07" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="af7e0e90-ee25-4f79-9c9d-04f59cfe0d05" data-cid="1545113216071" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="114" data-match="1" data-pattern="" data-tag-index="28_3" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433744" content-type="ins cts-3" specific-use="1545441313356" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441313356" id="3361942c-9efa-4556-bb17-cfc950e9b5b9">1</named-content><named-content data-cid="1545433747" content-type="del cts-3" specific-use="1545441318519" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441318519" id="604200f7-99d8-42b3-9830-84f57243a164">one</named-content></named-content> diabetes, with the frequent occurrence of DKA and low or undetectable C-peptide levels when tested, which implies lack of endogenous insulin production, most likely due to immune<named-content data-cid="1545433748" content-type="del cts-3" specific-use="1545441326356" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441326356" id="9d0c1747-c0ee-4365-a9d9-20ebc94e3fc6"> </named-content><named-content data-cid="1545433749" content-type="ins cts-3" specific-use="1545441327377" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441327377" id="374174ab-12bf-4683-85c4-02b4ecad7791">-</named-content>mediated loss of β cells. However<named-content data-cid="1545433750" content-type="ins cts-3" specific-use="1545441329684" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441329684" id="422dddb2-c3af-43d4-bd1f-85876aa2ae47">,</named-content> there are some differences, as noted with the more rapid presentation to insulin deficiency as <named-content data-cid="1545113216116" id="818f14ce-fbaa-4ce2-9508-a6ebd85788a9" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared to</named-content><named-content id="7b3382be-2356-4f25-98a0-e90ef34f8498" data-cid="1545113216116" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="425" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="28_7" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared with</named-content> spontaneous type <named-content data-cid="1545113216072" id="7dfdacc4-8e25-4d4b-86eb-5b45deccbc59" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="97e33bf2-548c-4c24-8ad0-378b0994cbea" data-cid="1545113216072" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="454" data-match="1" data-pattern="" data-tag-index="28_4" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433751" content-type="del cts-3" specific-use="1545441335110" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441335110" id="42bd18d0-3d06-484b-80e4-dbfed09cf2cc">one</named-content></named-content><named-content data-cid="1545433752" content-type="ins cts-3" specific-use="1545441335394" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441335394" id="84765fa8-dead-4f15-8f03-510e1678110f">1</named-content> diabetes. Also, these <named-content id="adc01042-36f6-4ae0-97d7-7123d4e6204a" data-cid="adc01042-36f6-4ae0-97d7-7123d4e6204a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="478" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="28_8" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> were much older with a median age of <named-content id="d7bf396c-1523-43b5-85ac-5ace93586530" data-cid="d7bf396c-1523-43b5-85ac-5ace93586530" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="524" data-match="61 years" data-replace="61" data-pattern="$1" data-tag-index="28_1" data-time="" data-username="" data-userid="">61</named-content><named-content id="3ece0d4c-33a1-444b-bf04-aa452c58244d" data-cid="3ece0d4c-33a1-444b-bf04-aa452c58244d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="526" data-match="61 years" data-replace=" years" data-pattern=" $2" data-tag-index="28_1" data-time="" data-username="" data-userid=""> years</named-content> as <named-content data-cid="1545113216117" id="ef024ddf-aa58-4c3a-a931-90163c936ba5" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared to</named-content><named-content id="7c02bcfc-a53e-4acc-98ae-f8877704ace0" data-cid="1545113216117" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="536" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="28_9" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared with</named-content> those with spontaneous type <named-content data-cid="1545113216073" id="45275c31-4d17-4230-8c84-d7ca9644d617" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="9c76584e-71c3-4798-a223-9a761cc83283" data-cid="1545113216073" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="576" data-match="1" data-pattern="" data-tag-index="28_5" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433753" content-type="del cts-3" specific-use="1545441340368" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441340368" id="7c517797-ee06-4cb3-9350-3e54e78fbbdb">one</named-content></named-content><named-content data-cid="1545433754" content-type="ins cts-3" specific-use="1545441340658" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441340658" id="55d4c743-f106-40f7-87ea-e3bd27eb5591">1</named-content> diabetes. The BMI was higher as <named-content data-cid="1545113216118" id="2b72937d-dbbd-448d-812a-10c21fd0e707" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared to</named-content><named-content id="e4576ec3-1c8b-4009-9883-737779ed6ee4" data-cid="1545113216118" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="610" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="28_10" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared with</named-content> the usually lean body habitus of <named-content id="e5da00c5-a437-44ea-b712-084beb169d11" data-cid="e5da00c5-a437-44ea-b712-084beb169d11" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="655" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="28_11" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with spontaneous type <named-content data-cid="1545113216074" id="949fc251-f84f-467f-ad91-6c1e925b0fff" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="40543201-b38a-415f-b10c-b3c638135aa1" data-cid="1545113216074" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="686" data-match="1" data-pattern="" data-tag-index="28_6" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433755" content-type="del cts-3" specific-use="1545441346388" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441346388" id="5c664aac-7f79-4ef9-8b33-16c1d722b216">one</named-content></named-content><named-content data-cid="1545433756" content-type="ins cts-3" specific-use="1545441346663" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441346663" id="6597f6af-4cee-45dc-8f37-12f8b4a47c26">1</named-content> diabetes. Hence, in our assessment<named-content data-cid="1545433757" content-type="ins cts-3" specific-use="1545441353735" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441353735" id="e1d8446f-767e-4e93-b386-d5b93c4e31c3">,</named-content> age or BMI of the <named-content id="355538dc-41a2-4b57-a031-9e9e11d15b4d" data-cid="355538dc-41a2-4b57-a031-9e9e11d15b4d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patient' to 'patient'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="741" data-match="patient" data-replace="patient" data-pattern="$1" data-tag-index="28_12" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patient</named-content> are not useful predictors for the development or severity of ICI<named-content data-cid="1545433758" content-type="del cts-3" specific-use="1545441357250" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441357250" id="be74a943-17a7-4020-b6db-53e91619fea0"> </named-content><named-content data-cid="1545433759" content-type="ins cts-3" specific-use="1545441357693" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:15am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441357693" id="4758d93e-4dee-4383-9516-c0bd7380c6e9">-</named-content>induced diabetes. The occurrence of new<named-content data-cid="1545433760" content-type="del cts-3" specific-use="1545441361628" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441361628" id="98749c47-2192-4f30-8281-05833fc973cf"> </named-content><named-content data-cid="1545433761" content-type="ins cts-3" specific-use="1545441362079" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441362079" id="c5783d7f-2c5f-4712-90f2-f27b16a158fd">-</named-content>onset insulin-dependent diabetes was characterized by a median weight loss of <named-content id="a95d8a06-f24c-49ad-926b-d3adcaff54bf" data-cid="a95d8a06-f24c-49ad-926b-d3adcaff54bf" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="932" data-match="3 kg" data-replace="3" data-pattern="$1" data-tag-index="28_2" data-time="" data-username="" data-userid="">3</named-content><named-content id="1158495d-1912-497d-9a01-f475e6d173b3" data-cid="1158495d-1912-497d-9a01-f475e6d173b3" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed '␣kg' to ' kg'" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="933" data-match="3 kg" data-replace=" kg" data-pattern=" $2" data-tag-index="28_2" data-track-change=" kg" data-time="" data-username="" data-userid=""> kg</named-content> when <named-content data-cid="1545113216119" id="5717bfd4-4053-4009-a307-af2299fa4ede" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared to</named-content><named-content id="8c240831-d539-47a8-8681-ee161991bb21" data-cid="1545113216119" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="942" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="28_13" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared with</named-content> the original weight prior to ICI initiation. Hence, loss of weight might be an indicator for the development of insulin deficiency in the setting of ICI use.</p><p data-class="jrnlSecPara" id="f6dd4e64-d02d-41d6-b5c6-2563f2562644">We also evaluated for increased FDG uptake in the pancreas on PET scan performed within <named-content id="199d914c-f7e5-41e6-81cb-a4103944a1d1" data-cid="199d914c-f7e5-41e6-81cb-a4103944a1d1" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="88" data-match="4 months" data-replace="4" data-pattern="$1" data-tag-index="29_1" data-time="" data-username="" data-userid="">4</named-content><named-content id="fe1fb675-8b43-4f76-bb96-eab39e172cc4" data-cid="fe1fb675-8b43-4f76-bb96-eab39e172cc4" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="89" data-match="4 months" data-replace=" months" data-pattern=" $2" data-tag-index="29_1" data-time="" data-username="" data-userid=""> months</named-content> of case development, which was done in <named-content data-cid="1545113216075" id="066e04c8-03b0-4c5e-8d20-21606e62bb55" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">9</named-content><named-content id="fcafe98b-d246-4bc0-8085-8a594ddfcafe" data-cid="1545113216075" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '9' to 'nine'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="136" data-match="9" data-pattern="" data-tag-index="29_2" data-function="numberToText,addTrackChanges" data-track-change="9" data-userid="preediting" data-username="Exeter" data-time="1545113216002">nine</named-content> <named-content id="706de1a4-369c-4b90-8c7c-a34681ef44e2" data-cid="706de1a4-369c-4b90-8c7c-a34681ef44e2" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="138" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="29_3" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content>. This had limited sensitivity to detect pancreatic inflammation. Mild to moderate elevation in pancreatic enzymes occurred in the setting of ICI therapy, but the clinical use, evaluation and long<named-content data-cid="1545433762" content-type="del cts-3" specific-use="1545441381465" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441381465" id="c3bd6cd3-f023-47c6-92e5-22c0bd827404"> </named-content><named-content data-cid="1545433763" content-type="ins cts-3" specific-use="1545441381802" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441381802" id="2b13da72-ff15-4b5b-8bf9-5a0786b7574c">-</named-content>term significance of this finding need<named-content data-cid="1545433764" content-type="del cts-3" specific-use="1545441388893" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441388893" id="7e0803bc-7b04-47ce-9596-8926c9998c6b">s</named-content> to be investigated further.</p><title data-level="1" data-class="jrnlHead1" old-class="" id="7b6f7115-e30b-46ef-a1af-23410000d6be">Conclusions</title><p data-class="jrnlSecPara" id="91a89e87-9765-4524-a9fc-3658aecf90fc">We have identified new-onset insulin-dependent diabetes induced by PD-1 inhibitors with a frequency of <named-content id="0eb6497d-ebe5-40dd-90ba-9345cafa7232" data-cid="0eb6497d-ebe5-40dd-90ba-9345cafa7232" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="VAL" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="VAL" data-offset="103" data-match="1%" data-replace="1" data-pattern="$1" data-tag-index="30_1" data-time="" data-username="" data-userid="">1</named-content><named-content id="169cd19a-d6ae-42c8-8338-e9fb6474498a" data-cid="169cd19a-d6ae-42c8-8338-e9fb6474498a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="UNT" data-track-detail="" data-tag-desc="VAL,UNT" data-tag-type="UNT" data-offset="104" data-match="1%" data-replace="%" data-pattern="%" data-tag-index="30_1" data-time="" data-username="" data-userid="">%</named-content>. This form of diabetes is characterized by more rapid progression to severe insulin deficiency as <named-content data-cid="1545113216120" id="b1952718-9e3e-4515-8aa9-db05fded9801" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared to</named-content><named-content id="01049950-1609-4487-b999-d417facaf851" data-cid="1545113216120" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from 'compared␣to' to 'compared with'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="204" data-match="compared to" data-replace="compared with" data-pattern="compared with" data-tag-index="30_4" data-function="addTrackChanges" data-track-change="compared to" data-userid="preediting" data-username="Exeter" data-time="1545113216002">compared with</named-content> spontaneous type <named-content data-cid="1545113216076" id="16f01b87-d6c6-4a88-bc56-d7c776e47942" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">1</named-content><named-content id="2dd21d02-2acb-4577-9438-e32dde070c25" data-cid="1545113216076" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '1' to 'one'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="233" data-match="1" data-pattern="" data-tag-index="30_2" data-function="numberToText,addTrackChanges" data-track-change="1" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433765" content-type="del cts-3" specific-use="1545441402242" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441402242" id="b7541ef2-97db-470e-bd09-c1fadcfcbf78">one</named-content></named-content><named-content data-cid="1545433766" content-type="ins cts-3" specific-use="1545441402537" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441402537" id="aa290213-03cd-49b4-b30a-fa1f82b57312">1</named-content> diabetes, frequently presents with DKA and does not appear to undergo remission. In addition to new-onset diabetes, PD-1 inhibitors can also worsen glycemic control in pre-existing type <named-content data-cid="1545113216077" id="083e05b5-b628-439d-9572-089f4a4577e3" content-type="del cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113216002">2</named-content><named-content id="70edc4ef-20e2-441c-9c47-f8aed06b5df4" data-cid="1545113216077" content-type="ins cts-1" specific-use="1545113216002" xlink:title="Exeter" alt="preediting" data-title="changed from '2' to 'two'" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="421" data-match="2" data-pattern="" data-tag-index="30_3" data-function="numberToText,addTrackChanges" data-track-change="2" data-userid="preediting" data-username="Exeter" data-time="1545113216002"><named-content data-cid="1545433767" content-type="del cts-3" specific-use="1545441409464" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441409464" id="44bc5ac0-fdf1-4592-bbba-8408e095e264">two</named-content></named-content><named-content data-cid="1545433768" content-type="ins cts-3" specific-use="1545441409741" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441409741" id="d6ce7157-417d-48f9-bee0-bb25c2e7b8a6">2</named-content> diabetes. ICI<named-content data-cid="1545433769" content-type="del cts-3" specific-use="1545441411877" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441411877" id="180f3fc6-6d38-4a6a-883c-74a20534ce71"> </named-content><named-content data-cid="1545433770" content-type="ins cts-3" specific-use="1545441412183" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441412183" id="b1f3e391-3f79-4077-9830-d0537daaa34d">-</named-content>induced diabetes requires complex insulin therapy for management<named-content data-cid="1545433771" content-type="del cts-3" specific-use="1545441416141" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:16am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441416141" id="b2a50006-b407-4211-81e3-23cfcfb24890">,</named-content> and adds significantly to the morbidity of these <named-content data-cid="1545433774" content-type="ins cts-3" specific-use="1545441420087" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:17am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441420087" id="f567513e-ab49-4cda-9012-69c6167e55ee">patients with </named-content>cancer<named-content data-cid="1545433788" content-type="del cts-3" specific-use="1545441425372" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:17am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441425372" id="e45a37df-8417-498f-9529-db4e81f2b71c"> </named-content><named-content id="3549dc12-4b55-4df8-82eb-425f45ddea1b" data-cid="3549dc12-4b55-4df8-82eb-425f45ddea1b" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="559" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="30_5" data-function="addTrackChanges" data-time="" data-username="" data-userid=""><named-content data-cid="1545433788" content-type="del cts-3" specific-use="1545441425372" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:17am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441425372" id="5b94af70-6826-4986-b709-7f676d2241bc">patients</named-content></named-content>. With the growing use of these agents for cancer therapy, clinicians are more likely to encounter this condition. This underscores the importance of monitoring blood glucose and HbA1c prior to initiating ICIs as well as during follow-up, having a heightened suspicion for the occurrence of diabetes and developing better risk prediction. Better characterization of ICI<named-content data-cid="1545433789" content-type="del cts-3" specific-use="1545441436531" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:17am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441436531" id="5aa26a86-8a61-4196-abd2-03be605e6516"> </named-content><named-content data-cid="1545433790" content-type="ins cts-3" specific-use="1545441436858" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:17am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441436858" id="316e0662-5b58-4164-993c-b5e2f2c1539e">-</named-content>induced diabetes will improve both the diagnosis and management of this condition<named-content data-cid="1545433791" content-type="del cts-3" specific-use="1545441439889" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:17am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441439889" id="26800ce7-7c40-4e2e-84e1-461f1d8e16c8">,</named-content> and also add to our knowledge of immune<named-content data-cid="1545433792" content-type="del cts-3" specific-use="1545441442333" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Deleted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:17am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441442333" id="d3b62472-0156-4c34-ad98-111498eabce6"> </named-content><named-content data-cid="1545433793" content-type="ins cts-3" specific-use="1545441442653" xlink:title="PV-A027-Ariel (COPYEDITOR)" alt="copyeditor 3519816058" data-title="Inserted by PV-A027-Ariel (COPYEDITOR) - Dec 22 2018 9:17am" data-track-detail="" data-userid="copyeditor 3519816058" data-username="PV-A027-Ariel (COPYEDITOR)" data-time="1545441442653" id="d16d77c4-f14f-43f1-90c2-2a37a1ff7672">-</named-content>mediated diabetes.</p><p data-class="jrnlDeleted" headweightage="41" id="bf881f30-5cb8-46d8-831a-b73e76abe0fe">Legend</p><p data-class="jrnlDeleted" id="49aa544f-ebed-46a5-bb94-d30f9bf9cd01"><xref ref-type="table" rid="T1" data-citation-string=" T1 " data-offset="0" data-match="Table 1" data-track="del" data-cid="1545127020511" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545127020511" data-cite-type="delete" id="f19b3d4f-2318-44d9-b061-2a7cfc24123a"><named-content data-cid="1546365745986" id="5edc6c11-7598-4a4b-bfa2-a8674e5c1dec" content-type="del cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Table 1:</named-content><named-content data-cid="1546365745986" id="057df724-6afb-4096-9547-9cdecc1a574c" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">table 1</named-content></xref> Baseline characteristics prior to initiation of PD-1 inhibitor in all <named-content id="8d41ef1a-2c26-490b-8c0a-e218cf2de16f" data-cid="8d41ef1a-2c26-490b-8c0a-e218cf2de16f" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HIGH" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="79" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="1_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with PD-1 inhibitor induced diabetes. RPG: random plasma glucose; FPG: fasting plasma glucose; HbA1c: hemoglobin A1c.</p><p data-class="jrnlDeleted" id="042eb970-8485-4961-bf2f-93d10f1a58d5"><xref ref-type="table" rid="T2" data-citation-string=" T2 " data-offset="0" data-match="Table 2" data-track="del" data-cid="1545127025408" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545127025408" data-cite-type="delete" id="0b2c42df-7f27-481f-8596-3e4da7d4115b"><named-content data-cid="1546365745989" id="e446f423-16fc-405c-b55c-09ffcbff92a2" content-type="del cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Table 2:</named-content><named-content data-cid="1546365745989" id="d34d1d4f-80a2-41cb-b152-d320aa8b022f" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">table 2</named-content></xref> Disease characteristics of <named-content id="fba2fff6-0ddf-477b-9f78-8b7477412b63" data-cid="fba2fff6-0ddf-477b-9f78-8b7477412b63" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HIGH" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="36" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="1_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with PD-1 inhibitor induced diabetes. RPG: random plasma glucose; FPG: fasting plasma glucose; HbA1c: hemoglobin A1c.</p><p data-class="jrnlDeleted" id="aee574d1-1304-49ee-a7a6-e2072dfe0ec5"><xref ref-type="table" rid="T3" data-citation-string=" T3 " data-offset="0" data-match="Table 3" data-track="del" data-cid="1545127030162" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545127030162" data-cite-type="delete" id="dfddd4e1-3b57-4b76-b941-9152dc7d0fbd"><named-content data-cid="1546365745991" id="a0604630-04fc-4749-baac-0d3c98b0c924" content-type="del cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Table 3:</named-content><named-content data-cid="1546365745991" id="9777bbee-2b74-4e0e-981a-a948dcad0096" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">table 3</named-content></xref> Disease characteristics and course of individual <named-content id="699679a3-cb41-442a-b14f-ec8a5166a44d" data-cid="699679a3-cb41-442a-b14f-ec8a5166a44d" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="HIGH" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="58" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="1_2" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with PD-1 inhibitor induced new-onset insulin-dependent diabetes. RPG: random plasma glucose; FPG: fasting plasma glucose; HbA1c: hemoglobin A1c.</p><p data-class="jrnlDeleted" id="ddf56011-c2c0-46ca-877d-9917befec299"><xref ref-type="table" rid="T4" data-citation-string=" T4 " data-offset="0" data-match="Table 4" data-track="del" data-cid="1545127034531" data-username="Varalakshmi (PREEDITOR)" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-time="1545127034531" data-cite-type="delete" id="badc8d79-17c4-4993-8f39-c359372c17a3"><named-content data-cid="1546365745993" id="de7d29bf-60fc-45de-aac1-995c08966e71" content-type="del cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">Table 4:</named-content><named-content data-cid="1546365745993" id="29447a8e-e326-4542-9f63-d06876820ec3" content-type="ins cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000">table 4</named-content></xref> Disease characteristics and course of individual <named-content id="b9afa0ea-ea19-4168-9979-359da6c5b61e" data-cid="b9afa0ea-ea19-4168-9979-359da6c5b61e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'patients' to 'patients'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="58" data-match="patients" data-replace="patients" data-pattern="$1" data-tag-index="1_3" data-function="addTrackChanges" data-time="" data-username="" data-userid="">patients</named-content> with PD-1 inhibitor induced worsening of pre-existing type <named-content id="3e0fb239-b19e-48ae-a1e5-3b674a8ab31e" data-cid="3e0fb239-b19e-48ae-a1e5-3b674a8ab31e" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="SNUM" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="126" data-match="2" data-pattern="" data-tag-index="1_2" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">2</named-content> diabetes. RPG: random plasma glucose; FPG: fasting plasma glucose; HbA1c: hemoglobin A1c.</p><p data-class="jrnlDeleted" headweightage="41" id="c1b57d23-9e0e-4c81-869d-1e44e51f9cbd">Acknowledgements</p><p data-class="jrnlDeleted" id="590ca75e-47c8-4da1-b6d4-f04cbdd8de7c">Author contributions: A A.K. researched the data, analyzed the data and wrote the manuscript; C.H. researched the data and wrote the manuscript, M.B. reviewed/edited the manuscript, Y.C.K. developed the research question, supervised all aspects of the project as principal investigator and reviewed/edited the manuscript.</p><p data-class="jrnlDeleted" id="f5e7ae70-6e96-4ee3-b718-0784a8889fe4">Funding: This work was supported by the Landow gift through the <named-content id="e54ed8ea-5050-4092-8b4a-9c951cdf4559" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="changed from 'Center' to 'Center'" data-track-detail="" data-tag-desc="HIGH" data-tag-type="HIGH" data-offset="64" data-match="Center" data-replace="Center" data-pattern="$1" data-tag-index="38_3" data-function="addTrackChanges">Center</named-content> for Immunology and Immune Therapies, Mayo Foundation. This publication was made possible by CTSA Grant Number UL1 TR002377 from the <named-content id="f8588184-71a2-4171-92b8-32415ee0fa8a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="203" data-match="National Center for Advancing Translational Sciences" data-pattern="" data-tag-index="" data-abbr="NCATS">National Center for Advancing Translational Sciences</named-content> (<named-content id="1409a552-afaf-44bb-ba63-928c6ce04883" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="257" data-match=" (NCATS)" data-pattern="" data-tag-index="38_1">NCATS</named-content>), a component of the <named-content id="371ca217-82c0-456c-b940-33908bc41491" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="EXPN" data-track-detail="" data-tag-desc="EXPN" data-tag-type="EXPN" data-offset="284" data-match="National Institutes of Health" data-pattern="" data-tag-index="" data-abbr="NIH">National Institutes of Health</named-content> (<named-content id="eed41763-d7fb-4989-ac04-c1bad70ce185" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="ABBR" data-track-detail="" data-tag-desc="ABBR" data-tag-type="ABBR" data-offset="315" data-match=" (NIH)" data-pattern="" data-tag-index="38_2">NIH</named-content>). Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NIH.</p><p data-class="jrnlDeleted" id="bf672274-632e-4fb7-8b35-23af727105e1">Conflict of interest: The authors have nothing to disclose.</p><p data-class="jrnlDeleted" id="b5871430-5b1e-4c08-8134-69f6ffea83cc">Prior presentation: The initial abstract of this manuscript was presented at Endocrine Society’s 100th Annual Meeting and Expo, Chicago, IL in March 2018, and published in<xref id="1e954888-f2da-4a4f-9b8d-c8fbbb84e4a0" ref-type="bibr" rid="R16" data-tag-desc="AUTHORYEARREF" data-tag-type="AUTHORYEARREF" data-offset="174" data-match="Endocrine Reviews. 2018;" data-pattern="" data-tag-index="40_3" data-citation-string=" R16 " data-track-change="Endocrine Reviews. 2018"><sup id="c342c909-fc8b-43c9-88f1-531dfe0cf138">16</sup></xref><named-content data-cid="1546365745996" content-type="del cts-1" specific-use="1545113235000" xlink:title="Exeter" alt="preediting" data-title="" data-track-detail="" data-userid="preediting" data-username="Exeter" data-time="1545113235000" id="ba6d8964-d315-485b-8d08-3faa25b56f03">Endocrine Reviews. 2018</named-content>;39.<xref id="9b4e8def-ddba-4284-bb03-2a60976c5ae5" ref-type="bibr" rid="R2" data-tag-desc="BIBREF" data-tag-type="BIBREF" data-offset="201" data-match="2" data-pattern="" data-tag-index="40_1" data-citation-string=" R2 " data-track-change="2"><sup id="c23a98d1-a5b9-49df-8bbe-64480b439997">2</sup></xref></p></body><back id="d1ccb28f-b2fe-4ed9-bad3-b35a04df7541" data-edited="true" data-edited-version="2"><ref-list section="back" node-xpath="back" id="4ac98f6e-f594-42d0-9e23-e4b6e157ab3f"><title data-level="1" id="c8cb7fa1-eaca-476f-b775-ed43e1b4fc83">References</title><ref data-class="jrnlRefText" seqid="R1" id="R1" data-id="R1" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R1" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/21376230" data-doi="10.1016/j.cell.2011.02.013" data-validated="true"><label id="7bef4707-f5c6-4997-9b9a-7ae9bc245a56">1.</label><element-citation publication-type="journal" id="aeb83339-9515-4efc-936b-b733cae0a0f1"><person-group person-group-type="author" id="5dbaec6e-8d59-4f08-b716-e2a8c6c6a2a2"><name id="71cdca44-abc2-4a65-b621-9c6c7b072541"><surname id="8396e16a-ec6f-4f94-8ea4-2789b4db8e50">Hanahan</surname> <given-names id="17b38dd4-428e-4505-a9aa-a7c439d32fb6">D</given-names></name><x>, </x><name id="b39504ff-c543-4ea6-b10d-1d3775c6813d"><surname id="cd2b9fcb-5290-48d7-9258-a9715a76a57d">Weinberg</surname> <given-names id="6e7759eb-b1e3-4c03-b44d-53bc2ae6de92">RA</given-names></name></person-group><x>. </x><article-title id="85a29abe-53d7-4a23-9e4a-dbc3598ad319">Hallmarks of cancer: the next generation</article-title><x>. </x><source id="02cc81a9-a55c-4881-9786-d5945a96c9be">Cell</source><x> </x><year id="78ca8c8c-a7ab-4ca1-a38a-2c59ebe18b4f">2011</year><x>;</x><volume id="0de2b7a9-bec7-47d1-bf00-d2a68193f18f">144</volume><x>:</x><fpage id="bb1a79f2-c4d0-431a-b2c2-a4b087af7461">646</fpage><x>–</x><lpage id="19eec727-3f23-4956-b7c3-dd974bab1e1d">74</lpage><x>.</x><pub-id pub-id-type="doi" id="245233ce-9320-4c28-b1de-52440ff87547">10.1016/j.cell.2011.02.013</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R2" id="R2" data-id="R2" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R2" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/22437870" data-doi="10.1038/nrc3239" data-validated="true"><label id="ef077120-7a68-4edf-a363-4e6934ce4e88">2.</label><element-citation publication-type="journal" id="f6416ad9-2701-455c-9686-2764621db112"><person-group person-group-type="author" id="1353df01-0db5-467a-9b4d-791fa67363fe"><name id="33186bbb-8aa0-4114-ae18-8c58b08235ec"><surname id="2219014f-0d60-4e5e-824c-e4fb9abc9d7e">Pardoll</surname> <given-names id="777e2fb6-3c3f-4033-98eb-a835e212c771">DM</given-names></name></person-group><x>. </x><article-title id="06f91995-168f-4fc3-97c5-02072a823ab7">The blockade of immune checkpoints in cancer immunotherapy</article-title><x>. </x><source id="fff8fd70-48d1-4e90-abf4-1a03c47f0b8f">Nat Rev Cancer</source><x> </x><year id="c1c353a1-8621-410f-b15d-d3fc0e5c6a6a">2012</year><x>;</x><volume id="d4dd3a2e-a0b9-468a-916b-65b3f84fa7c1">12</volume><x>:</x><fpage id="e15405a3-d3c9-4da2-b160-fe6e02e2a051">252</fpage><x>–</x><lpage id="8dec98bb-5893-4192-bb93-8e7ddbef7926">64</lpage><x>.</x><pub-id pub-id-type="doi" id="cfa425f1-b0ba-49d1-a977-50cf10bac297">10.1038/nrc3239</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R3" id="R3" data-id="R3" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R3" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/8596936" data-doi="10.1126/science.271.5256.1734" data-validated="true"><label id="7968fb9d-894f-4fce-88a4-dd98711dca24">3.</label><element-citation publication-type="journal" id="82068067-ce97-4c23-b35a-0be82ae8b233"><person-group person-group-type="author" id="f613c708-e782-4882-a82e-a63e23f48a1e"><name id="2929b7a5-1904-4eab-bc4b-2f4e163e2181"><surname id="d848ab5f-f5e5-44af-a7db-43e1045db6f3">Leach</surname> <given-names id="10e392ec-2497-4d09-9872-5fedd734408d">DR</given-names></name><x>, </x><name id="da8e2dbb-be0f-492d-b96a-feb388c6e287"><surname id="a4c1cbbf-1139-4f78-aaa7-3e9501ba3c7c">Krummel</surname> <given-names id="57ff3ba7-4eec-4fa1-a8a7-80c7951a8b64">MF</given-names></name><x>, </x><name id="79454ec0-7799-4f15-ba68-c3294ede0061"><surname id="e86af340-b4a6-4e26-95ef-11c51293cfc1">Allison</surname> <given-names id="31df64b5-e989-4a24-b79e-325977785c32">JP</given-names></name></person-group><x>. </x><article-title id="255af14a-1783-4ae0-8cce-054fcdd8c8a5">Enhancement of antitumor immunity by CTLA-4 blockade</article-title><x>. </x><source id="c0e3527f-0340-4444-8d16-3f1d763d8bfb">Science</source><x> </x><year id="1c317f1d-4729-43a7-b5d2-89ae718d4289">1996</year><x>;</x><volume id="0d048f09-ff12-48e4-bd34-bc9097f704f0">271</volume><x>:</x><fpage id="ab4b94e0-4366-453f-9f83-97aa0f4d313e">1734</fpage><x>–</x><lpage id="2889fca3-4b74-466d-92d7-c216ba000d2d">6</lpage><x>.</x><pub-id pub-id-type="doi" id="2a354867-9c7a-4a8e-9bc5-af2b27166ab9">10.1126/science.271.5256.1734</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R4" id="R4" data-id="R4" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R4" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/22020206" data-doi="10.1038/nrc3153" data-validated="true"><label id="a0ebe7fc-9953-4231-8361-8dc1aac985cf">4.</label><element-citation publication-type="journal" id="ac6bbba8-4567-447c-bce8-c48d8d4ae443"><person-group person-group-type="author" id="94219f7f-b005-45d3-a606-64692a92200c"><name id="7efa4ab7-b894-4549-847d-0d5cc54b25f9"><surname id="ee76495a-d3a7-4c89-be5a-b8bbb111797b">Sharma</surname> <given-names id="b75a74f8-82fa-4428-9d9a-cb126c951535">P</given-names></name><x>, </x><name id="4cd432d7-f5d7-4187-a862-4d99bef0eedf"><surname id="aafea1c0-a27a-4064-a9d2-1a99ffa7e005">Wagner</surname> <given-names id="ef8c10a2-97b2-4ad5-af7e-e8e232450ba9">K</given-names></name><x>, </x><name id="e23fb8b7-98d3-452d-beb5-d6250494dc3d"><surname id="4d6c0183-f288-418d-a34e-44ecf5212d50">Wolchok</surname> <given-names id="ca065e37-c023-4a82-bab9-6cd1e3d28532">JD</given-names></name><x>, </x><etal data-class="RefEtal" id="3d2e3347-93e6-45db-938d-6e19e8921182">et al</etal></person-group><x>. </x><article-title id="bd4b090f-0fa3-4645-8f46-b4614fab693b">Novel cancer immunotherapy agents with survival benefit: recent successes and next steps</article-title><x>. </x><source id="81b59f52-3381-4bc2-8f8a-fe694642be34">Nat Rev Cancer</source><x> </x><year id="9256a208-babd-4087-bbc5-0c3e2a72969f">2011</year><x>;</x><volume id="db545477-ebff-449d-9631-383b285baf7d">11</volume><x>:</x><fpage id="5ccf8609-a419-4e5f-a010-9227ec279953">805</fpage><x>–</x><lpage id="929fd93d-a3c5-4c29-9310-11e569ccd493">12</lpage><x>.</x><pub-id pub-id-type="doi" id="ed2671b3-4ef9-4900-8d44-123f94178409">10.1038/nrc3153</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R5" id="R5" data-id="R5" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R5" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/27084345" data-doi="10.1016/j.ejca.2016.02.024" data-validated="true"><label id="2207889c-c3a8-4aed-81ed-8a53079ef07a">5.</label><element-citation publication-type="journal" id="fe98ec6a-a1db-4d55-8806-56b54ba022ba"><person-group person-group-type="author" id="7c1ae263-c912-4d7f-a010-551f966309f5"><name id="556d4e5a-400e-4179-95c4-980788347b14"><surname id="e668021c-d434-48d3-97df-6479f5ea30ae">Zimmer</surname> <given-names id="e4ada19d-e423-4c47-8df3-b7a3dfd1d66a">L</given-names></name><x>, </x><name id="a71854e8-d32c-4669-8fb0-cc95b35763b3"><surname id="80ced025-a636-476e-b326-7b6fbdd272f4">Goldinger</surname> <given-names id="19d1ccd6-4ab8-4880-a605-d9dac2a44032">SM</given-names></name><x>, </x><name id="b5acc9e0-7620-4f78-ab4b-678be4a5d280"><surname id="969d689f-b034-44e7-bda6-9b8a41d8d663">Hofmann</surname> <given-names id="a4d80fd1-1d95-491e-af3e-4d98d7fd62e0">L</given-names></name><x>, </x><etal data-class="RefEtal" id="bd9d0876-ee5a-4c17-aebc-9560c221ee4f">et al</etal></person-group><x>. </x><article-title id="5cbd0624-8b4b-43c2-a272-09918117db08">Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy</article-title><x>. </x><source id="3bc5bb88-f38e-49b8-8dbd-c4d3f9f8078c">Eur J Cancer</source><x> </x><year id="62b35e87-8827-44af-9281-7addba607627">2016</year><x>;</x><volume id="f8d410b3-4c96-41ab-a8ff-01fc34281266">60</volume><x>:</x><fpage id="8e7b8094-2a97-4f15-a8bf-06c23b042971">210</fpage><x>–</x><lpage id="1a3ab27d-82a3-431e-905d-c3515cb2e493">25</lpage><x>.</x><pub-id pub-id-type="doi" id="997986ed-e9d9-4ab5-a507-1693f5c69321">10.1016/j.ejca.2016.02.024</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R6" id="R6" data-id="R6" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R6" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/25078147" data-doi="10.1210/jc.2014-2306" data-validated="true"><label id="f530acf7-bcd6-40a7-adec-d6c2c5f3c356">6.</label><element-citation publication-type="journal" id="f8bd1514-da53-4706-9bdc-01dd22769699"><person-group person-group-type="author" id="595b4f00-ff18-4c2e-9776-ab17cffb3e58"><name id="b753a1ca-44cf-45ee-8a03-b2e5d4cdd9b7"><surname id="9ef2c5fa-b325-4204-89df-40dbe282892f">Faje</surname> <given-names id="2ddfd766-71ba-4556-96e9-d7dbf9184c9d">AT</given-names></name><x>, </x><name id="48b5d638-9773-44d9-849c-d338dae1a055"><surname id="3654f4c5-958b-40df-b401-4f3018496b7a">Sullivan</surname> <given-names id="a9de8c74-c096-4d0e-a74c-f0410a110151">R</given-names></name><x>, </x><name id="0555e3ac-7a42-46f4-87bb-ae5a4212aa60"><surname id="31ff76f0-3a7e-4636-ada9-904785338098">Lawrence</surname> <given-names id="3a8b447e-e6ed-4d92-a84b-5ca62c7f0e85">D</given-names></name><x>, </x><etal data-class="RefEtal" id="9a00987e-4689-4b79-9549-90bc7debba4a">et al</etal></person-group><x>. </x><article-title id="d6f0f649-e4e1-44fb-a318-8a2fba0aceb2">Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma</article-title><x>. </x><source id="87ef75ef-6edc-4b12-b863-e9649b29d531"><named-content data-cid="1545113235002" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="eaff4b16-202b-4a26-9b07-ab4e9a2c608d">The</named-content><named-content data-cid="1545113235002" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="8d7be42e-53a4-41e8-8118-9216c9f51f62">J</named-content> <named-content data-cid="1545113235003" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="4c4f2e42-671d-48e2-9730-b7afeacef24c">Journal</named-content><named-content data-cid="1545113235003" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="cd578b6e-1e5c-41ce-8c4f-bcba0d13a717">Clin</named-content> <named-content data-cid="1545113235004" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="73a89da4-fc62-44fd-9884-f0d875653844">of</named-content><named-content data-cid="1545113235004" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="2ac43417-e64d-4982-845e-a5a72467124b">Endocrinol</named-content> <named-content data-cid="1545113235005" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="41c1ef04-cac7-4a21-a001-a9bd11018fa8">clinical endocrinology and metabolism</named-content><named-content data-cid="1545113235005" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="a97504b0-8fce-4449-adc2-9443a9155ddf">Metab</named-content></source><x> </x><year id="70436675-d37d-42ca-8394-2eac891e93a1">2014</year><x>;</x><volume id="992fb389-fe3d-4d22-a13f-acdedc576627">99</volume><x>:</x><fpage id="f28d8883-80d6-4998-ab7c-4e6fbccb1a92">4078</fpage><x>–</x><lpage id="afbb3d69-43ea-4fab-a0c7-ef076709ab7a">85</lpage><x>.</x><pub-id pub-id-type="doi" id="3f059dd9-8f16-4621-b636-cd6dcea83dc0">10.1210/jc.2014-2306</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R7" data-id="R7" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R7" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/28609832" data-doi="10.1210/jc.2017-00448" data-validated="true"><label id="9ae53d49-025c-4e55-a8c5-f8c33f069daf">7.</label><element-citation publication-type="journal" id="3914d4ad-27d3-4a14-90ca-1a9d28b024a9"><person-group person-group-type="author" id="709356b2-251a-4266-bd86-2771d0586302"><name id="31531bbc-1ac2-4893-a5dc-a2c3b191807d"><surname id="05c1f607-6a3b-4262-bd93-9c86d205bb48">Delivanis</surname> <given-names id="c0634aa9-4288-44c9-ac8a-4d1b9788adb8">DA</given-names></name><x>, </x><name id="0fdb15b4-7f09-479f-b0c6-4c27055ff996"><surname id="e274d1f0-8f94-4fbd-92f7-24e957d3e813">Gustafson</surname> <given-names id="2053e9dd-9501-4810-be8d-ac9e9be168ba">MP</given-names></name><x>, </x><name id="7f61d648-34d1-4ba4-a50c-f2f1afb4cbad"><surname id="93ac285b-97d2-4e77-b898-9476993070d2">Bornschlegl</surname> <given-names id="75b08b64-3eb2-4b1a-882f-add7273f5caa">S</given-names></name><x>, </x><etal data-class="RefEtal" id="c3a8c37b-cc29-4e7e-a0ff-9e35074c486d">et al</etal></person-group><x>. </x><article-title id="33b15b29-7251-4535-a144-82e17421f4a3">Pembroliz<named-content data-cid="1545213293" content-type="changeCase sty cts-1" specific-use="1545214345457" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/19/2018 3:42pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545214345457" id="a29e1490-3df6-4efd-a229-6c9ec99f4cc7">umab-induced thyroiditis: comprehensive clinical review and insights into underlying involved mechani<span data-class="hidden" hidden-track="track" id="c35d86ca-5b33-435d-880a-0487534ea6e2">umab-Induced Thyroiditis: Comprehensive Clinical Review and Insights Into Underlying Involved Mechani</span></named-content>sms</article-title><x>. </x><source id="249db693-7dce-49dc-b1fc-42e00fb4f9fd">J Clin Endocrinol Metab</source><x> </x><year id="6add8aa8-7541-4617-8a5c-5719fb72711a">2017</year><x>;</x><volume id="f53773ed-983f-4848-acff-0058e71e0568">102</volume><x>:</x><fpage id="3f039bbf-df47-4d1c-9ab9-40e3ce5cda70">2770</fpage><x>–</x><lpage id="302a2ea8-a6ae-4408-bba9-3d3fa878aa58">80</lpage><x>.</x><pub-id pub-id-type="doi" id="0d748d2e-8466-435d-b4a5-517e1151be06">10.1210/jc.2017-00448</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R8" data-id="R8" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R8" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/28537531" data-doi="10.1089/thy.2016.0562" data-validated="true"><label id="93cb1f9d-3406-4932-8632-2b46baba5783">8.</label><element-citation publication-type="journal" id="061311a4-d4e3-4280-9d6c-d31f7912bf37"><person-group person-group-type="author" id="7922521f-e7eb-40ce-96b1-512c5237020b"><name id="6c6fa6e8-555b-4ddf-a432-e9d230c85f7b"><surname id="c54f613b-e796-4fc4-9179-3bfdb4791e9c">Yamauchi</surname> <given-names id="9e7af38c-77f9-462a-9abb-f1bd08f5eddf">I</given-names></name><x>, </x><name id="ec977c57-d689-4f4c-b1d7-499ee928cec5"><surname id="b0af8c17-8525-43bf-8e02-0bdb7c61c012">Sakane</surname> <given-names id="1275ab43-d5c4-4d10-a700-c1f663f856fe">Y</given-names></name><x>, </x><name id="1f04c499-6b55-4e6b-9478-6447d50d98d4"><surname id="fc2d40e9-492c-4e2b-98a9-94dac79a5925">Fukuda</surname> <given-names id="3678a7be-7af5-4699-94b2-7adff2b9b73b">Y</given-names></name><x>, </x><etal data-class="RefEtal" id="d8bf5a9a-8784-4e53-997d-f4d814abd42b">et al</etal></person-group><x>. </x><article-title id="dc4ae2ef-0d41-4ed5-9b6e-0f807c77e272">Clinic<named-content data-cid="1545213294" content-type="changeCase sty cts-1" specific-use="1545214356810" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/19/2018 3:42pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545214356810" id="aab441d7-3617-4166-aa77-a5bfaf312934">al features of nivolumab-induced thyroiditis: a case series st<span data-class="hidden" hidden-track="track" id="f8b900a0-2e13-46a5-b447-16bab31b1779">al Features of Nivolumab-Induced Thyroiditis: A Case Series St</span></named-content>udy</article-title><x>. </x><source id="762bac30-1055-4e71-a6cd-35b2d720c00f">Thyroid<named-content data-cid="1545113235019" id="8f18d09a-d74b-4182-9d77-a1c53b829ef6" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000"> : official journal of the American Thyroid Association</named-content></source><x> </x><year id="342b0502-5723-48ff-a4d2-99fd276a6ace">2017</year><x>;</x><volume id="4778ff84-66dd-4f89-972b-950ee72f1c0a">27</volume><x>:</x><fpage id="27b15aec-f74d-4b86-8058-c611a19c10ae">894</fpage><x>–</x><lpage id="9a631142-cada-4ddb-8d3d-f845dd3b8dbe">901</lpage><x>.</x><pub-id pub-id-type="doi" id="1ec56c45-ff6f-481f-812d-afd4b5608f01">10.1089/thy.2016.0562</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R9" id="R9" data-id="R9" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R9" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/25888611" data-doi="10.1093/annonc/mdv182" data-validated="true"><label id="b5d73309-d05a-4e32-9862-4c0c253b551c">9.</label><element-citation publication-type="journal" id="83de7dda-1273-4c25-81cd-d4cc2d082952"><person-group person-group-type="author" id="8d2d91ce-72b7-4cbf-8186-fedcc05a201c"><name id="e057abca-4d0e-45e6-ab92-fc0124399748"><surname id="3a495292-5fbc-4ccd-ac48-93271c6274c1">Chen</surname> <given-names id="9c4c4d15-36f6-469c-9e81-bccfb1f4ad08">TW</given-names></name><x>, </x><name id="d88c0ddd-51dd-4ebd-9cde-d50997fefef7"><surname id="08154fdd-be3e-4b76-bd45-2974545bd111">Razak</surname> <given-names id="701f3772-f3ca-4f40-a659-3f6e29f604db">AR</given-names></name><x>, </x><name id="a4bdfd81-1e40-4954-b996-01d12ea31fea"><surname id="4962b985-5f96-4b79-bb40-7377d669cc2a">Bedard</surname> <given-names id="6737833d-9ccd-476f-aba2-5c2edd43f781">PL</given-names></name><x>, </x><etal data-class="RefEtal" id="b845922a-4e36-4cc0-a5ff-84f0ff25a098">et al</etal></person-group><x>. </x><article-title id="6a16d0db-4bdb-4cb1-8390-d435ac2ca6c0">A systematic review of immune-related adverse event reporting in clinical trials of immune checkpoint inhibitors</article-title><x>. </x><source id="1f1332c1-96fa-46fa-ac93-121b89c76c49">Ann Oncol</source><x> </x><year id="06b0bc82-6889-4681-86b7-5056c2250386">2015</year><x>;</x><volume id="ba4a978a-c7e4-48da-8c86-1d9f4556eab6">26</volume><x>:</x><fpage id="84e00cb0-7af7-4ec1-8469-e97755ce2a73">1824</fpage><x>–</x><lpage id="b1868343-d2e9-4036-92fe-69cc634f16e1">9</lpage><x>.</x><pub-id pub-id-type="doi" id="ab01684c-6703-4d31-a295-ac1f7dc24cec">10.1093/annonc/mdv182</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R10" data-id="R10" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R10" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/26027431" data-doi="10.1056/NEJMoa1504030" data-validated="true"><label id="393f1ce6-61c3-443f-98c1-36e4f99db198">10.</label><element-citation publication-type="journal" id="2ecac0a6-de5b-4c85-9c0f-50729777bcbb"><person-group person-group-type="author" id="360e735e-c73d-4cf0-adcc-7b01c7af3b89"><name id="b92dda0f-910e-4b69-8e24-c55989e7fd7b"><surname id="8813867d-1cb2-4b85-b3d3-9065f174d35c">Larkin</surname> <given-names id="9c54b7d8-dedb-4fc1-a551-f5b5050b3c11">J</given-names></name><x>, </x><name id="31e7df65-cf30-4c4f-b41b-ea6b6c7cbb19"><surname id="d1f3091f-7d27-474e-9fc1-62a67afd72b2">Chiarion-Sileni</surname> <given-names id="b5607fb5-7878-4181-9d68-aff0b8551d4f">V</given-names></name><x>, </x><name id="e9272c1e-274a-473f-ba4b-452eb7fc5e1e"><surname id="0e993516-7eef-4e3a-a45e-deb08132e442">Gonzalez</surname> <given-names id="dae2d6ff-999f-427c-9169-af36012c0e3c">R</given-names></name><x>, </x><etal data-class="RefEtal" id="5645c85e-be0f-4f3d-8ea0-0a605a8ca3ae">et al</etal></person-group><x>. </x><article-title id="eef1b17b-cc8f-4933-9196-361aa2ab4c4b">Com<named-content data-cid="1545213295" content-type="changeCase sty cts-1" specific-use="1545214371976" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/19/2018 3:42pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545214371976" id="f21617ac-1b13-4e4c-9c2a-ece1ad923250">bined nivolumab and ipilimumab or monotherapy in untreated mela<span data-class="hidden" hidden-track="track" id="e3514639-9615-46cc-82c2-d8784498d84f">bined Nivolumab and Ipilimumab or Monotherapy in Untreated Mela</span></named-content>noma</article-title><x>. </x><source id="b6c265bc-422d-4b11-9ace-d7fb1736238e"><named-content data-cid="1545113235020" id="74b28252-d666-4d57-bf21-a9303a0ae562" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">The</named-content><named-content data-cid="1545113235020" id="0f7bd989-ee51-4ab2-8575-068acd9d199e" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">N</named-content> <named-content data-cid="1545113235021" id="32f71a67-4f41-4e12-a9a3-5067dfeea195" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">New</named-content><named-content data-cid="1545113235021" id="98f5fc21-7282-42f5-9dfe-16d6625c2d8d" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Engl</named-content> <named-content data-cid="1545113235022" id="f453f96d-728a-4819-b16d-5c2c6b049241" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">England</named-content><named-content data-cid="1545113235022" id="ab25b679-b4f5-49c5-b738-40a1b5b7bdf3" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">J</named-content> <named-content data-cid="1545113235023" id="0d9bafe4-5a24-4f07-b143-36521e387dae" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">journal of medicine</named-content><named-content data-cid="1545113235023" id="3bd8590e-c80d-4fad-ada6-74f00eb99814" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R104" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Med</named-content></source><x> </x><year id="e202d300-4b6e-46ce-96b8-a4769cbedf9c">2015</year><x>;</x><volume id="ad24f57a-90b0-49ee-9b9a-3198ea39fb8d">373</volume><x>:</x><fpage id="c434b5cb-4845-472d-bbef-63df03328c6a">23</fpage><x>–</x><lpage id="651900d7-6d7b-4d1a-9e1d-867c6c525aa3">34</lpage><x>.</x><pub-id pub-id-type="doi" id="7bf964a8-307b-404c-a216-06d03fd4f5da">10.1056/NEJMoa1504030</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R11" data-id="R11" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R11" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/28255845" data-doi="10.1007/s11523-017-0480-y" data-validated="true"><label id="249ea09f-8c53-40bf-8a08-c872f25b4421">11.</label><element-citation publication-type="journal" id="26b5e720-1744-4cda-bdfc-5a1972e8ee36"><person-group person-group-type="author" id="379e7cb0-c3b7-4aaf-98b8-e5bf6d9c46b3"><name id="7b2fc48c-fd82-43af-add5-f1983c623e7a"><surname id="825b6608-96dd-4089-8693-04df07113b87">Hickmott</surname> <given-names id="35353530-3eab-446e-bc63-40a6aa750327">L</given-names></name><x>, </x><name id="379456b3-3420-4a14-a400-b65bc0ed6c73"><surname id="6d3ced8f-afec-4660-8cbd-b38caf4af16a">De La Peña</surname> <given-names id="06429c06-5e54-4843-9b71-0029f42053f2">H</given-names></name><x>, </x><name id="71e25922-c094-46f9-a49b-6c75e37dd205"><surname id="cdf2d57e-4d5e-4358-99d6-fc33ff072d42">Turner</surname> <given-names id="29c5f2f9-ab16-4608-8417-79f2ef8aaf91">H</given-names></name><x>, </x><etal data-class="RefEtal" id="c14ad6ac-6800-4a14-8fbd-c29586d28192">et al</etal></person-group><x>. </x><article-title id="fe04ad24-88f4-46ec-8a9a-e45abc320569">Anti-PD-L1 atez<named-content data-cid="1545213296" content-type="changeCase sty cts-1" specific-use="1545214383382" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/19/2018 3:43pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545214383382" id="0a806711-24a9-4464-b6f2-098176004261">olizumab-induced autoimmune diabetes: a case report and review of the lite<span data-class="hidden" hidden-track="track" id="e30263f4-56a5-4bed-a618-c412bfce9502">olizumab-Induced Autoimmune Diabetes: a Case Report and Review of the Lite</span></named-content>rature</article-title><x>. </x><source id="c770618c-0ca3-43d3-aade-23f0e349e0d7"><named-content data-cid="1545113235024" id="5e5493f0-72b4-46fa-b67b-805b2f9e62a0" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Targeted</named-content><named-content data-cid="1545113235024" id="7430898a-710a-46a6-bc94-d13a9fb670ea" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Target</named-content> <named-content data-cid="1545113235025" id="660059a0-7f1b-47e1-b6b0-12dc66751d07" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Oncology</named-content><named-content data-cid="1545113235025" id="f14e8147-ed59-4deb-9f25-0cae420b9ce1" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Oncol</named-content></source><x> </x><year id="381c301c-0f4a-4617-a278-dc63a6db78a9">2017</year><x>;</x><volume id="1022755f-0aa4-4544-b67b-4f11e8d09152">12</volume><x>:</x><fpage id="427652e0-8a33-4fdb-a404-292b86a4ad71">235</fpage><x>–</x><lpage id="7c4e94e1-3af7-4bf9-b29c-73994a35934f">41</lpage><x>.</x><pub-id pub-id-type="doi" id="f6dd773e-0a5b-4a9c-abee-630d6cc9d802">10.1007/s11523-017-0480-y</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R12" data-id="R12" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R12" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/28973656" data-doi="10.1001/jamaoncol.2017.3064" data-validated="true"><label id="22571fc3-69ee-4da1-86f1-bcc16dc3e0a2">12.</label><element-citation publication-type="journal" id="b15545f7-5fd2-4f94-bcb9-c926d7064090"><person-group person-group-type="author" id="324bb1ec-f506-470a-a1fc-9b8bfbae0fae"><name id="9f4b11af-19dc-42a4-a14e-285bb8d262f8"><surname id="b99b3155-f042-4692-90bd-1c1d1a9f2493">Barroso-Sousa</surname> <given-names id="324a9d5f-7918-424d-8fa5-8d623a916556">R</given-names></name><x>, </x><name id="5a9c7b93-518b-4b8a-addc-2ba95710b159"><surname id="cf92da7f-ba33-45f3-a140-a10413ac8b8d">Barry</surname> <given-names id="c56fb1fc-3acf-4384-8fe9-0de931bdb093">WT</given-names></name><x>, </x><name id="5b1d6c71-ab62-49d0-a33b-42da648ea00b"><surname id="3fd76b58-37cb-4800-8c58-0bc72688128e">Garrido-Castro</surname> <given-names id="6ea7fc3b-e71d-44fc-800a-9589c2902e3a">AC</given-names></name><x>, </x><etal data-class="RefEtal" id="96aeed50-606f-4de3-a987-fca2dd6e8669">et al</etal></person-group><x>. </x><article-title id="3ec0deb2-25e1-4df3-b25d-4d491e8f85ff">Incidence<named-content data-cid="1545213297" content-type="changeCase sty cts-1" specific-use="1545214396027" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/19/2018 3:43pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545214396027" id="a5cc7cfc-2dc7-46bd-885d-89cdcf8900e6"> of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-an<span data-class="hidden" hidden-track="track" id="46997706-e21d-4b18-b812-c669a279d2f2"> of Endocrine Dysfunction Following the Use of Different Immune Checkpoint Inhibitor Regimens: A Systematic Review and Meta-an</span></named-content>alysis</article-title><x>. </x><source id="40e99746-bc46-49ea-b992-c2b241c33db8">JAMA <named-content data-cid="1545113235026" id="2b1e978b-69f8-4dce-8e49-b84e3aef8388" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">oncology</named-content><named-content data-cid="1545113235026" id="73d05f1b-8a47-499d-8796-ef25e7a97196" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Oncol</named-content></source><x> </x><year id="ed82af00-e6d1-4ac9-a58d-1a51769c7a3e">2018</year><x>;</x><volume id="e89aed0a-0cc5-4bfa-8fe2-20e151a27c23">4</volume><x>:</x><fpage id="1343cda7-0b54-4c5f-b717-7cfe449cd339">173</fpage><x>–</x><lpage id="b6f33bd3-1685-4bd9-9bf5-b9c3c59583f1">82</lpage><x>.</x><pub-id pub-id-type="doi" id="d1ef4cd3-58c5-4d6d-a573-5f74ffc28bc0">10.1001/jamaoncol.2017.3064</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R13" id="R13" data-id="R13" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R13" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/28634815" data-doi="10.1007/s00262-017-2033-8" data-validated="true"><label id="d63a116a-5582-462b-b8e7-4fa08efd1677">13.</label><element-citation publication-type="journal" id="8f6ad8e9-19cb-43f1-a856-4db45fd7ec05"><person-group person-group-type="author" id="bc5446f9-26ba-46e8-8876-5bd5abd19a76"><name id="af6d8533-3654-442e-a0bf-cec5c2dd9924"><surname id="c1dc1372-78af-4c40-a2e9-7a5570f0384b">Gauci</surname> <given-names id="27cd0576-546b-4fb4-8b44-bf73f1d019ed">ML</given-names></name><x>, </x><name id="801a2c93-8efa-4ba8-b6cf-7122c7ae7568"><surname id="f3d46f17-87c9-4307-a34c-0ef30bfe5877">Laly</surname> <given-names id="35c38544-458c-4753-accd-824f621afa39">P</given-names></name><x>, </x><name id="9e9d313e-bd53-47a6-b9c2-2df8aff5dc3b"><surname id="426aa341-98d5-4319-a2df-5e6ab44ad64a">Vidal-Trecan</surname> <given-names id="263936e7-9d1b-477c-bfaa-ea64725b88df">T</given-names></name><x>, </x><etal data-class="RefEtal" id="22abed63-40a6-45da-a377-9824a839252a">et al</etal></person-group><x>. </x><article-title id="55105bb2-4d38-4c95-8c55-a8ec3e868907">Autoimmune diabetes induced by PD-1 inhibitor-retrospective analysis and pathogenesis: a case report and literature review</article-title><x>. </x><source id="dbf3bde9-e310-4e7b-a7ae-44f01eb1cd43">Cancer <named-content data-cid="1545113235027" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="8531caa2-6f90-476a-bce7-304779133e3f">immunology,</named-content><named-content data-cid="1545113235027" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="f2eb859a-1464-455d-9bd6-629fab735d78">Immunol</named-content> <named-content data-cid="1545113235028" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="b25084f3-9ea3-4a88-809b-989e39877f0f">immunotherapy : CII</named-content><named-content data-cid="1545113235028" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="e3b24464-ccec-4210-a283-d9c5ed9e65ec">Immunother</named-content></source><x> </x><year id="f310428c-1ec2-44e2-b5c5-3a1e5a867ce1">2017</year><x>;</x><volume id="cd34a126-0102-4380-9dc7-e04b509525fb">66</volume><x>:</x><fpage id="28503180-539d-4342-9e54-2e9c0c09cd3c">1399</fpage><x>–</x><lpage id="60b4bebc-e31f-49c7-8a80-9e897d9ee642">410</lpage><x>.</x><pub-id pub-id-type="doi" id="92b47c39-e3df-4c76-a9eb-fc914c13214e">10.1007/s00262-017-2033-8</pub-id></element-citation></ref><ref data-class="jrnlRefText" seqid="R14" id="R14" data-id="R14" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R14" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/25805871" data-doi="10.2337/dc14-2349" data-validated="true"><label id="320e2e96-5381-4136-b6af-1cd095a493e3">14.</label><element-citation publication-type="journal" id="defc2269-3226-42b4-a859-66e3def39b27"><person-group person-group-type="author" id="45a817b7-0ada-4874-9770-d0f91829352c"><name id="c4e0253e-8bae-4dc6-8b56-fa9d3c8e44a4"><surname id="9bbff442-178f-480d-adf9-db02089c240d">Hughes</surname> <given-names id="134568d7-0424-42dd-bb74-19d0e9d971ab">J</given-names></name><x>, </x><name id="5c461012-c4f2-497c-9081-9bbebb6e4591"><surname id="2f76ef5f-76d7-442a-a4f1-41c8895cb5cf">Vudattu</surname> <given-names id="af6196d0-4712-4611-892b-ec4412c4b38e">N</given-names></name><x>, </x><name id="ebb09df9-d5b8-4f3c-b993-5d9bacb0bd19"><surname id="f6c13992-bd9c-4dd0-b9d9-ae1ec8a7c309">Sznol</surname> <given-names id="3d73941d-500e-48f3-8826-f2b4b3c64a7e">M</given-names></name><x>, </x><etal data-class="RefEtal" id="e8bc46c7-2cf1-42f3-9260-b6d87b847007">et al</etal></person-group><x>. </x><article-title id="cc56c06e-0bc2-4454-85f8-b1927e2dc74f">Precipitation of autoimmune diabetes with anti-PD-1 immunotherapy</article-title><x>. </x><source id="c8dd340a-72de-42d2-a924-c4944e0a0660">Diabetes <named-content data-cid="1545113235029" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="50e9d463-0955-4b69-a697-d1fc9b2aed04">care</named-content><named-content data-cid="1545113235029" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000" id="795f28d4-5c1c-4f48-b68a-ed51f99f7fd2">Care</named-content></source><x> </x><year id="06e98042-bef2-4041-9c89-56c0cb5a7aa3">2015</year><x>;</x><volume id="354fa79f-1321-43be-9786-693c8532a152">38</volume><x>:</x><fpage id="18545aac-5291-41a6-b887-8e439adc27da">e55</fpage><x>–</x><lpage id="4e8d14d9-a3d6-4541-a1a5-208803ee7ae1">7</lpage><x>.</x><pub-id pub-id-type="doi" id="a173d5ad-9bb0-4c48-ab4e-a4493bda1096">10.2337/dc14-2349</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R15" data-id="R15" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R15" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/29937434" data-doi="10.2337/dbi18-0002" data-validated="true"><label id="2f96d74e-088e-4470-bc1b-1c2f348c053f">15.</label><element-citation publication-type="journal" id="56a2b4d6-f945-408c-8fbf-9b7ee892c97d"><person-group person-group-type="author" id="f9f3933b-aedc-49bd-89e0-31e4466dadb3"><name id="1bf260cc-0959-490e-976c-313703a4e0d1"><surname id="0cd26698-4973-48f4-b2c1-266d1e6c005b">Stamatouli</surname> <given-names id="ea8c4bba-fcdf-40cc-b2b7-74213383d28e">AM</given-names></name><x>, </x><name id="ce0cc624-cbcb-4f23-9f1d-3595f480db23"><surname id="74bf462d-89d3-4269-8c21-ed33fad39ea1">Quandt</surname> <given-names id="fa8210e2-248f-4272-918a-d9eff2149152">Z</given-names></name><x>, </x><name id="b5c9b72e-c349-4e35-9082-fe373c2711c9"><surname id="d5f7ba91-80a0-4e02-9568-8d3349a22c0b">Perdigoto</surname> <given-names id="3fb78fd7-9de3-4775-9f6d-befb8fabcd21">AL</given-names></name><x>, </x><etal data-class="RefEtal" id="3ed58ec9-356f-4d05-aa4c-5a035d86b496">et al</etal></person-group><x>. </x><article-title id="85673290-87b9-4eb3-b46b-bb67f2f25290">Collatera<named-content data-cid="1545213298" content-type="changeCase sty cts-1" specific-use="1545214410125" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/19/2018 3:43pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545214410125" id="963d29c8-bd0f-4a19-968d-20928f6becd7">l damage: insulin-dependent diabetes induced with checkpoint inhib<span data-class="hidden" hidden-track="track" id="c36f1e73-49cc-4c5c-9d48-e5f1aa78a171">l Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhib</span></named-content>itors</article-title><x>. </x><source id="c4535d20-dea9-48a9-bf6d-a5f38b45af19">Diabetes</source><x> </x><year id="2d1121fe-ba0a-44c3-a79b-9df49433a43f">2018</year><x>;</x><volume id="a009c1b7-5636-401d-9da6-98dcb986f50a">67</volume><x>:</x><fpage id="54eade26-5dd1-4e2c-92b5-5096fd2e123a">1471</fpage><x>–</x><lpage id="97d0b47e-979d-48ba-aac0-afbcca20d639">80</lpage><x>.</x><pub-id pub-id-type="doi" id="bc7ff227-e5ba-466a-a1ad-6da4ab779ba9">10.2337/dbi18-0002</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R16" data-id="R16" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R16" data-validated="true"><label id="a5ed8f75-8c85-4ea9-81c2-4d16f3ef49aa">16.</label><element-citation publication-type="journal" id="03b48ca2-c78e-4422-93fc-26efebaf94a5"><person-group person-group-type="author" id="c03a9eac-08a0-46e5-8361-796670f064d2"><name id="576d83d5-ac36-44bc-891d-921323f9db29"><surname id="8ef58564-5f01-4525-8267-c5079f0d3256">Iyer</surname> <given-names id="6255ae1d-9221-4b9f-9a90-e21491621532">P</given-names></name><x>, </x><name id="8749d522-2eb5-4497-a413-01f9753d6786"><surname id="d8b79903-3e86-4b4f-be87-9ef6fe6407ea">Best</surname> <given-names id="6cfedfdc-450b-472a-8340-b1a414497fbc">C</given-names></name><x>, </x><name id="41837e9d-4006-4448-b18a-506deefbd3c8"><surname id="20fdcbd1-19c2-4c54-828f-15a13e46e881">Lavis</surname> <given-names id="c4613fc5-cf98-45c3-99f1-df599999b6fe">VR</given-names></name></person-group><x>. </x><article-title id="79ddb13b-d03f-4d40-a57f-3dbe5c07e31c">Checkpoi<named-content data-cid="1545216179" content-type="changeCase sty cts-1" specific-use="1545216354363" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/19/2018 4:15pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545216354363" id="fa7aee33-6ef9-434c-9900-0c744b21a9b7">nt inhibitor mediated insulin dependent diabetes: a cancer center experie<span data-class="hidden" hidden-track="track" id="e907e361-68fc-43e6-a962-ab3e8741879a">nt Inhibitor Mediated Insulin Dependent Diabetes: A Cancer Center Experie</span></named-content>nce (Abstract)</article-title><x>. </x><source id="7e21b842-a6cf-423b-803f-bab21fb6fb35">Endocrine Reviews</source><x> </x><year id="e1e421db-1c88-45ed-bbfc-59f0831b28bd">2018</year><x>;</x><volume id="9661a76d-733d-4e03-b633-821570d2f584">39</volume><x>.</x></element-citation></ref><ref data-class="jrnlRefText" seqid="R17" id="R17" data-id="R17" data-styled="RefText" data-class-name="RefText" data-reftype="Journal" data-valid-id="R17" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/14617032" data-doi="10.1046/j.1399-0039.2003.00136.x" data-validated="true"><label id="003e8f03-1c13-48ab-91a7-0f4fcbf64a09">17.</label><element-citation publication-type="journal" id="f041642d-dbac-4993-a8db-e7cb3544dc7b"><person-group person-group-type="author" id="f9c8b419-8fe0-4416-a8dc-89d5164c2f42"><name id="139e7ccd-674e-4b85-9278-094285b27573"><surname id="fbcf0cb2-8b87-406a-888a-4e497f4bb695">Nielsen</surname> <given-names id="2d13c333-cffd-406d-9f80-2a9851453abe">C</given-names></name><x>, </x><name id="ad86c59d-ae32-4e6f-aec9-9c50aa1245aa"><surname id="51b9d5b6-b1be-4e61-b5a8-bf7580567de4">Hansen</surname> <given-names id="6dc1691b-eedc-4b2a-9589-c37ba67ed44e">D</given-names></name><x>, </x><name id="04d6bc6c-dc91-42cf-8602-7842c2aa1aa1"><surname id="f5613464-c0b6-4440-b0e3-2a4822cebe2c">Husby</surname> <given-names id="47cbdc66-1a46-4218-bf05-a523c263b8ce">S</given-names></name><x>, </x><etal data-class="RefEtal" id="608e17da-3627-40f4-b2e5-3c92d50481b3">et al</etal></person-group><x>. </x><article-title id="b529377e-9f5f-4f9e-aa7d-8a8e57ac7983">Association of a putative regulatory polymorphism in the PD-1 gene with susceptibility to type 1 diabetes</article-title><x>. </x><source id="f7036d8c-6e51-43dd-953a-5a5d7c5704ce">Tissue Antigens</source><x> </x><year id="9bfaea84-24ad-4b3b-a822-bcf1969e0b9c">2003</year><x>;</x><volume id="054c8f2f-1913-4f1d-8094-ae18c8d49ecd">62</volume><x>:</x><fpage id="b6a09a92-34e3-472e-aa8d-ed17db46a0d3">492</fpage><x>–</x><lpage id="078eb23a-ecd2-4e25-8709-9d5a300a8dfb">7</lpage><x>.</x><pub-id pub-id-type="doi" id="cf52f307-b9c6-42d1-811d-1381d9564c8b">10.1046/j.1399-0039.2003.00136.x</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R18" data-id="R18" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R18" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/26393578" data-doi="10.3390/ijms160922584" data-validated="true"><label id="8e38ea38-52a8-451d-8106-e7c609ec2226">18.</label><element-citation publication-type="journal" id="1dab4c89-35e8-4bbe-bd14-fc21e7e07d37"><person-group person-group-type="author" id="e6534549-ab08-4240-a8cd-9074de605bf3"><name id="5d6669a7-3560-4533-a3c9-9796334234d6"><surname id="38cf780b-2c4b-4d3b-bc44-8f30c9a08f26">Perri</surname> <given-names id="66c97dec-2c1a-4e16-ab86-23e7e3724b4f">V</given-names></name><x>, </x><name id="500eab49-065d-4944-a9dc-24b95f0b424c"><surname id="13532e5e-d2ba-4d60-beb6-49cc3df7630c">Russo</surname> <given-names id="7fa32801-8292-4981-9c25-9ddda4e652c1">B</given-names></name><x>, </x><name id="fe8283db-4715-4160-98ba-09201108a7af"><surname id="c7956bf7-1ed0-4e4b-8b33-a9e3cc06f4bc"><named-content data-cid="1545113235030" id="6182c5d8-ca09-45c8-be1c-48e75899a0ff" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Crino</named-content><named-content data-cid="1545113235030" id="df70b134-7bc9-4a5b-83cb-421594bf1590" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Crinò</named-content></surname> <given-names id="f4c26104-b299-4d99-a5ec-e72698320a1b">A</given-names></name><x>, </x><etal data-class="RefEtal" id="b9041cd7-8485-4fd7-9fcc-b16876f6d95f">et al</etal></person-group><x>. </x><article-title id="8c598613-d3ef-4a06-aa00-129ba5e41f97">Expression of PD-1 <named-content data-cid="1545216178" id="1896555a-e1aa-4066-b747-736c9d0e16c9" content-type="changeCase sty cts-1" specific-use="1545216340321" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/19/2018 4:15pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545216340321">molecule on regulatory t lymphocytes in patients with insulin-dependent diabetes me<span data-class="hidden" hidden-track="track" id="6c8faa8f-6668-4185-8397-4c8843a96c16">Molecule on Regulatory T Lymphocytes in Patients with Insulin-Dependent Diabetes Me</span></named-content>llitus</article-title><x>. </x><source id="6d2b3fa9-1c13-4c4c-89bb-fb0008bfae48">Int J Mol Sci</source><x> </x><year id="3b92b818-47b6-4adc-97bd-9522f7c89159"><span data-class="forceJustify" data-title="force justification used for typesetting" id="287c0cc4-f26e-44ae-9f4f-c7b3b5bb50ff"> </span>2015</year><x>;</x><volume id="5f579ab4-d307-466a-a824-e41d39a70471">16</volume><x>:</x><fpage id="db74f00a-e6fa-46ad-9ffd-d499d491cbe2">22584</fpage><x>–</x><lpage id="cf7aeff4-4312-441f-aefe-dcbe4be68769">605</lpage><x>.</x><pub-id pub-id-type="doi" id="0c459129-2d77-4aaf-89bd-2ef1105a028f">10.3390/ijms160922584</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R19" data-id="R19" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R19" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/25682896" data-doi="10.1111/cei.12603" data-validated="true"><label id="7cd3549c-45a1-4e74-8e2a-969a59acf275">19.</label><element-citation publication-type="journal" id="fca28302-eaeb-4ef6-81fa-b0ff18887efa"><person-group person-group-type="author" id="11177453-0df8-4d06-9bfd-1f9d34fdaaef"><name id="8ae58141-3b61-4d05-9c8b-8d6062a8b21f"><surname id="0578f3fe-8b52-4861-8538-6f9523797df1">Fujisawa</surname> <given-names id="2c973cdf-b90e-457d-985e-9f88f4ff59b5">R</given-names></name><x>, </x><name id="fc0a52a1-fafc-4411-9d16-93dba2a813a3"><surname id="b1ee8514-a2e5-46a4-a3fa-543a4d63e7cf">Haseda</surname> <given-names id="d7d5402e-a204-4c5a-a703-77cf8c9d457c">F</given-names></name><x>, </x><name id="a631c13e-0942-40ed-be37-22d70aa5b973"><surname id="da1f891e-6864-4919-988e-e552d3aa6e1f">Tsutsumi</surname> <given-names id="c7689771-a239-45c0-80e9-7eaa4473bba6">C</given-names></name><x>, </x><etal data-class="RefEtal" id="a90b332a-23a0-43f9-9e52-2c5211e1ac0e">et al</etal></person-group><x>. </x><article-title id="8a54b9d5-a6c4-451f-8571-8ed5e3ffe487">Low programmed cell death-1 (PD-1) expression in peripheral CD4<named-content data-cid="1545113235031" id="04750099-614a-4d5c-ab44-aed9d07500ab" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">(</named-content>+<named-content data-cid="1545113235032" id="eb5d1105-198a-4fd4-b5f5-2fa641b58d9a" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">)</named-content> T <named-content data-cid="1545213299" id="2e7fb81a-0c45-4eae-aeef-f443a6b7a175" content-type="changeCase sty cts-1" specific-use="1545214548550" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/19/2018 3:45pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545214548550">cells in japanese patients with autoimmune type 1 diab<span data-class="hidden" hidden-track="track" id="a145bc80-e213-445b-9c60-0ef5320cfe02">cells in Japanese patients with autoimmune type 1 diab</span></named-content>etes</article-title><x>. </x><source id="cc64b4ae-4f50-4be9-a7ab-a16c63f61fc8"><named-content data-cid="1545113235033" id="bf688c45-32a6-4456-9f4f-bc1a050c1576" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Clinical</named-content><named-content data-cid="1545113235033" id="9700ccd5-5653-4be3-a764-6e0c2e114fab" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Clin</named-content> <named-content data-cid="1545113235034" id="a8e1d8bb-5d78-4396-9000-869ffa9f3615" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">&amp;</named-content><named-content data-cid="1545113235034" id="18ac9d71-c977-4949-95de-95cd82e4b838" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Exp</named-content> <named-content data-cid="1545113235035" id="fdaf970f-9834-4cd0-b686-35a8f7ce5ee5" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Experimental Immunology</named-content><named-content data-cid="1545113235035" id="3905106e-01a8-415f-aa4a-7657434216bf" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Immunol</named-content></source><x> </x><year id="f2790085-8779-4304-bcf3-f74f5a33bff7"><span data-class="forceJustify" data-title="force justification used for typesetting" id="cc05ca3b-8b93-4b93-a616-578a9af4d889"> </span>2015</year><x>;</x><volume id="d457c9e9-96e1-462a-9946-b4d77d0e4965">180</volume><x>:</x><fpage id="8afc3bce-9a64-4a91-aa1f-3fd7aff9ebfa">452</fpage><x>–</x><lpage id="f74a5e07-4aff-4407-9912-b070a1bc7087">7</lpage><x>.</x><pub-id pub-id-type="doi" id="8704cefc-1407-4bf5-9749-bd0408cc9084">10.1111/cei.12603</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R20" data-id="R20" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R20" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/26446948" data-doi="10.1158/1078-0432.CCR-15-1136" data-validated="true"><label id="812f8b61-e81b-4746-ab72-eed01a199c93">20.</label><element-citation publication-type="journal" id="481f4887-866a-4117-a747-dbcf87acd02b"><person-group person-group-type="author" id="25b66468-f3f8-4bd4-81d4-fe4bc0ab6a8c"><name id="bc79c691-ecf3-45ec-a5db-670c7a869d9a"><surname id="2a73bf77-976f-4d40-a59c-a4ea22440282">Freeman-Keller</surname> <given-names id="87c629e4-431f-41ea-8780-fcbeda51b55e">M</given-names></name><x>, </x><name id="630a0d6b-d759-44fb-ad62-b6d33c31bf63"><surname id="5e0cb1cc-c096-48b8-99cb-fc2a77bc57cd">Kim</surname> <given-names id="a5ce36d5-43fe-45e3-909a-ed20bc23c7f1">Y</given-names></name><x>, </x><name id="1b9056a2-e9c6-4be3-9efc-79fd2d960bfc"><surname id="4d524ffa-052e-4076-96c3-e2f7f2fb08bb">Cronin</surname> <given-names id="57037e3a-8e11-4fe1-be74-25d079572f6e">H</given-names></name><x>, </x><etal data-class="RefEtal" id="aaf5559a-e09a-4aeb-9f54-e7065d596e10">et al</etal></person-group><x>. </x><article-title id="e66d3afd-f197-4e28-b4b8-486faa680143">Nivol<named-content data-cid="1545213301" content-type="changeCase sty cts-1" specific-use="1545214578719" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/19/2018 3:46pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545214578719" id="c3500eca-9d11-4b60-9e82-e665603bc574">umab in resected and unresectable metastatic melanoma: characteristics of immune-related adverse events and association with ou<span data-class="hidden" hidden-track="track" id="3fb85747-321a-4146-b399-fc248d3a4f35">umab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association with Ou</span></named-content>tcomes</article-title><x>. </x><source id="4ccde0e3-5491-4def-9f92-f09479fc12be"><named-content data-cid="1545113235036" id="f6e30fd5-4d1e-4276-83dd-f6ae69f0ab6b" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Clinical cancer research : an official journal of the American Association for</named-content><named-content data-cid="1545113235036" id="a2bbcdde-3e1b-4821-a9e5-1c041df4f257" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Clin</named-content> Cancer <named-content data-cid="1545113235037" id="a1d81428-1d6f-4db6-998c-6e21eca9c0b1" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Research</named-content><named-content data-cid="1545113235037" id="13d21adf-7233-4163-a086-782875ed8799" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Res</named-content></source><x> </x><year id="5eb8982f-93aa-4697-ad6f-268a8ddac25b">2016</year><x>;</x><volume id="16c0def6-9761-4076-9ec6-89ea66a8371a">22</volume><x>:</x><fpage id="2201343d-b701-494e-81ce-5b74e45c3f7a">886</fpage><x>–</x><lpage id="af42d2d3-be6d-49ad-bda9-d0d5f2bfc525">94</lpage><x>.</x><pub-id pub-id-type="doi" id="802472dd-bae3-4dc0-8df6-da9e0f3b0a3a">10.1158/1078-0432.CCR-15-1136</pub-id></element-citation></ref><ref data-class="jrnlRefText" id="R21" data-id="R21" data-styled="RefText" data-class-name="RefText" data-reftype="journal" data-valid-id="R21" data-pmid="http://www.ncbi.nlm.nih.gov/pubmed/28068177" data-doi="10.1200/JCO.2015.66.1389" data-validated="true"><label id="7fd7df94-054c-4f95-840a-0e65ef3e5766">21.</label><element-citation publication-type="journal" id="a22ef0ed-9ee6-4713-9a40-7b90e0d906d7"><person-group person-group-type="author" id="2f03e237-eed4-46b7-b5bd-845785eced2c"><name id="b845769e-cb34-4a43-bf46-c0c3ce73367d"><surname id="2edf3183-1a67-420f-995d-bb91e083979c">Weber</surname> <given-names id="4fd99389-7dba-481f-b017-1c3c5625a263">JS</given-names></name><x>, </x><name id="6e0e9df7-5f81-4bcc-95d2-c665f3b8e65d"><surname id="a5aa7c3f-cb00-4c44-8e61-f47d912a246a">Hodi</surname> <given-names id="eb2b77a3-6691-4db6-ab66-9f15176d1350">FS</given-names></name><x>, </x><name id="e396ede7-57c4-44d8-935b-ef5b9080077f"><surname id="a272047f-1757-442e-8740-507247abc061">Wolchok</surname> <given-names id="1b343348-c084-4edf-89dc-3ec181a0593a">JD</given-names></name><x>, </x><etal data-class="RefEtal" id="272822e9-45ee-4b5b-9476-15e4f5723361">et al</etal></person-group><x>. </x><article-title id="c154fbd8-1ad8-464a-a127-1abb23f5f208">Saf<named-content data-cid="1545213302" content-type="changeCase sty cts-1" specific-use="1545214584510" xlink:title="Varalakshmi (PREEDITOR)" alt="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-title="lowercase Added by Varalakshmi (PREEDITOR) - 12/19/2018 3:46pm" data-track-detail="" data-track-hint="lowercase Added" data-userid="preeditor 77ed9556-0bad-4403-9bf5-ecf656b6fcc6" data-username="Varalakshmi (PREEDITOR)" data-time="1545214584510" id="a9e8dbe8-4e36-4a16-a278-64f9526839d7">ety profile of nivolumab monotherapy: a pooled analysis of patients with advanced melan<span data-class="hidden" hidden-track="track" id="abc6f7cc-bab6-4d35-b4c2-1ce4e0860b35">ety Profile of Nivolumab Monotherapy: A Pooled Analysis of Patients With Advanced Melan</span></named-content>oma</article-title><x>. </x><source id="98b2e842-79dd-4fd4-b945-1e0220d2a1f2"><named-content data-cid="1545113235038" id="ee9166f8-7e1c-4384-942e-adbf4251a3b0" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Journal</named-content><named-content data-cid="1545113235038" id="ce243f7f-fe0f-47d6-b31d-60ae10775fb6" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R101" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">J</named-content> <named-content data-cid="1545113235039" id="d5d93b30-4e59-4484-98ad-956447a9fad4" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">of</named-content><named-content data-cid="1545113235039" id="072ed09d-0720-41c3-9d5b-f452e1f4beb6" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R102" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Clin</named-content> <named-content data-cid="1545113235040" id="7f6281e2-b84e-4293-b95f-dbc678e5502f" content-type="del cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Deleted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">clinical oncology : official journal of the American Society of Clinical Oncology</named-content><named-content data-cid="1545113235040" id="2434e4b3-6d6c-41d0-b1fe-2cbc74ec0719" content-type="ins cts-1" specific-use="1545113235000" xlink:title="cross-ref" alt="cross-ref" data-title="Inserted by cross-ref - 2018/12/18 11:37 am" data-track-detail="" data-diff-rid="R103" data-userid="cross-ref" data-username="cross-ref" data-time="1545113235000">Oncol</named-content></source><x> </x><year id="24b271d8-d6ab-4726-bbcd-c928b9913052">2017</year><x>;</x><volume id="2b7605d9-d2f4-409a-9bfd-40913ba6a0bd">35</volume><x>:</x><fpage id="3e0e8e9a-46fb-4150-9577-d7d14ff06f55">785</fpage><x>–</x><lpage id="7af7ca15-36cc-4138-aed1-44d86a427790">92</lpage><x>.</x><pub-id pub-id-type="doi" id="87036637-27a6-450b-acbd-9570024cb88b">10.1200/JCO.2015.66.1389</pub-id></element-citation></ref></ref-list><supplementary-material section="back" node-xpath="supplementary-group" direct-node="true" id="BLK_S1" data-id="BLK_S1" data-stream-name="a_S1" data-edited-node="true"><label id="95678c9d-d9a7-4b6c-b177-6db2441a1c40">online Supplementary table 1</label><caption id="3e17673d-baa9-4746-b2a8-c5627dd10b71"><title id="S1" data-id="S1">Family history of autoimmunity and personal history of autoimmunity and pre-existing type <named-content id="c81b5918-1c4d-48d4-9ff3-56a03b4c756a" data-cid="c81b5918-1c4d-48d4-9ff3-56a03b4c756a" content-type="jrnlPatterns" specific-use="" xlink:title="" alt="" data-title="SNUM" data-track-detail="" data-tag-desc="SNUM" data-tag-type="SNUM" data-offset="113" data-match="2" data-pattern="" data-tag-index="1_2" data-function="numberToText,addTrackChanges" data-time="" data-username="" data-userid="">2</named-content> diabetes in cases of ICI induced diabetes</title></caption><media xlink:href="/resources/bmj/bmjdrc/bmjdrc-2018-000591/resources/6bcab632-4dbf-4b47-b38f-b8dcbea09a61.docx" id="dfac6b84-3acd-4fa9-ab04-bd43772bb6a5">Supplemental Table S1.docx</media></supplementary-material></back><workflow ftp-file-name="bmjdrc-2018-000591" data-job-id="e5bde56d-ddae-4931-9aea-e70dc04e4ce4"><priority>priority</priority><current-stage>Archive</current-stage><paw-stage><previous>Revises</previous><current>Upload for Online First</current></paw-stage><word-count/><word-count-without-ref>6391</word-count-without-ref><stage><name>addJob</name><customer-stage-name>Add Job</customer-stage-name><start-date-time/><end-date-time/><start-date>2018-11-16</start-date><end-date>2018-11-16</end-date><duration>0</duration><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on/><reason/></assigned><time-log><log><start/><end/><duration/><status/></log></time-log></stage><stage><name>Convert Files</name><customer-stage-name>Clean up</customer-stage-name><start-date>2018-11-16</start-date><end-date>2018-11-16</end-date><duration>0</duration><sla-start-date>2018-11-16 20:35:13</sla-start-date><sla-end-date>2018-11-19 20:35:13</sla-end-date><planned-start-date>2018-11-16 20:35:13</planned-start-date><planned-end-date>2018-11-19 20:35:13</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage><stage><name>Pre-editing</name><customer-stage-name>Clean up</customer-stage-name><start-date>2018-11-16</start-date><end-date>2018-11-19</end-date><sla-start-date>2018-11-16 20:35:28</sla-start-date><sla-end-date>2018-11-19 20:35:28</sla-end-date><planned-start-date>2018-11-16 20:35:28</planned-start-date><planned-end-date>2018-11-19 20:35:28</planned-end-date><status>completed</status><comments>Moved to Hold</comments><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage><stage><name>Hold</name><customer-stage-name>Clean up</customer-stage-name><start-date>2018-11-16</start-date><end-date>2018-12-12</end-date><duration>26</duration><sla-start-date>2018-11-16 20:35:28</sla-start-date><sla-end-date>2018-11-19 20:35:28</sla-end-date><planned-start-date>2018-11-16 20:35:28</planned-start-date><planned-end-date>2018-11-19 20:35:28</planned-end-date><status>completed</status><held-stage/><hold-state/><comments/><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs/></stage><stage><name>Pre-editing</name><customer-stage-name>Clean up</customer-stage-name><start-date>2018-12-12</start-date><end-date>2018-12-18</end-date><duration>6</duration><sla-start-date>2018-12-12 00:30:04</sla-start-date><sla-end-date>2018-12-14 00:30:04</sla-end-date><planned-start-date>2018-12-12 00:30:04</planned-start-date><planned-end-date>2018-12-14 00:30:04</planned-end-date><status>completed</status><comments>Relesed based on PAW email, Moved to Support</comments><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Hemalatha</username><useremail>hemalatha.g@exeterpm.com</useremail><start-date>2018-12-13</start-date><start-time>12:20:40</start-time><end-date>2018-12-13</end-date><end-time>12:23:05</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Hemalatha</username><useremail>hemalatha.g@exeterpm.com</useremail><start-date>2018-12-13</start-date><start-time>12:56:13</start-time><end-date>2018-12-13</end-date><end-time>13:07:07</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Hemalatha G</username><useremail>hemalatha.g@exeterpm.com</useremail><start-date>2018-12-13</start-date><start-time>13:07:49</start-time><end-date>2018-12-13</end-date><end-time>13:07:53</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>01:47:18</start-time><end-date>2018-12-18</end-date><end-time>01:47:18</end-time><status type="system">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>03:30:07</start-time><end-date>2018-12-18</end-date><end-time>03:31:05</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>04:32:07</start-time><end-date>2018-12-18</end-date><end-time>04:41:55</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>05:18:00</start-time><end-date>2018-12-18</end-date><end-time>05:18:00</end-time><status type="user">signed-off</status></log></job-logs></stage><stage><name>Support</name><customer-stage-name>Clean up</customer-stage-name><start-date>2018-12-18</start-date><end-date>2018-12-18</end-date><duration>0</duration><sla-start-date>2018-12-12 00:30:04</sla-start-date><sla-end-date>2018-12-14 00:30:04</sla-end-date><planned-start-date>2018-12-18 05:29:30</planned-start-date><planned-end-date>2018-12-19 05:29:30</planned-end-date><status>completed</status><held-stage/><hold-state/><comments>contentRelated,high,Pre-editing</comments><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Karthick</username><useremail>karthickvs</useremail><start-date>2018-12-18</start-date><start-time>05:47:40</start-time><end-date>2018-12-18</end-date><end-time>05:46:27</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Karthick</username><useremail>karthickvs</useremail><start-date>2018-12-18</start-date><start-time>05:50:15</start-time><end-date>2018-12-18</end-date><end-time>05:56:39</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Karthick VS</username><useremail>karthickvs</useremail><start-date>2018-12-18</start-date><start-time>06:01:41</start-time><end-date>2018-12-18</end-date><end-time>06:03:15</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Karthick VS</username><useremail>karthickvs</useremail><start-date>2018-12-18</start-date><start-time>06:03:52</start-time><end-date>2018-12-18</end-date><end-time>06:04:29</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Karthick VS</username><useremail>karthickvs</useremail><start-date>2018-12-18</start-date><start-time>06:04:46</start-time><end-date>2018-12-18</end-date><end-time>06:06:47</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Karthick VS</username><useremail>karthickvs</useremail><start-date>2018-12-18</start-date><start-time>06:07:28</start-time><end-date>2018-12-18</end-date><end-time>06:08:38</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Karthick</username><useremail>karthickvs</useremail><start-date>2018-12-18</start-date><start-time>06:09:38</start-time><end-date>2018-12-18</end-date><end-time>06:12:02</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Karthick</username><useremail>karthickvs</useremail><start-date>2018-12-18</start-date><start-time>06:12:47</start-time><end-date>2018-12-18</end-date><end-time>06:12:47</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><name>Pre-editing</name><customer-stage-name>Clean up</customer-stage-name><start-date>2018-12-18</start-date><end-date>2018-12-19</end-date><duration>1</duration><sla-start-date>2018-12-12 00:30:04</sla-start-date><sla-end-date>2018-12-14 00:30:04</sla-end-date><planned-start-date>2018-12-18 06:15:00</planned-start-date><planned-end-date>2018-12-20 06:15:00</planned-end-date><status>completed</status><comments>styling,Support, Moved to Support</comments><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>06:32:39</start-time><end-date>2018-12-18</end-date><end-time>06:35:42</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>07:54:03</start-time><end-date>2018-12-18</end-date><end-time>08:00:42</end-time><status type="system">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>08:25:02</start-time><end-date>2018-12-18</end-date><end-time>08:32:26</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>08:34:31</start-time><end-date>2018-12-18</end-date><end-time>08:50:25</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>09:21:07</start-time><end-date>2018-12-18</end-date><end-time>09:26:25</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>09:28:01</start-time><end-date>2018-12-18</end-date><end-time>09:35:07</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>09:37:27</start-time><end-date>2018-12-18</end-date><end-time>09:42:31</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>09:43:41</start-time><end-date>2018-12-18</end-date><end-time>09:44:26</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>09:45:41</start-time><end-date>2018-12-18</end-date><end-time>09:46:04</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>09:47:18</start-time><end-date>2018-12-18</end-date><end-time>09:48:41</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>09:48:58</start-time><end-date>2018-12-18</end-date><end-time>09:52:24</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>09:52:32</start-time><end-date>2018-12-18</end-date><end-time>09:52:33</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>09:52:37</start-time><end-date>2018-12-18</end-date><end-time>09:52:47</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-18</start-date><start-time>09:54:43</start-time><end-date>2018-12-18</end-date><end-time>09:54:43</end-time><status type="system">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Sneka</username><useremail>sneka@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>08:49:39</start-time><end-date>2018-12-19</end-date><end-time>08:49:39</end-time><status type="system">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Amirthabalan</username><useremail>amirthabalan.r@exeterpremedia.com</useremail><start-date>2018-12-19</start-date><start-time>08:56:29</start-time><end-date>2018-12-19</end-date><end-time>09:03:11</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Sneka</username><useremail>sneka@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>09:01:34</start-time><end-date>2018-12-19</end-date><end-time>09:03:39</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>09:04:11</start-time><end-date>2018-12-19</end-date><end-time>09:04:11</end-time><status type="user">signed-off</status></log></job-logs></stage><stage><name>Support</name><customer-stage-name>Clean up</customer-stage-name><start-date>2018-12-19</start-date><end-date>2018-12-19</end-date><duration>0</duration><sla-start-date>2018-12-12 00:30:04</sla-start-date><sla-end-date>2018-12-14 00:30:04</sla-end-date><planned-start-date>2018-12-19 09:06:51</planned-start-date><planned-end-date>2018-12-20 09:06:51</planned-end-date><status>completed</status><held-stage/><hold-state/><comments>proofing,high,Pre-editing</comments><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Bharath (TYPESETTER)" role="typesetter" time="1545213106511" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server"/></proof></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Bharath</username><useremail>bharath.b@exeterpremedia.com</useremail><start-date>2018-12-19</start-date><start-time>09:25:08</start-time><end-date>2018-12-19</end-date><end-time>09:39:36</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Bharath</username><useremail>bharath.b@exeterpremedia.com</useremail><start-date>2018-12-19</start-date><start-time>09:41:41</start-time><end-date>2018-12-19</end-date><end-time>09:42:23</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Bharath</username><useremail>bharath.b@exeterpremedia.com</useremail><start-date>2018-12-19</start-date><start-time>09:43:09</start-time><end-date>2018-12-19</end-date><end-time>09:47:59</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Bharath</username><useremail>bharath.b@exeterpremedia.com</useremail><start-date>2018-12-19</start-date><start-time>09:48:23</start-time><end-date>2018-12-19</end-date><end-time>09:48:23</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><name>Pre-editing</name><customer-stage-name>Clean up</customer-stage-name><start-date>2018-12-19</start-date><end-date>2018-12-19</end-date><duration>0</duration><sla-start-date>2018-12-12 00:30:04</sla-start-date><sla-end-date>2018-12-14 00:30:04</sla-end-date><planned-start-date>2018-12-19 09:53:42</planned-start-date><planned-end-date>2018-12-21 09:53:42</planned-end-date><status>completed</status><comments>tables,Support</comments><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Varalakshmi (PREEDITOR)" role="preeditor" time="1545213438406" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server"/><pdf user="Varalakshmi (PREEDITOR)" role="preeditor" time="1545214410629" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server"/><pdf user="Varalakshmi (PREEDITOR)" role="preeditor" time="1545214955260" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server"/><pdf user="Jansi Verginiya (PREEDITOR)" role="preeditor" time="1545215348109" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server"/><pdf user="Varalakshmi (PREEDITOR)" role="preeditor" time="1545217231818" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server"/></proof></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>09:54:38</start-time><end-date>2018-12-19</end-date><end-time>10:00:33</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:02:38</start-time><end-date>2018-12-19</end-date><end-time>10:02:49</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:05:30</start-time><end-date>2018-12-19</end-date><end-time>10:13:56</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:14:10</start-time><end-date>2018-12-19</end-date><end-time>10:16:32</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:17:11</start-time><end-date>2018-12-19</end-date><end-time>10:17:27</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:17:59</start-time><end-date>2018-12-19</end-date><end-time>10:18:04</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:18:06</start-time><end-date>2018-12-19</end-date><end-time>10:18:33</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:18:36</start-time><end-date>2018-12-19</end-date><end-time>10:19:43</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:20:13</start-time><end-date>2018-12-19</end-date><end-time>10:23:32</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Jansi Verginiya</username><useremail>jansiverginiya.arokiadoss@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:25:53</start-time><end-date>2018-12-19</end-date><end-time>10:31:38</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Jansi Verginiya</username><useremail>jansiverginiya.arokiadoss@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:33:21</start-time><end-date>2018-12-19</end-date><end-time>10:36:30</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Jansi Verginiya</username><useremail>jansiverginiya.arokiadoss@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:40:41</start-time><end-date>2018-12-19</end-date><end-time>10:40:59</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>10:41:35</start-time><end-date>2018-12-19</end-date><end-time>11:03:47</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>11:03:48</start-time><end-date>2018-12-19</end-date><end-time>11:04:11</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>11:04:25</start-time><end-date>2018-12-19</end-date><end-time>11:05:59</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>11:06:30</start-time><end-date>2018-12-19</end-date><end-time>11:08:50</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>11:08:55</start-time><end-date>2018-12-19</end-date><end-time>11:09:06</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>11:10:47</start-time><end-date>2018-12-19</end-date><end-time>11:10:53</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Varalakshmi</username><useremail>varalakshmi.a@exeterpm.com</useremail><start-date>2018-12-19</start-date><start-time>11:11:07</start-time><end-date>2018-12-19</end-date><end-time>11:11:07</end-time><status type="system">signed-off</status></log></job-logs><time-tracker><process type="styling">0</process><process type="author-details">0</process><process type="footnotes">0</process><process type="figure-upload">0</process><process type="table-setting">0</process><process type="supplements">0</process><process type="references">0</process><process type="check-rulesets">0</process><process type="others">0</process></time-tracker></stage><stage><name>Waiting for CE</name><customer-stage-name>Copy edit</customer-stage-name><start-date>2018-12-19</start-date><end-date>2018-12-21</end-date><duration>2</duration><sla-start-date>2018-12-19 11:14:09</sla-start-date><sla-end-date>2018-12-20 11:14:09</sla-end-date><planned-start-date>2018-12-19 11:14:09</planned-start-date><planned-end-date>2018-12-20 11:14:09</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Satish</username><useremail>satishraju@exeterpm.com</useremail><start-date>2018-12-21</start-date><start-time>06:31:43</start-time><end-date>2018-12-21</end-date><end-time>06:31:43</end-time><status type="user">signed-off</status></log></job-logs><time-tracker><process type="styling">0</process><process type="author-details">0</process><process type="footnotes">0</process><process type="figure-upload">0</process><process type="table-setting">0</process><process type="supplements">0</process><process type="references">0</process><process type="check-rulesets">0</process><process type="others">0</process></time-tracker></stage><stage><name>Copyediting</name><customer-stage-name>Copy edit</customer-stage-name><start-date>2018-12-21</start-date><end-date>2018-12-22</end-date><duration>1</duration><sla-start-date>2018-12-21 06:32:27</sla-start-date><sla-end-date>2018-12-24 06:32:27</sla-end-date><planned-start-date>2018-12-21 06:32:27</planned-start-date><planned-end-date>2018-12-24 06:32:27</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="PV-A027-Ariel (COPYEDITOR)" role="copyeditor" time="1545442930649" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server"/><pdf user="PV-A027-Ariel (COPYEDITOR)" role="copyeditor" time="1545443335778" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server"/></proof></object><article-key><key live="true">https://kriya2.kriyadocs.com/review_content/?key=8e846e694f500fa895a31373e40f091fc2a17eb93b90fc73424ad063e3f4205e943f2b3d7a204010ad9175b480cf5441d920bcb7950fc0f7b67ca5da7e6299c41c2cd7f6adf0e37392da1881dbb29f9a761496dde402704c18d0ef8bfcbd8143359332366d573c474115b1d9190ef83e1ded2485efc86c46952397ee93cda7af93</key></article-key><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>PV-A027-Ariel</username><useremail>aabaquino@gmail.com</useremail><start-date>2018-12-21</start-date><start-time>22:58:56</start-time><end-date>2018-12-21</end-date><end-time>23:10:24</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>PV-A027-Ariel</username><useremail>aabaquino@gmail.com</useremail><start-date>2018-12-21</start-date><start-time>23:11:24</start-time><end-date>2018-12-21</end-date><end-time>23:36:26</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>PV-A027-Ariel</username><useremail>aabaquino@gmail.com</useremail><start-date>2018-12-21</start-date><start-time>23:36:51</start-time><end-date>2018-12-21</end-date><end-time>23:58:47</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>PV-A027-Ariel</username><useremail>aabaquino@gmail.com</useremail><start-date>2018-12-22</start-date><start-time>00:03:57</start-time><end-date>2018-12-22</end-date><end-time>00:14:58</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>PV-A027-Ariel</username><useremail>aabaquino@gmail.com</useremail><start-date>2018-12-22</start-date><start-time>00:22:34</start-time><end-date>2018-12-22</end-date><end-time>01:45:36</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>PV-A027-Ariel</username><useremail>aabaquino@gmail.com</useremail><start-date>2018-12-22</start-date><start-time>01:45:39</start-time><end-date>2018-12-22</end-date><end-time>01:45:39</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><name>Copyediting Check</name><customer-stage-name>Copy edit</customer-stage-name><start-date>2018-12-22</start-date><end-date>2018-12-22</end-date><duration>0</duration><sla-start-date>2018-12-22 01:50:46</sla-start-date><sla-end-date>2018-12-24 23:50:46</sla-end-date><planned-start-date>2018-12-22 01:50:46</planned-start-date><planned-end-date>2018-12-24 23:50:46</planned-end-date><status>completed</status><comments/><assigned><to>Exeter</to><by>Exeter</by><on>0</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Rangarajan</username><useremail>rangarajan.govindarajan@exeterpm.com</useremail><start-date>2018-12-22</start-date><start-time>05:05:49</start-time><end-date>2018-12-22</end-date><end-time>05:05:49</end-time><status type="user">signed-off</status></log></job-logs></stage><stage><name>Typesetter Check</name><customer-stage-name>Typeset</customer-stage-name><start-date>2018-12-22</start-date><end-date>2018-12-22</end-date><duration>0</duration><sla-start-date>2018-12-22 05:06:53</sla-start-date><sla-end-date>2018-12-24 23:06:53</sla-end-date><planned-start-date>2018-12-22 05:06:53</planned-start-date><planned-end-date>2018-12-24 23:06:53</planned-end-date><status>completed</status><comments/><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Asha (TYPESETTER)" role="typesetter" time="1545464389767" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="none" job-id="f4377556-72f7-4db9-ade3-5b306ae96dca"/><pdf user="Asha (TYPESETTER)" role="typesetter" time="1545469040477" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="none" job-id="9501f4b0-478a-49a7-92e6-69d1a4bc30b8"/><pdf user="Asha (TYPESETTER)" role="typesetter" time="1545469596335" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="none" job-id="1ae3e147-6f0d-45d5-8610-b0f644e9b89c"/></proof></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Asha</username><useremail>ashan@exeterpm.com</useremail><start-date>2018-12-22</start-date><start-time>07:26:46</start-time><end-date>2018-12-22</end-date><end-time>07:29:21</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Asha</username><useremail>ashan@exeterpm.com</useremail><start-date>2018-12-22</start-date><start-time>07:30:08</start-time><end-date>2018-12-22</end-date><end-time>07:30:12</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Asha</username><useremail>ashan@exeterpm.com</useremail><start-date>2018-12-22</start-date><start-time>07:30:52</start-time><end-date>2018-12-22</end-date><end-time>07:32:17</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Asha</username><useremail>ashan@exeterpm.com</useremail><start-date>2018-12-22</start-date><start-time>07:32:44</start-time><end-date>2018-12-22</end-date><end-time>07:53:32</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Asha</username><useremail>ashan@exeterpm.com</useremail><start-date>2018-12-22</start-date><start-time>08:51:14</start-time><end-date>2018-12-22</end-date><end-time>08:58:16</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Asha</username><useremail>ashan@exeterpm.com</useremail><start-date>2018-12-22</start-date><start-time>08:59:25</start-time><end-date>2018-12-22</end-date><end-time>09:00:19</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Asha</username><useremail>ashan@exeterpm.com</useremail><start-date>2018-12-22</start-date><start-time>09:02:29</start-time><end-date>2018-12-22</end-date><end-time>09:08:25</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><name>Author Review</name><customer-stage-name>Author proof</customer-stage-name><start-date>2018-12-22</start-date><end-date>2018-12-31</end-date><duration>9</duration><sla-start-date>2018-12-22 09:08:49</sla-start-date><sla-end-date>2018-12-25 23:08:49</sla-end-date><planned-start-date>2018-12-22 09:08:49</planned-start-date><planned-end-date>2018-12-25 23:08:49</planned-end-date><status>completed</status><comments/><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><article-key><key live="true">https://kriya2.kriyadocs.com/review_content/?key=8e846e694f500fa895a31373e40f091fc2a17eb93b90fc73424ad063e3f4205e943f2b3d7a204010ad9175b480cf5441d920bcb7950fc0f7b67ebfde6f688fdf0d33d0f4fca4fe709b82468fdebf92916d469cc2a30e71101ac9b69cfcf1995d27932f316d5d305f4757fade0345b03111e57ce1d0f92874cd31e3e399caaabc9e</key></article-key><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Yogish C Kudva</username><useremail>kudva.yogish@mayo.edu</useremail><start-date>2018-12-26</start-date><start-time>03:53:55</start-time><end-date>2018-12-26</end-date><end-time>03:53:55</end-time><status type="system">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Yogish C Kudva</username><useremail>kudva.yogish@mayo.edu</useremail><start-date>2018-12-26</start-date><start-time>04:01:58</start-time><end-date>2018-12-26</end-date><end-time>04:01:58</end-time><status type="system">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Yogish C Kudva</username><useremail>kudva.yogish@mayo.edu</useremail><start-date>2018-12-26</start-date><start-time>16:07:02</start-time><end-date>2018-12-26</end-date><end-time>17:24:13</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Yogish C Kudva</username><useremail>kudva.yogish@mayo.edu</useremail><start-date>2018-12-31</start-date><start-time>15:49:54</start-time><end-date>2018-12-31</end-date><end-time>15:49:54</end-time><status type="user">signed-off</status></log></job-logs></stage><chaser-info id="0f49b762-5d6b-4a41-a9be-bdb55a56acbc"><chaser stage="authorreview" hour="h48">Thu Dec 27 2018 00:00:03 GMT+0000</chaser><chaser stage="authorreview" hour="h72">Fri Dec 28 2018 00:00:04 GMT+0000</chaser></chaser-info><stage><name>Publisher Review</name><customer-stage-name>Production QC</customer-stage-name><start-date>2018-12-31</start-date><end-date>2019-01-02</end-date><duration>2</duration><sla-start-date>2018-12-31 15:51:25</sla-start-date><sla-end-date>2019-01-01 15:51:25</sla-end-date><planned-start-date>2018-12-31 15:51:25</planned-start-date><planned-end-date>2019-01-01 15:51:25</planned-end-date><status>completed</status><comments/><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Nabjyoti</username><useremail>nsingh@bmj.com</useremail><start-date>2019-01-02</start-date><start-time>15:59:43</start-time><end-date>2019-01-02</end-date><end-time>15:59:43</end-time><status type="user">signed-off</status></log></job-logs></stage><stage><name>Typesetter Review</name><customer-stage-name>Corrections</customer-stage-name><start-date>2019-01-02</start-date><end-date>2019-01-04</end-date><duration>2</duration><sla-start-date>2019-01-02 16:16:41</sla-start-date><sla-end-date>2019-01-03 16:16:41</sla-end-date><planned-start-date>2019-01-02 16:16:41</planned-start-date><planned-end-date>2019-01-03 16:16:41</planned-end-date><status>completed</status><comments/><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Thilip (TYPESETTER)" role="typesetter" time="1546513421851" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="float-placement" job-id="e135cee1-a372-4cee-9819-6bf1c1f90093"/><pdf user="Thilip (TYPESETTER)" role="typesetter" time="1546513578209" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="base-alignment" job-id="2e50780c-8aab-42f3-ac0a-4b42fd15e20e"/><pdf user="Thilip (TYPESETTER)" role="typesetter" time="1546594938144" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="base-alignment" job-id="e544a6d0-fe86-4fb5-bee2-e3dc605644ef"/><pdf user="Thilip (TYPESETTER)" role="typesetter" time="1546595273706" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="base-alignment" job-id="3d10f51c-7dcb-44f3-94ec-3c4dc171bb99"/><pdf user="Thilip (TYPESETTER)" role="typesetter" time="1546597341383" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server"/><pdf user="Thilip (TYPESETTER)" role="typesetter" time="1546598119359" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="base-alignment" job-id="70bc00c8-c8fb-4b35-b098-58701e360b2f"/><pdf user="Thilip (TYPESETTER)" role="typesetter" time="1546600940959" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="base-alignment" job-id="c4bf2877-3acd-40a3-ace4-8892ddc267a3"/><pdf user="Thilip (TYPESETTER)" role="typesetter" time="1546601227241" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="base-alignment" job-id="5e5f8f98-d429-4405-9725-b9ff0d09c7ba"/><pdf user="Thilip (TYPESETTER)" role="typesetter" time="1546601527809" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="base-alignment" job-id="9375ec4b-6646-4a5b-9727-25dcae72c0f0"/></proof></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-03</start-date><start-time>06:10:40</start-time><end-date>2019-01-03</end-date><end-time>06:11:10</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Sabarianand</username><useremail>sabarianand.s@exeterpremedia.com</useremail><start-date>2019-01-03</start-date><start-time>06:23:36</start-time><end-date>2019-01-03</end-date><end-time>06:24:05</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-03</start-date><start-time>10:55:49</start-time><end-date>2019-01-03</end-date><end-time>10:58:24</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-03</start-date><start-time>10:59:06</start-time><end-date>2019-01-03</end-date><end-time>11:06:08</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-03</start-date><start-time>11:06:31</start-time><end-date>2019-01-03</end-date><end-time>11:08:54</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-03</start-date><start-time>11:10:30</start-time><end-date>2019-01-03</end-date><end-time>11:10:42</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-03</start-date><start-time>11:10:49</start-time><end-date>2019-01-03</end-date><end-time>11:11:34</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-03</start-date><start-time>11:11:37</start-time><end-date>2019-01-03</end-date><end-time>11:12:31</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-03</start-date><start-time>11:12:55</start-time><end-date>2019-01-03</end-date><end-time>11:16:02</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-03</start-date><start-time>11:16:08</start-time><end-date>2019-01-03</end-date><end-time>11:18:22</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-03</start-date><start-time>11:19:34</start-time><end-date>2019-01-03</end-date><end-time>11:23:51</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-04</start-date><start-time>09:40:16</start-time><end-date>2019-01-04</end-date><end-time>09:47:44</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-04</start-date><start-time>09:58:35</start-time><end-date>2019-01-04</end-date><end-time>10:19:29</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-04</start-date><start-time>10:20:26</start-time><end-date>2019-01-04</end-date><end-time>10:33:11</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-04</start-date><start-time>10:33:55</start-time><end-date>2019-01-04</end-date><end-time>10:42:43</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-04</start-date><start-time>10:57:42</start-time><end-date>2019-01-04</end-date><end-time>11:02:42</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-04</start-date><start-time>11:03:02</start-time><end-date>2019-01-04</end-date><end-time>11:05:27</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-04</start-date><start-time>11:06:30</start-time><end-date>2019-01-04</end-date><end-time>11:19:43</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-04</start-date><start-time>11:20:56</start-time><end-date>2019-01-04</end-date><end-time>11:27:50</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-04</start-date><start-time>11:27:54</start-time><end-date>2019-01-04</end-date><end-time>11:32:42</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Thilip</username><useremail>thilipkumar@exeterpm.com</useremail><start-date>2019-01-04</start-date><start-time>11:34:02</start-time><end-date>2019-01-04</end-date><end-time>11:34:02</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><name>Publisher Review</name><customer-stage-name>Revises</customer-stage-name><start-date>2019-01-04</start-date><end-date>2019-02-07 10:09:59</end-date><duration>123</duration><sla-start-date>2019-01-04 11:34:47</sla-start-date><sla-end-date>2019-01-07 11:34:47</sla-end-date><planned-start-date>2019-01-04 11:34:47</planned-start-date><planned-end-date>2019-01-07 11:34:47</planned-end-date><status>completed</status><comments/><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Manoj</username><useremail>mmohan@bmj.com</useremail><start-date>2019-02-07</start-date><start-time>06:35:50</start-time><end-date>2019-02-07</end-date><end-time>07:32:03</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Manoj</username><useremail>mmohan@bmj.com</useremail><start-date>2019-02-07</start-date><start-time>08:59:57</start-time><end-date>2019-02-07</end-date><end-time>09:20:17</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Manoj</username><useremail>mmohan@bmj.com</useremail><start-date>2019-02-07</start-date><start-time>09:21:11</start-time><end-date>2019-02-07</end-date><end-time>09:58:54</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Manoj</username><useremail>mmohan@bmj.com</useremail><start-date>2019-02-07</start-date><start-time>09:59:10</start-time><end-date>2019-02-07</end-date><end-time>10:09:12</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><name>Validation Check</name><customer-stage-name>Revises</customer-stage-name><start-date>2019-02-07 10:09:59</start-date><end-date>2019-02-07 10:18:44</end-date><duration>1</duration><sla-start-date>2019-02-07 10:09:59</sla-start-date><sla-end-date>2019-02-08 10:09:59</sla-end-date><planned-start-date>2019-02-07 10:09:59</planned-start-date><planned-end-date>2019-02-08 10:09:59</planned-end-date><status>completed</status><comments/><assigned><to>Asha Narayanan, ashan@exeterpm.com</to><by>Asha Narayanan, ashan@exeterpm.com</by><on>2019-02-07 10:16:28</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Asha</username><useremail>ashan@exeterpm.com</useremail><start-date>2019-02-07</start-date><start-time>10:16:41</start-time><end-date>2019-02-07</end-date><end-time>10:18:06</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Asha</username><useremail>ashan@exeterpm.com</useremail><start-date>2019-02-07</start-date><start-time>10:18:36</start-time><end-date>2019-02-07</end-date><end-time>10:18:36</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><name>Final Deliverables</name><customer-stage-name>Upload for Online First</customer-stage-name><start-date>2019-02-07 10:18:44</start-date><end-date>2019-02-13 11:07:40</end-date><duration>8</duration><sla-start-date>2019-02-07 10:18:44</sla-start-date><sla-end-date>2019-02-08 10:18:44</sla-end-date><planned-start-date>2019-02-07 10:18:44</planned-start-date><planned-end-date>2019-02-08 10:18:44</planned-end-date><status>completed</status><comments/><assigned><to>Lakshmi K, lakshmik@exeterpm.com</to><by>Lakshmi K, lakshmik@exeterpm.com</by><on>2019-02-13 10:56:52</on><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user><proof><pdf user="Sri Ganesa Balaji (TYPESETTER)" role="typesetter" time="1549604758341" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="others" description="RFO" job-id="d4e49fad-dd6c-4f26-9adc-7970c6f193ea"/><pdf user="Lakshmi (TYPESETTER)" role="typesetter" time="1550055606041" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server"/><pdf user="Lakshmi (TYPESETTER)" role="typesetter" time="1550055887873" path="http://kriya2.kriyadocs.com/resources/bmj/bmjdrc/bmjdrc-2018-000591/proofing/bmjdrc-2018-000591.pdf?method=server" reason="others" description="RFO" job-id="26f043e4-bb82-4aee-8305-319cd67f0765"/></proof></object><job-logs><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Sri Ganesa Balaji</username><useremail>sriganesabalaji.s@exeterpremedia.com</useremail><start-date>2019-02-08</start-date><start-time>05:41:10</start-time><end-date>2019-02-08</end-date><end-time>05:39:13</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Sri Ganesa Balaji</username><useremail>sriganesabalaji.s@exeterpremedia.com</useremail><start-date>2019-02-08</start-date><start-time>05:39:42</start-time><end-date>2019-02-08</end-date><end-time>05:39:42</end-time><status type="system">open</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Sri Ganesa Balaji</username><useremail>sriganesabalaji.s@exeterpremedia.com</useremail><start-date>2019-02-08</start-date><start-time>05:39:43</start-time><end-date>2019-02-08</end-date><end-time>05:41:47</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Sri Ganesa Balaji</username><useremail>sriganesabalaji.s@exeterpremedia.com</useremail><start-date>2019-02-08</start-date><start-time>05:41:54</start-time><end-date>2019-02-08</end-date><end-time>05:42:44</end-time><status type="user">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Sri Ganesa Balaji</username><useremail>sriganesabalaji.s@exeterpremedia.com</useremail><start-date>2019-02-08</start-date><start-time>05:42:44</start-time><end-date>2019-02-08</end-date><end-time>05:42:44</end-time><status type="system">logged-off</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Lakshmi</username><useremail>lakshmik@exeterpm.com</useremail><start-date>2019-02-13</start-date><start-time>10:57:01</start-time><end-date>2019-02-13</end-date><end-time>11:00:13</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Lakshmi</username><useremail>lakshmik@exeterpm.com</useremail><start-date>2019-02-13</start-date><start-time>11:01:34</start-time><end-date>2019-02-13</end-date><end-time>11:01:34</end-time><status type="system">open</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Lakshmi</username><useremail>lakshmik@exeterpm.com</useremail><start-date>2019-02-13</start-date><start-time>11:01:34</start-time><end-date>2019-02-13</end-date><end-time>11:04:15</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Lakshmi</username><useremail>lakshmik@exeterpm.com</useremail><start-date>2019-02-13</start-date><start-time>11:04:34</start-time><end-date>2019-02-13</end-date><end-time>11:04:34</end-time><status type="system">open</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Lakshmi</username><useremail>lakshmik@exeterpm.com</useremail><start-date>2019-02-13</start-date><start-time>11:04:34</start-time><end-date>2019-02-13</end-date><end-time>11:05:47</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Lakshmi</username><useremail>lakshmik@exeterpm.com</useremail><start-date>2019-02-13</start-date><start-time>11:05:57</start-time><end-date>2019-02-13</end-date><end-time>11:05:57</end-time><status type="system">open</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Lakshmi</username><useremail>lakshmik@exeterpm.com</useremail><start-date>2019-02-13</start-date><start-time>11:05:57</start-time><end-date>2019-02-13</end-date><end-time>11:07:10</end-time><status type="system">in-active</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Lakshmi</username><useremail>lakshmik@exeterpm.com</useremail><start-date>2019-02-13</start-date><start-time>11:07:33</start-time><end-date>2019-02-13</end-date><end-time>11:07:33</end-time><status type="system">open</status></log><log data-doi="bmjdrc-2018-000591" data-project="bmjdrc" data-customer="bmj"><username>Lakshmi</username><useremail>lakshmik@exeterpm.com</useremail><start-date>2019-02-13</start-date><start-time>11:07:34</start-time><end-date>2019-02-13</end-date><end-time>11:07:34</end-time><status type="system">signed-off</status></log></job-logs></stage><stage><name>Upload for Online First</name><customer-stage-name>Upload for Online First</customer-stage-name><start-date>2019-02-13 11:07:40</start-date><duration>0</duration><end-word-count>7084</end-word-count><end-word-count-without-ref>6391</end-word-count-without-ref><end-date>2019-02-14 11:16:09</end-date><sla-start-date>2019-02-13 11:07:40</sla-start-date><sla-end-date>2019-02-14 11:07:40</sla-end-date><planned-start-date>2019-02-13 11:07:40</planned-start-date><planned-end-date>2019-02-14 11:07:40</planned-end-date><status>completed</status><held-stage/><hold-state/><comments/><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object><job-logs/></stage><stage><iteration>1</iteration><start-word-count>7084</start-word-count><start-word-count-without-ref>6391</start-word-count-without-ref><name>Archive</name><customer-stage-name/><start-date>2019-02-14 11:16:09</start-date><end-date>2019-02-14 11:16:09</end-date><sla-start-date>2019-02-14 11:16:09</sla-start-date><sla-end-date>2019-02-14 11:16:09</sla-end-date><planned-start-date>2019-02-14 11:16:09</planned-start-date><planned-end-date>2019-02-14 11:16:09</planned-end-date><status>completed</status><comments/><assigned><to/><by/><on/><reason/></assigned><time-log><log><start/><end/><duration/><status type="system"/></log></time-log><error/><object><figure/><table/><box/><user><name/><id/><inserted/><deleted/></user></object></stage></workflow><production-notes><note type="workflow"><id>bf6c7bf8-c511-4be7-bcfa-6739b52a50ae</id><fullname>Workflow</fullname><created>2018-11-16 20:35:00</created><content>Job created on 2018-11-16 20:35:00</content></note><note id="f9ce73a4-3582-4f7e-8cd4-96cf436b39f8" type="workflow"><id>f9ce73a4-3582-4f7e-8cd4-96cf436b39f8</id><fullname>Workflow</fullname><created>2018-11-16 20:35:01</created><content>Article signed-off from addJob to File download</content></note><note id="fb96f800-fdb3-490f-bb8b-6cba20f688b2" type="workflow"><id>fb96f800-fdb3-490f-bb8b-6cba20f688b2</id><fullname>Workflow</fullname><created>2018-11-16 20:35:13</created><content>Article signed-off from addJob to Convert Files</content></note><note id="c03a34f9-d3ba-419c-819c-752b7d541c15" type="workflow"><id>c03a34f9-d3ba-419c-819c-752b7d541c15</id><fullname>Workflow</fullname><created>2018-11-16 20:35:28</created><content>Article signed-off from Pre-editing to Hold</content></note><note id="1b36db09-e045-495f-b3b5-56118e157102" type="email"><id>1b36db09-e045-495f-b3b5-56118e157102</id><fullname>Workflow</fullname><created>2018-11-16 20:35:29</created><content><email-content><mail-id>0b8eb772-1c8b-3299-7622-9ce6b6ad952c@exeterpremedia.com</mail-id><mail-subject>Job Notification: Article 10.1136/bmjdrc-2018-000591 loaded </mail-subject><from>bmj@exeterpremedia.com</from><to>bmj@exeterpremedia.com</to><mail-body><p>Dear typesetter</p><p>The article '<span class="article-id">10.1136/bmjdrc-2018-000591</span>' is now ready for editing.</p><p>Thank you,</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="7f08bf9c-4db7-43f4-aed7-a1ab8c7b31cd" type="workflow"><id>7f08bf9c-4db7-43f4-aed7-a1ab8c7b31cd</id><fullname>Workflow</fullname><created>2018-12-12 00:30:03</created><content>Payment and license info has been updated {"license":"CC-BY-NC","copyrightStatement":"CC-BY-NC","paymentMethod":"Rightslink","paymentStatus":"true","currentStage":"Pre-editing","holdType":"NoHold","holdStatus":"false","matchStage":"Pre-editing"}</content></note><note id="9ed29f30-50a8-475d-bd49-8fb6ba693f73" type="workflow"><id>9ed29f30-50a8-475d-bd49-8fb6ba693f73</id><fullname>Workflow</fullname><created>2018-12-12 00:30:04</created><content>Article signed-off from Hold to Pre-editing</content></note><note id="d138bc5b-2627-4763-ae10-a9a5f7c7d4d0"><id>7cfbcc51-93cf-431b-a8d6-0c915f1b016d</id><fullname>Automation</fullname><created>2018-12-12 00:30:04</created><content>License has been modified (<span class="pre">CC-BY-NC</span>) and released from <span class="pre">Hold</span></content></note><note id="8ac65063-5c2e-4324-b448-0b504acb8a21" type="workflow"><id>8ac65063-5c2e-4324-b448-0b504acb8a21</id><fullname>xml</fullname><created>2018-12-12 15:04:49</created><content>Payment and license info has been updated {"license":"CC-BY-NC","copyrightStatement":"CC-BY-NC","paymentMethod":"Rightslink","paymentStatus":"true","currentStage":"Pre-editing","holdType":"NoHold","holdStatus":"false","matchStage":"Pre-editing"}</content></note><note id="dda502aa-fb8e-435a-943f-ef4cd4440f1e"><id>fd3559a8-19fe-4943-8ae3-db1d204f19b0</id><fullname>Automation</fullname><created>2018-12-12 18:00:05</created><content>Payment has been received</content></note><note id="e9c613b1-104a-4478-b162-39a169e69e88" type="workflow"><id>e9c613b1-104a-4478-b162-39a169e69e88</id><fullname>kriyā (automation)</fullname><created>2018-12-12 18:00:06</created><content>Payment and license info has been updated {"license":"CC-BY-NC","copyrightStatement":"CC-BY-NC","paymentMethod":"Rightslink","paymentStatus":"true","currentStage":"Pre-editing","holdType":"NoHold","holdStatus":"false","matchStage":"Pre-editing"}</content></note><note id="c15c66c4-7b37-4e86-a766-76e0b8f23a0e"><id>f6c242fe-aa34-47c4-8fc5-e946f2c0ca84</id><fullname>Automation</fullname><created>2018-12-12 18:00:06</created><content>License has been modified (<span class="pre">CC-BY-NC</span>) and released from <span class="pre">Hold</span></content></note><note id="9fa58cc0-7da4-4806-b092-c3b8b295f206" type="workflow"><id>9fa58cc0-7da4-4806-b092-c3b8b295f206</id><fullname>kriyā (automation)</fullname><created>2018-12-12 18:00:06</created><content>Payment and license info has been updated {"license":"CC-BY-NC","copyrightStatement":"CC-BY-NC","paymentMethod":"Rightslink","paymentStatus":"true","currentStage":"Pre-editing","holdType":"NoHold","holdStatus":"false","matchStage":"Pre-editing"}</content></note><note id="676898ab-c2f4-4473-9ae9-394234fe9864"><id>69e75371-8aeb-4372-a844-b999ae70faeb</id><fullname>Automation</fullname><created>2018-12-12 18:00:06</created><content>License has been modified (<span class="pre">CC-BY-NC</span>) and released from <span class="pre">Hold</span></content></note><note id="551019f5-0474-4fb4-8158-c81451cceb5f" type="workflow"><id>551019f5-0474-4fb4-8158-c81451cceb5f</id><fullname>Varalakshmi A</fullname><created>2018-12-18 05:29:30</created><content>Article signed-off from Pre-editing to Support</content></note><note id="2dd81d95-48de-42af-81e7-6dc1bd6f727b" type="support"><id>2dd81d95-48de-42af-81e7-6dc1bd6f727b</id><fullname>Varalakshmi A</fullname><created>2018-12-18 05:29:29</created><content><div class="issue-data"><div class="category-info"><span class="cause">supplementary pop up box not coming.</span><span class="category">Content Related</span><span class="priority">High</span><span class="stage">Pre-editing</span></div><div class="issue-notes">To add suplementary file while apply hous style supplementary popup box not coming.kindly fix this issue.</div></div></content></note><note id="f5938c77-ec19-43ff-9439-8645d3b7bea2" type="workflow"><id>f5938c77-ec19-43ff-9439-8645d3b7bea2</id><fullname>Karthick VS</fullname><created>2018-12-18 06:15:00</created><content>Article signed-off from Support to Pre-editing</content></note><note id="fb176cc5-775e-451e-8e58-209557cc1812" type="support"><id>fb176cc5-775e-451e-8e58-209557cc1812</id><fullname>Karthick (TYPESETTER)</fullname><created>2018-12-18 06:13:09</created><content><div class="issue-data"><div class="category-info"><span class="what">Styling Issue</span><span class="who">Product</span><span class="why">Product BUG</span><span class="where">Supplementary table </span><span class="stage">Support</span></div><div class="issue-notes">Supplementary table is not came in Editor</div></div></content><parent>2dd81d95-48de-42af-81e7-6dc1bd6f727b</parent></note><note id="dcae73f9-803e-42e8-acca-312090369a10" type="workflow"><id>dcae73f9-803e-42e8-acca-312090369a10</id><fullname>Varalakshmi A</fullname><created>2018-12-19 09:06:51</created><content>Article signed-off from Pre-editing to Support</content></note><note id="a3d0e6dc-dab1-4aa1-9e12-c29956972973" type="support"><id>a3d0e6dc-dab1-4aa1-9e12-c29956972973</id><fullname>Varalakshmi (PREEDITOR)</fullname><created>2018-12-19 09:06:50</created><content><div class="issue-data"><div class="category-info"><span class="cause">PDF generation failed.</span><span class="category">Proofing</span><span class="priority">High</span><span class="stage">Pre-editing</span></div><div class="issue-notes">PDF generation failed.</div></div></content></note><note id="bf8ca107-05d8-469a-8db8-c951f6a309a0" type="workflow"><id>bf8ca107-05d8-469a-8db8-c951f6a309a0</id><fullname>Bharath B</fullname><created>2018-12-19 09:53:42</created><content>Article signed-off from Support to Pre-editing</content></note><note id="b1b8f245-60cc-4a12-9b84-b026abbfdbf1" type="support"><id>b1b8f245-60cc-4a12-9b84-b026abbfdbf1</id><fullname>Bharath (TYPESETTER)</fullname><created>2018-12-19 09:49:45</created><content><div class="issue-data"><div class="category-info"><span class="what">Table Issue</span><span class="who">People</span><span class="why">People Training</span><span class="where">table 1 extra rowspan</span><span class="stage">Support</span></div><div class="issue-notes">Fixed</div></div></content><parent>a3d0e6dc-dab1-4aa1-9e12-c29956972973</parent></note><note id="82c93226-c549-4ed9-b72b-952fc257e14c" type="workflow"><id>82c93226-c549-4ed9-b72b-952fc257e14c</id><fullname>Varalakshmi A</fullname><created>2018-12-19 11:14:09</created><content>Article signed-off from Pre-editing to Waiting for CE</content></note><note id="18fb953d-a90c-4ddf-9005-509ab503487c" type="email"><id>18fb953d-a90c-4ddf-9005-509ab503487c</id><fullname>Varalakshmi A</fullname><created>2018-12-19 11:14:14</created><content><email-content><mail-id>ff170846-cded-6b4a-4876-02369ee3b078@exeterpremedia.com</mail-id><mail-subject>Ready for Copyediting - 10.1136/bmjdrc-2018-000591</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjdrc@bmj.com</to><cc>bmj@exeterpremedia.com</cc><mail-body><p>Dear Publisher</p><p>This article is ready for copyediting. Please assign the copy editor in paw.</p><p>Thank you</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="f6f960bc-8ecb-4d5a-b42b-4cbe4ca2ebec" type="paw"><id>f6f960bc-8ecb-4d5a-b42b-4cbe4ca2ebec</id><fullname>Varalakshmi A</fullname><created>2018-12-19 11:14:20</created><content>PAW SUCCESS: Article moved from Clean up to Copy edit</content></note><note id="0a23ea3d-aa89-41c7-a010-b11b43e06116" type="workflow"><id>0a23ea3d-aa89-41c7-a010-b11b43e06116</id><fullname>Satish Raju</fullname><created>2018-12-21 06:32:27</created><content>Article signed-off from Waiting for CE to Copyediting</content></note><note id="22afb416-0840-492c-b988-24eda4b9fce8" type="email"><id>22afb416-0840-492c-b988-24eda4b9fce8</id><fullname>Satish Raju</fullname><created>2018-12-21 06:32:36</created><content><email-content><mail-id>0bf26a0d-4ccf-6063-f3b3-af4ce3ba427d@exeterpremedia.com</mail-id><mail-subject>Copyediting for 10.1136/bmjdrc-2018-000591</mail-subject><from>bmj@exeterpremedia.com</from><to>aabaquino@gmail.com</to><cc>bmj@exeterpremedia.com,production.bmjdrc@bmj.com</cc><mail-body><p>Dear Copyeditor</p><p>This article is ready for copyediting. Click the following link to access the article <a style="background: #FF5722;padding: 3px 6px;border-radius: 3px;color: #fff !important;" href="https://kriya2.kriyadocs.com/review_content/?key=8e846e694f500fa895a31373e40f091fc2a17eb93b90fc73424ad063e3f4205e943f2b3d7a204010ad9175b480cf5441d920bcb7950fc0f7b67ca5da7e6299c41c2cd7f6adf0e37392da1881dbb29f9a761496dde402704c18d0ef8bfcbd8143359332366d573c474115b1d9190ef83e1ded2485efc86c46952397ee93cda7af93">LINK</a></p><p>Kindly note, the online editing system is currently not supported on Internet Explorer. Please use <a href="https://www.google.com/chrome/">Google Chrome</a> to access the article.</p><p>Thank you</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="c76c6506-ef9c-439c-9329-2a91012dc14b" type="workflow"><id>c76c6506-ef9c-439c-9329-2a91012dc14b</id><fullname>PV-A027-Ariel</fullname><created>2018-12-22 01:50:46</created><content>Article signed-off from Copyediting to Copyediting Check</content></note><note id="1ee7fbda-aa4b-4338-ab41-6c51933dfc16" type="email"><id>1ee7fbda-aa4b-4338-ab41-6c51933dfc16</id><fullname>PV-A027-Ariel</fullname><created>2018-12-22 01:50:51</created><content><email-content><mail-id>dd137413-bf7c-f3cd-8b4e-ecefec1b199f@exeterpremedia.com</mail-id><mail-subject>Copyediting has been completed for 10.1136/bmjdrc-2018-000591</mail-subject><from>bmj@exeterpremedia.com</from><to>bmj@exeterpremedia.com</to><mail-body><p>Dear Typesetter</p><p>Copyediting has been completed for <span class="article-id">bmjdrc-2018-000591</span></p><p>Thank you,</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="eac2f7b2-e245-45f4-bdb4-d0fc96db708b" type="workflow"><id>eac2f7b2-e245-45f4-bdb4-d0fc96db708b</id><fullname>Rangarajan Govindarajan</fullname><created>2018-12-22 05:06:53</created><content>Article signed-off from Copyediting Check to Typesetter Check</content></note><note id="ba0918e3-744c-450c-881c-afd428885ceb" type="email"><id>ba0918e3-744c-450c-881c-afd428885ceb</id><fullname>Rangarajan Govindarajan</fullname><created>2018-12-22 05:07:00</created><content><email-content><mail-id>dba4996f-191c-e5a9-0843-e8569e71c6ba@exeterpremedia.com</mail-id><mail-subject>Edited files to be typeset 10.1136/bmjdrc-2018-000591</mail-subject><from>bmj@exeterpremedia.com</from><to>bmj@exeterpremedia.com</to><mail-body><p><span class="article-id">10.1136/bmjdrc-2018-000591</span></p><p>Dear Typesetter</p><p>The above article has been sent to you for typesetting.</p><p>Best wishes</p><p>Production Office</p></mail-body></email-content></content></note><note id="90373bf4-5806-4c36-9670-c994fab216b5" type="paw"><id>90373bf4-5806-4c36-9670-c994fab216b5</id><fullname>Rangarajan Govindarajan</fullname><created>2018-12-22 05:07:07</created><content>PAW SUCCESS: Article moved from Copy edit to Typeset</content></note><note id="184bb8a6-b599-4670-85a2-8f11d4b4d275" type="workflow"><id>184bb8a6-b599-4670-85a2-8f11d4b4d275</id><fullname>Asha Narayanan</fullname><created>2018-12-22 09:08:49</created><content>Article signed-off from Typesetter Check to Author Review</content></note><note id="9d0f0ad8-65ee-4d8a-a0c9-632643a06d8a" type="email"><id>9d0f0ad8-65ee-4d8a-a0c9-632643a06d8a</id><fullname>Asha Narayanan</fullname><created>2018-12-22 09:09:00</created><content><email-content><mail-id>13869d77-e078-5f88-a13f-4efbd57a797c@exeterpremedia.com</mail-id><mail-subject>Proof of your article for BMJ Open Diabetes Research &amp; Care - 10.1136/bmjdrc-2018-000591</mail-subject><from>bmj@exeterpremedia.com</from><to>kudva.yogish@mayo.edu</to><cc>bmj@exeterpremedia.com,production.bmjdrc@bmj.com</cc><mail-body><p>Dear <span class="name">Yogish C Kudva</span>,</p><p>I’m pleased to provide the proof of your article, which is available on our author proofing system here:</p><p><a style="background: #FF5722;padding: 3px 6px;border-radius: 3px;color: #fff !important;" href="https://kriya2.kriyadocs.com/review_content/?key=8e846e694f500fa895a31373e40f091fc2a17eb93b90fc73424ad063e3f4205e943f2b3d7a204010ad9175b480cf5441d920bcb7950fc0f7b67ebfde6f688fdf0d33d0f4fca4fe709b82468fdebf92916d469cc2a30e71101ac9b69cfcf1995d27932f316d5d305f4757fade0345b03111e57ce1d0f92874cd31e3e399caaabc9e">LINK</a></p><p>Please submit any corrections then ensure you click ‘Approve’ to complete the author proofing process. Signing off the paper will send the article back to the Production team so they can make any changes.</p><p>Please note, the online author proofing system cannot be used in the browser Internet Explorer. Please review your proofs in <a href="https://www.google.com/chrome/">Google Chrome</a>.</p><p>A PDF version of the proof is available to download and review, but all corrections must be submitted using the online system. Please contact us at production.bmjdrc@bmj.com if you need any help using this.</p><p>This is the only opportunity you will have to correct your article before publication, so please review it carefully. Please ensure you respond to queries listed in the article. Minor errors cannot be corrected after publication and any serious scientific errors will result in a formal correction.</p><p>Reprints: If you wish to purchase reprints of your article, please fill in the <a href="http://authors.bmj.com/wp-content/uploads/2018/10/Standard_reprint_form_2018.pdf">reprint form</a>.</p><p>Thanks in advance.</p><p><span class="journal-title">BMJ Open Diabetes Research &amp; Care</span> Production Team</p></mail-body></email-content></content></note><note id="9af981e0-56c0-4184-bd8a-f535ff26186f" type="paw"><id>9af981e0-56c0-4184-bd8a-f535ff26186f</id><fullname>Asha Narayanan</fullname><created>2018-12-22 09:09:06</created><content>PAW SUCCESS: Article moved from Typeset to Author proof</content></note><note id="b8e69193-b390-4d38-b1be-e076e713f844"><id>55934f32-6588-4489-9943-d1fce634e27e</id><fullname>Automation</fullname><created>2018-12-27 00:00:10</created><content>Author chaser sent after 48 hours</content></note><note id="3b7fde5c-69ff-453c-b772-0f7f04b074c0"><id>c4629c42-5ce4-4f96-b435-6b1af6ad8141</id><fullname>Automation</fullname><created>2018-12-28 00:00:07</created><content>Author chaser sent after 72 hours</content></note><note id="9bd94de8-db42-4669-b829-0b95617dd950" type="workflow"><id>9bd94de8-db42-4669-b829-0b95617dd950</id><fullname>Yogish C Kudva</fullname><created>2018-12-31 15:51:25</created><content>Article signed-off from Author Review to Publisher Review</content></note><note id="481610b0-c8a7-4295-8f04-af4a5df84e7f" type="email"><id>481610b0-c8a7-4295-8f04-af4a5df84e7f</id><fullname>Yogish C Kudva</fullname><created>2018-12-31 15:51:31</created><content><email-content><mail-id>ef2f24e4-a188-8e5b-6bd7-479e0088bfca@exeterpremedia.com</mail-id><mail-subject>Author corrections completed for bmjdrc-2018-000591</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjdrc@bmj.com</to><cc>bmj@exeterpremedia.com</cc><mail-body><p>Dear Publisher</p><p>The corresponding author has finished reviewing the proof, the Production Editor should now sign in to Kriya 2 and review the corrections.</p><p>Thank you,</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="236ac102-a854-47ca-97ec-fe75e6abdb31" type="paw"><id>236ac102-a854-47ca-97ec-fe75e6abdb31</id><fullname>Yogish C Kudva</fullname><created>2018-12-31 15:51:35</created><content>PAW SUCCESS: Article moved from Author proof to Production QC</content></note><note id="85ea8f7e-0c8b-4646-9393-b34fd7dbb6e3" type="workflow"><id>85ea8f7e-0c8b-4646-9393-b34fd7dbb6e3</id><fullname>Nabjyoti Singh</fullname><created>2019-01-02 16:16:41</created><content>Article signed-off from Publisher Review to Typesetter Review</content></note><note id="f240a286-9472-4876-b74b-bae91f96e12c" type="email"><id>f240a286-9472-4876-b74b-bae91f96e12c</id><fullname>Nabjyoti Singh</fullname><created>2019-01-02 16:16:47</created><content><email-content><mail-id>82cdb9f1-60c5-48e1-20e3-d2884bee3326@exeterpremedia.com</mail-id><mail-subject>10.1136/bmjdrc-2018-000591 Corrections</mail-subject><from>bmj@exeterpremedia.com</from><to>bmj@exeterpremedia.com</to><mail-body><p>Dear Typesetter</p><p>The above proof has been sent to you for correction.</p><p>Best wishes</p><p>Production Office</p></mail-body></email-content></content></note><note id="ae2cd3db-92aa-4a0e-a142-b0e9d4f5de57" type="paw"><id>ae2cd3db-92aa-4a0e-a142-b0e9d4f5de57</id><fullname>Nabjyoti Singh</fullname><created>2019-01-02 16:16:52</created><content>PAW FAILURE: Article failed to move from Production QC to Corrections</content></note><note id="32aacdf1-fb82-4569-8a8b-0a76b22a503a" type="workflow"><id>32aacdf1-fb82-4569-8a8b-0a76b22a503a</id><fullname>Thilip Kumar</fullname><created>2019-01-04 11:34:47</created><content>Article signed-off from Typesetter Review to Publisher Review</content></note><note id="f1dbb41f-a9a1-42dc-924c-bbc58d449ac8" type="email"><id>f1dbb41f-a9a1-42dc-924c-bbc58d449ac8</id><fullname>Thilip Kumar</fullname><created>2019-01-04 11:34:53</created><content><email-content><mail-id>2aed2642-6509-3f25-f17d-9b36e7c01e84@exeterpremedia.com</mail-id><mail-subject>Corrections have been completed for 10.1136/bmjdrc-2018-000591</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjdrc@bmj.com</to><mail-body><p>Dear publisher</p><p>We have incorporated all requested corrections, resolved errors and ensured that the PDF and XML are in good shape.</p><p>Thank you,</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="51eae885-0ffd-4f83-a1db-4cd2acbae635" type="paw"><id>51eae885-0ffd-4f83-a1db-4cd2acbae635</id><fullname>Thilip Kumar</fullname><created>2019-01-04 11:35:02</created><content>PAW FAILURE: Article failed to move from Corrections to Revises</content></note><note id="a841a025-beb4-4dcc-bdfd-2879a684acce" type="workflow"><id>a841a025-beb4-4dcc-bdfd-2879a684acce</id><fullname>Manoj Mohan</fullname><created>2019-02-07 10:09:59</created><content>Article signed-off from Publisher Review to Validation Check</content></note><note id="c4a663ee-59be-4f4c-899e-7fc723c86dc6" type="email"><id>c4a663ee-59be-4f4c-899e-7fc723c86dc6</id><fullname>Manoj Mohan</fullname><created>2019-02-07 10:10:14</created><content><email-content><mail-id>dd1550f1-403e-00fd-22b5-f9caffd0db96@exeterpremedia.com</mail-id><mail-subject>10.1136/bmjdrc-2018-000591: Article has been moved to validation check</mail-subject><from>bmj@exeterpremedia.com</from><to>bmj@exeterpremedia.com</to><cc>sasikala@exeterpremedia.com</cc><mail-body><p>Dear Typesetter</p><p>Article requires further changes. Please update and send back to final deliverables.</p><p>Best wishes</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="12fb92ef-e8b4-48da-bf02-8f77ada14f32"><id>12fb92ef-e8b4-48da-bf02-8f77ada14f32</id><fullname>Asha Narayanan</fullname><created>2019-02-07 10:16:32</created><content>Assigned to : Asha Narayanan, ashan@exeterpm.com</content></note><note id="94f5c588-bc0d-421c-9aef-d3f5671d0264" type="workflow"><id>94f5c588-bc0d-421c-9aef-d3f5671d0264</id><fullname>Asha Narayanan</fullname><created>2019-02-07 10:18:44</created><content>Article signed-off from Validation Check to Final Deliverables</content></note><note id="608854b4-afbb-4f02-b2f7-91ca8d97f4b6" type="email"><id>608854b4-afbb-4f02-b2f7-91ca8d97f4b6</id><fullname>Asha Narayanan</fullname><created>2019-02-07 10:18:53</created><content><email-content><mail-id>37d60eb6-a46f-d554-f100-b336072e9ca3@exeterpremedia.com</mail-id><mail-subject>Upload for Online First approved for 10.1136/bmjdrc-2018-000591</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjdrc@bmj.com</to><cc>bmj@exeterpremedia.com</cc><mail-body><p>Dear Publisher</p><p><span class="article-id">10.1136/bmjdrc-2018-000591</span> has been approved for Upload for Online First.</p><p>Best wishes</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="3bd21fe1-8b27-43b7-aaec-bfb7cf8139d8" type="paw"><id>3bd21fe1-8b27-43b7-aaec-bfb7cf8139d8</id><fullname>Asha Narayanan</fullname><created>2019-02-07 10:19:11</created><content><div class="jsonresp">PAW updated Successfully: from Revises to Upload for Online First<div class="jsondata">{"url":"http://www.publishingatwork.com/completeArticleStageTo","soapXML":"&lt;?xml version=\"1.0\" encoding=\"utf-8\"?&gt;&lt;soap:Envelope xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:soap=\"http://schemas.xmlsoap.org/soap/envelope/\"&gt;&lt;soap:Body&gt;&lt;completeArticleStageTo xmlns=\"http://www.publishingatwork.com/\"&gt;&lt;guid&gt;5F52C243-5D08-44F3-AAC3-92517D348713&lt;/guid&gt;&lt;JOURNAL_ACRONYM&gt;bmjdrc&lt;/JOURNAL_ACRONYM&gt;&lt;MANUSCRIPT_NUM&gt;bmjdrc-2018-000591&lt;/MANUSCRIPT_NUM&gt;&lt;ARTICLE_STAGE&gt;Revises&lt;/ARTICLE_STAGE&gt;&lt;NEXT_ARTICLE_STAGE&gt;Upload for Online First&lt;/NEXT_ARTICLE_STAGE&gt;&lt;/completeArticleStageTo&gt;&lt;/soap:Body&gt;&lt;/soap:Envelope&gt;","response":"&lt;?xml version=\"1.0\" encoding=\"utf-8\"?&gt;&lt;soap:Envelope xmlns:soap=\"http://schemas.xmlsoap.org/soap/envelope/\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\" xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\"&gt;&lt;soap:Body&gt;&lt;completeArticleStageToResponse xmlns=\"http://www.publishingatwork.com/\"&gt;&lt;completeArticleStageToResult&gt;true&lt;/completeArticleStageToResult&gt;&lt;/completeArticleStageToResponse&gt;&lt;/soap:Body&gt;&lt;/soap:Envelope&gt;"}</div></div></content></note><note id="ff876bcc-9a2f-4e2f-bc21-5ebbbef30bd9"><id>495a94ac-23b3-40df-b89b-361bae85e9d4</id><fullname>Automation</fullname><created>2019-02-07 10:45:02</created><content>Approved email received for this article</content></note><note id="16a1803a-7b54-40ba-8e89-01a78de3408a"><id>16a1803a-7b54-40ba-8e89-01a78de3408a</id><fullname>Sri Ganesa Balaji Srinivasan</fullname><created>2019-02-08 05:40:59</created><content>Assigned to : Sri Ganesa Balaji Srinivasan, sriganesabalaji.s@exeterpremedia.com</content></note><note id="d73c4d6d-e5ec-4bb7-8a94-9934c5774039"><id>d73c4d6d-e5ec-4bb7-8a94-9934c5774039</id><fullname>Lakshmi K</fullname><created>2019-02-13 10:56:52</created><content>Assigned to : Lakshmi K, lakshmik@exeterpm.com</content></note><note id="a751af91-259b-49f3-97a8-5df472254689" type="workflow"><id>a751af91-259b-49f3-97a8-5df472254689</id><fullname>Lakshmi K</fullname><created>2019-02-13 11:07:40</created><content>Article signed-off from Final Deliverables to Upload for Online First</content></note><note id="b6b70045-2671-4dbd-959e-38ad6faebd6b" type="email"><id>b6b70045-2671-4dbd-959e-38ad6faebd6b</id><fullname>Lakshmi K</fullname><created>2019-02-13 11:07:47</created><content><email-content><mail-id>fd188af9-3f84-6488-a1f6-d172b051928d@exeterpremedia.com</mail-id><mail-subject>10.1136/bmjdrc-2018-000591: Article has been uploaded to HighWire Express site</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjdrc@bmj.com</to><cc>bmj@exeterpremedia.com</cc><mail-body><p>Dear Publisher</p><p>We have uploaded the article on the HighWire Express site.</p><p>Best wishes</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="26306908-6d2f-4874-8780-1893168b82bc" type="paw"><id>26306908-6d2f-4874-8780-1893168b82bc</id><fullname>Workflow</fullname><created>2019-02-14 11:16:25</created><content><div class="jsonresp"><div class="note-head">PAW SUCCESS: Article moved from Upload for Online First to Article Bank</div><div class="jsondata"><pre>{ <br/><span class="key">"pawstage":</span> <span class="string">"Not processed: PAW stage and current stage"</span>, <br/><span class="key">"pawpost":</span> { <br/><span class="key">"Typesetter":</span> <span class="string">"5F52C243-5D08-44F3-AAC3-92517D348713"</span>, <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjdrc"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjdrc-2018-000591"</span>, <br/><span class="key">"ArticleStageTypeName":</span> <span class="string">"Upload for Online First"</span> }, <br/><span class="key">"pawurl":</span> <span class="string">"http://typesetter.publishingatwork.com/api/typesetter/completearticle"</span>, <br/><span class="key">"pawresponse":</span> [ { <br/><span class="key">"JournalAcronym":</span> <span class="string">"bmjdrc"</span>, <br/><span class="key">"ManuscriptNum":</span> <span class="string">"bmjdrc-2018-000591"</span>, <br/><span class="key">"ManuscriptPages":</span> <span class="number">9.5</span>, <br/><span class="key">"AuthorName":</span> <span class="string">"Dr. Yogish Kudva"</span>, <br/><span class="key">"ArticleStage":</span> <span class="string">"Upload for Online First"</span>, <br/><span class="key">"Started":</span> <span class="string">"2019-02-07T00:00:00"</span>, <br/><span class="key">"Due":</span> <span class="null">null</span>, <br/><span class="key">"Ended":</span> <span class="string">"2019-02-14T11:16:00"</span> } ] }</pre></div></div></content></note><note id="cb43c872-623c-421d-bd4a-842ee6c111be" type="email"><id>cb43c872-623c-421d-bd4a-842ee6c111be</id><fullname>Workflow</fullname><created>2019-02-14 11:16:28</created><content><email-content><mail-id>e38a5bea-6b1a-8d6c-9589-91dcf21a1f2a@exeterpremedia.com</mail-id><mail-subject>10.1136/bmjdrc-2018-000591: Article has been moved to Archive</mail-subject><from>bmj@exeterpremedia.com</from><to>production.bmjdrc@bmj.com</to><mail-body><p>Dear Publisher</p><p>The uploaded article has been moved to Archive.</p><p>Best wishes</p><p style="font-size:10.0pt;">kriyā@BMJ</p></mail-body></email-content></content></note><note id="eda06b0b-3bf2-4b8d-a1f3-554f0fa2d612" type="workflow"><id>eda06b0b-3bf2-4b8d-a1f3-554f0fa2d612</id><fullname>Workflow</fullname><created>2019-02-14 11:16:09</created><content>Article signed-off from Upload for Online First to Archive</content></note><note id="40f0be86-ae3b-4efd-baac-911b01eb5466"><id>736ae6be-7e38-4679-a956-0465dd3bbf37</id><fullname>Automation</fullname><created>2019-02-14 11:15:37</created><content>Published</content></note></production-notes></article>